<SEC-DOCUMENT>0001178913-15-001193.txt : 20150403
<SEC-HEADER>0001178913-15-001193.hdr.sgml : 20150403
<ACCEPTANCE-DATETIME>20150403080005
ACCESSION NUMBER:		0001178913-15-001193
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20150228
FILED AS OF DATE:		20150403
DATE AS OF CHANGE:		20150403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORAMED PHARMACEUTICALS INC.
		CENTRAL INDEX KEY:			0001176309
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				980376008
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35813
		FILM NUMBER:		15750193

	BUSINESS ADDRESS:	
		STREET 1:		HI-TECH PARK 2/4 GIVAT-RAM
		STREET 2:		PO BOX 39098
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			91390
		BUSINESS PHONE:		011 972-2-566-0001

	MAIL ADDRESS:	
		STREET 1:		HI-TECH PARK 2/4 GIVAT-RAM
		STREET 2:		PO BOX 39098
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			91390

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integrated Security Technologies, Inc.
		DATE OF NAME CHANGE:	20040614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IGUANA VENTURES LTD
		DATE OF NAME CHANGE:	20020625
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>zk1516524.htm
<DESCRIPTION>10-Q
<TEXT>
<html>
<head>
    <title>zk1516524.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, D.C. 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">FORM 10-Q</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline;" face="Wingdings">x</font> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">For the quarterly period ended February 28, 2015</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Commission file number: 000-50298</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 16pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact Name of Registrant as Specified in Its Charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>
</td>
<td valign="bottom" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">98-0376008</font></div>
</td>
</tr><tr>
<td valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or Other Jurisdiction of Incorporation or Organization)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
</td>
<td valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr><tr>
<td valign="bottom" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Hi-Tech Park 2/4 Givat Ram</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PO Box 39098</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Jerusalem, Israel</font></div>
</td>
<td valign="bottom" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">91390</font></div>
</td>
</tr><tr>
<td valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of Principal Executive Offices)</font></div>
</td>
<td valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Zip Code)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">+ 972-2-566-0001</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Registrant&#8217;s Telephone Number, Including Area Code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Yes <font style="DISPLAY: inline;" face="Wingdings">x</font>&#160;&#160;&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;No <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Yes&#160;<font style="DISPLAY: inline;" face="Wingdings">x</font>&#160;&#160;&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;No <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Large accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Non-accelerated filer&#160;<font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> (Do not check if a smaller reporting company)</font></div>
</td>
<td align="left" valign="top" width="45%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Smaller reporting company <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Yes <font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;&#160;&#160;<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;No <font style="DISPLAY: inline;" face="Wingdings">x</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of March 31, 2015, there were 10,823,943 shares of the issuer&#8217;s common stock, $0.012 par value per share, outstanding.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FORM 10-Q</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TABLE OF CONTENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="1" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#part1"><!--efplaceholder--><font style="DISPLAY: inline">PART I &#8211; FINANCIAL INFORMATION</font></a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#item1"><!--efplaceholder--><font style="DISPLAY: inline">ITEM 1 - FINANCIAL STATEMENTS</font></a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#item2"><!--efplaceholder--><font style="DISPLAY: inline">ITEM 2 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#item3"><!--efplaceholder--><font style="DISPLAY: inline">ITEM 3 &#8211; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</font></a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#item4"><!--efplaceholder--><font style="DISPLAY: inline">ITEM 4 - CONTROLS AND PROCEDURES</font></a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><!--efplaceholder--><font style="DISPLAY: inline"><a href="#1111">PART II - OTHER INFORMATION</a></font></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: bold"><font style="FONT-WEIGHT: bold">&#160;&#160; <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><!--efplaceholder--><font style="DISPLAY: inline; FONT-WEIGHT: normal"><a href="#6666">ITEM 5 -</a></font><font style="FONT-WEIGHT: normal">&#160;</font><a name="1111" href="#6666"><!--efplaceholder--><font style="FONT-WEIGHT: normal">OTHER</font></a><font style="FONT-WEIGHT: normal">&#160;<a href="#6666">INFORMATION</a></font></font></font></font></font></font></font></font></font></td>
<td align="right" valign="top" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#item62"><!--efplaceholder--><font style="DISPLAY: inline">ITEM 6 - EXHIBITS</font></a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As used in this Quarterly Report on Form 10-Q, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;Company&#8221; mean Oramed Pharmaceuticals Inc. and our wholly-owned Israeli subsidiary, Oramed Ltd., unless otherwise indicated.&#160;&#160;All dollar amounts refer to U.S. Dollars unless otherwise indicated.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 28, 2015, the exchange rate between the New Israeli Shekel, or NIS, and the dollar, as quoted by the Bank of Israel, was NIS 3.966 to $1.00. Unless indicated otherwise by the context, statements in this Quarterly Report on Form 10-Q that provide the dollar equivalent of NIS amounts or provide the NIS equivalent of dollar amounts are based on such exchange rate.</font></div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;- i -</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="part1"><!--EFPlaceholder--></a>PART I &#8211; FINANCIAL INFORMATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 1 - FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AS OF&#160;FEBRUARY 28, 2015</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">1&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font><br>
</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AS OF&#160;FEBRUARY 28, 2015</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">TABLE OF CONTENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="74%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Page</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="74%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:</font></div>
</td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="74%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.2pt"></font><a href="#f2">Balance sheets</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="74%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.2pt"></font><a href="#f3">Statements of comprehensive loss</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-3</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="74%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.2pt"></font><a href="#f4">Statements of changes in stockholders&#8217; equity</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-4</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="74%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.2pt"></font><a href="#f5">Statements of cash flows</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-5</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="74%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 14.2pt"></font><a href="#f6">Notes to financial statements</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-6-F-14</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED P<a name="f2">HA</a>RMACEUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;(UNAUDITED)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">U.S. Dollars in thousands (except share and per share data)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">February 28,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">August 31,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font></div>
</td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT ASSETS:</font></div>
</td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,102</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,762</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Short term deposits</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,351</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,481</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">695</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,047</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Restricted cash</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Prepaid expenses and other current assets</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Related parties</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">330</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Grants receivable from the chief scientist</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 39.7pt"></font>&#160; Total&#160;current assets</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,295</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,778</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LONG TERM DEPOSITS AND INVESTMENT</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,665</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">AMOUNTS FUNDED IN RESPECT OF EMPLOYEE RIGHTS UPON RETIREMENT</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PROPERTY AND EQUIPMENT, NET</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total&#160;assets</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,802</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liabilities and stockholders' equity</font></div>
</td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT LIABILITIES:</font></div>
</td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts payable and accrued expenses</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">926</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Related parties</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total&#160;current liabilities</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">973</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LONG TERM LIABILITIES:</font></div>
</td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;&#160;&#160; Employee rights upon retirement</font></font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160; Provision for uncertain tax position</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">COMMITMENTS </font>(note 2)</font></div>
</td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STOCKHOLDERS' EQUITY:</font></div>
</td>
<td valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160; Common stock, $ 0.012 par value (30,000,000 authorized shares; 10,820,193 and 10,102,555 shares issued and outstanding as of February 28, 2015 and August 31, 2014, respectively)</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional paid-in capital</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48,040</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated other comprehensive income</font></div>
</td>
<td align="right" valign="bottom" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">452</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated loss</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(31,353</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,820</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total&#160;stockholders' equity</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,339</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,793</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total&#160;liabilities and stockholders' equity</font></div>
</td>
<td valign="bottom" width="13%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,802</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of the condensed consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PH<a name="f3">AR</a>MACEUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(UNAUDITED)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">U.S. Dollars in thousands (except share and per share data)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six months ended</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three months ended</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">February 28,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">February 28,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">February 28,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">February 28,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">RESEARCH AND DEVELOPMENT EXPENSES, NET</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,438</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,424</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,136</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">674</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GENERAL AND ADMINISTRATIVE EXPENSES</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,138</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">930</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">538</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">512</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OPERATING LOSS</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,576</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,354</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,674</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,186</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FINANCIAL INCOME</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(65</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(120</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(38</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(74</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">FINANCIAL EXPENSES</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NET LOSS FOR THE PERIOD</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,239</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,637</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,115</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SUBSEQUENT DECREASE (INCREASE) IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">RECLASSIFICATION ADJUSTMENT TO FINANCIAL INCOME&#160;OF GAINS </font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160; ON AVAILABLE-FOR-SALE SECURITIES</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNREALIZED LOSS (GAIN) ON AVAILABLE FOR SALE SECURITIES</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">343</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL OTHER COMPREHENSIVE LOSS (INCOME)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">352</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(544</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(513</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">TOTAL COMPREHENSIVE LOSS FOR THE PERIOD</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,885</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,695</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,630</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">602</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">LOSS PER COMMON SHARE</font>:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BASIC AND DILUTED LOSS PER COMMON SHARE</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.34</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER COMMON STOCK</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,482,190</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,531,150</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,826,146</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,127,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of the condensed consolidated financial statements.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARM<a name="f4">AC</a>EUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(UNAUDITED)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">U.S. Dollars in thousands (except for share data)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Additional</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">other</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">paid-in</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">comprehensive</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">stockholders'</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">&#160;</td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold">$</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">capital</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">income</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">loss</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">equity</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">In thousands</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BALANCE AS OF AUGUST 31, 2014</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,103</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48,040</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">452</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,820</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,79<font style="DISPLAY: inline; FONT-SIZE: 10pt">3</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#160;&#160; SHARES ISSUED FOR CASH, NET</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">696</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,825</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,833</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SHARES ISSUED FOR&#160;&#160;SERVICES</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXERCISE OF OPTIONS</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STOCK BASED COMPENSATION</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NET LOSS</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OTHER COMPREHENSIVE LOSS</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(352</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(352</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BALANCE AS OF FEBRUARY 28, 2015</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,820</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(31,353</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,339</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">&#160;</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Represents an amount of less than $1.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of the condensed consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMA<a name="f5">CE</a>UTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CONDENSED<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>CONSOLIDATED<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#160;</font>STATEMENTS OF CASH FLOWS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(UNAUDITED)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">U.S. dollars in thousands</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="96%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Six months ended</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">February 28,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">February 28,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2015</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH FLOWS FROM OPERATING ACTIVITIES:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Net loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,239</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments required to reconcile net loss to net cash used in operating activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation and amortization</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exchange differences and interest on deposits</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(33</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">333</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Common stock issued for services</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain on sale of investment</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;Changes in operating assets and liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Prepaid expenses, other current assets and related parties</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">341</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(167</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Accounts payable, accrued expenses and related parties</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(368</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(148</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Liability for employee rights upon retirement</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total net cash used in operating activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,003</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,230</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH FLOWS FROM INVESTING ACTIVITIES:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of property and equipment</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of short term deposits</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,573</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(18,600</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of long term deposits</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,652</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of short term deposits</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,236</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of marketable securities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Funds in respect of employee rights upon retirement</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total net cash used in investing activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,477</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13,294</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH FLOWS FROM FINANCING ACTIVITIES:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from issuance of common stock - net of issuance expenses*</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,833</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,887</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Proceeds from exercise of warrants and options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Proceeds from shares to be issued for exercise of warrants</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">118</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -27pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 22.6pt"></font>&#160;&#160;&#160;&#160;&#160; Net cash derived from financing activities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,841</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EFFECT OF EXCHANGE RATE CHANGES ON CASH</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(660</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">981</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,762</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,272</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH AND CASH EQUIVALENTS AT END OF PERIOD</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,102</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,253</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See note 5.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The accompanying notes are an integral part of the condensed consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">O<a name="f6">RA</a>MED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(UNAUDITED)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">U.S. Dollars in thousands (except share and per share data)</font></font></div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES:</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">a.</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">General:</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1)</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Incorporation and operations</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Oramed Pharmaceuticals Inc. (the &#8220;Company&#8221;) was incorporated on April 12, 2002, under the laws of the State of Nevada. On February 17, 2006, the Company entered into an agreement with Hadasit Medical Services and Development Ltd (&#8220;Hadasit&#8221;) to acquire the provisional patent related to an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 11, 2011, the Company was reincorporated from the State of Nevada to the State of Delaware.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 14, 2007, the Company incorporated a wholly-owned subsidiary in Israel, Oramed Ltd. (the &#8220;Subsidiary&#8221;), which is engaged in research and development. Unless the context indicates otherwise, the term &#8220;Group&#8221; refers to Oramed Pharmaceuticals Inc. and the Subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Following the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2014-10, Development Stage Entities (Topic 915), the Company removed the inception to date information and all reference to development.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Development and liquidity risks</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Group is engaged in research and development in the biotechnology field for innovative pharmaceutical solutions, including an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules for delivery of other polypeptides, and has not generated any revenues from its operations. Continued operation of the Company is contingent upon obtaining sufficient funding until it becomes profitable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Successful completion of the Company&#8217;s development programs and its transition to normal operations is dependent upon obtaining necessary regulatory approvals from the U.S. Food and Drug Administration (&#8220;FDA&#8221;) prior to selling its products within the United States, and foreign regulatory approvals must be obtained to sell its products internationally. There can be no assurance that the Company will receive regulatory approval of any of its product candidates, and a substantial amount of time may pass before the Company achieves a level of revenues adequate to support its operations, if at all. The Company also expects to incur substantial expenditures in connection with the regulatory approval process for each of its product candidates during their respective developmental periods. Obtaining marketing approval will be directly dependent on the Company&#8217;s ability to implement the necessary regulatory steps required to obtain marketing approval in the United States and in other countries. The Company cannot predict the outcome of these activities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(UNAUDITED)</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">U.S. Dollars in thousands (except share and per share data)</font></font></font></div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES </font>(continued):</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 81pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on its current cash resources and commitments, and cash received in private and public offerings in the six month period ended February 28, 2015 and in the year ended August 31, 2014, the Company believes it will be able to maintain its current planned development activities and the corresponding level of expenditures for at least the next 12 months and beyond the date that the financial statements are issued, although no assurance can be given that it will not need additional funds prior to such time. If there are unexpected increases in general and administrative expenses or research and development expenses, the Company may need to seek additional financing during the next 12 months.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Newly issued and recently adopted Accounting Pronouncements</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In August 2014, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, Presentation of Financial Statements-Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern (&#8220;ASU 2014-15&#8221;). This new standard requires management to assess the entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). ASU 2014-15 will be effective prospectively for annual reporting periods ending after the first annual period ending after December 15, 2016 and interim periods therein. Early application of the standard is permitted for any annual reporting period or interim period for which the entity&#8217;s financial statements have not yet been issued. The Company has elected to early adopt the provisions of ASU 2014-15 in fiscal year 2014. The adoption of ASU 2014-15 did not have any material effect on the consolidated financial statement presentation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(UNAUDITED)</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">U.S. Dollars in thousands (except share and per share data)</font></font></font></div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES </font>(continued):</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Condensed Consolidated Financial Statements Preparation</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The condensed consolidated financial statements included herein have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") and on the same basis as the audited consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended August&#160;31, 2014 (the &#8220;2014 Form 10-K&#8221;). These condensed consolidated financial statements reflect all adjustments that are of a normal recurring nature and that are considered necessary for a fair statement of the results of the periods presented. Certain information and disclosures normally included in annual consolidated financial statements have been omitted in this interim period report pursuant to the rules and regulations of the Securities and Exchange Commission. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by U.S. GAAP for annual financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in the 2014 Form 10-K. The results for interim periods are not necessarily indicative of a full fiscal year&#8217;s results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2 - <font style="DISPLAY: inline; FONT-SIZE: 10pt">COMMITMENTS:</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">On </font>September 11, 2011, the Subsidiary entered into an agreement with Hadasit, the Company's Medical and Chief Technology Officer (the &#8220;CTO&#8221;) and Dr. Daniel Schurr <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subsidiary&#160;</font>(the &#8220;Hadasit Agreement&#8221;) to retain consulting and clinical trial services. According to the Hadasit Agreement, Hadasit will be entitled to a consideration of $200 to be paid by the&#160;Subsidiary in accordance with the actual progress of the studies, $95 of which were recognized through February 28, 2015. See also note 1a(1).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 15, 2011, the Subsidiary entered into a consulting agreement with a third party (the &#8220;Consultant&#8221;) for a period of five years, pursuant to which the Consultant will provide consultation on scientific and clinical matters. The Consultant is entitled to a fixed monthly fee of $8, royalties of 8% of the net royalties actually received by the Subsidiary in respect of the patent that was sold to Entera Bio Ltd. (&#8220;Entera&#8221;) on March 31, 2011 and an option to purchase up to 20,834 shares of the Company at an exercise price of $6.00 per share. The option vests in five annual installments commencing February 16, 2012 and expires on February 16, 2021. The fair value of the option as of February 28, 2015 was $105, using the following assumptions: dividend yield of 0%; expected term of 5.97 years; expected volatility of 79.74%; and risk-free interest rate of 1.86%. The fair value of the unvested options is remeasured at each balance sheet reporting date and is recognized over the related service period using the straight-line method.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(UNAUDITED)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">U.S. Dollars in thousands (except share and per share data)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 2 - COMMITMENTS </font>(continued):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 28, 2013, the Subsidiary entered into a new lease agreement for its office facilities in Israel, which replaced the lease agreement from 2012. The new lease agreement is for a period of 36 months commencing November 4, 2013. The annual lease payment is NIS 89,000 from 2014 through 2016, and will be linked to the increase in the Israeli consumer price index (&#8220;CPI&#8221;) (as of February 28, 2015, the future annual lease payments under the new agreement will be $22, based on the exchange rate as of February 28, 2015).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 2.45pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As security for its obligation under this lease agreement the Company provided a bank guarantee in an amount equal to three monthly lease payments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 13, 2014, the Company entered into a consulting agreement with a third party advisor for a period of twelve months, pursuant to which the advisor will provide investor relations services and will be entitled to receive a monthly cash fee and 15,000 shares of the Company&#8217;s common stock that will be issued in four equal installments, on<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: normal">or about</font> </font></font>each of August 1, 2014, November 1, 2014, February 1, 2015 and May 1, 2015. As of February 28, 2015, the Company issued to such advisor 7,500 shares. The aggregate fair value of the shares at the dates of the grant was $64.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 6, 2014, the Subsidiary entered into a second agreement with a clinical research organization (&#8220;CRO&#8221;), for its Phase IIa clinical trial for an oral insulin capsule for type 1 diabetes patients, which was completed in October 2014. As consideration for its services, the Subsidiary paid the CRO a total amount of approximately $280 during the term of the engagement and based on achievement of certain milestones, all of which were recognized through February 28, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 22, 2014, the Subsidiary entered into a third agreement with the same CRO, for its Phase IIb clinical trial for an oral insulin capsule for type 2 diabetes patients, which is expected to begin in the second quarter of calendar year 2015. As consideration for its services, the Subsidiary will pay the CRO a total amount of approximately<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>$3,290 during the term of the engagement and based on achievement of certain milestones, $761 of which were recognized through February 28, 2015.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On March 3, 2014, the Subsidiary entered into an additional agreement with a vendor, for the process development and production of one of its oral capsule ingredients in the amount of $311, $40 of which were recognized through February 28, 2015, and bonus payments of up to $600 that will be paid upon achieving certain milestones, as described in the agreement and which were not recognized through February 28, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 15, 2014, the Subsidiary entered into an additional agreement with the same vendor, for the process development and production of the same capsule ingredients in the amount of $217, all of which was recognized through February 28, 2015.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 12, 2014, the Subsidiary entered into an additional agreement with the same vendor, for the process development and production of the same capsule ingredients in the amount of $550, $202 of which was recognized through February 28, 2015.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(UNAUDITED)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">U.S. Dollars in thousands (except share and per share data)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 72pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 2 - COMMITMENTS </font>(continued):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: -0.05pt" align="left">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">g.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 26, 2014, the Subsidiary entered into a supply agreement with another vendor, according to which the vendor will manufacture capsules for total consideration of $214, $174 of which was recognized through February 28, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">h.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 2, 2015, the Subsidiary entered into an agreement with a different CRO, for a glucose clamp clinical study for its oral insulin capsule. As consideration for its services, the Subsidiary will pay the CRO a total amount of approximately<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>$276 during the term of the engagement and based on achievement of certain milestones, none of which&#160;was recognized through February 28, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i.&#160;</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On January 20, 2015, the Subsidiary entered into a purchase order for the manufacturing of insulin capsules for total consideration of Swiss Franc (&#8220;CHF&#8221;) 211 (approximately $241) of which CHF 104 (approximately $118) was recognized through February 28, 2015.</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">j.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Grants from Bio-Jerusalem</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary is committed to pay royalties to the Bio-Jerusalem fund on proceeds from future sales at a rate of 4% and up to 100% of the amount of the grant received by the Company (Israeli CPI linked) at the total amount of $65. As of February 28, 2015, the Subsidiary had not yet realized any revenues and did not incur any royalty liability.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the six month period ended February 28, 2015, the Company received no grants from the Bio-Jerusalem fund.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 26pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">k.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Grants from the Office of the Chief Scientist of the Ministry of Economy (formerly the Ministry of Industry, Trade and Labor) of Israel (&#8220;OCS&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the Company&#8217;s funding from the OCS, royalties of 3%-3.5% are payable on sales of products developed from a project so funded, up to 100% of the amount of the grant received by the Company (dollar linked) with the addition of annual interest at a rate based on LIBOR.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At the time the grants were received, successful development of the related projects was not assured. In case of failure of a project that was partly financed as above, the Company is not obligated to pay any such royalties.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of February 28, 2015, the Subsidiary had not yet realized any revenues from said projects and did not incur any royalty liability. The total amount that was actually received through February 28, 2015 was $2,160.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">j.</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the six and three month periods ended February 28, 2015, the research and development expenses are presented net of OCS and Bio-Jerusalem fund grants, in the total amount of $17 and $1, respectively.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(UNAUDITED)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">U.S. Dollars in thousands (except share and per share data)</font></font></div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3 - FAIR VALUE:</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">&#160;</td>
<td align="right" style="WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1: </font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">&#160;</td>
<td align="right" style="WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2:</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Observable prices that are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">&#160;</td>
<td align="right" style="WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3:</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of February 28, 2015, the assets or liabilities measured at fair value were comprised of available for sale securities (Level 1). See also note 4.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of February 28, 2015, the carrying amount of cash and cash equivalents, short term deposits, other current assets, accounts payables and accrued expenses approximates their fair values due to the short-term maturities of these instruments<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The fair value of long-term deposits also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. The long-term bank deposits bear an annual interest rate of 0.93%-1.00% and will mature during the third quarter of fiscal year 2016. The amounts funded in respect of employee rights are stated at cash surrender value which approximates its fair value.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 4 - MARKETABLE SECURITIES:</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Available-for-sale securities are reported at fair value, with unrealized gains and losses recorded as a separate component of other comprehensive income in equity until realized. Unrealized losses that are considered to be other-than-temporary are charged to statement of operations as an impairment charge and are included in the consolidated statement of operations under impairment of available-for-sale securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company considers available evidence in evaluating potential impairments of its investments, including the duration and extent to which fair value is less than cost, and the Company&#8217;s ability and intent to hold the investment. Realized gains and losses on sales of the securities are included in the consolidated statement of operations as financial income or expenses.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of February 28, 2015, marketable securities consisted wholly of equity securities of D.N.A Biomedical Solutions Ltd ("D.N.A"). D.N.A&#8217;s ordinary shares are traded on the Tel Aviv Stock Exchange and have a quoted price. The fair value of those securities is measured at the quoted prices of the securities on the measurement date.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(UNAUDITED)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">U.S. Dollars in thousands (except share and per share data)</font></font></div>
</div>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 4 - MARKETABLE SECURITIES </font>(continued)<font style="DISPLAY: inline; FONT-WEIGHT: bold">:</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the six month period ended February 28, 2014, the Subsidiary sold in aggregate 1,625,989 of the D.N.A ordinary shares for total consideration of $80. During the six month period ended February 28, 2015, the Group did not sell any of the D.N.A ordinary shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of February 28, 2015, the Group owns approximately 9.8% of D.N.A&#8217;s outstanding ordinary shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The cost of the securities as of February 28, 2015 and August 31, 2014 is $595.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The cost of the securities sold and the amount reclassified out of accumulated other comprehensive income into financial income (amounting to $0 and $44 during the six month periods ended February 28, 2015 and 2014, respectively, and to $0 and $26 during the three month periods ended February 28, 2015 and 2014, respectively) were determined by specific identification.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 5 - STOCK HOLDERS&#8217; EQUITY:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: -0.05pt" align="left">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 3, 2014, the Company entered into a Stock Purchase Agreement with Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (the &#8220;Investor&#8221;), pursuant to which the Company issued to the Investor an aggregate of&#160;696,378 shares of common stock, at a price of $7.18 per share, which was equal to the closing price of the Company&#8217;s common stock on the Nasdaq Capital Market on October 31, 2014, for aggregate gross proceeds of approximately $5,000.&#160;&#160;The net proceeds to the Company from the offering were approximately $4,833, after deducting a finder's fee of $150 and other offering expenses of the Company. The offering closed on November 28, 2014.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See also note 8 with respect to an at market issuance sales agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 6 - STOCK BASED COMPENSATION:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 13, 2014, the Company granted a total of 19,576 restricted stock units (&#8220;RSUs&#8221;) representing a right to receive shares of the Company&#8217;s common stock to the Company&#8217;s Chief Executive Officer and director (the &#8220;CEO&#8221;), and the CTO, both related parties. The RSUs vested in two equal installments, each of 9,788 shares, on November 30 and December 31, 2014. The total fair value of these RSUs on the date of grant was $135, using the quoted closing market share price of $6.90 on the Nasdaq Capital Market on the date of grant. The shares of common stock underlying the RSUs will be issued upon request of the grantee. </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of February 28, 2015, a total of 19,576 RSUs were vested and outstanding.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 13, 2014, the Company granted a total of 10,872 RSUs representing a right to receive shares of the Company&#8217;s common stock to four members of the Company's Board of Directors. The RSUs vested on January 1, 2015. The total fair value of these RSUs on the date of grant was $75, using the quoted closing market share price of $6.90 on the Nasdaq Capital Market on the date of grant.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(UNAUDITED)</font></font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">U.S. Dollars in thousands (except share and per share data)</font></font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 6 - STOCK BASED COMPENSATION </font>(continued)<font style="DISPLAY: inline; FONT-WEIGHT: bold">:</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 23, 2015, the Company granted a total of 159,696 RSUs representing a right to receive shares of the Company&#8217;s common stock to the Company&#8217;s CEO and the CTO, both related parties. The RSUs vest in 23 installments consisting of one installment of 13,308 shares on February 28, 2015 and 22 equal monthly installments of 6,654 shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $728, using the quoted closing market share price of $4.56 on the Nasdaq Capital Market on the date of grant. The shares of common stock underlying the RSUs will be issued upon request of the grantee. As of February 28, 2015, a total of 13,308 RSUs were vested and outstanding.</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 23, 2015, the Company granted a total of 88,712 RSUs representing a right to receive shares of the Company&#8217;s common stock to four members of the Company's Board of Directors (22,178 RSUs to each director). The RSUs vest in two equal installments, each of 44,356 shares, on December 31, 2015 and December 31, 2016. The total fair value of these RSUs on the date of grant was $405, using the quoted closing market share price of $4.56 on the Nasdaq Capital Market on the date of grant.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.&#160;</font></div>
</td>
<td style="TEXT-ALIGN: justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 23, 2015, the Company granted a total of 46,560 RSUs to an employee of the Subsidiary. The RSUs vest in 23 installments, consisting of one installment of 3,880 shares on February 28, 2015 and 22 equal monthly installments of 1,940 shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $212, using the quoted closing market share price of $4.56 on the Nasdaq Capital Market on the date of grant.</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">&#160;</td>
<td align="right" style="WIDTH: 27pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">f.&#160;</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On February 23, 2015, the Company granted a total of 16,656 RSUs to employees of the Subsidiary. The RSUs vest in 23 installments, consisting of one installment of 1,388 shares on February 28, 2015 and 22 equal monthly installments of 694 shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $76, using the quoted closing market share price of $4.56 on the Nasdaq Capital Market on the date of grant.</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 7 - RELATED PARTIES &#8211; TRANSACTIONS:</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 1, 2008, the Subsidiary entered into two consulting agreements with KNRY Ltd. (&#8220;KNRY&#8221;), an Israeli company owned by the CEO, whereby the CEO and the CTO, through KNRY, provide services to the Group (the &#8220;Consulting Agreements&#8221;). The Consulting Agreements are both terminable by either party upon 60 days prior written notice. The Consulting Agreements provide that KNRY (i) will be paid a gross amount of NIS 50,400 per month for each of the CEO and CTO ($14) and (ii) will be reimbursed for reasonable expenses incurred in connection with performance of the Consulting Agreements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F-13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS Inc.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;(A development stage company)</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 20.15pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(UNAUDITED)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">U.S. Dollars in thousands (except share and per share data)</font></font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 7 - RELATED PARTIES &#8211; TRANSACTIONS </font>(continued):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 17, 2013, the Subsidiary entered into amendments to the Consulting Agreements with KNRY, according to which, the CEO's and CTO's annual payment was set at $250 and $200, respectively, calculated at an exchange rate of NIS 3.6 per U.S. dollar, and in addition to such payment they were granted the use of a company car and certain cash bonus payments, effective July 1, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 13, 2014, the Subsidiary entered into an amendment to the Consulting Agreements (the &#8220;Amendment Agreement&#8221;), according to which, the CEO and the CTO made some representations with regards to their relationship with KNRY and agreed to indemnify the Subsidiary in certain circumstances as defined in the amendment, among other revisions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE 8 &#8211; SUBSEQUENT EVEN</font>T</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On April 2, 2015, the Company entered into an at market issuance sales agreement (the &#8220;Sales Agreement&#8221;) with MLV &amp; Co. LLC (&#8220;MLV&#8221;) pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $25 million from time to time, at its option, through MLV as its sales agent, subject to certain terms and conditions. Any shares sold will be sold pursuant to the Company&#8217;s effective shelf registration statement on Form S-3 (Registration No. 333-193557), including a prospectus dated April 10, 2014, as supplemented by a prospectus supplement dated April 2, 2015.&#160; The Company will pay MLV a commission of 3.0% of the gross proceeds of the sale of any shares sold through MLV. To date, no shares have been sold under the Sales Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">F-14</font></div>
</div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="item2"><!--EFPlaceholder--></a>ITEM 2 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the related notes included elsewhere herein and in our consolidated financial statements, accompanying notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; contained in our Annual Report (as defined below).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Forward-Looking Statements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This Quarterly Report on Form 10-Q (including the section regarding Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, regarding our business, clinical trials, financial condition, expenditures, results of operations and prospects. Words such as &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;planned expenditures,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates&#8221; and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this Quarterly Report on Form 10-Q.&#160;&#160;Additionally, statements concerning future matters are forward-looking statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Although forward-looking statements in this Quarterly<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>Report on Form 10-Q reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading &#8220;Item 1A.&#160;&#160;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended August 31, 2014, or our Annual Report, as filed with the Securities and Exchange Commission, or the SEC, on November 14, 2014, as well as those discussed elsewhere in our Annual Report and in this Quarterly<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>Report on Form 10-Q.&#160;&#160;Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>Report on Form 10-Q. Except as required by law, we undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report on Form 10-Q. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this Quarterly<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>Report on Form 10-Q which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Overview of Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a pharmaceutical company currently engaged in the research and development of innovative pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent business developments</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Product Candidates</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In September 2013, we submitted a pre-Investigational New Drug, or pre-IND, package to the U.S. Food and Drug Administration, or FDA, for ORMD-0901, our oral exenatide capsule, for a Phase 2 clinical trial on healthy volunteers and type 2 diabetic patients.&#160;&#160;We began pre-clinical studies in November 2014 and expect to begin non-U.S. based Phase Ib trials and IND-enabling studies in the second quarter of calendar year 2015.&#160;&#160;We then intend to then file an IND and move immediately and directly into a large Phase II multi-center trial in the U.S.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We originally filed an IND with the FDA in December 2012 for clearance to begin a Phase II clinical trial of ORMD-0801, in order to evaluate the safety, tolerability and efficacy of our oral insulin capsule on type 2 diabetic volunteers. Because the identical formulation of ORMD-0801 had not yet been studied in humans at bedtime, in February 2013 the FDA noted concerns about mitigating potential risks of severe hypoglycemia and requested that we perform a sub-study in a controlled in-patient setting for a one-week period prior to beginning the larger multi-centered Phase II trial. As a result, we withdrew the original IND and, in April 2013, we submitted a new IND for the Phase IIa sub-study. Following the FDA&#8217;s clearance to proceed in May 2013, we began the Phase IIa sub-study in July 2013. As we announced in January 2014, the Phase IIa sub-study met all primary and secondary endpoints. Specifically, the Phase IIa study evaluated the pharmacodynamic effects of ORMD-0801 on mean nighttime glucose (determined using a continuous glucose monitor). The results showed that ORMD-0801 exhibited a sound safety profile, led to reduced mean daytime and nighttime glucose readings and lowered fasting blood glucose concentrations, when compared to placebo. In addition, no serious adverse events occurred during this study, and the only adverse events that occurred were not drug related. In light of these results, we believe that we should move forward with the Phase IIb clinical trial on approximately 180 type&#160;2 diabetic patients and it will be conducted in approximately 30 sites in the United States, which we are preparing to initiate in the second quarter of calendar year 2015. This double-blind, randomized, 28-day study clinical trial will be designed to assess the safety and efficacy of ORMD-0801 and will investigate ORMD-0801 over a longer treatment period and which will have statistical power to give us greater insight into the drug&#8217;s efficacy.&#160;&#160;We anticipate the last patient will complete this trial before the end of 2015.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160; We are also conducting an&#160;additional study of our oral insulin capsule on type 2 diabetic volunteers that will be performed at The University of Texas Health Science Center at San Antonio and University Health System&#8217;s Texas Diabetes Institute. The glucose clamp is a method for quantifying insulin absorption in order to measure a patient&#8217;s insulin sensitivity and how well a patient metabolizes glucose.&#160;&#160;As announced, the first patient has been enrolled and we anticipate <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">completing </font>the study in the fourth quarter of calendar year 2015.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2014, we submitted a protocol to the FDA to initiate a Phase IIa trial of our oral insulin capsule for type 1 diabetes volunteers. The protocol was submitted under our existing IND to include both type 1 and type 2 diabetes indications. The double-blind, randomized, placebo controlled, seven-day study design was carried out at an inpatient setting on 25 type 1 diabetic patients. We began this study in March 2014. As we announced in October 2014, the results showed that ORMD-0801 oral insulin given before meals appeared to be safe and well-tolerated for the dosing regimen in this study. Although the study was not powered to show statistical significance, there were internally consistent trends observed. Consistent with the timing of administration, the data showed a decrease in rapid acting insulin, a decrease in post-prandial glucose, a decrease in daytime glucose by continual glucose monitoring and an increase in post-prandial hypoglycemia in the active group.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The table below gives an overview of our product pipeline:</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="lightgrey">
<td valign="top" width="11%" style="BORDER-LEFT: black 2px solid; BORDER-TOP: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="14%" style="BORDER-TOP: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="9%" style="BORDER-TOP: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Phase I</font></div>
</td>
<td valign="top" width="10%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; BORDER-TOP: black 2px solid; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Phase II</font></div>
</td>
<td valign="top" width="15%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; BORDER-TOP: black 2px solid; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Phase III</font></div>
</td>
<td align="left" valign="top" width="38%" style="BORDER-TOP: black 2px solid">
<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Timeline</font></div>
</td>
<td valign="top" width="3%" style="BORDER-TOP: black 2px solid; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td rowspan="2" valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORMD-0801</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;oral insulin</font></div>
</td>
<td valign="middle" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Type 2 diabetes</font></div>
</td>
<td colspan="2" valign="middle" width="19%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; <img src="pp.jpg" alt=""></font></td>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="middle" width="41%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 14.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Q1 &#8217;14: Phase IIa completed</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 14.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Q2 &#8217;15: Phase IIb multi-center study&#160;&#160;projected initiation</font></div>
</td>
</tr><tr>
<td valign="middle" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Type 1 diabetes</font></div>
</td>
<td valign="middle" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; <img src="pp2.jpg" alt=""></font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="middle" width="41%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 14.05pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Q3 &#8217;14: Phase IIa completed</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="11%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORMD-0901</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">oral GLP-1</font></div>
</td>
<td valign="middle" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Type 2 diabetes</font></div>
</td>
<td valign="middle" width="9%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; <img src="pp3.jpg" alt=""></font></td>
<td valign="middle" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="middle" width="15%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="middle" width="41%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.7pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Q3 &#8217;14: Preclinical/IND studies initiated</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.7pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Q2 &#8217;15: Phase Ib ex-US study projected initiation. </font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Q1</font> &#8217;16: Phase II multi-center study projected initiation</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Results of Operations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Comparison of six and three month periods ended February 28, 2015 and 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160; The following table summarizes certain statements of operations data for the Company for the six and three month periods ended February 28, 2015 and 2014 (in thousands of dollars except share and per share data):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="85%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" width="22%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Six months ended</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="4" valign="bottom" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">February 28,</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="4" valign="bottom" width="20%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">February 28,</font></div>
</div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font></div>
</div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font></div>
</div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,438</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,424</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,136</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">674</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative&#160;expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,138</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">930</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">538</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">512</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="35%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial income, net</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(43</font></div>
</div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(115</font></div>
</div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(37</font></div>
</div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(71</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</div>
</td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="35%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,533</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,239</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,637</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,115</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss per common share &#8211; basic&#160;and diluted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.34</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.26</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.15</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.12</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="35%">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,482,190</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,531,150</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,826,146</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,127,799</font></div>
</div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and development expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses include costs directly attributable to the conduct of research and development programs, including the cost of salaries, payroll taxes, employee benefits, costs of materials, supplies, the cost of services provided by outside contractors, including services related to our clinical trials, clinical trial expenses, the full cost of manufacturing drug for use in research and&#160;preclinical development.&#160;&#160;All costs associated with research and development are expensed as incurred.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Clinical trial costs are a significant component of research and development expenses and include costs associated with third-party contractors. We outsource a substantial portion of our clinical trial activities, utilizing external entities such as contract research organizations, or CROs, independent clinical investigators, and other third-party service providers to assist us with the execution of our clinical studies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Clinical activities which relate principally to clinical sites and other administrative functions to manage our clinical trials are performed primarily by CROs. CROs typically perform most of the start-up activities for our trials, including document preparation, site identification, screening and preparation, pre-study visits, training, and program management.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Clinical trial and pre-clinical trial expenses include regulatory and scientific consultants&#8217; compensation and fees, research expenses, purchase of materials, cost of manufacturing of the oral insulin capsules, payments for patient recruitment and treatment, as well <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">as salaries and related expenses of research and development staff.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses, for the six months ended February 28, 2015 increased by 71% to $2,438,000, from $1,424,000 for the six months ended February 28, 2014. The increase is mainly attributable to preparing for the initiation of our Phase IIb clinical trial.&#160;&#160;Stock-based compensation costs for the six months ended February 28, 2015 totaled $293,000, as compared to $295,000 during the six months ended February 28, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">Research and development </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">expenses</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">, for the </font>three months ended February 28, 2015<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"> increased by 69% to </font>$1,136,000, from $674,000 for the three months ended February 28, 2014. The increase is mainly attributable to preparing for the initiation of our Phase IIb clinical trial.&#160;&#160;Stock-based compensation costs for the three months ended February 28, 2015 totaled $129,000, as compared to $117,000 during the three months ended February 28, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Government grants</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2014, our Israeli subsidiary, Oramed Ltd., was granted a fifth grant amounting to a total amount of NIS 1,206,990 (approximately $345,000) from the Office of the Chief Scientist of the Ministry of Economy of Israel, or OCS, which was designated for research and development expenses for the period of November 2013 to October 2014. In September 2014, the OCS extended the period of this fifth year until December 2014. We used the funds to support further research and development and clinical studies of our oral insulin capsule and oral GLP-1 analog.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the six and three month periods ended February 28, 2015, we recognized research and development grants in an amount of $17,000, and $1,000, respectively, and in the six months ended February 28, 2014, we recognized research and development grants in an amount of $139,000. In the three months ended February 28, 2014, we recognized no grants from the OCS.&#160;&#160;As of February 28, 2015, we had no contingent liabilities to the OCS.</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">General and administrative expenses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and administrative expenses include the salaries and related expenses of our management, consulting costs, legal and professional fees, traveling, business development costs, insurance expenses and other general costs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and administrative expenses for the six months ended February 28, 2015 increased by 22% to $1,138,000 from $930,000 for the six months ended February 28, 2014. The increase in costs incurred related to general and administrative activities during the six months ended February 28, 2015 is mainly due to the increase in stock-based compensation expenses, which increased from $38,000 during the six months ended February 28, 2014 to $272,000 in the six months ended February 28, 2015, which is attributed to awards granted to directors and officers during the six months ended February 28, 2015.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and administrative expenses for the three months ended February 28, 2015 increased by 5% to $538,000 from $512,000 for the three months ended February 28, 2014. The increase in costs incurred related to general and administrative activities during the three months ended February 28, 2015 is mainly due to the increase in stock-based compensation expenses, which increased from $12,000 during the three months ended February 28, 2014 to $136,000 in the three months ended February 28, 2015, which is attributed to awards granted to directors and officers during the three months ended February 28, 2015, which was offset by a decrease in <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">salaries and related expenses resulting from cash bonuses to employees</font> paid during the three months ended February 28, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial income, net</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net financial income decreased by 63% from net income of $115,000 for the six months ended February 28, 2014 to net income of $43,000 for the six months ended February 28, 2015. The decrease is mainly due to a decrease in income from exchange rate differences and to a decrease in capital gain on marketable securities, which decreased from $44,000 during the six months ended February 28, 2014 to zero in the six months ended February 28, 2015.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the three months ended February 28, 2015, net financial income totaled $37,000, compared to $71,000 for the three months ended February 28, 2014.&#160;&#160;The decrease of 48% in net financial income during the three months ended February 28, 2015, as compared to the three months ended February 28, 2014, is attributable to the same reasons described above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other comprehensive income</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">Subsequent decrease in the fair value of available for sale securities previously written down as impaired for the six months ended February 28, 2015 of $9,000 resulted from the decrease in fair value of the ordinary shares of D.N.A Biomedical Solutions Ltd, or D.N.A, that we hold, and </font>subsequent increase in the fair value of available for sale securities previously written down as impaired for the six months ended February 28, 2014 of $54<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">,000</font> resulted from the increase in fair value of the <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">shares o</font>f D.N.A that we hold<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">. Unrealized losses on available for sale securities for the six months ended February 28, 2015 of $343,000, resulted from the decrease in fair value of our D.N.A ordinary shares.</font> Unrealized gains on available for sale securities for the six months ended February 28, 2014 of $534,<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">000</font>, resulted from the increase in fair value of our D.N.A ordinary shares. Reclassification adjustments for gains included in net loss for the six months ended February 28, 2014 of $44,<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">000</font>, resulted from the sale of 1,625,989 of our D.N.A ordinary shares in October and November 2013 and January 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subsequent increase in the fair value of available for sale securities previously written down as impaired for the three months ended February 28, 2014 of $49,000 resulted from the increase in fair value of the D.N.A <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">ordinary </font>shares, while there was no change in the <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">fair value of available for sale securities previously written down as impaired for the three months ended February 28, 2015</font>. Unrealized gains on available for sale securities for the three months ended February 28, 2014 and 2015 of $490,000 and $7,000, respectively, resulted from the increase in fair value of our D.N.A ordinary shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and capital resources</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From inception through February 28, 2015, we have incurred losses in an aggregate amount of $31,353,000. During that period we have financed our operations through several private placements of our common stock, as well as public offerings of our common stock, raising a total of $40,580,000, net of transaction costs.&#160;&#160;During that period we also received cash consideration of $1,870,000 from the exercise of warrants and options. We will seek to obtain additional financing through similar sources in the future as needed. As of February 28, 2015, we had $1,102,000&#160;of available cash, $16,351,000&#160;of short term bank deposits, $4,660,000 of long term bank deposits and $695,000&#160;of marketable securities. We anticipate that we will require approximately $10.2 million to finance our activities during the 12 months following February 28, 2015.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management continues to evaluate various financing alternatives for funding future research and development activities and general and administrative expenses through fundraising in the public or private equity markets. Although there is no assurance that we will be successful with those initiatives, management believes that it will be able to secure the necessary financing as a result of ongoing financing discussions with third party investors, including the investor in connection with the private placement entered into in November 2014, and existing stockholders, future public offerings, and additional funding from the OCS. Based on our current cash resources and commitments, including cash received in a private placement in the period ended February 28, 2015, we believe we will be able to maintain our current planned development activities and the corresponding level of expenditures for at least the next 12 months and beyond.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of February 28, 2015, our total current assets were $18,295,000 and our total current liabilities were $605,000. On February 28, 2015, we had a working capital surplus of $17,690,000 and an accumulated loss of $31,353,000.&#160;As of August 31, 2014, our total current assets were $21,778,000 and our total current liabilities were $973,000. On August 31, 2014, we had a working capital surplus of $20,805,000 and an accumulated loss of $27,820,000. The decrease in working capital from August 31, 2014 to February 28, 2015 was primarily due to the investment of a portion of the proceeds from our private placement completed in November 2014 in long term bank deposits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the six month period ended February 28, 2015, cash and cash equivalents decreased to $1,102,000 from the $1,762,000 reported as of August 31, 2014, which is due to the reasons described below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Operating activities used cash of $3,003,000 in the six month period ended February 28, 2015, as compared to $2,231,000 used in the six months ended February 28, 2014. Cash used for operating activities in the six months ended February 28, 2015 and 2014 primarily consisted of net loss resulting from research and development and general and administrative expenses, partially offset by stock-based compensation amounts.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the six month period ended February 28, 2015, we received $93,000 in OCS grants towards our research and development expenses, while we recognized the amount of $17,000 during such period and $139,000 was recognized in the six month period ended February 28, 2014. During the six month period ended February 28, 2014, we received $125,000 in OCS grants. The amounts that were received but not recognized during the six month period ended February 28, 2015 were recognized during fiscal year 2014.&#160;&#160;The OCS has supported our activity in the past five years.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Investing activities used cash of $2,477,000 in the six month period ended February 28, 2015, as compared to $13,294,000 used in the six month period ended February 28, 2014. Cash used in investing activities in the six months ended February 28, 2015 consisted primarily of the investment in long term bank deposits, while cash used in investing activities in the six months ended February 28, 2014 consisted primarily of the acquisition of short-term bank deposits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financing activities provided cash of $4,841,000 in the six month period ended February 28, 2015, as compared to $16,495,000 in the six month period ended February 28, 2014.&#160;&#160;Financing activities in the six month periods ended February 28, 2015 and 2014 consisted of proceeds from our issuance of common stock and proceeds from exercise of warrants and options in each period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160; At the Market Issuance Sales Agreement</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;&#160;&#160; On April 2, 2015, we entered into an at the market issuance sales agreement, or the Sales Agreement, with MLV &amp; Co. LLC, or MLV, pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $25 million from time to time, at its option, through MLV as its sales agent, subject to certain terms and conditions. Any shares sold will be sold pursuant to the Company&#8217;s effective shelf registration statement on Form S-3 (Registration No. 333-193557), including a prospectus dated April 10, 2014, as supplemented by a prospectus supplement dated April 2, 2015. The Company will pay MLV a commission of 3.0% of the gross proceeds of the sale of any shares sold through MLV. To date, no shares have been sold under the Sales Agreement.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off-balance sheet arrangements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">February 28, 2015</font>, we had no off balance sheet arrangements that have had or that we expect would be reasonably likely to have a future material effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Planned Expenditures</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The estimated expenses referenced herein are in accordance with our business plan. Since our technology is still in the development stage, it can be expected that there will be changes in some budgetary items. Our planned expenditures for the twelve months beginning March 1, 2015 are as follows (in thousands):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="85%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Category</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="88%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development, net of OCS funds</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,933</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,268</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></div>
</td>
<td align="right" valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,201</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December 2012 and April 2013, we filed IND applications with the FDA for our orally ingested insulin and we are conducting, or planning to conduct, further clinical studies with our oral exenatide capsule, and others.&#160;&#160;Our ability to complete these expected activities is dependent on several major factors including the ability to attract sufficient financing on terms acceptable to us<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="item3"><!--EFPlaceholder--></a>ITEM 3 &#8211; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><a name="item4"><!--EFPlaceholder--></a>There has been no significant change in our exposure to market risk during the three months ended February 28, 2015. For a discussion of our exposure to market risk, refer to Part II, Item&#160;7A, &#8220;Quantitative and Qualitative Disclosures About Market Risk,&#8221; contained in our Annual Report on Form 10-K for the year ended August&#160;31, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 4 - CONTROLS AND PROCEDURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Disclosure Controls and Procedures</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of February 28, 2015. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in Internal Control over Financial Reporting</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There were no changes in our internal control over financial reporting that occurred during the quarter ended <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">February 28, 2015</font> that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PART II &#8211;<a name="1111"> OTHER</a> INFORMATION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">See Item 2, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8211; At the Market Issuance S<a name="6666">ales </a>Agreement.&#8221;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="item62"><!--EFPlaceholder--></a>ITEM 6 - EXHIBITS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="6%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Number</font></font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="83%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Exhibit</font></font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.1*</font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Opinion of Zysman, Aharoni, Gayer and Sullivan &amp; Worcester LLP.</font></td>
</tr><tr>
<td align="left" valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10.1*</font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">At the Market Issuance Sales Agreement, dated April 2, 2015, by and between Oramed Pharmaceuticals Inc. and MLV &amp; CO. LLC.</font></td>
</tr><tr>
<td align="left" valign="top" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23.1*</font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consent of Zysman, Aharoni, Gayer and Sullivan &amp; Worcester LLP (included in Exhibit 5.1).</font></td>
</tr><tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.1*</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification Statement of Principal Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.2*</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification Statement of Principal Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.1**</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification Statement of Principal Executive Officer pursuant to 18 U.S.C. Section 1350.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32.2**</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certification Statement of Principal Financial Officer pursuant to 18 U.S.C. Section 1350.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101.1*</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="83%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The following financial statements from the Company&#8217;s Quarterly Report on Form&#160;10-Q for the quarter ended <font style="DISPLAY: inline; FONT-FAMILY: times new roman">February 28, 2015</font>, formatted in XBRL: (i)&#160;Condensed Consolidated Balance Sheets, (ii)&#160;Condensed Consolidated Statements of Comprehensive Loss, (iii)&#160;Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity, (iv)&#160;Condensed Consolidated Statements of Cash Flows and (v)&#160;the Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and in detail.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">___________________</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></div>
</td>
<td align="left" valign="top" width="84%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Filed herewith</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="6%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">**</font></div>
</td>
<td align="left" valign="top" width="84%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Furnished herewith</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="50%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date:&#160;April 2, 2015</font></div>
</td>
<td align="left" valign="bottom" width="2%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td align="left" valign="bottom" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Nadav Kidron</font></div>
</td>
<td valign="top" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nadav Kidron</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="50%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date:&#160;April 2, 2015</font></div>
</td>
<td align="left" valign="bottom" width="2%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td align="left" valign="bottom" width="35%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Yifat Zommer</font></div>
</td>
<td valign="top" width="13%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yifat Zommer</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="35%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(principal financial and accounting officer)</font></div>
</td>
<td valign="top" width="13%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block">10</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit_5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
<head>
    <title>exhibit_5-1.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 5.1</font></div>

<div>&#160;</div>

<div><img src="zsw.jpg" alt=""></div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">April 2, 2015</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Oramed Pharmaceuticals Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Hi-Tech Park 2/4</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Givat-Ram</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PO Box 39098</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem 91390, Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Re: <font style="DISPLAY: inline; TEXT-DECORATION: underline">Sale of Common Stock pursuant to Registration Statement on Form S-3</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Ladies and Gentlemen:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This opinion is furnished to you in connection with a Registration Statement on Form S-3 (Registration No. 333-193557, the &#8220;Registration Statement&#8221;), the prospectus included therein and the related prospectus supplement (such prospectus, as supplemented by such prospectus supplement, the &#8220;Prospectus Supplement&#8221;) filed or to be filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with respect to the sale of shares of your common stock (the &#8220;Shares&#8221;) having an aggregate offering price of up to $25,000,000 from time to time pursuant to that certain At the Market Issuance Sales Agreement, dated April 2, 2015 (the &#8220;Sales Agreement&#8221;), between you and MLV &amp; Co. LLC. You are a Delaware corporation and are referred to herein as the &#8220;Company.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are acting as counsel for the Company in connection with the registration and sale of the Shares. We have examined copies of the Registration Statement and Prospectus Supplement filed or to be filed with the Commission. We have also examined and relied upon minutes of meetings of the Board of Directors of the Company as provided to us by the Company, the Certificate of Incorporation and By-Laws of the Company, each as restated and/or amended to date, and such other documents as we have deemed necessary for purposes of rendering the opinions hereinafter set forth.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our examination of the foregoing documents, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, the authenticity of the originals of such latter documents and the legal competence of all signatories to such documents.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other than our examination of the documents indicated above, we have made no other examination in connection with this opinion.&#160;&#160;This opinion is limited to the General Corporation Law of Delaware, and we express no opinions with respect to the laws of any other jurisdiction. We express no opinion herein concerning any state securities or blue sky laws.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based upon and subject to the foregoing, we are of the opinion that when issued and paid for in accordance with the terms and conditions of the Sales Agreement, the Shares will be validly issued, fully paid and nonassessable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Please note that we are opining only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, as further limited above, and we disclaim any obligation to advise you of any change in any of these sources of law or subsequent legal or factual developments which might affect any matters or opinions set forth herein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><img src="zsw2.jpg" alt=""><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Oramed Pharmaceuticals Inc.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">April 2, 2015</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Page 2 of 2</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This opinion is rendered to you in connection with the Registration Statement. This opinion may not be relied upon for any other purpose, or furnished to, quoted or relied upon by any other person, firm or corporation for any purpose, without our prior written consent, except that (A) this opinion may be furnished or quoted to judicial or regulatory authorities having jurisdiction over you, and (B) this opinion may be relied upon by purchasers and holders of the Shares currently entitled to rely on it pursuant to applicable provisions of federal securities law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We hereby consent to the filing of this opinion with the Commission as an exhibit to the Quarterly Report on Form 10-Q for the quarter ended February 28, 2015 of the Company being filed on the date hereof and to the reference to our firm in the Prospectus Supplement and the Registration Statement. In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Very truly yours,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">/s/ Zysman, Aharoni, Gayer and Sullivan &amp; Worcester LLP</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Zysman, Aharoni, Gayer and Sullivan &amp; Worcester LLP</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>exhibit_10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
<head>
    <title>exhibit_10-1.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 10.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Common Stock</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(par value $0.012 per share)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">At-the-Market Issuance Sales Agreement</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;April 2, 2015</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MLV &amp; Co. LLC</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1301 Avenue of the Americas </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">43<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> Floor</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">New York, New York 10019</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Ladies and Gentlemen:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Oramed Pharmaceuticals Inc., a Delaware corporation (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>&#8221;), confirms its agreement (this &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Agreement</font>&#8221;), with MLV &amp; Co. LLC (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">MLV</font>&#8221;), as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuance and Sale of Shares.</font> The Company agrees that, from time to time during </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the term of this Agreement, on the terms and subject to the conditions set forth herein, it may issue and sell through MLV, shares (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Placement Shares</font>&#8221;) of the Company&#8217;s common stock, par value $0.012 per share (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Common Stock</font>&#8221;),<font style="FONT-STYLE: italic; DISPLAY: inline"> provided however, </font>that in no event shall the Company issue or sell through MLV such number of Placement Shares that (a) if at any time General Instruction I.B.6 of Form S-3 is applicable, would cause the Company to exceed the limitations set forth therein, (b) exceeds the number of shares of Common Stock registered on the effective Registration Statement (as defined below) pursuant to which the offering is being made, or (c) exceeds the number of authorized but unissued shares of Common Stock (the lesser of (a), (b) and (c), the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Maximum Amount</font>&#8221;). Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 1</font> on the number of Placement Shares issued and sold under this Agreement shall be the sole responsibility of the Company and that MLV shall have no obligation in connection with such compliance. The issuance and sale of Placement Shares through MLV will be effected pursuant to the Registration Statement (as defined below), although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement to issue any Placement Shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has filed, in accordance with the provisions of the Securities Act of 1933, as amended (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Act</font>&#8221;), and the rules and regulations thereunder (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Act Regulations</font>&#8221;), with the Securities and Exchange Commission (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Commission</font>&#8221;), a registration statement on Form S-3 (File No. 333-193557), including a base prospectus, relating to certain securities, including the Placement Shares to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange Act</font>&#8221;), and the rules and regulations thereunder (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange Act Regulations</font>&#8221;). The Company has prepared a prospectus supplement to the base prospectus included as part of such registration statement specifically relating to the Placement Shares (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prospectus Supplement</font>&#8221;). The Company will furnish to MLV, for use by MLV, copies of the base prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Placement Shares. Except where the context otherwise requires, such registration statement, including all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such registration statement pursuant to Rule 430B of the Securities Act, is herein called the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement</font>.&#8221;&#160;&#160;The base prospectus, including all documents incorporated or deemed incorporated therein by reference to the extent such information has not been superseded or modified in accordance with Rule 412 under the Securities Act (as qualified by Rule 430B(g) of the Securities Act), included in the Registration Statement, as it may be supplemented by the Prospectus Supplement, in the form in which such base prospectus and/or Prospectus Supplement have most recently been filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act, is herein called the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prospectus</font>.&#8221; Any reference herein to the Registration Statement, the Prospectus or any amendment or supplement thereto shall be deemed to refer to and include the documents incorporated or deemed incorporated by reference therein, and any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Incorporated Documents</font>&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include the most recent copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System, or if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">EDGAR</font>&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Placements.</font> Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Placement</font>&#8221;), it will notify MLV by email notice (or other method mutually agreed to in writing by the Parties) of the number of Placement Shares, the time period during which sales are requested to be made, any limitation on the number of Placement Shares that may be sold in any one day and any minimum price below which sales may not be made (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Placement Notice</font>&#8221;), substantially in the form attached hereto as <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 1.</font> The Placement Notice shall originate from any of the individuals from the Company set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3</font> (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from MLV set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3</font>, as such <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3</font> may be amended from time to time. The Placement Notice shall be effective immediately upon receipt by MLV unless and until (i)&#160;MLV gives the Company written notice that it declines to accept the terms contained therein for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares thereunder has been sold, (iii) the Company suspends or terminates the Placement Notice or (iv) this Agreement has been terminated under the provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 13</font>. The amount of any discount, commission or other compensation to be paid by the Company to MLV in connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 2</font>. It is expressly acknowledged and agreed that neither the Company nor MLV will have any obligation whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to MLV and MLV does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified therein and herein. In the event of a conflict between the terms of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Sections 2</font> or <font style="DISPLAY: inline; TEXT-DECORATION: underline">3</font> of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Sale of Placement Shares by MLV.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">a.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions of this Agreement, for the period specified in a Placement Notice, MLV will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of The NASDAQ Capital Market (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange</font>&#8221;), to sell the Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. MLV will provide written confirmation to the Company no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the compensation payable by the Company to MLV pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 2</font> with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by MLV (as set forth in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 5(b)</font>) from the gross proceeds that it receives from such sales. Subject to the terms of a Placement Notice, MLV may sell Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act, including without limitation sales made directly on the Exchange, on any other existing trading market for the Common Stock or to or through a market maker. Subject to the terms of a Placement Notice, MLV may also sell Placement Shares by any other method permitted by law, including but not limited to negotiated transactions, with the Company&#8217;s prior written consent. &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Trading Day</font>&#8221; means any day on which Common Stock is purchased and sold on the Exchange.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">b.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;During the term of this Agreement, neither MLV nor any of its affiliates or subsidiaries shall engage in (i) any short sale of any security of the Company, (ii) any sale of any security of the Company that MLV does not own or any sale which is consummated by the delivery of a security of the Company borrowed by, or for the account of, MLV, or (iii) any market making bidding, stabilization or other trading activity with respect to the Common Stock or related derivative securities if such activity would be prohibited under Regulation M or other anti-manipulation rules under the Securities Act. Neither MLV nor any of its affiliates or subsidiaries shall engage in any proprietary trading or trading for MLV&#8217;s (or its affiliates&#8217; or subsidiaries&#8217;) own account.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Suspension of Sales.</font> The Company or MLV may, upon notice to the other party in writing (including by email correspondence to each of the individuals of the other party set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3</font>, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile transmission or email correspondence to each of the individuals of the other party set forth on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3</font>), suspend any sale of Placement Shares; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that such suspension shall not affect or impair any party&#8217;s obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. Each of the parties agrees that no such notice under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 4</font> shall be effective against any other party unless it is made to one of the individuals named on <font style="DISPLAY: inline; TEXT-DECORATION: underline">Schedule 3</font> hereto, as such Schedule may be amended from time to time.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Sale and Delivery to MLV; Settlement.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Sale of Placement Shares.</font> On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, unless MLV declines to accept the terms of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of this Agreement, MLV, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares up to the amount specified in, and otherwise in accordance with the terms of, such Placement Notice. The Company acknowledges and agrees that (i) there can be no assurance that MLV will be successful in selling Placement Shares, (ii) MLV will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by MLV to use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable law and regulations to sell such Placement Shares as required under this Agreement and (iii) MLV shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise agreed by MLV and the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Settlement of Placement Shares.</font> Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement Shares will occur on the third (3rd) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Settlement Date</font>&#8221;). The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Net Proceeds</font>&#8221;) will be equal to the aggregate sales price received by MLV, after deduction for (i) MLV&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 2</font> hereof, and (ii) any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Delivery of Placement Shares.</font> On or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Placement Shares being sold by crediting MLV&#8217;s or its designee&#8217;s account (provided MLV shall have given the Company written notice of such designee at least one Trading Day prior to the Settlement Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradable, transferable, registered shares in good deliverable form. On each Settlement Date, MLV will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the Company, or its transfer agent (if applicable), defaults in its obligation to deliver Placement Shares on a Settlement Date through no fault of MLV, the Company agrees that, in addition to, and in no way limiting, the rights and obligations set forth in Section<font style="DISPLAY: inline; TEXT-DECORATION: underline"> 11(a)</font> hereto, it will (i) hold MLV harmless against any loss, claim, damage, or reasonable, documented expense (including reasonable and documented legal fees and expenses), as incurred, arising out of or in connection with such default by the Company or its transfer agent (if applicable) and (ii) pay to MLV (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such default.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Limitations on Offering Size.</font> Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares, the aggregate number of, or aggregate gross proceeds of, the Placement Shares sold pursuant to this Agreement, as applicable, would exceed the lesser of (A) together with all sales of Placement Shares under this Agreement, the Maximum Amount, (B) the amount available for offer and sale under the currently effective Registration Statement and (C) the amount authorized from time to time to be issued and sold under this Agreement by the Company&#8217;s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to MLV in writing.&#160;&#160;Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price lower than the minimum price authorized from time to time by the Company&#8217;s board of directors, a duly authorized committee thereof or a duly authorized executive committee, and notified to MLV in writing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representations and Warranties of the Company.</font> Except as disclosed in the Registration Statement, the Prospectus or any Issuer General Use Free Writing Prospectus (as defined below), if any (including, in each case, the Incorporated Documents), the Company represents and warrants to, and agrees with MLV that as of the date of this Agreement and as of each Applicable Time (as defined below), unless such representation, warranty or agreement specifies a different date or time:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement and Prospectus.</font> The Company and, assuming no act or omission on the part of MLV that would make such statement untrue, the transactions contemplated by this Agreement meet the requirements for and comply with the conditions for the use of Form S-3 under the Securities Act. The Registration Statement has been filed with the Commission and has been declared effective under the Securities Act. The Prospectus Supplement will name MLV as the agent in the section entitled &#8220;Plan of Distribution.&#8221; The Company has not received, and has no notice of, any order of the Commission preventing or suspending the use of the Registration Statement, or threatening or instituting proceedings for that purpose. The Registration Statement and the offer and sale of Placement Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule. Any statutes, regulations, contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement have been so described or filed. Copies of the Registration Statement, the Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to MLV and its counsel. The Company has not distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Placement Shares, will not distribute any offering material in connection with the offering or sale of the Placement Shares other than the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus to which MLV has consented, such consent not to be unreasonably withheld, conditioned or delayed. The Common Stock is currently quoted on the Exchange. The Company has not, in the twelve (12) months preceding the date hereof, received notice from the Exchange to the effect that the Company is not in compliance with the listing or maintenance requirements of the Exchange. The Company has no reason to believe that it will not in the foreseeable future continue to be in compliance with all such listing and maintenance requirements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Pursuant</font><font style="DISPLAY: inline; TEXT-DECORATION: underline"> to the Exchange Act</font>. The shares of Common Stock are registered pursuant to Section 12(b) under the Exchange Act.&#160;&#160;The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the shares of Common Stock under the Exchange Act, nor has the Company received any notification that the Commission is contemplating terminating such registration.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">S-3 Eligibility</font>.&#160;&#160;The Company and the transactions contemplated by this Agreement meet the requirements for, and comply with the conditions for the use of, Form S-3 under the Securities Act, including but not limited to Instruction I.B.6 of Form S-3.&#160;&#160;The Company is not a shell company (as defined in Rule 405 of the Securities Act Regulations) and has not been a shell company for at least twelve (12) calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in Instruction I.B.6 of Form S-3) with the Commission at least twelve (12) calendar months previously reflecting its status as an entity that is not a shell company</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Exchange Listing</font>. The shares of Common Stock are listed on the Exchange, and the Company has taken no action designed to, or likely to have the effect of, delisting the shares of Common Stock from the Exchange, nor has the Company received any notification that the Exchange is contemplating terminating such listing.&#160;&#160;When and if required, the Company will file an application for the Listing of Additional Shares with the Exchange to list the Placement Shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Stop Orders, etc.</font> Neither the Commission nor, to the Company&#8217;s knowledge, any state regulatory authority has issued any order preventing or suspending the use of the Registration Statement or the Prospectus or has instituted or, to the Company&#8217;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied with each request (if any) from the Commission for additional information.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">f.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compliance with Securities Act and 10b-5 Representation</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all material respects with the requirements of the Securities Act and the Securities Act Regulations. Each of the base prospectus filed as part of the Registration Statement as originally filed or as part of any amendment or supplement thereto, and the Prospectus, at the time each was filed with the Commission and at the Applicable Time, complied in all material respects with the requirements of the Securities Act and the Securities Act Regulations.&#160;&#160;The Prospectus delivered to MLV for use in connection with this Offering and the Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Neither the Registration Statement nor any amendment thereto, at its effective time, contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Disclosure Package, as of the Applicable Time, did not, does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free Writing Prospectus hereto does not conflict with the information contained in the Registration Statement or the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Disclosure Package as of the Applicable Time, did not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that this representation and warranty shall not apply to statements made or statements omitted in reliance upon and in conformity with any written information furnished to the Company with respect to MLV by MLV expressly for use in the Registration Statement or the Prospectus or any amendment thereof or supplement thereto.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iv.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time of any filing with the Commission pursuant to Rule 424(b) or at the Applicable Time, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that this representation and warranty shall not apply to statements made or statements omitted in reliance upon and in conformity with any written information furnished to the Company with respect to MLV by MLV expressly for use in the Registration Statement or the Prospectus or any amendment thereof or supplement thereto.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">v.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The documents incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, when they became effective or were filed with the Commission, as the case may be, conformed in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder and none of such documents contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, when such documents become effective or are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission thereunder, and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">g.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disclosure of Agreements</font>. The agreements and documents described in the Registration Statement, the Disclosure Package and the Prospectus conform in all material respects to the descriptions thereof contained or incorporated by reference therein, and there are no agreements or other documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement or to be incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, that have not been so described or filed or incorporated by reference. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or affected that is material to the Company&#8217;s business, has been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company&#8217;s knowledge, the other parties thereto, in accordance with its terms, except (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&#8217; rights generally, (ii) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought. None of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the Company&#8217;s knowledge, any other party is in default thereunder and, to the Company&#8217;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder, except for any such default that would not have or reasonably be expected to result in a material adverse change in the financial position or results of operations of the Company or Oramed Ltd., the Company&#8217;s only subsidiary (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsidiary</font>&#8221;), either individually or taken as a whole, nor any change or development that, singularly or in the aggregate, would involve a material adverse change, in or affecting the condition (financial or otherwise), results of operations, business, prospects or assets of the Company or the Subsidiary, either individually or taken as a whole&#160;&#160;(a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Adverse Change</font>&#8221;). To the best of the Company&#8217;s knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses (each, a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Governmental Entity</font>&#8221;), including, without limitation, those relating to environmental laws and regulations except for any such violation that would not have or reasonably be expected to result in a Material Adverse Change.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">h.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prior Securities Transactions</font>.&#160;&#160;During the last three (3) years, no securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of, any person or persons controlling, controlled by or under common control with the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulations</font>. The disclosures in the Registration Statement, the Disclosure Package and the Prospectus concerning the effects of federal, state, local and all foreign regulation on the Placement and the Company&#8217;s business as currently contemplated are correct in all material respects and no other such regulations are required to be disclosed in the Registration Statement, the Disclosure Package and the Prospectus which are not so disclosed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">j.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Material Adverse Change</font>. Since the respective dates as of which information is given in the Registration Statement, the Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse change in the financial position or results of operations of the Company, nor any change or development that, singularly or in the aggregate, would involve a Material Adverse Change; (ii) there have been no material transactions entered into by the Company, other than as contemplated pursuant to this Agreement; and (iii) no officer or director of the Company has resigned from any position with the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">k.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Recent Securities Transactions, etc.</font> Subsequent to the respective dates as of which information is given in the Registration Statement, the Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company has not (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other distribution on or in respect to its capital stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">l.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disclosures in Commission Filings</font>.&#160;&#160;Since January 1, 2014, (i) none of the Company&#8217;s filings with the Commission contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; and (ii) the Company has made all filings with the Commission required under the Exchange Act and the Exchange Act Regulations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">m.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Independent Accountants</font>. To the knowledge of the Company, Kesselman &amp; Kesselman, a member of PricewaterhouseCoopers International Limited (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Auditor</font>&#8221;), whose report is filed with the Commission and included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, is an independent registered public accounting firm as required by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board. The Auditor has not, during the periods covered by the financial statements included in the Registration Statement, the Disclosure Package and the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">n.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Financial Statements, etc.</font>&#160;&#160;The financial statements, including the notes thereto and supporting schedules included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, fairly present the financial position and the results of operations of the Company at the dates and for the periods to which they apply; and such financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">GAAP</font>&#8221;), consistently applied throughout the periods involved (provided that unaudited interim financial statements are subject to year-end audit adjustments that are not expected to be material in the aggregate and do not contain all footnotes required by GAAP); and the supporting schedules included in the Registration Statement present fairly the information required to be stated therein. Except as included therein, no historical or pro forma financial statements are required to be included or incorporated by reference in the Registration Statement, the Disclosure Package or the Prospectus under the Securities Act, the Securities Act Regulations, the Exchange Act or the Exchange Act Regulations. All disclosures contained in the Registration Statement, the Disclosure Package or the Prospectus, or incorporated or deemed incorporated by reference therein, regarding &#8220;non-GAAP financial measures&#8221; (as such term is defined by the rules and regulations of the Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. Each of the Registration Statement, the Disclosure Package and the Prospectus discloses all material off-balance sheet transactions, arrangements, obligations (including contingent obligations), and other relationships of the Company with unconsolidated entities or other persons that may have a material current or future effect on the Company&#8217;s financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses. (i) Neither the Company nor the Subsidiary, has incurred any material liabilities or obligations, direct or contingent, or entered into any material transactions other than in the ordinary course of business, (ii) the Company has not declared or paid any dividends or made any distribution of any kind with respect to its capital stock, (iii) there has not been any change in the capital stock of the Company or the Subsidiary, or, other than in the ordinary course of business and consistent with the Company&#8217;s prior policies, any grants made under any stock compensation plan, and (iv) there has not been any material adverse change in the Company&#8217;s long-term or short-term debt.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">o.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Authorized Capital; Options, etc.</font> The Company had, at the date or dates indicated in the Registration Statement, the Disclosure Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions stated in the Registration Statement, the Disclosure Package and the Prospectus, the Company will have, at the Applicable Time, the adjusted stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Disclosure Package and the Prospectus as of the Applicable Time, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares of Common Stock of the Company or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts or commitments to issue or sell shares of Common Stock or any such options, warrants, rights or convertible securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">p.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Outstanding Securities</font>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission with respect thereto, and are not subject to personal liability by reason of being such holders; and none of such securities were issued in violation of the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in the Registration Statement, the Disclosure Package and the Prospectus. The offers and sales of the outstanding shares of Common Stock were at all relevant times either registered under the Securities Act and the applicable state securities or &#8220;blue sky&#8221; laws or, based in part on the representations and warranties of the purchasers of such shares of Common Stock, exempt from such registration requirements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">q.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Sold Pursuant to this Agreement</font>. The Placement Shares, when issued and delivered pursuant to the terms approved by the board of directors of the Company or a duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, will be validly issued, fully paid and non-assessable, and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company, except as otherwise waived by such holders; and all corporate action required to be taken for the authorization, issuance and sale of the Placement Shares has been duly and validly taken. The Placement Shares conform in all material respects to all statements with respect thereto contained in the Registration Statement, the Disclosure Package and the Prospectus.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">r.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Rights of Third Parties</font>. Except as have been waived in writing and delivered to MLV prior to the date hereof or with respect to securities already registered or as otherwise disclosed in the Disclosure Package and the Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the Company have the right to require the Company to register any such securities of the Company under the Securities Act or to include any such securities in a registration statement to be filed by the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">s.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Validity and Binding Effect of Agreements</font>. This Agreement has been duly and validly authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except: (i) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&#8217; rights generally; (ii) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws; (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may be brought; (iv) as such enforceability may be limited by an implied covenant of good faith and fair dealing; and (v) as such enforceability may be limited by the effects of the possible judicial application of foreign laws or foreign governmental or judicial action affecting creditors&#8217; rights.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">t.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Conflicts, etc.</font> The execution, delivery and performance by the Company of this Agreement and all ancillary documents, the consummation by the Company of the transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both: (i) result in a material breach of, or conflict with any of the terms and provisions of, or constitute a material default under, or result in the creation, modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any agreement or instrument to which the Company is a party; (ii) result in any violation of the provisions of the Company&#8217;s Certificate of Incorporation (as the same may be amended or restated from time to time, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Charter</font>&#8221;) or the amended and restated by-laws of the Company; or (iii) violate any existing applicable law, rule, regulation, judgment, order or decree of any Governmental Entity (including, without limitation, those promulgated by the Food and Drug Administration of the U.S. Department of Health and Human Services (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FDA</font>&#8221;) or by any foreign, federal, state or local regulatory authority performing functions similar to those performed by the FDA), except in the case of clause (iii), for any such violation that would not have or reasonably be expected to result in a Material Adverse Change.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">u.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Defaults; Violations</font>. No material default exists in the due performance and observance of any term, covenant or condition of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company is a party or by which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company is not in violation of any term or provision of its Charter, or in violation of any franchise, license, permit, applicable law, rule, regulation, judgment or decree of any Governmental Entity.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conduct of Business</font>. The Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates and permits of and from all governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business purpose as described in the Registration Statement, the Disclosure Package and the Prospectus except where the failure to have any such authorization, approval, order, license, certificate or permit would not have or reasonably be expected to result in a Material Adverse Change.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">w.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Transactions Contemplated Herein</font>. The Company has all corporate power and authority to enter into this Agreement and to carry out the provisions and conditions hereof, and all consents, authorizations, approvals and orders required in connection therewith have been obtained. No consent, authorization or order of, and no filing with, any court, government agency or other body is required for the valid issuance, sale and delivery of the Placement Shares and the consummation of the transactions and agreements contemplated by this Agreement and as contemplated by the Registration Statement, the Disclosure Package and the Prospectus, except with respect to applicable federal and state securities laws and the rules and regulations of the Financial Industry Regulatory Authority, Inc. (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FINRA</font>&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">x.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">D&amp;O Questionnaires</font>.&#160;&#160;To the Company&#8217;s knowledge, all information contained in the questionnaires (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Questionnaires</font>&#8221;) completed by each of the Company&#8217;s directors and officers immediately prior to the Offering (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Insiders</font>&#8221;) as supplemented by all information concerning the Company&#8217;s directors, officers and principal shareholders as described in the Registration Statement, the Disclosure Package and the Prospectus, provided to MLV, is true and correct in all material respects and the Company has not become aware of any information which would cause the information disclosed in the Questionnaires to become materially inaccurate and incorrect.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">y.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Litigation; Governmental Proceedings.</font> There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding pending or, to the Company&#8217;s knowledge, threatened against, or involving the Company or, to the Company&#8217;s knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the Disclosure Package and the Prospectus, except for any such action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding that would not have or reasonably be expected to result in a Material Adverse Change, or in connection with the Company&#8217;s listing application for the listing of the Placement Shares on the Exchange.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">z.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Good Standing</font>. The Company has been duly organized and is validly existing as a corporation and is in good standing under the laws of the State of Delaware as of the date hereof, and is duly qualified to do business and is in good standing in each other jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify, singularly or in the aggregate, would not have or reasonably be expected to result in a Material Adverse Change.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">aa.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Insurance</font>. The Company carries or is entitled to the benefits of insurance, with reputable insurers, in such amounts and covering such risks which the Company believes are adequate, and all such insurance is in full force and effect. The Company has no reason to believe that it will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Change.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">bb.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Finder&#8217;s Fees</font>. There are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder&#8217;s, consulting or origination fee by the Company or any Insider with respect to the sale of the Placement Shares hereunder or any other arrangements, agreements or understandings of the Company or, to the Company&#8217;s knowledge, any of its shareholders that may affect MLV&#8217;s compensation, as determined by FINRA.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">cc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Payments Within Twelve (12) Months</font>. The Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder&#8217;s fee, consulting fee or otherwise, solely in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member, within twelve (12) months prior to the date of this Agreement, other than the payment to MLV as provided hereunder in connection with the Offering.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">dd.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Proceeds</font>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates, except as specifically authorized herein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ee.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">FINRA Affiliation</font>. Neither the Company nor any of its affiliates (within the meaning of FINRA&#8217;s Conduct Rule 5121(f)(1)) directly or indirectly controls, is controlled by, or is under common control with, or is an associated person (within the meaning of Article I, Section 1(ee) of the By-laws of FINRA) of, any member firm of FINRA.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ff.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Information</font>. All information provided by the Company in its FINRA Questionnaire to MLV specifically for use by MLV or its counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all material respects.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">gg.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Foreign Corrupt Practices Act</font>. Neither the Company nor the Subsidiary or, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the Company or the Subsidiary or any other person acting on behalf of the Company or the Subsidiary, has, directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic or foreign) or other person who was, is, or may be in a position to help or hinder the business of the Company (or assist it in connection with any actual or proposed transaction) that (i) might subject the Company to any damage or penalty in any civil, criminal or governmental litigation or proceeding, (ii) if not given in the past, might have had a Material Adverse Change or (iii) if not continued in the future, might adversely affect the assets, business, operations or prospects of the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended or Title 5 of the Israeli Penalty Law (Bribery Transactions).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">hh.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compliance with OFAC</font>. Neither the Company nor the Subsidiary or, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the Company or the Subsidiary or any other person acting on behalf of the Company or the Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">OFAC</font>&#8221;), and the Company will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Money Laundering Laws</font>.&#160;&#160;The operations of the Company and the Subsidiary are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the Israeli Prohibition on Money Laundering Law, 2000, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Money Laundering Laws</font>&#8221;); and no action, suit or proceeding by or before any Governmental Entity involving the Company or the Subsidiary with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">jj.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulatory</font>. All preclinical and clinical studies conducted by or on behalf of the Company that are material to the Company or the Subsidiary, taken as a whole, are or have been adequately described in the Registration Statement, the Disclosure Package and the Prospectus in all material respects.&#160;&#160;The clinical and preclinical studies conducted by or on behalf of the Company or the Subsidiary that are described in the Registration Statement, the Disclosure Package and the Prospectus or the results of which are referred to in the Registration Statement, the Disclosure Package and the Prospectus were and, if still ongoing, are being conducted in material compliance with all laws and regulations applicable thereto in the jurisdictions in which they are being conducted and with all laws and regulations applicable to preclinical and clinical studies from which data will be submitted to support marketing approval.&#160;&#160;The descriptions in the Registration Statement, the Disclosure Package and the Prospectus of the results of such studies are accurate and complete in all material respects and fairly present the data derived from such studies, and the Company has no knowledge of, or reason to believe that, any large well-controlled clinical study the aggregate results of which are inconsistent with or otherwise call into question the results of any clinical study conducted by or on behalf of the Company or the Subsidiary that are described in the Registration Statement, the Disclosure Package and the Prospectus or the results of which are referred to in the Registration Statement, the Disclosure Package and the Prospectus.&#160;&#160;Neither the Company nor the Subsidiary has received any written notices or statements from the FDA, the European Medicines Agency (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">EMA</font>&#8221;) or any other governmental agency or authority imposing, requiring, requesting or suggesting a clinical hold, termination, suspension or material modification for or of any clinical or preclinical studies that are described in the Registration Statement, the Disclosure Package and the Prospectus or the results of which are referred to in the Registration Statement, the Disclosure Package and the Prospectus.&#160;&#160;Neither the Company nor the Subsidiary has received any written notices or statements from the FDA, the EMA or any other governmental agency, and otherwise has any knowledge of, or reason to believe that, (i) any investigational new drug application for potential product of the Company or the Subsidiary is or has been rejected or determined to be non-approvable or conditionally approvable; and (ii) any license, approval, permit or authorization to conduct any clinical trial of any potential product of the Company or the Subsidiary has been, will be or may be suspended, revoked, modified or limited.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">kk.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Subsidiary</font>.&#160;&#160;The Company does not have any direct or indirect subsidiaries other than Oramed Ltd.&#160;&#160;The Subsidiary is duly organized and validly existing under the laws of the State of Israel, and the Subsidiary is in good standing in each jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where the failure to qualify would not have a Material Adverse Change.&#160;&#160;The Company&#8217;s ownership and control of the Subsidiary is as described in the Registration Statement, the Disclosure Package and the Prospectus.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ll.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Related Party Transactions</font>. There are no business relationships or related party transactions involving the Company or any other person required to be described or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus that have not been described or incorporated by reference as required.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">mm.&#160;&#160;&#160;&#160;&#160;&#160;The qualifications of the persons serving as board members and the overall composition of the board comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Sarbanes-Oxley Act</font>&#8221;) applicable to the Company and the listing rules of the Exchange.&#160;&#160;At least one member of the Audit Committee of the Board of Directors qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined under Regulation S-K and the listing rules of the Exchange.&#160;&#160;In addition, at least a majority of the persons serving on the Board of Directors qualify as &#8220;independent,&#8221; as defined under the listing rules of the Exchange.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">nn.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disclosure Controls</font>. The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15 under the Exchange Act, and such controls and procedures are effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of the Company&#8217;s Exchange Act filings and other public disclosure documents.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">oo.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compliance</font>. The Company is, or at the Applicable Time will be, in material compliance with the provisions of the Sarbanes-Oxley Act applicable to it, and has implemented or will implement such programs and taken reasonable steps to ensure the Company&#8217;s future compliance (not later than the relevant statutory and regulatory deadlines therefor) with all of the material provisions of the Sarbanes-Oxley Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">pp.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Accounting Controls</font>. The Company maintains systems of &#8220;internal control over financial reporting&#8221; (as defined under Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware of any material weaknesses in its internal controls.&#160;&#160;The Company&#8217;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are known to the Company&#8217;s management and that have adversely affected or are reasonably likely to adversely affect the Company&#8217; ability to record, process, summarize and report financial information; and (ii) any fraud known to the Company&#8217;s management, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls over financial reporting.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">qq.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Investment Company Status</font>. The Company is not and, after giving effect to the Offering and the application of the proceeds thereof as described in the Registration Statement, the Disclosure Package and the Prospectus, will not be, an &#8220;investment company,&#8221; as defined in the Investment Company Act of 1940, as amended.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">rr.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Labor Disputes</font>. No labor related litigation and no labor dispute with the employees of the Company or the Subsidiary exists or, to the knowledge of the Company, is imminent. The Company and the Subsidiary are in compliance in all material respects with the labor and employment laws applicable to their employees.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ss.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Intellectual Property</font>. The Company and the Subsidiary own or possess or have valid rights to use all patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and similar rights (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Intellectual Property Rights</font>&#8221;) necessary for the conduct of the business of the Company and the Subsidiary as currently carried on and as described in the Registration Statement, the Disclosure Package and the Prospectus.&#160;&#160;To the knowledge of the Company, no action or use by the Company or the Subsidiary necessary for the conduct of its business as currently carried on and as described in the Registration Statement and the Prospectus will involve or give rise to any infringement of, or license or similar fees for, any Intellectual Property Rights of others.&#160;&#160;Neither the Company nor the Subsidiary has received any notice alleging any such infringement, fee or conflict with asserted Intellectual Property Rights of others. Except as would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (i) to the knowledge of the Company, there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the Company or the Subsidiary; (ii) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the rights of the Company in or to any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim, that would, individually or in the aggregate, together with any other claims in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 6(ss)</font>, reasonably be expected to result in a Material Adverse Change; (iii) the Intellectual Property Rights owned by the Company or the Subsidiary and, to the knowledge of the Company, the Intellectual Property Rights licensed to the Company or the Subsidiary have not been adjudged by a court of competent jurisdiction invalid or unenforceable, in whole or in part, and there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 6(ss)</font>, reasonably be expected to result in a Material Adverse Change; (iv) there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others that the Company or the Subsidiary infringes, misappropriates or otherwise violates any Intellectual Property Rights or other proprietary rights of others, the Company or the Subsidiary has not received any written notice of such claim and the Company is unaware of any other facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 6(ss)</font>, reasonably be expected to result in a Material Adverse Change; and (v) to the Company&#8217;s knowledge, no employee of the Company or the Subsidiary is in or has ever been in violation in any material respect of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&#8217;s employment with the Company or the Subsidiary, or actions undertaken by the employee while employed with the Company and could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&#8217;s knowledge, all material technical information developed by and belonging to the Company or the Subsidiary which has not been patented has been kept confidential. Neither the Company nor the Subsidiary is a party to or bound by any options, licenses or agreements with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth in the Registration Statement, the Disclosure Package and the Prospectus and are not described therein. The Registration Statement, the Disclosure Package and the Prospectus contain in all material respects the same description of the matters set forth in the preceding sentence. None of the technology employed by the Company or the Subsidiary has been obtained or is being used by the Company of the Subsidiary in violation of any contractual obligation binding on the Company or the Subsidiary or, to the Company&#8217;s knowledge, any of its officers, directors or employees, or otherwise in violation of the rights of any persons. Other than as set forth in the Registration Statement, the Disclosure Package or the Prospectus, neither the Company nor the Subsidiary has received claims for royalties or other compensation from individuals, including employees of the Company, who made inventive contributions to Company&#8217;s technology or products, and neither Company or the Subsidiary will have no obligation to pay royalties or other compensation to such individuals on account of such inventive contributions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">tt.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Taxes</font>. Each of the Company and the Subsidiary has filed all returns (as hereinafter defined) required to be filed with taxing authorities prior to the date hereof or has duly obtained extensions of time for the filing thereof.&#160;&#160;Each of the Company and the Subsidiary has paid all taxes (as hereinafter defined) shown as due on such returns that were filed and has paid all taxes imposed on or assessed against the Company or the Subsidiary.&#160;&#160;The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements.&#160;&#160;Except as disclosed in writing to MLV, (i) no issues have been raised (and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as due from the Company or the Subsidiary, and (ii) no waivers of statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the Company or the Subsidiary.&#160;&#160;The term &#8220;taxes&#8221; mean all federal, state, local, foreign and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, national insurance, value added, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments or charges of any kind whatever, together with any interest and any penalties, inflation linkages, additions to tax or additional amounts with respect thereto.&#160;&#160;The term &#8220;returns&#8221; means all returns, declarations, reports, statements and other documents required to be filed in respect to taxes.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">uu.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Environmental Matters</font>. Except as would not, singly or in the aggregate, reasonably be expected to result in a Material Adverse Change, (i) each of the Company and the Subsidiary is not in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively, &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Hazardous Materials</font>&#8221;) or to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Environmental Laws</font>&#8221;), (ii) each of the Company and the Subsidiary has all permits, authorizations and approvals required under any applicable Environmental Laws and is in compliance with their requirements, (iii) there are no pending or, to the Company&#8217;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or the Subsidiary and (iv) to the Company&#8217;s knowledge, there are no events or circumstances that might reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company or the Subsidiary relating to Hazardous Materials or any Environmental Laws.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">vv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">ERISA Compliance</font>.&#160;&#160;Neither the Company nor the Subsidiary has any employees in the United States and is not subject to Employee Retirement Income Security Act of 1974.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ww.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Compliance with Laws</font>.&#160;&#160;Each of the Company and the Subsidiary: (i) is and at all times has been in compliance with all statutes, rules, or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Applicable Laws</font>&#8221;), except as could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Change; (ii) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the FDA or any other governmental authority alleging or asserting noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Authorizations</font>&#8221;); (iii) possesses all material Authorizations and such Authorizations are valid and in full force and effect and are not in material violation of any term of any such Authorizations; (iv) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any governmental authority or third party alleging that any product operation or activity is in violation of any Applicable Laws or Authorizations and has no knowledge that any such governmental authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (v) has not received notice that any governmental authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental authority is considering such action; (vi) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed (or were corrected or supplemented by a subsequent submission); and (vii) has not, either voluntarily or involuntarily, initiated, conducted, or issued or caused to be initiated, conducted or issued, any recall, market withdrawal or replacement, safety alert, post-sale warning, &#8220;dear doctor&#8221; letter, or other notice or action relating to the alleged lack of safety or efficacy of any product or any alleged product defect or violation and, to the Company&#8217;s knowledge, no third party has initiated, conducted or intends to initiate any such notice or action.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">xx.&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Ineligible Issuer</font>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the time of effectiveness of the Registration Statement and any amendment thereto, at the earliest time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the Securities Act Regulations) of the Placement Shares and at the date hereof, the Company was not and is not an &#8220;ineligible issuer,&#8221; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">yy.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Forward-Looking Statements</font>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in the Registration Statement, the Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">zz.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="DISPLAY: inline; TEXT-DECORATION: underline">Margin Securities</font>.&#160;&#160;The Company owns no &#8220;margin securities&#8221; as that term is defined in Regulation U of the Board of Governors of the Federal Reserve System (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Federal Reserve Board</font>&#8221;), and none of the proceeds of Offering will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the shares of Common Stock to be considered a &#8220;purpose credit&#8221; within the meanings of Regulation T, U or X of the Federal Reserve Board.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">aaa.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Industry Data</font>. The statistical and market-related data included in each of the Registration Statement, the Disclosure Package and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate or represent the Company&#8217;s good faith estimates that are made on the basis of data derived from such sources.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">bbb.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Exchange Act Reports</font>.&#160;&#160;The Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(a), 13(e), 14 and 15(d) of the Exchange Act during the preceding twelve (12) months (except to the extent that Section 15(d) requires reports to be filed pursuant to Sections 13(d) and 13(g) of the Exchange Act, which shall be governed by the next clause of this sentence); and the Company has filed in a timely manner all reports required to be filed pursuant to Sections 13(d) and 13(g) of the Exchange Act since September 1, 2010, except where the failure to timely file could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Change.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ccc.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Currency of Registration Statement</font>.&#160;&#160;The Applicable Time is not more than three (3) years subsequent to the initial effective date of the Registration Statement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ddd.&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Israeli Law Matters</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary does not have any immunity from the jurisdiction of any court or from any legal process (whether through service or notice, attachment prior to judgment, attachment in aid of execution or otherwise) under the laws of the State of Israel.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">No consent, approval, authorization or order of, or filing, qualification or registration with, any Israeli court or governmental agency or body, which has not been made, obtained or taken and is not in full force and effect, is required for the execution, delivery and performance of this Agreement by the Company, the offer or sale of the Placement Shares or the consummation of the transactions contemplated hereby or thereby, other than the obligation to file certain information following the Applicable Time with the Israeli Investment Center and the Office of the Chief Scientist in the Israeli Ministry of Economy (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Chief Scientist</font>&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iii.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Neither the Company nor the Subsidiary is in violation of any condition or requirement stipulated (A) by any instruments of approval, granted to it by the Chief Scientist, the Law for Encouragement of Industrial Research and Development, 5744-1984 (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">R&amp;D Law</font>&#8221;), or the Bio-Jerusalem Fund&#160;&#160;(the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Bio-Jerusalem Fund</font>&#8221;) with respect to any research and development grants or benefits given to the Company or the Subsidiary by the Chief Scientist or the Bio-Jerusalem Fund&#160;&#160;or (B) with respect to any instrument of approval granted to it by the Investment Center of the Ministry of Industry, Trade and Labor of the State of Israel with respect to grants or benefits given to the Company and the Subsidiary.&#160;&#160;Neither the Company nor the Subsidiary has received any notice denying, revoking or modifying any &#8220;approved enterprise&#8221; or &#8220;benefited enterprise&#8221; or &#8220;privileged enterprise&#8221; status with respect to any of the Company&#8217;s or the Subsidiary&#8217;s facilities or operations or with respect to any grants or benefits from the Chief Scientist, the Investment Center or the Bio-Jerusalem Fund (including, in all such cases, notice of proceedings or investigations related thereto). All information supplied by the Company or the Subsidiary with respect to the applications or notifications relating to such &#8220;approved enterprise&#8221; status, &#8220;privileged enterprise status&#8221; and &#8220;benefitted enterprise&#8221; status and to grants and benefits from the Chief Scientist, the Investment Center and/or the Bio-Jerusalem Fund was true, correct and complete in all material respects when supplied to the appropriate authorities.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 108pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iv.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">No proceedings have been instituted in the State of Israel for the dissolution of the Subsidiary.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 99pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; Any certificate signed by an officer of the Company and delivered to MLV or to counsel for MLV pursuant to or in connection with this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to MLV as to the matters set forth therein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7.&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Covenants of the Company</font>.&#160;&#160;The Company covenants and agrees with MLV that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement Amendments.</font> After the date of this Agreement and during any period in which a prospectus relating to any Placement Shares is required to be delivered by MLV under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act) (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Prospectus Delivery </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Period</font>&#8221;) (i) the Company will notify MLV promptly of the time when any subsequent amendment to the Registration Statement, other than documents incorporated by reference or amendments not related to any Placement, has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment or supplement to the Registration Statement or Prospectus related to the Placement or for additional information related to the Placement; (ii) the Company will prepare and file with the Commission, promptly upon MLV&#8217;s request, any amendments or supplements to the Registration Statement or Prospectus that, in MLV&#8217;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement Shares by MLV (<font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that the only remedy MLV shall have with respect to the failure to make such filing shall be to cease making sales under this Agreement until such amendment or supplement is filed); (iii) the Company will not file any amendment or supplement to the Registration Statement or Prospectus relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof has been submitted to MLV within a reasonable period of time before the filing and MLV has not reasonably and in good faith objected thereto in writing within two Business Days of receiving such copy (<font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that (A) the failure of MLV to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect MLV&#8217;s right to rely on the representations and warranties made by the Company in this Agreement and (B) the Company has no obligation to provide MLV any advance copy of such filing or to provide MLV an opportunity to object to such filing if the filing does not name MLV or does not directly relate to the transaction herein provided; and provided, further, that the only remedy MLV shall have with respect to the failure by the Company to obtain such consent shall be to cease making sales under this Agreement) and the Company will furnish to MLV at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for those documents available via EDGAR; and (iv) the Company will cause each amendment or supplement to the Prospectus to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act or, in the case of any document to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed (the determination to file or not file any amendment or supplement with the Commission under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(a)</font>, based on the Company&#8217;s reasonable opinion or reasonable objections, shall be made exclusively by the Company).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice of Commission Stop Orders.</font> The Company will advise MLV, promptly after it receives notice or obtains knowledge thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. The Company will advise MLV promptly after it receives any request by the Commission for any amendments to the Registration Statement or any amendment or supplements to the Prospectus or any Issuer Free Writing Prospectus or for additional information related to the offering of the Placement Shares or for additional information related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Delivery of Prospectus; Subsequent Changes.</font> During the Prospectus Delivery Period, the Company will use commercially reasonable efforts to comply in all material respects with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If the Company has omitted any information from the Registration Statement pursuant to Rule 430A under the Securities Act, it will use its commercially reasonable efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430A and to notify MLV promptly of all such filings. If during the Prospectus Delivery Period any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then existing, not misleading, or if during such Prospectus Delivery Period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify MLV to suspend the offering of Placement Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that the Company may delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interest of the Company to do so.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Listing of Placement Shares.</font> During the Prospectus Delivery Period, the Company will use its commercially reasonable efforts to cause the Placement Shares to be listed on the Exchange and to qualify the Placement Shares for sale under the securities laws of such jurisdictions in the United States as MLV reasonably designates and to continue such qualifications in effect so long as required for the distribution of the Placement Shares; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that the Company shall not be required in connection therewith to qualify as a foreign corporation or dealer in securities or file a general consent to service of process in any jurisdiction.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Delivery of Registration Statement and Prospectus.</font>&#160;&#160;The Company will furnish to MLV and its counsel (at the reasonable expense of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during the Prospectus Delivery Period (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in each case as soon as reasonably practicable and in such quantities as MLV may from time to time reasonably request and, at MLV&#8217;s request, will also furnish copies of the Prospectus to each exchange or market on which sales of the Placement Shares may be made; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that the Company shall not be required to furnish any document (other than the Prospectus) to MLV to the extent such document is available on EDGAR.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">f.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Earning Statement.</font>&#160;&#160;The Company will make generally available to its security holders as soon as practicable, but in any event not later than fifteen (15) months after the end of the Company&#8217;s current fiscal quarter, an earning statement covering a 12-month period that satisfies the provisions of Section 11(a) and Rule 158 of the Securities Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">g.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Proceeds.</font> The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#8220;Use of Proceeds.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">h.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notice of Other Sales.</font> Without the prior written consent of MLV, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock during the period beginning on the date on which any Placement Notice is delivered to MLV hereunder and ending on the third (3rd) Trading Day immediately following the final Settlement Date with respect to Placement Shares sold pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date of such suspension or termination); and will not directly or indirectly in any other &#8220;at-the-market&#8221; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock prior to the termination of this Agreement; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that such restrictions will not be required in connection with the Company&#8217;s issuance or sale of (i) Common Stock, options to purchase Common Stock, restricted stock units or Common Stock issuable upon the exercise of options or settlement of restricted stock units, pursuant to any employee or director stock option or benefits plan, stock ownership plan or dividend reinvestment plan (but not Common Stock subject to a waiver to exceed plan limits in its dividend reinvestment plan) of the Company whether now in effect or hereafter implemented; (ii) Common Stock issuable upon conversion of securities or the exercise of warrants, options or other rights in effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to MLV, and (iii) Common Stock, or securities convertible into or exercisable for Common Stock, offered and sold in a privately negotiated transaction to vendors, consultants, service providers, customers, strategic partners or potential strategic partners or other investors conducted in a manner so as not to be integrated with the offering of Common Stock hereby.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Change of Circumstances.</font> The Company will, at any time during the pendency of a Placement Notice advise MLV promptly after it shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document required to be provided to MLV pursuant to this Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">j.&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Due Diligence Cooperation.</font> During the term of this Agreement, the Company will cooperate with any reasonable due diligence review conducted by MLV or its representatives in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during regular business hours and at the Company&#8217;s principal offices, as MLV may reasonably request.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">k.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Required Filings Relating to Placement of Placement Shares.</font> The Company agrees that on such dates as the Securities Act shall require, the Company will (i) file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b) under the Securities Act (each and every filing under Rule 424(b), a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Filing Date</font>&#8221;), which prospectus supplement will set forth, within the relevant period, the amount of Placement Shares sold through MLV, the Net Proceeds to the Company and the compensation payable by the Company to MLV with respect to such Placement Shares, and (ii) deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were effected as may be required by the rules or regulations of such exchange or market.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">l.&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representation Dates; Certificate.</font> Each time during the term of this Agreement that the Company:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(i)&#160;&#160;&#160;&#160;&#160;&#160; amends or supplements (other than a prospectus supplement relating solely to an offering of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration Statement or the Prospectus relating to the Placement Shares;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;files an annual report on Form 10-K under the Exchange Act (including any Form 10-K/A containing amended financial information or a material amendment to the previously filed Form 10-K);</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iii)&#160;&#160;&#160;&#160;&#160;files its quarterly reports on Form 10-Q under the Exchange Act; or</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 108pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(iv)&#160;&#160; &#160;&#160;files a current report on Form 8-K containing amended financial information (other than information &#8220;furnished&#8221; pursuant to Items 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to the reclassification of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) under the Exchange Act, </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 108pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Each date of filing of one or more of the documents referred to in clauses (i) through (iv) shall be a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representation Date.</font>&#8221;)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the Company shall furnish MLV (but in the case of clause (iv) above only if MLV determines that the information contained in such Form 8-K is material) with a certificate, in the form attached hereto as <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 7(l)</font>. The requirement to provide a certificate under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section&#160;</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">7(l)</font> shall be automatically waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date on which the Company files its annual report on Form 10-K. Notwithstanding the foregoing, (i) upon the delivery of the first Placement Notice hereunder and (ii) if the Company subsequently decides to sell Placement Shares following a Representation Date when the Company relied on such waiver and did not provide MLV with a certificate under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(l)</font>, then before MLV sells any Placement Shares, the Company shall provide MLV with a certificate, in the form attached hereto as <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 7(l)</font>, dated the date of the Placement Notice.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">m.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Legal Opinion.</font> On or prior to the date of the first Placement Notice given hereunder, the Company shall cause to be furnished to MLV a written opinion and a negative assurance letter of Zysman, Aharoni, Gayer and Sullivan &amp; Worcester LLP ( &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company Counsel</font>&#8221;), or other counsel reasonably satisfactory to MLV.&#160;&#160;Thereafter, within five (5) Trading Days after each Representation Date with respect to which the Company is obligated to deliver a certificate in the form attached hereto as <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 7(l)</font> for which no waiver is applicable, and not more than once per calendar quarter, the Company shall cause to be furnished to MLV a written letter of Company Counsel, or other counsel reasonably satisfactory to MLV, modified, as necessary, to relate to the Registration Statement and the Prospectus as then amended or supplemented; <font style="FONT-STYLE: italic; DISPLAY: inline">provided that</font>, in lieu of such negative assurance for subsequent periodic filings under the Exchange Act, counsel may furnish MLV with a letter (a &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Reliance Letter</font>&#8221;) to the effect that MLV may rely on the negative assurance letter previously delivered under this Section 7(m) to the same extent as if it were dated the date of such letter (except that statements in such prior letter shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of the date of the Reliance Letter).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">n.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Comfort Letter.</font> On or prior to the date of the first Placement Notice given hereunder and within five (5) Trading Days after each subsequent Representation Date, other than pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(l)(iii)</font>, with respect to which the Company is obligated to deliver a certificate in the form attached hereto as <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 7(l)</font> for which no waiver is applicable, the Company shall cause its independent accountants to furnish MLV letters (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Comfort </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letters</font>&#8221;), dated the date the Comfort Letter is delivered, which shall meet the requirements set forth in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(n)</font>; provided, that if requested by MLV, the Company shall cause a Comfort Letter to be furnished to MLV within ten (10) Trading Days of such request following the date of occurrence of any restatement of the Company&#8217;s financial statements. The Comfort Letter from the Company&#8217;s independent accountants shall be in a form and substance reasonably satisfactory to MLV, (i) confirming that they are an independent public accounting firm within the meaning of the Securities Act and the PCAOB, (ii) stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters in connection with registered public offerings (the first such letter, the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Initial Comfort Letter</font>&#8221;) and (iii) updating the Initial Comfort Letter with any information that would have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">o.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Market Activities.</font> The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii) sell, bid for, or purchase Common Stock in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than MLV.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">p.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Investment Company Act.</font> The Company will conduct its affairs in such a manner so as to reasonably ensure that neither it nor the Subsidiary will be or become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">q.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Offer to Sell. </font>Other than an Issuer Free Writing Prospectus approved in advance by the Company and MLV in its capacity as agent hereunder pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 23</font>, neither MLV nor the Company (including its agents and representatives, other than MLV in their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">r.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Sarbanes-Oxley Act.</font> The Company will maintain and keep accurate books and records reflecting its assets and maintain internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and including those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company, (ii) provide reasonable assurance that transactions are recorded as necessary to permit the preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP, (iii) that receipts and expenditures of the Company are being made only in accordance with management&#8217;s and the Company&#8217;s directors&#8217; authorization, and (iv) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on its financial statements. The Company will maintain such controls and other procedures, including, without limitation, those required by Sections 302 and 906 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure and to ensure that material information relating to the Company or the Subsidiary is made known to them by others within those entities, particularly during the period in which such periodic reports are being prepared.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8.&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representations and Covenants of MLV.</font> MLV represents and warrants that it is duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which MLV is exempt from registration or such registration is not otherwise required. MLV shall continue, for the term of this Agreement, to be duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which MLV is exempt from registration or such registration is not otherwise required, during the term of this Agreement.&#160;&#160;MLV shall comply with all applicable law and regulations, including but not limited to Regulation M, in connection with the transactions contemplated by this Agreement, including the issuance and sale through MLV of the Placement Shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Payment of Expenses.</font> The Company will pay all expenses incident to the performance of its obligations under this Agreement, including (i) the preparation, filing, including any fees required by the Commission, and printing of the Registration Statement (including financial statements and exhibits) as originally filed and of each amendment and supplement thereto and each Issuer Free Writing Prospectus, in such number as MLV shall deem reasonably necessary, (ii) the printing and delivery to MLV of this Agreement and such other documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Placement Shares, (iii) the preparation, issuance and delivery of the certificates, if any, for the Placement Shares to MLV, including any stock or other transfer taxes and any capital duties, stamp duties or other duties or taxes payable upon the sale, issuance or delivery of the Placement Shares to MLV, (iv) the reasonable fees and disbursements of the counsel, accountants and other advisors to the Company, (v) the fees and disbursements of counsel to MLV incurred in connection with the transactions contemplated by this agreement in an aggregate amount of up to $25,000; (vi) the fees and expenses of the transfer agent and registrar for the Common Stock, (vii) the filing fees incident to any review by FINRA of the terms of the sale of the Placement Shares, and (viii) the fees and expenses incurred in connection with the listing of the Placement Shares on the Exchange.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Conditions to MLV&#8217;s Obligations.</font> The obligations of MLV hereunder with respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its obligations hereunder, to the completion by MLV of a due diligence review satisfactory to it in its reasonable judgment, and to the continuing satisfaction (or waiver by MLV in its sole discretion) of the following additional conditions:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Registration Statement Effective.</font> The Registration Statement shall have become effective and shall be available for the sale of all Placement Shares contemplated to be issued by any Placement Notice.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Material Notices.</font> None of the following events shall have occurred and be continuing: (i) receipt by the Company of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv) the occurrence of any event that makes any material statement made in the Registration Statement or the Prospectus or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or documents so that, in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, that in the case of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Misstatement or Material Omission.</font> MLV shall not have advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in MLV&#8217;s reasonable opinion is material, or omits to state a fact that in MLV&#8217;s reasonable opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Material Changes.</font> Except as contemplated in the Prospectus, or disclosed in the Company&#8217;s reports filed with the Commission, there shall not have been any Material Adverse Change, or any development in the business or affairs of the Company that could reasonably be expected to cause a Material Adverse Change, or a downgrading in or withdrawal of the rating assigned to any of the Company&#8217;s securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it has under surveillance or review its rating of any of the Company&#8217;s securities (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of MLV (without relieving the Company of any obligation or liability it may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Legal Opinion.</font> MLV shall have received the opinions and negative assurances of Company Counsel required to be delivered pursuant <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(m)</font> on or before the date on which such delivery of such opinions are required pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(m)</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">f.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Comfort Letter.</font> MLV shall have received the Comfort Letter required to be delivered pursuant <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(n)</font> on or before the date on which such delivery of such letter is required pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(n)</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">g.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representation Certificate.</font> MLV shall have received the certificate required to be delivered pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(l)</font> on or before the date on which delivery of such certificate is required pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 7(l)</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">h.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Suspension.</font> Trading in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been delisted from the Exchange.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">i.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;[Reserved]</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">j.&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Securities Act Filings Made.</font> All filings with the Commission required by Rule 424 under the Securities Act to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">k.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Approval for Listing.</font> The Placement Shares shall either have been approved for listing on the Exchange, subject only to notice of issuance, or the Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement Notice.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">l.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">No Termination Event.</font> There shall not have occurred any event that would permit MLV to terminate this Agreement pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 13(a)</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11.&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Indemnification and Contribution.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="DISPLAY: inline; TEXT-DECORATION: underline">Company Indemnification.</font> The Company agrees to indemnify and hold</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">harmless MLV, its partners, members, directors, officers, employees and agents and each person, if any, who controls MLV within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 99pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160; (i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 99pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160; (ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">11(d)</font> below) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed or withheld; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 99pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160; (iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with written information furnished to the Company by MLV expressly for use in the Registration Statement (or any amendment thereto), or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font>(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">MLV Indemnification.</font> MLV agrees to indemnify and hold harmless the Company and its directors and each officer of the Company who signed the Registration Statement, and each person, if any, who (i) controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or (ii) is controlled by or is under common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(a)</font>, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information relating to MLV and furnished to the Company in writing by MLV expressly for use therein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font>(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Procedure.</font> Any party that proposes to assert the right to be indemnified under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font>, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i) any liability that it might have to any indemnified party otherwise than under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> and (ii) any liability that it may have to any indemnified party under the foregoing provision of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> unless, and only to the extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1) the employment of counsel by the indemnified party has been authorized in writing by the indemnifying party, (2) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (3) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the indemnifying party promptly after the indemnifying party receives a written invoice relating to fees, disbursements and other charges in reasonable detail. An indemnifying party will not, in any event, be liable for any settlement of any action or claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1) includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (2) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Contribution.</font> In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or MLV, the Company and MLV will contribute to the total losses, claims, liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons other than MLV, such as persons who control the Company within the meaning of the Securities Act or the Exchange Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the Company and MLV may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and MLV on the other hand. The relative benefits received by the Company on the one hand and MLV on the other hand shall be deemed to be in the same proportion as the total Net Proceeds from the sale of the Placement Shares (before deducting expenses) received by the Company bear to the total compensation received by MLV (before deducting expenses) from the sale of Placement Shares on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and MLV, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering.&#160;&#160;Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or MLV, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and MLV agree that it would not be just and equitable if contributions pursuant to this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(d)</font> were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(d)</font> shall be deemed to include, for the purpose of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(d)</font>, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(c)</font> hereof. Notwithstanding the foregoing provisions of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(d)</font>, MLV shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(d)</font>, any person who controls a party to this Agreement within the meaning of the Securities Act or the Exchange Act, and any officers, directors, partners, employees or agents of MLV, will have the same rights to contribution as that party, and each officer and director of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(d)</font>, will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(d)</font> except to the extent that the failure to so notify such other party materially prejudiced the substantive rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(c)</font> hereof, no party will be liable for contribution with respect to any action or claim settled without its written consent if such consent is required pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11(c)</font> hereof.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12.&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Representations and Agreements to Survive Delivery.</font>&#160;&#160;The indemnity and contribution agreements contained in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant hereto shall survive, as of their respective dates, regardless of (i) any investigation made by or on behalf of MLV, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons), (ii) delivery and acceptance of the Placement Shares and payment therefor or (iii) any termination of this Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13.&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Termination.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MLV may terminate this Agreement, by notice to the Company, as hereinafter specified at any time (1) if there has been, since the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse Change, or any development that is reasonably likely to result in a Material Adverse Change or, in the sole judgment of MLV, is material and adverse and makes it impractical or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (2) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of MLV, impracticable or inadvisable to market the Placement Shares or to enforce contracts for the sale of the Placement Shares, (3) if trading in the Common Stock has been suspended or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices for trading have been fixed on the Exchange for at least ten (10) consecutive Trading Days, (4) if any suspension of trading of any securities of the Company on any exchange or in the over-the-counter market shall have occurred and be continuing for at least ten (10) consecutive Trading Days, (5) if a major disruption of securities settlements or clearance services in the United States shall have occurred and be continuing, or (6) if a banking moratorium has been declared by either U.S. Federal or New York authorities. Any such termination shall be without liability of any party to any other party except that the provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section</font> 9 (Payment of Expenses), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> (Indemnification and Contribution), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 12</font> (Representations and Agreements to Survive Delivery), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 18</font> (Governing Law and Time; Waiver of Jury Trial) and <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 19</font> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination. If MLV elects to terminate this Agreement as provided in this Section 13(a), MLV shall provide the required notice as specified in Section 14 (Notices).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall have the right, by giving ten (10) days&#8217; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 9</font> (Payment of Expenses), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> (Indemnification and Contribution), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 12</font> (Representations and Agreements to Survive Delivery), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 18</font> (Governing Law and Time; Waiver of Jury Trial) and <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 19</font> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MLV shall have the right, by giving ten (10) days&#8217; notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 9</font> (Payment of Expenses), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> (Indemnification and Contribution), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 12</font> (Representations and Agreements to Survive Delivery), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 18</font> (Governing Law and Time; Waiver of Jury Trial) and <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 19</font> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless earlier terminated pursuant to this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 13</font>, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through MLV on the terms and subject to the conditions set forth herein except that the provisions of <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 9</font> (Payment of Expenses), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> (Indemnification and Contribution), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 12</font> (Representations and Agreements to Survive Delivery), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 18</font> (Governing Law and Time; Waiver of Jury Trial) and <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 19</font> (Consent to Jurisdiction) hereof shall remain in full force and effect notwithstanding such termination.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement shall remain in full force and effect unless terminated pursuant to <font style="DISPLAY: inline; TEXT-DECORATION: underline">Sections 13(a)</font>, <font style="DISPLAY: inline; TEXT-DECORATION: underline">(b</font>), <font style="DISPLAY: inline; TEXT-DECORATION: underline">(c</font>), or <font style="DISPLAY: inline; TEXT-DECORATION: underline">(d)</font> above or otherwise by mutual agreement of the parties; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that any such termination by mutual agreement shall in all cases be deemed to provide that <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 9</font> (Payment of Expenses), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> (Indemnification and Contribution), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 12</font> (Representations and Agreements to Survive Delivery), <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 18</font> (Governing Law and Time; Waiver of Jury Trial) and <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 19</font> (Consent to Jurisdiction) shall remain in full force and effect. Upon termination of this Agreement, the Company shall not have any liability to MLV for any discount, commission or other compensation with respect to any Placement Shares not otherwise sold by MLV under this Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">f.&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;Any termination of this Agreement shall be effective on the date specified in such notice of termination; <font style="FONT-STYLE: italic; DISPLAY: inline">provided, however</font>, that such termination shall not be effective until the close of business on the date of receipt of such notice by MLV or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Notices.</font> All notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified, and if sent to MLV, shall be delivered to:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="MARGIN-LEFT: 72pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" colspan="2" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">MLV &amp; Co. LLC</font></div>
</td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 201.6pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1301 Avenue of the Americas, 43<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">rd</font> Fl. New York, New York 10020</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attention:</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General Counsel</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Telephone:</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(212) 542-5880</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Email:</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">mlvlegal@mlvco.com</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">with a copy to (which copy shall not constitute notice):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 72pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" colspan="2" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 144pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">LeClairRyan, A Professional Corporation</font></div>
</td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 144pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">885 Third Avenue</font></div>
</td>
</tr><tr>
<td align="left" colspan="2" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">New York, NY 10022</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attention:</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James T. Seery</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Telephone:</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(973) 491-3315</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Email:</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">james.seery@leclairryan.com</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">and if to the Company, shall be delivered to:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="MARGIN-LEFT: 72pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oramed Pharmaceuticals Inc.</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hi-Tech Park 2/4</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Givat-Ram</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">P.O. Box 39098</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Jerusalem, Israel 91390</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attention: Chief Financial Officer</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Telephone: 972-2-566-0001</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Email: yifat@oramed.com</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">with copies to (which copies shall not constitute notice):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="MARGIN-LEFT: 72pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zysman, Aharoni, Gayer and Sullivan &amp; Worcester LLP</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 216pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1633 Broadway</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 216pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">New York, NY 10019</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attention:&#160;&#160;&#160;Oded Har-Even, Esq. and Howard E. Berkenblit, Esq.</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Telephone:&#160;&#160;(212) 660-3000</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Email: ohareven@zag-sw.com and hberkenblit@zag-sw.com</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i) when delivered personally, by email, or by verifiable facsimile transmission (with an original to follow) on or before 4:30 p.m., New York City time, on a Business Day or, if such day is not a Business Day, on the next succeeding Business Day, (ii) on the next Business Day after timely delivery to a nationally-recognized overnight courier and (iii) on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). For purposes of this Agreement, &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Business Day</font>&#8221; shall mean any day on which the Exchange and commercial banks in the City of New York are open for business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">An electronic communication (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Electronic Notice</font>&#8221;) shall be deemed written notice for purposes of this <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 14</font> if sent to the electronic mail address specified by the receiving party under separate cover. Electronic Notice shall be deemed received at the time the party sending Electronic Notice receives confirmation of receipt by the receiving party. Any party receiving Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Nonelectronic Notice</font>&#8221;) which shall be sent to the requesting party within ten (10) days of receipt of the written request for Nonelectronic Notice.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Successors and Assigns.</font> This Agreement shall inure to the benefit of and be binding upon the Company and MLV and their respective successors and the affiliates, controlling persons, officers and directors referred to in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section 11</font> hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Adjustments for Stock Splits.</font> The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be adjusted to take into account any share consolidation, stock split, stock dividend, corporate domestication or similar event effected with respect to the Placement Shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">36</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Entire Agreement; Amendment; Severability.</font> This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto), together with that certain side letter dated as of the date hereof, constitutes the entire agreement and supersedes all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and MLV. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">GOVERNING LAW AND TIME; WAIVER OF JURY TRIAL.</font> THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. THE COMPANY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">CONSENT TO JURISDICTION.</font> EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Use of Information.</font> MLV may not use any information gained in connection with this Agreement and the transactions contemplated by this Agreement, including due diligence, to advise any party with respect to transactions not expressly approved by the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">37</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Counterparts.</font> This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile transmission.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Effect of Headings.</font>&#160;&#160;The section and Exhibit headings herein are for convenience only and shall not affect the construction hereof.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Permitted Free Writing Prospectuses.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>The Company represents, warrants and agrees that, unless it obtains the prior consent of MLV (such consent not to be unreasonably, withheld, conditioned or delayed), and MLV represents, warrants and agrees that, unless it obtains the prior consent of the Company (such consent not to be unreasonably, withheld, conditioned or delayed), it has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a &#8220;free writing prospectus,&#8221; as defined in Rule 405, required to be filed with the Commission. Any such free writing prospectus consented to by MLV or by the Company, as the case may be, is hereinafter referred to as a &#8220;Permitted Free Writing Prospectus.&#8221; The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. For the purposes of clarity, the parties hereto agree that all free writing prospectuses, if any, listed in <font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 23</font> hereto are Permitted Free Writing Prospectuses.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Absence of Fiduciary Relationship.</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;</font>The Company acknowledges and agrees that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MLV is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any other party, on the one hand, and MLV, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not MLV has advised or is advising the Company on other matters, and MLV has no obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions contemplated by this Agreement;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MLV has not provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">38</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;it is aware that MLV and its affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and MLV has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise; and</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">e.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;it waives, to the fullest extent permitted by law, any claims it may have against MLV for breach of fiduciary duty or alleged breach of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that MLV shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company, other than in respect of MLV&#8217;s obligations under this Agreement and to keep information provided by the Company to MLV and MLV&#8217;s counsel confidential to the extent not otherwise publicly-available.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Definitions.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As used in this Agreement, the following terms have the respective meanings set forth below:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Applicable Time</font>&#8221; means (i) each Representation Date and (ii) the time of each sale of any Placement Shares pursuant to this Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Disclosure Package</font>&#8221; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time and the Prospectus, all considered together.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuer Free Writing Prospectus</font>&#8221; means any &#8220;issuer free writing prospectus,&#8221; as defined in Rule 433, relating to the Placement Shares that (1) is required to be filed with the Commission by the Company, (2) is a &#8220;road show&#8221; that is a &#8220;written communication&#8221; within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with the Commission, or (3) is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Placement Shares or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g) under the Securities Act Regulations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuer General Use Free Writing Prospectus</font>&#8221; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors (other than a &#8220;bona fide electronic road show,&#8221; as defined in Rule 433), as evidenced by its being specified in Schedule 25 hereto Regulations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Issuer Limited Use Free Writing Prospectus</font>&#8221; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 32.4pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 172</font>,&#8221; &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 405</font>,&#8221; &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 415</font>,&#8221; &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 424</font>,&#8221; &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 424(b)</font>,&#8221; &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 430B</font>,&#8221; and &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Rule 433</font>&#8221; refer to such rules under the Securities Act.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">39</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All references in this Agreement to financial statements and schedules and other information that is &#8220;contained,&#8221; &#8220;included&#8221; or &#8220;stated&#8221; in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is incorporated by reference in the Registration Statement or the Prospectus, as the case may be.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All references in this Agreement to the Registration Statement, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing Prospectus (other than any Issuer Free Writing Prospectuses that, pursuant to Rule 433, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all references in this Agreement to &#8220;supplements&#8221; to the Prospectus shall include, without limitation, any supplements, &#8220;wrappers&#8221; or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by MLV outside of the United States.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">[Remainder of the page intentionally left blank]</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">40</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If the foregoing correctly sets forth the understanding between the Company and MLV, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and MLV.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Very truly yours,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="3%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td align="left" valign="top" width="24%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Nadav Kidron</font></div>
</td>
<td align="left" valign="top" width="23%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="24%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name: Nadav Kidron</font></div>
</td>
<td align="left" valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="24%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title: Chief Executive Officer and President</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 9pt" align="left">&#160;</div>
</td>
<td align="left" valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 21.6pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ACCEPTED as of the date first-above written:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 21.6pt" align="left">&#160;</div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MLV &amp; CO. LLC</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="3%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td align="left" valign="top" width="24%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Patrice McNicoll</font></div>
</td>
<td align="left" valign="top" width="23%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="24%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 54pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name:&#160;&#160;Patrice McNicoll</font></div>
</td>
<td align="left" valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="24%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 36pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title:&#160;&#160;Chief Executive Officer</font></div>
</td>
<td align="left" valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">41</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE 1</font></div>

<div>
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
 &#160; </div>

<div style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">FORM OF PLACEMENT </font>NOTICE</div>

<div style="TEXT-ALIGN: center">&#160;</div>

<div style="TEXT-ALIGN: center">
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
</div>

<div>&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From:</font></div>
</td>
<td align="left" valign="top" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Oramed Pharmaceuticals Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">To:</font></div>
</td>
<td align="left" valign="top" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">MLV &amp; Co. LLC</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Attention:</font></div>
</td>
<td align="left" valign="top" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patrice McNicoll</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
</tr><tr>
<td align="left" valign="top" width="12%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject:</font></div>
</td>
<td align="left" valign="top" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">At-the-Market Issuance &#8211; Placement Notice</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Gentlemen:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the terms and subject to the conditions contained in the At-the-Market Issuance Sales Agreement between Oramed Pharmaceuticals Inc., a Delaware corporation (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>&#8221;), and MLV &amp; Co. LLC (&#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">MLV</font>&#8221;), dated April 2, 2015, the Company hereby requests that MLV sell up to [_______] shares of the Company&#8217;s Common Stock, $0.012 par value per share, at a minimum market price of $per share, during the time period beginning [month, day, time] and ending [month, day, time].</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE 2</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
</div>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compensation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160; </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company shall pay to MLV in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount equal to 3% of the gross proceeds from each sale of Placement Shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE 3</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
</div>

<br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Notice Parties</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">The Company</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nadav Kidron</font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">nadav@oramed.com</font></font></div>
</td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yifat Zommer</font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">yifat@oramed.com</font></font></div>
</td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">MLV</font></font></div>
</td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Randy Billhardt</font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">rbillhardt@mlvco.com</font></font></div>
</td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ryan Loforte</font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">rloforte@mlvco.com</font></font></div>
</td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patrice McNicoll</font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">pmcnicoll@mlvco.com</font></font></div>
</td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="60%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="20%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Miranda Toledano</font></div>
</td>
<td align="left" valign="top" width="60%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">mtoledano@mlvco.com</font></font></div>
</td>
<td valign="top" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">With a copy to <font style="DISPLAY: inline; TEXT-DECORATION: underline">mlvatmdesk@mlvco.com</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SCHEDULE 6(g)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Subsidiary</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<hr style="COLOR: black" align="center" noshade size="2" width="20%">
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Oramed Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Schedule 25</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Issuer General Use Free Writing Prospectuses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">EXHIBIT 7(l)</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Form of Representation Date Certificate</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This Representation Date Certificate (this &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Certificate</font>&#8221;) is executed and delivered in connection with <font style="DISPLAY: inline; TEXT-DECORATION: underline">Section </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">7(l)</font> of the At-the-Market Issuance Sales Agreement (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Agreement</font>&#8221;), dated April&#160;2, 2015, and entered into between Oramed Pharmaceuticals Inc. (the &#8220;<font style="DISPLAY: inline; TEXT-DECORATION: underline">Company</font>&#8221;) and MLV &amp; Co. LLC. All capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company hereby certifies as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;As of the date of this Certificate (i) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading and (ii) neither the Registration Statement nor the Prospectus contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading and (iii) no event has occurred as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein not untrue or misleading for this paragraph 1 to be true.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;Each of the representations and warranties of the Company contained in the Agreement were, when originally made, and are, as of the date of this Certificate, true and correct in all material respects (except for representations and warranties that are made as of a specific date, which representations and warranties shall be true and correct at and as of such respective specific date).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;Except as waived by MLV in writing, each of the covenants required to be performed by the Company in the Agreement on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement, has been duly, timely and fully performed in all material respects and each condition required to be complied with by the Company on or prior to the date of the Agreement, this Representation Date, and each such other date prior to the date hereof as set forth in the Agreement has been duly, timely and fully complied with in all material respects.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;No stop order suspending the effectiveness of the Registration Statement or of any part thereof has been issued, and, to the knowledge of the Company, no proceedings for that purpose have been instituted or are pending or threatened by any securities or other governmental authority (including, without limitation, the Commission).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;No order suspending the effectiveness of the Registration Statement or the qualification or registration of the Placement Shares under the securities or Blue Sky laws of any</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">jurisdiction are in effect and no proceeding for such purpose is pending before, or threatened, to the Company&#8217;s knowledge or in writing by, any securities or other governmental authority (including, without limitation, the Commission).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 10.8pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The undersigned has executed this Officer&#8217;s Certificate of behalf of the Company as of the date first written above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ORAMED PHARMACEUTICALS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="4%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By:</font></div>
</td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="4%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name:</font></div>
</td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="4%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title:</font></div>
</td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="23%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">EXHIBIT 23</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Permitted Free Writing Prospectuses</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</div>
</div>
</div>

<div>&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
    <title>exhibit_31-1.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 31.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO RULE 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Nadav Kidron, certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.&#160;&#160;&#160; I have reviewed this quarterly report on Form 10-Q of Oramed Pharmaceuticals Inc.;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.&#160;&#160; &#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></font></div>
</div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="51%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated:&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman">April 2</font>, 2015</font></div>
</td>
<td valign="top" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Nadav Kidron</font></div>
</td>
<td valign="top" width="23%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="51%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="26%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nadav Kidron</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and Chief Executive Officer</font></div>
</td>
<td align="left" valign="bottom" width="23%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
    <title>exhibit_31-2.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 31.2</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO RULE 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Yifat Zommer, certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of Oramed Pharmaceuticals Inc.;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 27pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="5%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b)</font></div>
</td>
<td valign="top" width="78%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></font></div>
</div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="59%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated:&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman">April 2</font>, 2015</font></div>
</td>
<td valign="top" width="25%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Yifat Zommer</font></div>
</div>
</td>
<td valign="top" width="15%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="59%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="25%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yifat Zommer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
<td align="left" valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
    <title>exhibit_32-1.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 32.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO 18 U.S.C. SECTION 1350</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the quarterly report of Oramed Pharmaceuticals Inc., or the Company, on Form 10-Q for the period ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Nadav Kidron, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, that to my knowledge:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="59%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated: <font style="DISPLAY: inline; FONT-FAMILY: times new roman">April 2</font>, 2015</font></div>
</td>
<td valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Nadav Kidron</font></div>
</div>
</td>
<td valign="top" width="15%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="59%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nadav Kidron, President and Chief Executive Officer</font></div>
</td>
<td align="left" valign="top" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
    <title>exhibit_32-2.htm</title>
    <!--Licensed to: ZKG-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 32.2</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO 18 U.S.C. SECTION 1350</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the quarterly report of Oramed Pharmaceuticals Inc., or the Company, on Form 10-Q for the period ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Yifat Zommer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, that to my knowledge:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="59%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dated:&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman">April 2</font>, 2015</font></div>
</td>
<td valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Yifat Zommer</font></div>
</div>
</td>
<td valign="top" width="15%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="59%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yifat Zommer, Chief Financial Officer</font></div>
</td>
<td align="left" valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>pp.jpg
<TEXT>
begin 644 pp.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0"J17AI9@``34T`*@````@`"0$:``4`
M```!````>@$;``4````!````@@$H``,````!``(```$Q``(````0````B@,!
M``4````!````F@,#``$````!`````%$0``$````!`0```%$1``0````!```.
MPU$2``0````!```.PP````````!@`````0```&`````!4&%I;G0N3D54('8U
M+C`P```!AJ```+&/_]L`0P`"`0$"`0$"`@("`@("`@,%`P,#`P,&!`0#!0<&
M!P<'!@<'"`D+"0@("@@'!PH-"@H+#`P,#`<)#@\-#`X+#`P,_]L`0P$"`@(#
M`P,&`P,&#`@'"`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,_\``$0@`,P"*`P$B``(1`0,1`?_$`!\```$%`0$!
M`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$```!?0$"
M`P`$$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G
M*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%
MAH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35
MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$!`0$`````
M```!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1!`4A,082
M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C
MY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`_?O<,X]*7/L37S3KW_!6
MCX)^&?$.H:7>>(=36[TVYDM)U71KMPDB.589$9!P0>E5/^'POP*//_"1:L,_
M]0.\_P#C=>-+B'+8MQE7BFO,]F'#F:22E&A)I^3/J'/L:,^QKY>_X?"?`K_H
M8M6_\$EY_P#&Z/\`A\)\"O\`H8M6_P#!)>?_`!NE_K'E?_/^/WE?ZLYM_P!`
M\_N9]0Y]C1GV-?+W_#X3X%?]#%JW_@DO/_C='_#X3X%?]#%JW_@DO/\`XW1_
MK'E?_/\`C]X?ZLYM_P!`\_N9]0Y]C1GV-?+W_#X3X%?]#%JW_@DO/_C='_#X
M3X%?]#%JW_@DO/\`XW1_K'E?_/\`C]X?ZLYM_P!`\_N9]0Y]C1GV-?+W_#X3
MX%?]#%JW_@DO/_C='_#X3X%?]#%JW_@DO/\`XW1_K'E?_/\`C]X?ZLYM_P!`
M\_N9]0Y]C1GV-?+W_#X3X%?]#%JW_@DO/_C='_#X3X%?]#%JW_@DO/\`XW1_
MK'E?_/\`C]X?ZLYM_P!`\_N9]0Y]C7(Z/8!/C?XBNOL5]'YVBZ9%]K=LVT^V
M?4#Y:#9PZ;\L=YR)8_E7J_AG_#X3X%?]#%JW_@DO/_C=<YIO_!5[X&6GQ6UO
M5SK6MK'?Z586JSG2[HQR&&:]8H(_)W*RB8$L6(?S%``*,6N'$>66E^_CMW\T
M9SX8S9N/^SSW[/L=1^TG^WY:_LL?M8^'O"OB6W`\'>(-%2YGU"-"9-*F-Q)'
MYK@?>A/R!L<KPW3(/TGI6JV^LZ=!=VD\-U:W,:S130N'CE1AE65AP00001P:
M_*7]N/\`:0\'?M6_M)Z5JOA*ZGU32K/PP]A<M/9RVX\PW18H5D49!4]<8'-=
M)^P]^W#>?LE:O;^$_%MS<W_PSO9=MI=R;I)?#4C-P#G):V+>Y*$Y'?=\1A./
ML/#.*F!KR7LVURR_1GW>+\.\3/)*698>#]HD^>#WT>Z^70_3Y7#<CI1N]C57
M2M5M=:TVWO+.>&ZM+J-9H9HI!)'*C#*LK#@@@Y!'!%3&<#C</S%?IB=U=:IG
MY<D[M/H?BW)C_A-O&6`!CQ-J7;_IY>IL_A4,O'C;QGD$'_A)=2_]*7J7GT/\
MZ_C#.)-8ZKK]I_F?W'DJC]0HZ?97Y(7/U_2C/U_2DP?0_E1@^A_*O-YWW/3Y
M8BY^OZ49^OZ4F#Z'\J,'T/Y4<[[ARQ%S]?THS]?TI,'T/Y48/H?RHYWW#EB+
MGZ_I1GZ_I28/H?RHP?0_E1SON'+$7/U_2C/U_2DP?0_E1@^A_*CG?<.6(N?K
M^E)GKU_/'^?\^M&#Z'\J"<>N334W?<'&(8ZY-,N+>.[MWBE1)(Y5*NK#<K`C
M&"#P:><`D$@$>O%+@XR00/H:E-[C<4]'U/9/V'OVXKS]DO6+;PIXMN;B^^&=
M[-MM;MR9)?#4C'@'.2UL6/3DIU'?=^F-AKMGJMA!=6MW#<6US&LL4L3ATD1A
ME65AP00001UK\?OA)\%?$?[5GQ$/@KPG&B1J`=;U:5-]KHT#<9;^]*P!"(""
M2">`"R_?GAW_`():?"G0O#]A8M:^([IK.WC@,S>(+V-IMJA=Q6.144G&<*H4
M9X`&!7]&^'>99O6R^U:GS06D6W9V/YC\2\LR6AF5Z%3EG+622NK]]U:YX1KW
M_!(7XA3>+M=O=-\;^%(;/5=4N=0CCFL)F>,2RL^TD,`2`<57_P"'0WQ/&`/'
M7@P@?]0V?_XJOT2HKZ*MX>Y)5FZDZ5VW?=GSM'Q'SZE!4X5K)*RT70_.W_AT
M/\3_`/H>O!G_`(+I_P#XNC_AT/\`$_\`Z'KP9_X+I_\`XNOT2HK+_B'&1?\`
M/K\6:?\`$3.(?^?_`."/SM_X=#_$_P#Z'KP9_P""Z?\`^+H_X=#_`!/_`.AZ
M\&?^"Z?_`.+K]$J*/^(<9%_SZ_%A_P`1,XA_Y_\`X(_.W_AT/\3_`/H>O!G_
M`(+I_P#XNC_AT/\`$_\`Z'KP9_X+I_\`XNOT2HH_XAQD7_/K\6'_`!$SB'_G
M_P#@C\[?^'0_Q/\`^AZ\&?\`@NG_`/BZ/^'0_P`3_P#H>O!G_@NG_P#BZ_1*
MBC_B'&1?\^OQ8?\`$3.(?^?_`."/SM_X=#_$_P#Z'KP9_P""Z?\`^+H_X=#_
M`!/_`.AZ\&?^"Z?_`.+K]$J*/^(<9%_SZ_%A_P`1,XA_Y_\`X(_.W_AT/\3_
M`/H>O!G_`(+I_P#XNLZU_P""5'Q2G\6WVEGQ=X7CBL[2WN5NVTNY$$[2O.IB
M4[L%T$09L'($R>HK](ZY'2+`1_&[Q'=?8;^/SM%TR+[6S9MI]L^H'RT&SATW
M[F.\Y$L?RKC+W#PWR&S_`'/3N^Z,ZGB=Q"FE[??R78_*OX^?`?Q-^S!\8+'P
MIXAUC1M9.H:0VJ)-8V\D`3]]Y04[F.>A-5/@Y\'/$W[4'Q-7PAX/40O"5DUG
M673,&B0GN2/O3-@A(P<D@DX`9E^E_P#@H/\`LW>,OVE/VY/"VC^%8S9P-X55
M-2U>1"8=)@:\E)D_VI#M(1,Y8YZ`,R_6W[.O[-_AC]F3X9V?AGPO:>1:P_O;
MBXDPUS?S$#?-*X^\[$?0```!0`/A<+X<4J^=5)2CRX>#5O[VE[(^^Q7B?5P^
M1TXQDIXFHG=_RZVOZB_LZ?LX^&/V8_AG9>&?"]IY%K#^]N+B3#7%_.<;YY7'
MWG8@>P```"@`=YM)YY_*E7.`",<TZOVJA2IT*:ITE9+1+R/PNO6J5ZCJ5GS2
M>K;"BBBMS,****`"BBB@`HHHH`****`"BBB@`K@]!)_X:3\6C)Q_PCFB_P#I
M3JM%%:1^&?I^J,:KUCZ_HSMP!F0X&<@?A3K?+0(2221FBBLK[%O=_(<PP"1U
)I:**+%1V/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>pp2.jpg
<TEXT>
begin 644 pp2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0"J17AI9@``34T`*@````@`"0$:``4`
M```!````>@$;``4````!````@@$H``,````!``(```$Q``(````0````B@,!
M``4````!````F@,#``$````!`````%$0``$````!`0```%$1``0````!```.
MPU$2``0````!```.PP````````!@`````0```&`````!4&%I;G0N3D54('8U
M+C`P```!AJ```+&/_]L`0P`"`0$"`0$"`@("`@("`@,%`P,#`P,&!`0#!0<&
M!P<'!@<'"`D+"0@("@@'!PH-"@H+#`P,#`<)#@\-#`X+#`P,_]L`0P$"`@(#
M`P,&`P,&#`@'"`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,_\``$0@`+0!_`P$B``(1`0,1`?_$`!\```$%`0$!
M`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$```!?0$"
M`P`$$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G
M*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%
MAH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35
MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$!`0$`````
M```!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1!`4A,082
M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C
MY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`_?O;C.":3GU-?F"/^"F_
MQ['_`"T^'?\`X+[K_P"/4?\`#S?X^?\`/3X=_P#@ON?_`(]7YVO$W)OYG]Q^
MD?\`$*\^_D7W_P#`/T_VGU-&T^IK\P/^'F_Q\_YZ?#O_`,%]S_\`'J/^'F_Q
M\_YZ?#O_`,%]S_\`'J/^(FY-_,_N#_B%>??R1^__`(!^G^T^IHVGU-?F!_P\
MW^/G_/3X=_\`@ON?_CU'_#S?X^?\]/AW_P""^Y_^/4?\1-R;^9_<'_$*\^_D
MC]__``#]/]I]31M/J:_,#_AYO\?/^>GP[_\`!?<__'J/^'F_Q\_YZ?#O_P`%
M]S_\>H_XB;DW\S^X/^(5Y]_)'[_^`?I_M/J:,'UK\P/^'F_Q\_YZ?#O_`,%]
MS_\`'J/^'F_Q\_YZ?#O_`,%]S_\`'J/^(FY-_,_N#_B%>??R1^__`(!^G_/.
M>?PIAY!P0!^=?F'_`,/.?CW_`'_AW_X+KG_X]2C_`(*<?'O))D^'7_@NNO\`
MX]0O$S)=^9_<)^%6??R+[SK_`/@KSXA\2>$_VB/AQ>>%-;O_``_K2:-J*Q75
MK,T3;2T0*%EYP02,]C@BOIO]BG]M;0_VM/!KXB71O%VD@1ZQHSL"]L_3S$_O
MQ-U##IG!YK\Y?C+\:?'?[27CW1=<\:/X<+Z%:S6MNNF6\D)82E22V]F_NCN*
MR=(U?6O`/C6P\5^$]0.D^*-(.ZWG`)CN$/6"9>CQ,."#R*^)AXC1H9Q.=-N5
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MW_:[^"T/B2/3KC3+ZVF:QOX&5C`MP@7?Y4G22,Y!#`G'0X(Y_/\`_9._9.UC
M]MCQ@X#7.E_#G2IO+U34T.U]3<$?Z+;'TQ]Y^0H)[D5^I7@3P#I/PU\)Z?H6
MA:?;:7I6EPK!:V\"[4B0=O4D]23DDDD\G-?T'X79;F5##NK7E:E+9/KYG\U>
M+&9Y9B,2J.'C>K'>2Z>3[L^?_P#AT3\$3_S`M9'_`'';W_X[1_PZ'^"7_0#U
MG_P>WO\`\=KZ;Z?A2Y-?H?\`JWEG_/B/W'YQ_K+FO_01/[SYC_X=#_!+_H!Z
MS_X/;W_X[1_PZ'^"7_0#UG_P>WO_`,=KZ<R:,FC_`%;RW_GQ'[@_UES;_H(G
M]Y\Q_P##H?X)?]`/6?\`P>WO_P`=H_X=#_!+_H!ZS_X/;W_X[7TYDT9-'^K>
M6_\`/B/W!_K+FW_01/[SYC_X=#_!+_H!ZS_X/;W_`..T?\.A_@E_T`]9_P#!
M[>__`!VOIS)HR:/]6\M_Y\1^X/\`67-O^@B?WGS'_P`.A_@E_P!`/6?_``>W
MO_QVC_AT/\$O^@'K`_[CE[_\=KZ<R:,FC_5O+?\`GQ'[@7$N;?\`01/[SYC_
M`.'0WP2_Z`>L?^#R]_\`CM)_PZ*^"2\?V'K(QS_R'KW_`..U].Y--^\"..?7
MFC_5O+/^?$?N!\39M_T$3^\_*[]OK]F+PC^RU\;?!5AX0MKW3[75]-O)KQ9K
M^:Z\QD9`I_>N<8W'I69^R9^R;K'[;/BYP'NM+^'.F3^5JFJ(2LFJNIYM;<XQ
MC'WG&0,\=17T'_P45_9V7]J+]L;X7^#I-;N-"AO]$U1Y+F&'SF(4(VW:67@E
M0#SD@GIP1]C>`/`VD?#CPQ9:!H.GV^EZ1I4*PVUM"N$B0$C`]3P22<DDDDYK
MX:EP%AZ^<5,95BE3C:T5W/NZWB)B</DE/`TI-U9IWD^B?;S%\`>`-)^&?A6P
MT/0=/M]+TG38A#;6T"[4B4=O<YY).23DDDFMLGW&:,<8&1DXI,G<<\@5^HTJ
3<8048*R6R/RB4Y2DY2=WU;/_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>pp3.jpg
<TEXT>
begin 644 pp3.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0"J17AI9@``34T`*@````@`"0$:``4`
M```!````>@$;``4````!````@@$H``,````!``(```$Q``(````0````B@,!
M``4````!````F@,#``$````!`````%$0``$````!`0```%$1``0````!```.
MPU$2``0````!```.PP````````!@`````0```&`````!4&%I;G0N3D54('8U
M+C`P```!AJ```+&/_]L`0P`"`0$"`0$"`@("`@("`@,%`P,#`P,&!`0#!0<&
M!P<'!@<'"`D+"0@("@@'!PH-"@H+#`P,#`<)#@\-#`X+#`P,_]L`0P$"`@(#
M`P,&`P,&#`@'"`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,_\``$0@`,@`Y`P$B``(1`0,1`?_$`!\```$%`0$!
M`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$```!?0$"
M`P`$$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G
M*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%
MAH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35
MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$!`0$`````
M```!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1!`4A,082
M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C
MY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`_?RBO./BY^US\./@/XD@
MTCQ?XMTK0=2N;9;N.WNG(=HF9U#X`/!9''_`37+?\/)/@=_T4CP[_P!_6_\`
MB:XJN982G)PJ5(IKHVCNI99BZD5.G2DT^JB['N%,F;8C$C(Q7B1_X*1_`XC_
M`)*1X=_[^M_\33)O^"C_`,#GB8#XD>'3D=/-;G_QVL9YO@K-JM'[T6LGQS:_
M<S_\!?\`D4/V+/V\=!_:M&JZ/,(M)\9Z!/+%>Z<6(%Q$DA07,&?O1DC!')1C
M@D@JS>^A\G&/H1WK\0?!-_=6^J+XE\,:K)I.NZ;J]W>:5J=L<-'F>0C.?OQN
M"05;(()'0D'].?V$_P!NO3OVI_#LFD:Q'#HGQ`T6,-J6F;L)<H"!]JM\\M$Q
M(R.2A(!X*LWR/"O&]+,*T\#7=JL6[=I+R/M.+^`ZV6THXZ@N:E)*_>+??R/H
M@#YJ=3"X+<<T^OT!>1^<H_,S_@JY"DO[=VE*RJX'@2VX(!'_`!_W=>%?8;?_
M`)XP_P#?L5[O_P`%6/\`D_#2CCKX$M__`$ONJ\,K^3N/I/\`M[$6?7]#^O\`
MPYC%\/8:ZOH_S(_L-O\`\\8?^_8H^PV__/&'_OV*DHKXY3EW9]Q[.#TLA$C6
M)`JJ`!V'`J$?VAHGB#3]>T'49]%\2:+*)]/U&#[\+8.58?QHV2"IR"&8<@D&
M<FFS2K;Q,[LJ(H+%F.``._/TK6A7JTJL:M-V:>C,L10I5J4J5:-TU9]K'Z._
ML)_MUZ=^U/X>DTC6(X-$^(&B1@ZGI@;Y+E>GVFWSRT3$C(Y*$X/!5F^B<_6O
MR^_X)Y?LHZ]^T/\`&'1?B.9K[PWX.\(W1DL;Z$F*\UZ925:.,GD6_57)'S`L
MG4ML_3[R/]N3_OJOZSX-S#'8S+85L?#EET\UWL?QWQKEN`P.:3H9?/FCU\GV
MOU/BK_@H#^PS\1OV@OVD]/\`&'@W_A&)+"#PW#H\JZE>R02>8MS<2D@+&V1B
M1.<]<UX__P`.Q/CO_P`\/A]_X-KC_P",U^FP0YZT[%<>9<`93CL3+%XB+YI:
MO4[<J\1,XR["PP>&E%0CM='YC_\`#L3X[_\`/#X??^#:X_\`C--?_@F/\=D4
MEH/A]@=?^)M<?_&:_3D]*CG`,+`\9!KSY^%^1J+:C+[ST5XL9_?XH_\`@)^)
MWA[6)KS2YI;]8+>>UGGAF$;_`"*8Y"I()'3@]NE>S?L4_L4W_P"V?KL>NZ]%
M<Z=\+-/FZ?-%-XGE1L&-.A6!2,,W4G*CYLF.+]B;]@K5OVJ/&>I:CXIAGTOX
M::;K-V\BABDWB.47#GRD/58%/#,#R054YRT?ZCZ#X=L_"^BVNG:=:P6-C8Q+
M#;V\$8CBAC48554``````#I7RG!WA[&6*ECL9'W%)\L7UMLWY'U_&WB3*.%C
M@,!*\W%<\NUUJEYAH7A^R\,:/::=IUI;V-C91+!;V\$8CCAC485%4#```P`.
ME7J0+2U^X0BHKEBK(_!G)MW;"BBBJ$%13?ZHT44I?"./Q(@TS3K?2;&WM[6"
B&VMX55(XHD"(B@<``<`>U7***PPO\-&E;XV%%%%=!D?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>zsw.jpg
<TEXT>
begin 644 zsw.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`@$!`0$!`@$!`0("`@("`@("`@,#!`,#`P,#`@(#!`,#!`0$
M!`0"`P4%!`0%!`0$!/_;`$,!`0$!`0$!`@$!`@0#`@,$!`0$!`0$!`0$!`0$
M!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!/_``!$(`%("
M0@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[ZM3U/3]%TW4-8U>^M=,TG2;&;4]4U*^G6ULM/MK>-I9YYI6(5
M$C1'9F8@*JDDC%?)"_\`!0S]A%@&7]L/]FQE8!E(^,F@D$$9!!^TU[#^T7_R
M;Y\=O^R-^*/_`$R7U?YJ/[)G[/GAG]I/XEVWPV\3_'/X4_LZ:8?"EUK_`/PL
M7XP7L6E^$/-M/LZI8><\T*^?/YS%`7&1"_!Z5^V^%7ACD?'64YGFV=XVIAZ>
M$<+NG!3O&49MMJTI-KET44V[['XQXH>)6=<$9KEN59+@Z=>IBE.RG-PM*+@D
MD[QBD^;5R:2[G^B=_P`/"OV$O^CPOV;?_#R:#_\`)-'_``\*_82_Z/"_9M_\
M/)H/_P`DU_'&G_!';X-2ND47_!6+]@2665UBBBB\864DLKLP5411J9)))```
M))(%?/G_``4'_P""9\O_``3TM/`-GXU_:'^''Q+\=_$1I;[2/A]X/\*7VFZO
M9:1`&676;N>:5DC@,VR")2NZ9S+LR(9"/O<!X,>%N9YC1RC!9_B)8FK?D@\-
M.+ERJ\FG.E%6BM6VTDMV?#8[QA\3<MRZMFV,R+#K#4N7GFL1"2CS.T4U&K)W
MD]$DFWT3/[G_`/AX5^PE_P!'A?LV_P#AY-!_^2:/^'A7["7_`$>%^S;_`.'D
MT'_Y)K_.Y_9#_9A\5_M@_M$_#7]GOP2\6G:GX[U61-3U^2R-Y:>%=+M()+O4
MM4GC&-R00Q.0N1OD>-,@N*\E^)GPV\2?"/XC>._A9XXTG^R?&'PZ\6W_`(,\
M2Z?+$`;>\TZYDMIMI(Y1C&'1NC(ZD<$5])'Z-7!L\QGE$<ZK?6HPC4<.6GS*
M$I2C&5NSE&2\FE?=7^;E](_B^.70S:634OJTIRIJ?-4Y7.,8RE&]]U&2?G=V
MO9V_TH/^'A7["7_1X7[-O_AY-!_^2:/^'A7["7_1X7[-O_AY-!_^2:_SPOV4
M_P!CKX[?MH?$E?AA\!/!:>(-5M;9=2\2^(=4F&D>#/!%BSE/MNKZ@5984)#"
M.-%>:9E*QQN0<?I7=?\`!([]E[0-3/P^\8_\%9OV3-#^,R3#3Y_"=MIL=]X5
ML;TD*;2XU=M3CV%7RI,D<;`CF,'Y1XF;^!GAMD>,_L[,,]K_`%CE4G"G1=:<
M8O:4XT85'"+W4IJ*:U5['MY3XV^(F=X19A@,CH>P;<5.I65*$I+>,)59P4Y+
MJH.374_L2_X>%?L)?]'A?LV_^'DT'_Y)KZ0^'WQ'\`?%GPIIWCOX8>-/#'Q!
M\%ZP\R:5XK\'ZU;^(?#^HM;S26UPL%W`S1N8Y8I8VVL=K1L#@@BO\V_]LG_@
MGU^T)^P[KVBVOQ;T'1-;\#>+U,W@#XP>`;MO$'PT\;Q[!*HMKPHKPSF-ED^S
M7"H[(V]/,3+U_:/_`,$(P%_X)B?``*`H_M+Q9P!@?\C;K7:OB?$CPIX8X3X-
MPW%O#>9RQ=.M6C33M#D:<*DFTXZ\R<+-.S3NFDT?9^'7BEQ+Q5Q?B>%.(LLC
MA:E&C*HU[_/=3IQ2:EIRM3YDU=-6:;3N?K[1117X$?NP4444`%%%%`!1110`
M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1
M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`>-_M%_\F^?';_LC?BC_`-,E]7^6';JK
M6MN&4,/(0X8`C[H[5_J>?M%_\F^?';_LC?BC_P!,E]7^<?\`L!_L:>.?VZ?V
M@_!7P2\)"[TW07CC\0_$_P`:0VYFM_`OAVW>);V]8GY3/+O6WM8V(\R>>//R
MJY7^POHS9C@LHX<X@S3,JBIX>E*E.<GM&,85&WYOLEJW9)-M(_D;Z2678W-^
M(L@RO+J;G7JQJPA%;N4ITTEY+NWHE=MI)L^]/^"5O[,_PR\!^%?'/_!3K]K+
M388?V>/V:IVF^%?AF_MT^T?&/QO`RI80V4#C$Z6=R\$<0P4>]D0D[+6<#\QO
MVH?VD?B-^UM\=/'OQ[^*-Z9_$OC;5#+:Z7#,\NE^$],AS'INC6"G[MO:0A(Q
MT+OYDC9>1B?UO_X*JZY\</B]XH\$_LG_`+,W[,WQ\T3]C7]D^U'@OX;Z;H_P
M=\1_V9X_U:T1K2^\1RN+3]^F3/%;3/EI!+<W!.ZZ./RB^'?[)OQU\??'3X1_
ML^W_`,-_'7@'QQ\9/%%KH'ANV\<^$;_PM<"UEGV7NJ+#=11L]O9Q)<3RR*"J
MK;OD@BOV_A3$8?&5<1QYQ!6A#$UJ;]G3<XMX7"0]]0:3=JDTO:XA])6AHJ:/
MQ?BK#XG"4</P)D%&<L-2FO:5%"26)Q<K0<DVE>$&_94%UC>>KJ,_6_\`8+O+
MC_@GS_P3U^/_`/P4;N8+&T^-GQNOT_9V_9-CU>S2Z\I/M#/JNL1P."'B,]G<
MRDX(*^'=IXF&>*_X+!>"/#OQJ\-_LT_\%-OA;IL-OX,_:Q\!V>@?%BSL(P8/
M"WCO1;4VUS#<%>%>:.SNK7+<N^ANYYD&?5?^"BG[27[*_@;]KGX(?LG>,?AE
MXB^,G['7[`OPX?X9S_"KP?XE7PH_C;QA/IT,-[<WM\KQL!9[;1)O+<2-<P70
MW8D<'ZB_9K^-/[#G_!0_]GKXZ?\`!,?]G[]GCQ/^S'=^)/!VI_&7X.V/C'QZ
MWCG2KKQ=ICVMRDFGS37$TMM(&A@DFC5@CVSWI"@ERWYW]=S++<;A?%&O@*_-
M7J.K7JI4_9T\NJI4Z=*:=15>:C"%'$OEI.*G*=WK*WZ%]2RS,L%BO#*ACZ-J
M--4J%)\_M*F84G[2=6#5-T^6K.=7#+FJ*3A&%EI&_P`D_%OQ?JG[$/\`P1E_
M9=\"_""[G\*^/OV_M9U?X@_&CQ[HTAL?$5_HEG'&4T>*\3$B1O;7FD6I"L"(
MUO0,?:),_@]X$^''CCXH>(K/P1\,_`WB7X@>+-1AFGL/"7@O0)_$>O7T=O&T
MUP\5G`C2.L:*[N0I"JI)X%?T)?"?P"/^"EG_``3?T;]BO3[W3O#'[=?[`'BG
M5I_`WP]\4WJ:-=?$#0!<7,%[IL+R$!9(]PLG8_+!<:39F4I'<%U_(/X:?#?]
MN[]G?X[:=;?"GX7?M%_#/]H31Y[GP]I,7AOX<:F/%MNU[&]I<PP,;62%XYHY
M'0RJ6C*MD/CYJ^[X+Q]#`X;.L#*I2AG"Q.(JU/:RY5-3G*6&JMJ\G0=%THQE
M%-147%6:L?"\8X"OC<3DV.C3JSRB6'P]*G[*/,X.$(QQ%))^ZJZK*I*49-.3
MDI.Z:9M_$_X=?\%$-&^`_A_P%\8OAK^U'HG[.?P;O;CQ'H6C>._`^MZ7\//`
MDM^\<$EPTL\*QQKND\N(2L4A-U*L03SG#?V@?\$)?^48OP`_["7BS_U+=:K\
M>OVXOC+\?_V9?^"5R_LX?MD_&K5OBG^V1^UOXKMO$6I^#=:UFSUK5_A#X.M+
MNPO'M;F2W54&6TR&)FY62XU*Y6-G6V=J_87_`((2_P#*,7X`?]A+Q9_ZENM5
M^(>+V=XO/O"M8W$8>C3IK,G&G.AS>RK15*KS5HN48N2G5=1<]O?<7*[O=_M?
MA-DV$R+Q0>#P^(K5*CRU2J1K\OM:,G5H\M&2C*2BXTU!\M_<YE&RM9?KY111
M7\C']7!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
M4444`%%5[N2YBM+J2SMX[N\CMW>UM99_LL5S*JDQQM+M;8&8`%]K;0<[3C!^
M9X_V@_$4'A3XEZ_J7PMEFU+P1XFMO`OAC1/"WC*W\0K\2M>G,,,FE:;=26]N
MJ/;W-Q':SRR(8XY(KD%O]'EV@'U!17SSJ?Q\@O(O"_\`PK[P];>*9/$'@"'X
MI:A?^(?$T/@;PSX3T.Y.RUGU&_DBF*33RK/&D"1,0;.Y,C1B,;LCXA?M)6O@
MB\\,:7;>&K/6[O7=#TO5M5UM_%]MI7P^\'MK,T\.E#4M<,4B);W36.II%<K&
M5=[:%-H-PA`!].T5\X:W^T''X?\`BOX5^$U_X5C.LZWX<T_Q+K$MOXG@DGTF
MTO1J2W-]:VIB#76GZ=)IH2]OF:!8?MUKA',@41V/[26C7>O_``M\/3>%]6L[
MOXA:UX@\/:W-)>V[V_P^N]!O+K3/+U`@Y<7E]:26MNT8PS$$X!H`^DZ*XWX?
M>,(_'_@S0/&EOIMUI5EXELCJNF6EZZR7+V<DCFSN&*\#SX1#.%ZJ)@#R#794
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`456O9+J*SNY;&VCO
M+V*VDDL[.:X^QQ74JHQCB>;:VP,P52^UMH.=IQ@^4_"3XB>*_B):^([WQ#X&
ML?!D&A>)]1\)P_9?&"^*9-0NM*O[G3[UBJVL/EQB2V)C)+,ZN,JA&"`>OT5X
MC\1/CSX)\!>$+_Q2M]9:NUMXX3X:P6<NIQ:!9MKC3^0]I<WUQMB@2';+)+*=
MP"0OL61MJ-%;?&6>6?X+Q?\`"+V^IV7Q>U2\TEO$_A/Q=9>)/!OAV6VTS4]3
M@"7N(Y;S[0FF3*IA@`0AMY4J%8`]SHKQKPS\2?%>J_%#6OAOKO@.RT=-'\*K
MXLD\0:5XQ7Q###%<W\EEIL%U;FTA:&6[6VOYD4-(%6PD!/*%N#\=_M/:/X-U
MOXEZ1:>$]5U^U^&OP\NO&5YK\.H0V.BZK?65W9VMWHL$A5F\RW_M"S:>XVF.
M(RNAR\4BH`?4-%?-.O\`QV\2:5\*G^*FC>#?!/C'3;.*]?4;?PQ\7(=3LY)(
M)DMK.TT^]33V2ZNKJ=Q;K`5B*3,B$DL2.N^,/Q7OOA+X(A\;76@^'[BUMX6F
MUJT\0>/[/P:;9U@,RV=E/-$\=W=RLKQ0P*8_,<#YUR*`/:**^1M6_:VT'0O'
M&H>%]6\)WMAI^CZ;+JNL_:=<M8O'^F6D'AAO%$VJ2^&,?:!IB1JUBU_YNP7R
MF'9QNK2B_:*\1M?V7@RX^%%S9?%?6;G3YM`\#W'C2T.G7>FZCIVJZG'J%SJR
MPLL`A31-3@EB$,C"XAC5#(D@E`!]3T5QWP^\::?\1/!?AWQIIEM=65KK]@+H
MZ??;#>Z;,CM#<VLQ0LA>&:.6)BA*EHR02"#78T`%%%%`!1110!Y3\>-,U'6O
M@=\9M'T>PN]4U;5OA3XBTS2],L(&NK[4;FXT>\B@MX(ERSR2.Z(J@$LS`#K7
M\"W[.?@#_@LG^RCI>OZ=^SS\"OVL/A9#XQEM+OQ4=%^`,MY=ZU)9Q21VHFGN
MM.EEVQ":;;&K!`9G.W+$U_?A\;M3U'1/@Q\7=9T>^N=,U;2?AAK^IZ7J5E*8
M+S3[FWTF[E@GA<<J\;HC*PY!4&OX+/@Y^U9_P5.^/GBO3?A_\&_VA/VJ_B5X
MUO[/[8NA^&?&UY=SP0(%$MU=3,5BMX$++NFG=$!8#=D@']2X`\2JO!&78W*Y
MY=0Q=#$RIRE&NG*-Z=[>[9Q>KOJM&DUJ?FG'/AQ3XUS#!YI',:V$KX:,XQE1
M:C*U3EYO>T:T5M'JFTSW3_A?7_!Q+_T"/VU/_$?(/_E17CE];_\`!<#4_C;H
MO[1^I?"W]L34?C=X;\)2^!/#GQ`OO@7-=:AH&D3F9I[*RMFTXVL*R&YN"[QQ
M!V\^3+'<<^V_'[4O^"W/[+_AN#QG\;?BE^U1X3\&S316TOBRR^*<?BOP[ILT
MS!88;ZZL9YEMF=B%7S]BLQVAB2`?G+X<_MD?\%-?B_XST/X=?"[]I3]J+QYX
MY\27#6VB>&/#GC>\OM3OF1&DD<+D*D<:*SR2R,L<:J69E`)K[C#^.^%PSD\+
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M00BS[`S#`)/%>.>*/VE?^"KG@KX8>!OC7XJ^/W[4FB_"7XEW+V?@/X@3_$1Y
M_#WB69%G9X89(Y69'`MKGY)50YMY!C*D#VY_2=SNM0EAJN3X:5*2<7%NHXN+
M5G%Q;LXM735K-:6L>+3^C-DM*O'%4LWQ"JQDI*24%)2334E):J2:NFG=/6]S
MP?5?V8O^"J.K_%[4?C[-^SE^U[I_QHU7Q-)XSO?B1X=^$^L^%?$S:K,P:>^C
MEL[>)8Y)#DOY:JKEFW`[FS^@5M^U3_P<6VOA4>$D\$?M12VRVPM%UVZ_97L[
MGQ>$"[=QU)M*,A?OYA!?/.ZOB&S_`."@W[?^HWEGIUC^UY^T3=WVH7<5C8VD
M'Q!O))[J::18HHHU')9W=5`[EA6AXC_;P_X*(^$/$.N^$_$_[6'[2&A^)?#&
ML7/A_P`0:+J'C^\AO](OK.9[>ZMIDSP\<D;HP]5->3F'C]'-HT89KPU@:RI)
M*"J0<U!*UE#F3Y4NB5EY'K9?X"RRJ56>6<1XVE*HVYN$^3G;W<N5KF;UU=WK
MN>3>//V-/^"E_P`4_%NL^/OB7^S%^U_X_P#&_B*X^U:YXK\7?#/Q!KFNZFX&
M%,MQ)$6VJ.%1<(@&%51Q7]K_`/P1E^''Q!^$W_!/#X)>!/BCX(\4_#OQMH^H
M>)GU;PEXST6?P_XBTU;CQ/J]Q;M/:3*LB"2*6*1-P&Y)%(X(K^3[X>_M*?\`
M!5WXL>$_B)X\^''Q^_:D\6^"_A)I8UOXF>*-.^(KPZ/X,M6@N;E9KR6:5.L5
MI<N%CWOB$_+R,_UO?\$B?B3\0?BW^P/\&_'GQ1\:>(_B#XUUB^\1IJOBOQ9J
M3ZOKNI+;>(]5MK<37#_,WEQ111KGHL:CM7S/B%XR9EQ]P_1X?Q.`I4*5.I&I
M%TW+3DA*"BD]%&TWHEI9):'T7`7@]EW`>?5N(,/CJM>M4IRIR511UYIPFY-K
M5RO#J];NY^EE%%%?BQ^PA1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`9FMV5[J6C:OIVG:K<:%J&H:9<65AK=I!%=76C3RPO
M'%=Q12`QN\+,LBJX*DH`002*^:]$_9CM&T/P-X3\>>-+WQEX4^'$[:AX:T32
MM,;P&QU`VDMHNI7UW9W`N)[G;=7\K.77S);^61P[$$?1?B9=;?PWX@3PT\,?
MB-]#NUT"2XQ]G2^-O(+1I,\;1*8R<\8!K\T;:[C\/^'/"NL_`/1?&.E?&/PQ
M\)?$5[\:;K4_"^I7&HOJ$?AVX:&'Q,ER@CU#56U\6<D"YED=8KPQ-Y#L6`/J
M/3OV8K7P?;01?#3QOJ'A0VL.I:'#9:WH=OXYT"?0M1U&;5TT:ZM+E@\R65W=
M7LEK.9A)&E[-&YE0@+:\(_LYS^`/A[J?@GPGXZQ?ZO'INDZAX@\3>#-/\207
M&D:7H]OH]OI!TTF.W\@1PR2@?=$EU.2K*Y6O#OB+X^_:`\':YJ'@NR\6ZBFA
M6OB"[BT[XK>)="M=-#74GAO0]0TK3;N2WT>YMVM7OKO6&8QVT<CK8K;"Y1^9
M.[_:"^&_C/XK^(O@MX;2U\+_`&J[\$^*5\1Z[J=AJE_H/A2]FM]`BCU+3!`\
M3+?0R/</9-/)&0$EPRL#1Y@4]6_8DT"[TRU\/Z7\1/$>DZ+#;:1YUP^D6&H^
M+9I='TJUT9;==690RZ9?6MG%%>Z48V@F2:X"&#S21WGB7]EKP[XBB^-NSQ?X
MHT:\^,EUI6HPZAI8MDN/AY=:6Z70N-%W1MM:XO1->R^;OW23L/NX`\0OOB/\
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M34H-%;6[HZM<7>H21FSDT1]#(2PB+O`'?3UCC\Y"J\[H/@+QAX.\,^"=>M?^
M$EUS5-$_9[NQ'I?B#P/IFHVHU/4O%.E27TDUNM@CF[DC9W<Y$D@MPS[\,2@/
MU&H)QR>`.23VK\[M9^+GQ2B\/VMW_P`)CX@L/$U[\29]#^+&D3:#;Z%8?!73
MD776TU;*9M'O&\FXFM=+MSJ-REY'.DZR(81,KQ^A?&>WN=4^"?PLU[XD^)/"
M,OBK1I+/7KW2+WPWJOB3X6_$O5&T>[BEL+S3H(1=^5-Y\L]L_E;H+B*!O(E*
MB%@#[/HK\Y=3^,OQ;BU_3[.QNO$O@;Q5K'B'^Q?#7P0N_`MM?Z99:,_P_N]8
ML)3J#6P8W(U>'R&E%QY9>W:U^SJP9ZN:_P#M%>-]5TK4O[`G\806=YI'AFPT
MGQ99>%'\.Z7H^M2Z1KNH:S#=37.DWCR;Y[*PM1;Q6K,+F5(=\19Z`/T.HK\Y
M[GXH?M"2^$(_&>JZIK6@66K>+O"GAO6[2/PS!H%KX"TR^\"Z7K>J:G'<2Z;>
M3!Y=<NSIS37$$T-LDK(8XW1I4^X?AK=>)[WX?^#KSQG?:/JGBFZ\.VL^N:GH
M$<T.CZE.\2LUQ;I)'$ZK("'VM&F"Y`10``P.WHHHI`%%%%`!1110`4444`%%
M%%`!7"^&?`6E>'-$\2Z`TL^K:?XI\3:YXDU**^55!.O7US?75L-F/W:FZ>-3
M]XJ!DYYKIM<$AT36!$)#*=+N!&(<^:6,+[0F.<YQC'.:^;_V;O"/BGX>_`'P
MZ4\*>"SXMO?!FF:S%H>AV-UX'?5[PZ3:`IK5S<&XD%XTBLLUP4.#UCR"*`,G
M1_V-?A=X0TO68_A_$O@_Q)=_$I?BCHGB:'3HM6;0;^&XDFM8/LDQ,<UO$LUQ
M$%;:^V=B)$<*Z^G^'?@II>@:7\/+$Z[J=]>>!?'^J_$RYU%[6VM/^$CU76X-
M>34GEMXT6*"%Y?$%Y*D4`41^7&N2`Q;X_P#$GBGX\?$#X8^"[CXP>&='^''A
MJ+XW:Q9^.M1GAOOB1IEYHMG+XK@TE-4T6R@LI&M%N[;0(0SNT%SOAFE&QBC>
MM^"]*U?6/$G[*WC+4O"%]X3O?^$$\1Z%J_A_28]2TKPAHEHUG`UH!I$CF.T^
MT^7#*D=PIN(U*0LY,9%%V!],>$_`UGX6UCQUX@^W7>JZSX^\2KK^J7UZD:/:
MQ06EO86.GP!0,06T-LNT'),DT[D[I&KR?3OV:?"?A7Q;+XW^'^N^*O"FNQ^%
M-7\.:;;7?B/4O%GAG3YM9U&+5+J^.F7=T\+L9XY',7RH6G9N&"L*OP*\`:!I
M7B_XL?$'0_!]KX)TO6M<3P%X6TBSTHZ(EWIOAZ6YAN-4DM@%!>]U&YU-DE*Y
MDM;6R8$@C/S[I*^!AXX^/&JQV7A'_A5NJ>#+.R-Y;_#S7K3P"FK'69Y(XO%6
MGR-NU34?,>*1KBT,(CMU=)E3S(F(!]-Z)\`[&RM--BUOQ5J6O7;_`!9'QF\7
MR)IEIHNG>+]8AM4@L$>SA4)!;6LEMIMTD:%G>?38GDDD9I"_5_%KX=:K\3M`
M_P"$7M_%D/AK1-1M[FP\1P/X3L?$]QJ=O<Q"(FV>ZREM/&IE,<VR0`R9*-M%
M?EKXBT3Q4/"G@&*XT;4H3IOAW7;SPU:S>%?$>SQ9-+XUN[RSM?AK$JM+X?OW
MM+>$64FI^:8;/4]/0H\<$TR_:G[5EWX+U>7P!X%UBPET[QAXENS=Z+\0YM*U
M":/X56-M=6,NH:E:7MM&P34W*P06<(96>5S(Y\B&8,`:FI?LB^%=6UZ[FU#Q
M3K-UX2O[QM4O/#\]A:S>(YYW\/GPV\#>(F4WILFM26:T)(,A/[SRR8JTX/V<
M-7BNK;Q9-\6=>O?BII-U8)X?\?W?AG3633]/T[3]4TR'3IM,55AG26+6M4EF
MD+*[7%PDB^6L:1#XP\76'BL?$CXS:C8:)XNO]8U*V^(>F-HOA/2]:TSXMZ+:
M75@T6G:CJVN&-K*^TAOLJR:59V:>?!_:5DL9N9(9T1W@^PT2"*6/XE:(^M?!
M@>)=>N#=?#OP5XBT;X6ZAKUQX>\/0Z.VBZ`WFWMJ\0M];C\PO+&VIW+/'(D[
MK'&7`_4/P!X+TSX=^#?#W@O2)[R[L?#^GK9K?:@Z2:AJ,C,TMQ=7#*JJ99I9
M)97V*J[I3A5&`.OKS[X31^*8?A9\-HO'!N3XTB\!Z1'XL-ZYDO3J2Z?;B],[
M9.9/.$N\Y.6S7H-`!1110`4444`>1?M`_P#)!?C;_P!DB\2_^F:]K^2K_@D#
M>Z[XH_9'_;?^"W[-_C+0/`?[;_C?3M+U7X::EJ.I0Z%XAUS0[6"-;BVTB^?_
M`%4D9.IIYBG]Q+J-O,VT*)$_K5_:!_Y(+\;?^R1>)?\`TS7M?YV6@?L]?M`>
M'/V?]&_;.\/Z=<Z'\*-(\=0>"-+^(WAWQ=%8^)=%UL;D0I;V\HO+95=%3[0X
MC7=-$`3YBYTCK%@>]>/?C)_P45_98\-?%']G3XR:]\:/!GA_XRZ<^D^,/#'Q
MB@F\86NN0!V-S+HFI7_VB)?/4E)9]/E.]"OS`A6&[_P3-_::TC]F/XL_%+4S
MX`^('Q!\=_%/X':M\)/A'IWPML8[_P`=V?B/4[JQ>SDL0V3'D02%ID5V3RE^
M1@2*_2?_`()V_M%_$O\`X*$?#/\`:6_9!_;%F@^-/P^\*_`B_P#B1X5^+/BV
MPAE\;_#/4;*2.WLY)=5559Y`9C<PW$G[\?V?,C22QNZCR/X`^++'_@G_`/\`
M!,CPY^V=\(O!^A>)OVFOVC_B?JGPHT_XM:]ID>N6?P3TNUDU.W6.TA<%$GG&
MERR*K86:2\3S?,2%8F=[W36H'2ZEX=\5?\$^?^"=W[1_PU_:Y^)4WB3X]_MH
MZ980?#W]FV_\5/XUUSX?QQ.[W/B;6I&ED6WG8R++(R':9K&VC#RR^9Y/(_L$
MN/VQO^">?[6O[!>H,+_XA?"RW_X:1_9X@F)DNVFMY#-?6%J.O-RC0X`Z>))#
MVKF_V*/V?_A)_P`%0OA_\=?A[XWU_P`:Z;_P4`MM>B^+%E^T5XRU74O&FB^+
M=&:6.S?3;Z`'R;:*(SLAMU"NS-!)"Q6*2%<:X\:_L^_\$V/^"GWPPA_9Z\0?
M$'6/!OP>N+'X5?M'ZQXU`C@UZ]O$.F^*Y].A**XMXTF@N]C@QK<VA\EFB5&)
MO==0/&_^"17P)TSXQ_MC>%O%7C.%(/AC^SKHUU\?OB-?7T8^P646@A9=-BN-
MW&#>FWE93UCLYN.#7H?_``6>^%GA72OVB_"?[3OPPEBU#X/?MC?#JQ^,?AC6
MK6%H;.XU$V]O'JJD'[LDJ2:?>NI^8/?R`@%37Z0_MW?#'P1_P36_98_:]/PZ
MU?3'\7?\%"?C>VC^!1I+%)?#'@B2T74]4LH7'_+.(WFKV^4)0IJ]KSD<>5_\
M$]OACX5_X*7?L3>#/V6O'FKVMKXM_8W_`&BM%\9:5<W9+WM_X!UBZDFU/2X2
M,MB5#JULO\*M;60)`%%]>;H!XA\>&/[%'_!(WX*?L^PYTOXP_MR>(6^-'Q3A
M&(M3L?#$'V2ZLK.<??57B308=IP"3?+C[U?OA_P1'_Y1N?`G_L(^*?\`U*M8
MK^4C_@JI^T=;_M)_MH?$S6?#]S%+\._AE(GP:^&D%HP_LV+3-`>2WN)[91A1
M'<WK7\Z[0`8Y(AV%?U;_`/!$?_E&Y\"?^PCXI_\`4JUBE+X5W`_6&BBBLP"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`SM8
MU%=(TG5-5>)YUTS3I]0:!"%>801/*44GH3L(!]Z^4_A1^UYX4^('ANY\0:SI
MMII9`T"/3+?P+KDGQ876;SQ#ILVJ0:-;BRM4G;4[6"WD>[LUA8P1E)"Y1B5^
MKM5T^+5]+U+2IWDC@U.PFT^:2(@2HD\;1,R$Y&0&.,@\BOEWP_\`LL1>'+71
MM0LOB;XF;QUX7AT6Q\*^+SH6D6UMI%IH>GZMI5K:R:5%;I;W`FM==U2.>6;,
MSF:(K)&(8E5]]`.PU+]ICX7V_AWQ5XCT6X\1^+[7P?X)F\=:U#X7\):GJ4EE
M;Q1SR+:W#>0$@O'^S7"_99RDJ&&3>B;&QM/\?_AA;ZBFEWVKZIIMP(XTO)]1
M\+ZI:Z7I5Y+I@UE-*O+TP?9X-0-F1/\`89'6?!4;-S*K><#]E+0W=%G\9Z\8
M3X/\0^&;^ZM-+T_3O$.OS^*5U%]8NM2U".(-<1-<ZI=WL-BR"W@N/*9%`0*=
M"]_9KCUB6\M];^(7B"^\/ZSK,/C3Q'X=M](T^PM-5\1P:7#IBZK',L9EAB)M
M[:\-DC&/[3`K!@C/$R_,#UKX?_%7P3\3HKZ;P?J%_=BPMK+4)8]3T"_\.W,M
MGJ4+7&G7T,-W#$\EM=1I(T4Z`H_E.`<JP')GXWZ3:_&GQ+\(=8TF;1H-!^'U
MKX\M?&EWJ$0T?5"\EV;^P,6`T4EK!!#<[F8B2.64@#R7)FTKX5:CX4\0>']6
M\(^)Y+2U32/#_A+Q?!JUE%J$VK:-X<L=;BM(+4A5$4\]SJEO)-,<@1VI5%4N
M367\0OV>/"?Q(U36]6UC6/$=A<Z]?:%<W1TBZAM&2#1TU*UN;%7,;'R-3LM7
MU*PNU)):&Z;88W"N`#@K;]K*SG^&'A7XE'X=^(8U\0^,]9TF_P##8OX7U?PU
MX?T#5+VTU?Q/=_)CR+:TM8;R2W`\Q3>1P[B_S5[7\1?B!J7A.;P?HOA?PY;^
M+O%OCO6)]+T#2KS71X<TE8[2PN=2N[NZOA!.4C2*VV*$BD9Y;B)<*I9U\\N/
MV5_A;K6HZE>>,;34?&-G=#78].T;5+^6RTS1(O$NMWVN:W%`ELT19;J2ZM8'
M$I<>3I=L``0Y?I+[X,,_A#X:Z#H_CGQ'H_B3X3I'%X0\=R6MEK.LF-=.GTB5
M+Z">)H+@36EPZN65298XI00R\L#FM/\`C_?ZE+\&]4MO`R'P?\8;^#0+&^'B
MF.3Q=HVIR6&H7MU#+I"VY26"S.FW$5Q<1W)*_?$;(I-2S?'K5!:^*+2/X=WE
MMXNTWXS0_!KPOX;U3Q):PP^(;BYTRRUF#4;F\@29;2W^Q74URZ!9Y46U*[3(
MP01>$?V=O^$(\:>%O$NA_$'79M%\(>$K7P9HWA?7-$TW5TL;2,%]1EM[XQ+-
M%<:G/Y=Q>3K\TK01*-L:*@ZGQ#\%-,UE/$]U8>(M9T/Q!K?Q)L?BMI.OVL5M
M=S>&=6L-*T_1XC!!)&8Y8)+:P:.6*4,76\G`9"49$!X1KO[5&@32VUUX@^'F
MFQ0?#35;#4/'\FM>-+6WU'P7J5SXAUCP<3H<'DG^U&MY['4&:0-;AH)XP@:6
M0PK]Q5\OWG[+OAK5H/"&FZ]KTNO:-X=U6?Q-K,>J>%M&N?$'BO5KO6I?$%]=
M2:L;8SVD-S>2!I;6Q\E&BC6(,J%E;Z@H`****`"BBB@`HHHH`****`"BBB@`
MHHHH`HZGJ>GZ+INH:QJ][;:;I6DV,VIZGJ-Y*MO9V%O;QM+//+(<!41$9F8G
M`"D]J\EU']HWX`Z19:MJ.I_&CX8V-CH4.E7&M7=QXVTZ.#2H]<L)=4T:2X;S
M<(M[9P3W=NS8$L$+R*2BEA[#<VUO>VUQ9W<$5S:W<#VUS;SH)8;B.12CQNIX
M*L"00>"#7YI?#?\`X)9?`CX>:_X5UE_$GCOQ=9^']&\1>']6T#Q/<V5WI/C2
MTU>QO-$T.+5%6!6?_A'-&U'4-(TTJ5,=O=MO+N`P][)Z'#M:C6GG>(J4YQMR
M1A!2Y]&VFW\/PJ*>NLTVN6,CQ,VKY_2K489-0ISA)OGE.3CR:I)I+66[DUII
M!I/FE$^U-5_:#^!6A_VH-8^,'PVTTZ'XFC\&ZT+SQGI\)TG5I;!-5CTZY!E_
M=W!LY$NA&^&\E@^-IS70:1\6/ACX@UI_#FA?$'P=K.OQ^(]4\(2:+I?B*TOM
M3BU71(H)]9TYX$<N+FRCNK9[B$@/$MQ&7"[US\#^`_\`@EC\$?!@G&I>,OB)
MXW_M3X*Z[\(O$Y\4W5C</XKO->DOHI_%UZR6ZYUF'3[^72X9UPB6L42["45J
M[#X.?\$]O!_P+\43>.O`GQ7^(R>-[GX=6O@RZ\1ZW;Z1K<MWJLNI6-_XF\6R
MV\EH8FU?Q!'IFG6M],5V^5:(8UC8;J]7$Y?P3&E46$S"K*HE:+E2:C*3T3=K
MN,4_>>CERNR3DF>7AL?QG*K3>*P%*--OWE&JG*,5JTKV4I->ZM4N97;46?1`
M_:M_9J-GXDU`?'3X7M9^#=7MM!\6SKXQLF3PS>78NFMK>_&_,#2+8WKKY@4%
M;25L[48CJ]/^.?P9U;X@2_"G2OBIX`U+XEPQ&>3P)8^*K*Z\5*@M([]F%DLA
ME.VVEAG;"G;'-&QPKJ3\.ZY_P3:MO%'AGX@>&O$G[1?Q1U8?$OXD:E\1O%^L
M/H6A6FL>)9=5TS5-'FLM6EBME%[!9VFH6\6G1S@QV`TJU\N)@'#<)X0_X)U:
MSI/[0.GRZOJ-OJ/[,?AR'Q)K1\,ZOXG6_P#$OB[6/%7AK0O#VHRQBUTVTNK&
M-SI#7$BOJ%PJML6!$1RL74LHX'J4JTJ>934H0G))QW<8QY5'FA!S<IW2C:-X
MM-RCROFY7FW&M.I1C4RZ'+*<(MJ6R<I<SERRFHJ,+-RO*S32C+F7+^C(^/'P
M6/BC4O!7_"U/`?\`PE>CZP?#VJ:$?$]H+^PU!;*YU%["5-_RW*VMG=W#0$^8
ML=O(S*`I(U?#GQ<^%GC#3)-:\*_$7P3XBT>'PC:>/I]6T;Q-9ZAID&AWXO#9
M:O)<)(46TF_L^^*7#$1L+.;#?(V/B#QA_P`$T_AIXO\`^%OPI\0O'7@W3?B?
MJV@:SI.D^`4LO#FG>`[S09Y<ZK:Q&.07&JWUE/<:5=ZI<`SSV4NQRSCS:ZOP
MO_P3Z^&7@[P7\9_AKH'C#QGI_P`/?COJ^M0^-O#-NFG*EIX9U71=2TJS\':3
M<&W,EEINF3:K>7UH8CYJRRLC.\3-&>*K@.#/JRE0Q]7VON:.EIM!U'===91A
M';FA[TN62D=M+'<8?6'&M@:?LO?U537>2IJSOI91E.6]I^['FBXOZ%TC]IS]
MG;7[SP3I^C?&[X7ZC?\`Q)263P#96WC2P>[\7I%/+;,^GQ^9NF5IH)XD9`1(
M\+JA8J0*WAK]JG]FKQGXATOPEX2^/7PD\2>)]<U`Z3H^@:+X^TS4=6U2Y%LU
MX(+>!)B[N84DD4*#N$3XR48#YND_X)_Z?K&N:'K7C'XV^.O$I:+P7!\1;./P
MQX=T&#XC)\.-9NM<\$[G@LQ)IILY[HK<?V<T*WB1*&5"6)L>"?\`@G;\+O`N
MH_#[4]+\6>*I;CX>3?#N?3S+9:;#_:!^'*^*QIPG9+=3_IA\6WKW&PC+6\13
M;E]VL\#P-&C4:QM5U+>XE%N-]=VZ<79=K+FBE*\93=.GE3QO&LJM)2P=)4[^
M^W))VTV2J25WU=WRR;C:48*=3]!:***^*/L0HHHH`****`/(OV@?^2"_&[_L
MD7B7_P!,U[7\$O[$O_!0;QC^R3X<\:?##7?A[X-^/?[._P`5H8I/B%\$OB#@
MZ->7`BCB-]I\[1RI!.\<422+)%)')Y$+;5>-)%_T)]6TK3M=TO4M$UBRM]2T
MC6=/FTK5=.NXQ-:7]M<1M#/!*AX9'1W5@>"&-?&*_P#!-;]@55"K^R-\"@J@
M*H'@*SP`!@`?+5*5E9H#^1GXN_\`!4C07^"OC7]GW]C?]EKX=_L<^`?BE$UK
M\4-:\+ZL/$'CWQ;:R(\4]BM\L$(AAECDDB9F\UQ'+(D9B#N6\@_9#_X*%:[^
MS9\/O&7P#^(OPG\#_M)?LR_$'4/[7\1?!SQ_*;2+3+UA&LE[I%[Y<H@>3R86
M9'B8!X4D1HGW,W]HW_#M?]@;_HT?X%?^$%9__$T?\.U_V!O^C1_@5_X05G_\
M35<RVL!_)-XZ_P""M.K>%/AY/\)?V$?@)X&_8;\&ZIJD&L^)=?\`!&I#Q-\3
MO$4UO(LD<<FK/!'LCRH5BZRRM&S1B1$=U;Y:_;4_;)MOVU_$?A#XC>*/@SX/
M^'GQ>TWPY#X=^(?CSP=KD\EI\5%MX(HK>ZO=+>)4@FB*2['21V\J58BS+%&5
M_M^_X=K_`+`W_1H_P*_\(*S_`/B:/^':_P"P-_T:/\"O_""L_P#XFCF6]M0/
MX5_VE?VN_B'^T]X9_9V\,^.9V-M^SW\(+?X6:7*UXUP=>FBN)#+J\P/2::UA
MTJW?J3_9^[/S&F_LD?M<_$#]C[QCX_\`&?P\DW7WC[X1:[\+;N(W9MH[234[
M<'3M34CK+I]W%;W*#OL=<C>:_NJ_X=K_`+`W_1H_P*_\(*S_`/B:/^':_P"P
M-_T:/\"O_""L_P#XFCG6UM`/\ZKS`>6EWL22SN^YW)Y+,>Y)))/<FO[T?^"(
MQS_P3;^!)'(_M'Q3R.?^9JUBOH3_`(=K_L#?]&C_``*_\(*S_P#B:^HOAM\,
M/A[\'?!VE_#[X6>#M`\!>"-%>>32?"_AC3TTO1=/:YGDN;@Q0(`JF26:61L=
M6D)[TI2NK6`[NBBBH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**
M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"
2BBB@`HHHH`****`"BBB@#__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>zsw2.jpg
<TEXT>
begin 644 zsw2.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`@$!`0$!`@$!`0("`@("`@("`@,#!`,#`P,#`@(#!`,#!`0$
M!`0"`P4%!`0%!`0$!/_;`$,!`0$!`0$!`@$!`@0#`@,$!`0$!`0$!`0$!`0$
M!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!/_``!$(`#X!
M!P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[^***_"6S^,>NZM\??VN/'O[.7QY\2:_KGP.\+^)=(^'O[-WQ.
M^+^J^,;3XT>*M+F74_%>H0^%I;A);+2K"&*71]+6WV*]R\T_,4<2.UJ!^[5%
M?B;??\%&?B]J^E?!#XRZ+:_#_P`._L[_`!S^.%YX9\)";0)/$7QOU+PQ!>:'
MH6F7EEX;EU6TEO1>ZG<ZNUQ<V*S265LMG)]DE4R.>,U[]O3]M2STCQ9XNT^'
MX"QZ)I?PX^)OQ;TW1+OX=>(;C58[#X:>/XO"2Z3+=+JJI)<:O#=Q3&X$:K;^
M0Q6*7?\`*68'[RT5^(OCW_@I7\3]#^,OQF\(^#-/\)^(/#GA#X<?$G4-'T;6
MO"$FB^(O"^O>!/"T&NVYO-FKRW=W97DYGA$L]CIZ7";6M7D".S?5/[-?[5?C
M;4O%GCGX??M,>(OAAIOB*#7?`.E_#?5/"&AZAX2LO%=_X[\*R^(X]`AM+JZN
MGFN+/[)>J)D=?,BB+O'$5(H::U`_1&BOQ7_X*)?M&_'KPY\9?#VA?L]6GQDU
M"P_9?\&VO[07QBM/A9H3:MX?\6S76J6XL?"OBF3S$\NPFT33?%-XPC$K^:UD
M=G`-4O"G[3OQ8T+]I7XC^/?!OB'0_%W[._Q2_:B^'/@)-`UK1]8U?Q/;Z;XI
M^%UCK2:EH5TMT+>SB@:WAD:T6UE\^:ZN-SQL%W/E=K@?MK17X,^"_P#@I7^T
M!\0M+\;6O@2'X6:WJE[XR^%VG_#7Q%X@\%W>CV&E6GQ"\4:CX>N[?7=*LM;O
M94FT]+:VN#')<6]U&972XMHB5`[[_AOOX_Z/\6/$7@753\)-;UCP_P".O&WP
MNU?X/:5X0UG3_BCX>L_"/A&_UNS^)5Y.U\\0T;5+NR@V6Q@5%M]6M4CO)IED
MI68'[445^'>D_M9?M#>,X/ACHGQ;L?`6HWWB#QC^S?\`%32+SX<:?XD\!6VB
MV?Q,U>_CU#2+L#4G>[-A_9J.&E<6\PN&2>U9``?M#]K_`..6MWO[%OQ`^+G[
M,_B^]U1);FRTS_A8GP\TT^*-7\-:*GB6UTCQ;K6D6WEOY]QIEDFKRH51PKVA
M<!M@R6>@'WI17X)>'_VU?#_PG\-?&CP]\&_'^N^*H]/^)O@[PIX*^,_C_P"-
MEW^U?X-\6CQ#IWB"_2XN;C4KS2+3P].8-%8W=M+?&**XN8HE1Y6C1O3/A_\`
M\%!?VA_&VK?LS>$S\/O!T'B/]K?P#X2\:?#2YM="U-])T$:=J.HI\5X[\O<_
M-]CTZRM+RP4LFQM6A21I]I)+,#]H:*_!/PE_P4B_:Q\7>`/B;XJL/!'P@L]9
MM-6\,:3X;T'6#&=3^&FJ:Y\1['P;-HOB+2+36Y]4D2.RO#<B\N;?3'%Q:3J+
M=HS&:^U_VU_VF_B/^R[\(?A@UKXB\)/\7/%;W=G=:U>>`OM'@#7+K1M`N]4U
M"-%N=;LDT\7,T$2V\3W5S<R!VBAAN)<$/E=T@/T5HK\8]!_;O_:4\3>,O".O
MV7AOX96'PQNO&'P0\)Z[X-?PSJ]WXWU.3XL>';;4=2>TU;[:D$`TRYN!Y(DM
M9#(I*2%"NYN8_8U_:@^*/[1_[9O@/6_&_CCP?-'=_LN^--0UOX0^`;'5]&3X
M0:E!XYT6QAT7Q/#<74T5QJMO!`<7!CMY0)IP(1$T;NK.UP/W#HK\%?%O[2?Q
M+^!?[0W[8O\`9WCBX_:&\?6'PZ^(/Q2^%5OX8^*^K>*O`GP>LO#-MI\\/@[Q
MI\.(1%!IUQ`XD%KJ<$K37IEG!*L3C>\;?M?Z]\?OB+X+MO`OBK3[SP!X'_:8
M\/\`AS1O$OPWO+ZVL?%<.K_`WQ9K^K07MRLIBNHK?524CV@(CVD8.Z2,-0T]
M^@'[F45_/G\!_P!JKXI_!WX/V'Q1O;.[\5>%_AA^SO\`L[^*?C?J'B.[\0>*
M_%6H^&/$$'BBS\3:G8VSW9@2_L"MG>O)%#YD\<,PG\TK$T?J^O?\%$?CEX6\
M2_LT:'X@TKP3IOB;XF1>"O$_Q#^'5WX.FTY[31/B'XMN=,TE--U2;64N9+S3
MM,:UDNUM=/NXH;B&0W#VZ2QHI9]@/VUHK\L?V5?VLOVAOBA\6?AWHOQ0M/AH
M_@;XP>'?BAJ?ANQ\(^%-6T+Q%X-E^'7C6V\-6YO[VXO)X;K^T;>Z\YE2*'RV
MA&TN":^+_B+^V'\1/AG_`,%)/$-SJ'BWQ_J/PX@^*]K\%_#WPCN/'BZ.;F^N
M]$T+3H_[3\/2/]CT_P`,R7&JW6M6WBAX99Y[K3GM&DC22,$46VT!_0]17Y`_
M\%$/&WQP\`?%WX:^%/AEX]\>^'+']KKP"_[,_A:;PWJ%PEE\.?&+^*M"NK;Q
M-;*N4MKK^QM0\1`W'RY&F1`GY5KYH^$O[8G[1MCX&U?XCZ[XKN-,M_"'C;X?
M?L+>*O&_Q<MM0U7X8_#G7=*CUF;QY\1-:L(YK<W$D]Q-HMD+EYX(C+/%YDRQ
MJ<EG:X']"M%?B9X;_;X_:J\7VNEZAX8\&_#+7K+PM^S_`/$GXV>(7TWPIKLC
M_'"'P)XHN/#FD2>#E-UFUM]>0V=Y&;@73(@E\LS!XVKE/&7_``47_:`\/Z/\
M#D\#^*_V=?B[>_$'P'??$/5_&^E6,'@KX;ZMJUO>:1"WP^MKK4O$<(L[VUAO
MYGFG,EU>DR6V-,4+,*+-@?N]17X*?'']MW]INXT+]L'PWHGC[X>?#7Q5\#/&
M/AO6M*U+P3X/B^)/A_0?!MYXSM]!N9-2\1Q:NZ0ZJD9DDU&PN[*UDMHK6Y,>
M4=+B+L;K_@H=^T-%\6/C;X8TW0_A-K'A?X8^%_%[:7!)+::3K^OQ^'_`Q\2Z
M-XQT^U.NOJ%_IVK729%O;V'D1V=S$4U&61),OE8'[=45\+I\?_BI\/?V6_@[
M\9OB_=?#*3Q5X^\6^"%\8W.E:??>&/`OA#1_&&LZ9;W!#7%U)*'TZSU%@US-
M((WDMR[1HI*#Q3QO^W)\7+\VOAOX">$OAK\3OB7=_M)^*/A1:>#+:_DO9KG0
M=&TS4]3TC4KAUOH19K?I8*6U&4O;I&[R1P3;1&RLP/U3HJ.)I&BC:5%CE:-3
M+&K^8L;$`LH;`R`<C.!G'2BD!)7BOB?_`(5-\2)_B5\'I_$!TWQ'IWARTF\=
MIX2UFZ\%^,=`L=7$SVT\>KVQBF@,RVTN7@E#JI&[:)%W>U5\1>(?V0=0UYO$
MFJ7/Q0U6\USQ\OB2P\>66KZ7;WWA#4=/\0RVL_V2UM%"3I]D.E:+%"9IY@(;
M2=-H\XE0#Z$\.:+\(/A7\/?`.B^&['PWHGP^\'0Z5X(^'PL8QJ=AI0N)[?2-
M-M[2X'F/NDFF@A,NXEFD)=^6:NIG\3>`K>73;6?7/"L<NM:R_A32X&O[4G4;
M]XI+R33XAGYIFC@DE,(^8A,X/%>6Q?`U;3P;K'@[3M7LM.L;[XS6OQ3TZ*ST
MD6]AI%O;^([#7SIL5NKA5W&SD3>NU0UP7V'D'S+2/V2K;PYIO@JUT*^\)V]U
MX6MO#$%Q/_PB:VJW=QH^C^(=$U+582C[H[Z>+7Q<0W!W.DVG0[V=>5`/JH7W
M@Z1I+X7?AIWOKE]-FO!/:LUY-`C126[29^=XU#(4))49!`Y%8VHZ?\,O$&I>
M#_$&J0>"]7U30M=FNO`FK71L[NZT[4C:7&G3/ILI)(N!;W%U;DQ'>(Y9%X!(
MKY)\(_L566B^'X-+U?5/#]_J5GX)\1>#X]3_`+.N]0BN;C5M%T;0K/6UM[B9
MEMKN.WTN43+;X\P71'F9!9M7Q7^R;KNH:A;0>$O&/A[PUX/'CBS\8OX6M_"Q
ML[73I;*V\)0)+:M!(A\QO^$<O,IE8BVK&1UD>(;P#ZJTWQQX%U6VO=6TO7M$
MO-)$+RW_`(BM[B)M!;R+F6PECEO_`/4EXY8)(F0ON4J,@`C.NEYX8AN([".Z
MT&*Z%L-5BLDGMTN!#$BA;E8P<[$5E`D`P`PY`(KY&?\`96U>V2VFTW5/`+GP
M_P"))=9T'PSJ/A&1_!>N0MK7B#5(HM:LTE&]T37B5>,82YTZVF"D#RQ!H_[(
M5WX=T9SH?C31['QQ"L(TGQNW@V&[O])2'P5?>%TM(HY)&_T..>]-S%:LS1I%
M"D9#L/,H`^I=+\1>!;S7T\,:-)I-UJ5SH0\9Q#3+2.:PN;5KV2W^TI<H#$S?
M:%DSABV[)]ZFTSQ)X&UEQJVF7^B75WJ,NH:'%.(TBU74VTBZN+34+:-'`FE6
MWGMYT95#*"A(R""?"_@;^S[KGPDU'4M;O?%&GZS>W^F:I:P:?!9W*V.GOJ.K
MOJR(LTLKR/'&SE"2%+%F8!,[1PD'[*'B-M0L;[4/%?A"YN-3U&RU_P`3:H/"
MMP^N^&[RQ\4ZOXK,/A:Y>Y)M;:[EU=[.X$NYV@B9B6:4J@!]47OBWX?V6B7F
MM:QJWA[2=+T_PVOB756UF6'3)M(TV*(2BXNX9-LD,<2N,^8J["V.#Q5/0;OX
M8_#NP\-_#WPROASPEHMGX/NM?\*^']%M$TW0+?1M->U6[GM/+40"*$ZA:,P4
MYQ<AL$$L/FD_L;Z6_A#4-`EU;P_+K.JZ!=^'M2\1R>%(Y;R_M[CX?6'@J.&<
MM(6>*.?3X=0$3,5S&B@!E$E>L_%'X*7GQ/\`!O@?0CKFG^$-:\.7$%KK%]X?
MTMGT^]T>\LVTOQ)HMI$SJT,-[9SSQQ.2QADBMI-KF(`@'H^CZM\.-3T$7^E3
M>%AH-_I]GXHG1H+?3X1!>(EU97EU;NJM'Y@*2(TRJV1V(XX&U\`_!74/CI%\
M3TU*UUCXMZ!\/XM(T2RG\8SZC8^$-%UN?+76E:*9C:VK:F^G(DMW!$LEPMFB
MERHP?)D_9&LY_'?B[Q'K&I:1K6DZ]XWM?%MC;ZC:W-S.EJOB#0M>N=&O+,R_
M8YH(VT.W@MI"A:*-44*`'$DB_LN:OHES#J'A/6?!EI?Z?9Z"^ES7_A>5&CG\
M.>+]8\1V-H[PS*XLI+;69+-HU(,9L;=D!4&,`'U3-=^#=/DU"YGN?#-C+/$F
MIZK<336EM),D<BQQW%PY()579%61S@,0`<D"GZIJ_AD:MH'AS5IK&;5=>%QJ
M/A[3[JV^U&\.GK%)/-$2I13$)XFW$@_O!C/-?%\W[&EV_A)+63Q3H%[XS2^\
M/7UWJS>'YM/TS7HM%.J-)IET%F>=;.23599XT#MY<UO"Y$A6O;-1^$WBO2!\
M#Y?AYJOABPD^$NA7'A:XL?%=OJ6NVE]8W5E86<GV>X%RMQYL0L5V-.TFX/\`
M,21F@#VJUO?#-REP]E=Z%/'93,MT]K/;RI:2680.)"I.UH=Z`YP4W+TR*P/%
MGBOP1\-](O/%>O>7I]HVL6NE3S:-H-QK>KWU_J=S;6EK;I:V<,ES-/<2S6R!
M41F8NA/`R/C>V_8L\0:K!JT7C;XCZ?JS>)O$-HOC*73=`FLCXOT![*ZLO$.E
MSH)Q'`VK;[*1_(01P?8D15<`-7K47[-<E_\`!C1_A9XN\6MXFU-_B%I/CSQM
MXJ-I<:3<>+7TW7+/4VB"PW`E@9K:PM;-9$ER@A5N<;:?S`]VTG7?!]T+C5+>
M.VT>?591!<OK6DMX9U34V6VCN2LD5PD<SE(I@6#*2A#J0"K`:.CS^$KQ1;:!
M-X<NDMHH[E8-'DM9UMXW5XX9`D>=JL!(JM@`@,`>M?*_B;]D;2_$5[XVGEU?
M2WMO$7AGQ+X:T&'4M$?5Y_#4?B&V\)6C.DTLQ=RD/AF2-VR'D6]P6&&W^@?#
M;]GS2/AKX\N_&6BMH5C%?2^+7O-/T;P]%H[W2^(M9TG5+-)9$/S"QCTV2!`0
M1BY)4(-P9`?0(LK)4>(6=J(I8EMY(Q;H$DC4$*C+C!4!C@'@9/%-ET^PFFAN
M9K&SEN+>,PP7$MLDDT"%E8HCD9`)1"0"!E!Z"KE%`$"6MK$4:*V@C:(.(V2%
M4,8D8,X4@<;B`3CJ1S5>;2],N)Y+JXTVPGN9K=;2:XFLXY9Y85<2+$SD$E`P
M#!2<`C.,U?HH`BDAAE:)I88I6AD\V%I(P[0N`0&0GH<$C(YYJ&2PL);>YM);
M*TEM;PN;NVDMD>WNB_WS*A&&W=]P.>]6Z*`(([6VA,1AMH(C!`+6$QPJAAB&
M,1I@<*-HPHXX'%4/[`T(0QVPT721;Q7O]I10?V;#Y,5R22;A4VX$F23O`W9/
M6M:B@#/32=*C6_2/3-/1-5=GU1$LHE74F==KM<`+^\)!()?.0:0:/I*SK<KI
M>G"Y2R&FI<"QB$Z6P&!;A]N1'_L9V^U:-%`%>>SM+FW-I<VMO<6C*$:VG@66
MW*KC`*$$8&!@8[5!!I>F6LIN+;3K"WG8*#-!9QQ2D*I506`!X!('/`-7Z*`"
MBBB@`HHKYDA_;,_9;EUGXF:`WQN\#VFK?!S3]3U7XDVVIWTFD)X8MM%O$T_5
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M_$7PW8^+_`^NV/B7PSJ4]U:V.LZ:[26=S)8WD]A=HI(!S%<6MQ$W'#1-]:Y<
M5EF98&+EC</4IJ]KSA**OKIJEK[KTWT?9G3ALRR_&M1P>(A4=K^[.,M--=&]
M-5KMJNZ.JHKSGQO\7/AI\-M<^'GAOQYXUT+PIKGQ8\4_\(1\.--UF[^R3^,-
M7^SR72Z=9$C#3-'%(RH2"Q``R2`?%Y?VX_V48KFWM1\9_#MS)<^!Y/B4)-/T
M_4M3L[708AJ9?5;JXAMGBMX/^)+JNUYV3<;"4*"5Q5X?*,VQ=-5<+A:DX-73
MC"4DU=JZ:35KQDK]XM;IDU\VRO"U'2Q6)IPFG:TIQB[V3M9M.]I1=NS3ZH^K
MJ*^?8OVK/V<[C6_$'ANW^,'@RYU[PM=>$;'7])M]0:XO=-F\>M"O@Z-XU4DG
M5C/#]G";MPD!.T<UMZK^T1\$M#\1ZWX/U?XD>'=/\5>'/&/A_P``:QX=N9I(
M]9M=8\51F7P[8K;;-\CWZ+(\+1AD*V\Y+`0RE$\IS52Y7A:E[*5N25[/E:>V
MS4X6>SYXV^)7%FN6./,L33M=J_/&UUS76^ZY)W6ZY)?RNWL]%?)MI^W5^R+?
M6_CZ[M/CSX'GL_AGHEUXE\87JSW(LK33;*^73;S4+.8Q!+ZV@NWCMI)[`SQI
M+*B,P9E!O0?ML?LHW'AI?%R?'3P+'X?.A:OXD:]N;Z6SEBM=!U+3]'U<2V\D
M:S)/;7VJZ;:-:N@N#-?0HL3%U!Z'P_GZ:3P-:]U'^%/XFN9+X=W'5+=K78P6
M?Y')-QQM&UG+^)#9/E;^+92T;VOIN?4E%06MS#>VUM>6Y9K>[@2Y@9XGA=DD
M4.A9&`93@C*L`1W`/%?/WCW]J_\`9\^&'Q(T7X1>//B/8^'?B/XC@CNM"\+7
M.BZI<W>JQ2%1YL$L5L\+*FY#*P?$0=3(4#`GAPN!QN.JNA@J,ZDTFW&$7)I+
M=M)-I+J]EU.W$XW!X*DJV,K1IP;23E)13;V2;:3;Z+=]#Z(HKYV^''[67[/'
MQ;7PH_P\^)^C^(X_'>M7'A_P3+'87^G0^+;NUTJ76YTTU[B"-;E5L8)KGS8B
MT92,X<GBO0O'?Q?^&/PQU?X>Z!\0/&_A_P`):U\6/%\?@+X<:;K-Z+6[\8ZS
M+#)<1Z?9)SOE9(G('`SM&<LH.E7+,RHXA8.MAJD:UF^1PDI6C?F?*U>RY97=
MK+E=]F9TLSRZMAWBZ.(A*C=+F4XN-W:RYD[7?-&ROK=6W1Z/17SWKW[5O[.G
MACP_<^*=?^+GA+2M!L_%OB#P)=W]W=2(+76/"EKJ%[XCL)8]AD633[?2[^:?
M<H");ELD,I;:T+]HOX(>)QX<_L#XE>&]5?Q;\0]0^%'AR"UGD:ZU7Q'I5K=7
MVHZ1'"4#B>WM[*ZGD#*%6.+=NPRDU+*<UC3]K+"U%#57<)6O&[>MK:)._:SO
MLR8YKE<I^RCB:;GIHIQO[UK:7OK=6[W5MT>U445\TI^V/^R\_P!A`^-W@4-J
M7PYU[XN62/J3123^&_"]W/8^(-7"E`1#87%K<PS9`97@D&T[3C'#8''8WF^I
MT9U+;\L92M=-J]D[749/7I%O9,VQ&-P>$<5BZT8-[<TE&]FD[7:O9RBM.K2Z
MH^EJ*\9@_:(^!]QXJ\3^!T^*'A%/%O@KX;6WQA\7:!<ZHMGJ'AKPO>+(]OKE
MZDFWR;5EC=B[D;%VE@H92</PG^U5^S]XXTS0]8\-?$K2KW3_`!+H^N>(?#\U
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M[(U['X^EB^-OAV&/X7ND'CQK_3-4TO\`X1VXENK:S@LI!-:H7NYIKRT2&SBW
MW$WVF,QQN&4GJM!_:^_9F\3GP`FB?&;P9=W'Q1NM?T_P)827LEEJFO7?A:#[
M5XBL5M)42:*ZT^+$D]K.D<R*0=G(JZF09]2BY5<#625[MTII*T'4>\>D$YO^
MXG+;4FGGN256HTL;2;=K6J0=[R4%:TNLVH+^\U'?0^D**\^B^*WPZG^%H^-D
M7B[2'^%+>!S\25\<K*W]AG019'4CJ@?;N\G[,#-G;G:.G:O'=._;7_93U7X=
MZ[\5;#XY>")_`_AG6;+PYKVI&[FAU+3=1U((VFV#Z6T8OC<WBR(UM`L!DN%.
MZ)7`)&%'*LUQ"DZ&%J249*#Y82=IMV4'9.TF]%%ZMZ)7-JN:Y90<57Q-.+E%
MS5YQ5X)7<U=ZQ2U<EHEK<^HZ*YCP9XQ\.?$'PMHGC3PCJ#:IX;\160U#2-0>
MQN=,DN8BS*&:WN(XYHR"K`I*BL".0*Z>N*I"I2G*E5BU)-IIIIIK1IIZIIZ-
M/8[85(581JTI)Q:333NFGJFFM&FM4UN%%%%04%%%%`!7XL:O_P`$K/&GB#QU
M\>/%-W\8O"^CVOQ$USQ#XK\%I9>%]4\0W,6HZGX_T+X@Z.NMVM[?O9)9V%YX
M?MH)[;2(;1M0CNI3<2LT<6W]IZ*]W).),WX=E4GE-50E/ENW&,OA=XZ236C\
MO/=)KQ,YX=RGB"-.&:TW-0YK6E*/Q*TM8M/5+OY;-I_D?\2_V!?C7\4[/XI>
M/]>\>?"'3/VBOBCXWT+Q%I'CWPEIGBKPE8_`5?#?AR^\/:1JWA"[M-1CU%]7
M4:A=2W$E[+]FNHIOLLD)A0;O6_B;^P[XG^)4'[12:C\6XSJ/QF^'7PMT#1=;
MO_#`OY-.U[X9:E>ZU;:KJUEYJPW5M?WLMLTUI&8\1&=0X+JR_HK17>^-N(7[
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M*33^,OVN/V1[7]JN\^$:ZEXG'AG3_AEJVO\`B&&ZM;-YM?LM4O\`P_=Z=H6J
MZ7.'4076E:C)9:C&[!@QL]O&XFOE#X`_\$X?B'\(?&_P^UWQ7\0_`_Q&T2R_
M9^TGX'_$J`IXG\)3ZY]CF\7RZE>VFFVFHIIEREZOBID$&K6]RMO]G9HMC.37
MZ^45MA.,>(,#E+R3#U[8:SCR\L;I.4I.TK<R;<VW9ZV2=TDC+%\(Y#C<T6<X
MBC?$W4N;FEJTHQ5XWY6DH))-::M6;;/QC^`O_!*GQ)\)OB%^S]X\\2_&NQ\8
MS?#?Q+J.N?%:"/PM+83_`!5BTB&.U^&,/F-.WDGP]#!;[V</YSQ97RP37W#\
M1?V2O"/Q$_:F^%W[2NHQ:0FH>`/A/XG^'%Y#]CE&MZE/K#6D>DZC%.'$2R:9
M;S>)887DC>1!XAGV,@9@WUW13Q_&G$>98U9ABL1^]]G4I7C&,5[.IS\\;123
M5IN*NO=BH1C:,(I+`\'\/9=@W@,+A_W7M*=6TI2D^>GR\LKR;:=X*3U]Z3E)
MW<Y-_C!KG_!,CXL>-?A9X6^#GC/XS?#X^$_@C\"]<^`_P(U/PMX$O]!\1W]G
MKEWH2RZGXKD%XRF>&PT"U@6'3_+22YGDN6=65(UK:O\`\$H_$Y\1?#_Q-X:^
M,^E6&M_`;QKXW^(_P1UKQ%X=O/%VJ7NK^)/%F@^)]*?QQ)<7+-K@MX]/U+3K
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M:?-"49Q=U9Z2BGV=K/1M'Y#_``>_8*_:`^"G@']FG1?"WQ#^$%]XN_9K\8WN
MKZ7>>)$\:^(_#7C"RO\`P=<^$YS-;76JRR:?,!<FX2VTUHK)#&`L"Y8GT[]L
M+]A'QO\`M9^.+'QF_P`>-1^&1^'WPR32/@_I?AKPQ8ZM;Z/XL?6K37KG7]2E
MO(I91$+C0O#4<:Z<]K=+%:72_:=L[(?TJHKZ.7''$,LTAG2J1^M1YTI^S@VE
M4DYR5I1::<I2W6BE**LG9?/1X+R".63R?V<OJLN2\/:32;A%0B[QDFK*,=GJ
MXQ;NU<_*#Q]_P3B\2^/?'O[1WC"Z^*&@V6D?&SX*>(=`\,>"8/#$[:)\/?B!
MXT\.:/X:\7^+XG,V^6*\M=`L52WPKH;J]._,Q->M?"_]B&Z^'W[5^H_M`7/C
MRUU3P,/"7V[PU\+H=%:TC\/^.=2T30?#/B3Q4EUYA#?;M+\.6,*P[`4>[O&+
M'S37Z"T5G5XTXBK89X.==>S=)T;*$%:FU"+BGRW3:@KR7O.\FW><KZ4N#^'Z
M6)6+A0?M%456[E)_O$Y--J]FDY.T?A5HI*T8V*_$_P`:_P#!)'5?%7C3X@^)
M+/XRV&DZ;XJ^.\7B7P]IJ>%I9)O"_P`-]6N?$6I>-_`:2><`W]KWWBG5IUN`
M`D86`&-M@Q^V%%<>1\2YSPY.K4RBKR.HDI7C&5^5W6DD[/=76KBY1>C:?9G7
M#N4<0PIPS:ESJFVX^]*-N96>L6KK9V>B:36J37Y0M_P3L\>+\<?$W[15Q\:=
M)\4^,/'_`(K\:VOC_P"&GB[P/:7/PBU_P7XHT./P]9>%G,*1ZK)':6NB^%"P
MGNY+=GL+LQV\)N"U<?HW_!+[Q5K?AWP=H'Q7^,$^LZ+X)L/B/I_@OP=X8\3^
M+['2?AG8^,-+\.Z=H>@Z-K,NJ'5[C2M*;1+J<VM_/(CC4?)5%BAC6OV.HKU5
MQ_Q3!05/$*+C%0BXPA%QBHSBE&T5:T:DXJ2]Y)VYK:'E/@3AF3EST')2DY24
MISDI2<H2;E>3O>5.,G%^ZVK\M]3\;;;_`()6:E?:;X>TGQ)\5M+D3P[%HU]I
M6KZ)X=GLM:\/ZSH'PGT?P#H^M:=(TQ$=Q9ZKH]MK$1/&Q!$<Y9CE^'O^":?[
M0/P\\%Z!X<^&_P"T;H6BZ[KOPX\"^#?BGXQM;#Q#X/\`$5KJ/@?4-2N(-6\.
M76F:C"QM;ZUUB_M[C1=2$UH9&2;ELK7[345M_P`1&XL<%2J8B,H>[[LJ=-Q]
MQWC=./1V;[N,;W2L9+P^X64W4A0E&?O>\JE1/WU:5GS=5=+JDW:S=S\[?'_[
M%?C'Q)?_`!=\5^'?B-X?T_QEXA_:T\)_M9?"Y=>\.7&K^%]&U#PIX=T'08M)
MURV6=))X+E=*NB9K9XY(3<0.@+P`-X)XL_X)@^,?B/?:QX^\8?%WPWI/Q?\`
M$?B3QW\5#XA\%>$[FPT/X?\`C'Q#8^#=/\,7_A^&6=I3!I</@ZW2[^TL9=0&
MH788QK*5'[&T5R83CGB3`*'U6NHRBE%/D@WRJ$8<EW%WBXQ3<7HY+F>K=^K%
M<%<.XUR^LT6XR;DUSS2YG-SYK*2M).32DM5%V6EK?!O@C]G;XOK^R)\0_P!D
MKQKK?@.STNT^`EM^SU\+?&F@6=Y/=:G;GP-::+?Z[K%H\F(]VIS7QALX6REM
M;1;I&>0[?!1_P3[^,VH>(M.^.&M_%_X9-^T+X/\`$O@+5O`EGIOPYO4^#:6/
M@'2/$.BVMCK-M)?-J%W<7T7BC5I7U!9HY+61;00Q[82'_6RBLZ'&6=X6=>>&
ME"+K-RG^[@U)RY>=>\G95'"+FE9-W6B;1K6X1R;$QHPQ$9R]DE&'[R2<4N;D
M?NM7<%.2@W=I6W:3.9\&CQDOA?11\09/#,OC3[&/^$BD\&PW=OX7-P68G[$E
MRS3B,+M'[UBQ()XR`.FHHKYBI/VDY3LE=MV2LE?HET2Z(^DA'DA&%V[)*[U;
0MU;ZONPHHHJ"@HHHH`__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>13
<FILENAME>ormp-20150228.xml
<DESCRIPTION>INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by Z-K Global, Powered by IRIS Carbon-->
<xbrli:xbrl xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:ormp="http://www.oramed.com/20150228">
  <link:schemaRef xlink:type="simple" xlink:href="ormp-20150228.xsd" />
  <xbrli:context id="C1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-09-01</xbrli:startDate>
      <xbrli:endDate>2014-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C4">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C5">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C6">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C7">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:HadasitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2002-04-12</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C8">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:ConsultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-09-01</xbrli:startDate>
      <xbrli:endDate>2011-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C9">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ormp:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-11-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C10">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ormp:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-11-02</xbrli:startDate>
      <xbrli:endDate>2014-11-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C11">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C12">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C13">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C14">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-08-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C15">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C16">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C17">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C18">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C19">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:ConsultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C20">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:ConsultantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C21">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C22">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C23">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C24">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C25">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:AdvisorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-05-01</xbrli:startDate>
      <xbrli:endDate>2014-05-13</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C26">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:AdvisorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C28">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-09-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C29">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C30">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ormp:BioJerusalemMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C31">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ormp:ChiefScientistOfficeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C32">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ormp:ChiefScientistOfficeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C33">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ormp:ChiefScientistOfficeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C34">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">ormp:ChiefScientistOfficeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2002-04-12</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C36">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-11-12</xbrli:startDate>
      <xbrli:endDate>2014-11-13</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C38">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-11-13</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C39">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-11-12</xbrli:startDate>
      <xbrli:endDate>2014-11-13</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C40">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-11-13</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C45">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:MasterServiceAgreementTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-03-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C47">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:MasterServiceAgreementThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-05-16</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C49">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:MasterServiceAgreementFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-05-27</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C50">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ormp:KnryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-07-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C51">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ExecutiveOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-07-17</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C52">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ormp:ChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-07-17</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C54">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ormp:KnryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2008-06-30</xbrli:startDate>
      <xbrli:endDate>2008-07-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635439">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-12-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635440">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-12-01</xbrli:startDate>
      <xbrli:endDate>2014-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635473">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:MasterServiceAgreementFiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-12-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635477">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:ClinicalResearchOrganizationServiceAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635479">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:MasterServiceAgreementSixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-01-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635505">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635506">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-23</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635507">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635508">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:DirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-23</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635509">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635510">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-23</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635518">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635519">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635520">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C635521">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674006">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674067">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeeOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674068">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeeOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674069">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeeOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674070">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:SubsidiaryEmployeeOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-23</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674082">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:DirectorOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674083">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:DirectorTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674084">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:DirectorThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674085">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:DirectorFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-16</xbrli:startDate>
      <xbrli:endDate>2015-02-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674093">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-04-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674097">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:SecondClinicalResearchOrganizationServiceAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2015-02-01</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674098">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">ormp:ThirdClinicalResearchOrganizationServiceAgreementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2014-07-22</xbrli:startDate>
      <xbrli:endDate>2015-02-28</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674116">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ormp:EquityIssuanceAxis">ormp:IssuanceOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="C674117">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001176309</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ormp:ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ormp:EquityIssuanceAxis">ormp:IssuanceTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2015-02-28</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USDPerShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="CHF">
    <xbrli:measure>iso4217:CHF</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="ILS">
    <xbrli:measure>iso4217:ILS</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Item">
    <xbrli:measure>ormp:item</xbrli:measure>
  </xbrli:unit>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="Tag1" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;NOTE &lt;font&gt;1&lt;/font&gt; - SIGNIFICANT ACCOUNTING POLICIES:&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;a.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none;"&gt;
&lt;div align="justify"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;General:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div class="CursorPointer"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;font&gt;1)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Incorporation and operations&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Oramed Pharmaceuticals Inc. (the &amp;#147;Company&amp;#148;) was incorporated on April 12, 2002, under the laws of the State of Nevada. On February 17, 2006, the Company entered into an agreement with Hadasit Medical Services and Development Ltd (&amp;#147;Hadasit&amp;#148;) to acquire the provisional patent related to an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 11, 2011, the Company was reincorporated from the State of Nevada to the State of Delaware.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 14, 2007, the Company incorporated a wholly-owned subsidiary in Israel, Oramed Ltd. (the &amp;#147;Subsidiary&amp;#148;), which is engaged in research and development. Unless the context indicates otherwise, the term &amp;#147;Group&amp;#148; refers to Oramed Pharmaceuticals Inc. and the Subsidiary.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Following the adoption of Accounting Standards Update (&amp;#147;ASU&amp;#148;) &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;10&lt;/font&gt;, Development Stage Entities (Topic &lt;font&gt;915&lt;/font&gt;), the Company removed the inception to date information and all reference to development.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div class="CursorPointer"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;font&gt;2)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Development and liquidity risks&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Group is engaged in research and development in the biotechnology field for innovative pharmaceutical solutions, including an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules for delivery of other polypeptides, and has not generated any revenues from its operations. Continued operation of the Company is contingent upon obtaining sufficient funding until it becomes profitable.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Successful completion of the Company's development programs and its transition to normal operations is dependent upon obtaining necessary regulatory approvals from the U.S. Food and Drug Administration (&amp;#147;FDA&amp;#148;) prior to selling its products within the United States, and foreign regulatory approvals must be obtained to sell its products internationally. There can be &lt;font&gt;no&lt;/font&gt; assurance that the Company will receive regulatory approval of any of its product candidates, and a substantial amount of time may pass before the Company achieves a level of revenues adequate to support its operations, if at all. The Company also expects to incur substantial expenditures in connection with the regulatory approval process for each of its product candidates during their respective developmental periods. Obtaining marketing approval will be directly dependent on the Company's ability to implement the necessary regulatory steps required to obtain marketing approval in the United States and in other countries. The Company cannot predict the outcome of these activities.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Based on its current cash resources and commitments, and cash received in private and public offerings in the six&amp;#160;month period ended February 28, 2015 and in the year ended August 31, 2014, the Company believes it will be able to maintain its current planned development activities and the corresponding level of expenditures for at least the next &lt;font&gt;12&lt;/font&gt; months and beyond the date that the financial statements are issued, although &lt;font&gt;no&lt;/font&gt; assurance can be given that it will not need additional funds prior to such time. If there are unexpected increases in general and administrative expenses or research and development expenses, the Company may need to seek additional financing during the next &lt;font&gt;12&lt;/font&gt; months.&lt;/font&gt;&lt;/div&gt;

&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;

&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;/font&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;b.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="justify"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Newly issued and recently adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In August 2014, the Financial Accounting Standards Board (the &amp;#147;FASB&amp;#148;) issued Accounting Standards Update (&amp;#147;ASU&amp;#148;) &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt;, Presentation of Financial Statements-Going Concern (Subtopic &lt;font&gt;205&lt;/font&gt;-&lt;font&gt;40&lt;/font&gt;): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (&amp;#147;ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt;&amp;#148;). This new standard requires management to assess the entity's ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (&lt;font&gt;1&lt;/font&gt;) provide a definition of the term substantial doubt, (&lt;font&gt;2&lt;/font&gt;) require an evaluation every reporting period including interim periods, (&lt;font&gt;3&lt;/font&gt;) provide principles for considering the mitigating effect of management's plans, (&lt;font&gt;4&lt;/font&gt;) require certain disclosures when substantial doubt is alleviated as a result of consideration of management's plans, (&lt;font&gt;5&lt;/font&gt;) require an express statement and other disclosures when substantial doubt is not alleviated, and (&lt;font&gt;6&lt;/font&gt;) require an assessment for a period of &lt;font&gt;one&lt;/font&gt; year after the date that the financial statements are issued (or available to be issued). ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt; will be effective prospectively for annual reporting periods ending after the first annual period ending after December 15, 2016 and interim periods therein. Early application of the standard is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has elected to early adopt the provisions of ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt; in fiscal year &lt;font&gt;2014&lt;/font&gt;. The adoption of ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt; did not have any material effect on the consolidated financial statement presentation.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;c.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="justify"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Condensed Consolidated Financial Statements Preparation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The condensed consolidated financial statements included herein have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") and on the same basis as the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended August&amp;#160;31, &lt;font&gt;2014&lt;/font&gt; (the &amp;#147;&lt;font&gt;2014&lt;/font&gt; Form 10-K&amp;#148;). These condensed consolidated financial statements reflect all adjustments that are of a normal recurring nature and that are considered necessary for a fair statement of the results of the periods presented. Certain information and disclosures normally included in annual consolidated financial statements have been omitted in this interim period report pursuant to the rules and regulations of the Securities and Exchange Commission. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by U.S. GAAP for annual financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in the &lt;font&gt;2014&lt;/font&gt; Form 10-K. The results for interim periods are not necessarily indicative of a full fiscal year's results.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div&gt;
&lt;div style="width: 100%;" align="left"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:NetIncomeLoss id="Tag2" contextRef="C18" unitRef="USD" decimals="-3">-3533000</us-gaap:NetIncomeLoss>
  <us-gaap:SharesOutstanding id="Tag3" contextRef="C11" unitRef="Shares" decimals="-3">10103000</us-gaap:SharesOutstanding>
  <us-gaap:NetIncomeLoss id="Tag4" contextRef="C1" unitRef="USD" decimals="-3">-3533000</us-gaap:NetIncomeLoss>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag5" contextRef="C15" unitRef="USD" xsi:nil="true" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag6" contextRef="C16" unitRef="USD" xsi:nil="true" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag7" contextRef="C17" unitRef="USD" decimals="-3">-352000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag8" contextRef="C18" unitRef="USD" xsi:nil="true" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag9" contextRef="C1" unitRef="USD" decimals="-3">-352000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:SharesOutstanding id="Tag10" contextRef="C21" unitRef="Shares" decimals="-3">10820000</us-gaap:SharesOutstanding>
  <us-gaap:StockholdersEquity id="Tag11" contextRef="C21" unitRef="USD" decimals="-3">129000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag12" contextRef="C22" unitRef="USD" decimals="-3">53463000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag13" contextRef="C11" unitRef="USD" decimals="-3">121000</us-gaap:StockholdersEquity>
  <us-gaap:NatureOfOperations id="Tag14" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;a.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none;"&gt;
&lt;div align="justify"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;General:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div class="CursorPointer"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;font&gt;1)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Incorporation and operations&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Oramed Pharmaceuticals Inc. (the &amp;#147;Company&amp;#148;) was incorporated on April 12, 2002, under the laws of the State of Nevada. On February 17, 2006, the Company entered into an agreement with Hadasit Medical Services and Development Ltd (&amp;#147;Hadasit&amp;#148;) to acquire the provisional patent related to an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 11, 2011, the Company was reincorporated from the State of Nevada to the State of Delaware.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 14, 2007, the Company incorporated a wholly-owned subsidiary in Israel, Oramed Ltd. (the &amp;#147;Subsidiary&amp;#148;), which is engaged in research and development. Unless the context indicates otherwise, the term &amp;#147;Group&amp;#148; refers to Oramed Pharmaceuticals Inc. and the Subsidiary.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Following the adoption of Accounting Standards Update (&amp;#147;ASU&amp;#148;) &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;10&lt;/font&gt;, Development Stage Entities (Topic &lt;font&gt;915&lt;/font&gt;), the Company removed the inception to date information and all reference to development.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div class="CursorPointer"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;"&gt;&amp;#160;&lt;/td&gt;
&lt;td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;&lt;font&gt;2)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Development and liquidity risks&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Group is engaged in research and development in the biotechnology field for innovative pharmaceutical solutions, including an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules for delivery of other polypeptides, and has not generated any revenues from its operations. Continued operation of the Company is contingent upon obtaining sufficient funding until it becomes profitable.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;

&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Successful completion of the Company's development programs and its transition to normal operations is dependent upon obtaining necessary regulatory approvals from the U.S. Food and Drug Administration (&amp;#147;FDA&amp;#148;) prior to selling its products within the United States, and foreign regulatory approvals must be obtained to sell its products internationally. There can be &lt;font&gt;no&lt;/font&gt; assurance that the Company will receive regulatory approval of any of its product candidates, and a substantial amount of time may pass before the Company achieves a level of revenues adequate to support its operations, if at all. The Company also expects to incur substantial expenditures in connection with the regulatory approval process for each of its product candidates during their respective developmental periods. Obtaining marketing approval will be directly dependent on the Company's ability to implement the necessary regulatory steps required to obtain marketing approval in the United States and in other countries. The Company cannot predict the outcome of these activities.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Based on its current cash resources and commitments, and cash received in private and public offerings in the six&amp;#160;month period ended February 28, 2015 and in the year ended August 31, 2014, the Company believes it will be able to maintain its current planned development activities and the corresponding level of expenditures for at least the next &lt;font&gt;12&lt;/font&gt; months and beyond the date that the financial statements are issued, although &lt;font&gt;no&lt;/font&gt; assurance can be given that it will not need additional funds prior to such time. If there are unexpected increases in general and administrative expenses or research and development expenses, the Company may need to seek additional financing during the next &lt;font&gt;12&lt;/font&gt; months.&lt;/font&gt;&lt;/div&gt;

&lt;/div&gt;
&lt;/div&gt;</us-gaap:NatureOfOperations>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Tag15" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;b.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="justify"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Newly issued and recently adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;In August 2014, the Financial Accounting Standards Board (the &amp;#147;FASB&amp;#148;) issued Accounting Standards Update (&amp;#147;ASU&amp;#148;) &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt;, Presentation of Financial Statements-Going Concern (Subtopic &lt;font&gt;205&lt;/font&gt;-&lt;font&gt;40&lt;/font&gt;): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (&amp;#147;ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt;&amp;#148;). This new standard requires management to assess the entity's ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (&lt;font&gt;1&lt;/font&gt;) provide a definition of the term substantial doubt, (&lt;font&gt;2&lt;/font&gt;) require an evaluation every reporting period including interim periods, (&lt;font&gt;3&lt;/font&gt;) provide principles for considering the mitigating effect of management's plans, (&lt;font&gt;4&lt;/font&gt;) require certain disclosures when substantial doubt is alleviated as a result of consideration of management's plans, (&lt;font&gt;5&lt;/font&gt;) require an express statement and other disclosures when substantial doubt is not alleviated, and (&lt;font&gt;6&lt;/font&gt;) require an assessment for a period of &lt;font&gt;one&lt;/font&gt; year after the date that the financial statements are issued (or available to be issued). ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt; will be effective prospectively for annual reporting periods ending after the first annual period ending after December 15, 2016 and interim periods therein. Early application of the standard is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has elected to early adopt the provisions of ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt; in fiscal year &lt;font&gt;2014&lt;/font&gt;. The adoption of ASU &lt;font&gt;2014&lt;/font&gt;-&lt;font&gt;15&lt;/font&gt; did not have any material effect on the consolidated financial statement presentation.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <ormp:CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock id="Tag16" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;c.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="justify"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;Condensed Consolidated Financial Statements Preparation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The condensed consolidated financial statements included herein have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") and on the same basis as the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended August&amp;#160;31, &lt;font&gt;2014&lt;/font&gt; (the &amp;#147;&lt;font&gt;2014&lt;/font&gt; Form 10-K&amp;#148;). These condensed consolidated financial statements reflect all adjustments that are of a normal recurring nature and that are considered necessary for a fair statement of the results of the periods presented. Certain information and disclosures normally included in annual consolidated financial statements have been omitted in this interim period report pursuant to the rules and regulations of the Securities and Exchange Commission. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by U.S. GAAP for annual financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in the &lt;font&gt;2014&lt;/font&gt; Form 10-K. The results for interim periods are not necessarily indicative of a full fiscal year's results.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;</ormp:CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag17" contextRef="C15" unitRef="USD" decimals="-3">8000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag18" contextRef="C16" unitRef="USD" decimals="-3">4825000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag19" contextRef="C17" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag20" contextRef="C18" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Tag21" contextRef="C1" unitRef="USD" decimals="-3">4833000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="Tag22" contextRef="C15" unitRef="Shares" decimals="-3">4000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="Tag23" contextRef="C16" unitRef="USD" decimals="-3">26000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="Tag24" contextRef="C17" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="Tag25" contextRef="C18" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="Tag26" contextRef="C1" unitRef="USD" decimals="-3">26000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross id="Tag27" contextRef="C16" unitRef="USD" decimals="-3">564000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross id="Tag28" contextRef="C17" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross id="Tag29" contextRef="C18" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross id="Tag30" contextRef="C1" unitRef="USD" decimals="-3">564000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
  <us-gaap:NetIncomeLoss id="Tag31" contextRef="C15" unitRef="USD" xsi:nil="true" />
  <us-gaap:NetIncomeLoss id="Tag32" contextRef="C16" unitRef="USD" xsi:nil="true" />
  <us-gaap:NetIncomeLoss id="Tag33" contextRef="C17" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockholdersEquity id="Tag34" contextRef="C23" unitRef="USD" decimals="-3">100000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag35" contextRef="C24" unitRef="USD" decimals="-3">-31353000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag36" contextRef="C5" unitRef="USD" decimals="-3">22339000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag37" contextRef="C12" unitRef="USD" decimals="-3">48040000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag38" contextRef="C13" unitRef="USD" decimals="-3">452000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag39" contextRef="C14" unitRef="USD" decimals="-3">-27820000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Tag40" contextRef="C3" unitRef="USD" decimals="-3">20793000</us-gaap:StockholdersEquity>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Tag41" contextRef="C15" unitRef="Shares" decimals="-3">696000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross id="Tag42" contextRef="C15" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="Tag43" contextRef="C15" unitRef="USD" xsi:nil="true" />
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax id="Tag44" contextRef="C1" unitRef="USD" decimals="-3">36000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax id="Tag45" contextRef="C2" unitRef="USD" decimals="-3">33000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ShareBasedCompensation id="Tag46" contextRef="C1" unitRef="USD" decimals="-3">564000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="Tag47" contextRef="C2" unitRef="USD" decimals="-3">333000</us-gaap:ShareBasedCompensation>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="Tag48" contextRef="C1" unitRef="USD" decimals="-3">26000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="Tag49" contextRef="C2" unitRef="USD" decimals="-3">64000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:GainLossOnSaleOfInvestments id="Tag50" contextRef="C1" unitRef="USD" xsi:nil="true" />
  <us-gaap:GainLossOnSaleOfInvestments id="Tag51" contextRef="C2" unitRef="USD" decimals="-3">44000</us-gaap:GainLossOnSaleOfInvestments>
  <ormp:IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent id="Tag52" contextRef="C1" unitRef="USD" decimals="-3">-341000</ormp:IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent>
  <ormp:IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent id="Tag53" contextRef="C2" unitRef="USD" decimals="-3">167000</ormp:IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent>
  <ormp:IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent id="Tag54" contextRef="C1" unitRef="USD" decimals="-3">-368000</ormp:IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent>
  <ormp:IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent id="Tag55" contextRef="C2" unitRef="USD" decimals="-3">-148000</ormp:IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent>
  <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations id="Tag56" contextRef="C1" unitRef="USD" xsi:nil="true" />
  <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations id="Tag57" contextRef="C2" unitRef="USD" decimals="-3">1000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Tag58" contextRef="C1" unitRef="USD" decimals="-3">-3003000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Tag59" contextRef="C2" unitRef="USD" decimals="-3">-2230000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Tag60" contextRef="C1" unitRef="USD" decimals="-3">2000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Tag61" contextRef="C2" unitRef="USD" decimals="-3">9000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireShortTermInvestments id="Tag62" contextRef="C1" unitRef="USD" decimals="-3">1573000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:PaymentsToAcquireShortTermInvestments id="Tag63" contextRef="C2" unitRef="USD" decimals="-3">18600000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments id="Tag64" contextRef="C1" unitRef="USD" decimals="-3">3750000</us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments>
  <us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments id="Tag65" contextRef="C2" unitRef="USD" decimals="-3">5236000</us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="Tag66" contextRef="C1" unitRef="USD" xsi:nil="true" />
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities id="Tag67" contextRef="C2" unitRef="USD" decimals="-3">80000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Tag68" contextRef="C1" unitRef="USD" decimals="-3">-2477000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Tag69" contextRef="C2" unitRef="USD" decimals="-3">-13294000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag70" contextRef="C1" unitRef="USD" decimals="-3">4833000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag71" contextRef="C2" unitRef="USD" decimals="-3">14887000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Tag72" contextRef="C1" unitRef="USD" decimals="-3">4841000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Tag73" contextRef="C2" unitRef="USD" decimals="-3">16495000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="Tag74" contextRef="C1" unitRef="USD" decimals="-3">-21000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents id="Tag75" contextRef="C2" unitRef="USD" decimals="-3">10000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="Tag76" contextRef="C1" unitRef="USD" decimals="-3">-660000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="Tag77" contextRef="C2" unitRef="USD" decimals="-3">981000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag78" contextRef="C3" unitRef="USD" decimals="-3">1762000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag79" contextRef="C4" unitRef="USD" decimals="-3">2272000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag80" contextRef="C5" unitRef="USD" decimals="-3">1102000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Tag81" contextRef="C6" unitRef="USD" decimals="-3">3253000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:NetIncomeLoss id="Tag82" contextRef="C2" unitRef="USD" decimals="-3">-2239000</us-gaap:NetIncomeLoss>
  <us-gaap:DepreciationDepletionAndAmortization id="Tag83" contextRef="C1" unitRef="USD" decimals="-3">3000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Tag84" contextRef="C2" unitRef="USD" decimals="-3">3000</us-gaap:DepreciationDepletionAndAmortization>
  <ormp:PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement id="Tag85" contextRef="C1" unitRef="USD" xsi:nil="true" />
  <us-gaap:FairValueDisclosuresTextBlock id="Tag86" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div&gt;
&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;NOTE &lt;font&gt;3&lt;/font&gt; - FAIR VALUE:&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into &lt;font&gt;three&lt;/font&gt; broad levels, which are described as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 43pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 63pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&amp;#160;Level &lt;font&gt;1&lt;/font&gt;:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level &lt;font&gt;1&lt;/font&gt; inputs.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 43pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 63pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&amp;#160;Level &lt;font&gt;2&lt;/font&gt;:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Observable prices that are based on inputs other than quoted prices included within Level &lt;font&gt;1&lt;/font&gt; that are observable for the asset or liability, either directly or indirectly.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 43pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 63pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&amp;#160;Level &lt;font&gt;3&lt;/font&gt;:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Unobservable inputs are used when little or &lt;font&gt;no&lt;/font&gt; market data is available. The fair value hierarchy gives the lowest priority to Level &lt;font&gt;3&lt;/font&gt; inputs.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of February 28, 2015, the assets or liabilities measured at fair value were comprised of available for sale securities (Level &lt;font&gt;1&lt;/font&gt;). See also note &lt;font&gt;4&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of February 28, 2015, the carrying amount of cash and cash equivalents, short term deposits, other current assets, accounts payables and accrued expenses approximates their fair values due to the short-term maturities of these instruments&lt;font style="display: inline;"&gt;.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;

&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;font style="display: inline;"&gt;The f&lt;font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;"&gt;air value of long-term deposits also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. The long-term bank deposits bear an annual interest rate of &lt;font&gt;0.93&lt;/font&gt;%-&lt;font&gt;1.00&lt;/font&gt;% and will mature during the third quarter of fiscal year 2016. The amounts funded in respect of employee rights are stated at cash surrender value which approximates its fair value.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:InvestmentSoldNotYetPurchasedBalanceShares id="Tag87" contextRef="C9" unitRef="Shares" decimals="INF">696378</us-gaap:InvestmentSoldNotYetPurchasedBalanceShares>
  <us-gaap:SharePrice id="Tag88" contextRef="C9" unitRef="USDPerShare" decimals="2">7.18</us-gaap:SharePrice>
  <ormp:GrossProceedsFromIssuanceOfCommonStock id="Tag89" contextRef="C10" unitRef="USD" decimals="-3">5000000</ormp:GrossProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Tag90" contextRef="C10" unitRef="USD" decimals="-3">4833000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <ormp:FindersFee id="Tag91" contextRef="C10" unitRef="USD" decimals="-3">150000</ormp:FindersFee>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="Tag92" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;NOTE &lt;font&gt;5&lt;/font&gt; - STOCK HOLDERS' EQUITY:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On &lt;font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;"&gt;November 3, 2014, the Company entered into a Stock Purchase Agreement with Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (the &amp;#147;Investor&amp;#148;), pursuant to which the Company issued to the Investor an aggregate of&lt;/font&gt;&amp;#160;&lt;font&gt;696,378&lt;/font&gt; shares of common stock, at a price of $&lt;font&gt;7.18&lt;/font&gt; per share, which was equal to the closing price of the Company's common stock on the Nasdaq Capital Market on October 31, 2014, for aggregate gross proceeds of approximately $&lt;font&gt;5,000&lt;/font&gt;.&amp;#160;&amp;#160;The net proceeds to the Company from the offering were approximately $&lt;font&gt;4,833&lt;/font&gt;, after deducting a finder's fee of $&lt;font&gt;150&lt;/font&gt; and other offering expenses of the Company. The offering closed on November 28, 2014.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;/font&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;"&gt;See also note 8 with respect to an at market issuance sales agreement.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue id="Tag93" contextRef="C5" unitRef="USD" decimals="-3">16000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue id="Tag94" contextRef="C3" unitRef="USD" decimals="-3">16000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Tag95" contextRef="C5" unitRef="USD" decimals="-3">129000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Tag96" contextRef="C3" unitRef="USD" decimals="-3">64000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DueFromOtherRelatedPartiesCurrent id="Tag97" contextRef="C5" unitRef="USD" xsi:nil="true" />
  <us-gaap:DueFromOtherRelatedPartiesCurrent id="Tag98" contextRef="C3" unitRef="USD" decimals="-3">330000</us-gaap:DueFromOtherRelatedPartiesCurrent>
  <us-gaap:OtherReceivablesNetCurrent id="Tag99" contextRef="C5" unitRef="USD" decimals="-3">2000</us-gaap:OtherReceivablesNetCurrent>
  <us-gaap:OtherReceivablesNetCurrent id="Tag100" contextRef="C3" unitRef="USD" decimals="-3">78000</us-gaap:OtherReceivablesNetCurrent>
  <us-gaap:AssetsCurrent id="Tag101" contextRef="C5" unitRef="USD" decimals="-3">18295000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="Tag102" contextRef="C3" unitRef="USD" decimals="-3">21778000</us-gaap:AssetsCurrent>
  <us-gaap:InvestmentsAndOtherNoncurrentAssets id="Tag103" contextRef="C5" unitRef="USD" decimals="-3">4665000</us-gaap:InvestmentsAndOtherNoncurrentAssets>
  <us-gaap:InvestmentsAndOtherNoncurrentAssets id="Tag104" contextRef="C3" unitRef="USD" decimals="-3">3000</us-gaap:InvestmentsAndOtherNoncurrentAssets>
  <us-gaap:PrepaidPensionCosts id="Tag105" contextRef="C5" unitRef="USD" decimals="-3">7000</us-gaap:PrepaidPensionCosts>
  <us-gaap:PrepaidPensionCosts id="Tag106" contextRef="C3" unitRef="USD" decimals="-3">7000</us-gaap:PrepaidPensionCosts>
  <us-gaap:PropertyPlantAndEquipmentNet id="Tag107" contextRef="C5" unitRef="USD" decimals="-3">13000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="Tag108" contextRef="C3" unitRef="USD" decimals="-3">14000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Assets id="Tag109" contextRef="C5" unitRef="USD" decimals="-3">22980000</us-gaap:Assets>
  <us-gaap:Assets id="Tag110" contextRef="C3" unitRef="USD" decimals="-3">21802000</us-gaap:Assets>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="Tag111" contextRef="C5" unitRef="USD" decimals="-3">570000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent id="Tag112" contextRef="C3" unitRef="USD" decimals="-3">926000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent id="Tag113" contextRef="C5" unitRef="USD" decimals="-3">35000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:DueToRelatedPartiesCurrent id="Tag114" contextRef="C3" unitRef="USD" decimals="-3">47000</us-gaap:DueToRelatedPartiesCurrent>
  <us-gaap:LiabilitiesCurrent id="Tag115" contextRef="C5" unitRef="USD" decimals="-3">605000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="Tag116" contextRef="C3" unitRef="USD" decimals="-3">973000</us-gaap:LiabilitiesCurrent>
  <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent id="Tag117" contextRef="C5" unitRef="USD" decimals="-3">9000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
  <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent id="Tag118" contextRef="C3" unitRef="USD" decimals="-3">9000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent id="Tag119" contextRef="C5" unitRef="USD" decimals="-3">27000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent id="Tag120" contextRef="C3" unitRef="USD" decimals="-3">27000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="Tag121" contextRef="C5" unitRef="USD" decimals="-3">36000</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="Tag122" contextRef="C3" unitRef="USD" decimals="-3">36000</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Tag123" contextRef="C5" unitRef="USDPerShare" decimals="INF">0.012</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Tag124" contextRef="C5" unitRef="Shares" decimals="INF">30000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Tag125" contextRef="C5" unitRef="Shares" decimals="INF">10820193</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="Tag126" contextRef="C3" unitRef="Shares" decimals="INF">10102555</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockValue id="Tag127" contextRef="C5" unitRef="USD" decimals="-3">129000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="Tag128" contextRef="C3" unitRef="USD" decimals="-3">121000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="Tag129" contextRef="C5" unitRef="USD" decimals="-3">53463000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock id="Tag130" contextRef="C3" unitRef="USD" decimals="-3">48040000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag131" contextRef="C5" unitRef="USD" decimals="-3">100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="Tag132" contextRef="C3" unitRef="USD" decimals="-3">452000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Tag133" contextRef="C5" unitRef="USD" decimals="-3">-31353000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Tag134" contextRef="C3" unitRef="USD" decimals="-3">-27820000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Tag135" contextRef="C5" unitRef="USD" decimals="-3">22980000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Tag136" contextRef="C3" unitRef="USD" decimals="-3">21802000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DepositsAssetsCurrent id="Tag137" contextRef="C5" unitRef="USD" decimals="-3">16351000</us-gaap:DepositsAssetsCurrent>
  <us-gaap:DepositsAssetsCurrent id="Tag138" contextRef="C3" unitRef="USD" decimals="-3">18481000</us-gaap:DepositsAssetsCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="Tag139" contextRef="C5" unitRef="USD" decimals="-3">695000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="Tag140" contextRef="C3" unitRef="USD" decimals="-3">1047000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:CommitmentsAndContingencies id="Tag141" contextRef="C3" unitRef="USD" xsi:nil="true" />
  <us-gaap:CommonStockSharesOutstanding id="Tag142" contextRef="C3" unitRef="Shares" decimals="INF">10102555</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesAuthorized id="Tag143" contextRef="C3" unitRef="Shares" decimals="INF">30000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommitmentsAndContingencies id="Tag144" contextRef="C5" unitRef="USD" xsi:nil="true" />
  <us-gaap:CommonStockSharesOutstanding id="Tag145" contextRef="C5" unitRef="Shares" decimals="INF">10820193</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Tag146" contextRef="C3" unitRef="USDPerShare" decimals="INF">0.012</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag147" contextRef="C7" unitRef="USD" decimals="-3">200000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ProfessionalFees id="Tag148" contextRef="C7" unitRef="USD" decimals="-3">95000</us-gaap:ProfessionalFees>
  <ormp:LongTermPurchaseCommitmentAmountMonthlyFixedFee id="Tag149" contextRef="C19" unitRef="USD" decimals="-3">8000</ormp:LongTermPurchaseCommitmentAmountMonthlyFixedFee>
  <ormp:RoyaltyPercentage id="Tag150" contextRef="C19" unitRef="Pure" decimals="2">0.08</ormp:RoyaltyPercentage>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross id="Tag151" contextRef="C8" unitRef="Shares" decimals="INF">20834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice id="Tag152" contextRef="C8" unitRef="USDPerShare" decimals="2">6.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost id="Tag153" contextRef="C20" unitRef="USD" decimals="-3">105000</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate id="Tag154" contextRef="C8" unitRef="Pure" decimals="2">0.00</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate id="Tag155" contextRef="C8" unitRef="Pure" decimals="4">0.7974</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate id="Tag156" contextRef="C8" unitRef="Pure" decimals="4">0.0186</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="Tag157" contextRef="C29" unitRef="ILS" decimals="0">89000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="Tag158" contextRef="C29" unitRef="USD" decimals="-3">22000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance id="Tag159" contextRef="C25" unitRef="Shares" decimals="INF">15000</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued id="Tag160" contextRef="C26" unitRef="Shares" decimals="INF">7500</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued>
  <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims id="Tag161" contextRef="C26" unitRef="USD" decimals="-3">64000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag162" contextRef="C45" unitRef="USD" decimals="-3">311000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ProfessionalFees id="Tag163" contextRef="C45" unitRef="USD" decimals="-3">40000</us-gaap:ProfessionalFees>
  <ormp:LongTermPurchaseCommitmentBonusAmount id="Tag164" contextRef="C45" unitRef="USD" decimals="-3">600000</ormp:LongTermPurchaseCommitmentBonusAmount>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag165" contextRef="C47" unitRef="USD" decimals="-3">217000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag166" contextRef="C49" unitRef="USD" decimals="-3">214000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ProfessionalFees id="Tag167" contextRef="C49" unitRef="USD" decimals="-3">174000</us-gaap:ProfessionalFees>
  <ormp:RoyaltyPercentage id="Tag168" contextRef="C30" unitRef="Pure" decimals="2">0.04</ormp:RoyaltyPercentage>
  <ormp:RoyaltyPercentageMaximumPercentageOfGrantsReceived id="Tag169" contextRef="C30" unitRef="Pure" decimals="2">1.00</ormp:RoyaltyPercentageMaximumPercentageOfGrantsReceived>
  <us-gaap:GrantsReceivable id="Tag170" contextRef="C30" unitRef="USD" decimals="-3">65000</us-gaap:GrantsReceivable>
  <ormp:RoyaltyPercentage id="Tag171" contextRef="C31" unitRef="Pure" decimals="2">0.03</ormp:RoyaltyPercentage>
  <ormp:RoyaltyPercentage id="Tag172" contextRef="C32" unitRef="Pure" decimals="3">0.035</ormp:RoyaltyPercentage>
  <ormp:RoyaltyPercentageMaximumPercentageOfGrantsReceived id="Tag173" contextRef="C33" unitRef="Pure" decimals="2">1.00</ormp:RoyaltyPercentageMaximumPercentageOfGrantsReceived>
  <us-gaap:RevenueFromGrants id="Tag174" contextRef="C34" unitRef="USD" decimals="-3">2160000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="Tag175" contextRef="C1" unitRef="USD" decimals="-3">17000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueFromGrants id="Tag176" contextRef="C635439" unitRef="USD" decimals="-3">1000</us-gaap:RevenueFromGrants>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Tag177" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;NOTE &lt;font&gt;2&lt;/font&gt; - COMMITMENTS:&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;a.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="justify"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On September 11, 2011, the Subsidiary entered into an agreement with Hadasit, the Company's Medical and Chief Technology Officer (the &amp;#147;CTO&amp;#148;) and Dr. Daniel Schurr Subsidiary (the &amp;#147;Hadasit Agreement&amp;#148;) to retain consulting and clinical trial services. According to the Hadasit Agreement, Hadasit will be entitled to a consideration of $&lt;font&gt;200&lt;/font&gt; to be paid by the Subsidiary&amp;#160;in accordance with the actual progress of the studies, $&lt;font&gt;95&lt;/font&gt; of which were recognized through February 28, 2015. See also note &lt;font&gt;1&lt;/font&gt;a&lt;font&gt;(1)&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;b.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On February 15, 2011, the Subsidiary entered into a consulting agreement with a third party (the &amp;#147;Consultant&amp;#148;) for a period of &lt;font&gt;five&lt;/font&gt; years, pursuant to which the Consultant will provide consultation on scientific and clinical matters. The Consultant is entitled to a fixed monthly fee of $&lt;font&gt;8&lt;/font&gt;, royalties of &lt;font&gt;8&lt;/font&gt;% of the net royalties actually received by the Subsidiary in respect of the patent that was sold to Entera Bio Ltd. (&amp;#147;Entera&amp;#148;) on March 31, 2011 and an option to purchase up to &lt;font&gt;20,834&lt;/font&gt; shares of the Company at an exercise price of $&lt;font&gt;6.00&lt;/font&gt; per share. The option vests in &lt;font&gt;five&lt;/font&gt; annual installments commencing February 16, 2012 and expires on February 16, 2021. The fair value of the option as of February 28, 2015 was $&lt;font&gt;105&lt;/font&gt;, using the following assumptions: dividend yield of &lt;font&gt;0&lt;/font&gt;%; and expected term of &lt;font&gt;5.97&lt;/font&gt;&amp;#160;years; expected volatility of &lt;font&gt;79.74&lt;/font&gt;%; and risk-free interest rate of &lt;font&gt;1.86&lt;/font&gt;%. The fair value of the unvested options is remeasured at each balance sheet reporting date and is recognized over the related service period using the straight-line method.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;c.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&lt;font style="font-size: 10pt;"&gt;On April 28, 2013, the Subsidiary entered into a new lease agreement for its office facilities in Israel, which replaced the lease agreement from &lt;font&gt;2012&lt;/font&gt;. The new lease agreement is for a period of &lt;font&gt;36&lt;/font&gt; months commencing November 4, 2013. The annual lease payment is NIS &lt;font&gt;89,000&lt;/font&gt; from &lt;font&gt;2014&lt;/font&gt; through &lt;font&gt;2016&lt;/font&gt;, and will be linked to the increase in the Israeli consumer price index (&amp;#147;CPI&amp;#148;) (as of &lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;February 28, 2015&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;, the future annual lease payments under the new agreement will be $&lt;font&gt;22&lt;/font&gt;, based on the exchange rate as of &lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;February 28&lt;/font&gt;&lt;font style="font-size: 10pt;"&gt;, 2015).&lt;/font&gt;&lt;br/&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 2.45pt;" align="left"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 2.45pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As security for its obligation under this lease agreement the Company provided a bank guarantee in an amount equal to &lt;font&gt;three&lt;/font&gt; monthly lease payments.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;d.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 13, 2014, the Company entered into a consulting agreement with a third party advisor for a period of &lt;font&gt;twelve&lt;/font&gt; months, pursuant to which the advisor will provide investor relations services and will be entitled to receive a monthly cash fee and &lt;font&gt;15,000&lt;/font&gt; shares of the Company's common stock that will be issued in &lt;font&gt;four&lt;/font&gt; equal installments, on or about&lt;font style="display: inline; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;each of August 1, 2014, November 1, 2014, February 1, 2015 and May 1, 2015. As of February 28, 2015, the Company issued to such advisor &lt;font&gt;7,500&lt;/font&gt; shares. The aggregate fair value of the shares at the dates of the grant was $&lt;font&gt;64&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;

&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;e.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;"&gt;On February 6, 2014, the Subsidiary entered into a second agreement with a clinical research organization (&amp;#147;CRO&amp;#148;), for its Phase IIa clinical trial for an oral insulin capsule for type 1 diabetes patients, which was completed in October 2014. As consideration for its services, the Subsidiary paid the CRO a total amount of approximately $&lt;font&gt;280&lt;/font&gt; during the term of the engagement and based on achievement of certain milestones, all of which were recognized through February 28, 2015.&lt;/font&gt;&lt;/font&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0pt; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 54pt; margin-right: -0.05pt; padding-left: 30px; background-color: #ffffff;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On July 22, 2014, the Subsidiary entered into a third agreement with the same CRO, for its Phase IIb clinical trial for an oral insulin capsule for type 2 diabetes patients, which is expected to begin in the second quarter of calendar year 2015. As consideration for its services, the Subsidiary will pay the CRO a total amount of approximately&lt;font style="display: inline; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;$&lt;font&gt;3,290&lt;/font&gt; during the term of the engagement and based on achievement of certain milestones, $&lt;font&gt;761&lt;/font&gt; of which were recognized through February 28, 2015.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;f.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On March 3, 2014, the Subsidiary entered into an additional agreement with a vendor, for the process development and production of &lt;font&gt;one&lt;/font&gt; of its oral capsule ingredients in the amount of $&lt;font&gt;311&lt;/font&gt;, $&lt;font&gt;40&lt;/font&gt; of which were recognized through February 28, 2015, and bonus payments of up to $&lt;font&gt;600&lt;/font&gt; that will be paid upon achieving certain milestones, as described in the agreement and which were not recognized through February 28, 2015.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 15, 2014, the Subsidiary entered into an additional agreement with the same vendor, for the process development and production of the same capsule ingredients in the amount of $&lt;font&gt;217&lt;/font&gt;, all&amp;#160;of which was recognized through February 28, 2015.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;/font&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt; &lt;!-- [if gte mso 9]&gt;&lt;xml&gt; &lt;o:OfficeDocumentSettings&gt; &lt;o:RelyOnVML&gt;&lt;/o:RelyOnVML&gt; &lt;o:AllowPNG&gt;&lt;/o:AllowPNG&gt; &lt;/o:OfficeDocumentSettings&gt;
&lt;/xml&gt;&lt;![endif]--&gt; &lt;!-- [if gte mso 9]&gt;&lt;xml&gt; &lt;w:WordDocument&gt; &lt;w:View&gt;Normal&lt;/w:View&gt; &lt;w:Zoom&gt;0&lt;/w:Zoom&gt; &lt;w:TrackMoves&gt;&lt;/w:TrackMoves&gt; &lt;w:TrackFormatting&gt;&lt;/w:TrackFormatting&gt; &lt;w:PunctuationKerning&gt;&lt;/w:PunctuationKerning&gt; &lt;w:ValidateAgainstSchemas&gt;&lt;/w:ValidateAgainstSchemas&gt; &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt; &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt; &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt; &lt;w:DoNotPromoteQF&gt;&lt;/w:DoNotPromoteQF&gt; &lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt; &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt; &lt;w:LidThemeComplexScript&gt;HE&lt;/w:LidThemeComplexScript&gt; &lt;w:Compatibility&gt; &lt;w:BreakWrappedTables&gt;&lt;/w:BreakWrappedTables&gt; &lt;w:SnapToGridInCell&gt;&lt;/w:SnapToGridInCell&gt; &lt;w:WrapTextWithPunct&gt;&lt;/w:WrapTextWithPunct&gt; &lt;w:UseAsianBreakRules&gt;&lt;/w:UseAsianBreakRules&gt; &lt;w:DontGrowAutofit&gt;&lt;/w:DontGrowAutofit&gt; &lt;w:SplitPgBreakAndParaMark&gt;&lt;/w:SplitPgBreakAndParaMark&gt; &lt;w:EnableOpenTypeKerning&gt;&lt;/w:EnableOpenTypeKerning&gt; &lt;w:DontFlipMirrorIndents&gt;&lt;/w:DontFlipMirrorIndents&gt; &lt;w:OverrideTableStyleHps&gt;&lt;/w:OverrideTableStyleHps&gt; &lt;/w:Compatibility&gt; &lt;m:mathPr&gt; &lt;m:mathFont m:val="Cambria Math"&gt;&lt;/m:mathFont&gt; &lt;m:brkBin m:val="before"&gt;&lt;/m:brkBin&gt; &lt;m:brkBinSub m:val="&amp;#45;-"&gt;&lt;/m:brkBinSub&gt; &lt;m:smallFrac m:val="off"&gt;&lt;/m:smallFrac&gt; &lt;m:dispDef&gt;&lt;/m:dispDef&gt; &lt;m:lMargin m:val="0"&gt;&lt;/m:lMargin&gt; &lt;m:rMargin m:val="0"&gt;&lt;/m:rMargin&gt; &lt;m:defJc m:val="centerGroup"&gt;&lt;/m:defJc&gt; &lt;m:wrapIndent m:val="1440"&gt;&lt;/m:wrapIndent&gt; &lt;m:intLim m:val="subSup"&gt;&lt;/m:intLim&gt; &lt;m:naryLim m:val="undOvr"&gt;&lt;/m:naryLim&gt; &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!-- [if gte mso 9]&gt;&lt;xml&gt; &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"&gt; &lt;w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="0" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" Name="Table Grid"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="60" Name="Light Shading"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="61" Name="Light List"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="62" Name="Light Grid"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="65" Name="Medium List 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="66" Name="Medium List 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="70" Name="Dark List"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="71" Name="Colorful Shading"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="72" Name="Colorful List"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="73" Name="Colorful Grid"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" SemiHidden="true" Name="Revision"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="41" Name="Plain Table 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="42" Name="Plain Table 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="43" Name="Plain Table 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="44" Name="Plain Table 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="45" Name="Plain Table 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="40" Name="Grid Table Light"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="Grid Table 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="Grid Table 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="Grid Table 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="List Table 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="List Table 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="List Table 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"&gt;&lt;/w:LsdException&gt; &lt;w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"&gt;&lt;/w:LsdException&gt; &lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt; &lt;!-- [if gte mso 10]&gt;
&lt;style&gt; /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif; mso-bidi-language:HE;}
&lt;/style&gt;
&lt;![endif]--&gt;&lt;/font&gt;&lt;/font&gt;
&lt;p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"&gt;&lt;font style="font-size: 10pt;"&gt;On December 12, 2014, the Subsidiary entered into an additional agreement with the same vendor, for the process development and production of the same capsule ingredients in the amount of $&lt;font&gt;550&lt;/font&gt;, $&lt;font&gt;202&lt;/font&gt; of which was recognized through February 28, 2015.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;g.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On May 26, 2014, the Subsidiary entered into a supply agreement with another vendor, according to which the vendor will manufacture capsules for total consideration of $&lt;font&gt;214&lt;/font&gt;, $&lt;font&gt;174&lt;/font&gt; of which was recognized through February 28, 2015.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;
&lt;div style="color: #000000; font-family: 'Times New Roman'; font-size: 16px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;"&gt;
&lt;div class="CursorPointer"&gt;
&lt;table width="100%" cellpadding="0" border="0" cellspacing="0"&gt;

&lt;tr&gt;
&lt;td style="width: 1.25%;"&gt;&lt;br/&gt;&lt;/td&gt;
&lt;td style="width: 0.82%; vertical-align: top;" valign="top"&gt;&lt;font style="font-size: 10pt;"&gt;h.&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 33%;"&gt;&lt;font style="font-size: 10pt;"&gt;&lt;font style="font-family: 'Times New Roman', serif;"&gt;&lt;b&gt;&lt;font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;"&gt;On February 2, 2015, the Subsidiary entered into an agreement with a different CRO, for a glucose clamp clinical study for its oral insulin capsule. As consideration for its services, the Subsidiary will pay the CRO a total amount of approximately&lt;/font&gt;&amp;#160;&lt;/b&gt;&lt;font style="layout-grid-mode: line;"&gt;$&lt;font&gt;276&lt;/font&gt; &lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: 'Times New Roman', serif;"&gt;during the term of the engagement and based on achievement of certain milestones, &lt;/font&gt;&lt;font style="font-family: 'Times New Roman', serif;"&gt;none of which was recognized through February 28, 2015.&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;br/&gt;&lt;/div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table width="100%" cellpadding="0" border="0" cellspacing="0"&gt;

&lt;tr&gt;
&lt;td style="width: 1.25%;"&gt;&lt;br/&gt;&lt;/td&gt;
&lt;td style="width: 0.82%; vertical-align: top;" valign="top"&gt;&lt;font style="font-size: 10pt;"&gt;i.&lt;/font&gt;&lt;/td&gt;
&lt;td style="width: 33%;"&gt;&lt;font style="font-size: 10pt;"&gt;On&amp;#160;January 20, 2015, the Subsidiary entered into a purchase order for the manufacturing of insulin capsules for a total consideration of Swiss Franc ("CHF")&amp;#160;&lt;font&gt;211&lt;/font&gt; (approximately $&lt;font&gt;241&lt;/font&gt;) of which CHF &lt;font&gt;104&lt;/font&gt; (approximately $&lt;font&gt;118&lt;/font&gt;) was recognized through February 28, 2015.&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;div class="CursorPointer"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;j.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none;"&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Grants from Bio-Jerusalem&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Subsidiary is committed to pay royalties to the Bio-Jerusalem fund on proceeds from future sales at a rate of &lt;font&gt;4&lt;/font&gt;% and up to &lt;font&gt;100&lt;/font&gt;% of the amount of the grant received by the Company (Israeli CPI linked) at the total amount of $&lt;font&gt;65&lt;/font&gt;. As of February 28, 2015, the Subsidiary had not yet realized any revenues and did not incur any royalty liability.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the six&amp;#160;month period ended February 28, 2015, the Company received &lt;font&gt;no&lt;/font&gt; grants from the Bio-Jerusalem fund.&lt;/font&gt;&lt;/div&gt;

&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 72pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&lt;/font&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;k.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Grants from the Office of the Chief Scientist of the Ministry of Economy (formerly the Ministry of Industry, Trade and Labor) of Israel ("OCS").&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Under the terms of the Company's funding from the OCS, royalties of &lt;font&gt;3&lt;/font&gt;%-&lt;font&gt;3.5&lt;/font&gt;% are payable on sales of products developed from a project so funded, up to &lt;font&gt;100&lt;/font&gt;% of the amount of the grant received by the Company (dollar linked) with the addition of annual interest at a rate based on &lt;font&gt;LIBOR&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;At the time the grants were received, successful development of the related projects was not assured. In case of failure of a project that was partly financed as above, the Company is not obligated to pay any such royalties.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of February 28, 2015, the Subsidiary had not yet realized any revenues from said projects and did not incur any royalty liability. The total amount that was actually received through February 28, 2015 was $&lt;font&gt;2,160&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div class="CursorPointer"&gt;
&lt;table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;"&gt;

&lt;tr valign="top"&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;"&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;"&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;j.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;
&lt;div align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;For the six and&amp;#160;&lt;font&gt;three&lt;/font&gt; month periods ended February 28, 2015, the research and development expenses are presented net of OCS and Bio-Jerusalem fund grants, in the total amount of $&lt;font&gt;17&lt;/font&gt;&amp;#160;and $&lt;font&gt;1&lt;/font&gt;, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1 id="Tag178" contextRef="C8">P5Y11M19D</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1>
  <ormp:LongTermPurchaseCommitmentAgreementTerm id="Tag179" contextRef="C8">P5Y</ormp:LongTermPurchaseCommitmentAgreementTerm>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="Tag180" contextRef="C29" unitRef="ILS" decimals="-3">89000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="Tag181" contextRef="C29" unitRef="USD" decimals="-3">22000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract id="Tag182" contextRef="C28">P36M</us-gaap:LesseeLeasingArrangementsOperatingLeasesTermOfContract>
  <us-gaap:AccruedRoyaltiesCurrentAndNoncurrent id="Tag183" contextRef="C30" unitRef="USD" decimals="-3">0</us-gaap:AccruedRoyaltiesCurrentAndNoncurrent>
  <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock id="Tag184" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div&gt;
&lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;NOTE &lt;font&gt;4&lt;/font&gt; - &lt;font style="display: inline; font-size: 10pt;"&gt;MARKETABLE SECURITIES&lt;/font&gt;:&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;Available-for-sale securities are reported at fair value, with unrealized gains and losses recorded as a separate component of other comprehensive income in equity until realized. Unrealized losses that are considered to be other-than-temporary are charged to statement of operations as an impairment charge and are included in the consolidated statement of operations under impairment of available-for-sale securities.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The Company considers available evidence in evaluating potential impairments of its investments, including the duration and extent to which fair value is less than cost, and the Company's ability and intent to hold the investment. Realized gains and losses on sales of the securities are included in the consolidated statement of operations as financial income or expenses.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of February 28, 2015, marketable securities consisted wholly of equity securities of D.N.A Biomedical Solutions Ltd ("D.N.A"). D.N.A's ordinary shares are traded on the Tel Aviv Stock Exchange and have a quoted price. The fair value of those securities is measured at the quoted prices of the securities on the measurement date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;During the &lt;font&gt;six&lt;/font&gt;&amp;#160;month period ended February 28, 2014, the Subsidiary sold in aggregate &lt;font&gt;1,625,989&lt;/font&gt; of the D.N.A ordinary shares for total consideration of $&lt;font&gt;80&lt;/font&gt;. During the &lt;font&gt;six&lt;/font&gt;&amp;#160;month period ended February 28, 2015, the Group did not sell any of the D.N.A ordinary shares.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;As of February 28, 2015, the Group owns approximately &lt;font&gt;9.8&lt;/font&gt;% of D.N.A's outstanding ordinary shares.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The cost of the securities as of February 28, 2015 and August 31, 2014 is $&lt;font&gt;595&lt;/font&gt;.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;The cost of the securities sold and the amount reclassified out of accumulated other comprehensive income into financial income (amounting to $&lt;font&gt;0&lt;/font&gt;&amp;#160;&lt;font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;"&gt;and $&lt;font&gt;44&lt;/font&gt; during the six month periods ended February 28, 2015 and 2014, respectively, and to $&lt;font&gt;0&lt;/font&gt; and $&lt;font&gt;26&lt;/font&gt; during the three month periods ended February 28, 2015 and 2014, respectively) were determined by specific identification.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
  <ormp:MarketableSecuritiesSold id="Tag185" contextRef="C2" unitRef="Shares" decimals="INF">1625989</ormp:MarketableSecuritiesSold>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity id="Tag186" contextRef="C2" unitRef="USD" decimals="-3">80000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
  <ormp:MarketableSecuritiesOwnershipPercentage id="Tag187" contextRef="C5" unitRef="Pure" decimals="3">0.098</ormp:MarketableSecuritiesOwnershipPercentage>
  <us-gaap:TradingSecuritiesEquityCost id="Tag188" contextRef="C5" unitRef="USD" decimals="-3">595000</us-gaap:TradingSecuritiesEquityCost>
  <ormp:MarketableSecuritiesSold id="Tag189" contextRef="C1" unitRef="Shares" decimals="INF">0</ormp:MarketableSecuritiesSold>
  <us-gaap:TradingSecuritiesEquityCost id="Tag190" contextRef="C3" unitRef="USD" decimals="-3">595000</us-gaap:TradingSecuritiesEquityCost>
  <ormp:MonthlyPaymentUnderConsultingAgreements id="Tag191" contextRef="C50" unitRef="ILS" decimals="0">50400</ormp:MonthlyPaymentUnderConsultingAgreements>
  <ormp:AnnualPaymentUnderConsultingAgreements id="Tag192" contextRef="C51" unitRef="USD" decimals="-3">250000</ormp:AnnualPaymentUnderConsultingAgreements>
  <ormp:AnnualPaymentUnderConsultingAgreements id="Tag193" contextRef="C52" unitRef="USD" decimals="-3">200000</ormp:AnnualPaymentUnderConsultingAgreements>
  <us-gaap:ForeignCurrencyExchangeRateTranslation1 id="Tag194" contextRef="C51" unitRef="Pure" decimals="INF">3.6</us-gaap:ForeignCurrencyExchangeRateTranslation1>
  <us-gaap:OperatingIncomeLoss id="Tag195" contextRef="C635439" unitRef="USD" decimals="-3">-1674000</us-gaap:OperatingIncomeLoss>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock id="Tag196" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"&gt;NOTE &lt;font&gt;7&lt;/font&gt; - RELATED PARTIES - TRANSACTIONS&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On July 1, 2008, the Subsidiary entered into &lt;font&gt;two&lt;/font&gt; consulting agreements with KNRY Ltd. (&amp;#147;KNRY&amp;#148;), an Israeli company owned by the CEO, whereby the CEO and the CTO, through KNRY, provide services to the Group (the &amp;#147;Consulting Agreements&amp;#148;). The Consulting Agreements are both terminable by either party upon &lt;font&gt;60&lt;/font&gt; days prior written notice. The Consulting Agreements provide that KNRY (i) will be paid a gross amount of NIS &lt;font&gt;50,400&lt;/font&gt; per month for each of the CEO and CTO ($&lt;font&gt;14&lt;/font&gt;) and (ii) will be reimbursed for reasonable expenses incurred in connection with performance of the Consulting Agreements.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On July 17, 2013, the Subsidiary entered into amendments to the Consulting Agreements with KNRY, according to which, the CEO's and CTO's annual payment was set at $&lt;font&gt;250&lt;/font&gt; and $&lt;font&gt;200&lt;/font&gt;, respectively, calculated at an exchange rate of NIS &lt;font&gt;3.6&lt;/font&gt; &amp;#160;per U.S. dollar, and in addition to such payment they were granted the use of a company car and certain cash bonus payments, effective July 1, 2013.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;On November 13, 2014, the Subsidiary entered into an amendment to the Consulting Agreements (the &amp;#147;Amendment Agreement&amp;#148;), according to which, the CEO and the CTO made some representations with regards to their relationship with KNRY and agreed to indemnify the Subsidiary in certain circumstances as defined in the amendment, among other revisions.&lt;/font&gt;&lt;/div&gt;

&lt;div style="text-indent: 0pt; display: block;"&gt;
&lt;div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <ormp:MonthlyPaymentUnderConsultingAgreements id="Tag197" contextRef="C50" unitRef="USD" decimals="-3">14000</ormp:MonthlyPaymentUnderConsultingAgreements>
  <ormp:NumberOfConsultingAgreementsEntered id="Tag198" contextRef="C54" unitRef="Item" decimals="INF">2</ormp:NumberOfConsultingAgreementsEntered>
  <us-gaap:ForeignCurrencyExchangeRateTranslation1 id="Tag199" contextRef="C52" unitRef="Pure" decimals="INF">3.6</us-gaap:ForeignCurrencyExchangeRateTranslation1>
  <ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments id="Tag200" contextRef="C36" unitRef="Item" decimals="INF">2</ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag201" contextRef="C1" unitRef="USD" decimals="-3">2438000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag202" contextRef="C2" unitRef="USD" decimals="-3">1424000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag203" contextRef="C635439" unitRef="USD" decimals="-3">1136000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="Tag204" contextRef="C635440" unitRef="USD" decimals="-3">674000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Tag205" contextRef="C1" unitRef="USD" decimals="-3">1138000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Tag206" contextRef="C2" unitRef="USD" decimals="-3">930000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Tag207" contextRef="C635439" unitRef="USD" decimals="-3">538000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Tag208" contextRef="C635440" unitRef="USD" decimals="-3">512000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:OperatingIncomeLoss id="Tag209" contextRef="C1" unitRef="USD" decimals="-3">-3576000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Tag210" contextRef="C2" unitRef="USD" decimals="-3">-2354000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Tag211" contextRef="C635440" unitRef="USD" decimals="-3">-1186000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherNonoperatingIncome id="Tag212" contextRef="C1" unitRef="USD" decimals="-3">65000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:OtherNonoperatingIncome id="Tag213" contextRef="C2" unitRef="USD" decimals="-3">120000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:OtherNonoperatingIncome id="Tag214" contextRef="C635439" unitRef="USD" decimals="-3">38000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:OtherNonoperatingIncome id="Tag215" contextRef="C635440" unitRef="USD" decimals="-3">74000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:OtherNonoperatingExpense id="Tag216" contextRef="C1" unitRef="USD" decimals="-3">22000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:OtherNonoperatingExpense id="Tag217" contextRef="C2" unitRef="USD" decimals="-3">5000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:OtherNonoperatingExpense id="Tag218" contextRef="C635439" unitRef="USD" decimals="-3">1000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:OtherNonoperatingExpense id="Tag219" contextRef="C635440" unitRef="USD" decimals="-3">3000</us-gaap:OtherNonoperatingExpense>
  <us-gaap:NetIncomeLoss id="Tag220" contextRef="C635439" unitRef="USD" decimals="-3">-1637000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Tag221" contextRef="C635440" unitRef="USD" decimals="-3">-1115000</us-gaap:NetIncomeLoss>
  <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax id="Tag222" contextRef="C1" unitRef="USD" decimals="-3">-9000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax id="Tag223" contextRef="C2" unitRef="USD" decimals="-3">54000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax id="Tag224" contextRef="C635439" unitRef="USD" xsi:nil="true" />
  <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax id="Tag225" contextRef="C635440" unitRef="USD" decimals="-3">49000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax id="Tag226" contextRef="C1" unitRef="USD" xsi:nil="true" />
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax id="Tag227" contextRef="C2" unitRef="USD" decimals="-3">44000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax id="Tag228" contextRef="C635439" unitRef="USD" xsi:nil="true" />
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax id="Tag229" contextRef="C635440" unitRef="USD" decimals="-3">26000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="Tag230" contextRef="C1" unitRef="USD" decimals="-3">-343000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="Tag231" contextRef="C2" unitRef="USD" decimals="-3">534000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="Tag232" contextRef="C635439" unitRef="USD" decimals="-3">7000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="Tag233" contextRef="C635440" unitRef="USD" decimals="-3">490000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag234" contextRef="C2" unitRef="USD" decimals="-3">544000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag235" contextRef="C635439" unitRef="USD" decimals="-3">7000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="Tag236" contextRef="C635440" unitRef="USD" decimals="-3">513000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Tag237" contextRef="C1" unitRef="USD" decimals="-3">-3885000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Tag238" contextRef="C2" unitRef="USD" decimals="-3">-1695000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Tag239" contextRef="C635439" unitRef="USD" decimals="-3">-1630000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="Tag240" contextRef="C635440" unitRef="USD" decimals="-3">-602000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag241" contextRef="C1" unitRef="USDPerShare" decimals="2">0.34</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag242" contextRef="C2" unitRef="USDPerShare" decimals="2">0.26</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag243" contextRef="C635439" unitRef="USDPerShare" decimals="2">0.15</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="Tag244" contextRef="C635440" unitRef="USDPerShare" decimals="2">0.12</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag245" contextRef="C1" unitRef="Shares" decimals="0">10482190</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag246" contextRef="C2" unitRef="Shares" decimals="0">8531150</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag247" contextRef="C635439" unitRef="Shares" decimals="0">10826146</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="Tag248" contextRef="C635440" unitRef="Shares" decimals="0">9127799</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Tag249" contextRef="C15" unitRef="Shares" decimals="-3">1000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Tag250" contextRef="C16" unitRef="USD" decimals="-3">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Tag251" contextRef="C17" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Tag252" contextRef="C18" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Tag253" contextRef="C1" unitRef="USD" decimals="-3">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Tag254" contextRef="C15" unitRef="USD" xsi:nil="true" />
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross id="Tag255" contextRef="C15" unitRef="Shares" decimals="-3">16000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
  <us-gaap:PaymentsToAcquireLongtermInvestments id="Tag256" contextRef="C1" unitRef="USD" decimals="-3">4652000</us-gaap:PaymentsToAcquireLongtermInvestments>
  <us-gaap:PaymentsToAcquireLongtermInvestments id="Tag257" contextRef="C2" unitRef="USD" xsi:nil="true" />
  <ormp:PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement id="Tag258" contextRef="C2" unitRef="USD" decimals="-3">1000</ormp:PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement>
  <ormp:ProceedsFromStockOptionsAndWarrantsExercised id="Tag259" contextRef="C1" unitRef="USD" decimals="-3">8000</ormp:ProceedsFromStockOptionsAndWarrantsExercised>
  <ormp:ProceedsFromStockOptionsAndWarrantsExercised id="Tag260" contextRef="C2" unitRef="USD" decimals="-3">1490000</ormp:ProceedsFromStockOptionsAndWarrantsExercised>
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="Tag261" contextRef="C1" unitRef="USD" xsi:nil="true" />
  <us-gaap:ProceedsFromIssuanceOrSaleOfEquity id="Tag262" contextRef="C2" unitRef="USD" decimals="-3">118000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
  <us-gaap:ProfessionalFees id="Tag263" contextRef="C47" unitRef="USD" decimals="-3">217000</us-gaap:ProfessionalFees>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag264" contextRef="C635473" unitRef="USD" decimals="-3">550000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ProfessionalFees id="Tag265" contextRef="C635473" unitRef="USD" decimals="-3">202000</us-gaap:ProfessionalFees>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag266" contextRef="C635477" unitRef="USD" decimals="-3">276000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ProfessionalFees id="Tag267" contextRef="C635477" unitRef="USD" xsi:nil="true" />
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag268" contextRef="C635479" unitRef="CHF" decimals="-3">211000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag269" contextRef="C635479" unitRef="USD" decimals="-3">241000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ProfessionalFees id="Tag270" contextRef="C635479" unitRef="CHF" decimals="-3">104000</us-gaap:ProfessionalFees>
  <us-gaap:ProfessionalFees id="Tag271" contextRef="C635479" unitRef="USD" decimals="-3">118000</us-gaap:ProfessionalFees>
  <ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments id="Tag272" contextRef="C635507" unitRef="Item" decimals="INF">2</ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments>
  <dei:AmendmentFlag id="Tag273" contextRef="C1">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate id="Tag274" contextRef="C1">--08-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentPeriodEndDate id="Tag275" contextRef="C1">2015-02-28</dei:DocumentPeriodEndDate>
  <dei:EntityFilerCategory id="Tag276" contextRef="C1">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityRegistrantName id="Tag277" contextRef="C1">ORAMED PHARMACEUTICALS INC.</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey id="Tag278" contextRef="C1">0001176309</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding id="Tag279" contextRef="C674006" unitRef="Shares" decimals="INF">10823943</dei:EntityCommonStockSharesOutstanding>
  <dei:DocumentFiscalYearFocus id="Tag280" contextRef="C1">2015</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus id="Tag281" contextRef="C1">Q2</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentType id="Tag282" contextRef="C1">10-Q</dei:DocumentType>
  <invest:InvestmentInterestRateRangeStart id="Tag283" contextRef="C1" unitRef="Pure" decimals="4">0.0093</invest:InvestmentInterestRateRangeStart>
  <invest:InvestmentInterestRateRangeEnd id="Tag284" contextRef="C1" unitRef="Pure" decimals="4">0.0100</invest:InvestmentInterestRateRangeEnd>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag285" contextRef="C36" unitRef="Shares" decimals="0">19576</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag286" contextRef="C36" unitRef="Shares" decimals="0">9788</ormp:ShareBasedCompensationInstallmentVestingShares>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding id="Tag287" contextRef="C38" unitRef="USD" decimals="-3">135000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
  <us-gaap:SharePrice id="Tag288" contextRef="C38" unitRef="USDPerShare" decimals="2">6.90</us-gaap:SharePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber id="Tag289" contextRef="C674116" unitRef="Shares" decimals="0">19576</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag290" contextRef="C39" unitRef="Shares" decimals="0">10872</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding id="Tag291" contextRef="C40" unitRef="USD" decimals="-3">75000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
  <us-gaap:SharePrice id="Tag292" contextRef="C40" unitRef="USDPerShare" decimals="2">6.90</us-gaap:SharePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag293" contextRef="C635505" unitRef="Shares" decimals="0">159696</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments id="Tag294" contextRef="C635505" unitRef="Item" decimals="INF">23</ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag295" contextRef="C635518" unitRef="Shares" decimals="0">13308</ormp:ShareBasedCompensationInstallmentVestingShares>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag296" contextRef="C635519" unitRef="Shares" decimals="0">6654</ormp:ShareBasedCompensationInstallmentVestingShares>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding id="Tag297" contextRef="C635506" unitRef="USD" decimals="-3">728000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber id="Tag298" contextRef="C674117" unitRef="Shares" decimals="0">13308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
  <us-gaap:SharePrice id="Tag299" contextRef="C635506" unitRef="USDPerShare" decimals="2">4.56</us-gaap:SharePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag300" contextRef="C635507" unitRef="Shares" decimals="0">88712</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag301" contextRef="C635507" unitRef="Shares" decimals="0">44356</ormp:ShareBasedCompensationInstallmentVestingShares>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding id="Tag302" contextRef="C635508" unitRef="USD" decimals="-3">405000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
  <us-gaap:SharePrice id="Tag303" contextRef="C635508" unitRef="USDPerShare" decimals="2">4.56</us-gaap:SharePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag304" contextRef="C674067" unitRef="Shares" decimals="0">46560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments id="Tag305" contextRef="C674067" unitRef="Item" decimals="INF">23</ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag306" contextRef="C674068" unitRef="Shares" decimals="0">3880</ormp:ShareBasedCompensationInstallmentVestingShares>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag307" contextRef="C674069" unitRef="Shares" decimals="0">1940</ormp:ShareBasedCompensationInstallmentVestingShares>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding id="Tag308" contextRef="C674070" unitRef="USD" decimals="-3">212000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
  <us-gaap:SharePrice id="Tag309" contextRef="C674070" unitRef="USDPerShare" decimals="2">4.56</us-gaap:SharePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag310" contextRef="C635509" unitRef="Shares" decimals="0">16656</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments id="Tag311" contextRef="C635509" unitRef="Item" decimals="INF">23</ormp:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag312" contextRef="C635520" unitRef="Shares" decimals="0">1388</ormp:ShareBasedCompensationInstallmentVestingShares>
  <ormp:ShareBasedCompensationInstallmentVestingShares id="Tag313" contextRef="C635521" unitRef="Shares" decimals="0">694</ormp:ShareBasedCompensationInstallmentVestingShares>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding id="Tag314" contextRef="C635510" unitRef="USD" decimals="-3">76000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
  <us-gaap:SharePrice id="Tag315" contextRef="C635510" unitRef="USDPerShare" decimals="2">4.56</us-gaap:SharePrice>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock id="Tag316" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;&lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"&gt;&lt;strong&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;NOTE 6 - STOCK BASED COMPENSATION:&lt;/font&gt;&lt;/strong&gt;&lt;br style="font-family: 'times new roman', times; font-size: 10pt;"/&gt;&lt;/div&gt; &lt;/div&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-indent: 0pt; display: block;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt; &lt;div class="CursorPointer"&gt;&lt;table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0"&gt;  &lt;tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;td style="width: 27pt; font-family: 'times new roman';"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td style="width: 27pt; text-align: left;" align="right"&gt; &lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;a.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="text-align: justify;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;On November 13, 2014, the Company granted a total of &lt;font&gt;19,576&lt;/font&gt; restricted stock units (&amp;#147;RSUs&amp;#148;) representing a right to receive shares of the Company's common stock to the Company's Chief Executive Officer and director (the &amp;#147;CEO&amp;#148;), and the CTO, both related parties. The RSUs vested in two equal installments, each of &lt;font&gt;9,788&lt;/font&gt; shares, on November 30 and December 31, 2014. The total fair value of these RSUs on the date of grant was $&lt;font&gt;135&lt;/font&gt;, using the quoted closing market share price of $&lt;font&gt;6.90&lt;/font&gt; on the Nasdaq Capital Market on the date of grant. The shares of common stock underlying the RSUs will be issued upon request of the grantee. As of February 28, 2015, a total of &lt;font&gt;19,576&lt;/font&gt; RSUs were vested and outstanding.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt; &lt;div class="CursorPointer"&gt;&lt;table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0"&gt;  &lt;tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;td style="width: 27pt; font-family: 'times new roman';"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td style="width: 27pt; text-align: left;" align="right"&gt; &lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;b.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="text-align: justify;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;On November 13, 2014, the Company granted a total of &lt;font&gt;10,872&lt;/font&gt; RSUs representing a right to receive shares of the Company's common stock to four members of the Company's Board of Directors. The RSUs vested on January 1, 2015. The total fair value of these RSUs on the date of grant was $&lt;font&gt;75&lt;/font&gt;, using the quoted closing market share price of $&lt;font&gt;6.90&lt;/font&gt; on the Nasdaq Capital Market on the date of grant.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="text-indent: 0pt; display: block;"&gt; &lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br style="font-family: 'times new roman', times; font-size: 10pt;"/&gt;&lt;/div&gt; &lt;div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt; &lt;div class="CursorPointer"&gt;&lt;table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0"&gt;  &lt;tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;td style="width: 27pt; font-family: 'times new roman';"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td style="width: 27pt;" align="right"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;c.&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="left" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;On February 23, 2015, the Company granted a total of &lt;font&gt;159,696&lt;/font&gt; RSUs representing a right to receive shares of the Company's common stock to the Company's CEO and the CTO, both related parties. The RSUs vest in &lt;font&gt;23&lt;/font&gt; installments consisting of one installment of &lt;font&gt;13,308&lt;/font&gt; shares on February 28, 2015 and 22 equal monthly installments of &lt;font&gt;6,654&lt;/font&gt; shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $&lt;font&gt;728&lt;/font&gt;, using the quoted closing market share price of $&lt;font&gt;4.56&lt;/font&gt; on the Nasdaq Capital Market on the date of grant. The shares of common stock underlying the RSUs will be issued upon request of the grantee. As of February 28, 2015, a total of &lt;font&gt;13,308&lt;/font&gt; RSUs were vested and outstanding.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="text-indent: 0pt; display: block;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt; &lt;div class="CursorPointer"&gt;&lt;table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0"&gt;  &lt;tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;td style="width: 27pt; font-family: 'times new roman';"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td style="width: 27pt; text-align: left;" align="right"&gt; &lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;d.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="left" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;On February 23, 2015, the Company granted a total of &lt;font&gt;88,712&lt;/font&gt; RSUs representing a right to receive shares of the Company's common stock to four members of the Company's Board of Directors (&lt;font&gt;22,178&lt;/font&gt; RSUs to each director). The RSUs vest in &lt;font&gt;two&lt;/font&gt; equal installments, each of &lt;font&gt;44,356&lt;/font&gt; shares, on December 31, 2015 and December 31, 2016. The total fair value of these RSUs on the date of grant was $&lt;font&gt;405&lt;/font&gt;, using the quoted closing market share price of $&lt;font&gt;4.56&lt;/font&gt; on the Nasdaq Capital Market on the date of grant.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt; &lt;div class="CursorPointer"&gt;&lt;table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0"&gt;  &lt;tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;td style="width: 27pt; font-family: 'times new roman';"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td style="width: 27pt;" align="right"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;e.&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="text-align: justify;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;On February 23, 2015, the Company granted a total of &lt;font&gt;46,560&lt;/font&gt; RSUs to an employee of the Subsidiary. The RSUs vest in &lt;font&gt;23&lt;/font&gt; installments, consisting of one installment of &lt;font&gt;3,880&lt;/font&gt; shares on February 28, 2015 and 22 equal monthly installments of &lt;font&gt;1,940&lt;/font&gt; shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $&lt;font&gt;212&lt;/font&gt;, using the quoted closing market share price of $&lt;font&gt;4.56&lt;/font&gt; on the Nasdaq Capital Market on the date of grant.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;div style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt; &lt;div class="CursorPointer"&gt;&lt;table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0"&gt;  &lt;tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;td style="width: 27pt; font-family: 'times new roman';"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt; &lt;td style="width: 27pt;" align="right"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="font-family: 'times new roman', times; font-size: 10pt;"&gt;f.&amp;#160;&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="left" style="font-family: 'times new roman', times; font-size: 10pt;"&gt; &lt;div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: Times New Roman; font-size: 10pt;"&gt;On February 23, 2015, the Company granted a total of &lt;font&gt;16,656&lt;/font&gt; RSUs to employees of the Subsidiary. The RSUs vest in &lt;font&gt;23&lt;/font&gt; installments, consisting of one installment of &lt;font&gt;1,388&lt;/font&gt; shares on February 28, 2015 and 22 equal monthly installments of &lt;font&gt;694&lt;/font&gt; shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $&lt;font&gt;76&lt;/font&gt;, using the quoted closing market share price of $&lt;font&gt;4.56&lt;/font&gt; on the Nasdaq Capital Market on the date of grant.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;  &lt;/table&gt;&lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag317" contextRef="C674082" unitRef="Shares" decimals="0">22178</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag318" contextRef="C674083" unitRef="Shares" decimals="0">22178</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag319" contextRef="C674084" unitRef="Shares" decimals="0">22178</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="Tag320" contextRef="C674085" unitRef="Shares" decimals="0">22178</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ProfessionalFees id="Tag321" contextRef="C674097" unitRef="USD" decimals="-3">280000</us-gaap:ProfessionalFees>
  <us-gaap:LongTermPurchaseCommitmentAmount id="Tag322" contextRef="C674098" unitRef="USD" decimals="-3">3290000</us-gaap:LongTermPurchaseCommitmentAmount>
  <us-gaap:ProfessionalFees id="Tag323" contextRef="C674098" unitRef="USD" decimals="-3">761000</us-gaap:ProfessionalFees>
  <us-gaap:SubsequentEventsTextBlock id="Tag324" contextRef="C1">&lt;div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"&gt;&lt;strong&gt;&lt;font style="font-size: 10pt;"&gt;NOTE 8 &amp;#150; SUBSEQUENT EVENT&lt;/font&gt;&lt;/strong&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;strong&gt;&amp;#160;&lt;/strong&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block; margin-left: 54pt; margin-right: 0pt;" align="left"&gt;&lt;font style="display: inline; font-family: Times New Roman; font-size: 10pt;"&gt;On April 2, 2015, the Company entered into an at market issuance sales agreement (the &amp;#147;Sales Agreement&amp;#148;) with MLV &amp;amp; Co. LLC (&amp;#147;MLV&amp;#148;) pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $&lt;font&gt;25&lt;/font&gt; million from time to time, at its option, through MLV as its sales agent, subject to certain terms and conditions. Any shares sold will be sold pursuant to the Company's effective shelf registration statement on Form S-3 (Registration No. 333-193557), including a prospectus dated April 10, 2014, as supplemented by a prospectus supplement dated April 2, 2015.&amp;#160; The Company will pay MLV a commission of &lt;font&gt;3.0&lt;/font&gt;% of the gross proceeds of the sale of any shares sold through MLV. To date, no shares have been sold under the Sales Agreement.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <ormp:MarketIssuanceSalesAgreementOfferingValue id="Tag325" contextRef="C674093" unitRef="USD" decimals="-6">25000000</ormp:MarketIssuanceSalesAgreementOfferingValue>
  <ormp:MarketIssuanceSalesAgreementCommissionPercentage id="Tag326" contextRef="C674093" unitRef="Pure" decimals="3">0.030</ormp:MarketIssuanceSalesAgreementCommissionPercentage>
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:label="value13" xlink:href="#Tag42" />
    <link:loc xlink:type="locator" xlink:label="value13" xlink:href="#Tag43" />
    <link:loc xlink:type="locator" xlink:label="value2" xlink:href="#Tag70" />
    <link:loc xlink:type="locator" xlink:label="value2" xlink:href="#Tag71" />
    <link:loc xlink:type="locator" xlink:label="value13" xlink:href="#Tag254" />
    <link:footnote xlink:type="resource" xml:lang="en-US" xlink:label="footnote2" xlink:role="http://www.xbrl.org/2003/role/footnote">See note 5.</link:footnote>
    <link:footnoteArc xlink:type="arc" xlink:from="value2" xlink:to="footnote2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="2" />
    <link:footnote xlink:type="resource" xml:lang="en-US" xlink:label="footnote13" xlink:role="http://www.xbrl.org/2003/role/footnote">Represents an amount of less than $1.</link:footnote>
    <link:footnoteArc xlink:type="arc" xlink:from="value13" xlink:to="footnote13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="13" />
  </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>ormp-20150228.xsd
<DESCRIPTION>TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by Z-K Global, Powered by IRIS Carbon-->
<xsd:schema xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ormp="http://www.oramed.com/20150228" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.oramed.com/20150228">
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ormp-20150228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ormp-20150228_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ormp-20150228_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ormp-20150228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.oramed.com/role/ormp-daei" id="ormp-daei">
        <link:definition>001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-ccbs" id="ormp-ccbs">
        <link:definition>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-ccbsp" id="ormp-ccbsp">
        <link:definition>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-ccsocl" id="ormp-ccsocl">
        <link:definition>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-ccsocise" id="ormp-ccsocise">
        <link:definition>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-ccsocisep" id="ormp-ccsocisep">
        <link:definition>006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-ccsocf" id="ormp-ccsocf">
        <link:definition>007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-sap" id="ormp-sap">
        <link:definition>101 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-c" id="ormp-c">
        <link:definition>102 - Disclosure - COMMITMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-fv" id="ormp-fv">
        <link:definition>103 - Disclosure - FAIR VALUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-ms" id="ormp-ms">
        <link:definition>104 - Disclosure - MARKETABLE SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-she" id="ormp-she">
        <link:definition>105 - Disclosure - STOCK HOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-sbc" id="ormp-sbc">
        <link:definition>106 - Disclosure - STOCK BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-rpt" id="ormp-rpt">
        <link:definition>107 - Disclosure - RELATED PARTIES - TRANSACTIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-se" id="ormp-se">
        <link:definition>108 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-fiae" id="ormp-fiae">
        <link:definition>110 - Disclosure - FINANCIAL INCOME AND EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-toi" id="ormp-toi">
        <link:definition>111 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITS" id="Disclosure-SHORTTERMDEPOSITS">
        <link:definition>114 - Disclosure - SHORT TERM DEPOSITS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-paen" id="ormp-paen">
        <link:definition>115 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-w" id="ormp-w">
        <link:definition>116 - Disclosure - WARRANTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-erur" id="ormp-erur">
        <link:definition>117 - Disclosure - EMPLOYEES RIGHTS UPON RETIREMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-sapp" id="ormp-sapp">
        <link:definition>201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policy)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESTables" id="Disclosure-SIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>301 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSTables" id="Disclosure-SHORTTERMDEPOSITSTables">
        <link:definition>302 - Disclosure - SHORT TERM DEPOSITS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYTables" id="Disclosure-STOCKHOLDERSEQUITYTables">
        <link:definition>305 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-rptt" id="ormp-rptt">
        <link:definition>307 - Disclosure - RELATED PARTIES - TRANSACTIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-sct" id="ormp-sct">
        <link:definition>309 - Disclosure - STOCKBASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-fiaet" id="ormp-fiaet">
        <link:definition>310 - Disclosure - FINANCIAL INCOME AND EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-toit" id="ormp-toit">
        <link:definition>311 - Disclosure - TAXES ON INCOME (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-paent" id="ormp-paent">
        <link:definition>315 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-wt" id="ormp-wt">
        <link:definition>316 - Disclosure - WARRANTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-mst" id="ormp-mst">
        <link:definition>8000 - Disclosure - MARKETABLE SECURITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-sapd" id="ormp-sapd">
        <link:definition>40101 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-csad" id="ormp-csad">
        <link:definition>40201 - Disclosure - COMMITMENTS (Service Agreements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-cld" id="ormp-cld">
        <link:definition>40202 - Disclosure - COMMITMENTS (Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-crgd" id="ormp-crgd">
        <link:definition>40203 - Disclosure - COMMITMENTS (Research Grants) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-msd" id="ormp-msd">
        <link:definition>40401 - Disclosure - MARKETABLE SECURITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYDetails" id="Disclosure-STOCKHOLDERSEQUITYDetails">
        <link:definition>40501 - Disclosure - STOCK HOLDERS' EQUITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails" id="Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails">
        <link:definition>40502 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Warrant Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-STOCKBASEDCOMPENSATIONDetails" id="Disclosure-STOCKBASEDCOMPENSATIONDetails">
        <link:definition>40601 - Disclosure - STOCK BASED COMPENSATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-scsofvad" id="ormp-scsofvad">
        <link:definition>40602 - Disclosure - STOCKBASED COMPENSATION (Schedule of Fair Value Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-scsosoad" id="ormp-scsosoad">
        <link:definition>40603 - Disclosure - STOCKBASED COMPENSATION (Schedule of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-scsoifooaebeprd" id="ormp-scsoifooaebeprd">
        <link:definition>40604 - Disclosure - STOCKBASED COMPENSATION (Summary of Information for Options Outstanding and Exercisable by Exercise Price Range) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-RELATEDPARTIES-TRANSACTIONSDetails" id="Disclosure-RELATEDPARTIES-TRANSACTIONSDetails">
        <link:definition>40701 - Disclosure - RELATED PARTIES - TRANSACTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-rptsobwrpd" id="ormp-rptsobwrpd">
        <link:definition>40702 - Disclosure - RELATED PARTIES - TRANSACTIONS (Schedule of Balances with Related Parties) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-sed" id="ormp-sed">
        <link:definition>40801 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-fiaed" id="ormp-fiaed">
        <link:definition>41001 - Disclosure - FINANCIAL INCOME AND EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-toind" id="ormp-toind">
        <link:definition>41101 - Disclosure - TAXES ON INCOME (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-toisoditd" id="ormp-toisoditd">
        <link:definition>41102 - Disclosure - TAXES ON INCOME (Schedule of Deferred Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-toisoitiiisd" id="ormp-toisoitiiisd">
        <link:definition>41103 - Disclosure - TAXES ON INCOME (Schedule of Income Taxes Included in the Income Statements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-toisoroitd" id="ormp-toisoroitd">
        <link:definition>41104 - Disclosure - TAXES ON INCOME (Schedule of Reconciliation of Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-toisoutbd" id="ormp-toisoutbd">
        <link:definition>41105 - Disclosure - TAXES ON INCOME (Schedule of Unrecognized Tax Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-TAXESONINCOMEValuationAllowanceRollforwardDetails" id="Disclosure-TAXESONINCOMEValuationAllowanceRollforwardDetails">
        <link:definition>41106 - Disclosure - TAXES ON INCOME (Valuation Allowance Rollforward) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSDetails" id="Disclosure-SHORTTERMDEPOSITSDetails">
        <link:definition>41501 - Disclosure - SHORT TERM DEPOSITS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-wd1" id="ormp-wd1">
        <link:definition>41601 - Disclosure - WARRANTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-erurd" id="ormp-erurd">
        <link:definition>41701 - Disclosure - EMPLOYEES RIGHTS UPON RETIREMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/ormp-paend" id="ormp-paend">
        <link:definition>41801 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.oramed.com/role/Disclosure-FAIRVALUEDetails" id="Disclosure-FAIRVALUEDetails">
        <link:definition>40301 - Disclosure - FAIR VALUE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2006/ref" schemaLocation="http://www.xbrl.org/2006/ref-2006-02-27.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/XLink" schemaLocation="http://www.xbrl.org/2003/xl-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd" />
  <xsd:element name="IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" id="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" id="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" id="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" id="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="MarketableSecuritiesSold" id="ormp_MarketableSecuritiesSold" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="MarketableSecuritiesOwnershipPercentage" id="ormp_MarketableSecuritiesOwnershipPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="HadasitMember" id="ormp_HadasitMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermPurchaseCommitmentAgreementTerm" id="ormp_LongTermPurchaseCommitmentAgreementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ConsultantMember" id="ormp_ConsultantMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="GrossProceedsFromIssuanceOfCommonStock" id="ormp_GrossProceedsFromIssuanceOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FindersFee" id="ormp_FindersFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="SecuritiesPurchaseAgreementMember" id="ormp_SecuritiesPurchaseAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermPurchaseCommitmentAmountMonthlyFixedFee" id="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="RoyaltyPercentage" id="ormp_RoyaltyPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="AdvisorMember" id="ormp_AdvisorMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="RoyaltyPercentageMaximumPercentageOfGrantsReceived" id="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="BioJerusalemMember" id="ormp_BioJerusalemMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ChiefScientistOfficeMember" id="ormp_ChiefScientistOfficeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" id="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LongTermPurchaseCommitmentBonusAmount" id="ormp_LongTermPurchaseCommitmentBonusAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="ClinicalResearchOrganizationServiceAgreementMember" id="ormp_ClinicalResearchOrganizationServiceAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="MasterServiceAgreementTwoMember" id="ormp_MasterServiceAgreementTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="MasterServiceAgreementThreeMember" id="ormp_MasterServiceAgreementThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="MasterServiceAgreementFourMember" id="ormp_MasterServiceAgreementFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="MonthlyPaymentUnderConsultingAgreements" id="ormp_MonthlyPaymentUnderConsultingAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="AnnualPaymentUnderConsultingAgreements" id="ormp_AnnualPaymentUnderConsultingAgreements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="KnryMember" id="ormp_KnryMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ChiefMedicalAndTechnologyOfficerMember" id="ormp_ChiefMedicalAndTechnologyOfficerMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfRelatedPartyBalancesTableTextBlock" id="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="CarAndCashBonus" id="ormp_CarAndCashBonus" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="CashBonus" id="ormp_CashBonus" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="TemporaryIncreasePaymentPerMonth" id="ormp_TemporaryIncreasePaymentPerMonth" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="ExchangeOfWarrants" id="ormp_ExchangeOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="AmendedAndRestated2008StockIncentivePlanMember" id="ormp_AmendedAndRestated2008StockIncentivePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SubsidiaryEmployeeOneMember" id="ormp_SubsidiaryEmployeeOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SubsidiaryEmployeeTwoMember" id="ormp_SubsidiaryEmployeeTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationInstallmentVestingShares" id="ormp_ShareBasedCompensationInstallmentVestingShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="LossPerCommonShareAbstract" id="ormp_LossPerCommonShareAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockOptionsAndWarrantsMember" id="ormp_StockOptionsAndWarrantsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfRestrictedCashTable" id="ormp_ScheduleOfRestrictedCashTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsAndRightsDisclosureTextBlock" id="ormp_WarrantsAndRightsDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ForeignInterestBearingDepositsMember" id="ormp_ForeignInterestBearingDepositsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ShortTermInvestmentsLineItems" id="ormp_ShortTermInvestmentsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ShortTermInvestmentWithBanksInterestRate" id="ormp_ShortTermInvestmentWithBanksInterestRate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="EmployeeRightsUponRetirementAbstract" id="ormp_EmployeeRightsUponRetirementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" id="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="ormp_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="FindersFeeShares" id="ormp_FindersFeeShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="MasterServiceAgreementMember" id="ormp_MasterServiceAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ProceedsFromStockOptionsAndWarrantsExercised" id="ormp_ProceedsFromStockOptionsAndWarrantsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" id="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" id="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="SharesToBeIssuedForServicesRendered" id="ormp_SharesToBeIssuedForServicesRendered" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodSharesLiquidationDamageFee" id="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodSharesMarketableSecurities" id="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" id="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueLiquidationDamageFee" id="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueMarketableSecurities" id="ormp_StockIssuedDuringPeriodValueMarketableSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" id="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="SubsidiaryEmployeesMember" id="ormp_SubsidiaryEmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsExchanged" id="ormp_WarrantsExchanged" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="WarrantsExercised" id="ormp_WarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="SeverancePayInsuranceDeposits" id="ormp_SeverancePayInsuranceDeposits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="SeverancePayInsuranceDepositExpectedAmount" id="ormp_SeverancePayInsuranceDepositExpectedAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="DefinedContributionPlanExpectedLiability" id="ormp_DefinedContributionPlanExpectedLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="EmployeeRightsUponRetirementTextBlock" id="ormp_EmployeeRightsUponRetirementTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="WarrantsTable" id="ormp_WarrantsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsAxis" id="ormp_WarrantsAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsDomain" id="ormp_WarrantsDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsOneMember" id="ormp_WarrantsOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsTwoMember" id="ormp_WarrantsTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NewWarrantMember" id="ormp_NewWarrantMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="KidronOptionMember" id="ormp_KidronOptionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsLineItems" id="ormp_WarrantsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="WarrantsGrantedShares" id="ormp_WarrantsGrantedShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ClassOfWarrantOrRightTerm" id="ormp_ClassOfWarrantOrRightTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="WarrantsAndRightsExpenseRecognized" id="ormp_WarrantsAndRightsExpenseRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" id="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" id="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element name="WarrantLiabilityPolicyPolicyTextBlock" id="ormp_WarrantLiabilityPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ConcentrationRiskCreditRiskPolicyTextBlock" id="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="TaxesOnIncomeLineItems" id="ormp_TaxesOnIncomeLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EnteraBioLtdMember" id="ormp_EnteraBioLtdMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="CostMethodInvestmentsOwnershipPercentageRetained" id="ormp_CostMethodInvestmentsOwnershipPercentageRetained" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="DnaBiomedicalSolutionsLtdMember" id="ormp_DnaBiomedicalSolutionsLtdMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="AdvisorTwoMember" id="ormp_AdvisorTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SecuritiesPurchaseAgreementTwoMember" id="ormp_SecuritiesPurchaseAgreementTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="LeadingInvestorMember" id="ormp_LeadingInvestorMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="OtherIndividualMember" id="ormp_OtherIndividualMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SecuritiesPurchaseAgreementNumberOfUnits" id="ormp_SecuritiesPurchaseAgreementNumberOfUnits" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="SecuritiesPurchaseAgreementsPurchasePricePerUnit" id="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" id="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" id="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ServiceAgreementConsiderationSharesOption" id="ormp_ServiceAgreementConsiderationSharesOption" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="PercentOwnershipByThirdParty" id="ormp_PercentOwnershipByThirdParty" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="SecuritiesPurchaseAgreementThreeMember" id="ormp_SecuritiesPurchaseAgreementThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfInstitutionalInvestors" id="ormp_NumberOfInstitutionalInvestors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="WarrantsPreviouslyIssuedInPrivatePlacementsMember" id="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" id="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" id="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ExercisePriceRangeOneMember" id="ormp_ExercisePriceRangeOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ExercisePriceRangeFourMember" id="ormp_ExercisePriceRangeFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ExercisePriceRangeTwoMember" id="ormp_ExercisePriceRangeTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ExercisePriceRangeThreeMember" id="ormp_ExercisePriceRangeThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockOptionActivityEmployeesAndNonemployeesAxis" id="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockOptionActivityEmployeesAndNonemployeesDomain" id="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EmployeesMember" id="ormp_EmployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NonemployeesMember" id="ormp_NonemployeesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" id="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" id="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" id="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="StockOptionActivityLineItems" id="ormp_StockOptionActivityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" id="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" id="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="SharesAndWarrantsToBeIssuedForCashValue" id="ormp_SharesAndWarrantsToBeIssuedForCashValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="SharesAndWarrantsToBeIssuedForCashShares" id="ormp_SharesAndWarrantsToBeIssuedForCashShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" id="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="SecuritiesPurchaseAgreementFourMember" id="ormp_SecuritiesPurchaseAgreementFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ScheduleOfAnnualDepreciationRatesTableTextBlock" id="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="PropertyPlantAndEquipmentGeneralAbstract" id="ormp_PropertyPlantAndEquipmentGeneralAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="PropertyPlantAndEquipmentDepreciationRate" id="ormp_PropertyPlantAndEquipmentDepreciationRate" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="MasterServiceAgreementFiveMember" id="ormp_MasterServiceAgreementFiveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="NumberOfConsultingAgreementsEntered" id="ormp_NumberOfConsultingAgreementsEntered" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ExtendedPriorWrittenNoticePeriod" id="ormp_ExtendedPriorWrittenNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" id="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xsd:element name="MasterServiceAgreementSixMember" id="ormp_MasterServiceAgreementSixMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="DirectorOneMember" id="ormp_DirectorOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="DirectorTwoMember" id="ormp_DirectorTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="DirectorThreeMember" id="ormp_DirectorThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="DirectorFourMember" id="ormp_DirectorFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="MarketIssuanceSalesAgreementOfferingValue" id="ormp_MarketIssuanceSalesAgreementOfferingValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="MarketIssuanceSalesAgreementCommissionPercentage" id="ormp_MarketIssuanceSalesAgreementCommissionPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xsd:element name="SecondClinicalResearchOrganizationServiceAgreementMember" id="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="ThirdClinicalResearchOrganizationServiceAgreementMember" id="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EquityIssuanceAxis" id="ormp_EquityIssuanceAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="EquityIssuanceDomain" id="ormp_EquityIssuanceDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="IssuanceOneMember" id="ormp_IssuanceOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xsd:element name="IssuanceTwoMember" id="ormp_IssuanceTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>ormp-20150228_cal.xml
<DESCRIPTION>TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by Z-K Global, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccbs" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccbs" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccsocl" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccsocl" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccsocf" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccsocf" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-fiaed" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-fiaed" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toisoditd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toisoditd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toisoitiiisd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toisoitiiisd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-paend" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-paend" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccbs">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="us-gaap_Assets" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="us-gaap_AssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" xlink:title="Calculation : us-gaap_Assets to us-gaap_AssetsCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="Calculation : us-gaap_LiabilitiesCurrent to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:title="us-gaap_LiabilitiesNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:title="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:title="Calculation : us-gaap_LiabilitiesNoncurrent to us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="us-gaap_CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_CommonStockValue" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" xlink:title="Calculation : us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesCurrent" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:title="us-gaap_DueToRelatedPartiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrent" xlink:title="Calculation : us-gaap_LiabilitiesCurrent to us-gaap_DueToRelatedPartiesCurrent" order="1.1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidPensionCosts" xlink:label="us-gaap_PrepaidPensionCosts" xlink:title="us-gaap_PrepaidPensionCosts" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PrepaidPensionCosts" xlink:title="Calculation : us-gaap_Assets to us-gaap_PrepaidPensionCosts" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesNoncurrent" xlink:title="Calculation : us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesNoncurrent" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:label="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:title="us-gaap_InvestmentsAndOtherNoncurrentAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:title="Calculation : us-gaap_Assets to us-gaap_InvestmentsAndOtherNoncurrentAssets" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:title="us-gaap_DepositsAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_DepositsAssetsCurrent" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:title="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:title="Calculation : us-gaap_LiabilitiesNoncurrent to us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_AdditionalPaidInCapitalCommonStock" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Calculation : us-gaap_Assets to us-gaap_PropertyPlantAndEquipmentNet" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:title="us-gaap_MarketableSecuritiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_MarketableSecuritiesCurrent" order="4" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" xlink:title="Calculation : us-gaap_LiabilitiesAndStockholdersEquity to us-gaap_StockholdersEquity" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="Calculation : us-gaap_StockholdersEquity to us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" order="5" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:label="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:title="us-gaap_DueFromOtherRelatedPartiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_DueFromOtherRelatedPartiesCurrent" order="6" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:title="us-gaap_OtherReceivablesNetCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent" xlink:title="Calculation : us-gaap_AssetsCurrent to us-gaap_OtherReceivablesNetCurrent" order="7" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccsocl">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="Calculation : us-gaap_ComprehensiveIncomeNetOfTax to us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="us-gaap_OperatingIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" xlink:title="Calculation : us-gaap_NetIncomeLoss to us-gaap_OperatingIncomeLoss" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="Calculation : us-gaap_OperatingIncomeLoss to us-gaap_ResearchAndDevelopmentExpense" order="1" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:title="Calculation : us-gaap_OtherComprehensiveIncomeLossNetOfTax to us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" order="1" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Calculation : us-gaap_ComprehensiveIncomeNetOfTax to us-gaap_NetIncomeLoss" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" xlink:title="us-gaap_OtherNonoperatingIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncome" xlink:title="Calculation : us-gaap_NetIncomeLoss to us-gaap_OtherNonoperatingIncome" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="Calculation : us-gaap_OtherComprehensiveIncomeLossNetOfTax to us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" order="2" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:title="us-gaap_OtherNonoperatingExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingExpense" xlink:title="Calculation : us-gaap_NetIncomeLoss to us-gaap_OtherNonoperatingExpense" order="3" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:title="us-gaap_GeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:title="Calculation : us-gaap_OperatingIncomeLoss to us-gaap_GeneralAndAdministrativeExpense" order="3" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="Calculation : us-gaap_OtherComprehensiveIncomeLossNetOfTax to us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="3" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccsocf">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivities to us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="Calculation : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_NetIncomeLoss" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivities to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="Calculation : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:title="us-gaap_DepreciationDepletionAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:title="us-gaap_PaymentsToAcquireShortTermInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivities to us-gaap_PaymentsToAcquireShortTermInvestments" order="2" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:label="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:title="ormp_ProceedsFromStockOptionsAndWarrantsExercised" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivities to ormp_ProceedsFromStockOptionsAndWarrantsExercised" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInFinancingActivities to us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="3" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:title="Calculation : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="3" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:title="us-gaap_PaymentsToAcquireLongtermInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivities to us-gaap_PaymentsToAcquireLongtermInvestments" order="3" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="us-gaap_ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_ShareBasedCompensation" order="4" weight="1" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:title="Calculation : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:title="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivities to us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="5" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivities to us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="5" weight="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:title="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivities to ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" order="6" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="us-gaap_GainLossOnSaleOfInvestments" xlink:title="us-gaap_GainLossOnSaleOfInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfInvestments" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_GainLossOnSaleOfInvestments" order="6" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" order="7" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:title="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInInvestingActivities to us-gaap_PaymentsForProceedsFromOtherInvestingActivities" order="7" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsExchanged" xlink:label="ormp_WarrantsExchanged" xlink:title="ormp_WarrantsExchanged" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ormp_WarrantsExchanged" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to ormp_WarrantsExchanged" order="8" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_DerivativeGainLossOnDerivativeNet" order="9" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_IncreaseDecreaseInAccountsPayable" order="11" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:label="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:title="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" order="12" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="13" weight="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:label="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:title="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" order="14" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:label="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:title="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:title="Calculation : us-gaap_NetCashProvidedByUsedInOperatingActivities to ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" order="15" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-fiaed">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:title="us-gaap_OtherNonoperatingExpense" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExchangeOfWarrants" xlink:label="ormp_ExchangeOfWarrants" xlink:title="ormp_ExchangeOfWarrants" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="ormp_ExchangeOfWarrants" xlink:title="Calculation : us-gaap_OtherNonoperatingExpense to ormp_ExchangeOfWarrants" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" xlink:title="us-gaap_OtherNonoperatingIncome" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:label="us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:title="us-gaap_GainLossOnSaleOfSecuritiesNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:title="Calculation : us-gaap_OtherNonoperatingIncome to us-gaap_GainLossOnSaleOfSecuritiesNet" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainOnDerivative" xlink:label="us-gaap_DerivativeGainOnDerivative" xlink:title="us-gaap_DerivativeGainOnDerivative" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_DerivativeGainOnDerivative" xlink:title="Calculation : us-gaap_OtherNonoperatingIncome to us-gaap_DerivativeGainOnDerivative" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionLossBeforeTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:title="Calculation : us-gaap_OtherNonoperatingExpense to us-gaap_ForeignCurrencyTransactionLossBeforeTax" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:title="us-gaap_InterestIncomeExpenseNonoperatingNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:title="Calculation : us-gaap_OtherNonoperatingIncome to us-gaap_InterestIncomeExpenseNonoperatingNet" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoninterestExpenseCommissionExpense" xlink:label="us-gaap_NoninterestExpenseCommissionExpense" xlink:title="us-gaap_NoninterestExpenseCommissionExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_NoninterestExpenseCommissionExpense" xlink:title="Calculation : us-gaap_OtherNonoperatingExpense to us-gaap_NoninterestExpenseCommissionExpense" order="3" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionGainBeforeTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:title="Calculation : us-gaap_OtherNonoperatingIncome to us-gaap_ForeignCurrencyTransactionGainBeforeTax" order="4" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:title="us-gaap_OtherIncome" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherIncome" xlink:title="Calculation : us-gaap_OtherNonoperatingIncome to us-gaap_OtherIncome" order="5" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLossOnDerivative" xlink:label="us-gaap_DerivativeLossOnDerivative" xlink:title="us-gaap_DerivativeLossOnDerivative" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_DerivativeLossOnDerivative" xlink:title="Calculation : us-gaap_OtherNonoperatingExpense to us-gaap_DerivativeLossOnDerivative" order="13" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNoninterestExpense" xlink:label="us-gaap_OtherNoninterestExpense" xlink:title="us-gaap_OtherNoninterestExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNoninterestExpense" xlink:title="Calculation : us-gaap_OtherNonoperatingExpense to us-gaap_OtherNoninterestExpense" order="23" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toisoditd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:title="us-gaap_DeferredTaxAssetsNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="Calculation : us-gaap_DeferredTaxAssetsNet to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="Calculation : us-gaap_DeferredTaxAssetsNet to us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="Calculation : us-gaap_DeferredTaxAssetsNet to us-gaap_DeferredTaxAssetsValuationAllowance" order="3" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toisoitiiisd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Calculation : us-gaap_IncomeTaxExpenseBenefit to us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="Calculation : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Calculation : us-gaap_IncomeTaxExpenseBenefit to us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" order="2" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="Calculation : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="2" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-paend">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="Calculation : us-gaap_PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Calculation : us-gaap_PropertyPlantAndEquipmentNet to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>ormp-20150228_def.xml
<DESCRIPTION>TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by Z-K Global, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccsocise" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccsocise" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sapd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sapd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-csad" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-csad" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-cld" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-cld" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-crgd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-crgd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-msd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-msd" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-STOCKHOLDERSEQUITYDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-STOCKBASEDCOMPENSATIONDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-STOCKBASEDCOMPENSATIONDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-scsofvad" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-scsofvad" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-scsosoad" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-scsosoad" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-scsoifooaebeprd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-scsoifooaebeprd" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-RELATEDPARTIES-TRANSACTIONSDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-RELATEDPARTIES-TRANSACTIONSDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-rptsobwrpd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-rptsobwrpd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toind" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toind" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-SHORTTERMDEPOSITSDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-wd1" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-wd1" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-paend" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-paend" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sed" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sed" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccsocise">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Definition : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_CommonStockMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Definition : us-gaap_StatementTable to us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="us-gaap_AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeMember" xlink:label="us-gaap_ComprehensiveIncomeMember" xlink:title="us-gaap_ComprehensiveIncomeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ComprehensiveIncomeMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_ComprehensiveIncomeMember" xlink:type="arc" order="2.45" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="us-gaap_RetainedEarningsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:title="Definition : us-gaap_EquityComponentDomain to us-gaap_RetainedEarningsMember" xlink:type="arc" order="2.9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StatementTable" xlink:type="arc" order="10" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1" xlink:title="us-gaap_EquityComponentDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_1" xlink:title="Definition : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockholdersEquity" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:title="us-gaap_SharesOutstanding" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_SharesOutstanding" xlink:type="arc" order="30" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:type="arc" order="40" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:type="arc" order="50" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" order="60" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="70" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:title="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" order="80" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_NetIncomeLoss" xlink:type="arc" order="90" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="100" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="110" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="120" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:label="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:title="ormp_SharesAndWarrantsToBeIssuedForCashValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:title="Definition : us-gaap_StatementLineItems to ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:type="arc" order="130" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:label="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:title="ormp_SharesAndWarrantsToBeIssuedForCashShares" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:title="Definition : us-gaap_StatementLineItems to ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:type="arc" order="140" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:label="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:title="ormp_StockIssuedDuringPeriodValueMarketableSecurities" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:title="Definition : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:type="arc" order="150" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:label="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:title="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:title="Definition : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:type="arc" order="160" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:title="Definition : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:type="arc" order="170" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="Definition : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:type="arc" order="180" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="190" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:label="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:title="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:title="Definition : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:type="arc" order="200" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:label="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:title="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:title="Definition : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="arc" order="210" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="220" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:type="arc" order="230" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" use="optional" order="240" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" use="optional" order="250" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" use="optional" order="260" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sapd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionsAndWarrantsMember" xlink:label="ormp_StockOptionsAndWarrantsMember" xlink:title="ormp_StockOptionsAndWarrantsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ormp_StockOptionsAndWarrantsMember" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesNameDomain to ormp_StockOptionsAndWarrantsMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Definition : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="us-gaap_ComputerEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_ComputerEquipmentMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MinimumMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_1" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Definition : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_1" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_1" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:label="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:title="ormp_PropertyPlantAndEquipmentDepreciationRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentLineItems to ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:title="us-gaap_OfficeEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_OfficeEquipmentMember" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MaximumMember" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_RangeAxis" xlink:title="Definition : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_RangeAxis" xlink:type="arc" order="20" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-csad">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:title="us-gaap_LongTermPurchaseCommitmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="us-gaap_LongTermPurchaseCommitmentTable" xlink:title="us-gaap_LongTermPurchaseCommitmentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentTable" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_LongTermPurchaseCommitmentTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_HadasitMember" xlink:label="ormp_HadasitMember" xlink:title="ormp_HadasitMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_HadasitMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_HadasitMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentTable to us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentBonusAmount" xlink:label="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:title="ormp_LongTermPurchaseCommitmentBonusAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_LongTermPurchaseCommitmentBonusAmount" xlink:type="arc" order="1.5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_1" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ConsultantMember" xlink:label="ormp_ConsultantMember" xlink:title="ormp_ConsultantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_ConsultantMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_ConsultantMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" xlink:title="us-gaap_ProfessionalFees" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ProfessionalFees" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ProfessionalFees" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorMember" xlink:label="ormp_AdvisorMember" xlink:title="ormp_AdvisorMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_AdvisorMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_AdvisorMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_ClinicalResearchOrganizationServiceAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:type="arc" order="3.5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementTwoMember" xlink:label="ormp_MasterServiceAgreementTwoMember" xlink:title="ormp_MasterServiceAgreementTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementTwoMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementTwoMember" xlink:type="arc" order="3.6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementThreeMember" xlink:label="ormp_MasterServiceAgreementThreeMember" xlink:title="ormp_MasterServiceAgreementThreeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementThreeMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementThreeMember" xlink:type="arc" order="3.7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:label="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:title="ormp_LongTermPurchaseCommitmentAgreementTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementMember" xlink:label="ormp_MasterServiceAgreementMember" xlink:title="ormp_MasterServiceAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementMember" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementFourMember" xlink:label="ormp_MasterServiceAgreementFourMember" xlink:title="ormp_MasterServiceAgreementFourMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementFourMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementFourMember" xlink:type="arc" order="4.7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:label="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:title="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentage" xlink:label="ormp_RoyaltyPercentage" xlink:title="ormp_RoyaltyPercentage" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_RoyaltyPercentage" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_RoyaltyPercentage" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:type="arc" order="8.5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" xlink:title="us-gaap_EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain" xlink:title="Definition : us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to us-gaap_EquityMethodInvesteeNameDomain" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="us-gaap_EquityMethodInvesteeNameDomain_1" xlink:title="us-gaap_EquityMethodInvesteeNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain_1" xlink:title="Definition : us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to us-gaap_EquityMethodInvesteeNameDomain" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_1" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_1" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EnteraBioLtdMember" xlink:label="ormp_EnteraBioLtdMember" xlink:title="ormp_EnteraBioLtdMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="ormp_EnteraBioLtdMember" xlink:title="Definition : us-gaap_EquityMethodInvesteeNameDomain to ormp_EnteraBioLtdMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DnaBiomedicalSolutionsLtdMember" xlink:label="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="ormp_DnaBiomedicalSolutionsLtdMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_DnaBiomedicalSolutionsLtdMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentTable to us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:type="arc" order="12" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:type="arc" order="13" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:type="arc" order="14" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:type="arc" order="15" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:type="arc" order="16" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:type="arc" order="17" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="18" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="21" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostMethodInvestments" xlink:label="us-gaap_CostMethodInvestments" xlink:title="us-gaap_CostMethodInvestments" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_CostMethodInvestments" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_CostMethodInvestments" xlink:type="arc" order="28" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:label="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:title="ormp_CostMethodInvestmentsOwnershipPercentageRetained" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:type="arc" order="38" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:title="us-gaap_DebtInstrumentFaceAmount" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="48" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="58" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="68" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementFiveMember" xlink:label="ormp_MasterServiceAgreementFiveMember" xlink:title="ormp_MasterServiceAgreementFiveMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementFiveMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementFiveMember" xlink:type="arc" use="optional" order="15" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementSixMember" xlink:label="ormp_MasterServiceAgreementSixMember" xlink:title="ormp_MasterServiceAgreementSixMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementSixMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementSixMember" xlink:type="arc" use="optional" order="25" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:type="arc" use="optional" order="35" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:title="Definition : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:type="arc" use="optional" order="45" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-cld">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="Definition : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="Definition : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="Definition : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" xlink:title="us-gaap_OperatingLeasedAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:title="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:title="Definition : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeBuildingMember" xlink:label="us-gaap_OfficeBuildingMember" xlink:title="us-gaap_OfficeBuildingMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeBuildingMember" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_OfficeBuildingMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfOperatingLeasedAssetsTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="Definition : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" xlink:title="us-gaap_VehiclesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_VehiclesMember" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="30" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:title="us-gaap_LeaseAndRentalExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" xlink:title="Definition : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_LeaseAndRentalExpense" xlink:type="arc" order="30" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:label="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:title="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:title="Definition : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:type="arc" order="40" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="Definition : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="50" xbrldt:closed="true" xbrldt:contextElement="segment" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-crgd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MinimumMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_BioJerusalemMember" xlink:label="ormp_BioJerusalemMember" xlink:title="ormp_BioJerusalemMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="ormp_BioJerusalemMember" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain to ormp_BioJerusalemMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_1" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_1" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MaximumMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefScientistOfficeMember" xlink:label="ormp_ChiefScientistOfficeMember" xlink:title="ormp_ChiefScientistOfficeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="ormp_ChiefScientistOfficeMember" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain to ormp_ChiefScientistOfficeMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentage" xlink:label="ormp_RoyaltyPercentage" xlink:title="ormp_RoyaltyPercentage" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="ormp_RoyaltyPercentage" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to ormp_RoyaltyPercentage" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_RangeAxis" xlink:title="Definition : us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to us-gaap_RangeAxis" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:label="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:title="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="us-gaap_GrantsReceivable" xlink:title="us-gaap_GrantsReceivable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_GrantsReceivable" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_GrantsReceivable" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="us-gaap_RevenueFromGrants" xlink:title="us-gaap_RevenueFromGrants" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_RevenueFromGrants" xlink:title="Definition : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_RevenueFromGrants" xlink:type="arc" order="6" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-msd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="Definition : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="Definition : us-gaap_FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:title="us-gaap_FairValueInputsLevel1Member" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" xlink:title="Definition : us-gaap_FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="Definition : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1" xlink:title="Definition : us-gaap_FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" xlink:title="us-gaap_MarketableSecurities" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecurities" xlink:title="Definition : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_MarketableSecurities" xlink:type="arc" order="2" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:title="us-gaap_StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:title="Definition : us-gaap_StatementScenarioAxis to us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorMember" xlink:label="ormp_AdvisorMember" xlink:title="ormp_AdvisorMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_AdvisorMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_AdvisorMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:label="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:title="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:title="Definition : us-gaap_ScenarioUnspecifiedDomain to ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Definition : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain_1" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain_1" xlink:title="Definition : us-gaap_StatementScenarioAxis to us-gaap_ScenarioUnspecifiedDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorTwoMember" xlink:label="ormp_AdvisorTwoMember" xlink:title="ormp_AdvisorTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_AdvisorTwoMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_AdvisorTwoMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:label="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:title="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:title="Definition : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_StatementScenarioAxis" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementMember" xlink:label="ormp_SecuritiesPurchaseAgreementMember" xlink:title="ormp_SecuritiesPurchaseAgreementMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_SecuritiesPurchaseAgreementMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_SecuritiesPurchaseAgreementMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SharePrice" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_SharePrice" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:label="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:title="ormp_GrossProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementTwoMember" xlink:label="ormp_SecuritiesPurchaseAgreementTwoMember" xlink:title="ormp_SecuritiesPurchaseAgreementTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_SecuritiesPurchaseAgreementTwoMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_SecuritiesPurchaseAgreementTwoMember" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementThreeMember" xlink:label="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:title="ormp_SecuritiesPurchaseAgreementThreeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_SecuritiesPurchaseAgreementThreeMember" xlink:type="arc" order="4.1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LeadingInvestorMember" xlink:label="ormp_LeadingInvestorMember" xlink:title="ormp_LeadingInvestorMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_LeadingInvestorMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_LeadingInvestorMember" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_OtherIndividualMember" xlink:label="ormp_OtherIndividualMember" xlink:title="ormp_OtherIndividualMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_OtherIndividualMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_OtherIndividualMember" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FindersFee" xlink:label="ormp_FindersFee" xlink:title="ormp_FindersFee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_FindersFee" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_FindersFee" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:label="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:title="ormp_SecuritiesPurchaseAgreementNumberOfUnits" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to us-gaap_DirectorMember" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DnaBiomedicalSolutionsLtdMember" xlink:label="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="ormp_DnaBiomedicalSolutionsLtdMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_DnaBiomedicalSolutionsLtdMember" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:type="arc" order="9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MinimumMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:type="arc" order="12" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RangeAxis" xlink:title="Definition : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RangeAxis" xlink:type="arc" order="12" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:type="arc" order="13" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClassOfWarrantOrRightTerm" xlink:label="ormp_ClassOfWarrantOrRightTerm" xlink:title="ormp_ClassOfWarrantOrRightTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_ClassOfWarrantOrRightTerm" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_ClassOfWarrantOrRightTerm" xlink:type="arc" order="14" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ServiceAgreementConsiderationSharesOption" xlink:label="ormp_ServiceAgreementConsiderationSharesOption" xlink:title="ormp_ServiceAgreementConsiderationSharesOption" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_ServiceAgreementConsiderationSharesOption" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_ServiceAgreementConsiderationSharesOption" xlink:type="arc" order="15" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PercentOwnershipByThirdParty" xlink:label="ormp_PercentOwnershipByThirdParty" xlink:title="ormp_PercentOwnershipByThirdParty" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_PercentOwnershipByThirdParty" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_PercentOwnershipByThirdParty" xlink:type="arc" order="16" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NumberOfInstitutionalInvestors" xlink:label="ormp_NumberOfInstitutionalInvestors" xlink:title="ormp_NumberOfInstitutionalInvestors" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_NumberOfInstitutionalInvestors" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_NumberOfInstitutionalInvestors" xlink:type="arc" order="17" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="18" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsExercised" xlink:label="ormp_WarrantsExercised" xlink:title="ormp_WarrantsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_WarrantsExercised" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_WarrantsExercised" xlink:type="arc" order="19" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_1" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_1" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MaximumMember" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="21" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="22" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:title="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="23" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:type="arc" order="24" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:label="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:title="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:type="arc" order="25" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="26" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="27" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_WarrantMember" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Definition : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:title="Definition : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="30" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Definition : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="30" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:type="arc" order="30" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="40" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" order="50" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:title="Definition : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="50" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-STOCKBASEDCOMPENSATIONDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:title="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:title="us-gaap_RelatedPartyTransactionDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" xlink:title="Definition : us-gaap_RelatedPartyTransactionAxis to us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="us-gaap_PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:title="Definition : us-gaap_PlanNameAxis to us-gaap_PlanNameDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember" xlink:title="us-gaap_ExecutiveOfficerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_ExecutiveOfficerMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to us-gaap_ExecutiveOfficerMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:label="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:title="ormp_AmendedAndRestated2008StockIncentivePlanMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:title="Definition : us-gaap_PlanNameDomain to ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:title="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_PlanNameAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_1" xlink:title="us-gaap_PlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_1" xlink:title="Definition : us-gaap_PlanNameAxis to us-gaap_PlanNameDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1" xlink:title="Definition : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_1" xlink:title="us-gaap_RelatedPartyTransactionDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_1" xlink:title="Definition : us-gaap_RelatedPartyTransactionAxis to us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to us-gaap_DirectorMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_CommonStockMember" xlink:title="Definition : us-gaap_PlanNameDomain to us-gaap_CommonStockMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeesMember" xlink:label="ormp_SubsidiaryEmployeesMember" xlink:title="ormp_SubsidiaryEmployeesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_SubsidiaryEmployeesMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_SubsidiaryEmployeesMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Definition : us-gaap_PlanNameDomain to us-gaap_WarrantMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeeOneMember" xlink:label="ormp_SubsidiaryEmployeeOneMember" xlink:title="ormp_SubsidiaryEmployeeOneMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_SubsidiaryEmployeeOneMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_SubsidiaryEmployeeOneMember" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeeTwoMember" xlink:label="ormp_SubsidiaryEmployeeTwoMember" xlink:title="ormp_SubsidiaryEmployeeTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_SubsidiaryEmployeeTwoMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_SubsidiaryEmployeeTwoMember" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefMedicalAndTechnologyOfficerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharePrice" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:label="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:title="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="12" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:label="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:title="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:type="arc" order="13" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="arc" order="14" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_FairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="15" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="16" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="17" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" xlink:title="us-gaap_FairValueAssumptionsExpectedTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsExpectedTerm" xlink:type="arc" order="18" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationInstallmentVestingShares" xlink:label="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:title="ormp_ShareBasedCompensationInstallmentVestingShares" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_ShareBasedCompensationInstallmentVestingShares" xlink:type="arc" order="19" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="20" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:title="us-gaap_VestingAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_VestingAxis" xlink:type="arc" use="optional" order="13" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:title="us-gaap_VestingDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:title="Definition : us-gaap_VestingAxis to us-gaap_VestingDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:title="Definition : us-gaap_VestingDomain to us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:title="Definition : us-gaap_VestingDomain to us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_1" xlink:title="us-gaap_VestingDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_1" xlink:title="Definition : us-gaap_VestingAxis to us-gaap_VestingDomain" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" use="optional" order="30" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorOneMember" xlink:label="ormp_DirectorOneMember" xlink:title="ormp_DirectorOneMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorOneMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorOneMember" xlink:type="arc" use="optional" order="17" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorTwoMember" xlink:label="ormp_DirectorTwoMember" xlink:title="ormp_DirectorTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorTwoMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorTwoMember" xlink:type="arc" use="optional" order="27" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorThreeMember" xlink:label="ormp_DirectorThreeMember" xlink:title="ormp_DirectorThreeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorThreeMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorThreeMember" xlink:type="arc" use="optional" order="37" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorFourMember" xlink:label="ormp_DirectorFourMember" xlink:title="ormp_DirectorFourMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorFourMember" xlink:title="Definition : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorFourMember" xlink:type="arc" use="optional" order="47" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EquityIssuanceAxis" xlink:label="ormp_EquityIssuanceAxis" xlink:title="ormp_EquityIssuanceAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ormp_EquityIssuanceAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ormp_EquityIssuanceAxis" xlink:type="arc" use="optional" order="23" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EquityIssuanceDomain" xlink:label="ormp_EquityIssuanceDomain" xlink:title="ormp_EquityIssuanceDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ormp_EquityIssuanceAxis" xlink:to="ormp_EquityIssuanceDomain" xlink:title="Definition : ormp_EquityIssuanceAxis to ormp_EquityIssuanceDomain" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IssuanceOneMember" xlink:label="ormp_IssuanceOneMember" xlink:title="ormp_IssuanceOneMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_EquityIssuanceDomain" xlink:to="ormp_IssuanceOneMember" xlink:title="Definition : ormp_EquityIssuanceDomain to ormp_IssuanceOneMember" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IssuanceTwoMember" xlink:label="ormp_IssuanceTwoMember" xlink:title="ormp_IssuanceTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_EquityIssuanceDomain" xlink:to="ormp_IssuanceTwoMember" xlink:title="Definition : ormp_EquityIssuanceDomain to ormp_IssuanceTwoMember" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EquityIssuanceDomain" xlink:label="ormp_EquityIssuanceDomain_1" xlink:title="ormp_EquityIssuanceDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ormp_EquityIssuanceAxis" xlink:to="ormp_EquityIssuanceDomain_1" xlink:title="Definition : ormp_EquityIssuanceAxis to ormp_EquityIssuanceDomain" xlink:type="arc" use="optional" order="20" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-scsofvad">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MinimumMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RangeAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MaximumMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="9" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-scsosoad">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityLineItems" xlink:label="ormp_StockOptionActivityLineItems" xlink:title="ormp_StockOptionActivityLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:label="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:title="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:title="Definition : ormp_StockOptionActivityLineItems to ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="Definition : ormp_StockOptionActivityEmployeesAndNonemployeesAxis to ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeesMember" xlink:label="ormp_EmployeesMember" xlink:title="ormp_EmployeesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_EmployeesMember" xlink:title="Definition : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_EmployeesMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="Definition : ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable to ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesDomain_1" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesDomain_1" xlink:title="Definition : ormp_StockOptionActivityEmployeesAndNonemployeesAxis to ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NonemployeesMember" xlink:label="ormp_NonemployeesMember" xlink:title="ormp_NonemployeesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_NonemployeesMember" xlink:title="Definition : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_NonemployeesMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Definition : ormp_StockOptionActivityLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Definition : ormp_StockOptionActivityLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Definition : ormp_StockOptionActivityLineItems to us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Definition : ormp_StockOptionActivityLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="Definition : ormp_StockOptionActivityLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Definition : ormp_StockOptionActivityLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Definition : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="8" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-scsoifooaebeprd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="Definition : ormp_StockOptionActivityEmployeesAndNonemployeesAxis to ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeOneMember" xlink:label="ormp_ExercisePriceRangeOneMember" xlink:title="ormp_ExercisePriceRangeOneMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeOneMember" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeOneMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeesMember" xlink:label="ormp_EmployeesMember" xlink:title="ormp_EmployeesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_EmployeesMember" xlink:title="Definition : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_EmployeesMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_1" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NonemployeesMember" xlink:label="ormp_NonemployeesMember" xlink:title="ormp_NonemployeesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_NonemployeesMember" xlink:title="Definition : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_NonemployeesMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeTwoMember" xlink:label="ormp_ExercisePriceRangeTwoMember" xlink:title="ormp_ExercisePriceRangeTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeTwoMember" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeTwoMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="Definition : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable to ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeThreeMember" xlink:label="ormp_ExercisePriceRangeThreeMember" xlink:title="ormp_ExercisePriceRangeThreeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeThreeMember" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeThreeMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeFourMember" xlink:label="ormp_ExercisePriceRangeFourMember" xlink:title="ormp_ExercisePriceRangeFourMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeFourMember" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeFourMember" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:label="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:title="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:label="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:title="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:title="Definition : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:type="arc" order="9" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-RELATEDPARTIES-TRANSACTIONSDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to us-gaap_DirectorMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Definition : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NumberOfConsultingAgreementsEntered" xlink:label="ormp_NumberOfConsultingAgreementsEntered" xlink:title="ormp_NumberOfConsultingAgreementsEntered" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_NumberOfConsultingAgreementsEntered" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_NumberOfConsultingAgreementsEntered" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KnryMember" xlink:label="ormp_KnryMember" xlink:title="ormp_KnryMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_KnryMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_KnryMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember" xlink:title="us-gaap_ExecutiveOfficerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_ExecutiveOfficerMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to us-gaap_ExecutiveOfficerMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:title="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MonthlyPaymentUnderConsultingAgreements" xlink:label="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:title="ormp_MonthlyPaymentUnderConsultingAgreements" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_MonthlyPaymentUnderConsultingAgreements" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AnnualPaymentUnderConsultingAgreements" xlink:label="ormp_AnnualPaymentUnderConsultingAgreements" xlink:title="ormp_AnnualPaymentUnderConsultingAgreements" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_AnnualPaymentUnderConsultingAgreements" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_AnnualPaymentUnderConsultingAgreements" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:title="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExtendedPriorWrittenNoticePeriod" xlink:label="ormp_ExtendedPriorWrittenNoticePeriod" xlink:title="ormp_ExtendedPriorWrittenNoticePeriod" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_ExtendedPriorWrittenNoticePeriod" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_ExtendedPriorWrittenNoticePeriod" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="us-gaap_OfficersCompensation" xlink:title="us-gaap_OfficersCompensation" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OfficersCompensation" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_OfficersCompensation" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CarAndCashBonus" xlink:label="ormp_CarAndCashBonus" xlink:title="ormp_CarAndCashBonus" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_CarAndCashBonus" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_CarAndCashBonus" xlink:type="arc" order="9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CashBonus" xlink:label="ormp_CashBonus" xlink:title="ormp_CashBonus" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_CashBonus" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_CashBonus" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_1" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_1" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_TemporaryIncreasePaymentPerMonth" xlink:label="ormp_TemporaryIncreasePaymentPerMonth" xlink:title="ormp_TemporaryIncreasePaymentPerMonth" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_TemporaryIncreasePaymentPerMonth" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to ormp_TemporaryIncreasePaymentPerMonth" xlink:type="arc" order="11" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefMedicalAndTechnologyOfficerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:type="arc" order="8000" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiaryOfCommonParentMember" xlink:label="us-gaap_SubsidiaryOfCommonParentMember" xlink:title="us-gaap_SubsidiaryOfCommonParentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_SubsidiaryOfCommonParentMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to us-gaap_SubsidiaryOfCommonParentMember" xlink:type="arc" order="8001" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="us-gaap_CorporateJointVentureMember" xlink:title="us-gaap_CorporateJointVentureMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_CorporateJointVentureMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to us-gaap_CorporateJointVentureMember" xlink:type="arc" order="8011" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-rptsobwrpd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Definition : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KnryMember" xlink:label="ormp_KnryMember" xlink:title="ormp_KnryMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_KnryMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to ormp_KnryMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Definition : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:title="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:title="Definition : us-gaap_RelatedPartyTransactionLineItems to us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember" xlink:title="us-gaap_ExecutiveOfficerMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_ExecutiveOfficerMember" xlink:title="Definition : us-gaap_RelatedPartyDomain to us-gaap_ExecutiveOfficerMember" xlink:type="arc" order="8000" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toind">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_TaxesOnIncomeLineItems" xlink:label="ormp_TaxesOnIncomeLineItems" xlink:title="ormp_TaxesOnIncomeLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ormp_TaxesOnIncomeLineItems" xlink:to="us-gaap_StatementTable" xlink:title="Definition : ormp_TaxesOnIncomeLineItems to us-gaap_StatementTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:title="dei_LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:title="dei_EntityDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:title="Definition : dei_LegalEntityAxis to dei_EntityDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiariesMember" xlink:label="us-gaap_SubsidiariesMember" xlink:title="us-gaap_SubsidiariesMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="us-gaap_SubsidiariesMember" xlink:title="Definition : dei_EntityDomain to us-gaap_SubsidiariesMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:title="Definition : us-gaap_StatementTable to dei_LegalEntityAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_1" xlink:title="dei_EntityDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_1" xlink:title="Definition : dei_LegalEntityAxis to dei_EntityDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_TaxesOnIncomeLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="Definition : ormp_TaxesOnIncomeLineItems to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:title="us-gaap_OperatingLossCarryforwards" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_TaxesOnIncomeLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" xlink:title="Definition : ormp_TaxesOnIncomeLineItems to us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="3" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSDetails">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShortTermInvestmentsLineItems" xlink:label="ormp_ShortTermInvestmentsLineItems" xlink:title="ormp_ShortTermInvestmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfRestrictedCashTable" xlink:label="ormp_ScheduleOfRestrictedCashTable" xlink:title="ormp_ScheduleOfRestrictedCashTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ormp_ShortTermInvestmentsLineItems" xlink:to="ormp_ScheduleOfRestrictedCashTable" xlink:title="Definition : ormp_ShortTermInvestmentsLineItems to ormp_ScheduleOfRestrictedCashTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Definition : us-gaap_RangeAxis to us-gaap_RangeMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="Definition : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis to us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MinimumMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestBearingDepositsMember" xlink:label="us-gaap_InterestBearingDepositsMember" xlink:title="us-gaap_InterestBearingDepositsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_InterestBearingDepositsMember" xlink:title="Definition : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember to us-gaap_InterestBearingDepositsMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ormp_ScheduleOfRestrictedCashTable" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:title="Definition : ormp_ScheduleOfRestrictedCashTable to us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1" xlink:title="Definition : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis to us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Definition : us-gaap_RangeMember to us-gaap_MaximumMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShortTermInvestmentWithBanksInterestRate" xlink:label="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:title="ormp_ShortTermInvestmentWithBanksInterestRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_ShortTermInvestmentsLineItems" xlink:to="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:title="Definition : ormp_ShortTermInvestmentsLineItems to ormp_ShortTermInvestmentWithBanksInterestRate" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ormp_ScheduleOfRestrictedCashTable" xlink:to="us-gaap_RangeAxis" xlink:title="Definition : ormp_ScheduleOfRestrictedCashTable to us-gaap_RangeAxis" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestBearingDepositsInBanks" xlink:label="us-gaap_InterestBearingDepositsInBanks" xlink:title="us-gaap_InterestBearingDepositsInBanks" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_ShortTermInvestmentsLineItems" xlink:to="us-gaap_InterestBearingDepositsInBanks" xlink:title="Definition : ormp_ShortTermInvestmentsLineItems to us-gaap_InterestBearingDepositsInBanks" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ForeignInterestBearingDepositsMember" xlink:label="ormp_ForeignInterestBearingDepositsMember" xlink:title="ormp_ForeignInterestBearingDepositsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="ormp_ForeignInterestBearingDepositsMember" xlink:title="Definition : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember to ormp_ForeignInterestBearingDepositsMember" xlink:type="arc" order="3" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-wd1">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsLineItems" xlink:label="ormp_WarrantsLineItems" xlink:title="ormp_WarrantsLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsTable" xlink:label="ormp_WarrantsTable" xlink:title="ormp_WarrantsTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ormp_WarrantsLineItems" xlink:to="ormp_WarrantsTable" xlink:title="Definition : ormp_WarrantsLineItems to ormp_WarrantsTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAxis" xlink:label="ormp_WarrantsAxis" xlink:title="ormp_WarrantsAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsDomain" xlink:label="ormp_WarrantsDomain" xlink:title="ormp_WarrantsDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ormp_WarrantsAxis" xlink:to="ormp_WarrantsDomain" xlink:title="Definition : ormp_WarrantsAxis to ormp_WarrantsDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsOneMember" xlink:label="ormp_WarrantsOneMember" xlink:title="ormp_WarrantsOneMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_WarrantsOneMember" xlink:title="Definition : ormp_WarrantsDomain to ormp_WarrantsOneMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ormp_WarrantsTable" xlink:to="ormp_WarrantsAxis" xlink:title="Definition : ormp_WarrantsTable to ormp_WarrantsAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsDomain" xlink:label="ormp_WarrantsDomain_1" xlink:title="ormp_WarrantsDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ormp_WarrantsAxis" xlink:to="ormp_WarrantsDomain_1" xlink:title="Definition : ormp_WarrantsAxis to ormp_WarrantsDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsTwoMember" xlink:label="ormp_WarrantsTwoMember" xlink:title="ormp_WarrantsTwoMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_WarrantsTwoMember" xlink:title="Definition : ormp_WarrantsDomain to ormp_WarrantsTwoMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsGrantedShares" xlink:label="ormp_WarrantsGrantedShares" xlink:title="ormp_WarrantsGrantedShares" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="ormp_WarrantsGrantedShares" xlink:title="Definition : ormp_WarrantsLineItems to ormp_WarrantsGrantedShares" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NewWarrantMember" xlink:label="ormp_NewWarrantMember" xlink:title="ormp_NewWarrantMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_NewWarrantMember" xlink:title="Definition : ormp_WarrantsDomain to ormp_NewWarrantMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClassOfWarrantOrRightTerm" xlink:label="ormp_ClassOfWarrantOrRightTerm" xlink:title="ormp_ClassOfWarrantOrRightTerm" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="ormp_ClassOfWarrantOrRightTerm" xlink:title="Definition : ormp_WarrantsLineItems to ormp_ClassOfWarrantOrRightTerm" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KidronOptionMember" xlink:label="ormp_KidronOptionMember" xlink:title="ormp_KidronOptionMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_KidronOptionMember" xlink:title="Definition : ormp_WarrantsDomain to ormp_KidronOptionMember" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Definition : ormp_WarrantsLineItems to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="4" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="Definition : ormp_WarrantsLineItems to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="5" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:title="us-gaap_WarrantsAndRightsOutstanding" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" xlink:title="Definition : ormp_WarrantsLineItems to us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="6" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Definition : ormp_WarrantsLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="7" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Definition : ormp_WarrantsLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="8" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Definition : ormp_WarrantsLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="9" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Definition : ormp_WarrantsLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="10" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAndRightsExpenseRecognized" xlink:label="ormp_WarrantsAndRightsExpenseRecognized" xlink:title="ormp_WarrantsAndRightsExpenseRecognized" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ormp_WarrantsLineItems" xlink:to="ormp_WarrantsAndRightsExpenseRecognized" xlink:title="Definition : ormp_WarrantsLineItems to ormp_WarrantsAndRightsExpenseRecognized" xlink:type="arc" order="11" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-paend">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:title="us-gaap_LeaseholdImprovementsMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Definition : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_1" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:title="us-gaap_OfficeEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_OfficeEquipmentMember" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="2" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="us-gaap_ComputerEquipmentMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_ComputerEquipmentMember" xlink:type="arc" order="3" xbrldt:closed="false" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:title="us-gaap_Depreciation" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" xlink:title="Definition : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_Depreciation" xlink:type="arc" order="5" xbrldt:closed="false" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sed">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xlink:title="us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xlink:title="us-gaap_SubsequentEventTable" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" xlink:title="Definition : us-gaap_SubsequentEventLineItems to us-gaap_SubsequentEventTable" xlink:type="arc" order="30" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="us-gaap_SubsequentEventMember" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Definition : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" xlink:type="arc" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="us-gaap_SubsequentEventTypeAxis" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Definition : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Definition : us-gaap_SubsequentEventTable to us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="3" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:label="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:title="ormp_MarketIssuanceSalesAgreementOfferingValue" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:title="Definition : us-gaap_SubsequentEventLineItems to ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:type="arc" use="optional" order="10" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:label="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:title="ormp_MarketIssuanceSalesAgreementCommissionPercentage" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:title="Definition : us-gaap_SubsequentEventLineItems to ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:type="arc" use="optional" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_1" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_1" xlink:title="Definition : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" xlink:type="arc" use="optional" order="11" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>ormp-20150228_lab.xml
<DESCRIPTION>TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by Z-K Global, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:label="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:title="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xml:lang="en-US" id="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent">The increase (decrease) during the period in the carrying value of prepaid expenses, other current assets and related parties reported as assets that are due to be disposed of within one year (or the normal operating cycle, if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:to="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:title="Label : ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent to label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_1" xml:lang="en-US" id="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_1">Increase (Decrease) in Prepaid Expenses other Current Assets and Related Parties Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:to="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_1" xlink:title="Label : ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent to label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_2" xml:lang="en-US" id="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_2">Prepaid expenses, other current assets and related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:to="label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_2" xlink:title="Label : ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent to label_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:label="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:title="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xml:lang="en-US" id="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent">The increase (decrease) during the period in the carrying value of accounts payable, accrued expenses and related parties reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:to="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:title="Label : ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent to label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_1" xml:lang="en-US" id="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_1">Increase (Decrease) in Accounts Payable Accrued Expenses and Related Parties Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:to="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_1" xlink:title="Label : ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent to label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_2" xml:lang="en-US" id="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_2">Accounts payable, accrued expenses and related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:to="label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_2" xlink:title="Label : ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent to label_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:title="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xml:lang="en-US" id="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement">The cash outflow from the purchase of funds in respect of employee rights upon retirement during the reporting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:title="Label : ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement to label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_1" xml:lang="en-US" id="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_1">Payments to Acquire Funds in Respect of Employee Rights upon Retirement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_1" xlink:title="Label : ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement to label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_2" xml:lang="en-US" id="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_2">Funds in respect of employee rights upon retirement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_2" xlink:title="Label : ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement to label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_2" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_3" xml:lang="en-US" id="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_3">Funds in respect of employee rights upon retirement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:to="label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_3" xlink:title="Label : ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement to label_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement_3" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:label="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:title="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xml:lang="en-US" id="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock">Disclosure of accounting policy for condensed consolidated financial statements preparation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:to="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:title="Label : ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock to label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_1" xml:lang="en-US" id="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_1">Condensed Consolidated Financial Statements Preparation Policy [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:to="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_1" xlink:title="Label : ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock to label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_2" xml:lang="en-US" id="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_2">Condensed Consolidated Financial Statements Preparation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:to="label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_2" xlink:title="Label : ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock to label_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketableSecuritiesSold" xlink:label="ormp_MarketableSecuritiesSold" xlink:title="ormp_MarketableSecuritiesSold" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketableSecuritiesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MarketableSecuritiesSold" xml:lang="en-US" id="label_ormp_MarketableSecuritiesSold">Number of shares of marketable securities sold.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketableSecuritiesSold" xlink:to="label_ormp_MarketableSecuritiesSold" xlink:title="Label : ormp_MarketableSecuritiesSold to label_ormp_MarketableSecuritiesSold" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketableSecuritiesSold_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MarketableSecuritiesSold_1" xml:lang="en-US" id="label_ormp_MarketableSecuritiesSold_1">Marketable Securities Sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketableSecuritiesSold" xlink:to="label_ormp_MarketableSecuritiesSold_1" xlink:title="Label : ormp_MarketableSecuritiesSold to label_ormp_MarketableSecuritiesSold_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketableSecuritiesSold_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MarketableSecuritiesSold_2" xml:lang="en-US" id="label_ormp_MarketableSecuritiesSold_2">Number of shares sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketableSecuritiesSold" xlink:to="label_ormp_MarketableSecuritiesSold_2" xlink:title="Label : ormp_MarketableSecuritiesSold to label_ormp_MarketableSecuritiesSold_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketableSecuritiesOwnershipPercentage" xlink:label="ormp_MarketableSecuritiesOwnershipPercentage" xlink:title="ormp_MarketableSecuritiesOwnershipPercentage" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketableSecuritiesOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MarketableSecuritiesOwnershipPercentage" xml:lang="en-US" id="label_ormp_MarketableSecuritiesOwnershipPercentage">The percentage of ownership of common stock or equity participation in the investee accounted for as marketable securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketableSecuritiesOwnershipPercentage" xlink:to="label_ormp_MarketableSecuritiesOwnershipPercentage" xlink:title="Label : ormp_MarketableSecuritiesOwnershipPercentage to label_ormp_MarketableSecuritiesOwnershipPercentage" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketableSecuritiesOwnershipPercentage_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MarketableSecuritiesOwnershipPercentage_1" xml:lang="en-US" id="label_ormp_MarketableSecuritiesOwnershipPercentage_1">Marketable Securities Ownership Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketableSecuritiesOwnershipPercentage" xlink:to="label_ormp_MarketableSecuritiesOwnershipPercentage_1" xlink:title="Label : ormp_MarketableSecuritiesOwnershipPercentage to label_ormp_MarketableSecuritiesOwnershipPercentage_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketableSecuritiesOwnershipPercentage_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MarketableSecuritiesOwnershipPercentage_2" xml:lang="en-US" id="label_ormp_MarketableSecuritiesOwnershipPercentage_2">Ownership percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketableSecuritiesOwnershipPercentage" xlink:to="label_ormp_MarketableSecuritiesOwnershipPercentage_2" xlink:title="Label : ormp_MarketableSecuritiesOwnershipPercentage to label_ormp_MarketableSecuritiesOwnershipPercentage_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_HadasitMember" xlink:label="ormp_HadasitMember" xlink:title="ormp_HadasitMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_HadasitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_HadasitMember" xml:lang="en-US" id="label_ormp_HadasitMember">Hadasit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_HadasitMember" xlink:to="label_ormp_HadasitMember" xlink:title="Label : ormp_HadasitMember to label_ormp_HadasitMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_HadasitMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_HadasitMember_1" xml:lang="en-US" id="label_ormp_HadasitMember_1">Hadasit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_HadasitMember" xlink:to="label_ormp_HadasitMember_1" xlink:title="Label : ormp_HadasitMember to label_ormp_HadasitMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:label="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:title="ormp_LongTermPurchaseCommitmentAgreementTerm" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_LongTermPurchaseCommitmentAgreementTerm" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentAgreementTerm">Term of a long-term purchase commitment for goods or services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:to="label_ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:title="Label : ormp_LongTermPurchaseCommitmentAgreementTerm to label_ormp_LongTermPurchaseCommitmentAgreementTerm" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentAgreementTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_LongTermPurchaseCommitmentAgreementTerm_1" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentAgreementTerm_1">Long Term Purchase Commitment Agreement Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:to="label_ormp_LongTermPurchaseCommitmentAgreementTerm_1" xlink:title="Label : ormp_LongTermPurchaseCommitmentAgreementTerm to label_ormp_LongTermPurchaseCommitmentAgreementTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentAgreementTerm_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_LongTermPurchaseCommitmentAgreementTerm_2" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentAgreementTerm_2">Agreement term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:to="label_ormp_LongTermPurchaseCommitmentAgreementTerm_2" xlink:title="Label : ormp_LongTermPurchaseCommitmentAgreementTerm to label_ormp_LongTermPurchaseCommitmentAgreementTerm_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ConsultantMember" xlink:label="ormp_ConsultantMember" xlink:title="ormp_ConsultantMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ConsultantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ConsultantMember" xml:lang="en-US" id="label_ormp_ConsultantMember">Consultant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ConsultantMember" xlink:to="label_ormp_ConsultantMember" xlink:title="Label : ormp_ConsultantMember to label_ormp_ConsultantMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ConsultantMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ConsultantMember_1" xml:lang="en-US" id="label_ormp_ConsultantMember_1">Consultant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ConsultantMember" xlink:to="label_ormp_ConsultantMember_1" xlink:title="Label : ormp_ConsultantMember to label_ormp_ConsultantMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:label="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:title="ormp_GrossProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_GrossProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="label_ormp_GrossProceedsFromIssuanceOfCommonStock">The gross cash inflow from the issuance of common stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:to="label_ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:title="Label : ormp_GrossProceedsFromIssuanceOfCommonStock to label_ormp_GrossProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_GrossProceedsFromIssuanceOfCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_GrossProceedsFromIssuanceOfCommonStock_1" xml:lang="en-US" id="label_ormp_GrossProceedsFromIssuanceOfCommonStock_1">Gross Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:to="label_ormp_GrossProceedsFromIssuanceOfCommonStock_1" xlink:title="Label : ormp_GrossProceedsFromIssuanceOfCommonStock to label_ormp_GrossProceedsFromIssuanceOfCommonStock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_GrossProceedsFromIssuanceOfCommonStock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_GrossProceedsFromIssuanceOfCommonStock_2" xml:lang="en-US" id="label_ormp_GrossProceedsFromIssuanceOfCommonStock_2">Aggregate gross proceeds from the offering</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:to="label_ormp_GrossProceedsFromIssuanceOfCommonStock_2" xlink:title="Label : ormp_GrossProceedsFromIssuanceOfCommonStock to label_ormp_GrossProceedsFromIssuanceOfCommonStock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FindersFee" xlink:label="ormp_FindersFee" xlink:title="ormp_FindersFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FindersFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_FindersFee" xml:lang="en-US" id="label_ormp_FindersFee">Finders fee associated with shares issued for services.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FindersFee" xlink:to="label_ormp_FindersFee" xlink:title="Label : ormp_FindersFee to label_ormp_FindersFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FindersFee_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_FindersFee_1" xml:lang="en-US" id="label_ormp_FindersFee_1">Finders Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FindersFee" xlink:to="label_ormp_FindersFee_1" xlink:title="Label : ormp_FindersFee to label_ormp_FindersFee_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FindersFee_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_FindersFee_2" xml:lang="en-US" id="label_ormp_FindersFee_2">Finders fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FindersFee" xlink:to="label_ormp_FindersFee_2" xlink:title="Label : ormp_FindersFee to label_ormp_FindersFee_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:title="dei_AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="label_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_AmendmentFlag" xml:lang="en-US" id="label_dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="label_dei_AmendmentFlag" xlink:title="Label : dei_AmendmentFlag to label_dei_AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="label_dei_AmendmentFlag_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_AmendmentFlag_1" xml:lang="en-US" id="label_dei_AmendmentFlag_1">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="label_dei_AmendmentFlag_1" xlink:title="Label : dei_AmendmentFlag to label_dei_AmendmentFlag_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementMember" xlink:label="ormp_SecuritiesPurchaseAgreementMember" xlink:title="ormp_SecuritiesPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementMember" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementMember">Securities Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementMember" xlink:title="Label : ormp_SecuritiesPurchaseAgreementMember to label_ormp_SecuritiesPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementMember_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementMember_1">Securities Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementMember_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementMember to label_ormp_SecuritiesPurchaseAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SecuritiesPurchaseAgreementMember_2" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementMember_2">Stock Purchase Agreement with Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementMember_2" xlink:title="Label : ormp_SecuritiesPurchaseAgreementMember to label_ormp_SecuritiesPurchaseAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:label="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:title="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee">The monthly fixed fee for the long term purchase commitment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:to="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:title="Label : ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee to label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_1" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_1">Long Term Purchase Commitment Amount Monthly Fixed Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:to="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_1" xlink:title="Label : ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee to label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_2" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_2">Commitments for consulting service, monthly fixed fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:to="label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_2" xlink:title="Label : ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee to label_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentage" xlink:label="ormp_RoyaltyPercentage" xlink:title="ormp_RoyaltyPercentage" />
    <link:label xlink:type="resource" xlink:label="label_ormp_RoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_RoyaltyPercentage" xml:lang="en-US" id="label_ormp_RoyaltyPercentage">The percentage of sales or another benchmark specified in an agreement payable as royalty.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_RoyaltyPercentage" xlink:to="label_ormp_RoyaltyPercentage" xlink:title="Label : ormp_RoyaltyPercentage to label_ormp_RoyaltyPercentage" />
    <link:label xlink:type="resource" xlink:label="label_ormp_RoyaltyPercentage_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_RoyaltyPercentage_1" xml:lang="en-US" id="label_ormp_RoyaltyPercentage_1">Royalty Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_RoyaltyPercentage" xlink:to="label_ormp_RoyaltyPercentage_1" xlink:title="Label : ormp_RoyaltyPercentage to label_ormp_RoyaltyPercentage_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_RoyaltyPercentage_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_RoyaltyPercentage_2" xml:lang="en-US" id="label_ormp_RoyaltyPercentage_2">Royalty percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_RoyaltyPercentage" xlink:to="label_ormp_RoyaltyPercentage_2" xlink:title="Label : ormp_RoyaltyPercentage to label_ormp_RoyaltyPercentage_2" />
    <link:label xlink:type="resource" xlink:label="label_ormp_RoyaltyPercentage_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_ormp_RoyaltyPercentage_3" xml:lang="en-US" id="label_ormp_RoyaltyPercentage_3">Royalty as percentage of net revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_RoyaltyPercentage" xlink:to="label_ormp_RoyaltyPercentage_3" xlink:title="Label : ormp_RoyaltyPercentage to label_ormp_RoyaltyPercentage_3" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorMember" xlink:label="ormp_AdvisorMember" xlink:title="ormp_AdvisorMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AdvisorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_AdvisorMember" xml:lang="en-US" id="label_ormp_AdvisorMember">Advisor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AdvisorMember" xlink:to="label_ormp_AdvisorMember" xlink:title="Label : ormp_AdvisorMember to label_ormp_AdvisorMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AdvisorMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_AdvisorMember_1" xml:lang="en-US" id="label_ormp_AdvisorMember_1">Advisor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AdvisorMember" xlink:to="label_ormp_AdvisorMember_1" xlink:title="Label : ormp_AdvisorMember to label_ormp_AdvisorMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AdvisorMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_AdvisorMember_2" xml:lang="en-US" id="label_ormp_AdvisorMember_2">Advisor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AdvisorMember" xlink:to="label_ormp_AdvisorMember_2" xlink:title="Label : ormp_AdvisorMember to label_ormp_AdvisorMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:label="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" />
    <link:label xlink:type="resource" xlink:label="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xml:lang="en-US" id="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived">When royalties are granted as a percentage of sales, this represents the maximum percentage of grants received from the entity that coincide with the percentage of royalties paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:to="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:title="Label : ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived to label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" />
    <link:label xlink:type="resource" xlink:label="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_1" xml:lang="en-US" id="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_1">Royalty Percentage Maximum Percentage Of Grants Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:to="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_1" xlink:title="Label : ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived to label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_2" xml:lang="en-US" id="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_2">Royalty percentage, maximum percentage of grants received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:to="label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_2" xlink:title="Label : ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived to label_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_BioJerusalemMember" xlink:label="ormp_BioJerusalemMember" xlink:title="ormp_BioJerusalemMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_BioJerusalemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_BioJerusalemMember" xml:lang="en-US" id="label_ormp_BioJerusalemMember">Bio Jerusalem [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_BioJerusalemMember" xlink:to="label_ormp_BioJerusalemMember" xlink:title="Label : ormp_BioJerusalemMember to label_ormp_BioJerusalemMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_BioJerusalemMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_BioJerusalemMember_1" xml:lang="en-US" id="label_ormp_BioJerusalemMember_1">Bio Jerusalem [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_BioJerusalemMember" xlink:to="label_ormp_BioJerusalemMember_1" xlink:title="Label : ormp_BioJerusalemMember to label_ormp_BioJerusalemMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_BioJerusalemMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_BioJerusalemMember_2" xml:lang="en-US" id="label_ormp_BioJerusalemMember_2">Bio-Jerusalem [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_BioJerusalemMember" xlink:to="label_ormp_BioJerusalemMember_2" xlink:title="Label : ormp_BioJerusalemMember to label_ormp_BioJerusalemMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefScientistOfficeMember" xlink:label="ormp_ChiefScientistOfficeMember" xlink:title="ormp_ChiefScientistOfficeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefScientistOfficeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ChiefScientistOfficeMember" xml:lang="en-US" id="label_ormp_ChiefScientistOfficeMember">Chief Scientist Office [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefScientistOfficeMember" xlink:to="label_ormp_ChiefScientistOfficeMember" xlink:title="Label : ormp_ChiefScientistOfficeMember to label_ormp_ChiefScientistOfficeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefScientistOfficeMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ChiefScientistOfficeMember_1" xml:lang="en-US" id="label_ormp_ChiefScientistOfficeMember_1">Chief Scientist Office [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefScientistOfficeMember" xlink:to="label_ormp_ChiefScientistOfficeMember_1" xlink:title="Label : ormp_ChiefScientistOfficeMember to label_ormp_ChiefScientistOfficeMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xml:lang="en-US" id="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember">Represents information pertaining to Chief Executive Officer and the CTO of the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:to="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:title="Label : ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember to label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_1" xml:lang="en-US" id="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_1">Chief Executive Officer and Chief Medical and Technology Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:to="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_1" xlink:title="Label : ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember to label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_2" xml:lang="en-US" id="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_2">Chief Executive Officer and the CTO [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:to="label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_2" xlink:title="Label : ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember to label_ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentBonusAmount" xlink:label="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:title="ormp_LongTermPurchaseCommitmentBonusAmount" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentBonusAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_LongTermPurchaseCommitmentBonusAmount" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentBonusAmount">The minimum amount the entity agreed to spend on bonuses under the long-term purchase commitment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:to="label_ormp_LongTermPurchaseCommitmentBonusAmount" xlink:title="Label : ormp_LongTermPurchaseCommitmentBonusAmount to label_ormp_LongTermPurchaseCommitmentBonusAmount" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentBonusAmount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_LongTermPurchaseCommitmentBonusAmount_1" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentBonusAmount_1">Long Term Purchase Commitment Bonus Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:to="label_ormp_LongTermPurchaseCommitmentBonusAmount_1" xlink:title="Label : ormp_LongTermPurchaseCommitmentBonusAmount to label_ormp_LongTermPurchaseCommitmentBonusAmount_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LongTermPurchaseCommitmentBonusAmount_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_LongTermPurchaseCommitmentBonusAmount_2" xml:lang="en-US" id="label_ormp_LongTermPurchaseCommitmentBonusAmount_2">Commitments for bonus payments upon achieving certain milestones</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:to="label_ormp_LongTermPurchaseCommitmentBonusAmount_2" xlink:title="Label : ormp_LongTermPurchaseCommitmentBonusAmount to label_ormp_LongTermPurchaseCommitmentBonusAmount_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_ClinicalResearchOrganizationServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ClinicalResearchOrganizationServiceAgreementMember" xml:lang="en-US" id="label_ormp_ClinicalResearchOrganizationServiceAgreementMember">Clinical Research Organization Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:to="label_ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:title="Label : ormp_ClinicalResearchOrganizationServiceAgreementMember to label_ormp_ClinicalResearchOrganizationServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_1" xml:lang="en-US" id="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_1">Clinical Research Organization Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:to="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_1" xlink:title="Label : ormp_ClinicalResearchOrganizationServiceAgreementMember to label_ormp_ClinicalResearchOrganizationServiceAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_2" xml:lang="en-US" id="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_2">Clinical Research Organization Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:to="label_ormp_ClinicalResearchOrganizationServiceAgreementMember_2" xlink:title="Label : ormp_ClinicalResearchOrganizationServiceAgreementMember to label_ormp_ClinicalResearchOrganizationServiceAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementTwoMember" xlink:label="ormp_MasterServiceAgreementTwoMember" xlink:title="ormp_MasterServiceAgreementTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MasterServiceAgreementTwoMember" xml:lang="en-US" id="label_ormp_MasterServiceAgreementTwoMember">Master Service Agreement Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementTwoMember" xlink:to="label_ormp_MasterServiceAgreementTwoMember" xlink:title="Label : ormp_MasterServiceAgreementTwoMember to label_ormp_MasterServiceAgreementTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MasterServiceAgreementTwoMember_1" xml:lang="en-US" id="label_ormp_MasterServiceAgreementTwoMember_1">Second Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementTwoMember" xlink:to="label_ormp_MasterServiceAgreementTwoMember_1" xlink:title="Label : ormp_MasterServiceAgreementTwoMember to label_ormp_MasterServiceAgreementTwoMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementThreeMember" xlink:label="ormp_MasterServiceAgreementThreeMember" xlink:title="ormp_MasterServiceAgreementThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MasterServiceAgreementThreeMember" xml:lang="en-US" id="label_ormp_MasterServiceAgreementThreeMember">Master Service Agreement Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementThreeMember" xlink:to="label_ormp_MasterServiceAgreementThreeMember" xlink:title="Label : ormp_MasterServiceAgreementThreeMember to label_ormp_MasterServiceAgreementThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementThreeMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MasterServiceAgreementThreeMember_1" xml:lang="en-US" id="label_ormp_MasterServiceAgreementThreeMember_1">Third Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementThreeMember" xlink:to="label_ormp_MasterServiceAgreementThreeMember_1" xlink:title="Label : ormp_MasterServiceAgreementThreeMember to label_ormp_MasterServiceAgreementThreeMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementFourMember" xlink:label="ormp_MasterServiceAgreementFourMember" xlink:title="ormp_MasterServiceAgreementFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MasterServiceAgreementFourMember" xml:lang="en-US" id="label_ormp_MasterServiceAgreementFourMember">Master Service Agreement Four [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementFourMember" xlink:to="label_ormp_MasterServiceAgreementFourMember" xlink:title="Label : ormp_MasterServiceAgreementFourMember to label_ormp_MasterServiceAgreementFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementFourMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MasterServiceAgreementFourMember_1" xml:lang="en-US" id="label_ormp_MasterServiceAgreementFourMember_1">Fourth Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementFourMember" xlink:to="label_ormp_MasterServiceAgreementFourMember_1" xlink:title="Label : ormp_MasterServiceAgreementFourMember to label_ormp_MasterServiceAgreementFourMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MonthlyPaymentUnderConsultingAgreements" xlink:label="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:title="ormp_MonthlyPaymentUnderConsultingAgreements" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MonthlyPaymentUnderConsultingAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MonthlyPaymentUnderConsultingAgreements" xml:lang="en-US" id="label_ormp_MonthlyPaymentUnderConsultingAgreements">Monthly payment to be made under the consulting agreements to the individuals.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:to="label_ormp_MonthlyPaymentUnderConsultingAgreements" xlink:title="Label : ormp_MonthlyPaymentUnderConsultingAgreements to label_ormp_MonthlyPaymentUnderConsultingAgreements" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MonthlyPaymentUnderConsultingAgreements_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MonthlyPaymentUnderConsultingAgreements_1" xml:lang="en-US" id="label_ormp_MonthlyPaymentUnderConsultingAgreements_1">Monthly Payment Under Consulting Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:to="label_ormp_MonthlyPaymentUnderConsultingAgreements_1" xlink:title="Label : ormp_MonthlyPaymentUnderConsultingAgreements to label_ormp_MonthlyPaymentUnderConsultingAgreements_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MonthlyPaymentUnderConsultingAgreements_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MonthlyPaymentUnderConsultingAgreements_2" xml:lang="en-US" id="label_ormp_MonthlyPaymentUnderConsultingAgreements_2">Monthly payment under Consulting Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:to="label_ormp_MonthlyPaymentUnderConsultingAgreements_2" xlink:title="Label : ormp_MonthlyPaymentUnderConsultingAgreements to label_ormp_MonthlyPaymentUnderConsultingAgreements_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AnnualPaymentUnderConsultingAgreements" xlink:label="ormp_AnnualPaymentUnderConsultingAgreements" xlink:title="ormp_AnnualPaymentUnderConsultingAgreements" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AnnualPaymentUnderConsultingAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_AnnualPaymentUnderConsultingAgreements" xml:lang="en-US" id="label_ormp_AnnualPaymentUnderConsultingAgreements">Annual payment to be made under the consulting agreements to the individuals.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AnnualPaymentUnderConsultingAgreements" xlink:to="label_ormp_AnnualPaymentUnderConsultingAgreements" xlink:title="Label : ormp_AnnualPaymentUnderConsultingAgreements to label_ormp_AnnualPaymentUnderConsultingAgreements" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AnnualPaymentUnderConsultingAgreements_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_AnnualPaymentUnderConsultingAgreements_1" xml:lang="en-US" id="label_ormp_AnnualPaymentUnderConsultingAgreements_1">Annual Payment under Consulting Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AnnualPaymentUnderConsultingAgreements" xlink:to="label_ormp_AnnualPaymentUnderConsultingAgreements_1" xlink:title="Label : ormp_AnnualPaymentUnderConsultingAgreements to label_ormp_AnnualPaymentUnderConsultingAgreements_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AnnualPaymentUnderConsultingAgreements_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_AnnualPaymentUnderConsultingAgreements_2" xml:lang="en-US" id="label_ormp_AnnualPaymentUnderConsultingAgreements_2">Annual payment under Consulting Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AnnualPaymentUnderConsultingAgreements" xlink:to="label_ormp_AnnualPaymentUnderConsultingAgreements_2" xlink:title="Label : ormp_AnnualPaymentUnderConsultingAgreements to label_ormp_AnnualPaymentUnderConsultingAgreements_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KnryMember" xlink:label="ormp_KnryMember" xlink:title="ormp_KnryMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_KnryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_KnryMember" xml:lang="en-US" id="label_ormp_KnryMember">KNRY [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_KnryMember" xlink:to="label_ormp_KnryMember" xlink:title="Label : ormp_KnryMember to label_ormp_KnryMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_KnryMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_KnryMember_1" xml:lang="en-US" id="label_ormp_KnryMember_1">KNRY [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_KnryMember" xlink:to="label_ormp_KnryMember_1" xlink:title="Label : ormp_KnryMember to label_ormp_KnryMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:title="dei_CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_CurrentFiscalYearEndDate" xml:lang="en-US" id="label_dei_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="label_dei_CurrentFiscalYearEndDate" xlink:title="Label : dei_CurrentFiscalYearEndDate to label_dei_CurrentFiscalYearEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_CurrentFiscalYearEndDate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_CurrentFiscalYearEndDate_1" xml:lang="en-US" id="label_dei_CurrentFiscalYearEndDate_1">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="label_dei_CurrentFiscalYearEndDate_1" xlink:title="Label : dei_CurrentFiscalYearEndDate to label_dei_CurrentFiscalYearEndDate_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefMedicalAndTechnologyOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ChiefMedicalAndTechnologyOfficerMember" xml:lang="en-US" id="label_ormp_ChiefMedicalAndTechnologyOfficerMember">Chief Medical And Technology Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:to="label_ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="Label : ormp_ChiefMedicalAndTechnologyOfficerMember to label_ormp_ChiefMedicalAndTechnologyOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefMedicalAndTechnologyOfficerMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ChiefMedicalAndTechnologyOfficerMember_1" xml:lang="en-US" id="label_ormp_ChiefMedicalAndTechnologyOfficerMember_1">Chief Medical and Technology Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:to="label_ormp_ChiefMedicalAndTechnologyOfficerMember_1" xlink:title="Label : ormp_ChiefMedicalAndTechnologyOfficerMember to label_ormp_ChiefMedicalAndTechnologyOfficerMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefMedicalAndTechnologyOfficerMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ChiefMedicalAndTechnologyOfficerMember_2" xml:lang="en-US" id="label_ormp_ChiefMedicalAndTechnologyOfficerMember_2">Miriam Kidron [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:to="label_ormp_ChiefMedicalAndTechnologyOfficerMember_2" xlink:title="Label : ormp_ChiefMedicalAndTechnologyOfficerMember to label_ormp_ChiefMedicalAndTechnologyOfficerMember_2" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ChiefMedicalAndTechnologyOfficerMember_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_ormp_ChiefMedicalAndTechnologyOfficerMember_3" xml:lang="en-US" id="label_ormp_ChiefMedicalAndTechnologyOfficerMember_3">CTO [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:to="label_ormp_ChiefMedicalAndTechnologyOfficerMember_3" xlink:title="Label : ormp_ChiefMedicalAndTechnologyOfficerMember to label_ormp_ChiefMedicalAndTechnologyOfficerMember_3" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:label="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:title="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xml:lang="en-US" id="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock">Tabular disclosure of related party balances. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:to="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:title="Label : ormp_ScheduleOfRelatedPartyBalancesTableTextBlock to label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_1" xml:lang="en-US" id="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_1">Schedule of Related Party Balances [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:to="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_1" xlink:title="Label : ormp_ScheduleOfRelatedPartyBalancesTableTextBlock to label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_2" xml:lang="en-US" id="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_2">Schedule of Balances with Related Parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:to="label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_2" xlink:title="Label : ormp_ScheduleOfRelatedPartyBalancesTableTextBlock to label_ormp_ScheduleOfRelatedPartyBalancesTableTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CarAndCashBonus" xlink:label="ormp_CarAndCashBonus" xlink:title="ormp_CarAndCashBonus" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CarAndCashBonus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_CarAndCashBonus" xml:lang="en-US" id="label_ormp_CarAndCashBonus">Car and cash bonus granted during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CarAndCashBonus" xlink:to="label_ormp_CarAndCashBonus" xlink:title="Label : ormp_CarAndCashBonus to label_ormp_CarAndCashBonus" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CarAndCashBonus_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_CarAndCashBonus_1" xml:lang="en-US" id="label_ormp_CarAndCashBonus_1">Car And Cash Bonus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CarAndCashBonus" xlink:to="label_ormp_CarAndCashBonus_1" xlink:title="Label : ormp_CarAndCashBonus to label_ormp_CarAndCashBonus_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CarAndCashBonus_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_CarAndCashBonus_2" xml:lang="en-US" id="label_ormp_CarAndCashBonus_2">Car and cash bonus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CarAndCashBonus" xlink:to="label_ormp_CarAndCashBonus_2" xlink:title="Label : ormp_CarAndCashBonus to label_ormp_CarAndCashBonus_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentInterestRateRangeStart" xlink:label="invest_InvestmentInterestRateRangeStart" xlink:title="invest_InvestmentInterestRateRangeStart" />
    <link:label xlink:type="resource" xlink:label="label_invest_InvestmentInterestRateRangeStart" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_invest_InvestmentInterestRateRangeStart" xml:lang="en-US" id="label_invest_InvestmentInterestRateRangeStart">Investment Interest Rate Range Start</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentInterestRateRangeStart" xlink:to="label_invest_InvestmentInterestRateRangeStart" xlink:title="Label : invest_InvestmentInterestRateRangeStart to label_invest_InvestmentInterestRateRangeStart" />
    <link:label xlink:type="resource" xlink:label="label_invest_InvestmentInterestRateRangeStart_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_invest_InvestmentInterestRateRangeStart_1" xml:lang="en-US" id="label_invest_InvestmentInterestRateRangeStart_1">Long-term bank deposit interest rate, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentInterestRateRangeStart" xlink:to="label_invest_InvestmentInterestRateRangeStart_1" xlink:title="Label : invest_InvestmentInterestRateRangeStart to label_invest_InvestmentInterestRateRangeStart_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CashBonus" xlink:label="ormp_CashBonus" xlink:title="ormp_CashBonus" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CashBonus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_CashBonus" xml:lang="en-US" id="label_ormp_CashBonus">Cash bonus granted during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CashBonus" xlink:to="label_ormp_CashBonus" xlink:title="Label : ormp_CashBonus to label_ormp_CashBonus" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CashBonus_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_CashBonus_1" xml:lang="en-US" id="label_ormp_CashBonus_1">Cash Bonus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CashBonus" xlink:to="label_ormp_CashBonus_1" xlink:title="Label : ormp_CashBonus to label_ormp_CashBonus_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CashBonus_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_CashBonus_2" xml:lang="en-US" id="label_ormp_CashBonus_2">Cash bonus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CashBonus" xlink:to="label_ormp_CashBonus_2" xlink:title="Label : ormp_CashBonus to label_ormp_CashBonus_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentInterestRateRangeEnd" xlink:label="invest_InvestmentInterestRateRangeEnd" xlink:title="invest_InvestmentInterestRateRangeEnd" />
    <link:label xlink:type="resource" xlink:label="label_invest_InvestmentInterestRateRangeEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_invest_InvestmentInterestRateRangeEnd" xml:lang="en-US" id="label_invest_InvestmentInterestRateRangeEnd">Investment Interest Rate Range End</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentInterestRateRangeEnd" xlink:to="label_invest_InvestmentInterestRateRangeEnd" xlink:title="Label : invest_InvestmentInterestRateRangeEnd to label_invest_InvestmentInterestRateRangeEnd" />
    <link:label xlink:type="resource" xlink:label="label_invest_InvestmentInterestRateRangeEnd_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_invest_InvestmentInterestRateRangeEnd_1" xml:lang="en-US" id="label_invest_InvestmentInterestRateRangeEnd_1">Long-term bank deposit interest rate, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="invest_InvestmentInterestRateRangeEnd" xlink:to="label_invest_InvestmentInterestRateRangeEnd_1" xlink:title="Label : invest_InvestmentInterestRateRangeEnd to label_invest_InvestmentInterestRateRangeEnd_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_TemporaryIncreasePaymentPerMonth" xlink:label="ormp_TemporaryIncreasePaymentPerMonth" xlink:title="ormp_TemporaryIncreasePaymentPerMonth" />
    <link:label xlink:type="resource" xlink:label="label_ormp_TemporaryIncreasePaymentPerMonth" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_TemporaryIncreasePaymentPerMonth" xml:lang="en-US" id="label_ormp_TemporaryIncreasePaymentPerMonth">Amount of temporary increase in compensation of individual per month for a specific period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_TemporaryIncreasePaymentPerMonth" xlink:to="label_ormp_TemporaryIncreasePaymentPerMonth" xlink:title="Label : ormp_TemporaryIncreasePaymentPerMonth to label_ormp_TemporaryIncreasePaymentPerMonth" />
    <link:label xlink:type="resource" xlink:label="label_ormp_TemporaryIncreasePaymentPerMonth_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_TemporaryIncreasePaymentPerMonth_1" xml:lang="en-US" id="label_ormp_TemporaryIncreasePaymentPerMonth_1">Temporary Increase Payment Per Month</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_TemporaryIncreasePaymentPerMonth" xlink:to="label_ormp_TemporaryIncreasePaymentPerMonth_1" xlink:title="Label : ormp_TemporaryIncreasePaymentPerMonth to label_ormp_TemporaryIncreasePaymentPerMonth_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_TemporaryIncreasePaymentPerMonth_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_TemporaryIncreasePaymentPerMonth_2" xml:lang="en-US" id="label_ormp_TemporaryIncreasePaymentPerMonth_2">Temporary increase in compensation per month for a specific period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_TemporaryIncreasePaymentPerMonth" xlink:to="label_ormp_TemporaryIncreasePaymentPerMonth_2" xlink:title="Label : ormp_TemporaryIncreasePaymentPerMonth to label_ormp_TemporaryIncreasePaymentPerMonth_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExchangeOfWarrants" xlink:label="ormp_ExchangeOfWarrants" xlink:title="ormp_ExchangeOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExchangeOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ExchangeOfWarrants" xml:lang="en-US" id="label_ormp_ExchangeOfWarrants">Exchange of warrants during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExchangeOfWarrants" xlink:to="label_ormp_ExchangeOfWarrants" xlink:title="Label : ormp_ExchangeOfWarrants to label_ormp_ExchangeOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExchangeOfWarrants_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ExchangeOfWarrants_1" xml:lang="en-US" id="label_ormp_ExchangeOfWarrants_1">Exchange Of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExchangeOfWarrants" xlink:to="label_ormp_ExchangeOfWarrants_1" xlink:title="Label : ormp_ExchangeOfWarrants to label_ormp_ExchangeOfWarrants_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExchangeOfWarrants_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ExchangeOfWarrants_2" xml:lang="en-US" id="label_ormp_ExchangeOfWarrants_2">Exchange of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExchangeOfWarrants" xlink:to="label_ormp_ExchangeOfWarrants_2" xlink:title="Label : ormp_ExchangeOfWarrants to label_ormp_ExchangeOfWarrants_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:label="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:title="ormp_AmendedAndRestated2008StockIncentivePlanMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_AmendedAndRestated2008StockIncentivePlanMember" xml:lang="en-US" id="label_ormp_AmendedAndRestated2008StockIncentivePlanMember">Amended and Restated 2008 Stock Incentive Plan [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:to="label_ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:title="Label : ormp_AmendedAndRestated2008StockIncentivePlanMember to label_ormp_AmendedAndRestated2008StockIncentivePlanMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_1" xml:lang="en-US" id="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_1">Amended and Restated 2008 Stock Incentive Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:to="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_1" xlink:title="Label : ormp_AmendedAndRestated2008StockIncentivePlanMember to label_ormp_AmendedAndRestated2008StockIncentivePlanMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_2" xml:lang="en-US" id="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_2">Amended and Restated 2008 Stock Incentive Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:to="label_ormp_AmendedAndRestated2008StockIncentivePlanMember_2" xlink:title="Label : ormp_AmendedAndRestated2008StockIncentivePlanMember to label_ormp_AmendedAndRestated2008StockIncentivePlanMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AwardTypeAxis" xml:lang="en-US" id="label_us-gaap_AwardTypeAxis">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="label_us-gaap_AwardTypeAxis" xlink:title="Label : us-gaap_AwardTypeAxis to label_us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeeOneMember" xlink:label="ormp_SubsidiaryEmployeeOneMember" xlink:title="ormp_SubsidiaryEmployeeOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SubsidiaryEmployeeOneMember" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeeOneMember">Subsidiary Employee One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeeOneMember" xlink:to="label_ormp_SubsidiaryEmployeeOneMember" xlink:title="Label : ormp_SubsidiaryEmployeeOneMember to label_ormp_SubsidiaryEmployeeOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeeOneMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SubsidiaryEmployeeOneMember_1" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeeOneMember_1">Subsidiary Employee One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeeOneMember" xlink:to="label_ormp_SubsidiaryEmployeeOneMember_1" xlink:title="Label : ormp_SubsidiaryEmployeeOneMember to label_ormp_SubsidiaryEmployeeOneMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeeOneMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SubsidiaryEmployeeOneMember_2" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeeOneMember_2">Subsidiary Employee One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeeOneMember" xlink:to="label_ormp_SubsidiaryEmployeeOneMember_2" xlink:title="Label : ormp_SubsidiaryEmployeeOneMember to label_ormp_SubsidiaryEmployeeOneMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeeTwoMember" xlink:label="ormp_SubsidiaryEmployeeTwoMember" xlink:title="ormp_SubsidiaryEmployeeTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SubsidiaryEmployeeTwoMember" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeeTwoMember">Subsidiary Employee Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeeTwoMember" xlink:to="label_ormp_SubsidiaryEmployeeTwoMember" xlink:title="Label : ormp_SubsidiaryEmployeeTwoMember to label_ormp_SubsidiaryEmployeeTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeeTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SubsidiaryEmployeeTwoMember_1" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeeTwoMember_1">Subsidiary Employee Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeeTwoMember" xlink:to="label_ormp_SubsidiaryEmployeeTwoMember_1" xlink:title="Label : ormp_SubsidiaryEmployeeTwoMember to label_ormp_SubsidiaryEmployeeTwoMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeeTwoMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SubsidiaryEmployeeTwoMember_2" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeeTwoMember_2">Subsidiary Employee Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeeTwoMember" xlink:to="label_ormp_SubsidiaryEmployeeTwoMember_2" xlink:title="Label : ormp_SubsidiaryEmployeeTwoMember to label_ormp_SubsidiaryEmployeeTwoMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationInstallmentVestingShares" xlink:label="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:title="ormp_ShareBasedCompensationInstallmentVestingShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationInstallmentVestingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationInstallmentVestingShares" xml:lang="en-US" id="label_ormp_ShareBasedCompensationInstallmentVestingShares">Number of shares that vest in each installment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:to="label_ormp_ShareBasedCompensationInstallmentVestingShares" xlink:title="Label : ormp_ShareBasedCompensationInstallmentVestingShares to label_ormp_ShareBasedCompensationInstallmentVestingShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationInstallmentVestingShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationInstallmentVestingShares_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationInstallmentVestingShares_1">Share Based Compensation Installment Vesting Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:to="label_ormp_ShareBasedCompensationInstallmentVestingShares_1" xlink:title="Label : ormp_ShareBasedCompensationInstallmentVestingShares to label_ormp_ShareBasedCompensationInstallmentVestingShares_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationInstallmentVestingShares_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationInstallmentVestingShares_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationInstallmentVestingShares_2">Shares per installment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:to="label_ormp_ShareBasedCompensationInstallmentVestingShares_2" xlink:title="Label : ormp_ShareBasedCompensationInstallmentVestingShares to label_ormp_ShareBasedCompensationInstallmentVestingShares_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LossPerCommonShareAbstract" xlink:label="ormp_LossPerCommonShareAbstract" xlink:title="ormp_LossPerCommonShareAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LossPerCommonShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_LossPerCommonShareAbstract" xml:lang="en-US" id="label_ormp_LossPerCommonShareAbstract">Loss Per Common Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LossPerCommonShareAbstract" xlink:to="label_ormp_LossPerCommonShareAbstract" xlink:title="Label : ormp_LossPerCommonShareAbstract to label_ormp_LossPerCommonShareAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LossPerCommonShareAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_LossPerCommonShareAbstract_1" xml:lang="en-US" id="label_ormp_LossPerCommonShareAbstract_1">Loss per common share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LossPerCommonShareAbstract" xlink:to="label_ormp_LossPerCommonShareAbstract_1" xlink:title="Label : ormp_LossPerCommonShareAbstract to label_ormp_LossPerCommonShareAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:title="dei_DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentPeriodEndDate" xml:lang="en-US" id="label_dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="label_dei_DocumentPeriodEndDate" xlink:title="Label : dei_DocumentPeriodEndDate to label_dei_DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentPeriodEndDate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_DocumentPeriodEndDate_1" xml:lang="en-US" id="label_dei_DocumentPeriodEndDate_1">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="label_dei_DocumentPeriodEndDate_1" xlink:title="Label : dei_DocumentPeriodEndDate to label_dei_DocumentPeriodEndDate_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionsAndWarrantsMember" xlink:label="ormp_StockOptionsAndWarrantsMember" xlink:title="ormp_StockOptionsAndWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionsAndWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockOptionsAndWarrantsMember" xml:lang="en-US" id="label_ormp_StockOptionsAndWarrantsMember">Stock Options And Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionsAndWarrantsMember" xlink:to="label_ormp_StockOptionsAndWarrantsMember" xlink:title="Label : ormp_StockOptionsAndWarrantsMember to label_ormp_StockOptionsAndWarrantsMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionsAndWarrantsMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockOptionsAndWarrantsMember_1" xml:lang="en-US" id="label_ormp_StockOptionsAndWarrantsMember_1">Stock Options and Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionsAndWarrantsMember" xlink:to="label_ormp_StockOptionsAndWarrantsMember_1" xlink:title="Label : ormp_StockOptionsAndWarrantsMember to label_ormp_StockOptionsAndWarrantsMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfRestrictedCashTable" xlink:label="ormp_ScheduleOfRestrictedCashTable" xlink:title="ormp_ScheduleOfRestrictedCashTable" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfRestrictedCashTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ScheduleOfRestrictedCashTable" xml:lang="en-US" id="label_ormp_ScheduleOfRestrictedCashTable">Schedule Of Restricted Cash [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfRestrictedCashTable" xlink:to="label_ormp_ScheduleOfRestrictedCashTable" xlink:title="Label : ormp_ScheduleOfRestrictedCashTable to label_ormp_ScheduleOfRestrictedCashTable" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfRestrictedCashTable_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ScheduleOfRestrictedCashTable_1" xml:lang="en-US" id="label_ormp_ScheduleOfRestrictedCashTable_1">Schedule of Restricted Cash [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfRestrictedCashTable" xlink:to="label_ormp_ScheduleOfRestrictedCashTable_1" xlink:title="Label : ormp_ScheduleOfRestrictedCashTable to label_ormp_ScheduleOfRestrictedCashTable_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAndRightsDisclosureTextBlock" xlink:label="ormp_WarrantsAndRightsDisclosureTextBlock" xlink:title="ormp_WarrantsAndRightsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAndRightsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsAndRightsDisclosureTextBlock" xml:lang="en-US" id="label_ormp_WarrantsAndRightsDisclosureTextBlock">Warrants And Rights Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAndRightsDisclosureTextBlock" xlink:to="label_ormp_WarrantsAndRightsDisclosureTextBlock" xlink:title="Label : ormp_WarrantsAndRightsDisclosureTextBlock to label_ormp_WarrantsAndRightsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAndRightsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsAndRightsDisclosureTextBlock_1" xml:lang="en-US" id="label_ormp_WarrantsAndRightsDisclosureTextBlock_1">Warrants And Rights Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAndRightsDisclosureTextBlock" xlink:to="label_ormp_WarrantsAndRightsDisclosureTextBlock_1" xlink:title="Label : ormp_WarrantsAndRightsDisclosureTextBlock to label_ormp_WarrantsAndRightsDisclosureTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAndRightsDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantsAndRightsDisclosureTextBlock_2" xml:lang="en-US" id="label_ormp_WarrantsAndRightsDisclosureTextBlock_2">WARRANTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAndRightsDisclosureTextBlock" xlink:to="label_ormp_WarrantsAndRightsDisclosureTextBlock_2" xlink:title="Label : ormp_WarrantsAndRightsDisclosureTextBlock to label_ormp_WarrantsAndRightsDisclosureTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ForeignInterestBearingDepositsMember" xlink:label="ormp_ForeignInterestBearingDepositsMember" xlink:title="ormp_ForeignInterestBearingDepositsMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ForeignInterestBearingDepositsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ForeignInterestBearingDepositsMember" xml:lang="en-US" id="label_ormp_ForeignInterestBearingDepositsMember">Foreign Interest-bearing Deposits [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ForeignInterestBearingDepositsMember" xlink:to="label_ormp_ForeignInterestBearingDepositsMember" xlink:title="Label : ormp_ForeignInterestBearingDepositsMember to label_ormp_ForeignInterestBearingDepositsMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ForeignInterestBearingDepositsMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ForeignInterestBearingDepositsMember_1" xml:lang="en-US" id="label_ormp_ForeignInterestBearingDepositsMember_1">Foreign Interest Bearing Deposits [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ForeignInterestBearingDepositsMember" xlink:to="label_ormp_ForeignInterestBearingDepositsMember_1" xlink:title="Label : ormp_ForeignInterestBearingDepositsMember to label_ormp_ForeignInterestBearingDepositsMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ForeignInterestBearingDepositsMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ForeignInterestBearingDepositsMember_2" xml:lang="en-US" id="label_ormp_ForeignInterestBearingDepositsMember_2">NIS deposits [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ForeignInterestBearingDepositsMember" xlink:to="label_ormp_ForeignInterestBearingDepositsMember_2" xlink:title="Label : ormp_ForeignInterestBearingDepositsMember to label_ormp_ForeignInterestBearingDepositsMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShortTermInvestmentsLineItems" xlink:label="ormp_ShortTermInvestmentsLineItems" xlink:title="ormp_ShortTermInvestmentsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShortTermInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShortTermInvestmentsLineItems" xml:lang="en-US" id="label_ormp_ShortTermInvestmentsLineItems">Short Term Investments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShortTermInvestmentsLineItems" xlink:to="label_ormp_ShortTermInvestmentsLineItems" xlink:title="Label : ormp_ShortTermInvestmentsLineItems to label_ormp_ShortTermInvestmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShortTermInvestmentWithBanksInterestRate" xlink:label="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:title="ormp_ShortTermInvestmentWithBanksInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShortTermInvestmentWithBanksInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShortTermInvestmentWithBanksInterestRate" xml:lang="en-US" id="label_ormp_ShortTermInvestmentWithBanksInterestRate">Interest rate for short term investments with banks as of the balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:to="label_ormp_ShortTermInvestmentWithBanksInterestRate" xlink:title="Label : ormp_ShortTermInvestmentWithBanksInterestRate to label_ormp_ShortTermInvestmentWithBanksInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShortTermInvestmentWithBanksInterestRate_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShortTermInvestmentWithBanksInterestRate_1" xml:lang="en-US" id="label_ormp_ShortTermInvestmentWithBanksInterestRate_1">Short Term Investment With Banks Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:to="label_ormp_ShortTermInvestmentWithBanksInterestRate_1" xlink:title="Label : ormp_ShortTermInvestmentWithBanksInterestRate to label_ormp_ShortTermInvestmentWithBanksInterestRate_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShortTermInvestmentWithBanksInterestRate_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShortTermInvestmentWithBanksInterestRate_2" xml:lang="en-US" id="label_ormp_ShortTermInvestmentWithBanksInterestRate_2">Interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:to="label_ormp_ShortTermInvestmentWithBanksInterestRate_2" xlink:title="Label : ormp_ShortTermInvestmentWithBanksInterestRate to label_ormp_ShortTermInvestmentWithBanksInterestRate_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeeRightsUponRetirementAbstract" xlink:label="ormp_EmployeeRightsUponRetirementAbstract" xlink:title="ormp_EmployeeRightsUponRetirementAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EmployeeRightsUponRetirementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_EmployeeRightsUponRetirementAbstract" xml:lang="en-US" id="label_ormp_EmployeeRightsUponRetirementAbstract">EMPLOYEE RIGHTS UPON RETIREMENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EmployeeRightsUponRetirementAbstract" xlink:to="label_ormp_EmployeeRightsUponRetirementAbstract" xlink:title="Label : ormp_EmployeeRightsUponRetirementAbstract to label_ormp_EmployeeRightsUponRetirementAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:label="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:title="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xml:lang="en-US" id="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature">Discount on convertible note related to beneficial conversion feature.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:to="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:title="Label : ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature to label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_1" xml:lang="en-US" id="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_1">Discount On Convertible Note Related To Beneficial Conversion Feature</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:to="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_1" xlink:title="Label : ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature to label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_2" xml:lang="en-US" id="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_2">Discount on convertible note related to beneficial conversion feature</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:to="label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_2" xlink:title="Label : ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature to label_ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DocumentAndEntityInformationAbstract" xlink:label="ormp_DocumentAndEntityInformationAbstract" xlink:title="ormp_DocumentAndEntityInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_DocumentAndEntityInformationAbstract" xml:lang="en-US" id="label_ormp_DocumentAndEntityInformationAbstract">Document and Entity Information [Abstract].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="label_ormp_DocumentAndEntityInformationAbstract" xlink:title="Label : ormp_DocumentAndEntityInformationAbstract to label_ormp_DocumentAndEntityInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DocumentAndEntityInformationAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DocumentAndEntityInformationAbstract_1" xml:lang="en-US" id="label_ormp_DocumentAndEntityInformationAbstract_1">Document and Entity Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="label_ormp_DocumentAndEntityInformationAbstract_1" xlink:title="Label : ormp_DocumentAndEntityInformationAbstract to label_ormp_DocumentAndEntityInformationAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:title="dei_EntityDomain" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityDomain" xml:lang="en-US" id="label_dei_EntityDomain">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="label_dei_EntityDomain" xlink:title="Label : dei_EntityDomain to label_dei_EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FindersFeeShares" xlink:label="ormp_FindersFeeShares" xlink:title="ormp_FindersFeeShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FindersFeeShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_FindersFeeShares" xml:lang="en-US" id="label_ormp_FindersFeeShares">Number of shares issued for finders' fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FindersFeeShares" xlink:to="label_ormp_FindersFeeShares" xlink:title="Label : ormp_FindersFeeShares to label_ormp_FindersFeeShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FindersFeeShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_FindersFeeShares_1" xml:lang="en-US" id="label_ormp_FindersFeeShares_1">Finders Fee Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FindersFeeShares" xlink:to="label_ormp_FindersFeeShares_1" xlink:title="Label : ormp_FindersFeeShares to label_ormp_FindersFeeShares_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FindersFeeShares_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_FindersFeeShares_2" xml:lang="en-US" id="label_ormp_FindersFeeShares_2">Shares issued for finders' fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FindersFeeShares" xlink:to="label_ormp_FindersFeeShares_2" xlink:title="Label : ormp_FindersFeeShares to label_ormp_FindersFeeShares_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementMember" xlink:label="ormp_MasterServiceAgreementMember" xlink:title="ormp_MasterServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MasterServiceAgreementMember" xml:lang="en-US" id="label_ormp_MasterServiceAgreementMember">Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementMember" xlink:to="label_ormp_MasterServiceAgreementMember" xlink:title="Label : ormp_MasterServiceAgreementMember to label_ormp_MasterServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MasterServiceAgreementMember_1" xml:lang="en-US" id="label_ormp_MasterServiceAgreementMember_1">Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementMember" xlink:to="label_ormp_MasterServiceAgreementMember_1" xlink:title="Label : ormp_MasterServiceAgreementMember to label_ormp_MasterServiceAgreementMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MasterServiceAgreementMember_2" xml:lang="en-US" id="label_ormp_MasterServiceAgreementMember_2">First Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementMember" xlink:to="label_ormp_MasterServiceAgreementMember_2" xlink:title="Label : ormp_MasterServiceAgreementMember to label_ormp_MasterServiceAgreementMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:label="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:title="ormp_ProceedsFromStockOptionsAndWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised" xml:lang="en-US" id="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised">The cash inflow associated with the amount received from holders exercising their stock options and warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:to="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:title="Label : ormp_ProceedsFromStockOptionsAndWarrantsExercised to label_ormp_ProceedsFromStockOptionsAndWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_1" xml:lang="en-US" id="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_1">Proceeds From Stock Options And Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:to="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_1" xlink:title="Label : ormp_ProceedsFromStockOptionsAndWarrantsExercised to label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_2" xml:lang="en-US" id="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_2">Proceeds from exercise of warrants and options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:to="label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_2" xlink:title="Label : ormp_ProceedsFromStockOptionsAndWarrantsExercised to label_ormp_ProceedsFromStockOptionsAndWarrantsExercised_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:label="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:title="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xml:lang="en-US" id="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment">Number of options to vest each vesting installment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:to="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:title="Label : ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment to label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_1" xml:lang="en-US" id="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_1">Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Options Vesting Each Installment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:to="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_1" xlink:title="Label : ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment to label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_2" xml:lang="en-US" id="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_2">Number of options to vest each installment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:to="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_2" xlink:title="Label : ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment to label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:label="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:title="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xml:lang="en-US" id="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods">The number of vesting periods for options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:to="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:title="Label : ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods to label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_1" xml:lang="en-US" id="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_1">Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Vesting Periods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:to="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_1" xlink:title="Label : ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods to label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_2" xml:lang="en-US" id="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_2">Number of vesting installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:to="label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_2" xlink:title="Label : ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods to label_ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesToBeIssuedForServicesRendered" xlink:label="ormp_SharesToBeIssuedForServicesRendered" xlink:title="ormp_SharesToBeIssuedForServicesRendered" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesToBeIssuedForServicesRendered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SharesToBeIssuedForServicesRendered" xml:lang="en-US" id="label_ormp_SharesToBeIssuedForServicesRendered">Cash flow effect of shares to be issued for services rendered.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesToBeIssuedForServicesRendered" xlink:to="label_ormp_SharesToBeIssuedForServicesRendered" xlink:title="Label : ormp_SharesToBeIssuedForServicesRendered to label_ormp_SharesToBeIssuedForServicesRendered" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesToBeIssuedForServicesRendered_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SharesToBeIssuedForServicesRendered_1" xml:lang="en-US" id="label_ormp_SharesToBeIssuedForServicesRendered_1">Shares To Be Issued For Services Rendered</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesToBeIssuedForServicesRendered" xlink:to="label_ormp_SharesToBeIssuedForServicesRendered_1" xlink:title="Label : ormp_SharesToBeIssuedForServicesRendered to label_ormp_SharesToBeIssuedForServicesRendered_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesToBeIssuedForServicesRendered_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SharesToBeIssuedForServicesRendered_2" xml:lang="en-US" id="label_ormp_SharesToBeIssuedForServicesRendered_2">Shares to be issued for services rendered</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesToBeIssuedForServicesRendered" xlink:to="label_ormp_SharesToBeIssuedForServicesRendered_2" xlink:title="Label : ormp_SharesToBeIssuedForServicesRendered to label_ormp_SharesToBeIssuedForServicesRendered_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee">Number of shares issued to investor for liquidation damage fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:to="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee to label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_1" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_1">Stock Issued During Period Shares Liquidation Damage Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:to="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_1" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee to label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_2" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_2">SHARES ISSUED (see notes 7f), shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:to="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_2" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee to label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_2" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_3" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_3">Number of shares issued for liquidation damage fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:to="label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_3" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee to label_ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee_3" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:label="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:title="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities">Shares issued during the period for marketable securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:to="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesMarketableSecurities to label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_1" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_1">Stock Issued During Period Shares Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:to="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_1" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesMarketableSecurities to label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_2" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_2">SHARES ISSUED FOR MARKETABLE SECURITIES (see note 8b), shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:to="label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_2" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesMarketableSecurities to label_ormp_StockIssuedDuringPeriodSharesMarketableSecurities_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:label="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:title="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised">Number of shares issued during the period for the exercise of stock options and warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:to="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised to label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_1" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_1">Stock Issued During Period Shares Stock Options And Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:to="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_1" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised to label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_2" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_2">EXERCISE OF WARRANTS AND OPTIONS, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:to="label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_2" xlink:title="Label : ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised to label_ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee">Value of shares issued to investor for liquidation damage fee.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:to="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:title="Label : ormp_StockIssuedDuringPeriodValueLiquidationDamageFee to label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_1" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_1">Stock Issued During Period Value Liquidation Damage Fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:to="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_1" xlink:title="Label : ormp_StockIssuedDuringPeriodValueLiquidationDamageFee to label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_2" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_2">SHARES ISSUED (see notes 7f)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:to="label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_2" xlink:title="Label : ormp_StockIssuedDuringPeriodValueLiquidationDamageFee to label_ormp_StockIssuedDuringPeriodValueLiquidationDamageFee_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:label="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:title="ormp_StockIssuedDuringPeriodValueMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities">Shares issued during the period for marketable securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:to="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:title="Label : ormp_StockIssuedDuringPeriodValueMarketableSecurities to label_ormp_StockIssuedDuringPeriodValueMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_1" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_1">Stock Issued During Period Value Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:to="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_1" xlink:title="Label : ormp_StockIssuedDuringPeriodValueMarketableSecurities to label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_2" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_2">SHARES ISSUED FOR MARKETABLE SECURITIES (see note 8b)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:to="label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_2" xlink:title="Label : ormp_StockIssuedDuringPeriodValueMarketableSecurities to label_ormp_StockIssuedDuringPeriodValueMarketableSecurities_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:label="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:title="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised">Value of stock issued as a result of the exercise of stock options and warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:to="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:title="Label : ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised to label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_1" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_1">Stock Issued During Period Value Stock Options And Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:to="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_1" xlink:title="Label : ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised to label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_2" xml:lang="en-US" id="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_2">EXERCISE OF WARRANTS AND OPTIONS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:to="label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_2" xlink:title="Label : ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised to label_ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeesMember" xlink:label="ormp_SubsidiaryEmployeesMember" xlink:title="ormp_SubsidiaryEmployeesMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SubsidiaryEmployeesMember" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeesMember">Employees of subsidiary [member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeesMember" xlink:to="label_ormp_SubsidiaryEmployeesMember" xlink:title="Label : ormp_SubsidiaryEmployeesMember to label_ormp_SubsidiaryEmployeesMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeesMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SubsidiaryEmployeesMember_1" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeesMember_1">Subsidiary Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeesMember" xlink:to="label_ormp_SubsidiaryEmployeesMember_1" xlink:title="Label : ormp_SubsidiaryEmployeesMember to label_ormp_SubsidiaryEmployeesMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SubsidiaryEmployeesMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SubsidiaryEmployeesMember_2" xml:lang="en-US" id="label_ormp_SubsidiaryEmployeesMember_2">Subsidiary employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SubsidiaryEmployeesMember" xlink:to="label_ormp_SubsidiaryEmployeesMember_2" xlink:title="Label : ormp_SubsidiaryEmployeesMember to label_ormp_SubsidiaryEmployeesMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsExchanged" xlink:label="ormp_WarrantsExchanged" xlink:title="ormp_WarrantsExchanged" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsExchanged" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsExchanged" xml:lang="en-US" id="label_ormp_WarrantsExchanged">Cash flow associated with the exchange of warrants during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsExchanged" xlink:to="label_ormp_WarrantsExchanged" xlink:title="Label : ormp_WarrantsExchanged to label_ormp_WarrantsExchanged" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsExchanged_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsExchanged_1" xml:lang="en-US" id="label_ormp_WarrantsExchanged_1">Warrants Exchanged</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsExchanged" xlink:to="label_ormp_WarrantsExchanged_1" xlink:title="Label : ormp_WarrantsExchanged to label_ormp_WarrantsExchanged_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsExchanged_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantsExchanged_2" xml:lang="en-US" id="label_ormp_WarrantsExchanged_2">Exchange of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsExchanged" xlink:to="label_ormp_WarrantsExchanged_2" xlink:title="Label : ormp_WarrantsExchanged to label_ormp_WarrantsExchanged_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsExercised" xlink:label="ormp_WarrantsExercised" xlink:title="ormp_WarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsExercised" xml:lang="en-US" id="label_ormp_WarrantsExercised">Number of warrants exercised during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsExercised" xlink:to="label_ormp_WarrantsExercised" xlink:title="Label : ormp_WarrantsExercised to label_ormp_WarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsExercised_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsExercised_1" xml:lang="en-US" id="label_ormp_WarrantsExercised_1">Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsExercised" xlink:to="label_ormp_WarrantsExercised_1" xlink:title="Label : ormp_WarrantsExercised to label_ormp_WarrantsExercised_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsExercised_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_ormp_WarrantsExercised_2" xml:lang="en-US" id="label_ormp_WarrantsExercised_2">Number of warrants exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsExercised" xlink:to="label_ormp_WarrantsExercised_2" xlink:title="Label : ormp_WarrantsExercised to label_ormp_WarrantsExercised_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SeverancePayInsuranceDeposits" xlink:label="ormp_SeverancePayInsuranceDeposits" xlink:title="ormp_SeverancePayInsuranceDeposits" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SeverancePayInsuranceDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SeverancePayInsuranceDeposits" xml:lang="en-US" id="label_ormp_SeverancePayInsuranceDeposits">The amount of deposits into an insurance company during the period for severance pay.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SeverancePayInsuranceDeposits" xlink:to="label_ormp_SeverancePayInsuranceDeposits" xlink:title="Label : ormp_SeverancePayInsuranceDeposits to label_ormp_SeverancePayInsuranceDeposits" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SeverancePayInsuranceDeposits_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SeverancePayInsuranceDeposits_1" xml:lang="en-US" id="label_ormp_SeverancePayInsuranceDeposits_1">Severance Pay Insurance Deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SeverancePayInsuranceDeposits" xlink:to="label_ormp_SeverancePayInsuranceDeposits_1" xlink:title="Label : ormp_SeverancePayInsuranceDeposits to label_ormp_SeverancePayInsuranceDeposits_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SeverancePayInsuranceDeposits_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SeverancePayInsuranceDeposits_2" xml:lang="en-US" id="label_ormp_SeverancePayInsuranceDeposits_2">Severance pay insurance deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SeverancePayInsuranceDeposits" xlink:to="label_ormp_SeverancePayInsuranceDeposits_2" xlink:title="Label : ormp_SeverancePayInsuranceDeposits to label_ormp_SeverancePayInsuranceDeposits_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:label="ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:title="ormp_SeverancePayInsuranceDepositExpectedAmount" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SeverancePayInsuranceDepositExpectedAmount" xml:lang="en-US" id="label_ormp_SeverancePayInsuranceDepositExpectedAmount">The amount of insurance deposits with respect to severance obligations expected to be incurred in the period following the balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:to="label_ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:title="Label : ormp_SeverancePayInsuranceDepositExpectedAmount to label_ormp_SeverancePayInsuranceDepositExpectedAmount" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SeverancePayInsuranceDepositExpectedAmount_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SeverancePayInsuranceDepositExpectedAmount_1" xml:lang="en-US" id="label_ormp_SeverancePayInsuranceDepositExpectedAmount_1">Severance Pay Insurance Deposit Expected Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:to="label_ormp_SeverancePayInsuranceDepositExpectedAmount_1" xlink:title="Label : ormp_SeverancePayInsuranceDepositExpectedAmount to label_ormp_SeverancePayInsuranceDepositExpectedAmount_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SeverancePayInsuranceDepositExpectedAmount_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SeverancePayInsuranceDepositExpectedAmount_2" xml:lang="en-US" id="label_ormp_SeverancePayInsuranceDepositExpectedAmount_2">Severance pay expected deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:to="label_ormp_SeverancePayInsuranceDepositExpectedAmount_2" xlink:title="Label : ormp_SeverancePayInsuranceDepositExpectedAmount to label_ormp_SeverancePayInsuranceDepositExpectedAmount_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DefinedContributionPlanExpectedLiability" xlink:label="ormp_DefinedContributionPlanExpectedLiability" xlink:title="ormp_DefinedContributionPlanExpectedLiability" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DefinedContributionPlanExpectedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_DefinedContributionPlanExpectedLiability" xml:lang="en-US" id="label_ormp_DefinedContributionPlanExpectedLiability">The expected liability for a defined contribution plan in the period following the balance sheet date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DefinedContributionPlanExpectedLiability" xlink:to="label_ormp_DefinedContributionPlanExpectedLiability" xlink:title="Label : ormp_DefinedContributionPlanExpectedLiability to label_ormp_DefinedContributionPlanExpectedLiability" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DefinedContributionPlanExpectedLiability_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DefinedContributionPlanExpectedLiability_1" xml:lang="en-US" id="label_ormp_DefinedContributionPlanExpectedLiability_1">Defined Contribution Plan Expected Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DefinedContributionPlanExpectedLiability" xlink:to="label_ormp_DefinedContributionPlanExpectedLiability_1" xlink:title="Label : ormp_DefinedContributionPlanExpectedLiability to label_ormp_DefinedContributionPlanExpectedLiability_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DefinedContributionPlanExpectedLiability_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_DefinedContributionPlanExpectedLiability_2" xml:lang="en-US" id="label_ormp_DefinedContributionPlanExpectedLiability_2">Severance pay expected liability to Contribution Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DefinedContributionPlanExpectedLiability" xlink:to="label_ormp_DefinedContributionPlanExpectedLiability_2" xlink:title="Label : ormp_DefinedContributionPlanExpectedLiability to label_ormp_DefinedContributionPlanExpectedLiability_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeeRightsUponRetirementTextBlock" xlink:label="ormp_EmployeeRightsUponRetirementTextBlock" xlink:title="ormp_EmployeeRightsUponRetirementTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EmployeeRightsUponRetirementTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_EmployeeRightsUponRetirementTextBlock" xml:lang="en-US" id="label_ormp_EmployeeRightsUponRetirementTextBlock">The entire disclosure for employee rights upon termination.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EmployeeRightsUponRetirementTextBlock" xlink:to="label_ormp_EmployeeRightsUponRetirementTextBlock" xlink:title="Label : ormp_EmployeeRightsUponRetirementTextBlock to label_ormp_EmployeeRightsUponRetirementTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EmployeeRightsUponRetirementTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_EmployeeRightsUponRetirementTextBlock_1" xml:lang="en-US" id="label_ormp_EmployeeRightsUponRetirementTextBlock_1">Employee Rights Upon Retirement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EmployeeRightsUponRetirementTextBlock" xlink:to="label_ormp_EmployeeRightsUponRetirementTextBlock_1" xlink:title="Label : ormp_EmployeeRightsUponRetirementTextBlock to label_ormp_EmployeeRightsUponRetirementTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EmployeeRightsUponRetirementTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_EmployeeRightsUponRetirementTextBlock_2" xml:lang="en-US" id="label_ormp_EmployeeRightsUponRetirementTextBlock_2">EMPLOYEE RIGHTS UPON RETIREMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EmployeeRightsUponRetirementTextBlock" xlink:to="label_ormp_EmployeeRightsUponRetirementTextBlock_2" xlink:title="Label : ormp_EmployeeRightsUponRetirementTextBlock to label_ormp_EmployeeRightsUponRetirementTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsTable" xlink:label="ormp_WarrantsTable" xlink:title="ormp_WarrantsTable" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsTable" xml:lang="en-US" id="label_ormp_WarrantsTable">Warrants [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsTable" xlink:to="label_ormp_WarrantsTable" xlink:title="Label : ormp_WarrantsTable to label_ormp_WarrantsTable" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsTable_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsTable_1" xml:lang="en-US" id="label_ormp_WarrantsTable_1">Warrants [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsTable" xlink:to="label_ormp_WarrantsTable_1" xlink:title="Label : ormp_WarrantsTable to label_ormp_WarrantsTable_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAxis" xlink:label="ormp_WarrantsAxis" xlink:title="ormp_WarrantsAxis" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsAxis" xml:lang="en-US" id="label_ormp_WarrantsAxis">Warrants [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAxis" xlink:to="label_ormp_WarrantsAxis" xlink:title="Label : ormp_WarrantsAxis to label_ormp_WarrantsAxis" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAxis_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsAxis_1" xml:lang="en-US" id="label_ormp_WarrantsAxis_1">Warrants [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAxis" xlink:to="label_ormp_WarrantsAxis_1" xlink:title="Label : ormp_WarrantsAxis to label_ormp_WarrantsAxis_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsDomain" xlink:label="ormp_WarrantsDomain" xlink:title="ormp_WarrantsDomain" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsDomain" xml:lang="en-US" id="label_ormp_WarrantsDomain">Warrants [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsDomain" xlink:to="label_ormp_WarrantsDomain" xlink:title="Label : ormp_WarrantsDomain to label_ormp_WarrantsDomain" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsDomain_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsDomain_1" xml:lang="en-US" id="label_ormp_WarrantsDomain_1">Warrants [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsDomain" xlink:to="label_ormp_WarrantsDomain_1" xlink:title="Label : ormp_WarrantsDomain to label_ormp_WarrantsDomain_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsOneMember" xlink:label="ormp_WarrantsOneMember" xlink:title="ormp_WarrantsOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsOneMember" xml:lang="en-US" id="label_ormp_WarrantsOneMember">Warrants One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsOneMember" xlink:to="label_ormp_WarrantsOneMember" xlink:title="Label : ormp_WarrantsOneMember to label_ormp_WarrantsOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsOneMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsOneMember_1" xml:lang="en-US" id="label_ormp_WarrantsOneMember_1">Warrants One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsOneMember" xlink:to="label_ormp_WarrantsOneMember_1" xlink:title="Label : ormp_WarrantsOneMember to label_ormp_WarrantsOneMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsOneMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantsOneMember_2" xml:lang="en-US" id="label_ormp_WarrantsOneMember_2">2011 Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsOneMember" xlink:to="label_ormp_WarrantsOneMember_2" xlink:title="Label : ormp_WarrantsOneMember to label_ormp_WarrantsOneMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsTwoMember" xlink:label="ormp_WarrantsTwoMember" xlink:title="ormp_WarrantsTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsTwoMember" xml:lang="en-US" id="label_ormp_WarrantsTwoMember">Warrants Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsTwoMember" xlink:to="label_ormp_WarrantsTwoMember" xlink:title="Label : ormp_WarrantsTwoMember to label_ormp_WarrantsTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsTwoMember_1" xml:lang="en-US" id="label_ormp_WarrantsTwoMember_1">Warrants Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsTwoMember" xlink:to="label_ormp_WarrantsTwoMember_1" xlink:title="Label : ormp_WarrantsTwoMember to label_ormp_WarrantsTwoMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsTwoMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantsTwoMember_2" xml:lang="en-US" id="label_ormp_WarrantsTwoMember_2">Three Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsTwoMember" xlink:to="label_ormp_WarrantsTwoMember_2" xlink:title="Label : ormp_WarrantsTwoMember to label_ormp_WarrantsTwoMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NewWarrantMember" xlink:label="ormp_NewWarrantMember" xlink:title="ormp_NewWarrantMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NewWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_NewWarrantMember" xml:lang="en-US" id="label_ormp_NewWarrantMember">New Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NewWarrantMember" xlink:to="label_ormp_NewWarrantMember" xlink:title="Label : ormp_NewWarrantMember to label_ormp_NewWarrantMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NewWarrantMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_NewWarrantMember_1" xml:lang="en-US" id="label_ormp_NewWarrantMember_1">New Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NewWarrantMember" xlink:to="label_ormp_NewWarrantMember_1" xlink:title="Label : ormp_NewWarrantMember to label_ormp_NewWarrantMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KidronOptionMember" xlink:label="ormp_KidronOptionMember" xlink:title="ormp_KidronOptionMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_KidronOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_KidronOptionMember" xml:lang="en-US" id="label_ormp_KidronOptionMember">Kidron Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_KidronOptionMember" xlink:to="label_ormp_KidronOptionMember" xlink:title="Label : ormp_KidronOptionMember to label_ormp_KidronOptionMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_KidronOptionMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_KidronOptionMember_1" xml:lang="en-US" id="label_ormp_KidronOptionMember_1">Kidron Option [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_KidronOptionMember" xlink:to="label_ormp_KidronOptionMember_1" xlink:title="Label : ormp_KidronOptionMember to label_ormp_KidronOptionMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_KidronOptionMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_KidronOptionMember_2" xml:lang="en-US" id="label_ormp_KidronOptionMember_2">CEO Options [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_KidronOptionMember" xlink:to="label_ormp_KidronOptionMember_2" xlink:title="Label : ormp_KidronOptionMember to label_ormp_KidronOptionMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsLineItems" xlink:label="ormp_WarrantsLineItems" xlink:title="ormp_WarrantsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsLineItems" xml:lang="en-US" id="label_ormp_WarrantsLineItems">Warrants [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsLineItems" xlink:to="label_ormp_WarrantsLineItems" xlink:title="Label : ormp_WarrantsLineItems to label_ormp_WarrantsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsLineItems_1" xml:lang="en-US" id="label_ormp_WarrantsLineItems_1">Warrants [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsLineItems" xlink:to="label_ormp_WarrantsLineItems_1" xlink:title="Label : ormp_WarrantsLineItems to label_ormp_WarrantsLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsGrantedShares" xlink:label="ormp_WarrantsGrantedShares" xlink:title="ormp_WarrantsGrantedShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsGrantedShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsGrantedShares" xml:lang="en-US" id="label_ormp_WarrantsGrantedShares">Number of warrants issued during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsGrantedShares" xlink:to="label_ormp_WarrantsGrantedShares" xlink:title="Label : ormp_WarrantsGrantedShares to label_ormp_WarrantsGrantedShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsGrantedShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsGrantedShares_1" xml:lang="en-US" id="label_ormp_WarrantsGrantedShares_1">Warrants Granted Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsGrantedShares" xlink:to="label_ormp_WarrantsGrantedShares_1" xlink:title="Label : ormp_WarrantsGrantedShares to label_ormp_WarrantsGrantedShares_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsGrantedShares_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantsGrantedShares_2" xml:lang="en-US" id="label_ormp_WarrantsGrantedShares_2">Number of warrants granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsGrantedShares" xlink:to="label_ormp_WarrantsGrantedShares_2" xlink:title="Label : ormp_WarrantsGrantedShares to label_ormp_WarrantsGrantedShares_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClassOfWarrantOrRightTerm" xlink:label="ormp_ClassOfWarrantOrRightTerm" xlink:title="ormp_ClassOfWarrantOrRightTerm" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ClassOfWarrantOrRightTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ClassOfWarrantOrRightTerm" xml:lang="en-US" id="label_ormp_ClassOfWarrantOrRightTerm">The term of the warrant or right.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ClassOfWarrantOrRightTerm" xlink:to="label_ormp_ClassOfWarrantOrRightTerm" xlink:title="Label : ormp_ClassOfWarrantOrRightTerm to label_ormp_ClassOfWarrantOrRightTerm" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ClassOfWarrantOrRightTerm_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ClassOfWarrantOrRightTerm_1" xml:lang="en-US" id="label_ormp_ClassOfWarrantOrRightTerm_1">Class Of Warrant Or Right Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ClassOfWarrantOrRightTerm" xlink:to="label_ormp_ClassOfWarrantOrRightTerm_1" xlink:title="Label : ormp_ClassOfWarrantOrRightTerm to label_ormp_ClassOfWarrantOrRightTerm_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ClassOfWarrantOrRightTerm_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ClassOfWarrantOrRightTerm_2" xml:lang="en-US" id="label_ormp_ClassOfWarrantOrRightTerm_2">Warrant term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ClassOfWarrantOrRightTerm" xlink:to="label_ormp_ClassOfWarrantOrRightTerm_2" xlink:title="Label : ormp_ClassOfWarrantOrRightTerm to label_ormp_ClassOfWarrantOrRightTerm_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAndRightsExpenseRecognized" xlink:label="ormp_WarrantsAndRightsExpenseRecognized" xlink:title="ormp_WarrantsAndRightsExpenseRecognized" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAndRightsExpenseRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsAndRightsExpenseRecognized" xml:lang="en-US" id="label_ormp_WarrantsAndRightsExpenseRecognized">Financial expense from the reclassification of warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAndRightsExpenseRecognized" xlink:to="label_ormp_WarrantsAndRightsExpenseRecognized" xlink:title="Label : ormp_WarrantsAndRightsExpenseRecognized to label_ormp_WarrantsAndRightsExpenseRecognized" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAndRightsExpenseRecognized_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsAndRightsExpenseRecognized_1" xml:lang="en-US" id="label_ormp_WarrantsAndRightsExpenseRecognized_1">Warrants And Rights Expense Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAndRightsExpenseRecognized" xlink:to="label_ormp_WarrantsAndRightsExpenseRecognized_1" xlink:title="Label : ormp_WarrantsAndRightsExpenseRecognized to label_ormp_WarrantsAndRightsExpenseRecognized_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsAndRightsExpenseRecognized_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantsAndRightsExpenseRecognized_2" xml:lang="en-US" id="label_ormp_WarrantsAndRightsExpenseRecognized_2">Financial expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsAndRightsExpenseRecognized" xlink:to="label_ormp_WarrantsAndRightsExpenseRecognized_2" xlink:title="Label : ormp_WarrantsAndRightsExpenseRecognized to label_ormp_WarrantsAndRightsExpenseRecognized_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:label="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:title="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xml:lang="en-US" id="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue">Change in fair value that has taken place during the period in relation to liabilities measured at fair value and categorized within Level 3 of the fair value hierarchy.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:to="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:title="Label : ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue to label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_1" xml:lang="en-US" id="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_1">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change In Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:to="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_1" xlink:title="Label : ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue to label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_2" xml:lang="en-US" id="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_2">Changes in fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:to="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_2" xlink:title="Label : ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue to label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:label="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:title="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xml:lang="en-US" id="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants">Fair value effect of the exchange of warrants.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:to="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:title="Label : ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants to label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_1" xml:lang="en-US" id="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_1">Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Exchange Of Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:to="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_1" xlink:title="Label : ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants to label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_2" xml:lang="en-US" id="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_2">Exchange of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:to="label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_2" xlink:title="Label : ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants to label_ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:label="ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:title="ormp_WarrantLiabilityPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantLiabilityPolicyPolicyTextBlock" xml:lang="en-US" id="label_ormp_WarrantLiabilityPolicyPolicyTextBlock">Policy for warrants issued as part of a capital raise that are classified as a liability.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:to="label_ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:title="Label : ormp_WarrantLiabilityPolicyPolicyTextBlock to label_ormp_WarrantLiabilityPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_1">Warrant Liability Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:to="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_1" xlink:title="Label : ormp_WarrantLiabilityPolicyPolicyTextBlock to label_ormp_WarrantLiabilityPolicyPolicyTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_2" xml:lang="en-US" id="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_2">Warrants issued as part of capital raisings that are classified as a liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:to="label_ormp_WarrantLiabilityPolicyPolicyTextBlock_2" xlink:title="Label : ormp_WarrantLiabilityPolicyPolicyTextBlock to label_ormp_WarrantLiabilityPolicyPolicyTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:label="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:title="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xml:lang="en-US" id="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock">Disclosure of accounting policy for credit risk.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:to="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:title="Label : ormp_ConcentrationRiskCreditRiskPolicyTextBlock to label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_1" xml:lang="en-US" id="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_1">Concentration Risk Credit Risk [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:to="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_1" xlink:title="Label : ormp_ConcentrationRiskCreditRiskPolicyTextBlock to label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_2" xml:lang="en-US" id="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_2">Concentration of credit risks</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:to="label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_2" xlink:title="Label : ormp_ConcentrationRiskCreditRiskPolicyTextBlock to label_ormp_ConcentrationRiskCreditRiskPolicyTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_TaxesOnIncomeLineItems" xlink:label="ormp_TaxesOnIncomeLineItems" xlink:title="ormp_TaxesOnIncomeLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ormp_TaxesOnIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_TaxesOnIncomeLineItems" xml:lang="en-US" id="label_ormp_TaxesOnIncomeLineItems">Taxes On Income [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_TaxesOnIncomeLineItems" xlink:to="label_ormp_TaxesOnIncomeLineItems" xlink:title="Label : ormp_TaxesOnIncomeLineItems to label_ormp_TaxesOnIncomeLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ormp_TaxesOnIncomeLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_TaxesOnIncomeLineItems_1" xml:lang="en-US" id="label_ormp_TaxesOnIncomeLineItems_1">Taxes On Income [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_TaxesOnIncomeLineItems" xlink:to="label_ormp_TaxesOnIncomeLineItems_1" xlink:title="Label : ormp_TaxesOnIncomeLineItems to label_ormp_TaxesOnIncomeLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EnteraBioLtdMember" xlink:label="ormp_EnteraBioLtdMember" xlink:title="ormp_EnteraBioLtdMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EnteraBioLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_EnteraBioLtdMember" xml:lang="en-US" id="label_ormp_EnteraBioLtdMember">Represents information pertaining to Entera Bio Ltd.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EnteraBioLtdMember" xlink:to="label_ormp_EnteraBioLtdMember" xlink:title="Label : ormp_EnteraBioLtdMember to label_ormp_EnteraBioLtdMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EnteraBioLtdMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_EnteraBioLtdMember_1" xml:lang="en-US" id="label_ormp_EnteraBioLtdMember_1">Entera Bio Ltd [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EnteraBioLtdMember" xlink:to="label_ormp_EnteraBioLtdMember_1" xlink:title="Label : ormp_EnteraBioLtdMember to label_ormp_EnteraBioLtdMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EnteraBioLtdMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_EnteraBioLtdMember_2" xml:lang="en-US" id="label_ormp_EnteraBioLtdMember_2">Entera [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EnteraBioLtdMember" xlink:to="label_ormp_EnteraBioLtdMember_2" xlink:title="Label : ormp_EnteraBioLtdMember to label_ormp_EnteraBioLtdMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:label="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:title="ormp_CostMethodInvestmentsOwnershipPercentageRetained" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained" xml:lang="en-US" id="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained">The percentage of ownership of common stock or equity participation in the investee accounted for under the cost method of accounting.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:to="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:title="Label : ormp_CostMethodInvestmentsOwnershipPercentageRetained to label_ormp_CostMethodInvestmentsOwnershipPercentageRetained" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_1" xml:lang="en-US" id="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_1">Cost Method Investments Ownership Percentage Retained</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:to="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_1" xlink:title="Label : ormp_CostMethodInvestmentsOwnershipPercentageRetained to label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_2" xml:lang="en-US" id="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_2">Ownership percentage retained</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:to="label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_2" xlink:title="Label : ormp_CostMethodInvestmentsOwnershipPercentageRetained to label_ormp_CostMethodInvestmentsOwnershipPercentageRetained_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DnaBiomedicalSolutionsLtdMember" xlink:label="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="ormp_DnaBiomedicalSolutionsLtdMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DnaBiomedicalSolutionsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DnaBiomedicalSolutionsLtdMember" xml:lang="en-US" id="label_ormp_DnaBiomedicalSolutionsLtdMember">Dna Biomedical Solutions Ltd [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DnaBiomedicalSolutionsLtdMember" xlink:to="label_ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="Label : ormp_DnaBiomedicalSolutionsLtdMember to label_ormp_DnaBiomedicalSolutionsLtdMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DnaBiomedicalSolutionsLtdMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_DnaBiomedicalSolutionsLtdMember_1" xml:lang="en-US" id="label_ormp_DnaBiomedicalSolutionsLtdMember_1">D.N.A. [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DnaBiomedicalSolutionsLtdMember" xlink:to="label_ormp_DnaBiomedicalSolutionsLtdMember_1" xlink:title="Label : ormp_DnaBiomedicalSolutionsLtdMember to label_ormp_DnaBiomedicalSolutionsLtdMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorTwoMember" xlink:label="ormp_AdvisorTwoMember" xlink:title="ormp_AdvisorTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AdvisorTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_AdvisorTwoMember" xml:lang="en-US" id="label_ormp_AdvisorTwoMember">Advisor Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AdvisorTwoMember" xlink:to="label_ormp_AdvisorTwoMember" xlink:title="Label : ormp_AdvisorTwoMember to label_ormp_AdvisorTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AdvisorTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_AdvisorTwoMember_1" xml:lang="en-US" id="label_ormp_AdvisorTwoMember_1">Advisor Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AdvisorTwoMember" xlink:to="label_ormp_AdvisorTwoMember_1" xlink:title="Label : ormp_AdvisorTwoMember to label_ormp_AdvisorTwoMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_AdvisorTwoMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_AdvisorTwoMember_2" xml:lang="en-US" id="label_ormp_AdvisorTwoMember_2">Advisor Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_AdvisorTwoMember" xlink:to="label_ormp_AdvisorTwoMember_2" xlink:title="Label : ormp_AdvisorTwoMember to label_ormp_AdvisorTwoMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementTwoMember" xlink:label="ormp_SecuritiesPurchaseAgreementTwoMember" xlink:title="ormp_SecuritiesPurchaseAgreementTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementTwoMember" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementTwoMember">Securities Purchase Agreement Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementTwoMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementTwoMember" xlink:title="Label : ormp_SecuritiesPurchaseAgreementTwoMember to label_ormp_SecuritiesPurchaseAgreementTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementTwoMember_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementTwoMember_1">Securities Purchase Agreement Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementTwoMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementTwoMember_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementTwoMember to label_ormp_SecuritiesPurchaseAgreementTwoMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LeadingInvestorMember" xlink:label="ormp_LeadingInvestorMember" xlink:title="ormp_LeadingInvestorMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LeadingInvestorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_LeadingInvestorMember" xml:lang="en-US" id="label_ormp_LeadingInvestorMember">Leading Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LeadingInvestorMember" xlink:to="label_ormp_LeadingInvestorMember" xlink:title="Label : ormp_LeadingInvestorMember to label_ormp_LeadingInvestorMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_LeadingInvestorMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_LeadingInvestorMember_1" xml:lang="en-US" id="label_ormp_LeadingInvestorMember_1">Leading Investor [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_LeadingInvestorMember" xlink:to="label_ormp_LeadingInvestorMember_1" xlink:title="Label : ormp_LeadingInvestorMember to label_ormp_LeadingInvestorMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_OtherIndividualMember" xlink:label="ormp_OtherIndividualMember" xlink:title="ormp_OtherIndividualMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_OtherIndividualMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_OtherIndividualMember" xml:lang="en-US" id="label_ormp_OtherIndividualMember">Subsequent Event Other Individual [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_OtherIndividualMember" xlink:to="label_ormp_OtherIndividualMember" xlink:title="Label : ormp_OtherIndividualMember to label_ormp_OtherIndividualMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_OtherIndividualMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_OtherIndividualMember_1" xml:lang="en-US" id="label_ormp_OtherIndividualMember_1">Other Individual [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_OtherIndividualMember" xlink:to="label_ormp_OtherIndividualMember_1" xlink:title="Label : ormp_OtherIndividualMember to label_ormp_OtherIndividualMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:label="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:title="ormp_SecuritiesPurchaseAgreementNumberOfUnits" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits">The number of units to be sold during the securities purchase agreements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:to="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:title="Label : ormp_SecuritiesPurchaseAgreementNumberOfUnits to label_ormp_SecuritiesPurchaseAgreementNumberOfUnits" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_1">Securities Purchase Agreement Number Of Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:to="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementNumberOfUnits to label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_2" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_2">Securities Purchase Agreements, number of units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:to="label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_2" xlink:title="Label : ormp_SecuritiesPurchaseAgreementNumberOfUnits to label_ormp_SecuritiesPurchaseAgreementNumberOfUnits_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit">The purchase price per unit for the Securities Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit to label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_1">Securities Purchase Agreements Purchase Price Per Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit to label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_2" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_2">Securities Purchase Agreements, purchase price per unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_2" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit to label_ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:title="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityWellKnownSeasonedIssuer" xml:lang="en-US" id="label_dei_EntityWellKnownSeasonedIssuer">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="label_dei_EntityWellKnownSeasonedIssuer" xlink:title="Label : dei_EntityWellKnownSeasonedIssuer to label_dei_EntityWellKnownSeasonedIssuer" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityWellKnownSeasonedIssuer_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityWellKnownSeasonedIssuer_1" xml:lang="en-US" id="label_dei_EntityWellKnownSeasonedIssuer_1">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="label_dei_EntityWellKnownSeasonedIssuer_1" xlink:title="Label : dei_EntityWellKnownSeasonedIssuer to label_dei_EntityWellKnownSeasonedIssuer_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit">The number of shares per unit for the Securities Purchase Agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit to label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_1">Securities Purchase Agreements Number Of Shares Per Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit to label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_2" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_2">Securities Purchase Agreements, number of shares per unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_2" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit to label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:title="dei_EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityVoluntaryFilers" xml:lang="en-US" id="label_dei_EntityVoluntaryFilers">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="label_dei_EntityVoluntaryFilers" xlink:title="Label : dei_EntityVoluntaryFilers to label_dei_EntityVoluntaryFilers" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityVoluntaryFilers_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityVoluntaryFilers_1" xml:lang="en-US" id="label_dei_EntityVoluntaryFilers_1">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="label_dei_EntityVoluntaryFilers_1" xlink:title="Label : dei_EntityVoluntaryFilers to label_dei_EntityVoluntaryFilers_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant">The number of shares the warrant entitles the holder to purchase for the securities purchase agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant to label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_1">Securities Purchase Agreements Number Of Shares Per Warrant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant to label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_2" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_2">Securities Purchase Agreements, number of shares per warrant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_2" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant to label_ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:title="dei_EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCurrentReportingStatus" xml:lang="en-US" id="label_dei_EntityCurrentReportingStatus">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="label_dei_EntityCurrentReportingStatus" xlink:title="Label : dei_EntityCurrentReportingStatus to label_dei_EntityCurrentReportingStatus" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCurrentReportingStatus_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityCurrentReportingStatus_1" xml:lang="en-US" id="label_dei_EntityCurrentReportingStatus_1">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="label_dei_EntityCurrentReportingStatus_1" xlink:title="Label : dei_EntityCurrentReportingStatus to label_dei_EntityCurrentReportingStatus_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ServiceAgreementConsiderationSharesOption" xlink:label="ormp_ServiceAgreementConsiderationSharesOption" xlink:title="ormp_ServiceAgreementConsiderationSharesOption" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ServiceAgreementConsiderationSharesOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ServiceAgreementConsiderationSharesOption" xml:lang="en-US" id="label_ormp_ServiceAgreementConsiderationSharesOption">Number of shares available for purchase under the option given as consideration for a service agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ServiceAgreementConsiderationSharesOption" xlink:to="label_ormp_ServiceAgreementConsiderationSharesOption" xlink:title="Label : ormp_ServiceAgreementConsiderationSharesOption to label_ormp_ServiceAgreementConsiderationSharesOption" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ServiceAgreementConsiderationSharesOption_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ServiceAgreementConsiderationSharesOption_1" xml:lang="en-US" id="label_ormp_ServiceAgreementConsiderationSharesOption_1">Service Agreement Consideration Shares Option</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ServiceAgreementConsiderationSharesOption" xlink:to="label_ormp_ServiceAgreementConsiderationSharesOption_1" xlink:title="Label : ormp_ServiceAgreementConsiderationSharesOption to label_ormp_ServiceAgreementConsiderationSharesOption_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ServiceAgreementConsiderationSharesOption_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ServiceAgreementConsiderationSharesOption_2" xml:lang="en-US" id="label_ormp_ServiceAgreementConsiderationSharesOption_2">Option to purchase shares of D.N.A.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ServiceAgreementConsiderationSharesOption" xlink:to="label_ormp_ServiceAgreementConsiderationSharesOption_2" xlink:title="Label : ormp_ServiceAgreementConsiderationSharesOption to label_ormp_ServiceAgreementConsiderationSharesOption_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:title="dei_EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityFilerCategory" xml:lang="en-US" id="label_dei_EntityFilerCategory">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="label_dei_EntityFilerCategory" xlink:title="Label : dei_EntityFilerCategory to label_dei_EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityFilerCategory_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityFilerCategory_1" xml:lang="en-US" id="label_dei_EntityFilerCategory_1">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="label_dei_EntityFilerCategory_1" xlink:title="Label : dei_EntityFilerCategory to label_dei_EntityFilerCategory_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PercentOwnershipByThirdParty" xlink:label="ormp_PercentOwnershipByThirdParty" xlink:title="ormp_PercentOwnershipByThirdParty" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PercentOwnershipByThirdParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_PercentOwnershipByThirdParty" xml:lang="en-US" id="label_ormp_PercentOwnershipByThirdParty">Percent of shares owned by third party.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PercentOwnershipByThirdParty" xlink:to="label_ormp_PercentOwnershipByThirdParty" xlink:title="Label : ormp_PercentOwnershipByThirdParty to label_ormp_PercentOwnershipByThirdParty" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PercentOwnershipByThirdParty_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_PercentOwnershipByThirdParty_1" xml:lang="en-US" id="label_ormp_PercentOwnershipByThirdParty_1">Percent Ownership By Third Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PercentOwnershipByThirdParty" xlink:to="label_ormp_PercentOwnershipByThirdParty_1" xlink:title="Label : ormp_PercentOwnershipByThirdParty to label_ormp_PercentOwnershipByThirdParty_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PercentOwnershipByThirdParty_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_PercentOwnershipByThirdParty_2" xml:lang="en-US" id="label_ormp_PercentOwnershipByThirdParty_2">Percent shares owned by investor</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PercentOwnershipByThirdParty" xlink:to="label_ormp_PercentOwnershipByThirdParty_2" xlink:title="Label : ormp_PercentOwnershipByThirdParty to label_ormp_PercentOwnershipByThirdParty_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:title="dei_EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityPublicFloat" xml:lang="en-US" id="label_dei_EntityPublicFloat">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="label_dei_EntityPublicFloat" xlink:title="Label : dei_EntityPublicFloat to label_dei_EntityPublicFloat" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityPublicFloat_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityPublicFloat_1" xml:lang="en-US" id="label_dei_EntityPublicFloat_1">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="label_dei_EntityPublicFloat_1" xlink:title="Label : dei_EntityPublicFloat to label_dei_EntityPublicFloat_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementThreeMember" xlink:label="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:title="ormp_SecuritiesPurchaseAgreementThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementThreeMember" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementThreeMember">Represents information pertaining to securities purchase agreement three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementThreeMember" xlink:title="Label : ormp_SecuritiesPurchaseAgreementThreeMember to label_ormp_SecuritiesPurchaseAgreementThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementThreeMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementThreeMember_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementThreeMember_1">Securities Purchase Agreement Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementThreeMember_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementThreeMember to label_ormp_SecuritiesPurchaseAgreementThreeMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementThreeMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SecuritiesPurchaseAgreementThreeMember_2" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementThreeMember_2">Securities Purchase Agreement Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementThreeMember_2" xlink:title="Label : ormp_SecuritiesPurchaseAgreementThreeMember to label_ormp_SecuritiesPurchaseAgreementThreeMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:title="dei_EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityRegistrantName" xml:lang="en-US" id="label_dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="label_dei_EntityRegistrantName" xlink:title="Label : dei_EntityRegistrantName to label_dei_EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityRegistrantName_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityRegistrantName_1" xml:lang="en-US" id="label_dei_EntityRegistrantName_1">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="label_dei_EntityRegistrantName_1" xlink:title="Label : dei_EntityRegistrantName to label_dei_EntityRegistrantName_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NumberOfInstitutionalInvestors" xlink:label="ormp_NumberOfInstitutionalInvestors" xlink:title="ormp_NumberOfInstitutionalInvestors" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NumberOfInstitutionalInvestors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_NumberOfInstitutionalInvestors" xml:lang="en-US" id="label_ormp_NumberOfInstitutionalInvestors">The number of institutional investors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NumberOfInstitutionalInvestors" xlink:to="label_ormp_NumberOfInstitutionalInvestors" xlink:title="Label : ormp_NumberOfInstitutionalInvestors to label_ormp_NumberOfInstitutionalInvestors" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NumberOfInstitutionalInvestors_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_NumberOfInstitutionalInvestors_1" xml:lang="en-US" id="label_ormp_NumberOfInstitutionalInvestors_1">Number of Institutional Investors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NumberOfInstitutionalInvestors" xlink:to="label_ormp_NumberOfInstitutionalInvestors_1" xlink:title="Label : ormp_NumberOfInstitutionalInvestors to label_ormp_NumberOfInstitutionalInvestors_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NumberOfInstitutionalInvestors_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_NumberOfInstitutionalInvestors_2" xml:lang="en-US" id="label_ormp_NumberOfInstitutionalInvestors_2">Number of institutional investors</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NumberOfInstitutionalInvestors" xlink:to="label_ormp_NumberOfInstitutionalInvestors_2" xlink:title="Label : ormp_NumberOfInstitutionalInvestors to label_ormp_NumberOfInstitutionalInvestors_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:title="dei_EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCentralIndexKey" xml:lang="en-US" id="label_dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="label_dei_EntityCentralIndexKey" xlink:title="Label : dei_EntityCentralIndexKey to label_dei_EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCentralIndexKey_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityCentralIndexKey_1" xml:lang="en-US" id="label_dei_EntityCentralIndexKey_1">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="label_dei_EntityCentralIndexKey_1" xlink:title="Label : dei_EntityCentralIndexKey to label_dei_EntityCentralIndexKey_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:label="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:title="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xml:lang="en-US" id="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember">Represents information pertaining to warrants previously issued in private placements.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:to="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:title="Label : ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember to label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_1" xml:lang="en-US" id="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_1">Warrants Previously Issued in Private Placements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:to="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_1" xlink:title="Label : ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember to label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_2" xml:lang="en-US" id="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_2">Warrants previously issued in private placements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:to="label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_2" xlink:title="Label : ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember to label_ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:label="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:title="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xml:lang="en-US" id="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation">The maximum number of common shares permitted to be issued by the entity's charter and bylaws before an amendment to the entity's Certificate of Incorporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:to="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:title="Label : ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation to label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_1" xml:lang="en-US" id="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_1">Common Stock Shares Authorized Before Amendment to Certificate of Incorporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:to="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_1" xlink:title="Label : ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation to label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_2" xml:lang="en-US" id="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_2">Common stock authorized before an amendment to the Company's Certificate of Incorporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:to="label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_2" xlink:title="Label : ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation to label_ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit">The number of warrants per unit for the securities purchase agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit to label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_1">Securities Purchase Agreements Number Of Warrants Per Unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit to label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_2" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_2">Securities Purchase Agreements, number of warrants per unit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:to="label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_2" xlink:title="Label : ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit to label_ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeOneMember" xlink:label="ormp_ExercisePriceRangeOneMember" xlink:title="ormp_ExercisePriceRangeOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ExercisePriceRangeOneMember" xml:lang="en-US" id="label_ormp_ExercisePriceRangeOneMember">Exercise Price Range One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeOneMember" xlink:to="label_ormp_ExercisePriceRangeOneMember" xlink:title="Label : ormp_ExercisePriceRangeOneMember to label_ormp_ExercisePriceRangeOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeOneMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ExercisePriceRangeOneMember_1" xml:lang="en-US" id="label_ormp_ExercisePriceRangeOneMember_1">Exercise Price Range One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeOneMember" xlink:to="label_ormp_ExercisePriceRangeOneMember_1" xlink:title="Label : ormp_ExercisePriceRangeOneMember to label_ormp_ExercisePriceRangeOneMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeOneMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ExercisePriceRangeOneMember_2" xml:lang="en-US" id="label_ormp_ExercisePriceRangeOneMember_2">$4.08 to 6.00 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeOneMember" xlink:to="label_ormp_ExercisePriceRangeOneMember_2" xlink:title="Label : ormp_ExercisePriceRangeOneMember to label_ormp_ExercisePriceRangeOneMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:title="dei_EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US" id="label_dei_EntityCommonStockSharesOutstanding">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="label_dei_EntityCommonStockSharesOutstanding" xlink:title="Label : dei_EntityCommonStockSharesOutstanding to label_dei_EntityCommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_dei_EntityCommonStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_EntityCommonStockSharesOutstanding_1" xml:lang="en-US" id="label_dei_EntityCommonStockSharesOutstanding_1">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="label_dei_EntityCommonStockSharesOutstanding_1" xlink:title="Label : dei_EntityCommonStockSharesOutstanding to label_dei_EntityCommonStockSharesOutstanding_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeFourMember" xlink:label="ormp_ExercisePriceRangeFourMember" xlink:title="ormp_ExercisePriceRangeFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ExercisePriceRangeFourMember" xml:lang="en-US" id="label_ormp_ExercisePriceRangeFourMember">Exercise Price Range Four [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeFourMember" xlink:to="label_ormp_ExercisePriceRangeFourMember" xlink:title="Label : ormp_ExercisePriceRangeFourMember to label_ormp_ExercisePriceRangeFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeFourMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ExercisePriceRangeFourMember_1" xml:lang="en-US" id="label_ormp_ExercisePriceRangeFourMember_1">Exercise Price Range Four [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeFourMember" xlink:to="label_ormp_ExercisePriceRangeFourMember_1" xlink:title="Label : ormp_ExercisePriceRangeFourMember to label_ormp_ExercisePriceRangeFourMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeFourMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ExercisePriceRangeFourMember_2" xml:lang="en-US" id="label_ormp_ExercisePriceRangeFourMember_2">$9.12 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeFourMember" xlink:to="label_ormp_ExercisePriceRangeFourMember_2" xlink:title="Label : ormp_ExercisePriceRangeFourMember to label_ormp_ExercisePriceRangeFourMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeTwoMember" xlink:label="ormp_ExercisePriceRangeTwoMember" xlink:title="ormp_ExercisePriceRangeTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ExercisePriceRangeTwoMember" xml:lang="en-US" id="label_ormp_ExercisePriceRangeTwoMember">Exercise Price Range Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeTwoMember" xlink:to="label_ormp_ExercisePriceRangeTwoMember" xlink:title="Label : ormp_ExercisePriceRangeTwoMember to label_ormp_ExercisePriceRangeTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ExercisePriceRangeTwoMember_1" xml:lang="en-US" id="label_ormp_ExercisePriceRangeTwoMember_1">Exercise Price Range Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeTwoMember" xlink:to="label_ormp_ExercisePriceRangeTwoMember_1" xlink:title="Label : ormp_ExercisePriceRangeTwoMember to label_ormp_ExercisePriceRangeTwoMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeTwoMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ExercisePriceRangeTwoMember_2" xml:lang="en-US" id="label_ormp_ExercisePriceRangeTwoMember_2">$6.48 to 7.88 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeTwoMember" xlink:to="label_ormp_ExercisePriceRangeTwoMember_2" xlink:title="Label : ormp_ExercisePriceRangeTwoMember to label_ormp_ExercisePriceRangeTwoMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeThreeMember" xlink:label="ormp_ExercisePriceRangeThreeMember" xlink:title="ormp_ExercisePriceRangeThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ExercisePriceRangeThreeMember" xml:lang="en-US" id="label_ormp_ExercisePriceRangeThreeMember">Exercise Price Range Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeThreeMember" xlink:to="label_ormp_ExercisePriceRangeThreeMember" xlink:title="Label : ormp_ExercisePriceRangeThreeMember to label_ormp_ExercisePriceRangeThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeThreeMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ExercisePriceRangeThreeMember_1" xml:lang="en-US" id="label_ormp_ExercisePriceRangeThreeMember_1">Exercise Price Range Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeThreeMember" xlink:to="label_ormp_ExercisePriceRangeThreeMember_1" xlink:title="Label : ormp_ExercisePriceRangeThreeMember to label_ormp_ExercisePriceRangeThreeMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExercisePriceRangeThreeMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ExercisePriceRangeThreeMember_2" xml:lang="en-US" id="label_ormp_ExercisePriceRangeThreeMember_2">$12.45 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExercisePriceRangeThreeMember" xlink:to="label_ormp_ExercisePriceRangeThreeMember_2" xlink:title="Label : ormp_ExercisePriceRangeThreeMember to label_ormp_ExercisePriceRangeThreeMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xml:lang="en-US" id="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis">Stock Option Activity Employees And Nonemployees [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:to="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="Label : ormp_StockOptionActivityEmployeesAndNonemployeesAxis to label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis_1" xml:lang="en-US" id="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis_1">Stock Option Activity Employees And Nonemployees [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:to="label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis_1" xlink:title="Label : ormp_StockOptionActivityEmployeesAndNonemployeesAxis to label_ormp_StockOptionActivityEmployeesAndNonemployeesAxis_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xml:lang="en-US" id="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain">Stock Option Activity Employees And Nonemployees [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="Label : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain_1" xml:lang="en-US" id="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain_1">Stock Option Activity Employees And Nonemployees [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain_1" xlink:title="Label : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to label_ormp_StockOptionActivityEmployeesAndNonemployeesDomain_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeesMember" xlink:label="ormp_EmployeesMember" xlink:title="ormp_EmployeesMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_EmployeesMember" xml:lang="en-US" id="label_ormp_EmployeesMember">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EmployeesMember" xlink:to="label_ormp_EmployeesMember" xlink:title="Label : ormp_EmployeesMember to label_ormp_EmployeesMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EmployeesMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_EmployeesMember_1" xml:lang="en-US" id="label_ormp_EmployeesMember_1">Employees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EmployeesMember" xlink:to="label_ormp_EmployeesMember_1" xlink:title="Label : ormp_EmployeesMember to label_ormp_EmployeesMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NonemployeesMember" xlink:label="ormp_NonemployeesMember" xlink:title="ormp_NonemployeesMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NonemployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_NonemployeesMember" xml:lang="en-US" id="label_ormp_NonemployeesMember">Nonemployees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NonemployeesMember" xlink:to="label_ormp_NonemployeesMember" xlink:title="Label : ormp_NonemployeesMember to label_ormp_NonemployeesMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NonemployeesMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_NonemployeesMember_1" xml:lang="en-US" id="label_ormp_NonemployeesMember_1">Nonemployees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NonemployeesMember" xlink:to="label_ormp_NonemployeesMember_1" xlink:title="Label : ormp_NonemployeesMember to label_ormp_NonemployeesMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:label="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:title="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xml:lang="en-US" id="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue">Aggregate intrinsic value of the options outstanding as of the balance sheet date for a range of exercise prices.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:to="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:title="Label : ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue to label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_1" xml:lang="en-US" id="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_1">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:to="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_1" xlink:title="Label : ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue to label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_2" xml:lang="en-US" id="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_2">Outstanding, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:to="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_2" xlink:title="Label : ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue to label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:label="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:title="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xml:lang="en-US" id="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue">The total dollar difference between fair values of the underlying shares reserved for issuance and exercise prices of vested portions of options outstanding and currently exercisable under the option plan as of the balance sheet date for a range of exercise prices.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:to="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:title="Label : ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue to label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_1" xml:lang="en-US" id="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_1">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:to="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_1" xlink:title="Label : ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue to label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_2" xml:lang="en-US" id="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_2">Exercisable, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:to="label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_2" xlink:title="Label : ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue to label_ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:label="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:title="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xml:lang="en-US" id="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable">Schedule of stock options issued to employees and nonemployees during the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:to="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:title="Label : ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable to label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable_1" xml:lang="en-US" id="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable_1">Schedule Of Stock Option Activity Employees And Nonemployees [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:to="label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable_1" xlink:title="Label : ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable to label_ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityLineItems" xlink:label="ormp_StockOptionActivityLineItems" xlink:title="ormp_StockOptionActivityLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionActivityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_StockOptionActivityLineItems" xml:lang="en-US" id="label_ormp_StockOptionActivityLineItems">Stock Option Activity [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="label_ormp_StockOptionActivityLineItems" xlink:title="Label : ormp_StockOptionActivityLineItems to label_ormp_StockOptionActivityLineItems" />
    <link:label xlink:type="resource" xlink:label="label_ormp_StockOptionActivityLineItems_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_StockOptionActivityLineItems_1" xml:lang="en-US" id="label_ormp_StockOptionActivityLineItems_1">Stock Option Activity [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="label_ormp_StockOptionActivityLineItems_1" xlink:title="Label : ormp_StockOptionActivityLineItems to label_ormp_StockOptionActivityLineItems_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice">Number of shares granted in the period at an exercise price above the market price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_1">Share Based Compensation Arrangement by Share Based Payment Award Options Grants in Period Above Market Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_2">Granted - above market price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice">Exercise price per share of options granted during the period at an exercise price higher than the market price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_1">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Above Market Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_2">Granted - above market price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:label="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:title="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xml:lang="en-US" id="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock">Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms, for nonemployees.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:to="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:title="Label : ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock to label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_1" xml:lang="en-US" id="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_1">Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range Nonemployee [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:to="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_1" xlink:title="Label : ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock to label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_2" xml:lang="en-US" id="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_2">Summary of Information for Options Granted and Exercisable for Non-Employees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:to="label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_2" xlink:title="Label : ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock to label_ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">The number of shares into which non-option equity instruments as of the balance sheet date can be currently converted.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_1">Share Based Compensation Arrangement By Share Based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2">Warrants exercisable as of August 31</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice">Weighted average exercise price of outstanding equity instrument other than options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_1">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2">Warrants outstanding as of August 31</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_3" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_3" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_3">Warrants outstanding as of September 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_3" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_3" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice">Weighted average exercise price of equity instrument other than options granted in the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_1">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_2">Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:title="dei_DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentFiscalYearFocus" xml:lang="en-US" id="label_dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="label_dei_DocumentFiscalYearFocus" xlink:title="Label : dei_DocumentFiscalYearFocus to label_dei_DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalYearFocus_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_DocumentFiscalYearFocus_1" xml:lang="en-US" id="label_dei_DocumentFiscalYearFocus_1">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="label_dei_DocumentFiscalYearFocus_1" xlink:title="Label : dei_DocumentFiscalYearFocus to label_dei_DocumentFiscalYearFocus_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice">Weighted average exercise price of equity instrument other than options exercised in the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_1">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_2">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:title="dei_DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="label_dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="label_dei_DocumentFiscalPeriodFocus" xlink:title="Label : dei_DocumentFiscalPeriodFocus to label_dei_DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentFiscalPeriodFocus_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_DocumentFiscalPeriodFocus_1" xml:lang="en-US" id="label_dei_DocumentFiscalPeriodFocus_1">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="label_dei_DocumentFiscalPeriodFocus_1" xlink:title="Label : dei_DocumentFiscalPeriodFocus to label_dei_DocumentFiscalPeriodFocus_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice">Weighted average exercise price of exercisable equity instrument other than options.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_1">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_2">Warrants exercisable as of August 31</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price [Abstract].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_1">Share Based Compensation Arrangement By Share Based Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_2">Weighted-Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to label_ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:label="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:title="ormp_SharesAndWarrantsToBeIssuedForCashValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SharesAndWarrantsToBeIssuedForCashValue" xml:lang="en-US" id="label_ormp_SharesAndWarrantsToBeIssuedForCashValue">Value of shares and warrants to be issued for cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:to="label_ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:title="Label : ormp_SharesAndWarrantsToBeIssuedForCashValue to label_ormp_SharesAndWarrantsToBeIssuedForCashValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_1" xml:lang="en-US" id="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_1">Shares And Warrants To Be Issued For Cash Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:to="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_1" xlink:title="Label : ormp_SharesAndWarrantsToBeIssuedForCashValue to label_ormp_SharesAndWarrantsToBeIssuedForCashValue_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_2" xml:lang="en-US" id="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_2">SHARES AND WARRANTS TO BE ISSUED FOR CASH (see note 8b)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:to="label_ormp_SharesAndWarrantsToBeIssuedForCashValue_2" xlink:title="Label : ormp_SharesAndWarrantsToBeIssuedForCashValue to label_ormp_SharesAndWarrantsToBeIssuedForCashValue_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:label="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:title="ormp_SharesAndWarrantsToBeIssuedForCashShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SharesAndWarrantsToBeIssuedForCashShares" xml:lang="en-US" id="label_ormp_SharesAndWarrantsToBeIssuedForCashShares">Number of shares and warrants to be issued for cash.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:to="label_ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:title="Label : ormp_SharesAndWarrantsToBeIssuedForCashShares to label_ormp_SharesAndWarrantsToBeIssuedForCashShares" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_1" xml:lang="en-US" id="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_1">Shares And Warrants To Be Issued For Cash Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:to="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_1" xlink:title="Label : ormp_SharesAndWarrantsToBeIssuedForCashShares to label_ormp_SharesAndWarrantsToBeIssuedForCashShares_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_2" xml:lang="en-US" id="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_2">SHARES AND WARRANTS TO BE ISSUED FOR CASH (see note 8b), shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:to="label_ormp_SharesAndWarrantsToBeIssuedForCashShares_2" xlink:title="Label : ormp_SharesAndWarrantsToBeIssuedForCashShares to label_ormp_SharesAndWarrantsToBeIssuedForCashShares_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:label="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:title="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xml:lang="en-US" id="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash">The value of shares and warrants to be issued for cash in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:to="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:title="Label : ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash to label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_1" xml:lang="en-US" id="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_1">Non Cash Investing And Financing Activities Shares And Warrants To Be Issued For Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:to="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_1" xlink:title="Label : ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash to label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_2" xml:lang="en-US" id="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_2">Shares and warrants to be issued for cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:to="label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_2" xlink:title="Label : ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash to label_ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementFourMember" xlink:label="ormp_SecuritiesPurchaseAgreementFourMember" xlink:title="ormp_SecuritiesPurchaseAgreementFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecuritiesPurchaseAgreementFourMember" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementFourMember">Securities Purchase Agreement Four [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementFourMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementFourMember" xlink:title="Label : ormp_SecuritiesPurchaseAgreementFourMember to label_ormp_SecuritiesPurchaseAgreementFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecuritiesPurchaseAgreementFourMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecuritiesPurchaseAgreementFourMember_1" xml:lang="en-US" id="label_ormp_SecuritiesPurchaseAgreementFourMember_1">Securities Purchase Agreement Four [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecuritiesPurchaseAgreementFourMember" xlink:to="label_ormp_SecuritiesPurchaseAgreementFourMember_1" xlink:title="Label : ormp_SecuritiesPurchaseAgreementFourMember to label_ormp_SecuritiesPurchaseAgreementFourMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:label="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:title="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xml:lang="en-US" id="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock">Tabular disclosure of annual depreciation rates.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:to="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:title="Label : ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock to label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_1" xml:lang="en-US" id="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_1">Schedule Of Annual Depreciation Rates [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:to="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_1" xlink:title="Label : ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock to label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_2" xml:lang="en-US" id="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_2">Schedule of Annual Depreciation Rates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:to="label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_2" xlink:title="Label : ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock to label_ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:label="ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:title="ormp_PropertyPlantAndEquipmentGeneralAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_PropertyPlantAndEquipmentGeneralAbstract" xml:lang="en-US" id="label_ormp_PropertyPlantAndEquipmentGeneralAbstract">Property Plant And Equipment General [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:to="label_ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:title="Label : ormp_PropertyPlantAndEquipmentGeneralAbstract to label_ormp_PropertyPlantAndEquipmentGeneralAbstract" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_1" xml:lang="en-US" id="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_1">Property Plant And Equipment General [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:to="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_1" xlink:title="Label : ormp_PropertyPlantAndEquipmentGeneralAbstract to label_ormp_PropertyPlantAndEquipmentGeneralAbstract_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_2" xml:lang="en-US" id="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_2">Property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:to="label_ormp_PropertyPlantAndEquipmentGeneralAbstract_2" xlink:title="Label : ormp_PropertyPlantAndEquipmentGeneralAbstract to label_ormp_PropertyPlantAndEquipmentGeneralAbstract_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:label="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:title="ormp_PropertyPlantAndEquipmentDepreciationRate" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_PropertyPlantAndEquipmentDepreciationRate" xml:lang="en-US" id="label_ormp_PropertyPlantAndEquipmentDepreciationRate">The annual rate of depreciation for the long-lived asset.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:to="label_ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:title="Label : ormp_PropertyPlantAndEquipmentDepreciationRate to label_ormp_PropertyPlantAndEquipmentDepreciationRate" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PropertyPlantAndEquipmentDepreciationRate_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_PropertyPlantAndEquipmentDepreciationRate_1" xml:lang="en-US" id="label_ormp_PropertyPlantAndEquipmentDepreciationRate_1">Property Plant And Equipment Depreciation Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:to="label_ormp_PropertyPlantAndEquipmentDepreciationRate_1" xlink:title="Label : ormp_PropertyPlantAndEquipmentDepreciationRate to label_ormp_PropertyPlantAndEquipmentDepreciationRate_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_PropertyPlantAndEquipmentDepreciationRate_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_PropertyPlantAndEquipmentDepreciationRate_2" xml:lang="en-US" id="label_ormp_PropertyPlantAndEquipmentDepreciationRate_2">Depreciation rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:to="label_ormp_PropertyPlantAndEquipmentDepreciationRate_2" xlink:title="Label : ormp_PropertyPlantAndEquipmentDepreciationRate to label_ormp_PropertyPlantAndEquipmentDepreciationRate_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementFiveMember" xlink:label="ormp_MasterServiceAgreementFiveMember" xlink:title="ormp_MasterServiceAgreementFiveMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MasterServiceAgreementFiveMember" xml:lang="en-US" id="label_ormp_MasterServiceAgreementFiveMember">Fifth Master Service Agreement [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementFiveMember" xlink:to="label_ormp_MasterServiceAgreementFiveMember" xlink:title="Label : ormp_MasterServiceAgreementFiveMember to label_ormp_MasterServiceAgreementFiveMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementFiveMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MasterServiceAgreementFiveMember_1" xml:lang="en-US" id="label_ormp_MasterServiceAgreementFiveMember_1">Master Service Agreement Five [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementFiveMember" xlink:to="label_ormp_MasterServiceAgreementFiveMember_1" xlink:title="Label : ormp_MasterServiceAgreementFiveMember to label_ormp_MasterServiceAgreementFiveMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementFiveMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MasterServiceAgreementFiveMember_2" xml:lang="en-US" id="label_ormp_MasterServiceAgreementFiveMember_2">Fifth Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementFiveMember" xlink:to="label_ormp_MasterServiceAgreementFiveMember_2" xlink:title="Label : ormp_MasterServiceAgreementFiveMember to label_ormp_MasterServiceAgreementFiveMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NumberOfConsultingAgreementsEntered" xlink:label="ormp_NumberOfConsultingAgreementsEntered" xlink:title="ormp_NumberOfConsultingAgreementsEntered" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NumberOfConsultingAgreementsEntered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_NumberOfConsultingAgreementsEntered" xml:lang="en-US" id="label_ormp_NumberOfConsultingAgreementsEntered">The number of consulting agreements entered into by the entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NumberOfConsultingAgreementsEntered" xlink:to="label_ormp_NumberOfConsultingAgreementsEntered" xlink:title="Label : ormp_NumberOfConsultingAgreementsEntered to label_ormp_NumberOfConsultingAgreementsEntered" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NumberOfConsultingAgreementsEntered_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_NumberOfConsultingAgreementsEntered_1" xml:lang="en-US" id="label_ormp_NumberOfConsultingAgreementsEntered_1">Number of consulting agreements entered</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NumberOfConsultingAgreementsEntered" xlink:to="label_ormp_NumberOfConsultingAgreementsEntered_1" xlink:title="Label : ormp_NumberOfConsultingAgreementsEntered to label_ormp_NumberOfConsultingAgreementsEntered_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_NumberOfConsultingAgreementsEntered_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_NumberOfConsultingAgreementsEntered_2" xml:lang="en-US" id="label_ormp_NumberOfConsultingAgreementsEntered_2">Number of consulting agreements entered</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_NumberOfConsultingAgreementsEntered" xlink:to="label_ormp_NumberOfConsultingAgreementsEntered_2" xlink:title="Label : ormp_NumberOfConsultingAgreementsEntered to label_ormp_NumberOfConsultingAgreementsEntered_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:title="dei_LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="label_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_LegalEntityAxis" xml:lang="en-US" id="label_dei_LegalEntityAxis">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="label_dei_LegalEntityAxis" xlink:title="Label : dei_LegalEntityAxis to label_dei_LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExtendedPriorWrittenNoticePeriod" xlink:label="ormp_ExtendedPriorWrittenNoticePeriod" xlink:title="ormp_ExtendedPriorWrittenNoticePeriod" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExtendedPriorWrittenNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ExtendedPriorWrittenNoticePeriod" xml:lang="en-US" id="label_ormp_ExtendedPriorWrittenNoticePeriod">The extended prior written notice period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExtendedPriorWrittenNoticePeriod" xlink:to="label_ormp_ExtendedPriorWrittenNoticePeriod" xlink:title="Label : ormp_ExtendedPriorWrittenNoticePeriod to label_ormp_ExtendedPriorWrittenNoticePeriod" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExtendedPriorWrittenNoticePeriod_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ExtendedPriorWrittenNoticePeriod_1" xml:lang="en-US" id="label_ormp_ExtendedPriorWrittenNoticePeriod_1">Extended Prior Written Notice Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExtendedPriorWrittenNoticePeriod" xlink:to="label_ormp_ExtendedPriorWrittenNoticePeriod_1" xlink:title="Label : ormp_ExtendedPriorWrittenNoticePeriod to label_ormp_ExtendedPriorWrittenNoticePeriod_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ExtendedPriorWrittenNoticePeriod_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ExtendedPriorWrittenNoticePeriod_2" xml:lang="en-US" id="label_ormp_ExtendedPriorWrittenNoticePeriod_2">Extended prior written notice period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ExtendedPriorWrittenNoticePeriod" xlink:to="label_ormp_ExtendedPriorWrittenNoticePeriod_2" xlink:title="Label : ormp_ExtendedPriorWrittenNoticePeriod to label_ormp_ExtendedPriorWrittenNoticePeriod_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:title="dei_DocumentType" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_dei_DocumentType" xml:lang="en-US" id="label_dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="label_dei_DocumentType" xlink:title="Label : dei_DocumentType to label_dei_DocumentType" />
    <link:label xlink:type="resource" xlink:label="label_dei_DocumentType_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_dei_DocumentType_1" xml:lang="en-US" id="label_dei_DocumentType_1">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="label_dei_DocumentType_1" xlink:title="Label : dei_DocumentType to label_dei_DocumentType_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments">The number of equal installments in which awards will vest.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_1" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_1">Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Vesting Number of Installments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_1" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_2" xml:lang="en-US" id="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_2">Number of equal installments in which awards will vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:to="label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_2" xlink:title="Label : ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments to label_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementSixMember" xlink:label="ormp_MasterServiceAgreementSixMember" xlink:title="ormp_MasterServiceAgreementSixMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MasterServiceAgreementSixMember" xml:lang="en-US" id="label_ormp_MasterServiceAgreementSixMember">Master Service Agreement Six [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementSixMember" xlink:to="label_ormp_MasterServiceAgreementSixMember" xlink:title="Label : ormp_MasterServiceAgreementSixMember to label_ormp_MasterServiceAgreementSixMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementSixMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MasterServiceAgreementSixMember_1" xml:lang="en-US" id="label_ormp_MasterServiceAgreementSixMember_1">Master Service Agreement Six [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementSixMember" xlink:to="label_ormp_MasterServiceAgreementSixMember_1" xlink:title="Label : ormp_MasterServiceAgreementSixMember to label_ormp_MasterServiceAgreementSixMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MasterServiceAgreementSixMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MasterServiceAgreementSixMember_2" xml:lang="en-US" id="label_ormp_MasterServiceAgreementSixMember_2">Sixth Master Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MasterServiceAgreementSixMember" xlink:to="label_ormp_MasterServiceAgreementSixMember_2" xlink:title="Label : ormp_MasterServiceAgreementSixMember to label_ormp_MasterServiceAgreementSixMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorOneMember" xlink:label="ormp_DirectorOneMember" xlink:title="ormp_DirectorOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_DirectorOneMember" xml:lang="en-US" id="label_ormp_DirectorOneMember">Director One [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorOneMember" xlink:to="label_ormp_DirectorOneMember" xlink:title="Label : ormp_DirectorOneMember to label_ormp_DirectorOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorOneMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DirectorOneMember_1" xml:lang="en-US" id="label_ormp_DirectorOneMember_1">Director One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorOneMember" xlink:to="label_ormp_DirectorOneMember_1" xlink:title="Label : ormp_DirectorOneMember to label_ormp_DirectorOneMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorTwoMember" xlink:label="ormp_DirectorTwoMember" xlink:title="ormp_DirectorTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_DirectorTwoMember" xml:lang="en-US" id="label_ormp_DirectorTwoMember">Director Two [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorTwoMember" xlink:to="label_ormp_DirectorTwoMember" xlink:title="Label : ormp_DirectorTwoMember to label_ormp_DirectorTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DirectorTwoMember_1" xml:lang="en-US" id="label_ormp_DirectorTwoMember_1">Director Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorTwoMember" xlink:to="label_ormp_DirectorTwoMember_1" xlink:title="Label : ormp_DirectorTwoMember to label_ormp_DirectorTwoMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorThreeMember" xlink:label="ormp_DirectorThreeMember" xlink:title="ormp_DirectorThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_DirectorThreeMember" xml:lang="en-US" id="label_ormp_DirectorThreeMember">Director Three [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorThreeMember" xlink:to="label_ormp_DirectorThreeMember" xlink:title="Label : ormp_DirectorThreeMember to label_ormp_DirectorThreeMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorThreeMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DirectorThreeMember_1" xml:lang="en-US" id="label_ormp_DirectorThreeMember_1">Director Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorThreeMember" xlink:to="label_ormp_DirectorThreeMember_1" xlink:title="Label : ormp_DirectorThreeMember to label_ormp_DirectorThreeMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorFourMember" xlink:label="ormp_DirectorFourMember" xlink:title="ormp_DirectorFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_DirectorFourMember" xml:lang="en-US" id="label_ormp_DirectorFourMember">Director Four [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorFourMember" xlink:to="label_ormp_DirectorFourMember" xlink:title="Label : ormp_DirectorFourMember to label_ormp_DirectorFourMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_DirectorFourMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_DirectorFourMember_1" xml:lang="en-US" id="label_ormp_DirectorFourMember_1">Director Four [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_DirectorFourMember" xlink:to="label_ormp_DirectorFourMember_1" xlink:title="Label : ormp_DirectorFourMember to label_ormp_DirectorFourMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:label="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:title="ormp_MarketIssuanceSalesAgreementOfferingValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MarketIssuanceSalesAgreementOfferingValue" xml:lang="en-US" id="label_ormp_MarketIssuanceSalesAgreementOfferingValue">The value of the shares that will be issued as part of a market issuance sales agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:to="label_ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:title="Label : ormp_MarketIssuanceSalesAgreementOfferingValue to label_ormp_MarketIssuanceSalesAgreementOfferingValue" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketIssuanceSalesAgreementOfferingValue_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MarketIssuanceSalesAgreementOfferingValue_1" xml:lang="en-US" id="label_ormp_MarketIssuanceSalesAgreementOfferingValue_1">Market Issuance Sales Agreement, Offering Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:to="label_ormp_MarketIssuanceSalesAgreementOfferingValue_1" xlink:title="Label : ormp_MarketIssuanceSalesAgreementOfferingValue to label_ormp_MarketIssuanceSalesAgreementOfferingValue_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketIssuanceSalesAgreementOfferingValue_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MarketIssuanceSalesAgreementOfferingValue_2" xml:lang="en-US" id="label_ormp_MarketIssuanceSalesAgreementOfferingValue_2">Market issuance sales agreement, offering value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:to="label_ormp_MarketIssuanceSalesAgreementOfferingValue_2" xlink:title="Label : ormp_MarketIssuanceSalesAgreementOfferingValue to label_ormp_MarketIssuanceSalesAgreementOfferingValue_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:label="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:title="ormp_MarketIssuanceSalesAgreementCommissionPercentage" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage" xml:lang="en-US" id="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage">The percent of gross proceeds payable as commission to sales agent as part of a market issuance sales agreement.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:to="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:title="Label : ormp_MarketIssuanceSalesAgreementCommissionPercentage to label_ormp_MarketIssuanceSalesAgreementCommissionPercentage" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_1" xml:lang="en-US" id="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_1">Market Issuance Sales Agreement, Commission, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:to="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_1" xlink:title="Label : ormp_MarketIssuanceSalesAgreementCommissionPercentage to label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_2" xml:lang="en-US" id="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_2">Market issuance sales agreement, commission, percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:to="label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_2" xlink:title="Label : ormp_MarketIssuanceSalesAgreementCommissionPercentage to label_ormp_MarketIssuanceSalesAgreementCommissionPercentage_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xml:lang="en-US" id="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember">Second Clinical Research Organization Service Agreement [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:to="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:title="Label : ormp_SecondClinicalResearchOrganizationServiceAgreementMember to label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember_1" xml:lang="en-US" id="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember_1">Second Clinical Research Organization Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:to="label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember_1" xlink:title="Label : ormp_SecondClinicalResearchOrganizationServiceAgreementMember to label_ormp_SecondClinicalResearchOrganizationServiceAgreementMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xml:lang="en-US" id="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember">Third Clinical Research Organization Service Agreement [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:to="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:title="Label : ormp_ThirdClinicalResearchOrganizationServiceAgreementMember to label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember_1" xml:lang="en-US" id="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember_1">Third Clinical Research Organization Service Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:to="label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember_1" xlink:title="Label : ormp_ThirdClinicalResearchOrganizationServiceAgreementMember to label_ormp_ThirdClinicalResearchOrganizationServiceAgreementMember_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EquityIssuanceAxis" xlink:label="ormp_EquityIssuanceAxis" xlink:title="ormp_EquityIssuanceAxis" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EquityIssuanceAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_EquityIssuanceAxis" xml:lang="en-US" id="label_ormp_EquityIssuanceAxis">Equity Issuance [Axis].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EquityIssuanceAxis" xlink:to="label_ormp_EquityIssuanceAxis" xlink:title="Label : ormp_EquityIssuanceAxis to label_ormp_EquityIssuanceAxis" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EquityIssuanceAxis_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_EquityIssuanceAxis_1" xml:lang="en-US" id="label_ormp_EquityIssuanceAxis_1">Equity Issuance [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EquityIssuanceAxis" xlink:to="label_ormp_EquityIssuanceAxis_1" xlink:title="Label : ormp_EquityIssuanceAxis to label_ormp_EquityIssuanceAxis_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US" id="label_us-gaap_AccountingPoliciesAbstract">SIGNIFICANT ACCOUNTING POLICIES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="label_us-gaap_AccountingPoliciesAbstract" xlink:title="Label : us-gaap_AccountingPoliciesAbstract to label_us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EquityIssuanceDomain" xlink:label="ormp_EquityIssuanceDomain" xlink:title="ormp_EquityIssuanceDomain" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EquityIssuanceDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_EquityIssuanceDomain" xml:lang="en-US" id="label_ormp_EquityIssuanceDomain">Equity Issuance [Domain].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EquityIssuanceDomain" xlink:to="label_ormp_EquityIssuanceDomain" xlink:title="Label : ormp_EquityIssuanceDomain to label_ormp_EquityIssuanceDomain" />
    <link:label xlink:type="resource" xlink:label="label_ormp_EquityIssuanceDomain_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_EquityIssuanceDomain_1" xml:lang="en-US" id="label_ormp_EquityIssuanceDomain_1">Equity Issuance [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_EquityIssuanceDomain" xlink:to="label_ormp_EquityIssuanceDomain_1" xlink:title="Label : ormp_EquityIssuanceDomain to label_ormp_EquityIssuanceDomain_1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IssuanceOneMember" xlink:label="ormp_IssuanceOneMember" xlink:title="ormp_IssuanceOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IssuanceOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_IssuanceOneMember" xml:lang="en-US" id="label_ormp_IssuanceOneMember">Issuance One [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IssuanceOneMember" xlink:to="label_ormp_IssuanceOneMember" xlink:title="Label : ormp_IssuanceOneMember to label_ormp_IssuanceOneMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IssuanceOneMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_IssuanceOneMember_1" xml:lang="en-US" id="label_ormp_IssuanceOneMember_1">Issuance One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IssuanceOneMember" xlink:to="label_ormp_IssuanceOneMember_1" xlink:title="Label : ormp_IssuanceOneMember to label_ormp_IssuanceOneMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IssuanceOneMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_IssuanceOneMember_2" xml:lang="en-US" id="label_ormp_IssuanceOneMember_2">Issued on November 13, 2014 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IssuanceOneMember" xlink:to="label_ormp_IssuanceOneMember_2" xlink:title="Label : ormp_IssuanceOneMember to label_ormp_IssuanceOneMember_2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IssuanceTwoMember" xlink:label="ormp_IssuanceTwoMember" xlink:title="ormp_IssuanceTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IssuanceTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ormp_IssuanceTwoMember" xml:lang="en-US" id="label_ormp_IssuanceTwoMember">Issuance Two [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IssuanceTwoMember" xlink:to="label_ormp_IssuanceTwoMember" xlink:title="Label : ormp_IssuanceTwoMember to label_ormp_IssuanceTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IssuanceTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ormp_IssuanceTwoMember_1" xml:lang="en-US" id="label_ormp_IssuanceTwoMember_1">Issuance Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IssuanceTwoMember" xlink:to="label_ormp_IssuanceTwoMember_1" xlink:title="Label : ormp_IssuanceTwoMember to label_ormp_IssuanceTwoMember_1" />
    <link:label xlink:type="resource" xlink:label="label_ormp_IssuanceTwoMember_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ormp_IssuanceTwoMember_2" xml:lang="en-US" id="label_ormp_IssuanceTwoMember_2">Issued on February 23, 2015 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ormp_IssuanceTwoMember" xlink:to="label_ormp_IssuanceTwoMember_2" xlink:title="Label : ormp_IssuanceTwoMember to label_ormp_IssuanceTwoMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="Label : us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent to label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1" xml:lang="en-US" id="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1" xlink:title="Label : us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent to label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2" xml:lang="en-US" id="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2" xlink:title="Label : us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent to label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:title="us-gaap_AccountsPayableOtherCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableOtherCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccountsPayableOtherCurrent" xml:lang="en-US" id="label_us-gaap_AccountsPayableOtherCurrent">Accounts Payable, Other, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="label_us-gaap_AccountsPayableOtherCurrent" xlink:title="Label : us-gaap_AccountsPayableOtherCurrent to label_us-gaap_AccountsPayableOtherCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccountsPayableOtherCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccountsPayableOtherCurrent_1" xml:lang="en-US" id="label_us-gaap_AccountsPayableOtherCurrent_1">Account payable with former shareholder</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableOtherCurrent" xlink:to="label_us-gaap_AccountsPayableOtherCurrent_1" xlink:title="Label : us-gaap_AccountsPayableOtherCurrent to label_us-gaap_AccountsPayableOtherCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:title="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xml:lang="en-US" id="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent">Accrued Royalties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:to="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:title="Label : us-gaap_AccruedRoyaltiesCurrentAndNoncurrent to label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1" xml:lang="en-US" id="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1">Royalty liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:to="label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1" xlink:title="Label : us-gaap_AccruedRoyaltiesCurrentAndNoncurrent to label_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Label : us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xml:lang="en-US" id="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1">Less - accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" xlink:title="Label : us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to label_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="Label : us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xml:lang="en-US" id="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1">Accumulated other comprehensive income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" xlink:title="Label : us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax to label_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalCommonStock">Additional Paid in Capital, Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="label_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="Label : us-gaap_AdditionalPaidInCapitalCommonStock to label_us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdditionalPaidInCapitalCommonStock_1" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalCommonStock_1">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="label_us-gaap_AdditionalPaidInCapitalCommonStock_1" xlink:title="Label : us-gaap_AdditionalPaidInCapitalCommonStock to label_us-gaap_AdditionalPaidInCapitalCommonStock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US" id="label_us-gaap_AdditionalPaidInCapitalMember">Additional paid-in capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember" xlink:title="Label : us-gaap_AdditionalPaidInCapitalMember to label_us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1">EXCHANGE OF WARRANTS (see note 5)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1">STOCK BASED COMPENSATION RELATED TO OPTIONS GRANTED TO EMPLOYEES AND DIRECTORS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="Label : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1">Adjustments required to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:title="Label : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1">STOCK BASED COMPENSATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition">Adjustments to Additional Paid in Capital, Share-based Compensation, Other Long-term Incentive Plans, Requisite Service Period Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_1" xml:lang="en-US" id="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_1">STOCK BASED COMPENSATION RELATED TO OPTIONS GRANTED TO CONSULTANTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_1" xlink:title="Label : us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition to label_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AllocatedShareBasedCompensationExpense" xml:lang="en-US" id="label_us-gaap_AllocatedShareBasedCompensationExpense">Allocated Share-based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Label : us-gaap_AllocatedShareBasedCompensationExpense to label_us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xml:lang="en-US" id="label_us-gaap_AllocatedShareBasedCompensationExpense_1">Stockbased compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="label_us-gaap_AllocatedShareBasedCompensationExpense_1" xlink:title="Label : us-gaap_AllocatedShareBasedCompensationExpense to label_us-gaap_AllocatedShareBasedCompensationExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Label : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="Label : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesNameDomain" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesNameDomain">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="label_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Label : us-gaap_AntidilutiveSecuritiesNameDomain to label_us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Label : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xml:lang="en-US" id="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1">Antidilutive securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" xlink:title="Label : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to label_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="us-gaap_Assets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Assets" xml:lang="en-US" id="label_us-gaap_Assets">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="label_us-gaap_Assets" xlink:title="Label : us-gaap_Assets to label_us-gaap_Assets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Assets_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_Assets_1" xml:lang="en-US" id="label_us-gaap_Assets_1">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="label_us-gaap_Assets_1" xlink:title="Label : us-gaap_Assets to label_us-gaap_Assets_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:title="us-gaap_AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsCurrentAbstract" xml:lang="en-US" id="label_us-gaap_AssetsCurrentAbstract">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract" xlink:title="Label : us-gaap_AssetsCurrentAbstract to label_us-gaap_AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AssetsCurrentAbstract_1" xml:lang="en-US" id="label_us-gaap_AssetsCurrentAbstract_1">CURRENT ASSETS:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract_1" xlink:title="Label : us-gaap_AssetsCurrentAbstract to label_us-gaap_AssetsCurrentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:title="us-gaap_AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsAbstract" xml:lang="en-US" id="label_us-gaap_AssetsAbstract">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract" xlink:title="Label : us-gaap_AssetsAbstract to label_us-gaap_AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_AssetsAbstract_1" xml:lang="en-US" id="label_us-gaap_AssetsAbstract_1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract_1" xlink:title="Label : us-gaap_AssetsAbstract to label_us-gaap_AssetsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="us-gaap_AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_AssetsCurrent" xml:lang="en-US" id="label_us-gaap_AssetsCurrent">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent" xlink:title="Label : us-gaap_AssetsCurrent to label_us-gaap_AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_AssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_AssetsCurrent_1" xml:lang="en-US" id="label_us-gaap_AssetsCurrent_1">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent_1" xlink:title="Label : us-gaap_AssetsCurrent to label_us-gaap_AssetsCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="Label : us-gaap_BasisOfAccountingPolicyPolicyTextBlock to label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1">Accounting principles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" xlink:title="Label : us-gaap_BasisOfAccountingPolicyPolicyTextBlock to label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="Label : us-gaap_CashAndCashEquivalentsPolicyTextBlock to label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1">Cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" xlink:title="Label : us-gaap_CashAndCashEquivalentsPolicyTextBlock to label_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xml:lang="en-US" id="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock">Cash, Cash Equivalents, and Short-term Investments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:to="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:title="Label : us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock to label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_1" xml:lang="en-US" id="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_1">SHORT TERM DEPOSITS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:to="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_1" xlink:title="Label : us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock to label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="Label : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" xlink:title="Label : us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease to label_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1">CASH AND CASH EQUIVALENTS AT END OF PERIOD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2">CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xml:lang="en-US" id="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" xlink:title="Label : us-gaap_CashAndCashEquivalentsAtCarryingValue to label_us-gaap_CashAndCashEquivalentsAtCarryingValue_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xml:lang="en-US" id="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract">SHORT TERM DEPOSITS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:title="Label : us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract to label_us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightOutstanding">Class of Warrant or Right, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="label_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:title="Label : us-gaap_ClassOfWarrantOrRightOutstanding to label_us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ClassOfWarrantOrRightOutstanding_1" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightOutstanding_1">Outstanding warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="label_us-gaap_ClassOfWarrantOrRightOutstanding_1" xlink:title="Label : us-gaap_ClassOfWarrantOrRightOutstanding to label_us-gaap_ClassOfWarrantOrRightOutstanding_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="Label : us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1">Exercise price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" xlink:title="Label : us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2">Exercise price of outstanding warrants (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:title="Label : us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to label_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Label : us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" xml:lang="en-US" id="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1">Number of shares authorized by warrant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" xlink:title="Label : us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to label_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">COMMITMENTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="Label : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to label_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:title="us-gaap_CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingencies" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingencies">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies" xlink:title="Label : us-gaap_CommitmentsAndContingencies to label_us-gaap_CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingencies_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommitmentsAndContingencies_1" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingencies_1">COMMITMENTS (note 2)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies_1" xlink:title="Label : us-gaap_CommitmentsAndContingencies to label_us-gaap_CommitmentsAndContingencies_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="Label : us-gaap_CommitmentsAndContingenciesDisclosureTextBlock to label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xml:lang="en-US" id="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1">COMMITMENTS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" xlink:title="Label : us-gaap_CommitmentsAndContingenciesDisclosureTextBlock to label_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US" id="label_us-gaap_CommonStockParOrStatedValuePerShare">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="Label : us-gaap_CommonStockParOrStatedValuePerShare to label_us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xml:lang="en-US" id="label_us-gaap_CommonStockParOrStatedValuePerShare_1">Common stock, par value per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare_1" xlink:title="Label : us-gaap_CommonStockParOrStatedValuePerShare to label_us-gaap_CommonStockParOrStatedValuePerShare_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockMember" xml:lang="en-US" id="label_us-gaap_CommonStockMember">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember" xlink:title="Label : us-gaap_CommonStockMember to label_us-gaap_CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockMember_1" xml:lang="en-US" id="label_us-gaap_CommonStockMember_1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember_1" xlink:title="Label : us-gaap_CommonStockMember to label_us-gaap_CommonStockMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="us-gaap_CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockValue" xml:lang="en-US" id="label_us-gaap_CommonStockValue">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue" xlink:title="Label : us-gaap_CommonStockValue to label_us-gaap_CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockValue_1" xml:lang="en-US" id="label_us-gaap_CommonStockValue_1">Common stock, $ 0.012 par value (30,000,000 authorized shares; 10,820,193 and 10,102,555 shares issued and outstanding as of February 28, 2015 and August 31, 2014, respectively)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue_1" xlink:title="Label : us-gaap_CommonStockValue to label_us-gaap_CommonStockValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:title="us-gaap_CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued" xlink:title="Label : us-gaap_CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesIssued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesIssued_1" xml:lang="en-US" id="label_us-gaap_CommonStockSharesIssued_1">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued_1" xlink:title="Label : us-gaap_CommonStockSharesIssued to label_us-gaap_CommonStockSharesIssued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:title="us-gaap_CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US" id="label_us-gaap_CommonStockSharesAuthorized">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized" xlink:title="Label : us-gaap_CommonStockSharesAuthorized to label_us-gaap_CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesAuthorized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesAuthorized_1" xml:lang="en-US" id="label_us-gaap_CommonStockSharesAuthorized_1">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized_1" xlink:title="Label : us-gaap_CommonStockSharesAuthorized to label_us-gaap_CommonStockSharesAuthorized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:title="us-gaap_CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding">Common Stock, Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding" xlink:title="Label : us-gaap_CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_CommonStockSharesOutstanding_1" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding_1">BALANCE, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding_1" xlink:title="Label : us-gaap_CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_CommonStockSharesOutstanding_2" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding_2">BALANCE, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding_2" xlink:title="Label : us-gaap_CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CommonStockSharesOutstanding_3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CommonStockSharesOutstanding_3" xml:lang="en-US" id="label_us-gaap_CommonStockSharesOutstanding_3">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding_3" xlink:title="Label : us-gaap_CommonStockSharesOutstanding to label_us-gaap_CommonStockSharesOutstanding_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComprehensiveIncomeNetOfTax" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTax">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="Label : us-gaap_ComprehensiveIncomeNetOfTax to label_us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeNetOfTax_1" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_us-gaap_ComprehensiveIncomeNetOfTax_1" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeNetOfTax_1">TOTAL COMPREHENSIVE LOSS FOR THE PERIOD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="label_us-gaap_ComprehensiveIncomeNetOfTax_1" xlink:title="Label : us-gaap_ComprehensiveIncomeNetOfTax to label_us-gaap_ComprehensiveIncomeNetOfTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeMember" xlink:label="us-gaap_ComprehensiveIncomeMember" xlink:title="us-gaap_ComprehensiveIncomeMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComprehensiveIncomeMember" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeMember">Comprehensive Income [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeMember" xlink:to="label_us-gaap_ComprehensiveIncomeMember" xlink:title="Label : us-gaap_ComprehensiveIncomeMember to label_us-gaap_ComprehensiveIncomeMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComprehensiveIncomeMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComprehensiveIncomeMember_1" xml:lang="en-US" id="label_us-gaap_ComprehensiveIncomeMember_1">Accumulated other comprehensive income [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeMember" xlink:to="label_us-gaap_ComprehensiveIncomeMember_1" xlink:title="Label : us-gaap_ComprehensiveIncomeMember to label_us-gaap_ComprehensiveIncomeMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="us-gaap_ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ComputerEquipmentMember" xml:lang="en-US" id="label_us-gaap_ComputerEquipmentMember">Computer Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="label_us-gaap_ComputerEquipmentMember" xlink:title="Label : us-gaap_ComputerEquipmentMember to label_us-gaap_ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ComputerEquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ComputerEquipmentMember_1" xml:lang="en-US" id="label_us-gaap_ComputerEquipmentMember_1">Computers and Peripheral Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="label_us-gaap_ComputerEquipmentMember_1" xlink:title="Label : us-gaap_ComputerEquipmentMember to label_us-gaap_ComputerEquipmentMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:title="us-gaap_ConsolidationPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ConsolidationPolicyTextBlock">Consolidation, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="label_us-gaap_ConsolidationPolicyTextBlock" xlink:title="Label : us-gaap_ConsolidationPolicyTextBlock to label_us-gaap_ConsolidationPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ConsolidationPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ConsolidationPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_ConsolidationPolicyTextBlock_1">Principles of consolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="label_us-gaap_ConsolidationPolicyTextBlock_1" xlink:title="Label : us-gaap_ConsolidationPolicyTextBlock to label_us-gaap_ConsolidationPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ContributionOfProperty" xlink:label="us-gaap_ContributionOfProperty" xlink:title="us-gaap_ContributionOfProperty" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ContributionOfProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ContributionOfProperty" xml:lang="en-US" id="label_us-gaap_ContributionOfProperty">Contribution of Property</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContributionOfProperty" xlink:to="label_us-gaap_ContributionOfProperty" xlink:title="Label : us-gaap_ContributionOfProperty to label_us-gaap_ContributionOfProperty" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ContributionOfProperty_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ContributionOfProperty_1" xml:lang="en-US" id="label_us-gaap_ContributionOfProperty_1">Contribution to paid in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContributionOfProperty" xlink:to="label_us-gaap_ContributionOfProperty_1" xlink:title="Label : us-gaap_ContributionOfProperty to label_us-gaap_ContributionOfProperty_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="us-gaap_CorporateJointVentureMember" xlink:title="us-gaap_CorporateJointVentureMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CorporateJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CorporateJointVentureMember" xml:lang="en-US" id="label_us-gaap_CorporateJointVentureMember">JV Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateJointVentureMember" xlink:to="label_us-gaap_CorporateJointVentureMember" xlink:title="Label : us-gaap_CorporateJointVentureMember to label_us-gaap_CorporateJointVentureMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostMethodInvestments" xlink:label="us-gaap_CostMethodInvestments" xlink:title="us-gaap_CostMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_CostMethodInvestments" xml:lang="en-US" id="label_us-gaap_CostMethodInvestments">Cost Method Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostMethodInvestments" xlink:to="label_us-gaap_CostMethodInvestments" xlink:title="Label : us-gaap_CostMethodInvestments to label_us-gaap_CostMethodInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_CostMethodInvestments_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_CostMethodInvestments_1" xml:lang="en-US" id="label_us-gaap_CostMethodInvestments_1">Investment in Entera</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostMethodInvestments" xlink:to="label_us-gaap_CostMethodInvestments_1" xlink:title="Label : us-gaap_CostMethodInvestments to label_us-gaap_CostMethodInvestments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xml:lang="en-US" id="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="Label : us-gaap_DebtConversionConvertedInstrumentSharesIssued1 to label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1" xml:lang="en-US" id="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1">Ordinary shares received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1" xlink:title="Label : us-gaap_DebtConversionConvertedInstrumentSharesIssued1 to label_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:title="us-gaap_DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentFaceAmount" xml:lang="en-US" id="label_us-gaap_DebtInstrumentFaceAmount">Debt Instrument, Face Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="label_us-gaap_DebtInstrumentFaceAmount" xlink:title="Label : us-gaap_DebtInstrumentFaceAmount to label_us-gaap_DebtInstrumentFaceAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentFaceAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentFaceAmount_1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentFaceAmount_1">Principal amount of promissory note received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="label_us-gaap_DebtInstrumentFaceAmount_1" xlink:title="Label : us-gaap_DebtInstrumentFaceAmount to label_us-gaap_DebtInstrumentFaceAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtConversionConvertedInstrumentAmount1" xml:lang="en-US" id="label_us-gaap_DebtConversionConvertedInstrumentAmount1">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="label_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="Label : us-gaap_DebtConversionConvertedInstrumentAmount1 to label_us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" xml:lang="en-US" id="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1">Exchange of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" xlink:title="Label : us-gaap_DebtConversionConvertedInstrumentAmount1 to label_us-gaap_DebtConversionConvertedInstrumentAmount1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateStatedPercentage">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="label_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="Label : us-gaap_DebtInstrumentInterestRateStatedPercentage to label_us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1" xml:lang="en-US" id="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1">Annual interest rate (as a percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1" xlink:title="Label : us-gaap_DebtInstrumentInterestRateStatedPercentage to label_us-gaap_DebtInstrumentInterestRateStatedPercentage_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="Label : us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment to label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1">Research and development expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1" xlink:title="Label : us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment to label_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:title="us-gaap_DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsNet" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNet">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="label_us-gaap_DeferredTaxAssetsNet" xlink:title="Label : us-gaap_DeferredTaxAssetsNet to label_us-gaap_DeferredTaxAssetsNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsNet_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_DeferredTaxAssetsNet_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsNet_1">Net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="label_us-gaap_DeferredTaxAssetsNet_1" xlink:title="Label : us-gaap_DeferredTaxAssetsNet to label_us-gaap_DeferredTaxAssetsNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="Label : us-gaap_DeferredTaxAssetsOperatingLossCarryforwards to label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1">Net operating loss carryforward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" xlink:title="Label : us-gaap_DeferredTaxAssetsOperatingLossCarryforwards to label_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="Label : us-gaap_DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance_1">Balance at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:title="Label : us-gaap_DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance_2" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance_2">Balance at beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance_2" xlink:title="Label : us-gaap_DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DeferredTaxAssetsValuationAllowance_3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_DeferredTaxAssetsValuationAllowance_3" xml:lang="en-US" id="label_us-gaap_DeferredTaxAssetsValuationAllowance_3">Less - Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_DeferredTaxAssetsValuationAllowance_3" xlink:title="Label : us-gaap_DeferredTaxAssetsValuationAllowance to label_us-gaap_DeferredTaxAssetsValuationAllowance_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" xlink:title="us-gaap_DefinedContributionPlanCostRecognized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DefinedContributionPlanCostRecognized" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanCostRecognized">Defined Contribution Plan, Cost Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="label_us-gaap_DefinedContributionPlanCostRecognized" xlink:title="Label : us-gaap_DefinedContributionPlanCostRecognized to label_us-gaap_DefinedContributionPlanCostRecognized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DefinedContributionPlanCostRecognized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DefinedContributionPlanCostRecognized_1" xml:lang="en-US" id="label_us-gaap_DefinedContributionPlanCostRecognized_1">Severance pay expenses in respect of Contribution Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="label_us-gaap_DefinedContributionPlanCostRecognized_1" xlink:title="Label : us-gaap_DefinedContributionPlanCostRecognized to label_us-gaap_DefinedContributionPlanCostRecognized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:title="us-gaap_DepositsAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DepositsAssetsCurrent" xml:lang="en-US" id="label_us-gaap_DepositsAssetsCurrent">Deposits Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="label_us-gaap_DepositsAssetsCurrent" xlink:title="Label : us-gaap_DepositsAssetsCurrent to label_us-gaap_DepositsAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepositsAssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DepositsAssetsCurrent_1" xml:lang="en-US" id="label_us-gaap_DepositsAssetsCurrent_1">Short term deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="label_us-gaap_DepositsAssetsCurrent_1" xlink:title="Label : us-gaap_DepositsAssetsCurrent to label_us-gaap_DepositsAssetsCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:title="us-gaap_DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DepreciationDepletionAndAmortization" xml:lang="en-US" id="label_us-gaap_DepreciationDepletionAndAmortization">Depreciation, Depletion and Amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="label_us-gaap_DepreciationDepletionAndAmortization" xlink:title="Label : us-gaap_DepreciationDepletionAndAmortization to label_us-gaap_DepreciationDepletionAndAmortization" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DepreciationDepletionAndAmortization_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DepreciationDepletionAndAmortization_1" xml:lang="en-US" id="label_us-gaap_DepreciationDepletionAndAmortization_1">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="label_us-gaap_DepreciationDepletionAndAmortization_1" xlink:title="Label : us-gaap_DepreciationDepletionAndAmortization to label_us-gaap_DepreciationDepletionAndAmortization_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:title="us-gaap_Depreciation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_Depreciation" xml:lang="en-US" id="label_us-gaap_Depreciation">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="label_us-gaap_Depreciation" xlink:title="Label : us-gaap_Depreciation to label_us-gaap_Depreciation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Depreciation_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_Depreciation_1" xml:lang="en-US" id="label_us-gaap_Depreciation_1">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="label_us-gaap_Depreciation_1" xlink:title="Label : us-gaap_Depreciation to label_us-gaap_Depreciation_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_Depreciation_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_Depreciation_2" xml:lang="en-US" id="label_us-gaap_Depreciation_2">Depreciation expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="label_us-gaap_Depreciation_2" xlink:title="Label : us-gaap_Depreciation to label_us-gaap_Depreciation_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativeGainLossOnDerivativeNet" xml:lang="en-US" id="label_us-gaap_DerivativeGainLossOnDerivativeNet">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="label_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="Label : us-gaap_DerivativeGainLossOnDerivativeNet to label_us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeGainLossOnDerivativeNet_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_DerivativeGainLossOnDerivativeNet_1" xml:lang="en-US" id="label_us-gaap_DerivativeGainLossOnDerivativeNet_1">Changes in fair value of warrant liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="label_us-gaap_DerivativeGainLossOnDerivativeNet_1" xlink:title="Label : us-gaap_DerivativeGainLossOnDerivativeNet to label_us-gaap_DerivativeGainLossOnDerivativeNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLossOnDerivative" xlink:label="us-gaap_DerivativeLossOnDerivative" xlink:title="us-gaap_DerivativeLossOnDerivative" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeLossOnDerivative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativeLossOnDerivative" xml:lang="en-US" id="label_us-gaap_DerivativeLossOnDerivative">Derivative, Loss on Derivative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLossOnDerivative" xlink:to="label_us-gaap_DerivativeLossOnDerivative" xlink:title="Label : us-gaap_DerivativeLossOnDerivative to label_us-gaap_DerivativeLossOnDerivative" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeLossOnDerivative_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DerivativeLossOnDerivative_1" xml:lang="en-US" id="label_us-gaap_DerivativeLossOnDerivative_1">Changes in fair value of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLossOnDerivative" xlink:to="label_us-gaap_DerivativeLossOnDerivative_1" xlink:title="Label : us-gaap_DerivativeLossOnDerivative to label_us-gaap_DerivativeLossOnDerivative_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainOnDerivative" xlink:label="us-gaap_DerivativeGainOnDerivative" xlink:title="us-gaap_DerivativeGainOnDerivative" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeGainOnDerivative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DerivativeGainOnDerivative" xml:lang="en-US" id="label_us-gaap_DerivativeGainOnDerivative">Derivative, Gain on Derivative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainOnDerivative" xlink:to="label_us-gaap_DerivativeGainOnDerivative" xlink:title="Label : us-gaap_DerivativeGainOnDerivative to label_us-gaap_DerivativeGainOnDerivative" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DerivativeGainOnDerivative_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DerivativeGainOnDerivative_1" xml:lang="en-US" id="label_us-gaap_DerivativeGainOnDerivative_1">Changes in fair value of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeGainOnDerivative" xlink:to="label_us-gaap_DerivativeGainOnDerivative_1" xlink:title="Label : us-gaap_DerivativeGainOnDerivative to label_us-gaap_DerivativeGainOnDerivative_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DirectorMember" xml:lang="en-US" id="label_us-gaap_DirectorMember">Director [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectorMember" xlink:to="label_us-gaap_DirectorMember" xlink:title="Label : us-gaap_DirectorMember to label_us-gaap_DirectorMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DirectorMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DirectorMember_1" xml:lang="en-US" id="label_us-gaap_DirectorMember_1">Directors [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectorMember" xlink:to="label_us-gaap_DirectorMember_1" xlink:title="Label : us-gaap_DirectorMember to label_us-gaap_DirectorMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="Label : us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1">STOCK BASED COMPENSATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" xlink:title="Label : us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xml:lang="en-US" id="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">STOCK BASED COMPENSATION [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="Label : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to label_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:title="us-gaap_DueToRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueToRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DueToRelatedPartiesCurrent" xml:lang="en-US" id="label_us-gaap_DueToRelatedPartiesCurrent">Due to Related Parties, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="label_us-gaap_DueToRelatedPartiesCurrent" xlink:title="Label : us-gaap_DueToRelatedPartiesCurrent to label_us-gaap_DueToRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueToRelatedPartiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DueToRelatedPartiesCurrent_1" xml:lang="en-US" id="label_us-gaap_DueToRelatedPartiesCurrent_1">Related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="label_us-gaap_DueToRelatedPartiesCurrent_1" xlink:title="Label : us-gaap_DueToRelatedPartiesCurrent to label_us-gaap_DueToRelatedPartiesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueToRelatedPartiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DueToRelatedPartiesCurrent_2" xml:lang="en-US" id="label_us-gaap_DueToRelatedPartiesCurrent_2">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrent" xlink:to="label_us-gaap_DueToRelatedPartiesCurrent_2" xlink:title="Label : us-gaap_DueToRelatedPartiesCurrent to label_us-gaap_DueToRelatedPartiesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:label="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:title="us-gaap_DueFromOtherRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_DueFromOtherRelatedPartiesCurrent" xml:lang="en-US" id="label_us-gaap_DueFromOtherRelatedPartiesCurrent">Due from Other Related Parties, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:to="label_us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:title="Label : us-gaap_DueFromOtherRelatedPartiesCurrent to label_us-gaap_DueFromOtherRelatedPartiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueFromOtherRelatedPartiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_DueFromOtherRelatedPartiesCurrent_1" xml:lang="en-US" id="label_us-gaap_DueFromOtherRelatedPartiesCurrent_1">Related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:to="label_us-gaap_DueFromOtherRelatedPartiesCurrent_1" xlink:title="Label : us-gaap_DueFromOtherRelatedPartiesCurrent to label_us-gaap_DueFromOtherRelatedPartiesCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_DueFromOtherRelatedPartiesCurrent_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_DueFromOtherRelatedPartiesCurrent_2" xml:lang="en-US" id="label_us-gaap_DueFromOtherRelatedPartiesCurrent_2">Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:to="label_us-gaap_DueFromOtherRelatedPartiesCurrent_2" xlink:title="Label : us-gaap_DueFromOtherRelatedPartiesCurrent to label_us-gaap_DueFromOtherRelatedPartiesCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:title="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:title="Label : us-gaap_EarningsPerShareBasicAndDilutedAbstract to label_us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1">LOSS PER COMMON SHARE:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="label_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1" xlink:title="Label : us-gaap_EarningsPerShareBasicAndDilutedAbstract to label_us-gaap_EarningsPerShareBasicAndDilutedAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDiluted">Earnings Per Share, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="Label : us-gaap_EarningsPerShareBasicAndDiluted to label_us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xml:lang="en-US" id="label_us-gaap_EarningsPerShareBasicAndDiluted_1">BASIC AND DILUTED LOSS PER COMMON SHARE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted_1" xlink:title="Label : us-gaap_EarningsPerShareBasicAndDiluted to label_us-gaap_EarningsPerShareBasicAndDiluted_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US" id="label_us-gaap_EarningsPerSharePolicyTextBlock">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="Label : us-gaap_EarningsPerSharePolicyTextBlock to label_us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_EarningsPerSharePolicyTextBlock_1">Loss per common share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock_1" xlink:title="Label : us-gaap_EarningsPerSharePolicyTextBlock to label_us-gaap_EarningsPerSharePolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xml:lang="en-US" id="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="Label : us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents to label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1" xml:lang="en-US" id="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1" xlink:title="Label : us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents to label_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xml:lang="en-US" id="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1">Corporate tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" xlink:title="Label : us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to label_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1">Unrecognized compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xml:lang="en-US" id="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1">Period over which compensation expense will be recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" xlink:title="Label : us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to label_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:label="us-gaap_EquityIssuancePerShareAmount" xlink:title="us-gaap_EquityIssuancePerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EquityIssuancePerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EquityIssuancePerShareAmount" xml:lang="en-US" id="label_us-gaap_EquityIssuancePerShareAmount">Development Stage Entities, Equity Issuance, Per Share Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityIssuancePerShareAmount" xlink:to="label_us-gaap_EquityIssuancePerShareAmount" xlink:title="Label : us-gaap_EquityIssuancePerShareAmount to label_us-gaap_EquityIssuancePerShareAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EquityIssuancePerShareAmount_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_EquityIssuancePerShareAmount_1" xml:lang="en-US" id="label_us-gaap_EquityIssuancePerShareAmount_1">Shares issued for cash, price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityIssuancePerShareAmount" xlink:to="label_us-gaap_EquityIssuancePerShareAmount_1" xlink:title="Label : us-gaap_EquityIssuancePerShareAmount to label_us-gaap_EquityIssuancePerShareAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" xlink:title="us-gaap_EquityMethodInvesteeNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EquityMethodInvesteeNameDomain" xml:lang="en-US" id="label_us-gaap_EquityMethodInvesteeNameDomain">Investment, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="label_us-gaap_EquityMethodInvesteeNameDomain" xlink:title="Label : us-gaap_EquityMethodInvesteeNameDomain to label_us-gaap_EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_EquityComponentDomain" xml:lang="en-US" id="label_us-gaap_EquityComponentDomain">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="label_us-gaap_EquityComponentDomain" xlink:title="Label : us-gaap_EquityComponentDomain to label_us-gaap_EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember" xlink:title="us-gaap_ExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ExecutiveOfficerMember" xml:lang="en-US" id="label_us-gaap_ExecutiveOfficerMember">Executive Officer [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExecutiveOfficerMember" xlink:to="label_us-gaap_ExecutiveOfficerMember" xlink:title="Label : us-gaap_ExecutiveOfficerMember to label_us-gaap_ExecutiveOfficerMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ExecutiveOfficerMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ExecutiveOfficerMember_1" xml:lang="en-US" id="label_us-gaap_ExecutiveOfficerMember_1">Nadav Kidron and Miriam Kidron [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExecutiveOfficerMember" xlink:to="label_us-gaap_ExecutiveOfficerMember_1" xlink:title="Label : us-gaap_ExecutiveOfficerMember to label_us-gaap_ExecutiveOfficerMember_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ExecutiveOfficerMember_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ExecutiveOfficerMember_2" xml:lang="en-US" id="label_us-gaap_ExecutiveOfficerMember_2">CEO [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExecutiveOfficerMember" xlink:to="label_us-gaap_ExecutiveOfficerMember_2" xlink:title="Label : us-gaap_ExecutiveOfficerMember to label_us-gaap_ExecutiveOfficerMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate">Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:title="Label : us-gaap_FairValueAssumptionsExpectedVolatilityRate to label_us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate_1" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate_1">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_FairValueAssumptionsExpectedVolatilityRate_1" xlink:title="Label : us-gaap_FairValueAssumptionsExpectedVolatilityRate to label_us-gaap_FairValueAssumptionsExpectedVolatilityRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="Label : us-gaap_FairValueMeasurementPolicyPolicyTextBlock to label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1">Fair value measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1" xlink:title="Label : us-gaap_FairValueMeasurementPolicyPolicyTextBlock to label_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US" id="label_us-gaap_FairValueByFairValueHierarchyLevelAxis">Fair Value, Hierarchy [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="label_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="Label : us-gaap_FairValueByFairValueHierarchyLevelAxis to label_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate">Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:title="Label : us-gaap_FairValueAssumptionsRiskFreeInterestRate to label_us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate_1" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate_1">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_FairValueAssumptionsRiskFreeInterestRate_1" xlink:title="Label : us-gaap_FairValueAssumptionsRiskFreeInterestRate to label_us-gaap_FairValueAssumptionsRiskFreeInterestRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xml:lang="en-US" id="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="Label : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" xlink:title="us-gaap_FairValueAssumptionsExpectedTerm" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsExpectedTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssumptionsExpectedTerm" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsExpectedTerm">Fair Value Assumptions, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="label_us-gaap_FairValueAssumptionsExpectedTerm" xlink:title="Label : us-gaap_FairValueAssumptionsExpectedTerm to label_us-gaap_FairValueAssumptionsExpectedTerm" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsExpectedTerm_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueAssumptionsExpectedTerm_1" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsExpectedTerm_1">Expected term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="label_us-gaap_FairValueAssumptionsExpectedTerm_1" xlink:title="Label : us-gaap_FairValueAssumptionsExpectedTerm to label_us-gaap_FairValueAssumptionsExpectedTerm_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US" id="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="Label : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to label_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="Label : us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1">Additions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1" xlink:title="Label : us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues to label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_FairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueAssumptionsExpectedDividendRate" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsExpectedDividendRate">Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:title="Label : us-gaap_FairValueAssumptionsExpectedDividendRate to label_us-gaap_FairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueAssumptionsExpectedDividendRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueAssumptionsExpectedDividendRate_1" xml:lang="en-US" id="label_us-gaap_FairValueAssumptionsExpectedDividendRate_1">Expected dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_FairValueAssumptionsExpectedDividendRate_1" xlink:title="Label : us-gaap_FairValueAssumptionsExpectedDividendRate to label_us-gaap_FairValueAssumptionsExpectedDividendRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="Label : us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1">Carrying value at the end of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1" xlink:title="Label : us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2">Carrying value at the beginning of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:title="Label : us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue to label_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:title="us-gaap_FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresAbstract">FAIR VALUE [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="label_us-gaap_FairValueDisclosuresAbstract" xlink:title="Label : us-gaap_FairValueDisclosuresAbstract to label_us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US" id="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="Label : us-gaap_FairValueMeasurementsFairValueHierarchyDomain to label_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:title="us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresTextBlock">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="label_us-gaap_FairValueDisclosuresTextBlock" xlink:title="Label : us-gaap_FairValueDisclosuresTextBlock to label_us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueDisclosuresTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueDisclosuresTextBlock_1" xml:lang="en-US" id="label_us-gaap_FairValueDisclosuresTextBlock_1">FAIR VALUE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="label_us-gaap_FairValueDisclosuresTextBlock_1" xlink:title="Label : us-gaap_FairValueDisclosuresTextBlock to label_us-gaap_FairValueDisclosuresTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:title="us-gaap_FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel1Member">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="label_us-gaap_FairValueInputsLevel1Member" xlink:title="Label : us-gaap_FairValueInputsLevel1Member to label_us-gaap_FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueInputsLevel1Member_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueInputsLevel1Member_1" xml:lang="en-US" id="label_us-gaap_FairValueInputsLevel1Member_1">Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="label_us-gaap_FairValueInputsLevel1Member_1" xlink:title="Label : us-gaap_FairValueInputsLevel1Member to label_us-gaap_FairValueInputsLevel1Member_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xml:lang="en-US" id="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:title="Label : us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock to label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1" xml:lang="en-US" id="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1">Schedule of Liabilities Measured at Fair Value Using Significant Unobservable Inputs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1" xlink:title="Label : us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock to label_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Label : us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1" xml:lang="en-US" id="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1">U.S.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1" xlink:title="Label : us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionGainBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax">Foreign Currency Transaction Gain, before Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:to="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:title="Label : us-gaap_ForeignCurrencyTransactionGainBeforeTax to label_us-gaap_ForeignCurrencyTransactionGainBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax_1" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax_1">Exchange rate differences</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:to="label_us-gaap_ForeignCurrencyTransactionGainBeforeTax_1" xlink:title="Label : us-gaap_ForeignCurrencyTransactionGainBeforeTax to label_us-gaap_ForeignCurrencyTransactionGainBeforeTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xml:lang="en-US" id="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations">Foreign Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Label : us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1" xml:lang="en-US" id="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1">Outside U.S.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:to="label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1" xlink:title="Label : us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations to label_us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="Label : us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock to label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1">Functional currency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1" xlink:title="Label : us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock to label_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionLossBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax">Foreign Currency Transaction Loss, before Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:to="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:title="Label : us-gaap_ForeignCurrencyTransactionLossBeforeTax to label_us-gaap_ForeignCurrencyTransactionLossBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1">Exchange rate differences</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:to="label_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1" xlink:title="Label : us-gaap_ForeignCurrencyTransactionLossBeforeTax to label_us-gaap_ForeignCurrencyTransactionLossBeforeTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="Label : us-gaap_ForeignCurrencyTransactionGainLossBeforeTax to label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1">Exchange differences and interest on deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1" xlink:title="Label : us-gaap_ForeignCurrencyTransactionGainLossBeforeTax to label_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:title="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ForeignCurrencyExchangeRateTranslation1" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyExchangeRateTranslation1">Foreign Currency Exchange Rate, Translation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="label_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:title="Label : us-gaap_ForeignCurrencyExchangeRateTranslation1 to label_us-gaap_ForeignCurrencyExchangeRateTranslation1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ForeignCurrencyExchangeRateTranslation1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ForeignCurrencyExchangeRateTranslation1_1" xml:lang="en-US" id="label_us-gaap_ForeignCurrencyExchangeRateTranslation1_1">Exchange rate (in NIS per U.S. dollar)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="label_us-gaap_ForeignCurrencyExchangeRateTranslation1_1" xlink:title="Label : us-gaap_ForeignCurrencyExchangeRateTranslation1 to label_us-gaap_ForeignCurrencyExchangeRateTranslation1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:title="us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xml:lang="en-US" id="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments">Gain (Loss) on Investments, Excluding Other than Temporary Impairments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:to="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:title="Label : us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments to label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_1" xml:lang="en-US" id="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_1">GAIN ON SALE OF INVESTMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:to="label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_1" xlink:title="Label : us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments to label_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="us-gaap_GainLossOnSaleOfInvestments" xlink:title="us-gaap_GainLossOnSaleOfInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GainLossOnSaleOfInvestments" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfInvestments">Gain (Loss) on Sale of Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfInvestments" xlink:to="label_us-gaap_GainLossOnSaleOfInvestments" xlink:title="Label : us-gaap_GainLossOnSaleOfInvestments to label_us-gaap_GainLossOnSaleOfInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfInvestments_1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="label_us-gaap_GainLossOnSaleOfInvestments_1" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfInvestments_1">Gain on sale of investment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfInvestments" xlink:to="label_us-gaap_GainLossOnSaleOfInvestments_1" xlink:title="Label : us-gaap_GainLossOnSaleOfInvestments to label_us-gaap_GainLossOnSaleOfInvestments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:label="us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:title="us-gaap_GainLossOnSaleOfSecuritiesNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GainLossOnSaleOfSecuritiesNet" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfSecuritiesNet">Gain (Loss) on Sale of Securities, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:to="label_us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:title="Label : us-gaap_GainLossOnSaleOfSecuritiesNet to label_us-gaap_GainLossOnSaleOfSecuritiesNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GainLossOnSaleOfSecuritiesNet_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GainLossOnSaleOfSecuritiesNet_1" xml:lang="en-US" id="label_us-gaap_GainLossOnSaleOfSecuritiesNet_1">Gain on sale of marketable securities (note 3)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:to="label_us-gaap_GainLossOnSaleOfSecuritiesNet_1" xlink:title="Label : us-gaap_GainLossOnSaleOfSecuritiesNet to label_us-gaap_GainLossOnSaleOfSecuritiesNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:title="us-gaap_GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpense">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense" xlink:title="Label : us-gaap_GeneralAndAdministrativeExpense to label_us-gaap_GeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GeneralAndAdministrativeExpense_1" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpense_1">GENERAL AND ADMINISTRATIVE EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense_1" xlink:title="Label : us-gaap_GeneralAndAdministrativeExpense to label_us-gaap_GeneralAndAdministrativeExpense_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_GeneralAndAdministrativeExpense_2" xml:lang="en-US" id="label_us-gaap_GeneralAndAdministrativeExpense_2">General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense_2" xlink:title="Label : us-gaap_GeneralAndAdministrativeExpense to label_us-gaap_GeneralAndAdministrativeExpense_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="us-gaap_GrantsReceivable" xlink:title="us-gaap_GrantsReceivable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GrantsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_GrantsReceivable" xml:lang="en-US" id="label_us-gaap_GrantsReceivable">Grants Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="label_us-gaap_GrantsReceivable" xlink:title="Label : us-gaap_GrantsReceivable to label_us-gaap_GrantsReceivable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_GrantsReceivable_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_GrantsReceivable_1" xml:lang="en-US" id="label_us-gaap_GrantsReceivable_1">Grants receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantsReceivable" xlink:to="label_us-gaap_GrantsReceivable_1" xlink:title="Label : us-gaap_GrantsReceivable to label_us-gaap_GrantsReceivable_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="us-gaap_IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeStatementAbstract" xml:lang="en-US" id="label_us-gaap_IncomeStatementAbstract">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="label_us-gaap_IncomeStatementAbstract" xlink:title="Label : us-gaap_IncomeStatementAbstract to label_us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1">Loss before income taxes as reported in the consolidated statement of comprehensive income (loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2">Loss before taxes on income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3">LOSS BEFORE TAXES ON INCOME</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureAbstract">TAXES ON INCOME [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="label_us-gaap_IncomeTaxDisclosureAbstract" xlink:title="Label : us-gaap_IncomeTaxDisclosureAbstract to label_us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1">Outside U.S.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1" xml:lang="en-US" id="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1">U.S.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1" xlink:title="Label : us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic to label_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxExpenseBenefit" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefit">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="label_us-gaap_IncomeTaxExpenseBenefit" xlink:title="Label : us-gaap_IncomeTaxExpenseBenefit to label_us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxExpenseBenefit_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefit_1">INCOME TAX EXPENSES (BENEFIT) (note 11)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="label_us-gaap_IncomeTaxExpenseBenefit_1" xlink:title="Label : us-gaap_IncomeTaxExpenseBenefit to label_us-gaap_IncomeTaxExpenseBenefit_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExpenseBenefit_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_IncomeTaxExpenseBenefit_2" xml:lang="en-US" id="label_us-gaap_IncomeTaxExpenseBenefit_2">Taxes on income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="label_us-gaap_IncomeTaxExpenseBenefit_2" xlink:title="Label : us-gaap_IncomeTaxExpenseBenefit to label_us-gaap_IncomeTaxExpenseBenefit_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="Label : us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance to label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1">Change in the balance of the valuation allowance for deferred tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" xlink:title="Label : us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance to label_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:title="us-gaap_IncomeTaxExaminationPenaltiesExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxExaminationPenaltiesExpense" xml:lang="en-US" id="label_us-gaap_IncomeTaxExaminationPenaltiesExpense">Income Tax Examination, Penalties Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:to="label_us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:title="Label : us-gaap_IncomeTaxExaminationPenaltiesExpense to label_us-gaap_IncomeTaxExaminationPenaltiesExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxExaminationPenaltiesExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxExaminationPenaltiesExpense_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxExaminationPenaltiesExpense_1">Penalties related to tax contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:to="label_us-gaap_IncomeTaxExaminationPenaltiesExpense_1" xlink:title="Label : us-gaap_IncomeTaxExaminationPenaltiesExpense to label_us-gaap_IncomeTaxExaminationPenaltiesExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureTextBlock">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="label_us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="Label : us-gaap_IncomeTaxDisclosureTextBlock to label_us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxDisclosureTextBlock_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxDisclosureTextBlock_1">TAXES ON INCOME</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="label_us-gaap_IncomeTaxDisclosureTextBlock_1" xlink:title="Label : us-gaap_IncomeTaxDisclosureTextBlock to label_us-gaap_IncomeTaxDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:title="Label : us-gaap_IncomeTaxReconciliationNondeductibleExpense to label_us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1">Disallowable deductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="label_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1" xlink:title="Label : us-gaap_IncomeTaxReconciliationNondeductibleExpense to label_us-gaap_IncomeTaxReconciliationNondeductibleExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="Label : us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1">Statutory tax benefit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" xlink:title="Label : us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to label_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:title="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_IncomeTaxPolicyTextBlock">Income Tax, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="label_us-gaap_IncomeTaxPolicyTextBlock" xlink:title="Label : us-gaap_IncomeTaxPolicyTextBlock to label_us-gaap_IncomeTaxPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxPolicyTextBlock_1">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="label_us-gaap_IncomeTaxPolicyTextBlock_1" xlink:title="Label : us-gaap_IncomeTaxPolicyTextBlock to label_us-gaap_IncomeTaxPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:title="us-gaap_IncomeTaxReconciliationTaxContingencies" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationTaxContingencies" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationTaxContingencies">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="label_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:title="Label : us-gaap_IncomeTaxReconciliationTaxContingencies to label_us-gaap_IncomeTaxReconciliationTaxContingencies" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationTaxContingencies_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationTaxContingencies_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationTaxContingencies_1">Uncertain tax position</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="label_us-gaap_IncomeTaxReconciliationTaxContingencies_1" xlink:title="Label : us-gaap_IncomeTaxReconciliationTaxContingencies to label_us-gaap_IncomeTaxReconciliationTaxContingencies_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:title="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:title="Label : us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential to label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1" xml:lang="en-US" id="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1">Increase in taxes resulting from different tax rates applicable to non U.S. subsidiary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1" xlink:title="Label : us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential to label_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsPayable" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsPayable">Increase (Decrease) in Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:title="Label : us-gaap_IncreaseDecreaseInAccountsPayable to label_us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayable_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInAccountsPayable_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInAccountsPayable_1">Accounts payable and accrued expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayable_1" xlink:title="Label : us-gaap_IncreaseDecreaseInAccountsPayable to label_us-gaap_IncreaseDecreaseInAccountsPayable_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="Label : us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities to label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1">Provision for uncertain tax position</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1" xlink:title="Label : us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities to label_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="Label : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" xlink:title="Label : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="Label : us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" xlink:title="Label : us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to label_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:label="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:title="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">Increase (Decrease) in Pension and Postretirement Obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:to="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:title="Label : us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations to label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_1" xml:lang="en-US" id="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_1">Liability for employee rights upon retirement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:to="label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_1" xlink:title="Label : us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations to label_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestAndOtherIncomeAbstract" xlink:label="us-gaap_InterestAndOtherIncomeAbstract" xlink:title="us-gaap_InterestAndOtherIncomeAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestAndOtherIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestAndOtherIncomeAbstract" xml:lang="en-US" id="label_us-gaap_InterestAndOtherIncomeAbstract">FINANCIAL INCOME AND EXPENSES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncomeAbstract" xlink:to="label_us-gaap_InterestAndOtherIncomeAbstract" xlink:title="Label : us-gaap_InterestAndOtherIncomeAbstract to label_us-gaap_InterestAndOtherIncomeAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:title="us-gaap_InterestIncomeExpenseNonoperatingNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestIncomeExpenseNonoperatingNet" xml:lang="en-US" id="label_us-gaap_InterestIncomeExpenseNonoperatingNet">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="label_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:title="Label : us-gaap_InterestIncomeExpenseNonoperatingNet to label_us-gaap_InterestIncomeExpenseNonoperatingNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestIncomeExpenseNonoperatingNet_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestIncomeExpenseNonoperatingNet_1" xml:lang="en-US" id="label_us-gaap_InterestIncomeExpenseNonoperatingNet_1">Income from interest on deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="label_us-gaap_InterestIncomeExpenseNonoperatingNet_1" xlink:title="Label : us-gaap_InterestIncomeExpenseNonoperatingNet to label_us-gaap_InterestIncomeExpenseNonoperatingNet_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestAndOtherIncomeTextBlock" xlink:label="us-gaap_InterestAndOtherIncomeTextBlock" xlink:title="us-gaap_InterestAndOtherIncomeTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestAndOtherIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestAndOtherIncomeTextBlock" xml:lang="en-US" id="label_us-gaap_InterestAndOtherIncomeTextBlock">Interest and Other Income [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncomeTextBlock" xlink:to="label_us-gaap_InterestAndOtherIncomeTextBlock" xlink:title="Label : us-gaap_InterestAndOtherIncomeTextBlock to label_us-gaap_InterestAndOtherIncomeTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestAndOtherIncomeTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestAndOtherIncomeTextBlock_1" xml:lang="en-US" id="label_us-gaap_InterestAndOtherIncomeTextBlock_1">FINANCIAL INCOME AND EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncomeTextBlock" xlink:to="label_us-gaap_InterestAndOtherIncomeTextBlock_1" xlink:title="Label : us-gaap_InterestAndOtherIncomeTextBlock to label_us-gaap_InterestAndOtherIncomeTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestBearingDepositsMember" xlink:label="us-gaap_InterestBearingDepositsMember" xlink:title="us-gaap_InterestBearingDepositsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestBearingDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestBearingDepositsMember" xml:lang="en-US" id="label_us-gaap_InterestBearingDepositsMember">Interest-bearing Deposits [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestBearingDepositsMember" xlink:to="label_us-gaap_InterestBearingDepositsMember" xlink:title="Label : us-gaap_InterestBearingDepositsMember to label_us-gaap_InterestBearingDepositsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestBearingDepositsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestBearingDepositsMember_1" xml:lang="en-US" id="label_us-gaap_InterestBearingDepositsMember_1">Dollars deposits [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestBearingDepositsMember" xlink:to="label_us-gaap_InterestBearingDepositsMember_1" xlink:title="Label : us-gaap_InterestBearingDepositsMember to label_us-gaap_InterestBearingDepositsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestBearingDepositsInBanks" xlink:label="us-gaap_InterestBearingDepositsInBanks" xlink:title="us-gaap_InterestBearingDepositsInBanks" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestBearingDepositsInBanks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InterestBearingDepositsInBanks" xml:lang="en-US" id="label_us-gaap_InterestBearingDepositsInBanks">Interest-bearing Deposits in Banks and Other Financial Institutions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestBearingDepositsInBanks" xlink:to="label_us-gaap_InterestBearingDepositsInBanks" xlink:title="Label : us-gaap_InterestBearingDepositsInBanks to label_us-gaap_InterestBearingDepositsInBanks" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InterestBearingDepositsInBanks_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InterestBearingDepositsInBanks_1" xml:lang="en-US" id="label_us-gaap_InterestBearingDepositsInBanks_1">Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestBearingDepositsInBanks" xlink:to="label_us-gaap_InterestBearingDepositsInBanks_1" xlink:title="Label : us-gaap_InterestBearingDepositsInBanks to label_us-gaap_InterestBearingDepositsInBanks_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:label="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:title="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xml:lang="en-US" id="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares">Investment Sold, Not yet Purchased, Balance, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:to="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:title="Label : us-gaap_InvestmentSoldNotYetPurchasedBalanceShares to label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares_1" xml:lang="en-US" id="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares_1">Number of shares to be sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:to="label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares_1" xlink:title="Label : us-gaap_InvestmentSoldNotYetPurchasedBalanceShares to label_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:label="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:title="us-gaap_InvestmentsAndOtherNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InvestmentsAndOtherNoncurrentAssets" xml:lang="en-US" id="label_us-gaap_InvestmentsAndOtherNoncurrentAssets">Investments and Other Noncurrent Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:to="label_us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:title="Label : us-gaap_InvestmentsAndOtherNoncurrentAssets to label_us-gaap_InvestmentsAndOtherNoncurrentAssets" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_1" xml:lang="en-US" id="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_1">LONG TERM DEPOSITS AND INVESTMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:to="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_1" xlink:title="Label : us-gaap_InvestmentsAndOtherNoncurrentAssets to label_us-gaap_InvestmentsAndOtherNoncurrentAssets_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_2" xml:lang="en-US" id="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_2">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:to="label_us-gaap_InvestmentsAndOtherNoncurrentAssets_2" xlink:title="Label : us-gaap_InvestmentsAndOtherNoncurrentAssets to label_us-gaap_InvestmentsAndOtherNoncurrentAssets_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="Label : us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock to label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xml:lang="en-US" id="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1">MARKETABLE SECURITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" xlink:title="Label : us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock to label_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xml:lang="en-US" id="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Label : us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims to label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:title="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" xml:lang="en-US" id="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1">Common stock issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" xlink:title="Label : us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims to label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2" xml:lang="en-US" id="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2">Shares issued for services rendered</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2" xlink:title="Label : us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims to label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_3" xml:lang="en-US" id="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_3">Value of shares issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_3" xlink:title="Label : us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims to label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:title="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xml:lang="en-US" id="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract">Lessee Leasing Arrangements, Operating Leases, Term of Contract</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:to="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:title="Label : us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract to label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_1" xml:lang="en-US" id="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_1">Operating lease term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:to="label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_1" xlink:title="Label : us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract to label_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:title="us-gaap_LeaseAndRentalExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LeaseAndRentalExpense" xml:lang="en-US" id="label_us-gaap_LeaseAndRentalExpense">Operating Leases, Rent Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="label_us-gaap_LeaseAndRentalExpense" xlink:title="Label : us-gaap_LeaseAndRentalExpense to label_us-gaap_LeaseAndRentalExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseAndRentalExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LeaseAndRentalExpense_1" xml:lang="en-US" id="label_us-gaap_LeaseAndRentalExpense_1">Lease expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="label_us-gaap_LeaseAndRentalExpense_1" xlink:title="Label : us-gaap_LeaseAndRentalExpense to label_us-gaap_LeaseAndRentalExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:title="us-gaap_LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LeaseholdImprovementsMember" xml:lang="en-US" id="label_us-gaap_LeaseholdImprovementsMember">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="label_us-gaap_LeaseholdImprovementsMember" xlink:title="Label : us-gaap_LeaseholdImprovementsMember to label_us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="us-gaap_LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrent">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent" xlink:title="Label : us-gaap_LiabilitiesCurrent to label_us-gaap_LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrent_1">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent_1" xlink:title="Label : us-gaap_LiabilitiesCurrent to label_us-gaap_LiabilitiesCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquity">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquity to label_us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquity_1">Total liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity_1" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquity to label_us-gaap_LiabilitiesAndStockholdersEquity_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:title="us-gaap_LiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesNoncurrent" xml:lang="en-US" id="label_us-gaap_LiabilitiesNoncurrent">Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="label_us-gaap_LiabilitiesNoncurrent" xlink:title="Label : us-gaap_LiabilitiesNoncurrent to label_us-gaap_LiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesNoncurrent_1">Total long term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="label_us-gaap_LiabilitiesNoncurrent_1" xlink:title="Label : us-gaap_LiabilitiesNoncurrent to label_us-gaap_LiabilitiesNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:title="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrentAbstract">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract" xlink:title="Label : us-gaap_LiabilitiesCurrentAbstract to label_us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LiabilitiesCurrentAbstract_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesCurrentAbstract_1">CURRENT LIABILITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract_1" xlink:title="Label : us-gaap_LiabilitiesCurrentAbstract to label_us-gaap_LiabilitiesCurrentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:title="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesNoncurrentAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesNoncurrentAbstract">Liabilities, Noncurrent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="label_us-gaap_LiabilitiesNoncurrentAbstract" xlink:title="Label : us-gaap_LiabilitiesNoncurrentAbstract to label_us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesNoncurrentAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LiabilitiesNoncurrentAbstract_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesNoncurrentAbstract_1">LONG TERM LIABILITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="label_us-gaap_LiabilitiesNoncurrentAbstract_1" xlink:title="Label : us-gaap_LiabilitiesNoncurrentAbstract to label_us-gaap_LiabilitiesNoncurrentAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquityAbstract to label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xml:lang="en-US" id="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1">Liabilities and stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" xlink:title="Label : us-gaap_LiabilitiesAndStockholdersEquityAbstract to label_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:title="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xml:lang="en-US" id="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">Liability for Uncertain Tax Positions, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:title="Label : us-gaap_LiabilityForUncertainTaxPositionsNoncurrent to label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_1" xml:lang="en-US" id="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_1">Provision for uncertain tax position</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_1" xlink:title="Label : us-gaap_LiabilityForUncertainTaxPositionsNoncurrent to label_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:title="us-gaap_LongTermPurchaseCommitmentLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentLineItems" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentLineItems">Long-term Purchase Commitment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="label_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentLineItems to label_us-gaap_LongTermPurchaseCommitmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to label_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentAmount" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentAmount">Long-term Purchase Commitment, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="label_us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentAmount to label_us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_LongTermPurchaseCommitmentAmount_1" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentAmount_1">Commitments for consulting services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="label_us-gaap_LongTermPurchaseCommitmentAmount_1" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentAmount to label_us-gaap_LongTermPurchaseCommitmentAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="us-gaap_LongTermPurchaseCommitmentTable" xlink:title="us-gaap_LongTermPurchaseCommitmentTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentTable" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentTable">Long-term Purchase Commitment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="label_us-gaap_LongTermPurchaseCommitmentTable" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentTable to label_us-gaap_LongTermPurchaseCommitmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xml:lang="en-US" id="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">Long-term Purchase Commitment by Category of Item Purchased [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="Label : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to label_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" xlink:title="us-gaap_MarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MarketableSecurities" xml:lang="en-US" id="label_us-gaap_MarketableSecurities">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="label_us-gaap_MarketableSecurities" xlink:title="Label : us-gaap_MarketableSecurities to label_us-gaap_MarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecurities_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MarketableSecurities_1" xml:lang="en-US" id="label_us-gaap_MarketableSecurities_1">Marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecurities" xlink:to="label_us-gaap_MarketableSecurities_1" xlink:title="Label : us-gaap_MarketableSecurities to label_us-gaap_MarketableSecurities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract" xlink:title="us-gaap_MarketableSecuritiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MarketableSecuritiesAbstract" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesAbstract">MARKETABLE SECURITIES [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="label_us-gaap_MarketableSecuritiesAbstract" xlink:title="Label : us-gaap_MarketableSecuritiesAbstract to label_us-gaap_MarketableSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:title="us-gaap_MarketableSecuritiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MarketableSecuritiesCurrent" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesCurrent">Marketable Securities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="label_us-gaap_MarketableSecuritiesCurrent" xlink:title="Label : us-gaap_MarketableSecuritiesCurrent to label_us-gaap_MarketableSecuritiesCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MarketableSecuritiesCurrent_1" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesCurrent_1">Marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="label_us-gaap_MarketableSecuritiesCurrent_1" xlink:title="Label : us-gaap_MarketableSecuritiesCurrent to label_us-gaap_MarketableSecuritiesCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:title="us-gaap_MarketableSecuritiesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MarketableSecuritiesTextBlock" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesTextBlock">Marketable Securities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="label_us-gaap_MarketableSecuritiesTextBlock" xlink:title="Label : us-gaap_MarketableSecuritiesTextBlock to label_us-gaap_MarketableSecuritiesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MarketableSecuritiesTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MarketableSecuritiesTextBlock_1" xml:lang="en-US" id="label_us-gaap_MarketableSecuritiesTextBlock_1">Schedule of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesTextBlock" xlink:to="label_us-gaap_MarketableSecuritiesTextBlock_1" xlink:title="Label : us-gaap_MarketableSecuritiesTextBlock to label_us-gaap_MarketableSecuritiesTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MaximumMember" xml:lang="en-US" id="label_us-gaap_MaximumMember">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="label_us-gaap_MaximumMember" xlink:title="Label : us-gaap_MaximumMember to label_us-gaap_MaximumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MaximumMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MaximumMember_1" xml:lang="en-US" id="label_us-gaap_MaximumMember_1">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="label_us-gaap_MaximumMember_1" xlink:title="Label : us-gaap_MaximumMember to label_us-gaap_MaximumMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_MinimumMember" xml:lang="en-US" id="label_us-gaap_MinimumMember">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="label_us-gaap_MinimumMember" xlink:title="Label : us-gaap_MinimumMember to label_us-gaap_MinimumMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_MinimumMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_MinimumMember_1" xml:lang="en-US" id="label_us-gaap_MinimumMember_1">Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="label_us-gaap_MinimumMember_1" xlink:title="Label : us-gaap_MinimumMember to label_us-gaap_MinimumMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" xlink:title="us-gaap_NatureOfOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NatureOfOperations" xml:lang="en-US" id="label_us-gaap_NatureOfOperations">Nature of Operations [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="label_us-gaap_NatureOfOperations" xlink:title="Label : us-gaap_NatureOfOperations to label_us-gaap_NatureOfOperations" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NatureOfOperations_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NatureOfOperations_1" xml:lang="en-US" id="label_us-gaap_NatureOfOperations_1">General</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="label_us-gaap_NatureOfOperations_1" xlink:title="Label : us-gaap_NatureOfOperations to label_us-gaap_NatureOfOperations_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetIncomeLoss" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetIncomeLoss_1" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss_1">NET LOSS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss_1" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_NetIncomeLoss_2" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss_2">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss_2" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetIncomeLoss_3" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_us-gaap_NetIncomeLoss_3" xml:lang="en-US" id="label_us-gaap_NetIncomeLoss_3">NET LOSS FOR THE PERIOD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss_3" xlink:title="Label : us-gaap_NetIncomeLoss to label_us-gaap_NetIncomeLoss_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract to label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to label_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivities">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivities to label_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInInvestingActivities_1">Total net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInInvestingActivities to label_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract to label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivities">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivities to label_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInFinancingActivities_1">Net cash derived from financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInFinancingActivities to label_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivities">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivities to label_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US" id="label_us-gaap_NetCashProvidedByUsedInOperatingActivities_1">Total net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:title="Label : us-gaap_NetCashProvidedByUsedInOperatingActivities to label_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="Label : us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock to label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1">Newly issued and recently adopted Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" xlink:title="Label : us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock to label_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:title="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xml:lang="en-US" id="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:title="Label : us-gaap_NoncashInvestingAndFinancingItemsAbstract to label_us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1" xml:lang="en-US" id="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1">Material non cash investing and financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="label_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1" xlink:title="Label : us-gaap_NoncashInvestingAndFinancingItemsAbstract to label_us-gaap_NoncashInvestingAndFinancingItemsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoninterestExpenseCommissionExpense" xlink:label="us-gaap_NoninterestExpenseCommissionExpense" xlink:title="us-gaap_NoninterestExpenseCommissionExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NoninterestExpenseCommissionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_NoninterestExpenseCommissionExpense" xml:lang="en-US" id="label_us-gaap_NoninterestExpenseCommissionExpense">Noninterest Expense Commission Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseCommissionExpense" xlink:to="label_us-gaap_NoninterestExpenseCommissionExpense" xlink:title="Label : us-gaap_NoninterestExpenseCommissionExpense to label_us-gaap_NoninterestExpenseCommissionExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_NoninterestExpenseCommissionExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_NoninterestExpenseCommissionExpense_1" xml:lang="en-US" id="label_us-gaap_NoninterestExpenseCommissionExpense_1">Bank commissions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseCommissionExpense" xlink:to="label_us-gaap_NoninterestExpenseCommissionExpense_1" xlink:title="Label : us-gaap_NoninterestExpenseCommissionExpense to label_us-gaap_NoninterestExpenseCommissionExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeBuildingMember" xlink:label="us-gaap_OfficeBuildingMember" xlink:title="us-gaap_OfficeBuildingMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OfficeBuildingMember" xml:lang="en-US" id="label_us-gaap_OfficeBuildingMember">Office Building [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeBuildingMember" xlink:to="label_us-gaap_OfficeBuildingMember" xlink:title="Label : us-gaap_OfficeBuildingMember to label_us-gaap_OfficeBuildingMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:title="us-gaap_OfficeEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OfficeEquipmentMember" xml:lang="en-US" id="label_us-gaap_OfficeEquipmentMember">Office Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="label_us-gaap_OfficeEquipmentMember" xlink:title="Label : us-gaap_OfficeEquipmentMember to label_us-gaap_OfficeEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OfficeEquipmentMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OfficeEquipmentMember_1" xml:lang="en-US" id="label_us-gaap_OfficeEquipmentMember_1">Office Furniture and Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="label_us-gaap_OfficeEquipmentMember_1" xlink:title="Label : us-gaap_OfficeEquipmentMember to label_us-gaap_OfficeEquipmentMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="us-gaap_OfficersCompensation" xlink:title="us-gaap_OfficersCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OfficersCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OfficersCompensation" xml:lang="en-US" id="label_us-gaap_OfficersCompensation">Officers' Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="label_us-gaap_OfficersCompensation" xlink:title="Label : us-gaap_OfficersCompensation to label_us-gaap_OfficersCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OfficersCompensation_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OfficersCompensation_1" xml:lang="en-US" id="label_us-gaap_OfficersCompensation_1">Actual payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="label_us-gaap_OfficersCompensation_1" xlink:title="Label : us-gaap_OfficersCompensation to label_us-gaap_OfficersCompensation_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1">Annual lease payments:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1">2017</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1">2016</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="us-gaap_OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingIncomeLoss" xml:lang="en-US" id="label_us-gaap_OperatingIncomeLoss">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="label_us-gaap_OperatingIncomeLoss" xlink:title="Label : us-gaap_OperatingIncomeLoss to label_us-gaap_OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingIncomeLoss_1" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_us-gaap_OperatingIncomeLoss_1" xml:lang="en-US" id="label_us-gaap_OperatingIncomeLoss_1">OPERATING LOSS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="label_us-gaap_OperatingIncomeLoss_1" xlink:title="Label : us-gaap_OperatingIncomeLoss to label_us-gaap_OperatingIncomeLoss_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1">2015</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" xlink:title="Label : us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent to label_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" xlink:title="us-gaap_OperatingLeasedAssetsLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasedAssetsLineItems" xml:lang="en-US" id="label_us-gaap_OperatingLeasedAssetsLineItems">Operating Leased Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="label_us-gaap_OperatingLeasedAssetsLineItems" xlink:title="Label : us-gaap_OperatingLeasedAssetsLineItems to label_us-gaap_OperatingLeasedAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:title="us-gaap_OperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLossCarryforwards" xml:lang="en-US" id="label_us-gaap_OperatingLossCarryforwards">Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="label_us-gaap_OperatingLossCarryforwards" xlink:title="Label : us-gaap_OperatingLossCarryforwards to label_us-gaap_OperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLossCarryforwards_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLossCarryforwards_1" xml:lang="en-US" id="label_us-gaap_OperatingLossCarryforwards_1">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="label_us-gaap_OperatingLossCarryforwards_1" xlink:title="Label : us-gaap_OperatingLossCarryforwards to label_us-gaap_OperatingLossCarryforwards_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:label="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:title="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xml:lang="en-US" id="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts">Operating Leases, Income Statement, Initial Direct Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:to="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:title="Label : us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts to label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts_1" xml:lang="en-US" id="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts_1">Deposit for lease</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:to="label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts_1" xlink:title="Label : us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts to label_us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xml:lang="en-US" id="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities">Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:to="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="Label : us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities to label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_1" xml:lang="en-US" id="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_1">IMPAIRMENT OF AVAILABLE- FOR-SALE SECURITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:to="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_1" xlink:title="Label : us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities to label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_2" xml:lang="en-US" id="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_2">Impairment of available for sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:to="label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_2" xlink:title="Label : us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities to label_us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1">OTHER COMPREHENSIVE LOSS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2">TOTAL OTHER COMPREHENSIVE LOSS (INCOME)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1">RECLASSIFICATION ADJUSTMENT TO FINANCIAL INCOME OF GAINS ON AVAILABLE-FOR-SALE SECURITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2">Amount reclassified to earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1">SUBSEQUENT DECREASE (INCREASE) IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1" xlink:title="Label : us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax to label_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:title="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xml:lang="en-US" id="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:title="Label : us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1 to label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_1" xml:lang="en-US" id="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_1">Shares issued for marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:to="label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_1" xlink:title="Label : us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1 to label_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:title="us-gaap_OtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherReceivablesNetCurrent" xml:lang="en-US" id="label_us-gaap_OtherReceivablesNetCurrent">Other Receivables, Net, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="label_us-gaap_OtherReceivablesNetCurrent" xlink:title="Label : us-gaap_OtherReceivablesNetCurrent to label_us-gaap_OtherReceivablesNetCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherReceivablesNetCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherReceivablesNetCurrent_1" xml:lang="en-US" id="label_us-gaap_OtherReceivablesNetCurrent_1">Grants receivable from the chief scientist</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="label_us-gaap_OtherReceivablesNetCurrent_1" xlink:title="Label : us-gaap_OtherReceivablesNetCurrent to label_us-gaap_OtherReceivablesNetCurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:title="us-gaap_OtherIncome" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherIncome" xml:lang="en-US" id="label_us-gaap_OtherIncome">Other Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="label_us-gaap_OtherIncome" xlink:title="Label : us-gaap_OtherIncome to label_us-gaap_OtherIncome" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherIncome_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherIncome_1" xml:lang="en-US" id="label_us-gaap_OtherIncome_1">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="label_us-gaap_OtherIncome_1" xlink:title="Label : us-gaap_OtherIncome to label_us-gaap_OtherIncome_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:label="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:title="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xml:lang="en-US" id="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract">Other Expense, Nonoperating [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:to="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:title="Label : us-gaap_OtherExpenseDisclosureNonoperatingAbstract to label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract_1" xml:lang="en-US" id="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract_1">Financial expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:to="label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract_1" xlink:title="Label : us-gaap_OtherExpenseDisclosureNonoperatingAbstract to label_us-gaap_OtherExpenseDisclosureNonoperatingAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:title="Label : us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax to label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1" xml:lang="en-US" id="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1">UNREALIZED LOSS (GAIN) ON AVAILABLE FOR SALE SECURITIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1" xlink:title="Label : us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax to label_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:label="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:title="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xml:lang="en-US" id="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract">Other Income, Nonoperating [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:to="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:title="Label : us-gaap_OtherIncomeDisclosureNonoperatingAbstract to label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract_1" xml:lang="en-US" id="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract_1">Financial income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:to="label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract_1" xlink:title="Label : us-gaap_OtherIncomeDisclosureNonoperatingAbstract to label_us-gaap_OtherIncomeDisclosureNonoperatingAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:title="us-gaap_OtherNonoperatingExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherNonoperatingExpense" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingExpense">Other Nonoperating Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="label_us-gaap_OtherNonoperatingExpense" xlink:title="Label : us-gaap_OtherNonoperatingExpense to label_us-gaap_OtherNonoperatingExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherNonoperatingExpense_1" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingExpense_1">FINANCIAL EXPENSES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="label_us-gaap_OtherNonoperatingExpense_1" xlink:title="Label : us-gaap_OtherNonoperatingExpense to label_us-gaap_OtherNonoperatingExpense_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingExpense_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OtherNonoperatingExpense_2" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingExpense_2">Financial expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="label_us-gaap_OtherNonoperatingExpense_2" xlink:title="Label : us-gaap_OtherNonoperatingExpense to label_us-gaap_OtherNonoperatingExpense_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNoninterestExpense" xlink:label="us-gaap_OtherNoninterestExpense" xlink:title="us-gaap_OtherNoninterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNoninterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherNoninterestExpense" xml:lang="en-US" id="label_us-gaap_OtherNoninterestExpense">Other Noninterest Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoninterestExpense" xlink:to="label_us-gaap_OtherNoninterestExpense" xlink:title="Label : us-gaap_OtherNoninterestExpense to label_us-gaap_OtherNoninterestExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNoninterestExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_OtherNoninterestExpense_1" xml:lang="en-US" id="label_us-gaap_OtherNoninterestExpense_1">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoninterestExpense" xlink:to="label_us-gaap_OtherNoninterestExpense_1" xlink:title="Label : us-gaap_OtherNoninterestExpense to label_us-gaap_OtherNoninterestExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" xlink:title="us-gaap_OtherNonoperatingIncome" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_OtherNonoperatingIncome" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncome">Other Nonoperating Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="label_us-gaap_OtherNonoperatingIncome" xlink:title="Label : us-gaap_OtherNonoperatingIncome to label_us-gaap_OtherNonoperatingIncome" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingIncome_1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_OtherNonoperatingIncome_1" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncome_1">Financial income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="label_us-gaap_OtherNonoperatingIncome_1" xlink:title="Label : us-gaap_OtherNonoperatingIncome to label_us-gaap_OtherNonoperatingIncome_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_OtherNonoperatingIncome_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_OtherNonoperatingIncome_2" xml:lang="en-US" id="label_us-gaap_OtherNonoperatingIncome_2">FINANCIAL INCOME</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="label_us-gaap_OtherNonoperatingIncome_2" xlink:title="Label : us-gaap_OtherNonoperatingIncome to label_us-gaap_OtherNonoperatingIncome_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:title="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xml:lang="en-US" id="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:title="Label : us-gaap_PaymentsForProceedsFromOtherInvestingActivities to label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1" xml:lang="en-US" id="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1" xlink:title="Label : us-gaap_PaymentsForProceedsFromOtherInvestingActivities to label_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:title="us-gaap_PaymentsToAcquireLongtermInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToAcquireLongtermInvestments" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireLongtermInvestments">Payments to Acquire Long-term Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="label_us-gaap_PaymentsToAcquireLongtermInvestments" xlink:title="Label : us-gaap_PaymentsToAcquireLongtermInvestments to label_us-gaap_PaymentsToAcquireLongtermInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquireLongtermInvestments_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsToAcquireLongtermInvestments_1" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireLongtermInvestments_1">Purchase of long term deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:to="label_us-gaap_PaymentsToAcquireLongtermInvestments_1" xlink:title="Label : us-gaap_PaymentsToAcquireLongtermInvestments to label_us-gaap_PaymentsToAcquireLongtermInvestments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="Label : us-gaap_PaymentsToAcquirePropertyPlantAndEquipment to label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1">Purchase of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xlink:title="Label : us-gaap_PaymentsToAcquirePropertyPlantAndEquipment to label_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US" id="label_us-gaap_PaymentsOfStockIssuanceCosts">Payments of Stock Issuance Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="label_us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="Label : us-gaap_PaymentsOfStockIssuanceCosts to label_us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsOfStockIssuanceCosts_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_PaymentsOfStockIssuanceCosts_1" xml:lang="en-US" id="label_us-gaap_PaymentsOfStockIssuanceCosts_1">Stock issuance costs including commisions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="label_us-gaap_PaymentsOfStockIssuanceCosts_1" xlink:title="Label : us-gaap_PaymentsOfStockIssuanceCosts to label_us-gaap_PaymentsOfStockIssuanceCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:title="us-gaap_PaymentsToAcquireShortTermInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PaymentsToAcquireShortTermInvestments" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireShortTermInvestments">Payments to Acquire Short-term Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="label_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:title="Label : us-gaap_PaymentsToAcquireShortTermInvestments to label_us-gaap_PaymentsToAcquireShortTermInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PaymentsToAcquireShortTermInvestments_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_PaymentsToAcquireShortTermInvestments_1" xml:lang="en-US" id="label_us-gaap_PaymentsToAcquireShortTermInvestments_1">Purchase of short term deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="label_us-gaap_PaymentsToAcquireShortTermInvestments_1" xlink:title="Label : us-gaap_PaymentsToAcquireShortTermInvestments to label_us-gaap_PaymentsToAcquireShortTermInvestments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:title="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xml:lang="en-US" id="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:title="Label : us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent to label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_1" xml:lang="en-US" id="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_1">Employee rights upon retirement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_1" xlink:title="Label : us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent to label_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="us-gaap_PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PlanNameDomain" xml:lang="en-US" id="label_us-gaap_PlanNameDomain">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="label_us-gaap_PlanNameDomain" xlink:title="Label : us-gaap_PlanNameDomain to label_us-gaap_PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="us-gaap_PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PlanNameAxis" xml:lang="en-US" id="label_us-gaap_PlanNameAxis">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="label_us-gaap_PlanNameAxis" xlink:title="Label : us-gaap_PlanNameAxis to label_us-gaap_PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidPensionCosts" xlink:label="us-gaap_PrepaidPensionCosts" xlink:title="us-gaap_PrepaidPensionCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidPensionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PrepaidPensionCosts" xml:lang="en-US" id="label_us-gaap_PrepaidPensionCosts">Prepaid Pension Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidPensionCosts" xlink:to="label_us-gaap_PrepaidPensionCosts" xlink:title="Label : us-gaap_PrepaidPensionCosts to label_us-gaap_PrepaidPensionCosts" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidPensionCosts_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PrepaidPensionCosts_1" xml:lang="en-US" id="label_us-gaap_PrepaidPensionCosts_1">AMOUNTS FUNDED IN RESPECT OF EMPLOYEE RIGHTS UPON RETIREMENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidPensionCosts" xlink:to="label_us-gaap_PrepaidPensionCosts_1" xlink:title="Label : us-gaap_PrepaidPensionCosts to label_us-gaap_PrepaidPensionCosts_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xml:lang="en-US" id="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="Label : us-gaap_PrepaidExpenseAndOtherAssetsCurrent to label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xml:lang="en-US" id="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" xlink:title="Label : us-gaap_PrepaidExpenseAndOtherAssetsCurrent to label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2" xml:lang="en-US" id="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2">Total prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2" xlink:title="Label : us-gaap_PrepaidExpenseAndOtherAssetsCurrent to label_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromWarrantExercises" xml:lang="en-US" id="label_us-gaap_ProceedsFromWarrantExercises">Proceeds from Warrant Exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="label_us-gaap_ProceedsFromWarrantExercises" xlink:title="Label : us-gaap_ProceedsFromWarrantExercises to label_us-gaap_ProceedsFromWarrantExercises" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromWarrantExercises_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProceedsFromWarrantExercises_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromWarrantExercises_1">Proceeds from exercise of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="label_us-gaap_ProceedsFromWarrantExercises_1" xlink:title="Label : us-gaap_ProceedsFromWarrantExercises to label_us-gaap_ProceedsFromWarrantExercises_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:title="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments">Proceeds from Sale, Maturity and Collection of Short-term Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:to="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:title="Label : us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments to label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1">Proceeds from sale of short term deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:to="label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1" xlink:title="Label : us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments to label_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">Proceeds from Issuance or Sale of Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="Label : us-gaap_ProceedsFromIssuanceOrSaleOfEquity to label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1">Proceeds from shares to be issued for exercise of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1" xlink:title="Label : us-gaap_ProceedsFromIssuanceOrSaleOfEquity to label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2">Proceeds from issuance of shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2" xlink:title="Label : us-gaap_ProceedsFromIssuanceOrSaleOfEquity to label_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1">Proceeds from issuance of common stock - net of issuance expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock_2" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock_2">Net proceeds from the offering, after deducting a finder's fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock_2" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromIssuanceOfCommonStock_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProceedsFromIssuanceOfCommonStock_3" xml:lang="en-US" id="label_us-gaap_ProceedsFromIssuanceOfCommonStock_3">Proceeds from issuance of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="label_us-gaap_ProceedsFromIssuanceOfCommonStock_3" xlink:title="Label : us-gaap_ProceedsFromIssuanceOfCommonStock to label_us-gaap_ProceedsFromIssuanceOfCommonStock_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:title="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromStockOptionsExercised" xml:lang="en-US" id="label_us-gaap_ProceedsFromStockOptionsExercised">Proceeds from Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="label_us-gaap_ProceedsFromStockOptionsExercised" xlink:title="Label : us-gaap_ProceedsFromStockOptionsExercised to label_us-gaap_ProceedsFromStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromStockOptionsExercised_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProceedsFromStockOptionsExercised_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromStockOptionsExercised_1">Proceeds from exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="label_us-gaap_ProceedsFromStockOptionsExercised_1" xlink:title="Label : us-gaap_ProceedsFromStockOptionsExercised to label_us-gaap_ProceedsFromStockOptionsExercised_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:title="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity">Proceeds from Sale of Available-for-sale Securities, Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:to="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:title="Label : us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity to label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_1">Proceeds from sale of securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:to="label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_1" xlink:title="Label : us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity to label_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="Label : us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities to label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1">Proceeds from sale of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" xlink:title="Label : us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities to label_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="Label : us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments to label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_1" xml:lang="en-US" id="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_1">Proceeds from sale of investment and marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_1" xlink:title="Label : us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments to label_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" xlink:title="us-gaap_ProfessionalFees" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ProfessionalFees" xml:lang="en-US" id="label_us-gaap_ProfessionalFees">Professional Fees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="label_us-gaap_ProfessionalFees" xlink:title="Label : us-gaap_ProfessionalFees to label_us-gaap_ProfessionalFees" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProfessionalFees_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ProfessionalFees_1" xml:lang="en-US" id="label_us-gaap_ProfessionalFees_1">Consulting services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="label_us-gaap_ProfessionalFees_1" xlink:title="Label : us-gaap_ProfessionalFees to label_us-gaap_ProfessionalFees_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ProfessionalFees_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ProfessionalFees_2" xml:lang="en-US" id="label_us-gaap_ProfessionalFees_2">Professional services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="label_us-gaap_ProfessionalFees_2" xlink:title="Label : us-gaap_ProfessionalFees to label_us-gaap_ProfessionalFees_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentPolicyTextBlock to label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1">Property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentPolicyTextBlock to label_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentGross" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentGross">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="label_us-gaap_PropertyPlantAndEquipmentGross" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentGross to label_us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentGross_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentGross_1" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentGross_1">Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="label_us-gaap_PropertyPlantAndEquipmentGross_1" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentGross to label_us-gaap_PropertyPlantAndEquipmentGross_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet_1" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet_1">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet_1" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentNet_2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentNet_2" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentNet_2">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="label_us-gaap_PropertyPlantAndEquipmentNet_2" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentNet to label_us-gaap_PropertyPlantAndEquipmentNet_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentAbstract" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentAbstract">PROPERTY AND EQUIPMENT, NET [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="label_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentAbstract to label_us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTextBlock">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentTextBlock to label_us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTextBlock_1" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTextBlock_1">Schedule of Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTextBlock_1" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentTextBlock to label_us-gaap_PropertyPlantAndEquipmentTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentTypeDomain">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="label_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentTypeDomain to label_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentByTypeAxis to label_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock to label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock to label_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_PropertyPlantAndEquipmentLineItems" xml:lang="en-US" id="label_us-gaap_PropertyPlantAndEquipmentLineItems">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="label_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="Label : us-gaap_PropertyPlantAndEquipmentLineItems to label_us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RangeAxis" xml:lang="en-US" id="label_us-gaap_RangeAxis">Range [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="label_us-gaap_RangeAxis" xlink:title="Label : us-gaap_RangeAxis to label_us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RangeMember" xml:lang="en-US" id="label_us-gaap_RangeMember">Range [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="label_us-gaap_RangeMember" xlink:title="Label : us-gaap_RangeMember to label_us-gaap_RangeMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="Label : us-gaap_RelatedPartyTransactionsDisclosureTextBlock to label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1">RELATED PARTIES - TRANSACTIONS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" xlink:title="Label : us-gaap_RelatedPartyTransactionsDisclosureTextBlock to label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:title="us-gaap_RelatedPartyTransactionDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionDomain" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionDomain">Related Party Transaction [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="label_us-gaap_RelatedPartyTransactionDomain" xlink:title="Label : us-gaap_RelatedPartyTransactionDomain to label_us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:title="us-gaap_RelatedPartyTransactionAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionAxis" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionAxis">Related Party Transaction [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="label_us-gaap_RelatedPartyTransactionAxis" xlink:title="Label : us-gaap_RelatedPartyTransactionAxis to label_us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionLineItems">Related Party Transaction [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="label_us-gaap_RelatedPartyTransactionLineItems" xlink:title="Label : us-gaap_RelatedPartyTransactionLineItems to label_us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:title="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction">Related Party Transaction, Amounts of Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:title="Label : us-gaap_RelatedPartyTransactionAmountsOfTransaction to label_us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction_1" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction_1">Amount of transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="label_us-gaap_RelatedPartyTransactionAmountsOfTransaction_1" xlink:title="Label : us-gaap_RelatedPartyTransactionAmountsOfTransaction to label_us-gaap_RelatedPartyTransactionAmountsOfTransaction_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis">Related Party Transactions, by Related Party [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Label : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:title="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:title="Label : us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty to label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1">Expenses to related parties</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1" xlink:title="Label : us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty to label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyDomain" xml:lang="en-US" id="label_us-gaap_RelatedPartyDomain">Related Party [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="label_us-gaap_RelatedPartyDomain" xlink:title="Label : us-gaap_RelatedPartyDomain to label_us-gaap_RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:title="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US" id="label_us-gaap_RelatedPartyTransactionsAbstract">RELATED PARTIES - TRANSACTIONS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="label_us-gaap_RelatedPartyTransactionsAbstract" xlink:title="Label : us-gaap_RelatedPartyTransactionsAbstract to label_us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis to label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentExpense" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense">Research and Development Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpense to label_us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpense_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpense_1" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpense_1">RESEARCH AND DEVELOPMENT EXPENSES, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="label_us-gaap_ResearchAndDevelopmentExpense_1" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpense to label_us-gaap_ResearchAndDevelopmentExpense_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpensePolicy">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="label_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpensePolicy to label_us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" xlink:title="Label : us-gaap_ResearchAndDevelopmentExpensePolicy to label_us-gaap_ResearchAndDevelopmentExpensePolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain to label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xml:lang="en-US" id="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="Label : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to label_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents" xlink:title="us-gaap_RestrictedCashAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalents" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalents">Restricted Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalents" xlink:title="Label : us-gaap_RestrictedCashAndCashEquivalents to label_us-gaap_RestrictedCashAndCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalents_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalents_1" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalents_1">Restricted deposit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalents_1" xlink:title="Label : us-gaap_RestrictedCashAndCashEquivalents to label_us-gaap_RestrictedCashAndCashEquivalents_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:title="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedStockUnitsRSUMember" xml:lang="en-US" id="label_us-gaap_RestrictedStockUnitsRSUMember">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="label_us-gaap_RestrictedStockUnitsRSUMember" xlink:title="Label : us-gaap_RestrictedStockUnitsRSUMember to label_us-gaap_RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedStockUnitsRSUMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RestrictedStockUnitsRSUMember_1" xml:lang="en-US" id="label_us-gaap_RestrictedStockUnitsRSUMember_1">Restricted stock units [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="label_us-gaap_RestrictedStockUnitsRSUMember_1" xlink:title="Label : us-gaap_RestrictedStockUnitsRSUMember to label_us-gaap_RestrictedStockUnitsRSUMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:label="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:title="us-gaap_RestrictedCashAndInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedCashAndInvestmentsAbstract" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndInvestmentsAbstract">Restricted Cash and Investments [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="label_us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:title="Label : us-gaap_RestrictedCashAndInvestmentsAbstract to label_us-gaap_RestrictedCashAndInvestmentsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndInvestmentsAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RestrictedCashAndInvestmentsAbstract_1" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndInvestmentsAbstract_1">Fair value measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="label_us-gaap_RestrictedCashAndInvestmentsAbstract_1" xlink:title="Label : us-gaap_RestrictedCashAndInvestmentsAbstract to label_us-gaap_RestrictedCashAndInvestmentsAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:title="Label : us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue to label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1" xlink:title="Label : us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue to label_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:title="Label : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis to label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xml:lang="en-US" id="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember">Cash and Cash Equivalents [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="Label : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember to label_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US" id="label_us-gaap_RetainedEarningsAccumulatedDeficit">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="Label : us-gaap_RetainedEarningsAccumulatedDeficit to label_us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xml:lang="en-US" id="label_us-gaap_RetainedEarningsAccumulatedDeficit_1">Accumulated loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit_1" xlink:title="Label : us-gaap_RetainedEarningsAccumulatedDeficit to label_us-gaap_RetainedEarningsAccumulatedDeficit_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="us-gaap_RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RetainedEarningsMember" xml:lang="en-US" id="label_us-gaap_RetainedEarningsMember">Deficit accumulated during the development stage [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember" xlink:title="Label : us-gaap_RetainedEarningsMember to label_us-gaap_RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RetainedEarningsMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RetainedEarningsMember_1" xml:lang="en-US" id="label_us-gaap_RetainedEarningsMember_1">Accumulated loss [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember_1" xlink:title="Label : us-gaap_RetainedEarningsMember to label_us-gaap_RetainedEarningsMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="us-gaap_RevenueFromGrants" xlink:title="us-gaap_RevenueFromGrants" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenueFromGrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_RevenueFromGrants" xml:lang="en-US" id="label_us-gaap_RevenueFromGrants">Revenue from Grants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="label_us-gaap_RevenueFromGrants" xlink:title="Label : us-gaap_RevenueFromGrants to label_us-gaap_RevenueFromGrants" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenueFromGrants_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_RevenueFromGrants_1" xml:lang="en-US" id="label_us-gaap_RevenueFromGrants_1">Grants received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="label_us-gaap_RevenueFromGrants_1" xlink:title="Label : us-gaap_RevenueFromGrants to label_us-gaap_RevenueFromGrants_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_RevenueFromGrants_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_RevenueFromGrants_2" xml:lang="en-US" id="label_us-gaap_RevenueFromGrants_2">Less - grants from the OCS and Bio Jerusalem Fund</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromGrants" xlink:to="label_us-gaap_RevenueFromGrants_2" xlink:title="Label : us-gaap_RevenueFromGrants to label_us-gaap_RevenueFromGrants_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_1">Exercisable, weighted average exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_1" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1">Expected option life (years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_1">Exercisable, weighted average remaining contractual life, years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_1" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1">Outstanding, weighted average exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1">Total fair value of awards on the date of grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1">Options vested in period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1" xlink:title="Label : us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares to label_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1" xml:lang="en-US" id="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1">Outstanding, weighted average remaining contractual life, years</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1" xlink:title="Label : us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 to label_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScenarioUnspecifiedDomain" xml:lang="en-US" id="label_us-gaap_ScenarioUnspecifiedDomain">Scenario, Unspecified [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="label_us-gaap_ScenarioUnspecifiedDomain" xlink:title="Label : us-gaap_ScenarioUnspecifiedDomain to label_us-gaap_ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Label : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to label_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1">Schedule of Stock Option Activity for Employees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1">Schedule of Fair Value Assumptions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to label_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1">Schedule of Reconciliation of Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to label_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1">Schedule of Income Taxes Included in the Income Statements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to label_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1">Schedule of Deferred Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to label_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock to label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1">Schedule of Unrecognized Tax Benefits Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock to label_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock to label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1">Schedule of Related Party Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock to label_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock">Schedule of Share-based Compensation, Nonemployee Director Stock Award Plan, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock_1">Schedule of Stock Option Activity for Non-Employees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:title="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:title="Label : us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock to label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1">Schedule of Short Term Deposits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock to label_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable">Schedule of Operating Leased Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="Label : us-gaap_ScheduleOfOperatingLeasedAssetsTable to label_us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xml:lang="en-US" id="label_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">Investment, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="label_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="Label : us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to label_us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Label : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Label : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to label_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:title="us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock">Schedule of Other Nonoperating Income, by Component [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:to="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:title="Label : us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock to label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_1">Schedule of Financial Income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:to="label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock to label_us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:title="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock">Schedule of Other Nonoperating Expense, by Component [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:to="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:title="Label : us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock to label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_1">Schedule of Financial Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:to="label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock to label_us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable to label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to label_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="Label : us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock to label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1">Schedule of Warrant Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock to label_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_1" xml:lang="en-US" id="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_1">Summary of Information for Options Granted and Exercisable for Employees</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_1" xlink:title="Label : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock to label_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xml:lang="en-US" id="label_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="label_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="Label : us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to label_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1" xlink:title="us-gaap_SeveranceCosts1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SeveranceCosts1" xml:lang="en-US" id="label_us-gaap_SeveranceCosts1">Severance Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="label_us-gaap_SeveranceCosts1" xlink:title="Label : us-gaap_SeveranceCosts1 to label_us-gaap_SeveranceCosts1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SeveranceCosts1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SeveranceCosts1_1" xml:lang="en-US" id="label_us-gaap_SeveranceCosts1_1">Severance pay expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="label_us-gaap_SeveranceCosts1_1" xlink:title="Label : us-gaap_SeveranceCosts1 to label_us-gaap_SeveranceCosts1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1">Expiration date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1">Awards granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1">Options granted, exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2">Granted - at market price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_1">Warrants outstanding as of September 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2">Warrants outstanding as of August 31</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3">Vested and outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1">Expected stock price volatility (%), maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1">Expected stock price volatility (%), minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="us-gaap_ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensation" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensation">Share-based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation" xlink:title="Label : us-gaap_ShareBasedCompensation to label_us-gaap_ShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensation_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensation_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensation_1">Stock based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation_1" xlink:title="Label : us-gaap_ShareBasedCompensation to label_us-gaap_ShareBasedCompensation_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1">Awards vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1">Risk-free interest rate (%), maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1">Vesting period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1">Options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2">Granted - at market price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharePrice" xml:lang="en-US" id="label_us-gaap_SharePrice">Share Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="label_us-gaap_SharePrice" xlink:title="Label : us-gaap_SharePrice to label_us-gaap_SharePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SharePrice_1" xml:lang="en-US" id="label_us-gaap_SharePrice_1">Quoted closing market share price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="label_us-gaap_SharePrice_1" xlink:title="Label : us-gaap_SharePrice to label_us-gaap_SharePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharePrice_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_SharePrice_2" xml:lang="en-US" id="label_us-gaap_SharePrice_2">Per share price of shares to be sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="label_us-gaap_SharePrice_2" xlink:title="Label : us-gaap_SharePrice to label_us-gaap_SharePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1">Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember">Share-based Compensation Award, Tranche One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:title="Label : us-gaap_ShareBasedCompensationAwardTrancheOneMember to label_us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1">First installment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="label_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1" xlink:title="Label : us-gaap_ShareBasedCompensationAwardTrancheOneMember to label_us-gaap_ShareBasedCompensationAwardTrancheOneMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember">Share-based Compensation Award, Tranche Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:title="Label : us-gaap_ShareBasedCompensationAwardTrancheTwoMember to label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1">Each subsequent installment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1" xlink:title="Label : us-gaap_ShareBasedCompensationAwardTrancheTwoMember to label_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1">Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1">Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1">Risk-free interest rate (%), minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1">Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1 to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1_1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1_1">Expected term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1_1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1 to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1">Expected dividend yield (%)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1">Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1">Forfeited</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1">Options exercisable at end of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1">Weighted average exercise price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1">Number of shares reserved for grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1">Intrinsic value of options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2">Expected stock price volatility (%)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2">Risk-free interest rate (%)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1">Weighted average grant-date fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2">Weighted average fair value of options granted during the year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1">Options outstanding at end of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2">Options outstanding at beginning of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="Label : us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy to label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1">Stock based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" xlink:title="Label : us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy to label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1">Options outstanding at end of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2">Options outstanding at beginning of year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:title="Label : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1">Fair value of options granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">Exercise Price Range [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:title="Label : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis to label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="Label : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1">Number of options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to label_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain">Equity Award [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Label : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to label_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:title="Label : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions to label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1">Number outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1" xlink:title="Label : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions to label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate">Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate_1">Expected volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate_1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:title="Label : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions to label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1" xml:lang="en-US" id="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1">Number exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1" xlink:title="Label : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions to label_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate">Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_1">Risk-free interest rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate">Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_1">Dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued">Share-based Goods and Nonemployee Services Transaction, Quantity of Securities Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued_1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued_1">Shares issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued_1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost">Share-based Goods and Nonemployee Services Transaction, Capitalized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_1">Capitalized cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance">Share-based Goods and Nonemployee Services Transaction, Shares Approved for Issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance_1" xml:lang="en-US" id="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance_1">Shares authorized for issuance for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:to="label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance_1" xlink:title="Label : us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance to label_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:title="us-gaap_SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SharesOutstanding" xml:lang="en-US" id="label_us-gaap_SharesOutstanding">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="label_us-gaap_SharesOutstanding" xlink:title="Label : us-gaap_SharesOutstanding to label_us-gaap_SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharesOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_SharesOutstanding_1" xml:lang="en-US" id="label_us-gaap_SharesOutstanding_1">BALANCE, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="label_us-gaap_SharesOutstanding_1" xlink:title="Label : us-gaap_SharesOutstanding to label_us-gaap_SharesOutstanding_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SharesOutstanding_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_SharesOutstanding_2" xml:lang="en-US" id="label_us-gaap_SharesOutstanding_2">BALANCE, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="label_us-gaap_SharesOutstanding_2" xlink:title="Label : us-gaap_SharesOutstanding to label_us-gaap_SharesOutstanding_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US" id="label_us-gaap_SignificantAccountingPoliciesTextBlock">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="Label : us-gaap_SignificantAccountingPoliciesTextBlock to label_us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xml:lang="en-US" id="label_us-gaap_SignificantAccountingPoliciesTextBlock_1">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock_1" xlink:title="Label : us-gaap_SignificantAccountingPoliciesTextBlock to label_us-gaap_SignificantAccountingPoliciesTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:title="us-gaap_StatementScenarioAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementScenarioAxis" xml:lang="en-US" id="label_us-gaap_StatementScenarioAxis">Scenario [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="label_us-gaap_StatementScenarioAxis" xlink:title="Label : us-gaap_StatementScenarioAxis to label_us-gaap_StatementScenarioAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementTable" xml:lang="en-US" id="label_us-gaap_StatementTable">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="label_us-gaap_StatementTable" xlink:title="Label : us-gaap_StatementTable to label_us-gaap_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="us-gaap_StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementLineItems" xml:lang="en-US" id="label_us-gaap_StatementLineItems">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="label_us-gaap_StatementLineItems" xlink:title="Label : us-gaap_StatementLineItems to label_us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfStockholdersEquityAbstract">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="label_us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="Label : us-gaap_StatementOfStockholdersEquityAbstract to label_us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:title="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfCashFlowsAbstract">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="label_us-gaap_StatementOfCashFlowsAbstract" xlink:title="Label : us-gaap_StatementOfCashFlowsAbstract to label_us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US" id="label_us-gaap_StatementEquityComponentsAxis">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="label_us-gaap_StatementEquityComponentsAxis" xlink:title="Label : us-gaap_StatementEquityComponentsAxis to label_us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US" id="label_us-gaap_StatementOfFinancialPositionAbstract">CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="label_us-gaap_StatementOfFinancialPositionAbstract" xlink:title="Label : us-gaap_StatementOfFinancialPositionAbstract to label_us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForServices to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1">SHARES ISSUED FOR SERVICES, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForServices to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2">Common stock issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForServices to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1">EXERCISE OF OPTIONS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash">Development Stage Entities, Stock Issued, Value, Issued for Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForCash to label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1">SHARES ISSUED FOR CASH, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForCash to label_us-gaap_StockIssuedDuringPeriodValueIssuedForCash_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForServices to label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1">SHARES ISSUED FOR SERVICES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueIssuedForServices to label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesOther" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesOther">Stock Issued During Period, Shares, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesOther to label_us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesOther_1">Shares issued for warrants exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesOther_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesOther to label_us-gaap_StockIssuedDuringPeriodSharesOther_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:title="us-gaap_StockIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssued1" xml:lang="en-US" id="label_us-gaap_StockIssued1">Stock Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="label_us-gaap_StockIssued1" xlink:title="Label : us-gaap_StockIssued1 to label_us-gaap_StockIssued1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssued1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssued1_1" xml:lang="en-US" id="label_us-gaap_StockIssued1_1">Shares issued for offering costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="label_us-gaap_StockIssued1_1" xlink:title="Label : us-gaap_StockIssued1 to label_us-gaap_StockIssued1_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssued1_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssued1_2" xml:lang="en-US" id="label_us-gaap_StockIssued1_2">Fair value of common stock issued for services</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="label_us-gaap_StockIssued1_2" xlink:title="Label : us-gaap_StockIssued1 to label_us-gaap_StockIssued1_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1">EXERCISE OF OPTIONS, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2">Shares issued for stock options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3">Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised to label_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues">Stock Issued During Period, Shares, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesNewIssues to label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1">SHARES ISSUED FOR CASH, NET, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesNewIssues to label_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:title="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">STOCK BASED COMPENSATION</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross to label_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">Stock Issued During Period, Shares, Share-based Compensation, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross to label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_1">STOCK BASED COMPENSATION, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross to label_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash">Development Stage Entities, Stock Issued, Shares, Issued for Cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForCash to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1">SHARES ISSUED FOR CASH, NET, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForCash to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_2" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_2">Shares issued for cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_2" xlink:title="Label : us-gaap_StockIssuedDuringPeriodSharesIssuedForCash to label_us-gaap_StockIssuedDuringPeriodSharesIssuedForCash_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueNewIssues">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueNewIssues to label_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US" id="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1">SHARES ISSUED FOR CASH, NET</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" xlink:title="Label : us-gaap_StockIssuedDuringPeriodValueNewIssues to label_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:title="us-gaap_StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityAbstract" xml:lang="en-US" id="label_us-gaap_StockholdersEquityAbstract">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="label_us-gaap_StockholdersEquityAbstract" xlink:title="Label : us-gaap_StockholdersEquityAbstract to label_us-gaap_StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityAbstract_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockholdersEquityAbstract_1" xml:lang="en-US" id="label_us-gaap_StockholdersEquityAbstract_1">STOCKHOLDERS' EQUITY:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="label_us-gaap_StockholdersEquityAbstract_1" xlink:title="Label : us-gaap_StockholdersEquityAbstract to label_us-gaap_StockholdersEquityAbstract_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquity" xml:lang="en-US" id="label_us-gaap_StockholdersEquity">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_StockholdersEquity_1" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_1">BALANCE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_1" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_StockholdersEquity_2" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_2">BALANCE</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_2" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity_2" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquity_3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="label_us-gaap_StockholdersEquity_3" xml:lang="en-US" id="label_us-gaap_StockholdersEquity_3">Total stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity_3" xlink:title="Label : us-gaap_StockholdersEquity to label_us-gaap_StockholdersEquity_3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteAbstract">STOCK HOLDERS' EQUITY [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="label_us-gaap_StockholdersEquityNoteAbstract" xlink:title="Label : us-gaap_StockholdersEquityNoteAbstract to label_us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="Label : us-gaap_StockholdersEquityNoteDisclosureTextBlock to label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1">STOCK HOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" xlink:title="Label : us-gaap_StockholdersEquityNoteDisclosureTextBlock to label_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="Label : us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 to label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_1" xml:lang="en-US" id="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_1">Reverse stock split ratio</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_1" xlink:title="Label : us-gaap_StockholdersEquityNoteStockSplitConversionRatio1 to label_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:title="us-gaap_SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US" id="label_us-gaap_SubsequentEventsTextBlock">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="label_us-gaap_SubsequentEventsTextBlock" xlink:title="Label : us-gaap_SubsequentEventsTextBlock to label_us-gaap_SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventsTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SubsequentEventsTextBlock_1" xml:lang="en-US" id="label_us-gaap_SubsequentEventsTextBlock_1">SUBSEQUENT EVENT</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="label_us-gaap_SubsequentEventsTextBlock_1" xlink:title="Label : us-gaap_SubsequentEventsTextBlock to label_us-gaap_SubsequentEventsTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:title="us-gaap_SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventsAbstract" xml:lang="en-US" id="label_us-gaap_SubsequentEventsAbstract">SUBSEQUENT EVENT [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="label_us-gaap_SubsequentEventsAbstract" xlink:title="Label : us-gaap_SubsequentEventsAbstract to label_us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xlink:title="us-gaap_SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTable" xml:lang="en-US" id="label_us-gaap_SubsequentEventTable">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="label_us-gaap_SubsequentEventTable" xlink:title="Label : us-gaap_SubsequentEventTable to label_us-gaap_SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xlink:title="us-gaap_SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventLineItems" xml:lang="en-US" id="label_us-gaap_SubsequentEventLineItems">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="label_us-gaap_SubsequentEventLineItems" xlink:title="Label : us-gaap_SubsequentEventLineItems to label_us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="us-gaap_SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventMember" xml:lang="en-US" id="label_us-gaap_SubsequentEventMember">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="label_us-gaap_SubsequentEventMember" xlink:title="Label : us-gaap_SubsequentEventMember to label_us-gaap_SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SubsequentEventMember_1" xml:lang="en-US" id="label_us-gaap_SubsequentEventMember_1">Subsequent event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="label_us-gaap_SubsequentEventMember_1" xlink:title="Label : us-gaap_SubsequentEventMember to label_us-gaap_SubsequentEventMember_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeDomain">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="label_us-gaap_SubsequentEventTypeDomain" xlink:title="Label : us-gaap_SubsequentEventTypeDomain to label_us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="us-gaap_SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US" id="label_us-gaap_SubsequentEventTypeAxis">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="label_us-gaap_SubsequentEventTypeAxis" xlink:title="Label : us-gaap_SubsequentEventTypeAxis to label_us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiariesMember" xlink:label="us-gaap_SubsidiariesMember" xlink:title="us-gaap_SubsidiariesMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsidiariesMember" xml:lang="en-US" id="label_us-gaap_SubsidiariesMember">Subsidiaries [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiariesMember" xlink:to="label_us-gaap_SubsidiariesMember" xlink:title="Label : us-gaap_SubsidiariesMember to label_us-gaap_SubsidiariesMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiaryOfCommonParentMember" xlink:label="us-gaap_SubsidiaryOfCommonParentMember" xlink:title="us-gaap_SubsidiaryOfCommonParentMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SubsidiaryOfCommonParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SubsidiaryOfCommonParentMember" xml:lang="en-US" id="label_us-gaap_SubsidiaryOfCommonParentMember">Subsidiary of Common Parent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOfCommonParentMember" xlink:to="label_us-gaap_SubsidiaryOfCommonParentMember" xlink:title="Label : us-gaap_SubsidiaryOfCommonParentMember to label_us-gaap_SubsidiaryOfCommonParentMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:title="us-gaap_SummaryOfValuationAllowanceTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_SummaryOfValuationAllowanceTextBlock" xml:lang="en-US" id="label_us-gaap_SummaryOfValuationAllowanceTextBlock">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="label_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:title="Label : us-gaap_SummaryOfValuationAllowanceTextBlock to label_us-gaap_SummaryOfValuationAllowanceTextBlock" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_SummaryOfValuationAllowanceTextBlock_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_SummaryOfValuationAllowanceTextBlock_1" xml:lang="en-US" id="label_us-gaap_SummaryOfValuationAllowanceTextBlock_1">Valuation Allowance Rollforward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="label_us-gaap_SummaryOfValuationAllowanceTextBlock_1" xlink:title="Label : us-gaap_SummaryOfValuationAllowanceTextBlock to label_us-gaap_SummaryOfValuationAllowanceTextBlock_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TradingSecuritiesEquityCost" xlink:label="us-gaap_TradingSecuritiesEquityCost" xlink:title="us-gaap_TradingSecuritiesEquityCost" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TradingSecuritiesEquityCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_TradingSecuritiesEquityCost" xml:lang="en-US" id="label_us-gaap_TradingSecuritiesEquityCost">Trading Securities, Equity, Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesEquityCost" xlink:to="label_us-gaap_TradingSecuritiesEquityCost" xlink:title="Label : us-gaap_TradingSecuritiesEquityCost to label_us-gaap_TradingSecuritiesEquityCost" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_TradingSecuritiesEquityCost_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_TradingSecuritiesEquityCost_1" xml:lang="en-US" id="label_us-gaap_TradingSecuritiesEquityCost_1">Cost of securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingSecuritiesEquityCost" xlink:to="label_us-gaap_TradingSecuritiesEquityCost_1" xlink:title="Label : us-gaap_TradingSecuritiesEquityCost to label_us-gaap_TradingSecuritiesEquityCost_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:title="us-gaap_UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefits">Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="label_us-gaap_UnrecognizedTaxBenefits" xlink:title="Label : us-gaap_UnrecognizedTaxBenefits to label_us-gaap_UnrecognizedTaxBenefits" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UnrecognizedTaxBenefits_1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_us-gaap_UnrecognizedTaxBenefits_1" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefits_1">Balance at End of Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="label_us-gaap_UnrecognizedTaxBenefits_1" xlink:title="Label : us-gaap_UnrecognizedTaxBenefits to label_us-gaap_UnrecognizedTaxBenefits_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UnrecognizedTaxBenefits_2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_us-gaap_UnrecognizedTaxBenefits_2" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefits_2">Balance at Beginning of Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="label_us-gaap_UnrecognizedTaxBenefits_2" xlink:title="Label : us-gaap_UnrecognizedTaxBenefits to label_us-gaap_UnrecognizedTaxBenefits_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:title="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:title="Label : us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease to label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1" xml:lang="en-US" id="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1">Increase (decrease) in uncertain tax positions for the current year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1" xlink:title="Label : us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease to label_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:title="us-gaap_UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_UseOfEstimates" xml:lang="en-US" id="label_us-gaap_UseOfEstimates">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates" xlink:title="Label : us-gaap_UseOfEstimates to label_us-gaap_UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_UseOfEstimates_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_UseOfEstimates_1" xml:lang="en-US" id="label_us-gaap_UseOfEstimates_1">Use of estimates in the preparation of financial statements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates_1" xlink:title="Label : us-gaap_UseOfEstimates to label_us-gaap_UseOfEstimates_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:title="us-gaap_VestingAxis" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_VestingAxis" xml:lang="en-US" id="label_us-gaap_VestingAxis">Vesting [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="label_us-gaap_VestingAxis" xlink:title="Label : us-gaap_VestingAxis to label_us-gaap_VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:title="us-gaap_VestingDomain" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_VestingDomain" xml:lang="en-US" id="label_us-gaap_VestingDomain">Vesting [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="label_us-gaap_VestingDomain" xlink:title="Label : us-gaap_VestingDomain to label_us-gaap_VestingDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xml:lang="en-US" id="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="Label : us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount to label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xml:lang="en-US" id="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1">Additions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" xlink:title="Label : us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount to label_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" xlink:title="us-gaap_VehiclesMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_VehiclesMember" xml:lang="en-US" id="label_us-gaap_VehiclesMember">Vehicles [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="label_us-gaap_VehiclesMember" xlink:title="Label : us-gaap_VehiclesMember to label_us-gaap_VehiclesMember" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WarrantMember" xml:lang="en-US" id="label_us-gaap_WarrantMember">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="label_us-gaap_WarrantMember" xlink:title="Label : us-gaap_WarrantMember to label_us-gaap_WarrantMember" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantMember_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_WarrantMember_1" xml:lang="en-US" id="label_us-gaap_WarrantMember_1">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="label_us-gaap_WarrantMember_1" xlink:title="Label : us-gaap_WarrantMember to label_us-gaap_WarrantMember_1" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantMember_2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_us-gaap_WarrantMember_2" xml:lang="en-US" id="label_us-gaap_WarrantMember_2">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="label_us-gaap_WarrantMember_2" xlink:title="Label : us-gaap_WarrantMember to label_us-gaap_WarrantMember_2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xml:lang="en-US" id="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">WARRANTS [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="Label : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to label_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:title="us-gaap_WarrantsAndRightsOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WarrantsAndRightsOutstanding" xml:lang="en-US" id="label_us-gaap_WarrantsAndRightsOutstanding">Warrants and Rights Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="label_us-gaap_WarrantsAndRightsOutstanding" xlink:title="Label : us-gaap_WarrantsAndRightsOutstanding to label_us-gaap_WarrantsAndRightsOutstanding" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WarrantsAndRightsOutstanding_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_WarrantsAndRightsOutstanding_1" xml:lang="en-US" id="label_us-gaap_WarrantsAndRightsOutstanding_1">Warrants (notes 6)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="label_us-gaap_WarrantsAndRightsOutstanding_1" xlink:title="Label : us-gaap_WarrantsAndRightsOutstanding to label_us-gaap_WarrantsAndRightsOutstanding_1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="Label : us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted to label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xlink:type="resource" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xml:lang="en-US" id="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1">WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER COMMON STOCK</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" xlink:title="Label : us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted to label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>ormp-20150228_pre.xml
<DESCRIPTION>TAXONOMY EXTENSION PRESENTATION LINKBASEBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--Created by Z-K Global, Powered by IRIS Carbon-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-STOCKBASEDCOMPENSATIONDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-STOCKBASEDCOMPENSATIONDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sapd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sapd" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-SHORTTERMDEPOSITSDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-erurd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-erurd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-erur" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-erur" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-daei" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-daei" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toind" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toind" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-wd1" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-wd1" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-scsosoad" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-scsosoad" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-scsoifooaebeprd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-scsoifooaebeprd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sapp" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sapp" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-SIGNIFICANTACCOUNTINGPOLICIESTables" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sap" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sap" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccsocf" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccsocf" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccbs" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccbs" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITS" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-SHORTTERMDEPOSITS" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSTables" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-SHORTTERMDEPOSITSTables" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-c" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-c" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-csad" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-csad" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-cld" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-cld" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-crgd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-crgd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sct" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sct" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sbc" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sbc" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-scsofvad" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-scsofvad" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccsocl" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccsocl" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccsocise" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccsocise" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-msd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-msd" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-FAIRVALUEDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-FAIRVALUEDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-fv" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-fv" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toisoditd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toisoditd" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-TAXESONINCOMEValuationAllowanceRollforwardDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-TAXESONINCOMEValuationAllowanceRollforwardDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toisoitiiisd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toisoitiiisd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toisoroitd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toisoroitd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toi" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toi" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toit" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toit" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-toisoutbd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-toisoutbd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-fiae" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-fiae" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-fiaed" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-fiaed" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-fiaet" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-fiaet" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ms" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ms" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-mst" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-mst" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-paent" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-paent" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-paen" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-paen" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-paend" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-paend" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-STOCKHOLDERSEQUITYDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-RELATEDPARTIES-TRANSACTIONSDetails" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-RELATEDPARTIES-TRANSACTIONSDetails" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-rptsobwrpd" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-rptsobwrpd" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-rptt" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-rptt" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-rpt" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-rpt" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccsocisep" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccsocisep" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-ccbsp" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-ccbsp" />
  <link:roleRef roleURI="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="ormp-20150228.xsd#Disclosure-STOCKHOLDERSEQUITYTables" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-she" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-she" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-se" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-se" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-sed" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-sed" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-w" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-w" />
  <link:roleRef roleURI="http://www.oramed.com/role/ormp-wt" xlink:type="simple" xlink:href="ormp-20150228.xsd#ormp-wt" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYScheduleofWarrantActivityDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Presentation : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" order="40" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="Presentation : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodWeightedAverageExercisePrice" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" xlink:title="Presentation : ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="30" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_ShareBasedCompensationArrangementByShareBasedAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceAbstract" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" order="30" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_WarrantMember" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-STOCKBASEDCOMPENSATIONDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xlink:title="us-gaap_AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="Presentation : us-gaap_AwardTypeAxis to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EquityIssuanceAxis" xlink:label="ormp_EquityIssuanceAxis" xlink:title="ormp_EquityIssuanceAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EquityIssuanceDomain" xlink:label="ormp_EquityIssuanceDomain" xlink:title="ormp_EquityIssuanceDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EquityIssuanceAxis" xlink:to="ormp_EquityIssuanceDomain" xlink:title="Presentation : ormp_EquityIssuanceAxis to ormp_EquityIssuanceDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IssuanceOneMember" xlink:label="ormp_IssuanceOneMember" xlink:title="ormp_IssuanceOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EquityIssuanceDomain" xlink:to="ormp_IssuanceOneMember" xlink:title="Presentation : ormp_EquityIssuanceDomain to ormp_IssuanceOneMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IssuanceTwoMember" xlink:label="ormp_IssuanceTwoMember" xlink:title="ormp_IssuanceTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EquityIssuanceDomain" xlink:to="ormp_IssuanceTwoMember" xlink:title="Presentation : ormp_EquityIssuanceDomain to ormp_IssuanceTwoMember" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain" xlink:title="us-gaap_PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:label="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:title="ormp_AmendedAndRestated2008StockIncentivePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="ormp_AmendedAndRestated2008StockIncentivePlanMember" xlink:title="Presentation : us-gaap_PlanNameDomain to ormp_AmendedAndRestated2008StockIncentivePlanMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_CommonStockMember" xlink:title="Presentation : us-gaap_PlanNameDomain to us-gaap_CommonStockMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" xlink:title="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_WarrantMember" xlink:title="Presentation : us-gaap_PlanNameDomain to us-gaap_WarrantMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" xlink:title="us-gaap_PlanNameAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" xlink:title="Presentation : us-gaap_PlanNameAxis to us-gaap_PlanNameDomain" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:title="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefMedicalAndTechnologyOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_ChiefMedicalAndTechnologyOfficerMember" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeeOneMember" xlink:label="ormp_SubsidiaryEmployeeOneMember" xlink:title="ormp_SubsidiaryEmployeeOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_SubsidiaryEmployeeOneMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_SubsidiaryEmployeeOneMember" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeeTwoMember" xlink:label="ormp_SubsidiaryEmployeeTwoMember" xlink:title="ormp_SubsidiaryEmployeeTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_SubsidiaryEmployeeTwoMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_SubsidiaryEmployeeTwoMember" order="56" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SubsidiaryEmployeesMember" xlink:label="ormp_SubsidiaryEmployeesMember" xlink:title="ormp_SubsidiaryEmployeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_SubsidiaryEmployeesMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_SubsidiaryEmployeesMember" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorOneMember" xlink:label="ormp_DirectorOneMember" xlink:title="ormp_DirectorOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorOneMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorOneMember" use="optional" priority="0" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorTwoMember" xlink:label="ormp_DirectorTwoMember" xlink:title="ormp_DirectorTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorTwoMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorTwoMember" use="optional" priority="0" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorThreeMember" xlink:label="ormp_DirectorThreeMember" xlink:title="ormp_DirectorThreeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorThreeMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorThreeMember" use="optional" priority="0" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DirectorFourMember" xlink:label="ormp_DirectorFourMember" xlink:title="ormp_DirectorFourMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="ormp_DirectorFourMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to ormp_DirectorFourMember" use="optional" priority="0" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to us-gaap_DirectorMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember" xlink:title="us-gaap_ExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_ExecutiveOfficerMember" xlink:title="Presentation : us-gaap_RelatedPartyTransactionDomain to us-gaap_ExecutiveOfficerMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:title="us-gaap_RelatedPartyTransactionAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" xlink:title="Presentation : us-gaap_RelatedPartyTransactionAxis to us-gaap_RelatedPartyTransactionDomain" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_AwardTypeAxis" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ormp_EquityIssuanceAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ormp_EquityIssuanceAxis" use="optional" priority="0" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_PlanNameAxis" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RelatedPartyTransactionAxis" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" xlink:title="us-gaap_VestingAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_VestingAxis" use="optional" priority="0" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationInstallmentVestingShares" xlink:label="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:title="ormp_ShareBasedCompensationInstallmentVestingShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_ShareBasedCompensationInstallmentVestingShares" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_ShareBasedCompensationInstallmentVestingShares" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:label="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:title="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfOptionsVestingEachInstallment" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:label="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:title="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfVestingPeriods" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsExpectedVolatilityRate" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsRiskFreeInterestRate" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" xlink:title="us-gaap_FairValueAssumptionsExpectedTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsExpectedTerm" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_FairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_FairValueAssumptionsExpectedDividendRate" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" use="optional" priority="0" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharePrice" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:title="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_RestrictedStockUnitsRSUMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain" xlink:title="us-gaap_VestingDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" xlink:title="Presentation : us-gaap_VestingAxis to us-gaap_VestingDomain" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:title="Presentation : us-gaap_VestingDomain to us-gaap_ShareBasedCompensationAwardTrancheOneMember" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:title="Presentation : us-gaap_VestingDomain to us-gaap_ShareBasedCompensationAwardTrancheTwoMember" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sapd">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LossPerCommonShareAbstract" xlink:label="ormp_LossPerCommonShareAbstract" xlink:title="ormp_LossPerCommonShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_LossPerCommonShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="Presentation : ormp_LossPerCommonShareAbstract to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:label="ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:title="ormp_PropertyPlantAndEquipmentGeneralAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Presentation : ormp_PropertyPlantAndEquipmentGeneralAbstract to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ormp_LossPerCommonShareAbstract" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to ormp_LossPerCommonShareAbstract" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ormp_PropertyPlantAndEquipmentGeneralAbstract" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to ormp_PropertyPlantAndEquipmentGeneralAbstract" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:label="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:title="us-gaap_RestrictedCashAndInvestmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_RestrictedCashAndInvestmentsAbstract" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesNameDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionsAndWarrantsMember" xlink:label="ormp_StockOptionsAndWarrantsMember" xlink:title="ormp_StockOptionsAndWarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="ormp_StockOptionsAndWarrantsMember" xlink:title="Presentation : us-gaap_AntidilutiveSecuritiesNameDomain to ormp_StockOptionsAndWarrantsMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="us-gaap_ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_ComputerEquipmentMember" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:title="us-gaap_OfficeEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_OfficeEquipmentMember" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:label="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:title="ormp_PropertyPlantAndEquipmentDepreciationRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="ormp_PropertyPlantAndEquipmentDepreciationRate" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to ormp_PropertyPlantAndEquipmentDepreciationRate" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents" xlink:title="us-gaap_RestrictedCashAndCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalents" xlink:title="Presentation : us-gaap_RestrictedCashAndInvestmentsAbstract to us-gaap_RestrictedCashAndCashEquivalents" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="Presentation : us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentLineItems" order="30" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_RangeAxis" order="20" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSDetails">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfRestrictedCashTable" xlink:label="ormp_ScheduleOfRestrictedCashTable" xlink:title="ormp_ScheduleOfRestrictedCashTable" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShortTermInvestmentsLineItems" xlink:label="ormp_ShortTermInvestmentsLineItems" xlink:title="ormp_ShortTermInvestmentsLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ScheduleOfRestrictedCashTable" xlink:to="ormp_ShortTermInvestmentsLineItems" xlink:title="Presentation : ormp_ScheduleOfRestrictedCashTable to ormp_ShortTermInvestmentsLineItems" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ScheduleOfRestrictedCashTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : ormp_ScheduleOfRestrictedCashTable to us-gaap_RangeAxis" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ScheduleOfRestrictedCashTable" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:title="Presentation : ormp_ScheduleOfRestrictedCashTable to us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShortTermInvestmentWithBanksInterestRate" xlink:label="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:title="ormp_ShortTermInvestmentWithBanksInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ShortTermInvestmentsLineItems" xlink:to="ormp_ShortTermInvestmentWithBanksInterestRate" xlink:title="Presentation : ormp_ShortTermInvestmentsLineItems to ormp_ShortTermInvestmentWithBanksInterestRate" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestBearingDepositsInBanks" xlink:label="us-gaap_InterestBearingDepositsInBanks" xlink:title="us-gaap_InterestBearingDepositsInBanks" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ShortTermInvestmentsLineItems" xlink:to="us-gaap_InterestBearingDepositsInBanks" xlink:title="Presentation : ormp_ShortTermInvestmentsLineItems to us-gaap_InterestBearingDepositsInBanks" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="ormp_ScheduleOfRestrictedCashTable" xlink:title="Presentation : us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract to ormp_ScheduleOfRestrictedCashTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:title="Presentation : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis to us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ForeignInterestBearingDepositsMember" xlink:label="ormp_ForeignInterestBearingDepositsMember" xlink:title="ormp_ForeignInterestBearingDepositsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="ormp_ForeignInterestBearingDepositsMember" xlink:title="Presentation : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember to ormp_ForeignInterestBearingDepositsMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestBearingDepositsMember" xlink:label="us-gaap_InterestBearingDepositsMember" xlink:title="us-gaap_InterestBearingDepositsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_InterestBearingDepositsMember" xlink:title="Presentation : us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember to us-gaap_InterestBearingDepositsMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-erurd">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeeRightsUponRetirementAbstract" xlink:label="ormp_EmployeeRightsUponRetirementAbstract" xlink:title="ormp_EmployeeRightsUponRetirementAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SeverancePayInsuranceDeposits" xlink:label="ormp_SeverancePayInsuranceDeposits" xlink:title="ormp_SeverancePayInsuranceDeposits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EmployeeRightsUponRetirementAbstract" xlink:to="ormp_SeverancePayInsuranceDeposits" xlink:title="Presentation : ormp_EmployeeRightsUponRetirementAbstract to ormp_SeverancePayInsuranceDeposits" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:label="ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:title="ormp_SeverancePayInsuranceDepositExpectedAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EmployeeRightsUponRetirementAbstract" xlink:to="ormp_SeverancePayInsuranceDepositExpectedAmount" xlink:title="Presentation : ormp_EmployeeRightsUponRetirementAbstract to ormp_SeverancePayInsuranceDepositExpectedAmount" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DefinedContributionPlanExpectedLiability" xlink:label="ormp_DefinedContributionPlanExpectedLiability" xlink:title="ormp_DefinedContributionPlanExpectedLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EmployeeRightsUponRetirementAbstract" xlink:to="ormp_DefinedContributionPlanExpectedLiability" xlink:title="Presentation : ormp_EmployeeRightsUponRetirementAbstract to ormp_DefinedContributionPlanExpectedLiability" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" xlink:title="us-gaap_DefinedContributionPlanCostRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EmployeeRightsUponRetirementAbstract" xlink:to="us-gaap_DefinedContributionPlanCostRecognized" xlink:title="Presentation : ormp_EmployeeRightsUponRetirementAbstract to us-gaap_DefinedContributionPlanCostRecognized" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1" xlink:title="us-gaap_SeveranceCosts1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EmployeeRightsUponRetirementAbstract" xlink:to="us-gaap_SeveranceCosts1" xlink:title="Presentation : ormp_EmployeeRightsUponRetirementAbstract to us-gaap_SeveranceCosts1" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-erur">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeeRightsUponRetirementAbstract" xlink:label="ormp_EmployeeRightsUponRetirementAbstract" xlink:title="ormp_EmployeeRightsUponRetirementAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeeRightsUponRetirementTextBlock" xlink:label="ormp_EmployeeRightsUponRetirementTextBlock" xlink:title="ormp_EmployeeRightsUponRetirementTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_EmployeeRightsUponRetirementAbstract" xlink:to="ormp_EmployeeRightsUponRetirementTextBlock" xlink:title="Presentation : ormp_EmployeeRightsUponRetirementAbstract to ormp_EmployeeRightsUponRetirementTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-daei">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DocumentAndEntityInformationAbstract" xlink:label="ormp_DocumentAndEntityInformationAbstract" xlink:title="ormp_DocumentAndEntityInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:title="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_AmendmentFlag" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xlink:title="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_CurrentFiscalYearEndDate" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:title="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_DocumentPeriodEndDate" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:title="dei_EntityWellKnownSeasonedIssuer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityWellKnownSeasonedIssuer" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" xlink:title="dei_EntityVoluntaryFilers" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityVoluntaryFilers" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityVoluntaryFilers" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xlink:title="dei_EntityCurrentReportingStatus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityCurrentReportingStatus" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:title="dei_EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityFilerCategory" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" xlink:title="dei_EntityPublicFloat" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityPublicFloat" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityPublicFloat" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:title="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityRegistrantName" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:title="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityCentralIndexKey" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:title="dei_EntityCommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_EntityCommonStockSharesOutstanding" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xlink:title="dei_DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_DocumentFiscalYearFocus" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:title="dei_DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_DocumentFiscalPeriodFocus" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:title="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType" xlink:title="Presentation : ormp_DocumentAndEntityInformationAbstract to dei_DocumentType" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toind">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:title="dei_EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiariesMember" xlink:label="us-gaap_SubsidiariesMember" xlink:title="us-gaap_SubsidiariesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="us-gaap_SubsidiariesMember" xlink:title="Presentation : dei_EntityDomain to us-gaap_SubsidiariesMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_TaxesOnIncomeLineItems" xlink:label="ormp_TaxesOnIncomeLineItems" xlink:title="ormp_TaxesOnIncomeLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_TaxesOnIncomeLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="Presentation : ormp_TaxesOnIncomeLineItems to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:title="us-gaap_OperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_TaxesOnIncomeLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" xlink:title="Presentation : ormp_TaxesOnIncomeLineItems to us-gaap_OperatingLossCarryforwards" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:title="dei_LegalEntityAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:title="Presentation : dei_LegalEntityAxis to dei_EntityDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:title="us-gaap_IncomeTaxExaminationPenaltiesExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesExpense" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxExaminationPenaltiesExpense" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_StatementTable" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_StatementTable" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="ormp_TaxesOnIncomeLineItems" xlink:title="Presentation : us-gaap_StatementTable to ormp_TaxesOnIncomeLineItems" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" xlink:title="Presentation : us-gaap_StatementTable to dei_LegalEntityAxis" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-wd1">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsTable" xlink:label="ormp_WarrantsTable" xlink:title="ormp_WarrantsTable" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAxis" xlink:label="ormp_WarrantsAxis" xlink:title="ormp_WarrantsAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsTable" xlink:to="ormp_WarrantsAxis" xlink:title="Presentation : ormp_WarrantsTable to ormp_WarrantsAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsLineItems" xlink:label="ormp_WarrantsLineItems" xlink:title="ormp_WarrantsLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsTable" xlink:to="ormp_WarrantsLineItems" xlink:title="Presentation : ormp_WarrantsTable to ormp_WarrantsLineItems" order="2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsDomain" xlink:label="ormp_WarrantsDomain" xlink:title="ormp_WarrantsDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsAxis" xlink:to="ormp_WarrantsDomain" xlink:title="Presentation : ormp_WarrantsAxis to ormp_WarrantsDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsOneMember" xlink:label="ormp_WarrantsOneMember" xlink:title="ormp_WarrantsOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_WarrantsOneMember" xlink:title="Presentation : ormp_WarrantsDomain to ormp_WarrantsOneMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsTwoMember" xlink:label="ormp_WarrantsTwoMember" xlink:title="ormp_WarrantsTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_WarrantsTwoMember" xlink:title="Presentation : ormp_WarrantsDomain to ormp_WarrantsTwoMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NewWarrantMember" xlink:label="ormp_NewWarrantMember" xlink:title="ormp_NewWarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_NewWarrantMember" xlink:title="Presentation : ormp_WarrantsDomain to ormp_NewWarrantMember" order="3" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KidronOptionMember" xlink:label="ormp_KidronOptionMember" xlink:title="ormp_KidronOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsDomain" xlink:to="ormp_KidronOptionMember" xlink:title="Presentation : ormp_WarrantsDomain to ormp_KidronOptionMember" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsGrantedShares" xlink:label="ormp_WarrantsGrantedShares" xlink:title="ormp_WarrantsGrantedShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="ormp_WarrantsGrantedShares" xlink:title="Presentation : ormp_WarrantsLineItems to ormp_WarrantsGrantedShares" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClassOfWarrantOrRightTerm" xlink:label="ormp_ClassOfWarrantOrRightTerm" xlink:title="ormp_ClassOfWarrantOrRightTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="ormp_ClassOfWarrantOrRightTerm" xlink:title="Presentation : ormp_WarrantsLineItems to ormp_ClassOfWarrantOrRightTerm" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAndRightsExpenseRecognized" xlink:label="ormp_WarrantsAndRightsExpenseRecognized" xlink:title="ormp_WarrantsAndRightsExpenseRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="ormp_WarrantsAndRightsExpenseRecognized" xlink:title="Presentation : ormp_WarrantsLineItems to ormp_WarrantsAndRightsExpenseRecognized" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="Presentation : ormp_WarrantsLineItems to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Presentation : ormp_WarrantsLineItems to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Presentation : ormp_WarrantsLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Presentation : ormp_WarrantsLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Presentation : ormp_WarrantsLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Presentation : ormp_WarrantsLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:title="us-gaap_WarrantsAndRightsOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_WarrantsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" xlink:title="Presentation : ormp_WarrantsLineItems to us-gaap_WarrantsAndRightsOutstanding" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ormp_WarrantsTable" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to ormp_WarrantsTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:label="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:title="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to ormp_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInFairValue" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:label="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:title="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to ormp_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisExchangeOfWarrants" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1" xlink:title="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-scsosoad">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="Presentation : ormp_StockOptionActivityEmployeesAndNonemployeesAxis to ormp_StockOptionActivityEmployeesAndNonemployeesDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeesMember" xlink:label="ormp_EmployeesMember" xlink:title="ormp_EmployeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_EmployeesMember" xlink:title="Presentation : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_EmployeesMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NonemployeesMember" xlink:label="ormp_NonemployeesMember" xlink:title="ormp_NonemployeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_NonemployeesMember" xlink:title="Presentation : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_NonemployeesMember" order="2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:label="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:title="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="Presentation : ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable to ormp_StockOptionActivityEmployeesAndNonemployeesAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityLineItems" xlink:label="ormp_StockOptionActivityLineItems" xlink:title="ormp_StockOptionActivityLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:to="ormp_StockOptionActivityLineItems" xlink:title="Presentation : ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable to ormp_StockOptionActivityLineItems" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" xlink:title="Presentation : ormp_StockOptionActivityLineItems to us-gaap_AllocatedShareBasedCompensationExpense" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="Presentation : ormp_StockOptionActivityLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="Presentation : ormp_StockOptionActivityLineItems to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="Presentation : ormp_StockOptionActivityLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:title="Presentation : ormp_StockOptionActivityLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="Presentation : ormp_StockOptionActivityLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ormp_ScheduleOfStockOptionActivityEmployeesAndNonemployeesTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceAboveMarketPrice" order="2.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:label="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAboveMarketPrice" order="2.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-scsoifooaebeprd">
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:label="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:title="Presentation : ormp_StockOptionActivityEmployeesAndNonemployeesAxis to ormp_StockOptionActivityEmployeesAndNonemployeesDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EmployeesMember" xlink:label="ormp_EmployeesMember" xlink:title="ormp_EmployeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_EmployeesMember" xlink:title="Presentation : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_EmployeesMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NonemployeesMember" xlink:label="ormp_NonemployeesMember" xlink:title="ormp_NonemployeesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ormp_StockOptionActivityEmployeesAndNonemployeesDomain" xlink:to="ormp_NonemployeesMember" xlink:title="Presentation : ormp_StockOptionActivityEmployeesAndNonemployeesDomain to ormp_NonemployeesMember" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="ormp_StockOptionActivityEmployeesAndNonemployeesAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable to ormp_StockOptionActivityEmployeesAndNonemployeesAxis" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" order="3" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:label="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:title="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:label="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:title="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to ormp_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:title="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis to us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeOneMember" xlink:label="ormp_ExercisePriceRangeOneMember" xlink:title="ormp_ExercisePriceRangeOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeOneMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeOneMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeFourMember" xlink:label="ormp_ExercisePriceRangeFourMember" xlink:title="ormp_ExercisePriceRangeFourMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeFourMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeFourMember" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeTwoMember" xlink:label="ormp_ExercisePriceRangeTwoMember" xlink:title="ormp_ExercisePriceRangeTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeTwoMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeTwoMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExercisePriceRangeThreeMember" xlink:label="ormp_ExercisePriceRangeThreeMember" xlink:title="ormp_ExercisePriceRangeThreeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="ormp_ExercisePriceRangeThreeMember" xlink:title="Presentation : us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain to ormp_ExercisePriceRangeThreeMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sapp">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:label="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:title="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock" order="2.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:label="ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:title="ormp_WarrantLiabilityPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ormp_WarrantLiabilityPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to ormp_WarrantLiabilityPolicyPolicyTextBlock" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:label="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:title="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ormp_ConcentrationRiskCreditRiskPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to ormp_ConcentrationRiskCreditRiskPolicyTextBlock" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:title="us-gaap_ConsolidationPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ConsolidationPolicyTextBlock" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_EarningsPerSharePolicyTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:title="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_IncomeTaxPolicyTextBlock" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" xlink:title="us-gaap_NatureOfOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NatureOfOperations" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_NatureOfOperations" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ResearchAndDevelopmentExpensePolicy" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" xlink:title="us-gaap_UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_UseOfEstimates" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-SIGNIFICANTACCOUNTINGPOLICIESTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:label="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:title="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to ormp_ScheduleOfAnnualDepreciationRatesTableTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sap">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:title="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:title="Presentation : us-gaap_AccountingPoliciesAbstract to us-gaap_SignificantAccountingPoliciesTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccsocf">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesToBeIssuedForServicesRendered" xlink:label="ormp_SharesToBeIssuedForServicesRendered" xlink:title="ormp_SharesToBeIssuedForServicesRendered" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ormp_SharesToBeIssuedForServicesRendered" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ormp_SharesToBeIssuedForServicesRendered" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsExchanged" xlink:label="ormp_WarrantsExchanged" xlink:title="ormp_WarrantsExchanged" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ormp_WarrantsExchanged" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ormp_WarrantsExchanged" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:title="us-gaap_DepreciationDepletionAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_DepreciationDepletionAndAmortization" order="0.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="us-gaap_DerivativeGainLossOnDerivativeNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DerivativeGainLossOnDerivativeNet" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_DerivativeGainLossOnDerivativeNet" order="8003" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfInvestments" xlink:label="us-gaap_GainLossOnSaleOfInvestments" xlink:title="us-gaap_GainLossOnSaleOfInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfInvestments" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_GainLossOnSaleOfInvestments" order="6.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="5" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" order="8001" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xlink:title="us-gaap_ShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" xlink:title="Presentation : us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_ShareBasedCompensation" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:label="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:title="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:label="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:title="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:title="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInAccountsPayable" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="8001" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:label="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:title="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:title="Presentation : us-gaap_IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:label="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:title="ormp_ProceedsFromStockOptionsAndWarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ormp_ProceedsFromStockOptionsAndWarrantsExercised" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract to ormp_ProceedsFromStockOptionsAndWarrantsExercised" order="1.875" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivities" order="8001" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_ProceedsFromIssuanceOfCommonStock" order="1" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:label="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:title="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivities" order="8000" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:title="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_PaymentsForProceedsFromOtherInvestingActivities" order="8001" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireLongtermInvestments" xlink:label="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:title="us-gaap_PaymentsToAcquireLongtermInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireLongtermInvestments" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_PaymentsToAcquireLongtermInvestments" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:title="us-gaap_PaymentsToAcquireShortTermInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_PaymentsToAcquireShortTermInvestments" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:title="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" order="4.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="4.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="8011" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetIncomeLoss" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:title="Presentation : us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:title="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:label="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:title="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" xlink:title="Presentation : us-gaap_NoncashInvestingAndFinancingItemsAbstract to ormp_DiscountOnConvertibleNoteRelatedToBeneficialConversionFeature" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:label="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:title="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" xlink:title="Presentation : us-gaap_NoncashInvestingAndFinancingItemsAbstract to ormp_NonCashInvestingAndFinancingActivitiesSharesAndWarrantsToBeIssuedForCash" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ContributionOfProperty" xlink:label="us-gaap_ContributionOfProperty" xlink:title="us-gaap_ContributionOfProperty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_ContributionOfProperty" xlink:title="Presentation : us-gaap_NoncashInvestingAndFinancingItemsAbstract to us-gaap_ContributionOfProperty" order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="us-gaap_DebtConversionConvertedInstrumentAmount1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:title="Presentation : us-gaap_NoncashInvestingAndFinancingItemsAbstract to us-gaap_DebtConversionConvertedInstrumentAmount1" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:label="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:title="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:title="Presentation : us-gaap_NoncashInvestingAndFinancingItemsAbstract to us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:title="us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:title="Presentation : us-gaap_StatementOfCashFlowsAbstract to us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccbs">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:title="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xlink:title="us-gaap_AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_AssetsCurrent" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:title="us-gaap_DepositsAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_DepositsAssetsCurrent" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:label="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:title="us-gaap_DueFromOtherRelatedPartiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_DueFromOtherRelatedPartiesCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_DueFromOtherRelatedPartiesCurrent" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent" xlink:title="us-gaap_MarketableSecuritiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_MarketableSecuritiesCurrent" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:title="us-gaap_OtherReceivablesNetCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_OtherReceivablesNetCurrent" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="6.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:title="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:title="Presentation : us-gaap_AssetsCurrentAbstract to us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xlink:title="us-gaap_AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xlink:title="us-gaap_Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_Assets" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_AssetsCurrentAbstract" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:label="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:title="us-gaap_InvestmentsAndOtherNoncurrentAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_InvestmentsAndOtherNoncurrentAssets" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidPensionCosts" xlink:label="us-gaap_PrepaidPensionCosts" xlink:title="us-gaap_PrepaidPensionCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PrepaidPensionCosts" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_PrepaidPensionCosts" order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" xlink:title="Presentation : us-gaap_AssetsAbstract to us-gaap_PropertyPlantAndEquipmentNet" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:title="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="us-gaap_AccountsPayableOtherCurrent" xlink:title="us-gaap_AccountsPayableOtherCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableOtherCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_AccountsPayableOtherCurrent" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrent" xlink:title="us-gaap_DueToRelatedPartiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_DueToRelatedPartiesCurrent" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xlink:title="us-gaap_LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" xlink:title="Presentation : us-gaap_LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrent" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" xlink:title="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:title="us-gaap_LiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" xlink:title="Presentation : us-gaap_LiabilitiesNoncurrentAbstract to us-gaap_LiabilitiesNoncurrent" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:label="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:title="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:title="Presentation : us-gaap_LiabilitiesNoncurrentAbstract to us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:label="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:title="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:title="Presentation : us-gaap_LiabilitiesNoncurrentAbstract to us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:title="us-gaap_CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_CommitmentsAndContingencies" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquity" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesCurrentAbstract" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesNoncurrentAbstract" order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:title="us-gaap_StockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" xlink:title="Presentation : us-gaap_LiabilitiesAndStockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_AssetsAbstract" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_AdditionalPaidInCapitalCommonStock" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xlink:title="us-gaap_CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_CommonStockValue" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_RetainedEarningsAccumulatedDeficit" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" xlink:title="Presentation : us-gaap_StockholdersEquityAbstract to us-gaap_StockholdersEquity" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITS">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:title="Presentation : us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract to us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-SHORTTERMDEPOSITSTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:title="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:title="Presentation : us-gaap_CashCashEquivalentsAndShortTermInvestmentsAbstract to us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-c">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-csad">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:label="us-gaap_LongTermPurchaseCommitmentTable" xlink:title="us-gaap_LongTermPurchaseCommitmentTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LongTermPurchaseCommitmentTable" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_LongTermPurchaseCommitmentTable" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityMethodInvesteeNameDomain" xlink:label="us-gaap_EquityMethodInvesteeNameDomain" xlink:title="us-gaap_EquityMethodInvesteeNameDomain" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_EnteraBioLtdMember" xlink:label="ormp_EnteraBioLtdMember" xlink:title="ormp_EnteraBioLtdMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvesteeNameDomain" xlink:to="ormp_EnteraBioLtdMember" xlink:title="Presentation : us-gaap_EquityMethodInvesteeNameDomain to ormp_EnteraBioLtdMember" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:label="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:title="us-gaap_LongTermPurchaseCommitmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:label="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:title="ormp_LongTermPurchaseCommitmentAgreementTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_LongTermPurchaseCommitmentAgreementTerm" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_LongTermPurchaseCommitmentAgreementTerm" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:label="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:title="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentage" xlink:label="ormp_RoyaltyPercentage" xlink:title="ormp_RoyaltyPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_RoyaltyPercentage" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_RoyaltyPercentage" order="8.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LongTermPurchaseCommitmentBonusAmount" xlink:label="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:title="ormp_LongTermPurchaseCommitmentBonusAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_LongTermPurchaseCommitmentBonusAmount" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_LongTermPurchaseCommitmentBonusAmount" order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:label="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:title="ormp_CostMethodInvestmentsOwnershipPercentageRetained" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="ormp_CostMethodInvestmentsOwnershipPercentageRetained" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to ormp_CostMethodInvestmentsOwnershipPercentageRetained" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostMethodInvestments" xlink:label="us-gaap_CostMethodInvestments" xlink:title="us-gaap_CostMethodInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_CostMethodInvestments" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_CostMethodInvestments" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="8.25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:title="us-gaap_DebtInstrumentFaceAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_DebtInstrumentFaceAmount" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_DebtInstrumentInterestRateStatedPercentage" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="58" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_LongTermPurchaseCommitmentAmount" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" xlink:title="us-gaap_ProfessionalFees" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ProfessionalFees" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ProfessionalFees" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentLineItems to us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:label="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_HadasitMember" xlink:label="ormp_HadasitMember" xlink:title="ormp_HadasitMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_HadasitMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_HadasitMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ConsultantMember" xlink:label="ormp_ConsultantMember" xlink:title="ormp_ConsultantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_ConsultantMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_ConsultantMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorMember" xlink:label="ormp_AdvisorMember" xlink:title="ormp_AdvisorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_AdvisorMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_AdvisorMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_ClinicalResearchOrganizationServiceAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_ClinicalResearchOrganizationServiceAgreementMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_ClinicalResearchOrganizationServiceAgreementMember" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementTwoMember" xlink:label="ormp_MasterServiceAgreementTwoMember" xlink:title="ormp_MasterServiceAgreementTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementTwoMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementTwoMember" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementThreeMember" xlink:label="ormp_MasterServiceAgreementThreeMember" xlink:title="ormp_MasterServiceAgreementThreeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementThreeMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementThreeMember" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementFourMember" xlink:label="ormp_MasterServiceAgreementFourMember" xlink:title="ormp_MasterServiceAgreementFourMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementFourMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementFourMember" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementMember" xlink:label="ormp_MasterServiceAgreementMember" xlink:title="ormp_MasterServiceAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementMember" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementFiveMember" xlink:label="ormp_MasterServiceAgreementFiveMember" xlink:title="ormp_MasterServiceAgreementFiveMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementFiveMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementFiveMember" use="optional" priority="0" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MasterServiceAgreementSixMember" xlink:label="ormp_MasterServiceAgreementSixMember" xlink:title="ormp_MasterServiceAgreementSixMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_MasterServiceAgreementSixMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_MasterServiceAgreementSixMember" use="optional" priority="0" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_SecondClinicalResearchOrganizationServiceAgreementMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_SecondClinicalResearchOrganizationServiceAgreementMember" use="optional" priority="0" order="5" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:label="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:title="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain to ormp_ThirdClinicalResearchOrganizationServiceAgreementMember" use="optional" priority="0" order="6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_LongTermPurchaseCommitmentLineItems" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentTable to us-gaap_LongTermPurchaseCommitmentLineItems" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:label="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentTable to us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentTable to us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:title="Presentation : us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis to us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DnaBiomedicalSolutionsLtdMember" xlink:label="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="ormp_DnaBiomedicalSolutionsLtdMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_DnaBiomedicalSolutionsLtdMember" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="us-gaap_EquityMethodInvesteeNameDomain" xlink:title="Presentation : us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis to us-gaap_EquityMethodInvesteeNameDomain" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-cld">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="us-gaap_ScheduleOfOperatingLeasedAssetsTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_ScheduleOfOperatingLeasedAssetsTable" order="30" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:title="Presentation : us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract to us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems" xlink:title="us-gaap_OperatingLeasedAssetsLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:label="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:title="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense" xlink:title="us-gaap_LeaseAndRentalExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_LeaseAndRentalExpense" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:label="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:title="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" xlink:title="Presentation : us-gaap_OperatingLeasedAssetsLineItems to us-gaap_OperatingLeasesIncomeStatementInitialDirectCosts" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeBuildingMember" xlink:label="us-gaap_OfficeBuildingMember" xlink:title="us-gaap_OfficeBuildingMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeBuildingMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_OfficeBuildingMember" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" xlink:title="us-gaap_VehiclesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_VehiclesMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_VehiclesMember" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" order="20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_OperatingLeasedAssetsLineItems" xlink:title="Presentation : us-gaap_ScheduleOfOperatingLeasedAssetsTable to us-gaap_OperatingLeasedAssetsLineItems" order="20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfOperatingLeasedAssetsTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-crgd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="Presentation : us-gaap_CommitmentsAndContingenciesDisclosureAbstract to us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" order="1.5" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_BioJerusalemMember" xlink:label="ormp_BioJerusalemMember" xlink:title="ormp_BioJerusalemMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="ormp_BioJerusalemMember" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain to ormp_BioJerusalemMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefScientistOfficeMember" xlink:label="ormp_ChiefScientistOfficeMember" xlink:title="ormp_ChiefScientistOfficeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="ormp_ChiefScientistOfficeMember" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain to ormp_ChiefScientistOfficeMember" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentage" xlink:label="ormp_RoyaltyPercentage" xlink:title="ormp_RoyaltyPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="ormp_RoyaltyPercentage" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to ormp_RoyaltyPercentage" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:label="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:title="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_AccruedRoyaltiesCurrentAndNoncurrent" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="us-gaap_GrantsReceivable" xlink:title="us-gaap_GrantsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_GrantsReceivable" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_GrantsReceivable" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueFromGrants" xlink:label="us-gaap_RevenueFromGrants" xlink:title="us-gaap_RevenueFromGrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_RevenueFromGrants" xlink:title="Presentation : us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_RevenueFromGrants" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to us-gaap_RangeAxis" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="Presentation : us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sct">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:label="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:title="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ormp_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeNonemployeeTableTextBlock" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationNonemployeeDirectorStockAwardPlanActivityTableTextBlock" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:title="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sbc">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-scsofvad">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="Presentation : us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_RangeAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="Presentation : us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:title="Presentation : us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccsocl">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:title="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" xlink:title="Presentation : us-gaap_EarningsPerShareBasicAndDilutedAbstract to us-gaap_EarningsPerShareBasicAndDiluted" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:title="Presentation : us-gaap_EarningsPerShareBasicAndDilutedAbstract to us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xlink:title="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_ComprehensiveIncomeNetOfTax" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_EarningsPerShareBasicAndDilutedAbstract" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:label="us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:title="us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" order="8001" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:title="us-gaap_GeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_GeneralAndAdministrativeExpense" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="8003" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="us-gaap_IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_IncomeTaxExpenseBenefit" order="8004" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_NetIncomeLoss" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xlink:title="us-gaap_OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OperatingIncomeLoss" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNetAvailableforsaleSecurities" order="8002" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:title="us-gaap_OtherNonoperatingExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherNonoperatingExpense" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" xlink:title="us-gaap_OtherNonoperatingIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncome" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_OtherNonoperatingIncome" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:title="us-gaap_ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" xlink:title="Presentation : us-gaap_IncomeStatementAbstract to us-gaap_ResearchAndDevelopmentExpense" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccsocise">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xlink:title="us-gaap_EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:title="us-gaap_AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_AdditionalPaidInCapitalMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" xlink:title="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_CommonStockMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeMember" xlink:label="us-gaap_ComprehensiveIncomeMember" xlink:title="us-gaap_ComprehensiveIncomeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_ComprehensiveIncomeMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_ComprehensiveIncomeMember" order="2.45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" xlink:title="us-gaap_RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" xlink:title="Presentation : us-gaap_EquityComponentDomain to us-gaap_RetainedEarningsMember" order="2.9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xlink:title="us-gaap_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xlink:title="us-gaap_StatementLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" xlink:title="Presentation : us-gaap_StatementTable to us-gaap_StatementLineItems" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:title="us-gaap_StatementEquityComponentsAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" xlink:title="Presentation : us-gaap_StatementTable to us-gaap_StatementEquityComponentsAxis" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" order="210" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:label="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:title="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesMarketableSecurities" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodSharesMarketableSecurities" order="190" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:label="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:title="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" order="240" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodValueLiquidationDamageFee" order="200" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:label="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:title="ormp_StockIssuedDuringPeriodValueMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodValueMarketableSecurities" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodValueMarketableSecurities" order="180" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:label="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:title="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" order="230" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:label="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:title="ormp_SharesAndWarrantsToBeIssuedForCashValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_SharesAndWarrantsToBeIssuedForCashValue" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_SharesAndWarrantsToBeIssuedForCashValue" order="160" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:label="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:title="ormp_SharesAndWarrantsToBeIssuedForCashShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ormp_SharesAndWarrantsToBeIssuedForCashShares" xlink:title="Presentation : us-gaap_StatementLineItems to ormp_SharesAndWarrantsToBeIssuedForCashShares" order="170" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="220" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="250" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:title="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" order="260" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" xlink:title="us-gaap_NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_NetIncomeLoss" order="100" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="110" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" xlink:title="us-gaap_SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_SharesOutstanding" order="130" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_1" xlink:title="us-gaap_SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_1" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_SharesOutstanding" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="60" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForCash" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueIssuedForCash" order="140" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" use="optional" priority="0" order="71" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:title="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" order="80" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" use="optional" priority="0" order="90" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodSharesIssuedForCash" order="150" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockIssuedDuringPeriodValueNewIssues" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xlink:title="us-gaap_StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockholdersEquity" order="120" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_1" xlink:title="us-gaap_StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_1" xlink:title="Presentation : us-gaap_StatementLineItems to us-gaap_StockholdersEquity" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" xlink:title="Presentation : us-gaap_StatementOfStockholdersEquityAbstract to us-gaap_StatementTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" xlink:title="Presentation : us-gaap_StatementEquityComponentsAxis to us-gaap_EquityComponentDomain" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-msd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:title="Presentation : us-gaap_FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="8000" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="us-gaap_MarketableSecurities" xlink:title="us-gaap_MarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_MarketableSecurities" xlink:title="Presentation : us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_MarketableSecurities" order="800" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:title="us-gaap_FairValueInputsLevel1Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" xlink:title="Presentation : us-gaap_FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueInputsLevel1Member" order="8000" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract" xlink:title="us-gaap_MarketableSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketableSecuritiesSold" xlink:label="ormp_MarketableSecuritiesSold" xlink:title="ormp_MarketableSecuritiesSold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="ormp_MarketableSecuritiesSold" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to ormp_MarketableSecuritiesSold" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketableSecuritiesOwnershipPercentage" xlink:label="ormp_MarketableSecuritiesOwnershipPercentage" xlink:title="ormp_MarketableSecuritiesOwnershipPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="ormp_MarketableSecuritiesOwnershipPercentage" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to ormp_MarketableSecuritiesOwnershipPercentage" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="8020" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:title="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" xlink:title="us-gaap_StockIssued1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_StockIssued1" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to us-gaap_StockIssued1" order="8030" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TradingSecuritiesEquityCost" xlink:label="us-gaap_TradingSecuritiesEquityCost" xlink:title="us-gaap_TradingSecuritiesEquityCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_TradingSecuritiesEquityCost" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to us-gaap_TradingSecuritiesEquityCost" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-FAIRVALUEDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:title="us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentInterestRateRangeStart" xlink:label="invest_InvestmentInterestRateRangeStart" xlink:title="invest_InvestmentInterestRateRangeStart" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="invest_InvestmentInterestRateRangeStart" xlink:title="Presentation : us-gaap_FairValueDisclosuresAbstract to invest_InvestmentInterestRateRangeStart" use="optional" priority="0" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_InvestmentInterestRateRangeEnd" xlink:label="invest_InvestmentInterestRateRangeEnd" xlink:title="invest_InvestmentInterestRateRangeEnd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="invest_InvestmentInterestRateRangeEnd" xlink:title="Presentation : us-gaap_FairValueDisclosuresAbstract to invest_InvestmentInterestRateRangeEnd" use="optional" priority="0" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-fv">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:title="us-gaap_FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:title="us-gaap_FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" xlink:title="Presentation : us-gaap_FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toisoditd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:title="us-gaap_DeferredTaxAssetsNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_DeferredTaxAssetsNet" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_DeferredTaxAssetsValuationAllowance" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-TAXESONINCOMEValuationAllowanceRollforwardDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_DeferredTaxAssetsValuationAllowance" order="30" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_1" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_DeferredTaxAssetsValuationAllowance" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toisoitiiisd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="us-gaap_IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxExpenseBenefit" order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toisoroitd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:title="us-gaap_IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxExpenseBenefit" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:label="us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:title="us-gaap_IncomeTaxReconciliationTaxContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxReconciliationTaxContingencies" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:title="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toi">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toit">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:label="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:title="us-gaap_SummaryOfValuationAllowanceTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_SummaryOfValuationAllowanceTextBlock" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-toisoutbd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:title="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:title="us-gaap_UnrecognizedTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_UnrecognizedTaxBenefits" order="3" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_1" xlink:title="us-gaap_UnrecognizedTaxBenefits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_1" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_UnrecognizedTaxBenefits" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:title="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:title="Presentation : us-gaap_IncomeTaxDisclosureAbstract to us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-fiae">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestAndOtherIncomeAbstract" xlink:label="us-gaap_InterestAndOtherIncomeAbstract" xlink:title="us-gaap_InterestAndOtherIncomeAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestAndOtherIncomeTextBlock" xlink:label="us-gaap_InterestAndOtherIncomeTextBlock" xlink:title="us-gaap_InterestAndOtherIncomeTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestAndOtherIncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncomeTextBlock" xlink:title="Presentation : us-gaap_InterestAndOtherIncomeAbstract to us-gaap_InterestAndOtherIncomeTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-fiaed">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestAndOtherIncomeAbstract" xlink:label="us-gaap_InterestAndOtherIncomeAbstract" xlink:title="us-gaap_InterestAndOtherIncomeAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:label="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:title="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestAndOtherIncomeAbstract" xlink:to="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:title="Presentation : us-gaap_InterestAndOtherIncomeAbstract to us-gaap_OtherExpenseDisclosureNonoperatingAbstract" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:label="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:title="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestAndOtherIncomeAbstract" xlink:to="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:title="Presentation : us-gaap_InterestAndOtherIncomeAbstract to us-gaap_OtherIncomeDisclosureNonoperatingAbstract" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExchangeOfWarrants" xlink:label="ormp_ExchangeOfWarrants" xlink:title="ormp_ExchangeOfWarrants" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:to="ormp_ExchangeOfWarrants" xlink:title="Presentation : us-gaap_OtherExpenseDisclosureNonoperatingAbstract to ormp_ExchangeOfWarrants" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLossOnDerivative" xlink:label="us-gaap_DerivativeLossOnDerivative" xlink:title="us-gaap_DerivativeLossOnDerivative" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:to="us-gaap_DerivativeLossOnDerivative" xlink:title="Presentation : us-gaap_OtherExpenseDisclosureNonoperatingAbstract to us-gaap_DerivativeLossOnDerivative" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionLossBeforeTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionLossBeforeTax" xlink:title="Presentation : us-gaap_OtherExpenseDisclosureNonoperatingAbstract to us-gaap_ForeignCurrencyTransactionLossBeforeTax" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoninterestExpenseCommissionExpense" xlink:label="us-gaap_NoninterestExpenseCommissionExpense" xlink:title="us-gaap_NoninterestExpenseCommissionExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:to="us-gaap_NoninterestExpenseCommissionExpense" xlink:title="Presentation : us-gaap_OtherExpenseDisclosureNonoperatingAbstract to us-gaap_NoninterestExpenseCommissionExpense" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNoninterestExpense" xlink:label="us-gaap_OtherNoninterestExpense" xlink:title="us-gaap_OtherNoninterestExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherExpenseDisclosureNonoperatingAbstract" xlink:to="us-gaap_OtherNoninterestExpense" xlink:title="Presentation : us-gaap_OtherExpenseDisclosureNonoperatingAbstract to us-gaap_OtherNoninterestExpense" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeGainOnDerivative" xlink:label="us-gaap_DerivativeGainOnDerivative" xlink:title="us-gaap_DerivativeGainOnDerivative" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:to="us-gaap_DerivativeGainOnDerivative" xlink:title="Presentation : us-gaap_OtherIncomeDisclosureNonoperatingAbstract to us-gaap_DerivativeGainOnDerivative" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:title="us-gaap_ForeignCurrencyTransactionGainBeforeTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:title="Presentation : us-gaap_OtherIncomeDisclosureNonoperatingAbstract to us-gaap_ForeignCurrencyTransactionGainBeforeTax" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:label="us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:title="us-gaap_GainLossOnSaleOfSecuritiesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:to="us-gaap_GainLossOnSaleOfSecuritiesNet" xlink:title="Presentation : us-gaap_OtherIncomeDisclosureNonoperatingAbstract to us-gaap_GainLossOnSaleOfSecuritiesNet" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:title="us-gaap_InterestIncomeExpenseNonoperatingNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:title="Presentation : us-gaap_OtherIncomeDisclosureNonoperatingAbstract to us-gaap_InterestIncomeExpenseNonoperatingNet" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncome" xlink:label="us-gaap_OtherIncome" xlink:title="us-gaap_OtherIncome" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeDisclosureNonoperatingAbstract" xlink:to="us-gaap_OtherIncome" xlink:title="Presentation : us-gaap_OtherIncomeDisclosureNonoperatingAbstract to us-gaap_OtherIncome" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-fiaet">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestAndOtherIncomeAbstract" xlink:label="us-gaap_InterestAndOtherIncomeAbstract" xlink:title="us-gaap_InterestAndOtherIncomeAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:title="us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestAndOtherIncomeAbstract" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" xlink:title="Presentation : us-gaap_InterestAndOtherIncomeAbstract to us-gaap_ScheduleOfOtherNonoperatingIncomeByComponentTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:title="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InterestAndOtherIncomeAbstract" xlink:to="us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" xlink:title="Presentation : us-gaap_InterestAndOtherIncomeAbstract to us-gaap_ScheduleOfOtherNonoperatingExpenseByComponentTextBlock" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ms">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract" xlink:title="us-gaap_MarketableSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-mst">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="us-gaap_MarketableSecuritiesAbstract" xlink:title="us-gaap_MarketableSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="us-gaap_MarketableSecuritiesTextBlock" xlink:title="us-gaap_MarketableSecuritiesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MarketableSecuritiesAbstract" xlink:to="us-gaap_MarketableSecuritiesTextBlock" xlink:title="Presentation : us-gaap_MarketableSecuritiesAbstract to us-gaap_MarketableSecuritiesTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-paent">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-paen">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-paend">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentAbstract to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" xlink:title="us-gaap_ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_ComputerEquipmentMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:title="us-gaap_LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_LeaseholdImprovementsMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" xlink:title="us-gaap_OfficeEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_OfficeEquipmentMember" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentTypeDomain to us-gaap_OfficeEquipmentMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentTypeDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" xlink:title="us-gaap_Depreciation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_Depreciation" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" xlink:title="Presentation : us-gaap_PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentGross" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:title="Presentation : us-gaap_ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_PropertyPlantAndEquipmentLineItems" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xlink:title="us-gaap_RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xlink:title="us-gaap_RangeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" xlink:title="Presentation : us-gaap_RangeAxis to us-gaap_RangeMember" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xlink:title="us-gaap_MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MaximumMember" order="20" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xlink:title="us-gaap_MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" xlink:title="Presentation : us-gaap_RangeMember to us-gaap_MinimumMember" order="10" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:label="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:title="ormp_GrossProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_GrossProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_GrossProceedsFromIssuanceOfCommonStock" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FindersFee" xlink:label="ormp_FindersFee" xlink:title="ormp_FindersFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_FindersFee" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_FindersFee" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:label="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_StockIssuedDuringPeriodSharesLiquidationDamageFee" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsExercised" xlink:label="ormp_WarrantsExercised" xlink:title="ormp_WarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_WarrantsExercised" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_WarrantsExercised" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ClassOfWarrantOrRightTerm" xlink:label="ormp_ClassOfWarrantOrRightTerm" xlink:title="ormp_ClassOfWarrantOrRightTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_ClassOfWarrantOrRightTerm" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_ClassOfWarrantOrRightTerm" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:label="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:title="ormp_SecuritiesPurchaseAgreementNumberOfUnits" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementNumberOfUnits" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementNumberOfUnits" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsPurchasePricePerUnit" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerUnit" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsNumberOfSharesPerWarrant" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ServiceAgreementConsiderationSharesOption" xlink:label="ormp_ServiceAgreementConsiderationSharesOption" xlink:title="ormp_ServiceAgreementConsiderationSharesOption" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_ServiceAgreementConsiderationSharesOption" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_ServiceAgreementConsiderationSharesOption" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_PercentOwnershipByThirdParty" xlink:label="ormp_PercentOwnershipByThirdParty" xlink:title="ormp_PercentOwnershipByThirdParty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_PercentOwnershipByThirdParty" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_PercentOwnershipByThirdParty" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NumberOfInstitutionalInvestors" xlink:label="ormp_NumberOfInstitutionalInvestors" xlink:title="ormp_NumberOfInstitutionalInvestors" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_NumberOfInstitutionalInvestors" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_NumberOfInstitutionalInvestors" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:label="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:title="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_CommonStockSharesAuthorizedBeforeAmendmentToCertificateOfIncorporation" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:label="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:title="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_SecuritiesPurchaseAgreementsNumberOfWarrantsPerUnit" order="11" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:title="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ClassOfWarrantOrRightOutstanding" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:label="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:title="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_InvestmentSoldNotYetPurchasedBalanceShares" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_PaymentsOfStockIssuanceCosts" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" xlink:title="us-gaap_ProceedsFromWarrantExercises" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ProceedsFromWarrantExercises" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:title="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ProceedsFromStockOptionsExercised" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xlink:title="us-gaap_SharePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_SharePrice" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_SharePrice" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_StockIssuedDuringPeriodSharesOther" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementMember" xlink:label="ormp_SecuritiesPurchaseAgreementMember" xlink:title="ormp_SecuritiesPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_SecuritiesPurchaseAgreementMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_SecuritiesPurchaseAgreementMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorMember" xlink:label="ormp_AdvisorMember" xlink:title="ormp_AdvisorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_AdvisorMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_AdvisorMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_DnaBiomedicalSolutionsLtdMember" xlink:label="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="ormp_DnaBiomedicalSolutionsLtdMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_DnaBiomedicalSolutionsLtdMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_DnaBiomedicalSolutionsLtdMember" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AdvisorTwoMember" xlink:label="ormp_AdvisorTwoMember" xlink:title="ormp_AdvisorTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_AdvisorTwoMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_AdvisorTwoMember" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementTwoMember" xlink:label="ormp_SecuritiesPurchaseAgreementTwoMember" xlink:title="ormp_SecuritiesPurchaseAgreementTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_SecuritiesPurchaseAgreementTwoMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_SecuritiesPurchaseAgreementTwoMember" order="4" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_LeadingInvestorMember" xlink:label="ormp_LeadingInvestorMember" xlink:title="ormp_LeadingInvestorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_LeadingInvestorMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_LeadingInvestorMember" order="5" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_OtherIndividualMember" xlink:label="ormp_OtherIndividualMember" xlink:title="ormp_OtherIndividualMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_OtherIndividualMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_OtherIndividualMember" order="6" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_SecuritiesPurchaseAgreementThreeMember" xlink:label="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:title="ormp_SecuritiesPurchaseAgreementThreeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_SecuritiesPurchaseAgreementThreeMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_SecuritiesPurchaseAgreementThreeMember" order="4.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to us-gaap_DirectorMember" order="7" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="us-gaap_ScenarioUnspecifiedDomain" xlink:title="us-gaap_ScenarioUnspecifiedDomain" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:label="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:title="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScenarioUnspecifiedDomain" xlink:to="ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" xlink:title="Presentation : us-gaap_ScenarioUnspecifiedDomain to ormp_WarrantsPreviouslyIssuedInPrivatePlacementsMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RangeAxis" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RangeAxis" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionLineItems" order="13" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" xlink:title="us-gaap_StatementScenarioAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_StatementScenarioAxis" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_StatementScenarioAxis" order="3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_ScenarioUnspecifiedDomain" xlink:title="Presentation : us-gaap_StatementScenarioAxis to us-gaap_ScenarioUnspecifiedDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityIssuancePerShareAmount" xlink:label="us-gaap_EquityIssuancePerShareAmount" xlink:title="us-gaap_EquityIssuancePerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_EquityIssuancePerShareAmount" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_EquityIssuancePerShareAmount" order="8001" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0.1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-RELATEDPARTIES-TRANSACTIONSDetails">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MonthlyPaymentUnderConsultingAgreements" xlink:label="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:title="ormp_MonthlyPaymentUnderConsultingAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_MonthlyPaymentUnderConsultingAgreements" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_MonthlyPaymentUnderConsultingAgreements" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_AnnualPaymentUnderConsultingAgreements" xlink:label="ormp_AnnualPaymentUnderConsultingAgreements" xlink:title="ormp_AnnualPaymentUnderConsultingAgreements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_AnnualPaymentUnderConsultingAgreements" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_AnnualPaymentUnderConsultingAgreements" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CarAndCashBonus" xlink:label="ormp_CarAndCashBonus" xlink:title="ormp_CarAndCashBonus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_CarAndCashBonus" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_CarAndCashBonus" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_CashBonus" xlink:label="ormp_CashBonus" xlink:title="ormp_CashBonus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_CashBonus" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_CashBonus" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_TemporaryIncreasePaymentPerMonth" xlink:label="ormp_TemporaryIncreasePaymentPerMonth" xlink:title="ormp_TemporaryIncreasePaymentPerMonth" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_TemporaryIncreasePaymentPerMonth" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_TemporaryIncreasePaymentPerMonth" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_NumberOfConsultingAgreementsEntered" xlink:label="ormp_NumberOfConsultingAgreementsEntered" xlink:title="ormp_NumberOfConsultingAgreementsEntered" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_NumberOfConsultingAgreementsEntered" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_NumberOfConsultingAgreementsEntered" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ExtendedPriorWrittenNoticePeriod" xlink:label="ormp_ExtendedPriorWrittenNoticePeriod" xlink:title="ormp_ExtendedPriorWrittenNoticePeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="ormp_ExtendedPriorWrittenNoticePeriod" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to ormp_ExtendedPriorWrittenNoticePeriod" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:label="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:title="us-gaap_ForeignCurrencyExchangeRateTranslation1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_ForeignCurrencyExchangeRateTranslation1" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="us-gaap_OfficersCompensation" xlink:title="us-gaap_OfficersCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OfficersCompensation" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_OfficersCompensation" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:title="us-gaap_RelatedPartyTransactionAmountsOfTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KnryMember" xlink:label="ormp_KnryMember" xlink:title="ormp_KnryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_KnryMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_KnryMember" order="2" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:label="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="ormp_ChiefMedicalAndTechnologyOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_ChiefMedicalAndTechnologyOfficerMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_ChiefMedicalAndTechnologyOfficerMember" order="8000" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CorporateJointVentureMember" xlink:label="us-gaap_CorporateJointVentureMember" xlink:title="us-gaap_CorporateJointVentureMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_CorporateJointVentureMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to us-gaap_CorporateJointVentureMember" order="8011" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DirectorMember" xlink:label="us-gaap_DirectorMember" xlink:title="us-gaap_DirectorMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_DirectorMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to us-gaap_DirectorMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember" xlink:title="us-gaap_ExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_ExecutiveOfficerMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to us-gaap_ExecutiveOfficerMember" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiaryOfCommonParentMember" xlink:label="us-gaap_SubsidiaryOfCommonParentMember" xlink:title="us-gaap_SubsidiaryOfCommonParentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_SubsidiaryOfCommonParentMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to us-gaap_SubsidiaryOfCommonParentMember" order="8001" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:title="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsAbstract to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionLineItems" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-rptsobwrpd">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:title="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:title="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:title="Presentation : us-gaap_RelatedPartyTransactionLineItems to us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" xlink:title="us-gaap_RelatedPartyDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsByRelatedPartyAxis to us-gaap_RelatedPartyDomain" order="1" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_KnryMember" xlink:label="ormp_KnryMember" xlink:title="ormp_KnryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="ormp_KnryMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to ormp_KnryMember" order="1" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExecutiveOfficerMember" xlink:label="us-gaap_ExecutiveOfficerMember" xlink:title="us-gaap_ExecutiveOfficerMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_ExecutiveOfficerMember" xlink:title="Presentation : us-gaap_RelatedPartyDomain to us-gaap_ExecutiveOfficerMember" order="8000" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:title="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsAbstract to us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionLineItems" order="2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:title="Presentation : us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable to us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-rptt">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:title="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:label="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:title="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsAbstract to ormp_ScheduleOfRelatedPartyBalancesTableTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:title="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsAbstract to us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-rpt">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:title="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="Presentation : us-gaap_RelatedPartyTransactionsAbstract to us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccsocisep">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_FindersFeeShares" xlink:label="ormp_FindersFeeShares" xlink:title="ormp_FindersFeeShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="ormp_FindersFeeShares" xlink:title="Presentation : us-gaap_StatementOfStockholdersEquityAbstract to ormp_FindersFeeShares" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-ccbsp">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:title="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockParOrStatedValuePerShare" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xlink:title="us-gaap_CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesIssued" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:title="us-gaap_CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesAuthorized" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:title="us-gaap_CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" xlink:title="Presentation : us-gaap_StatementOfFinancialPositionAbstract to us-gaap_CommonStockSharesOutstanding" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYTables">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-she">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:title="us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:title="Presentation : us-gaap_StockholdersEquityNoteAbstract to us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-se">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:title="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:title="us-gaap_SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" xlink:title="Presentation : us-gaap_SubsequentEventsAbstract to us-gaap_SubsequentEventsTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-sed">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:title="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" xlink:title="us-gaap_SubsequentEventTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" xlink:title="Presentation : us-gaap_SubsequentEventsAbstract to us-gaap_SubsequentEventTable" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" xlink:title="us-gaap_SubsequentEventLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" xlink:title="Presentation : us-gaap_SubsequentEventTable to us-gaap_SubsequentEventLineItems" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:title="us-gaap_SubsequentEventTypeAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" xlink:title="Presentation : us-gaap_SubsequentEventTable to us-gaap_SubsequentEventTypeAxis" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:label="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:title="ormp_MarketIssuanceSalesAgreementOfferingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ormp_MarketIssuanceSalesAgreementOfferingValue" xlink:title="Presentation : us-gaap_SubsequentEventLineItems to ormp_MarketIssuanceSalesAgreementOfferingValue" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:label="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:title="ormp_MarketIssuanceSalesAgreementCommissionPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="ormp_MarketIssuanceSalesAgreementCommissionPercentage" xlink:title="Presentation : us-gaap_SubsequentEventLineItems to ormp_MarketIssuanceSalesAgreementCommissionPercentage" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:title="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" xlink:title="us-gaap_SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" xlink:title="Presentation : us-gaap_SubsequentEventTypeDomain to us-gaap_SubsequentEventMember" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" xlink:title="Presentation : us-gaap_SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeDomain" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-w">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="ormp-20150228.xsd#ormp_WarrantsAndRightsDisclosureTextBlock" xlink:label="ormp_WarrantsAndRightsDisclosureTextBlock" xlink:title="ormp_WarrantsAndRightsDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="ormp_WarrantsAndRightsDisclosureTextBlock" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to ormp_WarrantsAndRightsDisclosureTextBlock" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://www.oramed.com/role/ormp-wt">
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:title="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:title="Presentation : us-gaap_WarrantsAndRightsNoteDisclosureAbstract to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>19
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0#J;;DZQ@$``%<1```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,F-]*PS`4QN\%WZ'D5M8L
M];^L\V+JI0KJ`\3D;"U+DY!DNKV]IYT.D;DQ''AN&MHDY_LUE(]^9W`];TSV
M!B'6SI9,Y'V6@55.UW92LI?GN]X%RV*25DOC+)1L`9%=#P\/!L\+#S'#W3:6
MK$K)7W$>506-C+GS8'%F[$(C$]Z&"?=23>4$>-'OGW'E;`*;>JFMP8:#&QC+
MF4G9[1P?+TD"F,BRT7)AJU4RZ;VIE4Q(RM^L_J'2^U3(<6>W)E:UCT>(P?A:
MA7;F=X'/?0]X-*'6D#W*D.YE@QA\;OB["]-7YZ;YYB)K*-UX7"O03LT:/($\
M^@!2QPH@-2;OQKR1M?WBWJ#?+8Z\&\2>0=KWZPKOR%$0X3@FPG%"A..4",<9
M$8YS(AP71#@NB7"(/A40*HXJJ%BJH.*I@HJI"BJN*JC8JJ#BJX**L0HJSEI0
M<=:"BK,65)RUH.*LQ7\Y:\+8"+R[_OWKZ,ILR2TQ+0S$/?]K+(MN4ZYD`/V4
M`@;LO0-\K[V%0TFC1A4FS3T?PJKN)GV,OX_!^8B-@`"[`WPE_79WSV,A"*F&
M5=9?EYE7BMA$V%WP1VB'MDVA0:_1YEU;9/@!``#__P,`4$L#!!0`!@`(````
M(0"U53`C]0```$P"```+``@"7W)E;',O+G)E;',@H@0"**```@``````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````C)+/3L,P#,;O2+Q#Y/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1`
M]_:$`X)*8]O1]N?//UO>[N9I5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4
MQQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9
MJ&7<E.4]AK\>4"T\U<%J"`=[!ZH^^CSYLK<T36]X+^9]8I=.C$">$SO+=N5#
M9@NIS]NHFD++28,5\YS3$<G[(F,#GB;:7$_T_[8X<2)+B=!(X/,\WXIS0.OK
M@2Z?:*GXO<X\XJ>$X4UD^&'!Q0]47P```/__`P!02P,$%``&``@````A`(96
M?W*L`0``#!```!H`"`%X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<R"B!`$H
MH``!````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````````+Q7RVK#,!"\%_H/
M1O=&7N5=XN304LBU33]`V(IM8DM&4A_Y^XHTE1-HMQ>S%X-6>#7,S*Y6J\UG
MVR3ORKK:Z(S!*&6)TKDI:EUF['7W=+=@B?-2%[(Q6F7LJ!S;K&]O5L^JD3[\
MY*JZ<TG(HEW&*N^[>\Y=7JE6NI'IE`X[>V-;Z</2EKR3^4&6BHLTG7%[F8.M
MKW(FVR)C=EN$\W?'+IS\?VZSW]>Y>C3Y6ZNT_^4(_F'LP55*^9!4VE+YC,60
MXZ>=Q2@@9OQW,#`F1@-C%`XU.8"R(V9#LN/\L0EFBT)]KS$ZJ,5!M1$P)!G1
MI3T?,70VK@",FSDQFCD&!@0Q&A`H'&IR`&5'3(=DQX=6K'K7G);\]$7]0JT0
M+M"@C2463L]*#)UK"6:87T2X)$GO))%B<*@;#>H;:J50H8"<&I0;,:'VS03S
MS:!M)E;0WT4UQ<``-1I`X0CJ64+@P\2@@UXNF_RADK7NM8HA5"/JO@=XWUL2
MEQ,L,7:HBQNM;6IJ4&:`FAI`N1'DLPTZW(A!IT]72:N*%V_#`_[R\709_G$Q
MOWK#K[\```#__P,`4$L#!!0`!@`(````(0"Y;]?=\`(``#8(```/````>&PO
M=V]R:V)O;VLN>&ULE)5=<Z(P%(;O=V;_`\/]E@]MM^U4.XBTS131!;2S5YFL
M1,T4P2&QMO]^#[#B\6.Z]D8X0-Z\Y\UC<G?_ODRU-UY(D6<=W;HP=8UGTSP1
MV;RCC^.'']>Z)A7+$I;F&>_H'USJ]]WOW^XV>?'Z)\]?-1#(9$=?*+6Z-0PY
M7?`EDQ?YBF?P9I872Z:@+.:&7!6<)7+!N5JFAFV:5\:2B4RO%6Z+<S3RV4Q,
M>3^?KI<\4[5(P5.FP+Y<B)74NW<SD?))W9'&5JN`+<'W>ZIK*9/*2X3B24>_
MA#+?\+T'Q7K56XL4WMZTS)9N=)LF1X66\!E;IRJ&]K;JD)?=MNVK\LLRBHG@
M&[D;5);:^XO(DGQ3?@K1?C15"PQLJE<O(E$+>&^:9O/LB8OY0FT?@KR!]*L$
M89[JJF55>]M$**P4]3(EU`<E69V^R&$)R]0)=&;I6G$KX*8@B54:QRKN,.A[
M0>3U*=Q%0Y_TG1B*GN,[@>LA%1N<-C+VUV3`0>.FA62JP,]P$\5@:H#=M)%*
M^TPS_U2P&5C(75.77].Q45-8IF(#-Q61QX`\$-<)8NJX[G`<Q"1XI",(VR6X
M*?LG<O/SV,U@0.*!%\01FMF&/VNS+->'8QX<$M*)XX_WIKE!0VX.APR<\-F+
MG9[OT<ASQR&)B8<G;`'3S826>3@\BH?N,WT:^GTOC*CW:TSBW\AN:P_&(QKK
MT3VGYG$P`C*=F`P#K`"Y[^8_`C'T_`K@D1.6QFD<.J#AEB)[76`,K2,.HW$O
M`N^0-?4F\(OGQ^A91^Q]OMB8O7([V#5R`KYFN6G$BS?8`ZDS+SCL19F2V!"&
MSSJBSQWN='S.))>TSQ43Z9X&)L_Z##T:<LE9,5W0QX*!$1!#7BQ,(Q0'F\T.
MQQ,>+(PE%`=C3W)Y0J;<<YM8H3B0.<7G*17,J7TVI[42"J2%`[&_1"OM8QT<
MCOU?7D]TU-[+I>+6J'8I.%:F+)W">5=>J@.C?7E5]VQLC_SN7P```/__`P!0
M2P,$%``&``@````A`/_@;ES5!```H1$``!@```!X;"]W;W)K<VAE971S+W-H
M965T-"YX;6R46%N/JS80?J_4_X!X3\!<DRC)T>&R[9%:J:IZ>6:)DZ`%'`&[
MV?WWG<$0[*'9R\MNXN^;P=_,>`9G^^VU*HT7WK2%J'<F6]JFP>M<'(KZM#/_
M_NMAL3*-MLOJ0U:*FN_,-]Z:W_8__[2]BN:I/7/>&>"A;G?FN>LN&\MJ\S.O
MLG8I+KP&Y"B:*NO@:W.RVDO#LT-O5)668]N!565%;4H/F^8S/L3Q6.0\$?ES
MQ>M..FEXF76P__9<7-K16Y5_QEV5-4_/ET4NJ@NX>"S*HGOKG9I&E6]^G&K1
M9(\EZ'YE7I:/OOLO,_=5D3>B%<=N">XLN=&YYK6UML#3?GLH0`&&W6CX<6=^
M9YN4A::UW_8!^J?@UU;Y;+1G<?VE*0Z_%36':$.>,`./0CPA]<<!E\#8FED_
M]!GXHS$._)@]E]V?XOHK+T[G#M+M@R(4MCF\);S-(:+@9NGXZ"D7)6P`_AI5
M@:4!$<E>^__7XM"==Z8;+/W0=AG0C4?>=@\%NC2-_+GM1/6O)+'!E73B#$[`
M8G#"G*6S\ID??.S%DCOJ!299E^VWC;@:4#7PS/:280VR#7@>E<E]W+3>DPH:
MT<EW]-+[`A4MY.=E[X=;ZP5"F@^42%)"TY@H:YT2CQ0,(+I-QH7)ANDFZ<C`
M[(&BFRP(%I7E0MK_/V&C"C0B*E;Z\Z(YQ=$9\9P1V#HEF5.(DW3.4)QH0MVY
M4.]N98Y"T0AJ4,E%0`(;28K75R#F(J8+"5U(E05MB]Y\BQ_G`HUV)L3A5BX!
M"5(D*:N^W!AS`SW*L0H'H:>CB8HZGDORG*HP\YS)6E,&@?YZE:$14>;JFXLD
MQ9,'B>XMUE!&HI)(-!BC0H6IQFMWJDQ-5Z#K>O_4()GHF<+5G^-(4H8]S7(1
M:S!;D40F*NSZ(8%3%79<?WJV)@D:CYJJ]R4AF4CR28HD1:9H,4N1ALYJ3T,#
MXCG54.;<21&^6BA]^WT]2"9Z2!0C29%Z2"^(58R4:J)B#JG%5`4GF5I>UE_1
M@62B@XX921E+S25PK,&,39N2`T>%7=\E8E,5=AQWFE^:)`:#1LT-SM3@P^'3
M6Q%QY/!&`P>:TZTK.M,F>@GQC8-3>.$1.-%@`J8:N+AWE!@.7:7V4-_',Z>W
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MF@C\1(N7HUT3.*5X$"@YPP"S5T[`/-+D8KCJ8D8E9\V<,%R33IIH%&9[*X?1
M5H(WYLG-RG=A'$[=1LJ5-V)Y8:QX<^(Q+\O6R,4SWG8=R,)M5=[$([:!:QS<
MQLAZ@C=T7+=N`%R0+]F)_YXUIZ)NC9(?P:6]#*%<&WG%EE\Z<>DO98^B@ZMQ
M__$,/X5PN)382R`?A>C&+_B`VX\K^_\```#__P,`4$L#!!0`!@`(````(0`3
M"C&]N@@``"4L```9````>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;)Q:VV[C
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MIK&O3I*`_']V+M72D!7)O^F?;^6A?=EY83*/5\O0E_#94]&TGTN5TIOM7YNV
M.O\'(%^1ZI,$)HG\:9+XP3Q8QWZ<W)$E-%GDSR'+O50BDT3^')*X4EE`<72M
M1=[FCP]U]3:3"UA>?G/-U7;PMS)S5V0H25_V]ZHN*Z62_*RRZ%RRH(U<*E\?
M0]]_6'R5[=T;3`J8E3?K,4&XH9BLPZ@6J,2B2ZP6BF3<TY;]X+1#N<)NKXV.
MI9I$6<9K2B"U(7*Y4$QV"Q-1C``,N=@>02Y$+@E\(>,7H,#J`KKRI%U@J&GH
MA_T'Z1)F#A@!F)7>C[C,<D5@=FIU3)=93=IYL@)]HT,_IJ12P$3]E60\(%"`
M%$SN74XI>E<5NLZK29(ZH90P2H!!E'A`H`"AE%!*XSU48%Z=%:,"F$1O)#_>
M)!O&-2.`3;QBXP+&];40IG)!\N)-]U--XHSYO@%,I!D'?`6207JIHAOC&URY
M.-*E\9HJ,&?(I"4%#&HO!*#(F]6:79%`>%+"#27FMB74)$8P6-)*I(!9ZQ*N
M`D8GPZ-^R+:3@%&[W[[41/<R:C2G:<FX2KGS-IIG-(_C#?['%F)F4@(ZF;.F
M"#-\@[@2?M1_5>;I;>Z#71#I"9A\IP:$5H(5$3A"NN\K8;^?%]C!N/[HU/(J
M!TVT(@)'*"^EX(C7^'[Q0>]IG=BN30T(\X%I0T08C%$J(D24GE)S1,^QG>`!
ME"9SVM1'1@&&9T4$CE!>2M+OYP5&,-%.Y!:&%X\(=9R5>TD7E/)2`HYX3;03
MY)[6R6HG\@3#AT>$#Q'3SC!<#BI$Z2G51O3<1-`'K:<TF9*E!C2LL<R*"!RA
MO)1H,UX.J@%2/]%.Y`>F?#PB?!2AO)0^(UX3[00U)W7RF7*F/H!NM<K00YZ@
M(\),L5=;P%S";7?J6=PMF/ZG!H3::44$CI"R!1\R`3UKZK!G0)@7>,<0$1A#
M><G6N+<S4&A6)ZN=!@3M3)*8J5QFQC$[2*LCE)U2:>?%%H"FD\46\/.H`0V?
MGED1@2.4SX>T/P!9']^4!H1Y<3<0&$-Y*?%UKQ-(-:F3;]4)0-#%]7IEWSIB
M@+]<K]CA1*B'"C<=(5#2C-BZ2:Z>Q=?>(.I:%U(#,H=W>BK-^L'NGE/@""TH
M<X5QE0MNN(&]+0`$!8VB,&;ZDIDLPPH0.$+I*76^OX*@Z:3OUM$]Z(1?/?F(
MELS3,C*\8J.B'^6W0,%=KJ'1K-4!/[P;D./AG:#MP[L9MA5(W5+B2H\O!(WF
MQ/D:-:"ASYD5$3A".A]^R$?TK"D?,2#,R_(1C*&\E(2C%3E1)X5F=;(4*`00
M;)@@\%>LD)D!#(0%CE!Z=QE)>,M(^*G%@(9/SZR(P!'*YT-&$KH8B0%A7I:1
M8`SEI33;O8V@\$10[#9BG[C91N03<+H+48328\XQL<K@%H#0"_FCBA!`N%P\
M(C"&\F$VX7;:#,$)QL\#!H1YP;0A(C"&\F+^,%&G&[Y@MQ%`([NQ,X[>74,4
MH?3N<H,03O^TC=P-#&@H3F9%!(X0/A$3>;<VZEE3HFI`B)<5$3A">3&Q'V]C
M!&I-ZF2UT8#>;Z,!#(0%CE!Z\J/<Q2)2:*;Y(3LSI@8T?'IF102.4#Y,Y!W;
M"&(_OALC`&%>/"(PAO)B8C_11E#KB38""-KHRYLL?IB,+,W'$4I/J2W2?+?C
MN'H6P=OI,X=.#>B=9^G]:*\8.$(Y,N%WY'C#`*P#;]3)O3KP\F\?LGYTX-CA
M^1DW8F8PT690<])FZXRK4SH_H#;H89$*'*'U5-)\?\]!T`GGD#^<BY#JP^,;
M*R)PA/)BSN"XA<$A)K8P@(;J9!&/"!PAO&+F$..]U6@F==;]H`&9+1SR+VTR
M,S[P%3A"V3&?<-L=\0V_"-G#FM2`!A:9%1$X0GDIR6>K3&WQB>JI65.^&@,(
M\^(1@3&4E])NQ&N"#RB]3(^^!.9W`W%G!TI%D@TK8]8/]S*"(Y3<76X1WW`+
M_I5::D"X6)8]8`SE<\,>')H(]C"^)6,`85X\(C"&\F*6,-'$&U9@'8YB`,&6
MC*2ILIN%S``&P@)'*#WF!HY[\H8K6*X:`^@=5^U'AZ76X;ECQ1]R`3V+J9OE
MJ@8$7P$'UL-#,XP+B6R#%I)9PD2?0=/)9K5L-0:0XZ,C@\9<D7$0K@FS";>F
MZUFLH"$[T*4&-+#(K(C`$<KKAD%,[^$$#&)\#QL0Y@73AHC`&,I+:;:S$">@
M\*2WEJT:$.QAZ:I\"YMQS`[2Z@AEIS0=L7,[C"3@!(1ER)^N&]#`(K,B`D<H
M+^80CKQ`\B>ZR7TA2WA$X`CEQ9QB?*?*]RWM&PANJP9D#DF;R.JFY1=F!NHF
MO)4);PJ>B_JYR(K3J9GMJU?UQF4@7_[HH_`V:.IO,_UB&HN+8"O?+E,BV@_(
MES2O^7/Q1UX_EY=F=BJ.,N5ROI*T:GC-$_YHJZM^6^^I:N7KF?K7%_DZ;B'?
M"US.)?A856WWA_J`_@7?Q_\!``#__P,`4$L#!!0`!@`(````(0!RW>30400`
M`-0.```9````>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;)Q7VXZC1A!]CY1_
M0+POT%QL;-E>C0TD*VVD*,HFSQBW;31`6S0>S_Q]JBDNW<VN%^7%;0Y5ASI5
MU;?-Y_>R,-YHS7-6;4UB.:9!JXR=\NJR-;_]G7P*38,W:75*"U;1K?E!N?EY
M]^LOFP>K7_F5TL8`AHIOS6O3W-:VS;,K+5-NL1NMX,V9U67:P&-]L?FMINFI
M=2H+VW6<A5VF>64BP[J>P\'.YSRC$<ON):T:)*EID380/[_F-]ZSE=D<NC*M
M7^^W3QDK;T!QS(N\^6A)3:/,UE\N%:O38P&ZWXF?9CUW^S"A+_.L9IR=&POH
M;`QTJGEEKVQ@VFU..2@0:3=J>MZ:+V2=$,^T=YLV0?_D],&E_P:_LL=O=7[Z
MFE<4L@UU$A4X,O8J3+^<!`3.]L0[:2OP9VV<Z#F]%\U?[/$[S2_7!LH=@"(A
M;'WZB"C/(*-`8[F!8,I8`0'`KU'FHC4@(^E[.S[R4W/=FM[""I:.1\#<.%+>
M)+F@-(WLSAM6_HM&I*-"$K<C@;$C":TP"/Q%N`22)XY>YPAC_W6+^,Y"?/N)
MF]^YP=BYK>:X`6FK%<;.S9T7YJ)SA+%S)('EN\$RG)$E&S/>%C!*FW2WJ=G#
M@%D!.>6W5,PQL@;FOG*H>ZCECTH)-10D+X*EY8(J<>B_MYWGN!O[#7HFZVSV
M:+,TC<&&J!:'WD(TB*"-="#6@00!^!U(76\UT-H@<E`*?:$K]:#3O]^CO3#A
MI`H+PH&^#7*/)K(N3?FAMQAT]<`8]<)16>/>I/=)$)"5>HXW."E*H9%EI<\5
M"F.8;U(&/<<?>%$BVOCM=!.%.>A`I`.Q#B02H`0+TT<.5C3@S\LBG+8FI&0H
MN^<$6M!H$[;=Z(?>F*M6TP%?$^B`@2/42AO)%,0/PZ7ZB7@&1X(V;>X4W3#_
M==T^8,^+)9QTW0LUJ#W:2,72@4@'8AU()$`)&E8(.>CGP0KCGW46VDC!ZD"D
M`[$.)!*@!`M3<GZPPEC/K%;N/=I(P>I`I`.Q#B0(+-JN7*P6WG+L.25X<322
MUN7GF1;&>O`C+\YAM)&"UX%(!V(=2!!8M<$O+3)^0@E]I88^;T8+)UW"N)"C
M!+21).A`I`.Q#B0(8/X#QQF7746"6!;D],_3T'KI(O1EJ3.25$R0:(+$$R3I
M$%2BK&^J$K%#SFXD@ONILK"2,4=8ALY(5H!N(Q)-;.()DG0(KM`D&#^C"A`;
MWWP!W3:)1T.Q5^W)!#I,H6@*Q5,H42`U3+&_26'^WX,4;I-R`?1=:0\G>3%7
M1"S#UD6\,7VXOXU6_1$BFD+Q%!(7A8X>'%$C'OSQW%C2^D(/M"BXD;&[.-0'
ML!X,*%XX]F0-9S7PUW%W#:>A*1ZY:SCQ3/$7XL+-Y7MO(`O]G<8>/@)WBEMZ
MH7^D]26ON%'0,X3G6.+\7^.M!!\:=FL/=4?6P&VB_7N%VR.%=G$L,#XSUO0/
M(@G#?73W'P```/__`P!02P,$%``&``@````A`'%D83)Y`P``CPH``!D```!X
M;"]W;W)K<VAE971S+W-H965T,C`N>&ULE%9=;^(X%'U?:?Y#E/?F"P()`JI"
MDIE*,])J-;/S'!(#5I,XLDUI__U>VQAB9[=+^U#(S;F'>\Z]_E@^OK6-\XHH
MPZ1;N:$7N`[J*E+C[K!R?_TL'A+78;SLZK(A'5JY[XBYC^LO?RS/A+ZP(T+<
M`8:.K=PCY_W"]UEU1&W)/-*C#M[L"6U+#H_TX+.>HK*626WC1T$P\]L2=ZYB
M6-![.,A^CRN4D>K4HHXK$HJ:DD/][(A[IMG:ZAZZMJ0OI_ZA(FT/%#O<8/XN
M25VGK1;/AX[0<M>`[K=P6E::6SZ,Z%M<4<+(GGM`YZM"QYI3/_6!:;VL,2@0
MMCL4[5?N4[@H$M=?+Z4_?V-T9H/O#CN2\U>*Z^^X0V`VM$DT8$?(BX`^UR($
MR?XHNY`-^),Z-=J7IX;_1<[?$#X<.70[!D%"UZ)^SQ"KP%"@\:)8,%6D@0+@
MO]-B,1E@2/DF/\^XYL>5.YEY\3R8A`!W=HCQ`@M*UZE.C)/VMP*%%RI%$EU(
M(.-"$D9>E,1A//L$R^S"`I\WEFD4SY,[:O&5+FE35O)RO:3D[,#H0>6L+\4@
MAPM@UOXH-5?'_LLP<$J0/`D6R05>,&CRZSI*9TO_%3I373`;A9F[SA43IR9D
MJR&B#X(WTX%;3FBFY!JA4PH5D`WP0>-5*#3!%CJ!<?KW0="Z1)*I*T[,`C9C
M2&0BMF/$+#`AV1ABD>1CA$U2C"'1S2W#BXGIQ<<>"#",_:!O86HU;J,P4SGU
MHG%;.Y#9@=P.%(.`4>ST,\4*\,H%)ZY#%J5ST^R-P@R*M0.9#HA!MEJ5JW<S
M.>0AK-\TL<PH=+;8EX83",M_.($?NR[`MA![]!1F(,0.9'8@5X%$5I]8THH!
MVB@<]H7["Q=@NW#+H8W"3":RC-1+`N-OFC]8T[]5"3>EV6<9<INA&`0,L;!!
MW2]6@$VQD\!R=:,P4ZDU3F-S&+?ZK=Z_,AT0LS>"Y_JMAA<Z8,,-3>(R,]CD
M/YX\`;8UW?81N2]O%`8&?;#,+&$*HB8MLLZ"[/_S\V'^=&J2PXU!U"CG00E5
M%P!ULK6('M`6-0US*G(2AWL$YE^CZMZQ"1=PW("-5CP+%W"FB*5[?0'W@;X\
MH!\E/>"..0W:`V7@S6&Y4'6C4`^<]/*LV!$.-P'Y]0@7/P3[8>`!>$\(UP_B
M!ZY7R?4_````__\#`%!+`P04``8`"````"$`;:.QB7,"``"^!0``&0```'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6R45,ENVS`4O!?H/Q"\1]1BQ[%A.4B:
MI@W0`D71Y4Q33Q(1411(.D[^OH^DHWH)"E<'2:2&,_,V+:^?54>>P%BI^Y)F
M24H)]$)7LF]*^O/'_<45)=;QON*=[J&D+V#I]>K]N^56FT?;`CB"#+TM:>O<
ML&#,BA84MXD>H,<OM3:*.UR:AMG!`*_"(=6Q/$TOF>*RIY%A8<[AT'4M!=QI
ML5'0NTABH.,._=M6#O:538ESZ!0WCYOA0F@U(,5:=M*]!%)*E%@\-+TV?-UA
MW,_9A(M7[K`XH5=2&&UU[1*D8]'H:<QS-F?(M%I6$B/P:2<&ZI+>9(O;*66K
M9<C/+PE;N_=.;*NWGXRLOL@>,-E8)E^`M=:/'OI0^2T\S$Y.WX<"?#.D@IIO
M.O==;S^#;%J'U9YB0#ZN1?5R!U9@0I$FR8,-H3LT@'>BI.\,3`A_#L^MK%Q;
MTN(RF<[2(D,X68-U]])34B(VUFGU.X(R;VHDR7<D^-R19--DDD]G5V>PL.@H
M!'C''5\MC=X2;!K4M`/W+9@MD/GMB-"%Q]YX<$EGE*!9BU5X6N7S8LF>,'5B
MA[F-&+R/F&Q$,!0=E5'M?&4/]LH^(=[*;=S8E\G?EBG^1\:#L3C[YJ\N1]ZH
M'#&3T##[\4P.A7R/%-AI_\ZH/U12#&;,5CZ?'`E&3%&$A,^3?'YPY1\O_I;@
M(,'86OL)/L^0/W1L:'ID*&)VAM(D/2YPG*/89@I,`Q^@ZRP1>N-G),,XQMUQ
M?&_RD-#Q`X[/P!OXRDTC>TLZJ/%HFLQ0V\0!C`NGA]#$:^UP<,)KB_])P!Y)
M$P376KO7A1_Q\<^[^@,``/__`P!02P,$%``&``@````A`'_WO1"``P``9PL`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,C,N>&ULG%9=;YLP%'V?M/^`>"\?
M`?*E)%43Z#9IDZ9I'\\.F&`5,+*=IOWWN\:!8"=+T[VTX?KX<,Z]U^8N[E^J
MTGK&C!-:+VW?\6P+URG-2+U;VK]^/MY-;8L+5&>HI#5>VJ^8V_>KCQ\6!\J>
M>(&QL("AYDN[$**9NRY/"UPA[M`&U["24U8A`8]LY_*&892UFZK2'7G>V*T0
MJ6W%,&>W<-`\)RF.:;JO<"T4"<,E$J"?%Z3A'5N5WD)7(?:T;^Y26C5`L24E
M$:\MJ6U5Z?S+KJ8,;4OP_>*'*.VXVX<S^HJDC'*:"P?H7"7TW//,G;G`M%ID
M!!S(M%L,YTO[P9\GOF>[JT6;H-\$'_C@M\4+>OC$2/:5U!BR#762%=A2^B2A
M7S(9@LWNV>['M@+?F97A'.U+\8,>/F.R*P24.P)'TM@\>XTQ3R&C0..,(LF4
MTA($P%^K(K(U("/HI?U_()DHEG8P=J*)%_@`M[:8BT<B*6TKW7-!JS\*Y!^I
M%,GH2!*`^N-Z]&Z2\$@"K^U(0F<TC?QH_+845]EJLQ0C@58+1@\6M!X(YPV2
MC>S/@;E+CS+3)^Q?^8)$29('R;*T)[8%J>!0Y.=5$$P7[C,4)CUBUN>843#3
M,9L.(^L@B6,SD`P"+ECH?4"*ASXNE[>3*\%2;O>:M0H`]T"_J>T&3'P!$_JZ
MQ^0Z1C,%_7*[*0G63*F`9BKT=#&;&S#Q)<Q(YTDN88(>HYF"/K[=E`1KIE1@
M:&H4AOV+VJ;97,!,C&Z,+V!,GN0Z1C,%1^=V4Q*LF5*!H:G`/V5/F;H!$W>8
MKJ^304"3.WZ/7`F&:V]X.#PCY6N%"?L3M3$#L1E(!@%-&]PBPU3*&RF`:__Z
MB9:;EC8<K=,!-LNY5IBPO9Z,_MU<68N[M3ZK@X"F7,X,QEWZMG*YR50>Z0V]
M5IAIJ]P//<\\Q6I]W*Y''@#T_;%:/U4G&00T![/_<2`WF0[&NH*UPIP4;,Q`
MK`+*XR@"CX:)1`/(]1-`\P#3A%:&ZXW3HDWU$T/]$320?Q:)^TC[]7.,!,@9
M1V9)=5\P6%;:U?RBOLP59CN\P67)K93NY6P20&7[:#\W/;3SBA%?^W/XBD*K
M&O%8SEDR[O8+,.8T:(>_(;8C-;=*G,.K/&<"EP93@Y)Z$+1IYX0M%3#@M#\+
M&&@Q?)\]!\`YI:)[D"_H1^357P```/__`P!02P,$%``&``@````A`(W9-F)Z
M`@``'08``!D```!X;"]W;W)K<VAE971S+W-H965T,C0N>&ULG%3+;MLP$+P7
MZ#\0O$?4PX_$L!S$#=(&:(&BZ.-,4RN)B"@*)!TG?]\EZ2B.7;1)+Y(HSL[L
M['*YO'Q0';D'8Z7N2YHE*270"UW)OBGIC^\W9^>46,?[BG>ZAY(^@J67J_?O
MECMM[FP+X`@R]+:DK7/#@C$K6E#<)GJ`'G=J;11WN#0-LX,!7H4@U;$\36=,
M<=G3R+`PK^'0=2T%7&NQ5="[2&*@XP[SMZT<[!.;$J^A4]S<;8<SH=6`%!O9
M2?<82"E18G';]-KP38>^'[()%T_<87%"KZ0PVNK:)4C'8J*GGB_8!4.FU;*2
MZ,"7G1BH2WJ5+=8SRE;+4)^?$G;VX)O85N\^&EE]ECU@L;%-O@$;K>\\]+;R
MOS"8G43?A`9\-:2"FF\[]TWO/H%L6H?=GJ(A[VM1/5Z#%5A0I$GRJ6<2NL,$
M\$F4]"<#"\(?PGLG*]>6M)@ETWE:9`@G&[#N1GI*2L36.JU^15"VIXHD^9X$
MWWN2+$^R23K[-P>+^01[U]SQU=+H'<$C@XIVX/X`9@OD];X*K,Z??:$A'W/E
M@T(HHBWVXGY53,Z7[!X+*/:8=<3,*7G&3-,1PU!^S`%U#W/XN[8''VM?C+PA
MOW7$S$-'#X6*MPAY<$F1ZL!`=B04,9,3H<E;A#P8J_Y"*#\2BIA3(3P\AZ5[
M7?M\T+&SXD@P8LY#<_/IN/FB;[/_$?=!Q^*3D3_V+V**(JBG2?J<7-2/8QK/
ML0+3P`?H.DN$WOH1S#!L_!MOAS7>#GGHTKB!TSGP!KYPT\C>D@YJ#$V3.1HW
M<;[CPNDA'+>-=CB7X;/%:QAP#M($P;76[FGA;Y#Q8E_]!@``__\#`%!+`P04
M``8`"````"$`^V*E;90&``"G&P``$P```'AL+W1H96UE+W1H96UE,2YX;6SL
M64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))?1O:XX`!
MP[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7U
MVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=
MQ9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK5
M9B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)
M=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!<QM6)M85W?_-)UZ8+Q=,WP
M%,$H9UKKUUM7=G+Z!L#4,J[7ZW5[M9R>`6#?!TVM+$6:]?Y&K9/1+(#LXS+M
M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]<YVM]MT
M\`9D\<TE?/]*JUEW\084,AI/E]#:H?U^2CV'3#C;+85O`'RCFL(7*(B&/+HT
MBPF/U:I8B_!]+OH`T$"&%8V1FB=D@GV(XBZ.1H)BS0!O$ER8L4.^7!K2O)#T
M!4U4V_LPP9`1"WJOGG__ZOE3].KYD^.'SXX?_G3\Z-'QPQ\M+6?A+HZ#XL*7
MWW[VY]<?HS^>?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[
MQR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF
M9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F
M8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8
M=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<<NDA(
M",Q*A!\2YICQ.IXI')61'.*(%0U^$ZNP3,C!7/A%7$\J\'1`&$>],9&R;,UM
M`?H6G'X#0[TJ=?L>FT<N4B@Z+:-Y$W->1.[P:3?$45*&'=`X+&(_D%,(48SV
MN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5
M!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;U
MKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C<
MAT&]SAPZ27X02T)XU)D,#!Q<(+!9@P17'U$5#D*<0-]>\S210*:D`XD2+N&\
M:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D
M1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K.
M.YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:<E,7*DB):#QL,^NQXBM4*W%J:
M[!MP.XN3BNSJ*]AEWGL3+V41O/`24#N9CBPN)B>+T5';:S76&A[R<=+V)G!4
MAL<H`:]+W4QB%L!]DZ^$#?M3D]ED^<*;K4PQ-PEJ</MA[;ZDL%,'$B'5#I:A
M#0TSE88`BS4G*_]:`\QZ40J45*.S2;&^`<'PKTD!=G1=2R83XJNBLPLCVG;V
M-2VE?*:(&(3C(S1B,W&`P?TZ5$&?,95PXV$J@GZ!ZSEM;3/E%N<TZ8J78@9G
MQS%+0IR66YVB629;N"E(N0SFK2`>Z%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q
M/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY
M2\.D-9PDU0$-D*"P'ZE0$+(/9<E$WRG$:NG>94FRE)")J(*X,K%BC\@A84-=
M`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV
M#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO
M-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(
M%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:
M.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:<J@:&'
M'I@\@.2W',W2K;\```#__P,`4$L#!!0`!@`(````(0`UII!U4@4``-<5```8
M````>&PO=V]R:W-H965T<R]S:&5E=#(N>&ULE%A;;^HX$'Y?:?]#E/>2V+D!
M`HY.4G7W2'NDU6HOSVDP$)40E*2E_?<[SAAL3Z`E+Z5X/D^^N7T.7GQ[K_;.
MFVC:LCXL73;Q74<<BGI='K9+]Y^_GQZFKM-V^6&=[^N#6+H?HG6_K7[]97&J
MFY=V)T3G@(=#NW1W77><>UY;[$25MY/Z*`Y@V=1-E7?PM=EZ[;$1^;K?5.T]
M[ONQ5^7EP44/\^8>'_5F4Q;BL2Y>*W'HT$DC]GD'_-M=>6S/WJKB'G=5WKR\
M'A^*NCJ"B^=R7W8?O5/7J8KYC^VA;O+G/<3]SL*\./ONOPS<5V71U&V]Z2;@
MSD.BPYAGWLP#3ZO%NH0(9-J=1FR6[G<VSP+F>JM%GZ!_2W%JC?^==E>??FO*
M]1_E04"VH4ZR`L]U_2*A/]9R"39[@]U/?07^;)RUV.2O^^ZO^O2[*+>[#LH=
M040RL/GZXU&T!604W$QX)#T5]1X(P%^G*F5K0$;R]_[S5*Z[W=(-XDF4^`$#
MN/,LVNZIE"Y=IWAMN[KZ#T%]1!<G7#F!3^6$\0F?1BR*1W@)E!?XU%Y"'B73
M.[AX&%>?IL>\RU>+ICXYT'O`O#WFLI/9'#S+_`20Y>OY@<3(/=_EIGXKH%LH
MZMN*S1;>&]2A4)`4(8GK7"#<1F17$.P"\8#>A2/D;3Q'N<GFR/V+^SZ,%"%)
M7W895V8L6`0@,2:!SY,CP9!$,W(2>HJ04#_86+`>'(YYL`0O78A!ISP@$2-D
MBB5C/N&56>8DUF:+%#3^_=F08$(J)*00$B.I.(AT%_1ERBS[-)QJNT4K'D-+
M@@FMB-!"2-C3BF?$FJ%5D?;#Y++9X@3]?W^J))APBB]NL6,1@IP8,68WC!8A
M>:Z-'G>YB1#3\2(QA"ABG(A!9EIC77Z+V<QF]OF,23!A-"6I0@ATM)X&2NL,
MD0(6!%H=+%X,U'!\ROI=-D/C`9@SA<&DZ5G#IK>,B0[.YD;4^_.D,51<4R`"
M/4N*$V)47T_YH.^5$P1PEMRD)K5T=*<Q5&"+(LE,JC#(((QC.IG*CFG5`F@G
M3@KN>'8HTQ8[_0"5P+.4RZ8B4Y*QZT:;FA1A@]H7-47)MBCI`5.4$*.&DQ#.
MF&75>VU2HS1?OF"1\0Q(E5*%47W$9U,]?FH`3-GG;&H<5C:U4;K/4+>A#A=9
M"(B.I@IC',_FBOUP(O!WOCX-E3X@K9(R4\WAA=-6M\PRS[@.P:9'Y/Z+7KJB
M\UIX5"^94DZ+FC'3>NM,9*.4OD<3(1V0,H4\]DFK9<H%]O\LT0-@Y8H3G?\\
M5SW:?LL+R/&2*HS11^:*_?!10LZ'0AZ2!DD51@5-NN>&T:8DI?AN'>(2;9<I
MI&>+PB`E3AH^NV6U24D!O9\4RJTICB$]3;@IR50*LEM6F]0HQ>9#Q0YU2^*4
M*0P@+RHU>*?Z'&,3'*7>\B<IE-*4R%`?"XH@8LS6-E;LAQ-]EA*9`/B+^4*=
MMDI'YCKEB%'GVC!!MEEWHTV/*/@7M(;*'6KM5;E!#)YL41#&I+H9-P'AU#=F
MUZ9&U/N^PX4/5=Q08D71U&GF$^W(E`M,;!CID;'IC=)QCAIM%93JN,)@YAX"
M%D2#U*$7A>#)U/A-;Y&3=QCW"T6/)NI%U5QASB\L`97[S`;XR4R3MZD1K;^O
MK'!)1@4V(G5+%09_WO,K[U0VX,H[%=ZCX051)9JMR,1^WSI%_2KOR#C\%KZL
MXOU=RN8IE_<89#V#>[U^W;L8X%KMF&_%S[S9EH?6V8L-N/0G4@L:O)C#+UU]
M[.]MGNL.+M3Z?W=P@2K@@L:?`'A3U]WYB[SZNUS)KOX'``#__P,`4$L#!!0`
M!@`(````(0!$3VODCP(```,'```8````>&PO=V]R:W-H965T<R]S:&5E=#,N
M>&ULE)5?;YLP%,7?)^T[6'XOQB30)`JIFG3=*FW2-.W/LP,F6,48V4[3?OM=
MVVE32!4E>0!,C@^_>ZXQ\YMGV:`GKHU0;8YI%&/$VT*5HMWD^,_O^ZL)1L:R
MMF2-:GF.7[C!-XO/G^8[I1]-S;E%X-":'-?6=C-"3%%SR4RD.M["/Y72DED8
MZ@TQG>:L])-D0Y(XSHADHL7!8:;/\5!5)0I^IXJMY*T-)IHWS`*_J45G7MUD
M<8Z=9/IQVUT52G9@L1:-L"_>%"-9S!XVK=)LW4#=SW3,BE=O/SBREZ+0RJC*
M1F!'`NAQS5,R)>"TF)<"*G"Q(\VK'-_2V2K#9#'W^?P5?&?>72-3J]U7+<KO
MHN40-K3)-6"MU*.3/I3N%DPF1[/O?0-^:E3RBFT;^TOMOG&QJ2UT.X6"7%VS
M\N6.FP("!9LH29U3H1H`@".2PJT,"(0]^_-.E+;.\2B+TNMX1$&.UMS8>^$L
M,2JVQBKY+XCHWBJ8)'L3..]-:!(EDY2FV04NH[T+G`\NXR2]GIS!0D)=/J8[
M9MEBKM4.P=(#<M,QMY#I#)Q=/B-(^>-\(!@WY]9-\E-!;:"G3XN4SLD3]*'8
M2Y;'DJ2O6'V@.)@0P'MCA-PN9W23H!:,#HP#@F60C'VO7%VK=S=Z`.#R'N!T
M.$Z<8[`Z/'C4+WT9)%.?'(V2+U<#LM4)00]L?`F8$P_`Q@.P(,D\V"@.O[YD
M=5+2@X,7Y/S4G'@`E_:?O`R2`$?C21+3Z2#855]"XR1-#RX]N.P2."<>P&4#
MN"`Y"=>7?`@7]K'P@G9LPW\PO1&M00VO8#7%T344J,,N%@96=?Y%7"L+NX^_
MK.%CPV$UQQ&(*Z7LZ\#MDV^?K\5_````__\#`%!+`P04``8`"````"$`@8@)
M5VLO``"!F```%````'AL+W-H87)E9%-T<FEN9W,N>&ULY)W;<AO)F>?O-V+>
MH4+!7K,C*#;!DR2[NR<@$I1@DP1-@&WW.N8"!(IDN4$`1@&2Z-B+>8>]W8W0
ML^A1YDGF]_\RLXX`2,EJSVYLA`\4*BOSR^]\RJSO__7#_2AZ%\_29#+^X5EC
M>^=9%(\'DV$ROOWAV57OY/G+9U$Z[X^'_=%D'/_P["%.G_WKC__RW[Y/TWG$
MN^/TAV=W\_GTM]]]EP[NXOM^NCV9QF.>W$QF]_TY_YS=?I=.9W%_F-[%\?Q^
M]-WNSL[A=_?]9/PL&DP6X_D/SPY>'3R+%N/D;XOXR/VR=W#P[,?OT^3'[^<_
M'D\&B_MX/(\`(VJ-Y\G\(6J/W?R`_?UW\Q^__TY#W?##Z&PRGM^E#!W&P^K3
MD_AZ.]I]N17M[C0.J@_/^K/M:*^Q_.$C8$1_:5ZG\UE_,/^WZK39F[V':5Q]
MV-AY_L?J;TVV.[0MGXSZM]6GV707\2R9""7#Z+@_K\WL4749WR8"#`2>]^]K
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MO5^=].CJ\K)UWHN:W2Y+_[;VN)_>F=@-]$?\MT7RKC^"M#72=.]`6#2/9_?1
M$.2E27T(PO5+/.]?CX`U'BQFR3R):_-<QK!J,IC'PTA+5N&YF,73?C*,X@\H
MF11D2R48#B)F-*;KIVE<7_PR'D'S833M0]?ZLI\^?OI87>N-1":-9O$@9M<"
M^V8VN8]`>#2X2^*;*!TDH`+9JK[9F\QA^_4`G7;.WT2]UN59=-RZZ'3;T+UY
M?HS8_=3J]LX@2772YEGGZIQ1)U?PD`9&EZWN1>NH%W5.HM;9Q6GGYU8KNFR_
M><N@JXN.GO?:EZUE<UU<=BY:E[V?;<G6'Z_:%QJU%9VW:LNZO2Q':F">TW;S
M=?NTW6NWZAS4')B.3\'\@R%1%.L/!K,%U`ADK.[5+1H0.$KZU\EH*;OD6%P'
M0^M^.IH\Q'$T2V[O(.EBBM#.XGDRBZ5DJZM?S";O$AG$"!N#H`WBV1QK%<W[
M'R)C[25&QT&,C;QU0K`&YJ/.V5G;2(RHCR?S.-JMR7JWUSGZP]O.Z7'KLON;
M2!3J_5P73J=]4J=]-J*=[9W&KC@\0D@7<;2YM[.ULV/_C?J+.1*:_!VDIZ:F
M?A<U=K9>[NYL-5[MF13QS\;.[M;!P8$?$25I*B*9B.4Z+>JC=6XB[.ALT9\]
M9+;4QJ%K%C@&WH3N;X%EZ:5Y\BX>/=1VV1P.H>IDC+!(JI^#XT%_FB`\59+`
M18O[A1-A+^XHYEE\AQ9@[BC!9ZF;MN);HTE:4S:.:(:_N\EHB!?T&]-Q\YJ^
M]^3-&=%V^Y0WGZCR+YI2PV^16*SOMZM,P-,F6^V(8,UDKSS'Y)PRQ>896U3Q
M7G[!<4Z!EYXTW+'1DX9.<C:KC5]N.KL]+*B45U=J$-&ZN&R]Q<2V?VI%IYWN
M$XUI_&$03^?.@$?#_KS_.?9U[\G^YO[7VM1J"F,36LW+H[>FV8];/[5..Z;;
MH]:?+^1Y=)<J^3>M\]9E\]1>:AZ?M<_;W=YELR<DAO>JH,N`,`(C)C17GYZT
MS_%HVDR)']DY:ZU^OFI^3)$CX$GG,D(P(M9K=XZK$W6O7G=1CS``=O3HLM7L
MMJ)-UK2_OI65U+LGS?9E]%/S]*HE+FG^U&R?-E^?\CMS=YO\T6UAR\R`13#0
M3^W.5??TY^A/_-1KG4?'G3^=XR%%[;,+)FK5@+AL'9WB0+5/$-Y>&\O;//[]
ME;/B4:\359$A&-XTV^>P+$,#,,\!YGD%F.INK\[9UVG[?V#_'7-KFF]+TRS;
M4W6:7J<'93I@YG*IR#B:U=2U>VV)C*TGD4$*];34&3ON$FFT:L;L=;/;/G)<
MVSZ]DE>\]+WJ5O[4DL/#Z.9/\..;5G1^=?::M4"QK1/4@BTLHQI=R?V&+[0/
M@AT8^`E+Z\WJTBN4<44CO6V>OVDIG(J6V?15BK[HZU?7-5M4_=$KZJY\@>@O
M9_']=3RKQ:&K[>WJ5YYD>)_TNBSPRH$A!.K/H[7QBA^W%7R4Q\9[)FAWNU>0
M78QZU.R^7:H$UPP-RU6Q7G^EV[K\J7W4JBG$OS1JU%C]\JKE6G]N71ZUT7!P
M=^="FJ:VSI(AJV8S?A3S@Q@)`^;!M%=MDR8V]7&KY@V:NSK/*GU3'5=@A;7)
MFB6LL'8\03W>*/Z^HL:H?Z]$DSQ9BZ/G=_RVT:BE/)XFY+!4='+:^=-*=T-,
MYT><7';.H%ZPGLTCS.SRT.D\GD?+W-;F\*\XV8I<%)T2D\_PTN<3_AY,Q@,2
M'-'8OZE?];=%[XN48;C8Y.=F?4MND*M*WEE<55/'QT+6(&$<_J*%;/?*B/S=
M?JA2K/5A`/INXVB8W-S$1.&#V$7FR9B,`!%]Q"2KT@).95WW!1U.O.+ZI8L4
M7=$0FB@^2^/9NX0%JT"]4<@F9Y>$A<B<C-\!R;)X[\B`3RNXL32";;T0R]7P
M=%%)2&PMS4;8-+/U*8AJH+Q5BY*?,LNI#U$>+':-/R_P-<OR-(:I8KO*X"Z/
M(>NZAL$O%C,8A]P5Y)G.Q)=D=L5L8NKI,E(5WT@?3SD5A^>Q^2I.).X?Q/$P
M=7F>P#=/66;IB_=/R7>=+,CFB?-\H"Q4?!VJ.7Y7#C,7\\>HYCW51ZA6VJVB
MNSX"+\`1WRR\C)X;(TGPPHA5V9XRWN,/\6R@A":OON_/7!+.<A!3*:.:G)??
M]B$J>N^:K(!+8$A++)NUB@WI6].49`)(*@P=']PD8_:W'H^MDY.0B/OSD7E\
M$<%1*W)_FY\O`:DN&.*4:#/$+A:QF"PI&6A_*/E#Z*(0M_K^RH%1LQ>];KUI
MGY]+`O$6E@=/:]]O`<#*-[LDT\9*71W4+&:W_>;<(B%EE8^.E+04$!=DNX](
M$%;W\,CP-565\PX8;L!GCTQ1T]G]&LQOXC$V<50;V:C%0&T233.*`[EA].9T
M"6=V9I1;AM$%^;;[_B!>S!.J(2EED\%VM*DT\G_\^__&JDVI+_S'O_^?;^%V
M:8(P/V]BO9K363**&KLJ29&=(QL)<UH.>M1_;XDX3=2=D]R6P)S'[_K#_G;4
M&><)NL8+>_EPRU[S"U+EDVF60X"LR!^ZG<66#8W>)_.[Z"W3D,2/SN*AH(ZZ
MWLJ:>CZ.2>=-3$%'I_-AM,E&_`NV$<TX,+_$ED2UNWRJY?GFK(RV<[D\MS;H
M'(T>`.46"YTHTYZ,T\4(K4@ZD#]B^3'(LWDPDF;M>4Y)T<RY]IV,AW@RPX7P
M:_`/L8/Q/$YKI`8S%"(&=U'#E?GX7\T6T"(:S.(2%;*L?P7+`JJ$_&,VA<:*
MEZ_Y$#7(AT)%R%%<L;16/WI/)G+T\'SR?@QQTL5UFK`5TJP@HYW.^O%H*_)\
M!>9S/NIF(T6!+:9)V&.20N?;_JW162:&2AP_2YL.<QIN1U>NF"2P<"'G\8>Y
M870`5Q5*3`YNV.9>G/MF-EE,68QI\?E286,=PVM-PU8&:`U-)^Q\\EZ:5@/[
MPXDI?)'7^T9Z!!$H1L\PFE=3,G5DN8&EV;TRQJ.FN_^<1'94Y%#>P#5MJ6Y,
MY2?:[$VFR2!ZU3@`345"4`R82.OK-XA"0E"^+]NR99*\X&SX@V/=SN7MVJ@"
M0JM*KI[@+P(HU(RH?4-I_)]9DOY2,W(]8#*$/Y&D8A?MXSI!20_NQI/1Y!:7
M,(E'6#4$*!F/)^_08:3.IR7U%*63$8H*;;8E)(P6Z@20?O@5911/US,'`BYR
MU]?R>@#7#."'\0C`D0D-99<SJC(C*NL0;!@#MV;#K92!BFY-LZORAY:%8._B
M\0(F,)FF1AF"(?:[C0Z`1WB,XG4A$N1G">$QJ`<$2@(B3846LSK2Y%K%(6$I
M7=S<)%83C&[0T_IIP=A1A!Z])C:[9V%TX0T%#G1<C?V[BP%A3'JSH'2(51A1
MGZH!\)NT*+B:[18CXX,MMJ,R/VK;,^Y8+1BC?#>8%[U/B#5<`OZ80F>:2M?,
MXEO56BB01_VIM+?4:J8&K[:[V]')A,8#(?IXMKB-FL-[4*`F`UM:(GERW#21
MQ'Y)84^(TT9H]%N085@8+@;\(5WM6?5JG(A,IF0]$2%VG-S*-UX"SSTQL(R"
MP[_DUJU17L`BT+&!)1NS30D=LX==&>O=,88*'Q&D28;O2"85B?T^,1E7^9?2
M81T&,8>XBO\K;$IS#Q/I#+^+OJEQU-8\@1AYWF&>W,?1??^!VA>)L>M8NRVM
MWU>9F:`UZI.CP.)JH8R#^T.").D_;7LQ5;^"09&Q+JLGP#>/V+=M.V-BJ#FQ
MTJLHP.O(^8(X&L4<@#1/'6VTP&1(E<#S<(?1UJRKL+0,(?"*>,C%GH"_&C71
MD`8`N(&9DAESA2IAD;W!%G)(APNRV<FDS(55>C?P)EP$H2#GD$S(8(XGD?.X
M-'@NOXB/*R4_V+XE9(HR;<A2]D_G\;2<9''L!MW4S%""8AD?FXCP(-0LT0<S
MC%"9'C",5-44=XS.!P.&0ICTA?`'^&C%/(:KZ8W7ECIAHV+"4#.W.`:T3@BQ
MQ4%(*A/>)RYMY'2D'V/\;9DA9!6CP&*,GBZN1YC)B1(Z;-/80)A,DP^?/A+E
MX2,ZXN!A#)&^Y?5@CY,'=0"Y<;4*<8$\T'#D.!Z-&8AJ30-PJ1K&K`Q?W.9T
M!.Y8O>#-%%!E&]'\^-1BL8E3RIDPE=A<E@5I&<5]](I>&LL-HJ!NFW4HO(X?
MF,.>FE.0J0P?),*QR-#<F(HWD&<7@H+O$?7WQ>U=6>5X-72+@A&?LGS8N!AB
M3#("-RBKD<NH2'<&A;I`P*1$MJ.VL0G+:<D%@*OFSLM(-EYRZH38F4(T$#OH
M%Q0VRBU$YEA>R>)2+S$;5/::I,`,4%._\2\E@+/0.9?V"EIKW'Q=^^4\?J_@
MP,7R`AXA1VCYS5Q$MEEP#R]FDS&)W8$C0=4/:Q-0N0X%>8IN(R<.2$A7F`8K
MY+W,UQ.<S2Q<.VEV7YM9\^`L?66E8WJP%5T(O?!QL.WYZF;X+*G[_,U$B@5W
MA,Z3<;2);S\WGW5WY^#Y_LZWOXV.::PC,XQZEH:XTCB)AOFW_6N4!T1V'N\#
M*J]IW3.F\H*+HR:.?E19QSG2:HS$B3[0-J6G<!G&\7O?!`HJ?,8Y12#'.-9.
M?YH=E>:7X+`_'-FRKG5>$TTIMO"M;9#?;(/7BFY"V&LJ%2+#DI!`_S(OR^]0
MW$\R!KVMI63<0('7>19!1N:=]'%;33G+HEFTL!UU77\<P>SHP5&>Z-QU61(4
M-+YE:L+4(1"B39!GYT4Y!>QZ>HH6<CB!*%O1YNZW`2%".='W"*,L]PN#;9Z4
M#+-VX94ET'N?VCR3Y#Z8..;:RV$H;%-Z"4P1!YHB-@RCQY-;UF'>&`6-T0#.
MG!Z@7HH1#V!S/X<OH'"8,0_^%PTT)<MO^Y*;")KB=^3_I8+$*_#M8F3K!&`R
M'EZZ\$&^L!#S8<H$::X=30LYJ_@T>*00<YB<`=L\+"VB)K4T-88T91YP#F[H
M78[,"/5OB%\-AY^EP*--68=W_604S-%UT.T(">%GD)K,;#FZ6(`UFP3O!A8U
MR,9C,A6@M,P<"M:-XW,@;Y(9U@@;I_&YO34AL9T<HPM5ZXT:*!<D]]`06^$M
M[5=)C>VHU9]);TZGV/:,?I+9("@B/>O`8**\`U8Y^:4`RUR4E[(W7.ZAI`F6
MVL>[/J9'='T@\7H=PXE.JY:](T5R\<C9,VP,MBEH?B.C2:V:]2P95J0$OL>-
M:T`VRDNMN9E+F84"Z?#:#1R#2XX]_>O(')@/0N:<20G`9&0N/BC*S`<H=)9?
MGERFY&OF;%#[Y0B?0MVL0ZG\?.9EID'V@[8M(UW5N/7,T0E3/0:DI1I11:SJ
MF(.0&7(8&8"?17@""OOT;\Z&%B"9ZU\*TWQXK>0=XPC`>4<OX.::SLN5]>8S
M4\QOFLV+9]\ZX7?(3-'"$=4_J1QG/DQY,]%G[,"[F4<NF2J3YQCVTB1,>=03
M0F$Z'I__P3A4O%GDC:)K^NECZ%[,K+Y8)Y\A&$:YY<#H2?<XM.3)Q,;28G@N
M>0DWLV/HJ3X,:#$[/@[]S$(BP:OLO!R?;*06DST`2WG8XG3>39]X*F=%;[^<
M]C81T=Z=)I$O:8P:DT@\\DVNU3Q743L[V""VLV*>01RJ']]_SE\3KUZ,;!"^
MHD.<7B0"F:FTA#/N\JPS$L$PB3F`E@\(0J\==;..<AN15:1AB7NT"D.WH]?Q
MH+^`:!J_@G`!DB523>:$8CK:RF_>Z.C1NPYI684>-R>3@:(96+:6.2@/-+E,
M%F3LL#4Z/R-Q!.Z_XMZ60_&G2XRPQQXL()`CXD@HA)1YW"G*P#7BK("9P#IR
MO(2-P'^)L86*!995-%XFE34JRAF"Z:>LZ\"\*;JJU]0V%OJE5S<^GJL:M$LU
MJ#"\5L_I<%9#6LI9S%(!($^@RW\UT6++:THCI3"(G85*B5!\9.<#>GGFM:/,
M(%8Z*_OT.A9&:/`Q9XZ.^V-RLU%W<(?41P58P@NA'M,,91I['?AH8\?S-V6)
M?V:.`7,.2+59W89T`_8K]=4;7!53YQKFI:HV\596^PD1N/GS(UA%Z+"5I'LR
M]V&#FH8>P:5V-@,^-XG,$OV?/@)@U8YH"$D-\VN4Q91WZ*4IG>.^*WNV\>I`
MOSE_XCTT8;>#R>W8VMCG=Q0@"*AKB0=<?:J3EN02JT>-/MY]C>%@A>Q-[SOY
M4E`!^V5.*"$YT,%2F*"%/";!$6:3%'X@VA%J&J*@PXQ:3D%[+XY]W<@[E&_"
M5HO*+O>?\@F<7QE"%+2`3>RB2#QX=Q(%'C/MEU$?!P96SM)-`1HY>66BWB0?
MH*]E.I#C&_`'?!N<DIM-'DA=J&["#R^_"2124U'^R-&1%Q69LRDT5I4'I+N@
ML?(288XI[I+EW@CC5';#\S$6:TG\^M'K9*+B(B4NXE+WFV$18^X*>-Y,-VS+
MQ!B^7`0G@DS75[*8BC$YY/!R;S]T#+(/\9[W%2Q!JOC$-QT0>)$*UN8/MV%K
MB.7><PK1+Z%&(DN(&06]<TS)DH,+(X4?*A+<\X=U#>1<1@46+;MK\!(0D:P$
MJT4VM`&[#;>6&7+%DP:.0/:K@RK@RZ8-9QD-AQN-'>*`16H"SBLW64E->>Y[
M*VFEOR51JD@7/?%@%2&FV_GF=P$N[VJKS,>#@^U7+SY]-"[]G:6`++'T;C)"
M_CF38]GO%Z^V7^S["52^>GY#+=E9##`5H2IL#XWMEX??K-K<PMJS8!VW2]`K
M8W%/]@KO!Z]RCN=/ONNZ3V`+A>PL*0-"!&71G+2IO98I"0IZ+MH+!6>O"4,L
ME6-*Q0N=#GJ.YB0M'Y.N&RY3&JX@[Y&^YXS`:HVAS(DRBNBC3&&8-85'2*V*
MUV[ZM.P1SYM-SFJ\3@>POQ&=`_+\XOH\.HTFAG(H7;84R*@JG;W#D-`L\.@Y
M>#*;:!7JQIZ;T3.V@Y_C6Q99,R6G`Z*7KW2TR!6%S'4(ZIA_P,:B1#`?(/07
M;<%Y<7A/EI*40M"N7%$[<;KU'FHY":2@S]E2B?[11=OD?G,%WSL2W"R\EVR!
M:@EDSGLQF6,#(2FG1(!P8Y?."M>!B#P**@Z$N(Y&X]T5*]>-2A,MYAQ1%^@K
M53TACZY<#3,'.,!AE2FT:%!)7LO#]``U_B6Z71#QH10E4F`VE)!4_QDYM$K<
M@O(N[[W&PE6FGNF$=4<ZE08%^%G$++DV%7?HR4:P/Z3I`\>QRH#S]_$(N^>R
MZJL,7WC9*!2LGNMH8TH39O/^@V-38C@T<#+W_HJW2*`RX,>J'K)PXE$LO]C8
M=XVA[@ITP*>3B$`W.R_%(QDJ7VKR^5\(<D.)10V+T*)H`F@$5=&<>A/I6.?2
M@FK]YX+_N?Z.T^I_USD]#MTWGO&O`25ZX]%[3MG;+[,3JBQNR%%_E%S/$HV[
MZ=_+U;8W=_6#';N/W0]482<S_?B=K3+_,9QJ+2S]SUC65#78],EVYVC#5IF>
MR7[)S)C[Y<"H8KQHK'B`Q[K<W)5YU),#'9.J*A+8Y\76049=K]-NT<.(H_0N
M@7+)OGHN@,KB`ED46UK_H,H.+>2E;!SN>YD"IX5;!^KU?(0JVYTS_5ZP5IL+
ME(?J2T4-19T-GSNX\[@,^(LJK,YN"1E<.[93DY<646R9O$GOT':&V6FW"V^[
M8,`$4KSI.+;49Z5G<UHIZ*L+'53XM!@GG)K05"0L(!CDX)7N00(Z@_E$*4BI
M#J.7W-,\1-"<`BC(JJ-<`0D6-9C@77;D2=OIZ;Q.;F7>#XF2<3#^QN[+G4+Q
MV&7FO>"Z7B<S4Q+N3*/C.*BL:`\8.O"I#@0)]X34,%M34H9'GQMJE&-5.,)T
MZ>\7`"J;DBO3PG;!92&\A-<4.%1(+FQ89NSHLE,GZ77.$)]!TMW5),4@J01H
MKATR=,V-$21C?8+.\20*;@;<0A(E%'Q'*KHAK^JD]#.I[E0[5N>)E/__38=N
M[&WMOOHU6'WCQ6'CRWF]K/5N:OZ%N1+24'M/8G^\F;S`71&"/A?3C(>3F1,`
ML0F>@/67E,K]2#J_JY](/A;\J6(/_V?.EY1<:"(E*%*+A05HGKES+;.QIX;0
MC?V=+T"-\W>O)^,%*57G)YOE<.'GQB$VJ.0\F,*SLJ;33(K6EBHE=6NE@UER
M[12M4)#CR'QL:_.TU`BY#ARC+/()_GAF@D*<N)QB.'^N@/28C5I'L$QK?1G=
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M4`92)=VOC6HT7KKS*5^D7?]:0Y2_6\EZBDGT/O]]/.-B*[HQRP[U_,=>&7<X
MJHK)77<"GBK6-LKST#[%5)K06K$5BYOOD)WN\_DBK4E-<4[8$;*4^]]8#.IL
M=V-GYQMA1R3,?07]RT6$/KV0);Q#"F<SI+7(7M';KP0856\76%;CFXW#QZ+<
M`O/<40:4I5?+!'FTD95"2JWM<@M")P/)M@4I"'6^6Q[_`5A\`VR-),<+*S=K
M;T_N\2P'X1DR:*LV]!2:QNLTJ0'P2^V7(I<(+E=%"_1P1;9NN(0K_'SF.M$M
M,=W"2DSN*<@@5>06L4N:ICB".^SH(Y_1$=:;T5)MI#\E9S,SH7!41(`Z1]UG
M]73?5997)#*B"]\SBF<"\D?A&$#6.\\\E9K*WC?/][8/X#FJ6^&*++C5,283
M>M<VZ_O'$[39^GKR5Y53:.;6.O&0Q+_5.[Z8:8=4"PCK`K]FK=[!1=<&LVJ'
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M6&%$G:@!!6)^H832B7A$1A"SG]*WCU7+]+V0H2*IG`SI00V!!10R<U#RO;KO
MW)D&DPR.,4W)>)II%"B^#F<9-"5&3="<P\)Z64W'G'+.3(P'1``@6&E":A>^
M_Q@("DG7PI3DWTPC<`+.BGOH%=HL$VI\`%!\AS3>3.E/Z7$4#PCB3CMNI5"B
M]EKY1>O.U,J+<>&'9#SE8C%W?!1P_<K%B:W5PW'N]6R"C;4S`L#EW$0IYSP2
M1U6XNFI:H^:GCZ=BX*A1>_+'!;T(DF#=51%M+L:N!4Q^@2AC'.@I4&AM)DZB
M,<*.Q'KOH8`V=S!1#J-Q`#B0[G;8S@Z9%#">8T\'#ERSW1TU3ZEQCTH02]7=
M;0&XA+::4(0][M;VV,EIX/=I9!+V,L;VM'#A((_'T=]*F/'=52H?VM&P`$PV
M4X&NP5?.!"#L'G,>\SH2D!T)`C<Z)(R/@MI?N:>]VIZNEC"2-D0C&3"J?9KB
M+=4F(1^_Q\L0,M)7*3IK&:Z5O9<1@].ORVFQMXH6S75&9BE7!.['XLV+$F!V
M6/)*`9^=R=*_"^W.PK,<DE#<5*UZTQ.&]N=RNTTHC^07,J\%<L`5#P\*<7+W
MVBITICXJE\[JQJ':-;,4VHS2_A2`EP4R0Y6+1R$&>H%?2S>/ND-DKKI@$D%1
M*!<9O*Z%G;"3>K*UG\O3@\JD)5S-WGDF>!PJ_LT6TI!UD>GQ>CZKD*O;2-Q<
MX382U[%4B,X".!F&K%@%#A`1<Z$>T-RX:]:9YUTQ!3&$2)P-R<#&<(J00K%G
M3AOD&#('XUJ5Y@P6FUBFQ35W9DN$(&EG^Q6.*]>%[[AHR7(*AA4491Y(N-I&
MH710;+HE.#[T13F[B\FYR_`>^M!;96&J>AN*A,_Z6XV#C5=H$>'2(0R;K^=Y
MI3W%70J453(XIT!-_L^:EW]H]9JZ$S"_"K!J\Y<.6FG^E3+2#>F_3:>T</SP
MS!R8V;OXV8_6JKB/6^`68*#^H[)P5IO]%?,J2W>Q&I)?L3CM=2W[+M11FV)6
MF?'G:)WG5:TCXKNF'_BDI,`PU;JW8C'.HN);^B*=T.L2+<1"N0O<'UZ46Y&Z
M1GJU`M]/20I1WX7;O"Z1'JQ<+BNVU+U$M#PM:##0\0T7?NOZA/"WW==EIA7@
M!&Q(4[(JEO4:,R%E]5R&#_%G8?P9?"6-Y!R^+FI@6*E].S_0:W!3E\.G2@AG
M`=B]XQ0;4V2V$U"EL;1X=E!AU:0*'5$B^:1@(5/]RXA0$QYI-Q_S9OLMF#Z.
M0JG9#)TE#$J)45!&&TUQB$`D!9I\<3-GDM7\MBZ<,+<OO:-=H5]<.XWT.6<T
MA0B0YH0^EW&97Y([YDRI/S:=NS*-IO#0$J$'WU1S2<NYN70;L*V5@[$=789T
M2XVQBO&ZIL^O-S?*?A%9Y&1F1TN8P4X#ZQXC%Q/5B+#2R#JE;XYQ`:[@J<N'
MT84CIFD==Q=&P0K'V^?;S8@@BZMLW$TPX8((=_7+,QM`<L2-!*7(&(##U:&?
M`LXDW)#@@2CAIX>'W'R7O..POZZKS)KU101W^*;D%-9\)\"B/0\35P`5:GO7
MV!2#EBD[EO92Z14/3=6CKJ'V"S)C]2J:=;<B`/VL`:6Q=;A[L/7JY2OA7O`Z
M5%?19TZNNU"^U%;!2QLO=T![;FX_,V_G+A0)N4(?31HGK(2FAIN5;*<IW`)<
M98.<Y<889GNU[5J);<=BF?S>YRK[U%;L,;&D.6"MP`/(#%BII1E,/U;.G4L[
M;/#9D<^9WD@H'M7>O+N*31GA9]N'%[0-`8"/^83+RJ5NR-Q597S336S*;A)M
M[/A,Q?Y^T:]2LL7ZV1[+L-C671=*,='A-:'FMQ$;N^52R]-3."L6H%B@O-Z0
M%B'.$NJ$/AWA2K2`J$$D<S#77Z;':R1P%Y-6;K^O.F-+!ZUTQN;.Z3K`Z5KZ
M8BWLZXSS9K6]8B=#,'3L@!V:T="I"*?)+D+C>;-<]GO#.:;;#TGTI\7?.=%3
MN1$LVC0Y^1:KM+WE6][%8?2^MJTI>C)3`^RJ5LD`4-X"IY?#F]"GH'(F-Y\^
M'KXZW-I[\3)H9_@5VY)U.<(9."XN32%>WGBQW7B9M\&'A(CRKH7^4R02'\N,
M>NB?%Q`>-`2\N$2P`N?]=-C_&]]BF>K&?S7U<Z.&'H9^LG`.S_5_Y(KSE@.U
M.KOF;VN4Q)6TRX8U=6[KFQX]H%"^,!N,R!4@RR^U"?=<.+ZMS+?/^0&8P!W+
MQ8ZIU401JZ07YXG]A1,3C0,G4,Z-S"8-5COH+(\89]BR41:VF9',^B1]TT8]
MIB['W"^=\QNB)C8ILL]#P"?6<%WSKMP5F'.%Y-6O^GU,K@XSN:J_NU:TEG<<
M6_$(V0J]@%"X\6KK@'HP.Z3CS?K4Z-S#=^"C47B+ZA._[%ZEUBA.?,`P:1BC
MD7WS0PZB+T\5&+_`"54>+?,)3UVUJ?6!]FX[X.9J42JNJ=RFM!))DNS@3\LW
M8P9K<=2CC>\:K@"*$3$ZB4#J#UF23K#3&T'FU*+?^7O..2_I*`YMM:^V7KP,
M`FQ]QAF_[#GVRWI9@@@Y3G.)\(*+#&+!`8Z4`>#](>5WQ:BNPBE)WVCLE4Z5
M>,<JR+Q/*YB[5]`<A]NTK_DY5\JZ2%!:T$'J74>@*&D.BU5&EB[2BP9UI2/;
MVJITYE(9$;<_MY.8I/5*;Z7.:6YN&3%/%Y&RX*?49*=H,9[.UAQ->K'K-O*U
M^-8:TN_M/(?Y0V4N=_>9@)ACS[2IPWB1!2%:Z&+P;=G_(/^\^.>Q3]5/&&`'
MJK]!JMQ)=-;=MVEXQ>PYIJR!#EYM83N_+JW*M#EJT?_L_<NG:@S<R&A7^6'B
M^_ST&?W7J>D_"*V&E\)C"07\N;<3-(AD-$>'+\T9'+N[7@V%LQ.%:8RU#K<.
M#[*#==).6R:O_N0;%EU]H%^)A60*\^-:3U-!^]L'A_\OJB!'GB]103DAG\K7
M+U]NO>!0HBWV7Z6"N$>'ZC).J4&![35+%\RJ74/DM;V4L5C^,1.YO[^U!^V=
M'3$;6;6)!\;BU5]]1OJ++>5^^?SEK\JF5;46?RU5MW^X=7"XDQ$#7S)+PGN+
MFO<O5*S'$G4DG?"(/MK;>LFICF#TOU@=-;9>T;_MI_EUU=&NKF3^)ZFC*IUO
MOA:=.:EYB)!D0N>_%I!Y#5^9RHVMO<QM_4>,SJM_ELFAY?F_B,27K5/[,NA%
M\U)?522\XGM<YUU]2V')1U_6CWXL>'O![.MGJ#(@_I,=<3++OH-=EAN3,TOY
MQ*@TM11`N)TB!)_N\M?H#^>7/^?G_/4OE^Q`Z80>2D*`J1JNW)W8_FH!?"4E
M(W#0\Q_*SE-H9]*<)$_\[6[A%)HB0H'M<I19X)8#FJ5P+*IT:NYHV6/+\5ML
MYY)=EFH'*-^!H$"/DM$4+PN=.NP_*'6A*QS?4T&FX*`&,WI"UBT08+<>"$/8
M9D*&S1]%M:X?>L@M*Y)7T75*FX,!^QP^T2T&+EVH9'*((LWW]!XGWF:TN='@
MMCCYGYM)87HN#KN_YBH>0E.]3:4KY8N-NJ0]RVI0GE`%UF)72%VZ*I:U>8UN
M9NH_WG@LQ>*R>,HQ&:<\R&#BSJSCLL)=?IZP2U=Q>1+'$6H04*G"KD*QZI%;
M`LXBWA<>P(K]Y6Y?\P?@%1"KWXKTRL:N3_?H"I1R*QE&KS\:Z!9ET**4FNZ8
M&!3.E(,+46AO^S#Z]%$$LKN!7`>F2\^J6.#/1EE14`=;PRE\4/'@4E4A5R+D
MT),B'.N.%B<QM`[81L+A(JN6E\\IT2EC-PCJ+I)<J+D"8(G09VF&<GR[2O+9
M<T:6(&[+J1+$KTE5<VB5S4SZO#9832O;H/$R/'RO'MY4M;+,E;4<LU<V.OJK
MJ^,=B]C%PU!()\GODFG.&S9E7XK*RK%*\MV/DQO7/5S8+13*,)O,2/H3@\'G
M,(_:=4D..I$0<!DBH"VB2$<_OTJ:."2O]6OH+GS8D*\XUC\'7'W^F)9_23[Y
M?T75MY80V5]P43R\$*+B<L[[*1G&+"/6M<QCB:H.WV>G/T7_G5,OOU/Z.SH]
M/;)D'K]:+F_5M3B.O77WK*6]C6!6P`H^I#O^AQQDF6U5%BTC"-Q9#2[+O5J_
MFH3'G]G;/8@X'CQ2>Z1KWK:V94P&_V\Y<CM=:/>I2&NXJXBT%TBO1VI<@`]T
M3;R:FJ^M4QNV"_PB4^&4#`K3W?";DI]26[%]GM?=AA-4O%6>BK@P?G="CH;*
M)9B6R9$N"7=??+?NSD+='\=:U^!UG^]%FY?%,>>@?F]O[SG?`CXX>$&I(:^X
M6Y^YM<@N8&I39XY#])D%5UF20M2I+SM@#<MC^TIOY0]+$[AC=@<XL]:E')C,
M]JQS'89-RR=`8Q$"ZNQM[WP3S$B]#""L6,>(E&`%E04:86K=1QVVU+'G\9W?
M3F?(=ET1FK#"N75!7?^]FVCS@A:,0?WCQV_<-V>J$EBXOHR;?]V]75$F-RF?
M!C[6C5^CM/9IF@9?;C[3Q=PI5_]2I:C.3)"_[O'.VJ>-M4]?K'WZ:NW3]5!=
M=8]Q3&I[#;>6K?K2I3<SNK1AU1`*PC"]2TXUJKAJ^LM+5KW<I95(#D*XE^&2
M)+IENSK%>QEJY%L)3,\N`?AJTWGPSKC*'"/SN6!\]FLG7(%":>/SWTMNON2U
MKX>FY,,7K?_VI,HOIUD[9U8"1I]Q3LV<F;^<ZDZI-OU>:>TKH/DPJHCXU_!5
M")52?VM?=;'J*V6'SH4:ZPZ6U^=[=,E,`=E]&]4)#MPM=M6?JW#6M[:5W<KC
M+J"CC%J=Y-(?7,-%'F!,L:C5$1UWJUG(V3_R&'_W0_&NM^IP7XZV<W5J,ZD^
M/RY=G59]VLINT<"^5Q]Z-/'E*;?ME*JF!835@=DL^35KU2&7RZ]9JP[K.F>B
MOZ!?:F9[$H]E]6#]8Q67^5?-OW*AW^>/Q!-1@;QNBTI6[M0^45"P;-&FJZY&
MKQ?)R"*TH(=KAJ!]6ONB7`=6P:G'Q[:)^3R`^Y3G.BG,WW'79\D]J^(RNSFM
M^J#IFJ3+%V_5RMZE+6?VPAUQ+.U=)J]N\;(W%)@6OQ[5U"<2W3W\6_C0?&"$
MPR2*<"Y<Y&U:I:-H@Z\OKU%$#A(HY@X853=)!V!^2G>E':M+*R+>IPE[81?=
M>PF6!V=QJ_7DVLF_ZG)AHNQ$1W5`"5RE(ZH#JL=#/4L%3OK,X='_M&.CVL<_
M,(/'Q*H93K+C9JN]O-S2%#OV<=AA6=5&U*$/SCD$"ZS533[Q90=F]>6EC>,Y
MH*L^97Z^L)L%(7DALJG.?1&:>?Q91YVGX87L4N?J^`Z?QYM9T+[:+ASY)L'5
MLS3=-Z!+/7P(#IZ<ON=5^PA;MZ?OQU?ZTIZ`@,F[[6C'E>/VJQNY].T@%Y8E
M[!5.Y:V357VI-&MI<O$ID4H(9A_K5*K"\'5[UU8Q=XT/P/2UDC6C6J2"YG+,
MDG>3>-Y9_4XSB^DK<6$-/=7MGU@3E_5P51\YBM=[FHI$1S$O:TD*:-B*ENMS
M"K7;%.Y=FJ6Z+E]"J\DNR;?M[(;&Z@OKNI,L5T!N+$!4?=<,_7-W0`^73?WE
MEA.+"I9%,7UQW(5/AC;?Z^LXZUC51J2KG+.<*>K]3BHE^I,\6D4I/,Z[J@"\
M=`>DU6&;0H="=53/FJC+W4_Z7B<SDUP0EDJ-2-77_^B.*:YN>JJ^\#DTP;RT
MW0>.`*669EU)NI]`AO++N`2%UJ2O!DBMF6`E()^YUQ/[K$F!5E]KXA9QC])M
MJ1K`"/Z?LD36"+42B#""S^K&CP_J4?!:)6O93#UKL7YTF"+KE9,5,M&A/H^+
M=V:=7_]698*U@V&_IY/DL9F^A`:%.5N^"KT6V8^-_](-+5V<R;YD3^MKJKD)
MJ5***@S^@J^M5A]:]6\5C>U-W8JF>EGU3367K7I1Y;]5SW(578C?K3BBW(9=
M)+\LPK-4(T<]0L7*)52)3T)V(TLIU/PL'T]]P9O922)YP90QT:74V&07"M6U
M6@Q9+8KDI"$#F^L23L47THFK['J;JY1=X2"E>\!]5]EJ/5S(A+?CCD#4`V)R
MZA#=I\2KI%L)Q)J!+0?MFH#/-]QGR8!0LJ#L)<K2-.6__>A.U5;7>O3U@1)@
MEKFG^KXD>_-=FLY__$\!````__\#`%!+`P04``8`"````"$`/P-E6E,*``!%
M5```#0```'AL+W-T>6QE<RYX;6SL7&UOX[@1_EZ@_T'0MD4/:-:V+,=V+LYA
M[43M`MOT<)NB!7I%(=MRHHM>7$G>3:[H?^\SE"P-XS>JEDV@Z`6WMB1SYIEY
MAD-R*.GZNY<P,+YX2>K'T<CLO&^;AA?-XKD?/8[,/S\X%P/32#,WFKM!''DC
M\]5+S>]N?OF+ZS1[#;S/3YZ7&1`1I2/S*<N65ZU6.GOR0C=]'R^]"%<6<1*Z
M&0Z3QU:Z3#QWGE*C,&A9[?9E*W3]R,PE7(4S%2&AFSROEA>S.%RZF3_U`S][
M%;),(YQ=?7R,XL2=!H#ZTK'=V5JV.-@0'_JS)$[C1?8>XEKQ8N'/O$V4P]:P
M!4DWU]$J=,(L-6;Q*LI&IE6>,O(K'^<C\](T<I,G\1P@?O//59Q]^ZO\X]WO
MWKUK_^.;;__V@S?_^X^_W;SVXS=F:ZV&R00'^V6^;^\5B\NYY%9AP<WU(HZ8
M(1;<1-ZZ>H[BKY%#UQ`,,(]^=G.=_FQ\<0.<Z1"\61S$B9&!9=@GSD1NZ.6_
MF+B!/TU\^MG"#?W@-3]MT0D1&,7O0A\TT<E6KN&\>J:$9FW3@&!(-G7I#+<I
MA$DNG=QOD_O3%ILD7;W#NH[QGZ1+6+'?KL9T;<;%A@^/T55RQ?0DC].1Z3C(
M(9UVF]S*"3N1LN&D#7UG4W;9.YME7:?K]!NU3(K%3=Y(8==ITI4'%#H?^K=G
M<V?SRG995Z3A<_4`ZG#->M%'U]W3O_L._9TC3LX\H#7*&"9PV8?`?XSRX39=
M+3&CFR7^,B//;7/O2:T5MDE#CT@`365HJ2^<6%?INX-Z'OS02XU[[ZOQ0QRZ
M$3F>3Q>$!XK9COA(<=T/@G(VV>W2?`MG;JXQL<V\)')P8!3?'UZ7F&U%F(.3
MX%;^NP._?DS<UXXEYAQJ#=(X\.>$XG$BYGC%&#NYO',F=T(O0Z:*8H=0QYGT
M3R#T;CR<-(]T,APV+=1R\->PT`\]^FM8J(/_)HWYM,@[=E,@2WE&YM.:K/V^
M/QP.!YW+P6`PM+L=VQ9.GA81[4=S[\6C95IC;MI$T`."87<PO+0`I&T/A*JS
M(N@"0+_7&_0Z0\O&_R+YG!Y!TS[MF;I990@TL<H0:&)5+`M:#63^HJ>@0J*Y
MKS($FEAE"#2QVF\X`_>UL\H0:&*5(=#$JBAF-=A747G4W%<9`DVL,@2:6&UL
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M7S;ZQMBB/S&+W&+I@1:;=AYHL,7*`RU4;93C9LVN)+Q<XE-ZWH+DC;^EG^^#
M4:1ZC!PS+P@^4R[_ZZ(</E"YN+E^6;!]8&S.TT8I;3/35Y0'BZ_Y4)$?`..N
M1MCFW='(<)?+X/5^%4Z]Q!$[]D*%..M`3W4T%F-<=2S*SJ$G:B]F+N;[),Z\
M62;N*!!ETUUXNCOP=`I!*GB.T6_OT`\_*?OC&/U8VV_E`W[1JA_!I:R_R7B@
M>R>*H`8%/*CWX6D2`59P:P0@00<"NM>C\`'"4P<"S(S7"!"@%0+`V1,5Q_0#
M3)1+E8B!2B7TGTHE<LS:2DGE":W<E7ZA?X^5CI1^CW(SR[<(],K-.-@#X"B5
MNU*LKA3#:$=/JUR`@STN<##J-C/D=7;E?&T.84D7&"J/(`WL\TAS4<ER+G16
M`/9[9-S@/(0%!:4BW1``1PL$1D1'T_C;X1@TC<`\&C0-P1R"-`:?L4]P)J01
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M.8CLUU]VG_Q>^'VT_,]"^6F59O[BE:]+:J\++$P=&NTPG+8F`)YTUKHY1!SJ
MX\T&4^F@.EVK\1S'*:OOD<8)JN6+4X;OIB_*K)/?U;^1=?BR4]TOV]>=BD,Y
M)^^(.H6XX4/#*DP4C%`B8C?<R;?;E04E@QY6QBM>VK\V+HP/,[(5Y.>K(9J4
M3%=^@"<CJ%)$Q;X9DF,<CO.317EFGRP4QG)9%I7PF2Q4T^O*@H1"%A6`F2PL
MZ^K*@OI<5A?6,EFX%[&V+!3E"UE4GJ]PV5B"U\6%)H4LV?<]1=_;VW@4&UD5
M+C)9!1>75?%(VR!,%DRN*ZOBD8KH3!9,KBNKXA$(F2P;2NK*JG@$"UP6PJVN
MK))'&\0Q63U%WU]NY5&.5:HZJ^#BLBH>Y5CM*L8JEU7Q*,<JF5P75\4CI#)_
MV;A05U;%HYPG;,4\P6VL>)1]WU/T_=N,*D>\I1CQN92*.WQC/L(+%91\E$NI
M6).CO*L8Y;F4BB\YOFW%^,ZE5$Q!'K/(Q@45UG,I)4==V;NVHG?'[GR==>6`
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MM!3Q)J,HROB+FT346Z2N^R9&=UA4[15C]C]_J1ZS$7[/Z)61X@&<<CT`]\Z]
MA;L*LH?RXLBLOO]1/):(8"I^];W_)<Z$B)%9??]$SWNB%V.ECW3S*<4SA/@T
M5HD_,O]U-^X/;^\<ZV+0'@\N[*[7NQCVQK<7/7LROKUUAFVK/?DW7$;OU[S"
M"QJ/>'^E>,\F=HL[]E4:X"V726%L`?YS=6YDLH,<OGC("[!1D5P;T4K+]W_>
M_`<``/__`P!02P,$%``&``@````A`+\!N(]^`P``\`H``!@```!X;"]W;W)K
M<VAE971S+W-H965T,2YX;6R45MN.HS@0?1]I_P'Y/0%#[@H9=6CU[D@STFBO
MSPZ8Q&K`K.UTNO]^JC`PX(Q:]`L7<WSJ^%25\?[S:UEX+UQI(:N8T'E`/%ZE
M,A/5.2;__/TTVQ!/&U9EK)`5C\D;U^3SX;=/^YM4S_K"N?&`H=(QN1A3[WQ?
MIQ=>,CV7-:_@2RY5R0R\JK.O:\59UDPJ"S\,@I5?,E$1R[!34SADGHN4/\KT
M6O+*6!+%"V9`O[Z(6G=L93J%KF3J^5K/4EG60'$2A3!O#2GQRG3WY5Q)Q4X%
MK/N5+EC:<3<O=_2E2)74,C=SH/.MT/LU;_VM#TR'?29@!6B[IW@>DP>Z2VA$
M_,.^,>A?P6]Z\.SIB[S]KD3V550<W(8\&7;ZBQ<\-3R#S!$/,W*2\AFG?H&A
M`(+H!H!!]/]=F(<0H_A]F.%S%_*I2=MWY64\9]?"_"EO?W!QOAB(M`0;T(U=
M]O;(=0II@%CS<(FLJ2R``JY>*;">P$;V:M6)S%QB$JWFRW4048![)Z[-DT!*
MXJ57;63YGP71ELJ2A"T)W&\M"9V'FR5=KC[`$K4L<&]9:#A5BF^7U3CVR`P[
M[)6\>5"O(%S7#*N?[H#XU[:`'XA]0'!,UI"XF&C(S<LAV/LOX'[:(HX6`=<>
M0<>(I$-@`D%#+P2\F2X$P2@$\X7*CG9@&#=TXMXCHAXQ$@(N#(5@P410J^\[
M@Y,`-UCWHF>W"BUBT4M.!@.C^(MQ_/?C(C@FL+;>[Z43UR+@VB-68T32(=R,
M0'T/C7A?"(+'0M;C,$>+L$).ORJ>I$.X0E8?$8+@L9"-(\0BEHV$11BL?M9!
MDZG$?F\R-4H,U/UT/Q`\EK%U9%C$,#'4Z::D@[B&X!]M<M,B>*R$.CUYM)!%
MXPBEZU44.&*3#N$JV7Y$"8(=)4Z7'BT$E>2'V6PSBT!JCAO-+'33U$%=212:
M=;H[#=H1Y40ZMIA1JISV3GK,G1S<\"8GB]KM<=C0U.WH%F/3%0;N]Z3_?B<%
M]\#I4NR..9+B;!U':C$C9YR^3WK,G1S<`0=RINVT<,*XJR*WPUO,8+-M1U:V
MQ(--&&T7/]-LV]R>)^S?L>3JS!->%-I+Y17/!Q2F]J/]@:<]B?0?X.A0LS/_
MQM195-HK>`Y3@_D:MC9E#Q_VQ<BZ^?>>I(%#0_-X@9,EAW]9,`=P+J7I7M"W
M_JQZ^`$``/__`P!02P,$%``&``@````A`$0+2GTJ!```K1```!D```!X;"]W
M;W)K<VAE971S+W-H965T,3@N>&ULE%A;;^LV#'X?L/]@^+V^YHXD!R?6NAU@
M`X9AEV?'5A*CMF58:M/^^Y&2TTIR8[M]:&/R(_OQ(M+*]MMK53HOM.4%JW=N
MZ`6N0^N,Y45]WKG__/WXL'(=+M(Z3TM6TYW[1KG[;?_S3]LK:Y_XA5+A@(>:
M[]R+$,W&]WEVH57*/=;0&C0GUE:I@,?V[/.FI6DNC:K2CX)@X5=I4;O*PZ:=
MXH.=3D5&"<N>*UH+Y:2E92J`/[\4#;]YJ[(I[JJT?7IN'C)6->#B6)2%>)-.
M7:?*-C_.-6O38PEQOX:S-+OYE@\]]U61M8RSD_#`G:^(]F->^VL?/.VW>0$1
M8-J=EIYV[O=P0Z+`]?=;F:!_"WKEVF>'7]CUU[;(?R]J"MF&.F$%CHP](?1'
MCB(P]GO6C[("?[9.3D_I<RG^8M??:'&^""CW'"+"P#;Y&Z$\@XR"&R^:HZ>,
ME4``?CM5@:T!&4E?Y=]KD8O+SHT7WGP9Q"'`G2/EXK%`EZZ3/7/!JO\4*.Q<
M*2=1YR0&]IU^[LVB^7+U%2^SS@O\O7E93J7BJ[!DED@JTOVV95<'6@^(\R;%
M1@XWX!C3$T.2/T\/Y`5MOJ.1-`4TAYJ^[*-5O/5?H`Y9ASGT,?.U"4GZD-!$
MD#XBBI?O&!]B>`\$<OSU0-#("B1X=R]C/7P",1')*((,(8P@H$'L(&9WF_56
M#32"JKF.5HV9R?&@,#/9E5C"Q!8036!0@J;0*0TW!H)W+H2K49E;5!1F)=O&
MJG=BZ#X*+2M!E%+&8#"$!$UGB&";X<)BJ#!:LFP!T00&E85)!4_3>/W0:*Q^
M"J-1L@5$$QB4EB:EX?HAV,K.PJZ?PL2Q+&#@!5:K)2-Z<E]O\,8%_.7!A$86
M_Y751@>%Z?C;#3BD)'>4!NVU27LXW0BVZ:ZL9E28F<JVJ4L&=.1SG<$UA$&O
MYWB8K$3;;*V1?NA`BJ[=.LF@EMS3FIQQ)6A],<)9+1!C(*WM"1\JD':X>A*B
M2TP^.-LU/M..?*@VPO#,[D`Z+V7V(2$ZQN2%\]SB-6&QJRU@Y*MW@$(%NG."
M!K7DGM;DCI->XSY28[473,[VT`JUY2&W2=*3D$ZB-E,4+C[ZQ&2'PU]C-_&5
M2:T,@^7:FCX'?#&%@?!1WZ0G(;K$Y(4;P.(UOGQ"M3=&.E%;+EWV;`GI'$GN
M)B\<^!JOD6JJ]6#DR9XCA]#>(=;+9S(&(`,`DSS.?(W\Q&*K36$$L8[,X7T(
M%4@OMBTA.L;DA>/=XC6AV&HIC!3[MCGP,B3?%4-;0G2)P0NN<@:OX6)+M+52
M>L7N0-VXB;UY8/S$OSQ8F4V^;($W4#QXD_Z'BE==.-55JDG/](^T/1<U=TIZ
M@I>^P%O"46[5=5,]"-;(F\:1";@FRH\7^%J`PLMXX`'XQ)BX/>"%]OV+AOW_
M````__\#`%!+`P04``8`"````"$`B=+)<R`(``"4*0``&0```'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6R<FDESVSH6A?==U?]!I7TDD9ILE^U7C^(\LZN'
MM2S3MBJ2Z!*5./GW#R`(&;B';5$OBSC^<'!)XER`N`SN__BUWPU^EL=Z6QT>
MAL9H,AR4ATWUO#V\/@S_\V_WV\UP4)_6A^?UKCJ4#\/?93W\X_&?_[C_J([?
MZ[>R/`U8A$/],'P[G=[OQN-Z\U;NU_6H>B\/K.6E.N[7)_;K\75<OQ_+]7/3
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MW]=\6AMW/++,%N'M.7_^7_JPO.%1_N1AFF`L,VJ6\S\?S>GB?OR3Y>FFU5A"
MPZYQUABZ8B45/"EY6+LK[%+OY*"&A'5184YO]"A>E^96U_BH(5<*4&'.)GJ4
ML$M#XD0=&GK'L="HPVG.3/U:B=3(`4TQ\)P\9882>(9<QOVTTIQ-]6L74L/7
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M'`I<"CP*?`H""D(*(@IB"A(*4@HR"G(*"@5H`\[J`6W`OYZ]7/TP9"^J\Q;8
MI/LO2VB4@:;`%N!&;+,G9$EUJ-REP*/`IR"@(!1`7')JWI)K1EJS01=PM=4T
M/C.WV>,G>BM9D%.U=4Y?'YG::B[)(IQKK3-R5X5HG8E15.Y9LY=MKS5[^\TG
MWHO83#>:EM`H-E-@4^!0X%+@4>!3$%`04A!)P(NX!<VN6+;*!3ZA(*4@HR"G
MH%"`-OK\DY1:G'X]N;B:CCHQW1(:9=0IL"7@CW]+7OV.;)1/[U+@4>!3$$C0
M%,DW9":%:NMR06X_4EMI81FKC3C-U%9C2:>9VFI.R.XJDZW*LD4V>[F4\*<R
M#+*E++36R>?%-;?9!XXKW.9JZC:Y;TMH%+<IL"EP*'`E4)Y]07:6GM3(M/`I
M""@(*8@HB"E(*$@IR"C(*2@4H(V]P0IP;?#[+71--^K"I[W-`F^U(L4&(#80
MYTQX1I%\<L^-<L0](#Z0`$@()`(2`TF`I$`R(#F00B6Z&_S;2?^%SQ"?6K1M
MQ8(L758K4ET0W3Z)#1JG)=-I\YJ<C";@!`WB01`?2``D!!(!B8$D0%(@&9`<
M2*$2W0G^4>$*)\0W"-T)LBVQ#"'Z'/<5$!N(`\1MR:+=!]Y,R<3SH(L/)``2
M`HF`Q$`2("F0#$@.I%")[@0OJ:]P0E3@NA-DZVD90J0Z08D-&@>(VQ*Q/29V
M>R#W@01`0B`1D!A(`B0%D@')@10JT5W@M>@5+HC257>!+"&6(42J"Y38H''.
MI-EQ3,ARYYZ;/]\0-*@/F@!(""0"$@-)@*1`,B`YD$(EN@^\'KW"!U&^ZCZ0
M+9S%_Y.0;:E4'RBQ0>,`<5LBWQGZETP/]#Z0`$@()`(2`TF`I$`R(#F00B6Z
M#;R(O,(&47-J-BQ)!6`9LC"5F;L"8@-Q@+AGHNQ<EZ2@\,XB>3$?2``D!!(!
MB8$D0%(@&9`<2*$2W0U>1U[AAB@[=3=H"<'_3Y1,"DILT#A`W);(23%:WM(:
MS(-./I``2`@D`A(#28"D0#(@.9!");H7O.2[P@M1(>I>D#++,F09*9-U!<0&
MX@!Q6])Z88QNYK?JGQOG&\D"#V+X0`(@(9`(2`PD`9("R8#D0`J5Z-;P(E"U
MIF>M)VI'W2*RY;0,I<!LJK\5$!N(`\0%XK5$[':-^81^F?*A2P`D!!(!B8$D
M0%(@&9`<2*$2S1&35M]??^AJY*3J7I(-D-6*E+<Y$!N(`\0%X@'Q6R*\63)O
M]'=^`#U"(!&0&$@")`62`<F!%"K1C;BN\#8["F_Z%=IJ1>WG>E(=K+36!9E.
M=MOZ::(#Q`7B`?%;TA8HY"H!Z$,@$9`82`(D!9(!R8'PTW'G=ZZP1QQV$P>7
M]N7QM5R5NUT]V%0_^$$V_G'B3,4A.\NX8Z>)V'N"\-BX8X=BD.?L4%[#Q^<.
M[$S<^_JU3-;'U^VA'NS*%W:IR6C)]L1'<:I._'*JWIN#*4_5B9V&:_[YQDX_
MENS\TF3$Q"]5=9*_L`N/S^<I'_\"``#__P,`4$L#!!0`!@`(````(0#NJ];(
MY@<``*(B```8````>&PO=V]R:W-H965T<R]S:&5E=#@N>&ULK%K;CN(X$'U?
M:?\!Y7V`7(`&-3UJ8LWN2+O2:K67YS2$)AH@*$E/S_S]5OD25]ENTHSVI6F.
MRY7CX_*QP=Q__'8ZCKZ635O5YW44CZ?1J#QOZUUU?EY'?__UZ<-=-&J[XKPK
MCO6Y7$??RS;Z^/#S3_>O=?.E/91E-X(,YW8=';KNLII,VNVA/!7MN+Z49VC9
MU\VIZ.!M\SQI+TU9[&2GTW&23*?SR:FHSI'*L&K>DZ/>[ZMM*>KMRZD\=RI)
M4QZ+#OBWA^K2FFRG[7O2G8KFR\OEP[8^72#%4W6LNN\R:30Z;5>?G\]U4SP=
M8=S?XJS8FMSRC9?^5&V;NJWWW1C23111?\S+R7("F1[N=Q6,`&4?->5^'3W&
M*Y'-H\G#O13HGZI\;<G_H_90O_[25+O?JG,):L,\X0P\U?47#/V\0P@Z3[S>
MG^0,_-&,=N6^>#EV?]:OOY;5\Z&#Z9[!B'!@J]UW4;9;4!32C),99MK61R``
M?T>G"DL#%"F^R=?7:M<=UE&2C1?Q=)DN(,M3V7:?*DP9C;8O;5>?_E5!L4ZE
MDB0Z";SJ)'$VCK/I'!YYK5^J^\&K[I==C8=6219>=7PZ'\\6TS3&!UTG.U$#
MESJ*HBL>[IOZ=03%"4-K+P66>KR"Q$9`-=Q>TK<4!2DQR2-F64>+:`1BM5`&
M7Q_B67H_^0I3M]4QFT`,C\A-!,X3IA4$F`#?GC0H_3^0QBQ(VCQN8P`[BL1A
M:"),%T$`QA#FE#(,UZ-1#X/7$?PEZF7\R1L5$ZO*0W%R#Q$486Q@8BF;'YQD
MS`)E`D,F/-U9UD%0D"1HQ@>3]T&]CA1AU"$1I7Y=2`R6#$W>C4:(;!XB*,*>
M/>?/1MF2&#SJ.@GLQ4DH).D++3<`T2AU)EP$8F;S7D?&$];=^S7"8$Y/(T0C
M#Q$48<_&G=3QCVRZ'(.FUU7"?IR&0HA*!B`J98M>`>40.@V4#RDW&\2H+CG5
MZ_PPF//3")')0P1%V+.Q;%R=XOELC-O,=2*R)V>B(2)5CU`9IHY6)A-H1L2Z
MZZ,X8?1>,K$#))53@S?T*P^L2BIH_37W(<$@3@"ME1#`U9>!6K?N3,JA&3,-
M04T3'9:]#K*R<O0YK`#+7S"(DT7K)60'U-)&3=6BWJT)>)"(*<0)H($2`M*K
MLD&OBK7O4B8*LDBN@T`/*]?<*RZ="5Y(5-R+RMFBY1*V`W)AM+,"-$06(Q[[
M,,I"@D&<`+HK(:!V1%!W@(DR959,QJ=-X>>Q0:@0SD%"Z*`8#(/(93=3SA;=
ME[`=(*F]VL[@!HK8T2;W(<$@3@!MEA"0<J4@^*V+4=LUI:8A2$:$<#;#/.ZC
MC,R"09PMNC!A.R"7]FS*B=JX7HP>)'#N^H)C!)*0V=\-+D;9C=>YABRWO$>H
M7,[Y2IA,?#&^<7I(;G)Z&>V0U$YO5UYNHBPD&,3E0J<E\X75A?OBC<65:,.V
M8FT,Q)Q^;H\':FYM5%]<#.)DT8()V>O%E6C#IIPT9/>5W$192#"($T"C)010
MK1G,P*UJ:;^FS!2$8R=+T9X/M%I]E%6+0IPLFC(A.Z`61CNUI2%;2#E^V.W7
MG>0D&,0).$8_0,#W]T1#E(`'"1;%"3C>+:US"D,88.*;>*(@.V%YC]#Y<LXQ
M0@?A)FYG=6&W;\[6,?H!DKZ=)QJB<GF08%&<`)HJ*1@I5W*'W]X,*:;MV.JS
M2124]8?27".X=Q`Q["E%EY/JARY*HNP6SABG`;-?#GJ][,5+74.$K0GB;.TA
M0;'54>BOA*W=03G;F\P^U<Y.--601?(>H8]W=R23B5?A&SM2ZFP(UZM01CM2
MZJV`5*&)LI!@$%?),7FL0IS3&STV]=W?0&Q'6K@[DHWJ/99!G"RZ+UDR`VHI
MKZ9'V%1#5IK<AP2#.`$T9$(`U<*BO%4M[>NVM#9XQ$2KYVJY.Y*-LFKU'0'B
M9&_:$%)_0S`05<O?$%@4)X`V3M0:F"YE^FRZ-$0)>)!(*<0)H!\3`CA=\V'#
MTBY.9T=!%LE3@U`K<#<D'<0WI+LW-J34V0\&U/+W`)D`2HBJI:,L)%@44PL_
M0[MJ_<#A5*;A)F4@F"CKVW?.7I3;J+ZX&<3)WN3NF>_N!K+2Y#XD&,0).,YM
M:NM&*\BT?]O2VAB(JV7W9'4XM5%6+9U+'JXY6<?EK]=6YINY@:A:.LI"@D5Q
M`HYS_ZA:OJ5G&N)J.2>'W$99M?J.KG'B=V]T(0RHY9NY3,!7H@\)!G&U'.=&
MM88/6G#[Z'ZFT)`MKKQ'R$I<N$<8DPD4(NO5/6>IJTIUQ78JF^<R+X_'=K2M
M7_`:$K:%A_L>5G>DFRR#2U)Y[/-:9M`B[RW=EG2Q0HN'2?):EM"R#+5D4\@F
M[U/=/AE>T\J2]5H2:)%*>2TIM*2AYR1W*SSAA[A!-CAUA5H@&QQQ0BV@#IP]
M0BV@#NS]H98YM,AK9Y=U`B.%DW*@3P+<X*-OJ`6XP>?Q4`MP2X+<$N`&GUE"
M?8`;?%P,M,3`0&WT+NL8&,!WOZ$^\!SXFC/4`A4"!Z=0"\P/?`(*M4#MP-=:
M?@O<XS\&M0$YPVK"(`-Y-CC-`?PQ6SW"^O(?O,&U$<)AW,%APZB#@X:1A0:V
MB7$$<@B37G7XA<"E>"Y_+YKGZMR.CN4>ENY4WM4TZC<&ZDU77\#/X.J][N"W
M`?+?`_P6I(3;V2G>@.WKNC-O8&B3_M<E#_\!``#__P,`4$L#!!0`!@`(````
M(0`!(`:^4`8``&@;```8````>&PO=V]R:W-H965T<R]S:&5E=#<N>&ULK%E-
MCZ,X$+VOM/\!<9\0($EWHB2C#FAV1]J15JO].-.$)&A"B(">GOGW6X5M7&5[
MTZ&UET[GN5Q^?E6\&%A__%Z=O6]%TY;U9>.'DZGO%9>\WI>7X\;_Z\]/'QY]
MK^VRRSX[UY=BX_\H6O_C]N>?UJ]U\[4]%47G089+N_%/77==!4&;GXHJ:R?U
MM;C`R*%NJJR#K\TQ:*]-D>W[2=4YB*;315!EY<47&5;-/3GJPZ',B[3.7ZKB
MTHDD37'..N#?GLIKJ[)5^3WIJJSY^G+]D-?5%5(\E^>R^]$G];TJ7WT^7NHF
M>S[#OK^'LRQ7N?LO5OJJS)NZK0_=!-(%@JB]YV6P#"#3=KTO80<HN]<4AXW_
M%*[2>.X'VW4OT-]E\=J2_[WV5+_^TI3[W\I+`6I#G;`"SW7]%4,_[Q&"R8$U
M^U-?@=\;;U\<LI=S]T?]^FM1'D\=E'L..\*-K?8_TJ+-05%(,XEZ&GE]!@+P
MUZM*;`U0)/O>?[Z6^^ZT\>/%9/XPC4,(]YZ+MOM48DK?RU_:KJ[^$4$ADAJ2
M1#()?,HDX6P2SJ8+S'%C7BSGP:><-[L9#Z,]6?@<3380&^]U3+,NVZZ;^M6#
MYH2MM=<,6SU<06(EH*`]2/I?BH(*F.0)LVS\!]\#L5IH@V_;,`[7P3<H72YC
M=HX8'I&H"!07TZ8$"(#O0!J4_A](8Q8DK9;;*4#O(C(8J@@U)24`8P@U-1G&
MT-WNOE0JXB3H0*:BP6`G8D+1@2A28B$I11@K*+#)"J^6D<7&+-`NL/4;U99!
MD)T$Q8:<0]"@)T48=4A$J=\6$H-[ABKO3B)$-@M)*<+67HQ9&X/YVA(A:UM(
M2A&V-EQ3]^\;@_G:`HF&'D\40,LRXV5)73'S(8;1PQ]28A^WRX+!G)Y$B#06
MDE*$K;T<LS8&\[4%0J21(=""I&47P[Z%)3F#'H8@1C"$*_Y^=?IH3E%!1!\;
M2AG$":"!DO+T[CZ%/A]YQ8/=F.HI"!J7J/4X"-&KE>@H=26F#.)LT4P)V]O-
MA/YC5%1!5"X9I:&417$":)R$`,J%KCU6+>F_NK5VH82X6DM3K2%*JT4A3A:M
MDI!]0RUIK)23A+0T26A!*8,X`?1+0@#5>GA';TG;I<PDQ-2:34VUABBM%H4X
M63180O8-M3#:N!0E1-6RH#2D$">`IDH(H%J+=_26\&;H8;7I72@A6%I?B3/C
M])7H*#4Q91`GBYY+R+ZAEG1HRHF:MK0""TI#"G$":+/W$Y"F3`D(2"-)Z'+N
MF7&\2MU1^MS"6$:C_+V/YDVE(-)4-I0RB!-P^3N&CW2LR/9W!?&N,DX*B8X:
MNHI!G.TH?X]L?U<0E<OV=Q;%":"9WMU5D;1>W4,[!5$",DI#*8OB!`S/1A.(
M'L&TQM;+=O-(0KQ>^M0F+D(=I>LU3`2(LT4WO5\NZ;U4+@EI;1*\)49GU5#*
M($X`W9000+G")608*Q?F,:X\"7&YC,->$@U16BX*<;:&P]\VS<@V<@5I;1(;
M2AG$":"=&G*]?=,921.F=1.01A(9!!<;^8G1IUYQ-'8&Z1,AYSK*X"/;X!5$
MQ9)1&DI9%".`PIABS:;+"91W9'?UF7AW*0AJ3/0RCWLZ:N@N!G&^AM7?[J[8
M-G0%:742&TH9Q`D8[HT7(])]@XCMXK&`2'<-"%%K;ASW4F>0/N5PKJ.,/K:-
M7D%4+-OH610GX##Z^!V/6F+;Z!7$>FMNG&,2':5[2^;J'WAQMFC*Q#C>**FT
M<%W`'3SB-5P]L2%\$*RC!`'Q8%<\D*R*YE@DQ?G<>GG]@@]MH>3;]0"+)\J[
M&!\I]W6Q1F(8B?%@;(W,8&3F')FK!]3FG`CFP,^E(UL$<^!'RS6R@)&%<^0!
M1GKEK766,+)TS8FGP*U__FW."2$;G-X=#,)'&'ETC420#8Z&CCD1*`JG-M=(
M!"-]G4T&$6@-YQS'G!"RB9]W<TX(V<2-BS4"V>`6V94-J@"WH*X1J`)<4:X1
MJ`+<B-DC\#;BR;D;I.R(W^'V73@VF@-_FJV>Q-L.<X.P"^<F8`_.+<`.7!O8
M076=Q0VAN/`8"+8<#$O#>XYK=BR^9,VQO+3>N3C`)36=X"UZ(]Z4B"]=?85?
M+WC;47?PAJ/_]P1OM`IXMCR=0/"AKCOU!1<8WI%M_P4``/__`P!02P,$%``&
M``@````A`#8:@&+]!@``N!T``!@```!X;"]W;W)K<VAE971S+W-H965T-BYX
M;6R<6=MNVT80?2_0?R#X;DF[I*@+;`<AN6D#M$!1]/),2Y1%1!(%DHZ3O^\,
M9W>Y.W05R2]1/#?-F<L>4GO_X=OQ$'PMF[:J3P^AF,S"H#QMZFUU>GX(__[K
MT]TR#-JN.&V+0WTJ'\+O91M^>/SYI_O7NOG2[LNR"R#"J7T(]UUW7D^G[69?
M'HMV4I_+$VAV=7,L.OBS>9ZVYZ8LMKW3\3"5LUDR/1;5*:0(Z^::&/5N5VW*
MO-Z\',M31T&:\E!TD'^[K\ZMB7;<7!/N6#1?7LYWF_IXAA!/U:'JOO=!P^"X
M67]^/M5-\70`W-]$7&Q,[/Z/4?ACM6GJMMYU$P@WI43'F%?3U10B/=YO*T"`
M90^:<O<0?A1K%<7A]/&^+]`_5?G:.O\/VGW]^DM3;7^K3B54&_J$'7BJZR]H
M^GF+(G">CKP_]1WXHPFVY:YX.71_UJ^_EM7SOH-VSP$1`EMOO^=ENX&*0IB)
MG&.D37V`!.#?X%CA:$!%BF_]YVNU[?8/891,YHM9),`\>"K;[E.%(<-@\])V
M]?%?,A(Z%`61.@A\ZB"KB8AG"8:XX!9I-_C4;G*RG,_C9+FX[!AK1_B\Y?L@
M:(\5/J_ZOBG5JB]]7G3%XWU3OP8PSU"-]ES@=H@U!#,U)ZBV"__7!*@^!OF(
M4?I84-\6)N?KXVIU/_T*S=YHDY1,%F%@381OD1D+["Q&S;E`.8(IY&]!0+,X
MB`C&[^W!,3FCDY^SG/D9I63BYBQ]B\Q8V)R-8("9L*C*F.`NN"A@=FY'@4XP
MZ&Y99^P+4[+I-[<O;,8%.1<H1^#E"&/JYGBYPFC\$`+<H>4SUO24;);]S-Q%
M\RAB!2;]D'ON.4@9L3E3CH.7.0RWFSD.>@RRRPC0B5>7C4!*-D.&&1?D7*`<
M@9=CXN=X.3<TYM5EU4O))NZKRW29T=G1-0)<7V:LC([/+.P&K^J/-P^=>.:Q
MW_>4;"CSNRCQM9G1VMR-`'._XT.DC)9GCT\.SN%WN=YHS+.>^WFE9$-9SQ.&
M*3-:F[41]!4?96VT/.O5+5FC,<^:53,E&\I:,F5FE#9I(\"D.41EE#QG`<?Q
M]:7NK7G6"U9K;03[;H\7R0Z#S-K8[*VDGY28M4A9]0@`<H\S*WA^_'C2!3$6
MG*8V1S%;<B!DY)P@VFV0Y".)<B7>(2*07V[/E%C)/ZQ9.=,^-)R;=)[$["S/
MK'JH-D75:RP2UD/E>O@@D(!N!T&TY8$0G`V%X38Z*Q+6CLSJ!Q2>AXB9AW(]
M?!1(1K>C(`KS4;!:I\+PW#!9X^DW-@,2(T'L+*2R(4>SCWQU.PQB.1\&)T]\
MOH?S*='\/YLQXLFT@;L*G@L\`;`&*]?%;P>RV.TXB/M@!H8=%BS-5#@$2<]8
M(TD^DBA7XF>*C.5D>IF9!/&;7VEVLJ7:2*\BZT-FM<.H&-+LUX2=!,JU]S-'
MUKH^<^(X/W-.JH*,](R(^8(5/],&[HSX+LN$/Q,KU\<'@!1V/0`B/!\`H]!4
MD)$&$"?S4?4=VM2O/D8R#!U?;Z7#]K`]")*1[75<U7LQTA7LP$ZU$4&)%G.V
M>YG6.ZWP/.:2/\HIU\-'\2[&E42F?D/8@9UJ(S@,[4KSZF;6QFZ$E>!&+!ER
M9;7\])20BSM05W8#O7@WV!:F?6CDXTLX*)#;$2/I-YNS@(TYPH$LZ"S&E3B(
M.^$K;:G%^#V;C/2"R'C!QBZ39.""\%Q$)%?LP%.NCS]82(*W`R'JA*]U@+#B
MI9*,ACRSD20?290K\3-]%_'B3U5\="0[<E)M1"6/E_SE(]-Z?!ZV>)=LCW(O
M"#P7+5G?U`^B^&#?Q<Z2B->?+T80J38B[F,@,JL<%IUB4FU$O!JMND/V/@1&
MVU>NR!OT+=DTI]+0\=".\9%E;`8D1M(_[PD&7=F@HUUG+'XED#?87'(VERXU
MQ\O12X36#RN4>QXBB5<LI')=_'X@B]Z^Z<2]_DAQ3I>&H/M#5+*#(+/JH16N
M`W\I4:Z]!P'?,6^'T'LQ]I!L.5-MI)\($_X[96;U%H.5(.C5DH%65LW'*7H7
ME?=>'`0;X50;Z5U=).R<R[3>&2?/0\H%\U"NA]\*Y,V;IRE"+XZ"$[DVHI]!
MA9BQG#*M=U%06/*(Y)P=><KU\%$@<3HH+K]:1$2S\&.#&8)T+,K&HGPL4I[(
MS^D-1L:WN!MO(>!RBI>:4U:J;?"'!\MK@K]"9H.5@9V/17@9AM\'L>S`T^46
MW;`<R^:YS,K#H0TV]0M>7,WA-==*Z5(MA4NUOKA<+M=9'Y?)<[F&"P3X/B;_
M&$5P.Q>]H0'(YMYN:IW@WNQ</)>_%\US=6J#0[F#]&83O*QJZ.:-_NCJ<W]'
M\E1W<&/6_W</-Z0E7,_,)F"\J^O._(%%L'>NC_\!``#__P,`4$L#!!0`!@`(
M````(0"FI^I7H@4``&H6```8````>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
MG%A=CZLV$'VOU/^`>-^`(0E)E.1J`X%>Z5:JJGX\L\1)T`:(@/WZ]QUC;.QQ
M$G'[LBS'9P;/F;$]\?K;9W&QWFG=Y%6YL<G$M2U:9M4A+T\;^^^_XJ>%;35M
M6A[22U72C?U%&_O;]M=?UA]5_=J<*6TM\%`V&_O<MM>5XS39F19I,ZFNM(21
M8U47:0NO]<EIKC5-#YU1<7$\UYT[19J7-O>PJL?XJ(['/*-1E;T5M&RYDYI>
MTA;FWYSS:R.\%=D8=T5:O[Y=G[*JN(*+E_R2MU^=4]LJLM7W4UG5Z<L%XOXD
MTS03OKL7PWV19W755,=V`NX</E$SYJ6S=,#3=GW((0(FNU73X\9^)JN$+&QG
MN^X$^B>G'XWRO]6<JX^DS@\_\I*"VI`GEH&7JGIEU.\'!H&Q8UC'70;^J*T#
M/:9OE_;/ZN,WFI_.+:1[!A&QP%:'KX@V&2@*;B;>C'G*J@M,`/Y:1<Y*`Q1)
M/[OG1WYHSQO;GT]F@>L3H%LOM&GCG+FTK>RM::OB7TXBO2ONQ.N=P+-W`N4U
MTM;O;>'9VY)@0J;NG'W_P3>GO1T\>[OY)"#NT@\>V\%H%S`\>SO?_^F`Y[T3
M>`HG/Z]:T#N!9^_$&^W$X6GLJB)*VW2[KJL/"Y8:)*JYIFSADA4X%N7`A90%
M<J\^H#"8DV?FI?,%J6^@J-^WP7SMO$,=9CUEQRGPB8&RT"GA#<I2IT2"P@J3
M?7DO@,'MPM5MXAL4HE.2&Q1/4AR02NH%):OJ=7O9"%D8&<D22+?=_'><$G3+
M@P448B#"P!X#,082!=`F#VMF_.09>6.#*YFPA8\FSRF++N&>&RS1>*B.$P^)
M'O'1J0Q]K]*G"W>*$ZF-SX8$=4HFZNB3%RR\P5P3`3:`\2(P,A)ABD3@E"&,
MD`/S3A7B$A>I$F&#/09B#"0*H,4"F]+X6!@9Q3)#L7`*G_ITX:.9AWQXVD6&
M%F\DQN3*U'UYZ%.QX`_EY:'%GCRD:#K`OCI>!T9&.N#-BE.4G`J`;6WS):)'
M8E3&CH$8`XD":)'`!JE&TNW'`3N*[YS08JMA=B@HO-5P"L^>AT((Q>#]=$2<
M0J#E&'8$5`5[X8;IA+\1B\'!WDCY0XHF%&M(E8/K\4;,R$@=5&P[3E%2+@`6
M"EKSD1B3"<=`C(%$`;0XEGH<HQ/.[/20EL.&Q\\63KFY7$,Q=C\7$:<\SK=P
MPT1"M1"+L?N?2!Y2-)G8-,;GNV,C==#QL^LY2L8EPJ)!]$@.RIP;2&P@B8KH
M\;"60ZG?T7DGO%=1S^4E.@IW/8=G?C9'U1O*X?N9B7H.F__]U2X=,<&,[\1R
M>'!A+/C''%TRUM8HDCU>\H0W09I.Z#S;]1RU!+@55XZ@33(R^'L#B0TD41$]
M(-:RC`^(-SA:0"BS.\(Y_`!_\F?&"=X3H)^06<4IB21GJ'3N]I%5+*WN>TX>
M3$\7AO4[XX7AW9$F#.HV=H1S>%Y!&+1B0CE^?_:1Y`RZ"*_WK6)IQ=:(^>5$
MCM_TH<O"&J+QLO#V29,%%?2._?*'4Z3OX#W?1Z=BJ!&(62K<?EA`>\U@YD_G
M:,W%&H&XZ,Q*M.$GGT`-RQY5%X-U4./%X/V6)@;NCXC2DW4':-@CHI57?U)T
MA,@PV1M(;"")BN@QL?9G?$R\68(=5!3DCAA0:$*1">U-*#:A1(/TF;/V1IGY
M_[U'X%V2FJ8%:BMV<#O&:I;MJG(/6R)2.)"$-I$)[4TH-B%V'==_$'SQJ/GU
M&K](*6A]HB&]7!HKJ][8U5D`/Y`DRJ_U8-;B7L\86<$E`'A&>$A6\-/?Q/=D
M!3<`)AZ3%5P$F'@"%XJW\&<2P(RZBP='?AIN^J[IB?Z>UJ>\;*P+/4(X[H1=
MD=7\KI"_M-6UN]=XJ5JXX^O^/<.=+H4+#'<"Y&-5M>(%IN3(6^+M?P```/__
M`P!02P,$%``&``@````A`&E4XR'3`@``[P<``!D```!X;"]W;W)K<VAE971S
M+W-H965T,3<N>&ULE%7+;MLP$+P7Z#\0O$<O/R0;EH/$0=H`+5`4?9QIBI*(
MB*)`TG'R]UV*MB+)<>I<;)$[FIT=+E>KZV=1H2>F-)=UBD,OP(C55&:\+E+\
M^]?]58*1-J3.2"5KEN(7IO'U^O.GU5ZJ1UTR9A`PU#K%I3'-TO<U+9D@VI,-
MJR&22R6(@:4J?-TH1K+V)5'Y41#,?4%XC1W#4EW"(?.<4W8GZ4ZPVC@2Q2IB
M0+\N>:./;()>0B>(>MPU5U2*!BBVO.+FI27%2-#E0U%+1;85U/T<3@D]<K>+
M$WK!J9):YL8#.M\)/:UYX2]\8%JO,@X56-N18GF*;\+E)L'^>M7Z\X>SO>X]
M(UW*_1?%LV^\9F`V'),]@*V4CQ;ZD-DM>-D_>?N^/8`?"F4L)[O*_)3[KXP7
MI8'3GD%!MJYE]G+'-`5#@<:+9I:)R@H$P"\2W'8&&$*>V_\]STR9XLG<F\7!
M)`0XVC)M[KFEQ(CNM)'BKP.%!RI'$AU()J#^$(^\*)F%L_G_67RGJ"WPCABR
M7BFY1]`TD%,WQ+9@N`3F8V5.1U?KN5*A1DMR8UE2'&,$56@XGJ=U%,<K_PD\
MI0?,[2DF'"(V1X0]"I#7:83*^QK?=OTHQ8*M%'L*5MNMVP#N5VVCO.\A!D+`
MH,N%6/!`B-L8")E.1U+>P,1)AQF(F7Y$C`5#U_5-B!<=KS/*8::=<YO>QB`S
M].SE-EAPBL'B5_N38)3982!=#S-NCO<Q`WWSC^BSX)$S2332YS`]9WH;@\QP
M`RYWQH*M,^UU"<+9**D+)RX,\WYDVL;%YVT\6?3C`TGV$]2[X.]?'@ON29J/
M)+GP>4DN?EZ2&[!N_@BF"K9A5:41E3L[/*T3W6XWUV\FMB%'^[<P[]OIZ'<!
MF+<-*=AWH@I>:U2Q'"@#+X:^46YBNX6133OUMM+`I&T?2_BP,A@5@0?@7$IS
M7-A!U'VJU_\```#__P,`4$L#!!0`!@`(````(0`0;;K0H`0``,H0```8````
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&ULK%A=C^HV$'VOU/\0Y?T2$CZ#@"L@
MVO9*O5)5]>,Y&PQ$F\0H#LONO^^,[829)(7=J[[P<3P^/G,\'F*67]_RS'D5
MI4IEL7+]P=!U1)'(?5H<5^Y??SY]F;N.JN)B'V>R$"OW72CWZ_KGGY976;ZH
MDQ"5`PR%6KFGJCHO/$\E)Y'':B#/HH"1@RSSN(*OY=%3YU+$>STIS[Q@.)QZ
M>9P6KF%8E!_AD(=#FHA()I=<%)4A*4465Z!?G=*SJMGRY"-T>5R^7,Y?$IF?
M@>(YS=+J79.Z3IXLOAT+6<;/&>3]YH_CI.;67SKT>9J44LE#-0`ZSPCMYAQZ
MH0=,Z^4^A0S0=J<4AY6[\1>1'[K>>JD-^CL55T4^.^HDK[^4Z?ZWM!#@-NP3
M[L"SE"\8^FV/$$SV.K.?]`[\7CI[<8@O6?6'O/XJTN.I@NV>0$:8V&+_'@F5
M@*-`,P@FR)3(#`3`JY.G6!K@2/RFWZ_IOCJMW&`XF/G#<#0#EF>AJJ<4*5TG
MN:A*YO^8(-]2&9+`DL"[)0D'D]EPY,.2]^:-[#QXM_/F@W$PF<T?31S;B?!N
M)XZFMQ7OJ_:,`]K0**[B];*45P>J%')4YQAKWE\`<>VDR;OQ]K^L!4^19(,L
M*W?F.N":@GIX7?OSR=)[A3U,;,RV)X9'[.H(W#"DC0C@@=Y&-%C^/XA&%A1=
M+[>M@5L604MA'5%/B0C`%,+F4H7]A5F[A\$K%UZ)>U.^\M;$^*8$T9Q=!XDH
MPM3`QE(U/[C)R`)E`BD3G>U=MD%P!$C0C">S:X(:'RG"I`,1E7[?2`S6"FO>
MK46(;1TDH@A;>\K7UK8%T*P^>3B0AJLR2`!)$Y/F+9.:H#J9B"),*!R\CYN$
MP5R.18A)'22B"%L;?U-;#20$C^YO%$[B&@P2-(=Q5P/4HI!;%%D:YF,X;(*8
MSI#KO*\/@[D^BQ"/.DA$$;:V#X:T3<)?FOLB]"RNPD+$I@8A/H5^8X'MH[@^
M,'&C;LV-B\6N2W;T@4C3HZ$KU&6ZA2:E5R->=:&(05P`-E4B`,_=]&%)85]J
M[9F%;M)V#4+=&K7=LDS<K7$3Q<5BTR5B'[AE6_1-TM:G75MOUZX+10SB`D`F
M%8!NC:&V/MFDL#;:]AF(MZFPU?!W=B)$U040,8B+Q5[[<;=L9Z9N68C65@>*
M\%D0D]%17`#V4"(`W<*3^%FW3"MF5=]T9UI;K9_QG=]$W=RB$!>+39>(?5!;
MMD53MVC7MK75@2*?0EP`-E@B0/\"#G_`+MNHJ33;W_DA:S\H^$W4S2X*<;78
M?XG:!W;9;DTUT09N[>I`>+%I%Y>YJ)CGZER41[$36::<1%[P$@))K)<-;&Y(
M6W\.5Z0YGIG.2%A?GCHC>*W2-=T9&<'(J)=M#"/Z;';F3&!$WXXZ(U,8F?:R
MS6!$/S&WYL"-;Z.=;.%;E-S'%"S@V;DG>TBD+X_->+$Q-\KV`I!?;WJ076]R
MD%MO:I!97V);V`U]D_6:A>$F>8Z/XGM<'M-".9DXP";#_1'.16GNHN9+)<^P
M^7"?E!7<(?7'$_QG(.#A?3B`X(.45?T%G/":?R'6_P(``/__`P!02P,$%``&
M``@````A`.[!<UN8`@``UP8``!D```!X;"]W;W)K<VAE971S+W-H965T,3$N
M>&ULE%7+;MLP$+P7Z#\0O$>49,=)!,N!TR!M@`8HBC[.-$5)A$51(.DX^?ON
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M*Z'8L$VX`2MCU@A]+#`$B]G)ZH=^`WY84LB2;QK_TVR_2575'G;[$@RAKZQX
MO9=.0$&!)DHOD4F8!A*`*]$*.P,*PE_Z^U85OL[I)(TNK^))`G"RDLX_**2D
M1&R<-_IO`"4[JD"2[DC@OB>9G4O"0D*]OWON^6)NS99`SX"DZSAV8)(!\=N&
MP`EBEPC.Z14ED*N#37A>I/'UG#U#Y<0.<Q<P<!TPR8!@(#HH@]KYR@A&92PM
MIG(7`H<RZ=LRDX_((!CVYB#Y-+X9>(-RP$S[?CGT,_V($(*AY.!B*--I*7>@
M43I)/*0SJB:TT?G51'"O/I0S1$Y-S<:TV/>3&1R?]_L$5XWY0R0=6_E/8T!_
MG6\%P6.I$#FU@J/XH-/1RA1LO^\$%XWI0^3(R7'OA4$2#IJ6MI)?9-,X(LP&
MAT0*1V>(#O-KF6)+'<>GV;*?:VSX`'.EXY5\XK92K2.-+($RCJ[`BPV3*;QX
MTT'F,%V,AXG2/];P`Y%P>N((P*4Q?O\"PFSX)2W^`0``__\#`%!+`P04``8`
M"````"$`B*DG(.,%``#T%P``&0```'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6RL6%UOZC@0?5]I_T.4]TMPH+0@X*K!ZNZ5]DJKU7X\I\%`5$)0DG[<?[\S
MCA//V-D6JGTIY7@\.3XS/C%>?GTKCL&+JNJ\/*U",1J'@3IEY38_[5?A7W\^
M?+D+@[I)3]OT6)[4*ORAZO#K^N>?EJ]E]50?E&H"R'"J5^&A:<Z+**JS@RK2
M>E2>U0E&=F55I`U\K?91?:Y4NM63BF,4C\>SJ$CS4]AF6%27Y"AWNSQ3LLR>
M"W5JVB25.J8-\*\/^;GNLA79)>F*M'IZ/G_)RN(,*1[S8][\T$G#H,@6W_:G
MLDH?C[#N-S%-LRZW_N*E+_*L*NMRUXP@7=02]=<\C^819%HOMSFL`&4/*K5;
MA?=B(>-Y&*V76J"_<_5:D_^#^E"^_E+EV]_RDP*UH4Y8@<>R?,+0;UN$8'+D
MS7[0%?B]"K9JESX?FS_*UU]5OC\T4.X;6!$N;+'](56=@:*09A3?8*:L/`(!
M^!L4.;8&*)*^Z<_7?-L<5N%D-KJY'4\$A`>/JFX><DP9!MESW93%/VV0,*G:
M)+%)`I\FB9B.Q'0\PQSOS)N8>?!IYDW?C8=1318^KR8;M0O7.LJT2=?+JGP-
MH#EA:?4YQ587"TC<"=C2[B7]+T5!2DQRCUE6X6T8@%@UM,'+.IY,E]$+E"XS
M,8D?(WC$IHO`.F%:28`(^/:D0>G_@31F0=+=XY(.(*MP&'81W11)`,80:NHR
MG$!W#_=EIR).@@XD*HI)S!DD;8QH.Q!%VGB(I`AC!06FK-YG@\'0%;!"4M0;
MATX;%/<:;CK`3A)N)\BA&)N8,88==#EC#-:,N_(D!B%J>8BD"'OV[)IG8S!_
M=HL0:4P(K+X75$QF7%`Y&'3;!S&"L-\N%P>#.4&#$'$\1%*$/1O?H*YOC$'*
M*XT#TW!6!@$=B$IWO0#:&#9]4%=I21%&=,Z)OM_S&,SI&(2(Y"&2(NS9`K:\
MJQ+:P)4BZ32<5@=QF>:.3#:JUXE!G"RZ+2GI^TJ!`[E2=1#1RH<D@S@!-%-"
M`-]%M]>W%#J64\0.8FI-QZY:9N*L=S-I)X*`G"R:+"'[@5K&DJT;)(*Z=-O5
M/B09Q`F@BQ("J-;L$[W5FC$LM&N11!B(J^6]K/NH;J*T$SVUT&0)V0_4,I9,
M.1F(]I8'23SZ8>EU%%<+%G,%`8QV-EP+64H;88)`!^M44^=]+8>C)GWK<99H
MMY?+9,S9<DH$]6O35!XD610G@#9*".CC8/R)KC)V3*GU#DWE<@Z)&]%'V:ZB
M$&>+QDO8?M!5QJ8I)^K<1BX/DH)"C``J<SD!'<V[JH-(6_N09!`GX'@VUBN^
M@UUPY1LF]MV\@Z#+27O;8UHKEXWJZ\4@SM8Q^/?K%?L^WD%4+A-E(<FB.`''
MM'5[SS\AEV_GL8&X7,[I;F.CK%S]1-<T8W18TM[(]N,?$7J6[C):-^<`E9@H
MNQ<V/4*GV8.G+K<<#+*YN=AHQH3^!]4VUFT9)?CSN7=STVX>)%D4)X`&30B@
M?M/Q?`3PM=L#,SD[UT#@KF1[N`>PN(^R]:80YXM.[?"]H-[&WV$?6"(WSMLZ
MB=LHJ^ZF1^@TYT@D!X-L;DX??9K0_Z#>QM4MHR0VD-W*&Q^2#.($T*<)`;U?
M\$AP;;6-WU-J!F+5OG'>]1NXZ=)M8J\4\/++0BW;]C*KO80I5+57&W4\UD%6
M/N-%%2QOO>QA<XL63Q?WT$K00\X([!&X8-,W6][(#$:&YMS'MY!-7\IY<^Y@
MSMW@<^;=19X[1\`<>&L/<!,P!]Z=`R/Q&++IFSTW6XP7AKH!O)$81G1)O)$)
MC$R&GB,@6WL8=.<(R-:>>;T1R`:G[@'68@HCT\$1J`(TVM"<6QC1_>`\!VY&
M[P=7@Y2',N'RAW"@.\3V'EMF:"`!KH-4@>D0T03J.UA>J.Y@<044%WYE@AA1
MOV:X<SVG>_4]K?;YJ0Z.:@>M/A[AK[NJO;5MOS3E&6P6;E[+!FY;];\'N%U7
M<,\U'D'PKBR;[@L^H+^O7_\+``#__P,`4$L#!!0`!@`(````(0!HM=*&?P(`
M`!$&```9````>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;)14R6[;,!2\%^@_
M$+Q'U.(E%BP'3H.T`5J@*+J<:>I)(B**`DG'R=_W4714VTE;YR*)U'#FS5NX
MO'I4+7D`8Z7N"II$,270"5W*KB[HC^^W%Y>46,>[DK>Z@X(^@:57J_?OECMM
M[FT#X`@R=+:@C7-]SI@5#2AN(]U#AW\J;11WN#0UL[T!7@Z'5,O2.)XQQ65'
M`T-NSN'0524%W&BQ5="Y0&*@Y0[CMXWL[3.;$N?0*6[NM_V%T*I'BHULI7L:
M2"E1(K^K.VWXID7?C\F$BV?N8?&"7DEAM-65BY".A4!?>EZP!4.FU;*4Z,"G
MG1BH"KI.\NL99:OED)^?$G;VX)O81N\^&EE^EAU@LK%,O@`;K>\]]*[T6WB8
MO3A].Q3@JR$E5'S;NF]Z]PEDW3BL]A0->5]Y^70#5F!"D29*IYY)Z!8#P"=1
MTG<&)H0_#N^=+%U3T/0RFB?Q(ILCRP:LNY6>DA*QM4ZK7P&4[*D"2;HGP?>>
M))M%TWF<):CY'Q(6`AK\W7#'5TNC=P1[!B5MSWT')CD2OVX(G7CLVH,+.J<$
M8[58A(=5FL5+]H"9$WO,=<#@<\0D(X*AZ*B,:N<K>[!7]JGUH5R'C4.9]'69
M["TR'EQ0?([!I]F?\(-RP$R&?CGT,WF+D`=CRM'%@=)I*@,H71R!_F(3.^#\
M;'KPH#ZF,^QD80H.7<V.>7WC9]-YY-OVW[WB#QYKA)WLJ&99=E*U,(*A1168
M&CY`VUHB]-:/5XI--^Z.D[].?3%.]R?Y>K@1V/@#)[+G-7SAII:=)2U42!D/
M7DR8Z;!PNL?(<:2TPUD</AN\>@'[+H[0>*6U>UZ@,!LO\]5O````__\#`%!+
M`P04``8`"````"$`YU]A)SX#``#K"@``&0```'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6R<5MN.FS`0?:_4?T!^7QP(N2K)*MO5MI5:J:IZ>7;`!&L!(]O9
M[/Y]9S`AX9)-TA<NP_B<.>/Q,(O[URQU7KC20N9+XKD#XO`\E)'(MTOR^]?3
MW90XVK`\8JG,^9*\<4WN5Q\_+/92/>N$<^,`0JZ7)#&FF%.JPX1G3+NRX#E\
MB:7*F(%7M:6Z4)Q%Y:(LI?Y@,*89$SFQ"'-U#8:,8Q'R1QGN,IX;"Z)XR@S$
MKQ-1Z`-:%EX#ES'UO"ON0ID5`+$1J3!O)2AQLG#^=9M+Q38IZ'[U`A8>L,N7
M#GPF0B6UC(T+<-0&VM4\HS,*2*M%)$`!IMU1/%Z2M3=_\*:$KA9E@OX(OM<G
MSXY.Y/ZS$M$WD7/(-NP3[L!&RF=T_1JA"1;3SNJG<@=^*"?B,=NEYJ?<?^%B
MFQC8[A$H0F'SZ.V1ZQ`R"C"N/T*D4*80`%R=3&!I0$;8:WG?B\@D2S+TW>EH
M%(RG$X#9<&V>!&(2)]QI([._ULNKL"R*7Z'`_8`R=D>3P=`#T@L@U$94"GQD
MAJT62NX=J!J@U`7#&O3F`-RO"*2@[QJ=EV1"'(A5PS:\K+S9=$%?('5AY?-@
M?>!Z]*D]*)#6S,!V/3,Z(S/F%D-YL(93&K^?9G@+#3K#YIP&/YO5N);9^@1E
MP9SJ"6XA0F=(.:@XIJF3RLKI-!PX^'4XC6Q"!5R?370NV>MT6DM7U+@)BX7O
M!W!^WJ\37-7$MQ:_*<7KEP+U=;T4=&Y264M7"C;CDTHOI7@7I>"J)KZUM*2<
M*;Y9D_/]K*%SD\I:NE(P[+86;WI12[FLR5"96FJ&_1OCX=D^2>'[<DKO%IMM
M#CV"6LW`-MC+@JHNX!_[`AXIR&)+4'!&$)[EZP79DP\,];'QK*E'4*L;H*#Q
M93UU6S@R6%-+S^B,GINZ`/[!6@57F7KT]#2"`-9?*(%N(_!Z.\'XC)Z;6H'7
M[065J4?/_W4#&#(Z*>OM!Y.6(#M:V#]OQM66?^)IJIU0[G!L\.%?6EOKD69=
M%EK;'LS7=M2A]1<8-0JVY=^9VHI<.RF/`7/@XFBA[+!B7XPLX#S"J"`-S!CE
M8P)#)8?_Z<`%YUA*<WB!`J3UF+KZ!P``__\#`%!+`P04``8`"````"$`Y$/@
MCL("``#.!P``&0```'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6R<5=MNHS`0
M?5]I_\'R>^-`;@T*J=*MNEMI*ZU6>WEVC`&K@)'M-.W?[XR=TE"B-MH7!,/Q
M.7-FAF%U]517Y%$:JW23TF@TID0V0F>J*5+Z^]?MQ24EUO$FXY5N9$J?I:57
MZ\^?5GMM'FPII2/`T-B4ELZU"6-6E++F=J1;V<";7)N:.W@T!;.MD3SSA^J*
MQ>/QG-5<-30P).8<#IWG2L@;+7:U;%P@,;+B#O*WI6KM"ULMSJ&KN7G8M1="
MURU0;%6EW+,GI:06R5W1:,.W%?A^BJ9<O'#[AP%]K8315N=N!'0L)#KTO&1+
M!DSK5:;``9:=&)FG=!,EUU%$V7KE"_1'R;T]NB>VU/NO1F7?52.AVM`G[,!6
MZP>$WF48@L-L</K6=^"'(9G,^:YR/_7^FU1%Z:#=,W"$QI+L^49:`14%FE$\
M0R:A*T@`KJ16.!I0$?Z4TAB$5>;*E$[FH]EB/(D`3K;2NEN%E)2(G76Z_AM`
MWA$+7#ZU&^[X>F7TGD"_`6U;CM,3)4!\.A=(`K$;!*=T00G(6"C@XSJ.IROV
M"*;%`7,=,'#M,%&'8"#:*8/:^<H(1F6L"J9R'0+',O%IF4E?!HL^@=:];Q0/
M`>[(1!S/.OZ00<!,?<N/?4W_1Q`/00O`55>V86D/H'Y:\RZM7G5A(LZO+H*]
M>E?>$!F:F_=I?34_+B>>ZO.'2-RWLCAM!>;M?"L([DN%R-`*KM6CR4<KT.2/
M)@-/]?E#Y(V5R]-6EGW-]X<0P7VI$!E:B6"@!UXP^+Z`/]97.(3>N%F>=@/+
MLB?[@=IA,\2O'[$G@`0FKQ]1V)YA1=72%/*+K"I+A-[A9HQAZ731;FMO/.7;
M^#39A&W.NC>P35M>R'MN"M584LD<.,>C!73=A'T<'IQN(2O8J=K!'O6W)?PW
M)2R>\0C`N=;NY0$W?O<G7O\#``#__P,`4$L#!!0`!@`(````(0!"0[+S.00`
M`&8.```9````>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*Q778^K-A!]K]3_
M@'B_`1.2;%"2JP2T[95:J:KZ\<R"DZ`%'&%GL_OO.V,;L(&[R97ZLBR'\?&9
MXV&8;+Z^5Z7S1AM>L'KKDIGO.K3.6%[4IZW[]U_/7YY<AXNTSM.2U73K?E#N
M?MW]_-/FQII7?J94.,!0\ZU[%N(2>1[/SK1*^8Q=:`U/CJRI4@&WS<GCEX:F
MN5Q4E5[@^TNO2HO:50Q1\P@'.QZ+C"8LNU:T%HJDH64J0#\_%Q?>LE79(W15
MVKQ>+U\R5EV`XJ4H"_$A25VGRJ)OIYHUZ4L)>;^3,,U:;GDSHJ^*K&&<'<4,
MZ#PE=)SSVEM[P+3;Y`5D@+8[#3UNW3V)$K)TO=U&&O1/06_<^-_A9W;[I2GR
MWXJ:@MMP3G@"+XR]8NBW'"%8[(U6/\L3^*-Q<GI,KZ7XD]U^I<7I+."X%Y`1
M)A;E'PGE&3@*-+-@@4P9*T$`_'6J`DL#'$G?Y?56Y.*\=>?+V6+ESPF$.R^4
MB^<"*5TGNW+!JG]5$-%4BF2N2>#:DLQ(Z"]_@"+4%'!M*1[6X:F<I$5)*M+=
MIF$W!^H.5/-+BE5,(B!NO5&9=&Y]SRQP"4GVR+)U5ZX#/G`XX;?=.MAX;W`H
MF0XYC$.('1&W$7@"R)H8@`=R.\W!_Z(965!SN]VA!?HD!CG$;42[)#$`2R&<
M\M#5.=3M=,6U)N(BJ"W#Q(#,;8\.*H:HVD*3XA&2F(BE"LYWJ`K?@Q\\:V2!
M:H'4OW_8*B8P"R(@H9U+W`5U=IJ(I1Q4FLH_]Q&#I<"6]Z`1P[41DIB(M??2
MWAO?D+E_]S!QE2U"(4%7;[$.@:0[(\E\8%*B5X&Z+B@@B\Y)2RG8_;A+&&P+
MU(CAT@A)3,3:&S^6PSZR!-6?'Q6NLD4HQ'!)AU@NA:O.`-4I]"K;I6479"E=
MVTH_%XC!MD"%!$_].8Z0Q$2LO0G4S="F!XI)+K-E:,@PJD5L$X9.34<]35L%
M?<:2^[E7,GJ@4K5PLU^U47V9)19D^X4-=E!6`:9P1XGJR]"CNA:`_0I.LD=B
MC1"KLI9^YX3^!FDJ,RH@ZR[*EHNMUY![1Z5NU+VF`S%[MQ00CZ'$@FP!(-,4
M(#_GZ[NO(7HP*',-]=KB%K'J*QCYI:APK.D;5M!_ZFVY$&7*O>,71@_J2T-]
M,<7X1<.H'DHLR!:`[=4X,.E7*.?`>R6FNW=OT`%FV&&)377O8#!5X.PKU\'%
ML*S_\BO%:KQ5LUM%FQ.-:5ER)V-7'%VAF'>;#E9S-503#-9S?`=&3Q;P1,ZZ
M@R<PB^]E2@/\@#/Z%%,0P1`TL0-L/;7S/HSV:M8?;A!&23A%!$JGA!Y6$7R,
M)C9>1]!^)W""&<@4O&YKF/(OZ8G^GC:GHN9.28]@I3];00DUZG>"NA'L`A;#
MK,\$S/?RWS/\GJ,P?_DS"#XR)MH;V-KK?B'N_@,``/__`P!02P,$%``&``@`
M```A`(]=->DQ`0``0`(``!$`"`%D;V-0<F]P<R]C;W)E+GAM;""B!`$HH``!
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````)R104_#(!B&[R;^AX9[
M"VW5&-*R1,U.+C%Q1N,-X=M&+)0`VN[?2[NNSNC)(WE?'I[OHUKTNDD^P7G5
MFAKE&4$)&-%*9;8U>EHOTVN4^,"-Y$UKH$9[\&C!SL\J8:EH'3RXUH(+"GP2
M2<9386NT"\%2C+W8@>8^BPT3PTWK-`_QZ+;8<O'.MX`+0JZPAL`E#QP/P-3.
M1#0AI9B1]L,U(T`*#`UH,,'C/,OQ=S>`T_[/"V-RTM0J[&V<:=(]94MQ".=V
M[]5<[+HNZ\I1(_KG^&5U_SB.FBHS[$H`8L-^&N[#*JYRHT#>[%G_YIK$^UV%
M?V>5%*,=%0YX`)G$]^C![I@\E[=WZR5B!<DO4W*1DG*=%Y04M""O%3ZVIOML
M!NI)X-_$(X"-WC__G'T!``#__P,`4$L#!!0`!@`(````(0"=\+4BF`(``$@'
M```0``@!9&]C4')O<',O87!P+GAM;""B!`$HH``!````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````)Q576^;,!1]G[3_@'AO2;-HFBI"Y0!M40EDX&3:
MD^7!36*5`++=J-VOWR4L#6EIMO8%V??CW.-[\+5]];@IC"U():IR;%Z<#TP#
MRJS*1;D:FW-Z??;--)3F9<Z+JH2Q^03*O'(^?[)GLJI!:@'*0(A2C<VUUO6E
M9:EL#1NNSM%=HF=9R0W7N)4KJUHN109>E3ULH-36<##X:L&CAC*'_*Q^!C1;
MQ,NM_BAH7F4-/[6@3S42=FQ2UX7(N,93.E.1R4I52VWXCQD4MM5UVL@NA>Q!
M"OWD#&RKN[73C!?@(K"SY(4"VSH8[%O@3=-F7$CEV%M]N85,5])0XC>V;6@:
MO[B"AL[8W'(I>*F15A/6;G;KHE9:.C\J>:_6`%K9%@:TQMVR&]M=BY$S'.TB
M<'4<V2"T3-!QS)$*78"*ES,N=1_E49?SCD7+N"6T5Y'AO\'\4F._6%"V:HNJ
MR_SY#&X<>7Z4^A[#51J'@4<H;B8D))'K?R#EXCTY*<5JTW>5^9ORD3+#7FII
M<!,%UX%+(LJ(Z\;SB`;1#9MA+]S@+6K3:4"G?D337LAK$B1L0<)Y?_J4)'<^
M)9/09ZGOSI.`!GX_4$IC]X[=QJ'G)RGSO\\#^K.W8ALX(:V0TQE*2F@01[W!
MB1_N1)Z1I*G,:$(PW&WBWZ`QGZ18',_+_`5^>U%/]_$MO9X;R5*06YQ$C*PD
M0#.+CJY:YX<]I(2`]U<Q#S07Q;_#$U#`9;9F-Q*O>I/7>Y"#>B>1>U4\F=&G
MYG\DO%:U3>HE?TI;YO6FI"_4[:-T-+)>#*E0E/=J7M/*XQKV4_C8:*=K+B''
M^;3W'PSV+0Y@630@[IJ7*\CW,:\=S9NQ:!]&YV)T/O@RP.>@8[.MPQ/H_`$`
M`/__`P!02P,$%``&``@````A`*>?O/>5````J0```!````!X;"]C86QC0VAA
M:6XN>&UL/(Y!"@(Q$`3O@G\8YNYF]2`J2184?($^(&1'$T@F2R:(_MYX\=)0
M-%2WGMXYP8NJQ,(&M\.(0.S+'/EI\'Z[;@X(TAS/+A4F@Q\2G.QZI;U+_A)<
M9.@&%H.AM>6DE/A`V<E0%N+>/$K-KG6L3R5+)3=+(&HYJ=TX[E7N`K3:0S5X
M/B+$_@$A_5)9K?XC]@L``/__`P!02P$"+0`4``8`"````"$`ZFVY.L8!``!7
M$0``$P``````````````````````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M
M`!0`!@`(````(0"U53`C]0```$P"```+`````````````````/\#``!?<F5L
M<R\N<F5L<U!+`0(M`!0`!@`(````(0"&5G]RK`$```P0```:````````````
M`````"4'``!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+`0(M`!0`!@`(
M````(0"Y;]?=\`(``#8(```/`````````````````!$*``!X;"]W;W)K8F]O
M:RYX;6Q02P$"+0`4``8`"````"$`_^!N7-4$``"A$0``&```````````````
M```N#0``>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!`BT`%``&``@````A
M`!,*,;VZ"```)2P``!D`````````````````.1(``'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"+0`4``8`"````"$`<MWDT%$$``#4#@``&0``````
M```````````J&P``>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+`0(M`!0`
M!@`(````(0!Q9&$R>0,``(\*```9`````````````````+(?``!X;"]W;W)K
M<VAE971S+W-H965T,C`N>&UL4$L!`BT`%``&``@````A`&VCL8ES`@``O@4`
M`!D`````````````````8B,``'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"+0`4``8`"````"$`?_>]$(`#``!G"P``&0`````````````````,)@``
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+`0(M`!0`!@`(````(0"-V39B
M>@(``!T&```9`````````````````,,I``!X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,`````````````
M````="P``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`-::0
M=5(%``#7%0``&``````````````````Y,P``>&PO=V]R:W-H965T<R]S:&5E
M=#(N>&UL4$L!`BT`%``&``@````A`$1/:^2/`@```P<``!@`````````````
M````P3@``'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+`0(M`!0`!@`(````
M(0"!B`E7:R\``(&8```4`````````````````(8[``!X;"]S:&%R9613=')I
M;F=S+GAM;%!+`0(M`!0`!@`(````(0`_`V5:4PH``$54```-````````````
M`````"-K``!X;"]S='EL97,N>&UL4$L!`BT`%``&``@````A`+\!N(]^`P``
M\`H``!@`````````````````H74``'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+`0(M`!0`!@`(````(0!$"TI]*@0``*T0```9`````````````````%5Y
M``!X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L!`BT`%``&``@````A`(G2
MR7,@"```E"D``!D`````````````````MGT``'AL+W=O<FMS:&5E=',O<VAE
M970Q-BYX;6Q02P$"+0`4``8`"````"$`[JO6R.8'``"B(@``&```````````
M```````-A@``>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!`BT`%``&``@`
M```A``$@!KY0!@``:!L``!@`````````````````*8X``'AL+W=O<FMS:&5E
M=',O<VAE970W+GAM;%!+`0(M`!0`!@`(````(0`V&H!B_08``+@=```8````
M`````````````*^4``!X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"+0`4
M``8`"````"$`IJ?J5Z(%``!J%@``&`````````````````#BFP``>&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L!`BT`%``&``@````A`&E4XR'3`@``[P<`
M`!D`````````````````NJ$``'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"+0`4``8`"````"$`$&VZT*`$``#*$```&`````````````````#$I```
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!`BT`%``&``@````A`.[!<UN8
M`@``UP8``!D`````````````````FJD``'AL+W=O<FMS:&5E=',O<VAE970Q
M,2YX;6Q02P$"+0`4``8`"````"$`B*DG(.,%``#T%P``&0``````````````
M``!IK```>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+`0(M`!0`!@`(````
M(0!HM=*&?P(``!$&```9`````````````````(.R``!X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L!`BT`%``&``@````A`.=?82<^`P``ZPH``!D`````
M````````````.;4``'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"+0`4
M``8`"````"$`Y$/@CL("``#.!P``&0````````````````"NN```>&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+`0(M`!0`!@`(````(0!"0[+S.00``&8.
M```9`````````````````*>[``!X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L!`BT`%``&``@````A`(]=->DQ`0``0`(``!$`````````````````%\``
M`&1O8U!R;W!S+V-O<F4N>&UL4$L!`BT`%``&``@````A`)WPM2*8`@``2`<`
M`!``````````````````?\(``&1O8U!R;W!S+V%P<"YX;6Q02P$"+0`4``8`
M"````"$`IY^\]Y4```"I````$`````````````````!-Q@``>&PO8V%L8T-H
=86EN+GAM;%!+!08`````(@`B`!<)```0QP``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001178913-15-001193-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-15-001193-xbrl.zip
M4$L#!!0````(``A`@T87RE4^-5T``,>6`P`1`!P`;W)M<"TR,#$U,#(R."YX
M;6Q55`D``\^`'E7/@!Y5=7@+``$$)0X```0Y`0``[%U;<]LZDGZ?JOD/6&WM
M)*<JLG7U+9<IQ[F,]R2Q*W)FM_8-(B$)<RB"!R!M:W[]=@,DQ8MD2;9NM/&2
M6"*(;G9_W>AN@*UW?[\?>^262<6%_[[6/&C4"/,=X7)_^+X6J3I5#N<UHD+J
MN]03/GM?FS!5^_N'O_[EW7_4ZQ>2T9"YI#\A_U?_G7SU1)]Z;\BUN&/2?'WY
M\[)'+JCL"[]>Q[ON^]+C9_@O`=J^.N-*=%K-X_>U41@&9X>'=W=W!WCY0,CA
M8:O1:!_&(VKQ#1[W_WA@-%[N4\62X5$HYXX^/82KR4"\X/)T;';<T:&YF!W*
M'^+81XDY*0_W)9[OVGIT\_3T]%!?38<J/FL@3-L\_-_OWWK.B(UIO4B`^[=,
MA7G>%7,.AN+VT%R#&9KM>J-9;S>3FUS&9]\!%W!X)S\<X#"D-$AO&5#5U[S%
M%V;<(N0XR#V-D'3,W`-'C'%TM]%JG=0`%82\0QF<*?UT/]F`:)F<A9,`$*?X
M./#P4?5W(\D&[VLX<SV9XN!>N35R:"8R`'.$'[+[D'#W?>VB:6BD%YD?\G`2
M?Y=^RUW\?L"9))H/EN,\D<W%Y>^U#PW01O/XJ-TX?7=8O#DA=3B#5DPI8)(+
MMT@?-"K#3V!/'XP@3T&6R2S3:X6;F.\FMW3KC5:]=3(E[&9N2+[-D$Z^BD4U
M5WJMZDFOO;KT.AN27KL2TC/^)(P%<0(FG$X>7WFR(#I5$T1[0X+H5DT0!<>R
M-D$<54T0G0T)XG@'@I@Z3C8<L_0IT@LNL'$?>-SAX7<V[@-1E\,X$RC&*_[9
M-^$/;Y@<7T?2&4',=2'&8Q[B=!\G%^`^AT).K@:7(4M'N.?W7-4^X/)]]@_J
M4I5,_^YP)M4IMX>SV'W:.@':;'3JS=8^K+(G+Q,#%\)7D8=FM#L8-!NKAPO-
M_.*P-AB<5A4&/YF'J>`UB&YR(ZFOJ!/"`/5QDKV2T7R/.9'D(6<JP<7Y4#*&
M#&P7"CD'CXIMK]W!-QM6K3NU<*/8E1Q]`0MKL_#F+K+1M6"A%X(`\.[/?T;`
M,3CZ0/CP41GU)\-P`1!^+Q3.'SLTY,W$[LU=),/;5-ZYZW(T<.I=4^Y>^A<T
MX"'UGI\B=Y&7;]D*`\E&>/<MN_0=,6;/3XF[J"EL4XD_64BYS]S/5/K<'ZKG
MI\%=%$->Q&*XK]7DYBZJ/B]N!=U;[5>VU%6597=O-5_9`E<EUNJ]57ME"UK5
MK&MN8=NF5=EB5C55NJ^FW;*%K`H;L2UD/1-%VD+6,U"B+61578.5+60]+2@Z
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MU\?:5T.FN67]M:]V9<L>%IEK7QX+(%O?\EC9`LM>@RP9](E+YH0[+N3NC4?K
M5+8.9,&V2R?5>:%;@=^I"IGL,7D+:T_ZTM_-G=CMYD![3S8'.I4]^KP16(S@
MCUWO&C>/]@(8E0UJ-@&,+R+:^6F"UO$^X*);V?ACY9?&?_?E9%=Q0..DWCC.
MK!'KZ_-3W4VF%?27W%-,3W<6UK51G<WC]:NSNIL[JYKCWM85-J;;"I?=]][5
MYFKIX&R/ZNW&"NMKT3^O;7T]:G<[.RDH/;U$TMJ3G`9%N),RR1-%V%Y=A)OJ
M#XDB/*[L!N]&,@`((G9;@=PG\SI^H66#"X_[&'\D^\I7<DA]_F^*JUL1,3M$
MBU;]'J'%UA(RN.CQ^]U"H[D_T.@V*EN6WNOMC`IMT)8=UV,*H.O?:-/HM`=;
M7C@Z2Z?KUK\SIX%6V7AJKX&V1T<(]LVSV8-1SP]PVW)6E0WG]QH[IE%QU%?<
MY51./H\#3TP8VV7+ICUS6M5M6&V!MR_.J[H=W_8?0YL-Z5?A]9\@%.X/\Y+J
MC:AD'[%&@PU!X!9=MC-BA><!-5_YNZSQ[INWM<N\M91YEK+;`Y1[9BG5[3VX
M_Y;RZ+C$+A=;-H+*'BRS1F!7@G48P7&GL9,-@Z?F6NU-_(8"2N.HLE7MQYCD
MTJO!KGW32S#$H\JF^<\:>C8HV[(95#:'MV9@P[*UF<%Q91/T9VT&5=HZ`!2=
M/+=W;3(H2C:L7QQV]MEMG53V!/ZN%\WE`6_7R2S@*OO&684`M^,>`_L&.7L`
M?..0VW'W@CU#W&EE5U4,]=F?$=S^^1;^*6.O,&"747@G\\/V:XW"3RM;5'[:
MRT0]!J)P[0MHC\),9:O!3\/,S8C+JD"F@R_4M_:BGRU`IEG=7X3>_[AD]Z>?
M-!OFQ\$NE8JH[V0[/2=?;7TK80N]O#6V*[N$6FRO"]M;KWML!ML1J%H#^U?O
M4P'48T95)-D'KD2GU3P^@Q')1,FE[.0XT[R9KYG4.RX%"BZ_!9@7'Q1O_!&-
MF:20>A4UMS1;65',GC%#[A/SQ9C[#Q.,U8C/H9:A6)XTN9IY[H72TW)3<U2S
MB*6%LT/04U1*?NX`_GS4S!?_^+(`3S#B43-??NLMF!E&/&YF"`/G3*UMG\/U
MY29.$TH^],&)._C[6XXC(A^W(J\%^@FF;L`6/WK@;S7Q&SILUDALHC_9`']F
MO?;A;U[X%N""(UY]=H=4]L[/FZUVIWM\<@J+1N,54>'$@Y5E`#?6!W3,O0DY
M(Z]NP)\I\H/=D9]B3/U7;VM_&X9O__J79+[X+J15IQYP>48\-@C?$OT-]W'U
M.2.-`+X94SGD?ATOY[^1?#B*OWK\["Y7@4<G9Z2/DEB!&M+"ATZ(I1-Q'P)V
M]I9D)#)+(.:ZXO]F9Z2I">DO[IBATQ>>:PC]N+KY3!)J^$43/QPFGTB=]"Z_
M_KC\<GEQ_N.&G%]<7/WZ<7/YXRNYOOIV>7'YN7>6&Z\_@)"F$LM_*LKO(6D9
M0=!Q\/8_FT>-&5,_<6:XJ2\/9W.]\FQS.'(\JA2`/9)*R&O!`?\R,SZD?8\1
M#:+W-8?IJZ`<Z3+YOM8`@V&>%U`7?[,N_:P"ZB2?L^914G:*CE"CPP=TR!@=
M=]P-1SBX\5\)^S%#DMS&[(0BR'+J)L0,>S&&?8%@C+^*09S[#F8I?-,782C&
MR9<Q)YWN0;M;,K5%`#@,W:UQV#I^V!,\SJMLS<[IP2([W8(L"^*+@?:O2$$N
M,-FN/+XR'R(F;Z'WRDKE,)196SG4UCO/T^W*[VUJ15K1I^VY$ULT]T9<R'$K
M-?N\=@NF%_.N*=7F*W<G;J[R`4\NUOFM;/[+>\A83?ALV]+2<U;,I>\(&0BI
M2\^$^B[!W_?5G]26O/3C??9R\IRYXCWLZ!_)P>GI`A8T:C>B7SWKE:1CYI)K
M2-['U&%1B)4M14#'!^1U.&(D?NS.\5L\HTK]2?+%R=O?R!U50#Z!`\P#@#@/
M)/=(L_6&X,_;O2$1R$(2G,JC=XJ(@?Z[%\)X_/"#W5*7'I`KGWQA?1E1.2'-
M8WWST1L]-*9+=-0--&`=$P`[0I/M#G")X8C\`Z91D$+'U3D2;XHHC=#,SP:2
M;^`27D\?*[XO^U@XO_-GQ"73#`12W'*LRL&L`;`-<TA3022&$WAX#Q)>6"?Q
ME"^NJMQ7$6B%.#2`/QB.ZS,2*;AE((PT0LFHW@)"*0!@L!H3H>SUT[B<]EG(
MU*)HT&+_"=CWR7?<2B/-)N(-_\WB#<$M60[>`P@[9L$7]9O[^A/@XXY*9M6W
M8?6!L^AH9W&<5UY.;93<C018:%W<^?!1I6>M81BY5)(R[PV)/2%XAY+GFQ[.
MSGB)-S`I!_!P!9YI2(?:,P%@S/:L]CKNU.L<D%^^QY323*9;.3ZZ*K!R(O#'
M2N^X8N8IP-&-,_2_2A$%4])`9,"D0M`]Y+Z1`PW*E'N+QLVA\0L`3-S!$J!E
M3ET1Z/`(?,&TY(K^P7>I=!7Y%;CH*C+KT'GO5W8-RH:_N*^>4UT]%QPW<M?>
MY!8[H#ADY#/N[W!XC-<W(N!.;O+39C=W_V]Y0Y)L+&Z901(8%3./!=#3_',?
M?VUW&@G".FC0R6"H'I4Q@36B;V4@5;.Z;'-YF\L_AY0QY\QL+K\_BLDN%>B_
M/0YIC\M#\/M<_;'_Z?QZ-X@61Q3UQD&CN\6HX@9671W]+1EFXC5<J?M<A.G9
M%#+@S#.))_=]<4OQ3`L)<C$C4<*+=`GG#2[S7H0KQX9SVS=IB`HWX\@RK9B&
MTC.[S`/&(6K'H1@PDT!XDP!#$C>9;01)FR]",M3;!CKXUT',+?,CG`83.!ZJ
M3,GJ`$(=C,XBEBED)66*-)U0.FA'SN"AH@!']$/*?922BO#P#\<K@\C7@L-X
MSP-"(!E'H*8#*09<F\3ZPZ!Y\+?F5#2G7N0XD(0-(@_4.0X\-D/7KU3.H$!Q
M0TBR3!D)D1/B@3&>1,$^AK]>!DX(%9<%3,NEB!2?(7E,/"4;1AX>RID0&F"!
M":TC+2_\.N@=D"]"N*9X):,A.7?',(<*8WQF$H<OG\ZSB4,@.5JA(`I"/B2*
M3`,%-W)"8X"QC\#S=8!Y7;.(K0>L#)8(?S9W8\CAT-+-XYCB%]+($]"1J:^9
M1&,^(.#")!JRC_=F`P%?Y"R!0(`;X5OO6'2C8;X4PW5>X3!T7#.80Q7B./0V
M4V:0J,O=Z>-1G?KC*34.]]`QIF5:^X`>0.:$!,`#L(EBR-&GSH@#)@`$L-8#
M-O"FU*=0E_T983*$\HB"0,BPX&+`I0)_(69'6A[3>3TE"+L/&$H.;@?/&\D<
MDW@1'B*,P..C<P<O!"#2$-"^%+F<)1#X#Z&F_28#]N>+AKB1C--6+G%A06Y0
MSADKP`GU03[PEE<IFL&6_V`ZKTW):D6!GEW]SA+X\JDI"+]@9;3//8PT\+G1
M%K6YX9"95J)"%F`]3I=E-?8,#F=Q,0O@QG[]>.'0&;F$C#BO#Y`*+AZ!Q!JR
M849$(7KPV$G`.H5G16]U-KT]3UY]SZN[7"`&$(0`<HG*=J@:(>)$))-"O9.^
M&1';;#Q&F[Y6(/BW6[0VO!A$?8\[H)L!0PRK1/.*WT^SO3'P,XKQ2Q",[G2G
MH76B*[_=!!UX\P0BJWC<>31$I]<V]>%.OC+2AW!$.P4>IKC7:3A@<PS(U.C,
M/BZ(T4>_F5U>IFA*@R%'2+1"82*)U-_D/`&:-3@4CU&5V,Q]F#\>ULI[5RT%
M0Z3/)B*FI8LXJ;L=<!_\+[H=A3:CM4`H^$(.KIFYH!`O'(EH.%K2C\=.?PBJ
M\PV51%1H93[#Z,QUN5DK=.RD,LM7!%X+/?,!N=2V!WP@+Y%O'*9&@P.!IC*>
MT41\GG'TF<42/)D6'0X3<G[DG`S**QE7!<VH7NS8'SF&C;A`25,7NJPB'O(=
M&TB1Y@6#U2R+;<9%E30RUQ4_)<3>6-U\R7KAD@\V:])'5"3MB4E[8G+3-:S^
MBB<F\P^ZR[.-<`^6._3BJM<CC'-\#)OU_A$&(-.]HVLI?/C;,<OREBIS^Q+"
MZBK^CD/82S^)!Z>QX)<T8IJYR_=1P'_%W>0OY[V/V80]UO_&MPGSVWQO`%`0
M"D&4FM1`IL_22Z._^E>!#%T(P)WTR>M>U`]+.XBM1G<^V4Y^=_*W,_*)*\<3
M^-H*4OV%,V.H;&+@/N1;6';4.Y:8)9Y/L\2D3@<1)B3B!<YR$GJ\6#*RQ=20
MF\5%Q0I)\D\%4/3I,$Y9!8:\R=X^2QC/I+=.CO&A9MR)&>]GSRJ8FJN+L2B-
M"XE80(HEA+$Q*"C`>JB.IC$<CI,+738U=2,:882*=<D$1@>D!Q&S?@/(\R8&
MN11X=TV$_SHGC[RZS.$G%\9#L`P!+\]6S/0QA6RUPA6`CS?Y"5N%"6,1HI(9
M+,B1P1_3A5W)L'J"O,?IVK04K>,+/D[J$`4B[3E<9R2&*1,(7<'7:;`.J28?
M&K$SR"$=70V:JA:TB#E;D5AGSA,E:G)3@"MR-X+4IR0B+!*"*M@M-R5JA`6,
MCCS-0,)E:ID+.>H^(./[0"(VTXS.G-C459#E&,5<;<JLR<ISU(_F4S>&H<GJ
ME#71*SQ4=@:(1O))DL[!Z2",3PZNE*:2UTCIEG(OR<;[R26PZ2=YAS3/-VC1
MVRA2)!4SL$']D+X?4:^$9=R_,9LJZ6,-N%1A,GY:H)@.^@3Q@'XQN-G5%8BC
MN$Z1,P63&W/_@'RFTM,U0`^/%64,-?5?H$ZX"V`?QKLUN@HYFV&B]XNRI/0=
MYM13SM7-5,B(@G00.Q.&96-`E]%!ON*&^S7,,^D\:(J9)\#H)W_T4A\<?9KN
MP#('`'C@4J/KP8D,D[E3/$^B[7)7RT(+Q=054+!8X(W]CI^<#%/"TX59=Y98
ML329+MK;K3]N.#"TZ:M-7U]D^NI4-GV%V-O%DJF+4?C4;<W*(S#9"*B):&SJ
MNI-C)$ZJK46+C(K#;KAJ(@NS;.DU/-!Z-#LQ%#)6Z>I*O]Z+S.^WQ?5X7,X=
M/#:*<>XTQ<T$YJ]K.FWY>GY^7?O-1*?Q+@[D**1/%0;+)KG2J<UJ3\"+VX[G
M)MKYJ:,=)/5%0!;3;-1_3X^O9,.$[$;0U./ACM"#T4`QZ7]X<,I"(?W$_<95
M]";9`&,I?0R7NN@4S/=IMHC[Y,F9!<DP=]3'$BCN*L4;4$E>&2<A0&JZ'VMB
M^`'E,A.2Q#&FR5_2%WR2X#0.6##NNXCSH^*AX6P:8GC3V>Q4@7&`NOCYIS@5
M<8RKU<]5,9`UL2X)8/6/J,GA]3/HLT:F$J=WGI/(4Y^C1WE-M^H^WSLCZ@\U
MM,80VF)`1CXRA^)AIG"^P26<S'P`5^@P,7YXK<>8^D-"2W?%^Q.2VE(V%YE%
M2Y<!)D2-1.3AGB#,0MWXB,&_(K]PQF!YRT/FX!E8V0:7M`$3>R=P&I2R$)/K
MF1U$`TRN\:+?I<"43(-\$'E>UI!?J63*9Q4VKR'2>?A=]5Q`.G.Y6O+1E_GT
M[G"UEC7Y-C<_6(COIH[9-Z%4TLVF5>QF<U(CV"%'?\)V4\1E#@>?`\E`O5W[
M4&]WV^U&HS%E)3=MH;&.[GET%84ZP=9E*D.U7:3:S%"-FRD5"#<;S4:><&GV
M)1ZW4VK>L[ZGO<)"`RZDDHVP3=DMFXZ$VZX&-_0^X:-;Y*-;9.1>\3.?>P!=
M&;$:.7P\K:,BK:/-T3HNTCI>*.!63K[+$'L\>R<+T;X^49RN#+6G2F*NN34;
M!5Y:R]C;"?*SO+WIIH0CR'Z85*8Q7TJ^V#*KM4`6S=9IGG)IZJ5)%_U;J_4P
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MR+8_LNV/7FC[H^R;LJNEK";A%7(<G*6=4[*-4](`9!I_9+JFS,M_2R^_VOS7
MYK\O*?^U_9-L[FO[)]G^2;9_DNV?9/LG/=O^2>\.UQ0YSVAN<:DSLT]Z6^Q:
MR^B?U(L8+`OZRK3I1*G[2ZFK3;[?Q4FYV\4B6D]AK]3]I=0()\]>YZ35W2Z'
MI9XQI?8Y#_>G68E:J]@59M5N.*M1*S:!6=`+I7/2GM&'92W"-XULS/?@%M)W
M"Q-.2SVQN@N[Y726874.W>6%.I_E4J>9!=!N'2TMVXWP6VI/LT:@SZ=:V@Q?
M(^#G4RV7(/9`-1J+^AP/AJZP9.BUX*O,MH8KN?,%H.H>+64&B^BO]R%*3G^-
M2%N&?LFEKQ%S2]!OEYS\#G0XLQ5?N[0@K-@#;_:L)>>]8K>[V;.6_.MC4#2S
M25B[Z`K1ES_8)*S16%-_LG;1'Z);?KA'7;/=75=WM';1+RX(%ENM=GM=;>':
M)=>VH"U<YZ3169O82RYI@<8[A<Z`3R!=\D:+--XZ+K4!?#3U3M$7+7CN5N/X
M]!%HFQ=XE4+2SH,>:':@=W2ZU/)<H+A6E]YY,#[=5!C3*;G`%:E^,:\C7.@3
M"9!PXIL75)<!OE+NH[?]J,_J9UIH=E9LU]K.ZV8%BD]GM>1+%[#:7@^KL_&2
M<K5B[%E:_6?.OA('14^[4"XSFOPNX``QBV7BJX%&]KGO_@^5(,%097!\)2\\
MRL=3/)>\\$IA^4HTU\%NT7,OD&-!D4]@-P'@E=^C'DQPZ=^RI/";=#->&&0^
M[!J6(5'J(;M@S<P__P,4,OO.E_$1]$_,_/__[7UID^,VLN#W%_'^`Z?F>=W]
M0JH6=:L]=H2Z#KMFZG)5M;VS$^\#)4(2IRE2PZ..V=C_OID`>(&W!$K5[7*$
M[1()(A-`(B\D,B\LZB<S]#,>3LYR\K*8JJGK$L^%F;QCZ8-N-0>=M_QMB'>*
M69>I6'V6`U8V0@T/4Y0.)<NC#D?['R4/1W!OM1<\YX.?0(PAD-(AULX=/AP7
MC7$[;)H<8$T1UE;[C0TPY%MITL!<V+8%G]_:KN<0SW"H2_MF9M)@O5@2Y$&I
M]"MF2[L!KRGXDIF?MP*=,F1/-'=URV(=]4\OGT&(7EC\AHFUG$:7E0*4:XK$
M-HCJ5';\BC!WQK6F/&R#^=B1@BN0,Y4;#_:4I96#'N`;[^76Q&H,EHZ&";^_
MSQ/PU_3!)*V]ZO!VQK.FC)TT@^?]RG:\!^*L,]2`84UQJ@Y&O6(LLZ#M@F!=
M03@>"OZ<;3#$^\%$=\\=>XWZS14>N(-Q#)-^8ILFNV(,JA]VY.7@7=?4&@T$
MM+?'0?Y@:DJR05>P'!L;#'00]'6SN**7G5$VQL[^@R'L*+NV!UQ3;HV+R:`4
M;B5!P.8W4Q`,ZPJM;G\TJB((,F#NC&M=H:7VNI.^%&3CZQ(9@QA;8EO4)`PK
MN-045JESVE)(VR)64SJ!=CH>[8)9SE2?!Q>%T^L[JBF=^N.^6F5U,T#NC&IM
M@ZT_&4C!]8R&M-\L@@"G.[`!;BSL"KDK_`_UA$=@'3&&/JIK>PF%5.K`E(!M
M3?&C=B0AF]V&>7=%BR)$MJ:+L#T<)M&M`U0"NC7%TV2L-HKM%#:!X[P`O5/W
M>8BF*)7*#O5&PVX%/`5HNR`HBJ*2@Z!N=[1?!,>B'"HY'E35SIX1%.51271$
MKRL<G6Z!8.;A]#A5XZK<%)Z(K#ROJ-TIV3CP-74PP-\LR19@/5WC;;!_)WS]
MX]014<F,))"H`FD'W%+'[,W@1GUA*1/N'+.A7%AW+!\3L/;UQK1?"+G#>'WW
M\\:&5X%#)\0XG;JCWGF;9CB4A*(;U5%ER!#(H>Y'??WI?/>7!^+FX2P1W)R\
MSJRTE?/IQ9WRV_3R\UEI9:57>8>E/SC\'1;<+G@%#AF\B]="2'A19.,801Z[
MIRB:G2>Q"O+F\>O,'MZ+Q;,+&O./Q[@+@I<:3".X\4\O'"CTPAGL&R\ZZ85N
MO2>\7,"2H$$OP%OFQD:C8>_LQNL:]!*?\PF,[3Y6+GA?/.,<4Y;H[0K7PZ/D
M(!$7AGM'&"RBT<:ZY.F2EK[!KMV`20G&NN&N:+*\V#<K@SB8=^F%S0I-\P2J
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MKXT[?<XPKVA>7>1,-&D7,`@/WME.89I?;G*"&J71[&-!?JQ*FA,86N6*D^"T
MV+OB]-760GL-SI$IS5*02K3=B@22J'('VKF.VGJ,?IYH_0![#<1"A><BEHL-
M)9RKP1]N%)7PKDQ6OC]6[@EAR?<Q+T"BJ9"V2^+-_*^!2O99,:^00N;\1"-6
MI8%F@@]3PI/H_*.%*2,<CV6/U,G&=@U\R#/]\XA51G*M(..+JVQ8C"E+#Z&Q
M2-,H4SBM)?!LK&GB&%8:(2))K)E`@@P=%':;PEZSL!4DPK!<@&&YGN.'*7:+
MIO$HA^*RR>^-`'<6ZU76@PHSL>7<-FWGH_)G&H?7J0>^=]RC_P"I]_OJ9/,<
MO,:N/_)T,_S9H^88FN4)3P-_?_#0)!A1UN9:;.PY#**]$AK;S@:L#?>CHOF>
MS4\W^'D'=#S[8GCMS'./9_Z$.:BALU"?6QD>H<!CV(.2AZY4184_00F,<*,=
M!8!HA[`]["^DS=5"^EY8".5/QAJ3X\!,P`R8MA:IG-K\R]*!_:RW@R59T'_8
MVD4R!+:C:5O+=H)%,`F0L=-#YD,_!O9BL*HT!(L^:#S["^HO(*@<^AV>EH4<
M8>,0%%!1B136B"E&$1HSS?H2X4([UL+,0B$(AU<4CLNHSO$DJ1M]E\P5>=Q)
MYDC^CO(XFFITS1(KQ0H6@'GIZ&!]:@XF"`5(\5Q3F"*4IZY<,[:)51K"&F0;
MGN&6\,-)A>YBID_2!#Q4EE-^[5(^C*<.7*HS)WQ\\G$:(B9;Q@AEILLY0"%1
M[+LT14]>HLS"@UKQ1D(09WIOF_JU[?V=>+<^J./HB?BDF7AJPZZ>A@>\8KS,
MI/"*Z\7U.;WCVAN-XY<1JD+-N!EX2P_/`FS$L)A)\DS[ECCTHSA*W:.?1L=J
M#)VHV]B1.[TA6SF6<)RZ!]TIB1#N\"CM&L"VC'.<I`(P2W#;-@*3#N4<"=YQ
MSTFX1I/4K>@2^.H@-C51?V6WPH&.8A2?BDR8I&,I]Q^9($\!:T[[J1PV("0=
M;BOW#S<G?U-^N;D\/;N[_UXY^_7SQ</?*YR8OL4,1$7K_QC*)#<?O@D]\MI^
M9%G3>UEUP*B/F:51!&U289PY$';*=.D0=N!(,Q?^#*QU^6PHO_O_7MF^<ILL
MPOJ.UGI]#UT?MY1+3S\6DW8RN6H[L:R<K43.R"B9>E2ZE.:PY[IIT`%5-9>`
MVY+IE\DMG-"'@J<@XUL@Y),LP66J`RTR@,("B!J&WZ+5#GD4#+S[KW@_*)J3
MG6Q@:FE'06S&$R9Q_Q?JP1QM9/D\2>L\J,47RZ`:AQV$X%QKKJ[]2SG1-@;6
M+V072?#ES=RSZ6*&5=WH*7`X&4N:.6/#)2+U-T5:*DB'Q&`&K8Z@;!_'9B_\
MZX%6!O.B7OFX@D4**W\&I>R8UZL`<+\%,CP!N,5S_(-Z[L]9Y0_,APGB$S/J
MD_1"@!1.KD-4R"%$(RJ=EIAS9A.$K:CY0\^UPJW"W3G]YCQHKX&=IP;WC8JM
M-YGUM<FLI(=[S*1/8+*CH+*01W/_A,%5?NI+!_,]D%F5G9%5C-;*^GS2#+@#
M>05<WR-ZK5C[B1A97G89('F=LR94.2B+`>=E-T`DHIQ,GP$?TP0:+'.&D/1A
M(D:9E\UL5[CU70YJ>]S$X/22*11RWM1&[=0G:#+39H69,B:B4Z5F*JSJ@&I>
M(^H).0Y*`27QXNTPLIF>IN`5/P$AT7%2EK0O@4Y^_W7Q4#LU<\F-QEMADDF7
M:D=TD91MFG%7N#Q90(4Y($5W2%GN/'4D#+D`9.SZ>K!-KFUK'D^X$R%2DQ7W
MA\/DT"L`VP&[FERWMQMJG,7PW"PGMAM'I29G%>\JIWJN`;HFXZP-.B>QQS6)
M$6PICQ3V2,J'F0MC&VSJWL<414E5;$1ZK,LONQ,AH4(6V0E`U+IY-=6Q<%<R
M$XB0OLG2>0:GRRC*0^12:DW&.!@)@ZT.4P*R-5GJ1$@!N#6R()4?[$*YKZHU
MN6QO(,K]'`CU,:G)4?NCK3`I6J>:C'3824Y&V7(4@:[)2"="MJ$RT%%2+RIL
MDIF]3K&B*M$_$0O^\)#UN+'^(L$485N3Y0J:O`Q<&AU>31[>^/"")B_GMA,6
M*G[0GF\Q"``3LF4-HJY`&&425`60N^.:*A!2)E<DXYI-!JE"(F6L<9BW);>$
M7U-LU(<?.ZD%EGGCT+(]+#US<$`>85,B*+).U.DA?^>XHW9CR0C*8>8BR<[^
MI[ZWLAWCWWAX$B`GRH[B_-H4KUXG.&JO`*D$)9;,.D*G2)#DH`.:8[>C3GH%
MZ#`H-5$I$BRYJ(`5.!@,MD<EX:!24_4]:KI^Q(ZK@JVKB@NY?(K!3G6=,A?-
MO`4;YL+B)T89<19JJC1'F;+:ZP^3XKT<V-;(I>IVE*E=J0(%M9&;S_VU3Q4U
MEF\7@[3)"L7F(XG2@X#%<[.()3Y74W4\RLBHD]+YZ\"5A'1-)BZ68-@)Z3N"
MDI#H9YIC&=;2C76&BLC<B(1-JO!(R>1F5.@HA[8]=C5M@XQJ$G6QBXE/4.7R
M:TVHJ>(FM2WO,E#;(E;3IDA;Z_40.^5!J=E^Q50EE-*3E=X@R8\S^Z^%0EV!
M,.Z/:Z.0E7HRA4A-@3`4G+H%,.HC4[=8BMH1+._*V-`"HZ'7\\2F%72)-8]E
M"U13I5)2V!2?>*0TE1O?<SW-PIN;$9`BIKR]4A0#55^%394]J8#3CBILZ5H4
M:=72UJ(97;G*6I3:/*FJ)KT]V3R7MK7$1,Q!/%BT6E-VL2G$4.2JJ7)AZ6.R
M!(<O`93R@"\(K1"LF><D3BDB9RU!0^!G8K^QL.$R!*\`ZLI\.3>>B1Z++593
M94S423%*L0H#-6'&L+VS7S33>X%%Q3ODVC+")UVY)(X/0!)#T8&$QAR?5*]5
MZN),L>K*DCJ=/KU$37C&N.F3YN@W&^H=^9F69\'$_YB;,E$!2DU50QF7[\YN
M9]SKEQ76V0F]FN-W:T'XG4;^$'WZ2!R8Z[-GF';#35XO4%/55L;EG`$6=7A<
M7G*H$<3S9NQGV]91`%S;5G`;)RC2$RL-Q2TZE")X2A?-0BJW;UD$O^`QWQ&1
MW4:%_)?.^!4!&4G#-S`,YM3`-,.6CMEPHY&*HG!<NGMW&&8%S!H9^F\VEHI'
M3VIR\**(+AI\'P<_FHPR.8!$[*1.P)WA?CEW"!C4[/Y<<OBB%E`Z_(XZ'DH;
M?A9N0A1+4$GD$G/RN><^7M:[,BQC[:^##*&G/A$5_W3AF+A(NKB\CX^K`Q(R
MZ96K!U4.QJ*:T2T1ZMVN-)3KKB)7OS$4^Y'6.0PN2$6C227IKZ+Z[L9`<[':
M;;"_XD4"6GDA,@$%1W2J-DUW6#Y:K/VQ_6#SL9)0)T]-%[$IR<LLKU)>9?,@
M5<6F7W:&I:I-V`>I8C5E>`@NYJT,A$^VY;OBA(ARO`R1H&A.=5C;+I4H9/ME
MIIPZVF&IJN,E2K]^&<\50IIDD9`HK<KP4$>IT*H\&LHWVU)%7WJ=4L6O7VRV
M9;^[TIZI%`H?W"R8=G\7Y/\-41+%1AE*ZG%(P/7!"O4S8^]8)BB.5*J82Z_$
M$A!B-<6.*RU.JE!+3RU=G-XVBQ-!3#D.NP40>PSBH%EZ2!58Z?7V1@]WY)%8
M+/2;-8NP2IW8E-5]4(5R'ZF^*X,NS6<O,@I)<$5..>P-^KTR+E4'=H'3MN""
MNYHJ9=+<#?>W=/L[W)M/IBQ5VLK)S=75Q</5V?7#?7/Y]AO+[_26@'.K!)R#
MX][@5>?@[(Z^GAR<6JW$CSFI-1,TWU1^AWNR\=@=:)7=,%=9OH![?^8:NH&Y
M[I(I`ZSHPB6[IOF+IFNNX;6$6^Y71*=9`O":]LG*(`OE@<Q7EFW:RQ?E9K$`
M,],1$P:</-S$<@703T^=8^54LPQB*O?SE>\X<<R$SSDF41:#>&>`NT-C,6CQ
M"-]D=\XQ01],(,74<PSXK\M-X&,%X]\=>FC([[^G^F^%CVBZJAG!N3(\DV4P
MT%B9"ITZ?VPK=:.]*]S%QV^@"UI<8_8BK$*T"VD.><2,>G7H$M`LE7,/4Q!L
M'!NP<\,K\*[GZR"G6TG0$R%7"C3FN0SP(K]#YO;2HL?$WLJQ_>4JG?BP*"ME
M,H&E%G_U3GU?*V7E(1*D5LKJ\B9EWJ3,H:7,3(:4:3Z%4,@[,%UJ!0F38-!)
M6:/Q!(!8.BC%_D_89UJ2[]-T*9BTQ;!U,37A`DS+)"/$/()N?I*:``#C]QM6
M&C3`EW-Y2W'!,@(Y`"(N*6#6&F9^X*D58YT9KB`W%GC$KZS9>7]F-I1D3IH6
M['BTJ'DNU_R&WP5B`=.[1-\PV0&@PJI/*?DCY%"DF2,U#Q>&U8W27,4%$P/Q
M/\/5U)1/ALVS`D5+Q%[%EP>FZPKS;0<);E26X1;FD9XU8W^;(#N1OU&$ZDG=
M3FO<2R9!CB7YB>>LP10_ED+XX71.LI^AF(LR2O;#<\@PI/`6+58]*"&F,#NF
MZ\'LL@K>F/R'T/JQL7TQI$/OTJ&3YXU!\;?$!ETUE:V<#Y*CI67G**:+D\RE
MTQD(]..[089-5EB*[CW7]=?LQ/\CR$AV"*R\@"J6VDA"!L\?@I'0`U26ZECX
M8G`\&>6D<:)[\(?H\\?P`%;L9#0Y'O6S0#N&^Z6]<`@I3DVJ'H^'R<_S9MBG
M-Z<Q:Q";$-RS>+4JR@%.-"#B&4L6"21#<(,13(:"4TG+]R!B]+-0N[(?":MY
MX;`+A('R&;"K:%5<S]%0IK1IFI4U/:%]TYW>=*<WW6E+O62^A>XD8I*G\$Q!
MNI@!^^V5:3M(=":M:A@I.ZBT8()AF]K)P(_F0=D!$#H7KJ,1,\@^!TS&U.;4
M5"/I?C!36U)@JDEW'V-X63@8;J'NU$MR3J:M).1;F%VMSR:"IV9F0I%!V[#H
M!X1U?7&?5%PFJ61UF<,1I']@L`JMDLBVHA338'`#%7V)<@Z&-28-EIF/S;;!
ME+PUC(:I#DC+SW'5YN3V(J[7O--"52Q!9*7TDQ+?];M@%+>@82:9\^TJ/DUN
M[?&ECVO9;$Z2CHJN,'N)ZJ&$EW%G$E;"L+<9,$[4^_26CDNA@Y=:&7737*Y[
MW,_)C-=($8-Z*#3">*=N4/[D)6)S,P#-S*>`,($CB`PIKLYSTPLT+Y:9?@FT
M`Z845?BHCY)%$X1I.>/DG%%R-3"UDKM$9C;(-\7H33'Z*A2C>F;%P9Q*5QJ8
MQ54R'%=U)FGZHP'[K%#G\9Z(*1KY3._)<QD%O2;\14:0UIB:?=2<#$X=$HI)
MW"G$/3.`6L"K:*$*]`WA)PFK-IWF-]LI(N8B9IX<#IQG8A:='+;O)'MF+#;N
MXVBA9H"S.+-]KQH!I$^IA:T;@*-6-HQBZB]],.K#I,BAKAD^B9PGW`N"TT2I
M)CC`*"SIE$Y([?I8`H2O9\(+T1ID3S=7>,-<S6FW`E\67O!7IX5%^*NE0_V,
MHNMF6*_DEPRMYTW8O0F[;U389=7MD2?L,D&*C;[-Y-3?7'6N^#G6,*YVY#MV
MP,RQ\2Q#U#K"\R!@_82>?=C.4K.,?S,+*.Y3N(O'0[1">^F6'H=<7&AB\,*"
MU4JP'2:2?1/#';0-_,'K*[]LB*+"I&@S@K)F`R"9R(Y*&6#Q2B`#)ON#\@,T
M.3Y*S&1(0X!0H+ZDIH0&,U!Y>G>#"I>-U0VB*HD%)0.Z8T&FQJN`\0,%ZGZP
MEAJ[MD@E?.B:`$7!((_L!19\8.FY%-A7J'M9B"LH+-M$/J191I[+X96XXQ."
M04K._VSV_@=D9=XA6%F69V?0SZ^[H'#-B#?MT=X*^-W^K+B_^K#MN]UJ_)19
M:P([I5JTMJ8,)LT@9ULQR&X^@\2C^O!8$\.U8+H#3S'G]['BA'/,9:]K3EB>
M<+`-#V6VH_92E8]*-KD27+G7ZDX:Y\O)`CS#9#B9'([]=MSY9NC\D0R=Q=?B
MU:.A0)7D`;"2,`-@6LE^!,9K.TPBL#*W]AS#8G4LMVYO0KX$SVD!*A:?&V<\
ML-0IQD,/*U!V!#(#MAU@1$5$(`8BKISDG&J2CPELKM_9E<NQ0\T9W@B-SOF@
M&Q8UE70BI2*/XYX_JK/[FY!7TYI96>HSSJ8[=XP9LQ7HX,-UH([,:`26[<GA
MU:\UJ$7BB=P!RCQ2Q^A@YWT7:F/;;;_P\_K;JZN.A.T%UETD*:+MI+E2Z/#K
M7O'J5NO7/T[YO5(Q\:=V6_F'L5"6'E'6KJU,_B<`^+PVPU;V1W;5Y=2>^[3`
M-!BEF`8TUN`.5/8;Z[>KRW`!A&>\W13C,F^O?XXUBS]2^+-\>)P-<O3H&/X!
MV]18_$^[77-83Q]_!\4H`!)[_)M!GO#G-;5X*;SH(6_S?VQ[C3\[_'7PF[]^
M<,`RO;(?B1N.5'P8;WF.D.@@Q>;)-_R;6]_"8&?D.'\C-"5K[+/LE\'0@&3Q
MA&:ZU/"TZWZ^(FLMCF-^`][#O?9(+A;_^^KRPD*5F@JRA6:ZA'>0]9Y_>K&T
M;,P9\TSH_5L^Z?&/LUOPSZ?FD_;BWJ^`6C!8C&53Q1N[8B^%#7EGI_:U[=V"
MX6![Y-?SV`2D7_`O+@W]`2:#T%3"^/SLNOWYGG^5>BE\-'4-S<+G_[M]?7-]
M)GP5OA6^.J%>S.=[4$\V%/E?Q"]3+7@/].3/,UAJ_]CS3P[1OOSN@*E-]`=:
M5"LV].R7P;I;VN;!_MFA6:K!7HM]E_4JV&'0&\[\[R!8*6'&/LM\Q[_[[+))
MH2C=^4D\LU^&"VMY/SOVT]3W[(7A)58V]288VP:FZ79)^YM:6`)%P\2L\2'F
MM^!]G%DX8S<;8CV\;$AZ6^:^C^%];AJ;*\-Q;.>"2BA7P#[S/?_^YI$XL`*$
M+MP]2HI?-O'O<]\KO$$VR:P_`OM9W3K"@W.41^N/L,-_/#K1UC/'T$#]\E:1
M8([:Q3Z=.5\^H0+./IP1T*Q(_!/V/O4!J''!-TP;Z@]^:*>_@V:Q3UW@W>8Y
M\-#@4WNQB'\3OH]]@Z+UE"QBK6)/>!OSBFH#0:^=>)_\7:RU4]#:2;76R>*O
M(;[,<4+K4\>_HFUBWSS!-F+D$'RH]OL).%&+V&>@!U\:Z^`3UY_=)\&P][$/
M+-`L8U_XEG[SZ,2_X`TBFHK33K#G!8E;)L[K2/-+>I6'DK:KP)I=@CI'=)HO
M]L<C*A^.\/%G:P7;X/<5L8"/Z/$W]V1M_&+H,%'QI[\R$1Q_=.L8-L;^_7B$
MI19C<$]0K?_QJ#=2C^*(N?K9\YRP^RT,J["WJ*O.D1*"8BF!K\&*^/&(:2%'
ML4F,]U<;S"0'S(IH])JP*A-2?$89,''VV=-"C+JO#J/>J\.H_^HP&KPZC(:O
M#J/1J\-H_.HPFNR(454D&%1V(V)7'K@-S%VYW#8P=^5CV\#<E5-M`W-77K0-
MS%VYS38P=^4GV\#<E6-L`W-7GA!QJ5X--L4P\.RY1!UI._CR-*+MX,O3?[:#
M+T_;V0Z^/-UF._CR-)GMX,O36[:#+T]+V0[^?G429@`JS(+?*^2%;7LT,1*>
MFNP5LF8!7!9:M'?8J'D29^\3O6>03))R+5O>?AKLJ/;/-0IAKU/!PI7LA;(P
MECZF4M\G<&+1PV2\9:5CSK/#`'>(YSO[G?60N3AD01QBS<FA.,QA$*"1_):/
M%[[V"G>#29D/`)=8^@&7.X"^=VD2,A>-59/#!!A[16"MS1U[OT.V-4F"I1[<
M2\/=[]HB0.63;YKD`'"O][^%*=S].JHHR/WZJ2C(_;JI*,C]>JEBM'N()>60
M#["R'/(!%IA#/L`Z,UYQB'7FD`^PSASR`=:90Y;G)5+SSH8?,+7"7@=X8MKN
MON7ZO;&T-,P#)6]"ZZ)P2A::;WH*!OXL'6VS4C"R9:^S\,G67Y2'?:NO(=1#
M^)_H;F*E.OS]DGD"\B'X9@C[`)PSA'T`WAG"WJ^4O"*NBW;Q+S)\?S$^H^8P
M[GM_YNV==]]KIL]<'GL%>ZIY^QUGQ+/.#<<]".?*1F'/C.0:'1Z_',`0CT:_
MWP%'</?+-44A>;!A<_!['CTMF+5WS>27EPUQ,.WI7J&>T\SB1)<%/9(5W6Z>
MK/`<6^(133?/F#A;;U:::^S7.QD$`RM7VF:O@&]-O`JZ=ZH]:Z\UPU1DF30U
MM\S#U:7R8&]HRCB@@/T#_T3OH$N"GXB=WNI,_=WO9/9^_[,PG<..?CG`]$\/
M<,9(`9\8>]8!&51;/P#44[(P+&/O:C:%_3?R,K,U1]\_Y%L';_/0ZC`'@'ZO
MX3VX`S!34`.>@`?M^2"&POX-,TC-]CQJSC@?]@XX=E[O^K-_DOE^Y?:UK>S]
M>/'&]VB0`'6,[#<F/0%ZO]9,`O1^+1E*U:";(2_9\X0G0.]WPA.@#S'A)YA-
MRM@]K'H7V(>8\@#V(>=\ORY>#AM3]2U\\S`+'@`_R(H'P`^RY+;IKRWW4+-.
M81]HTBGL0\[Y@;89A;W?DQ0&&Y-!'(30*.!#4!D%?`@2HX`/05\4\,&(:[_W
MZV*`]WO)+@9XOS?M&.`#F!XQP(?8QP<S.PX0=A@#?(A]3`$?8A]3P(?8QQ3P
M(?9Q[U0ABP69>X=1_V+@#[&G8^`/HP1:'L&*#9KS<@#P9R99:GN.?V"0;QU[
M0<#,Q"R;AW!I^#/O4(X<!OH0Q/X[F1UDR`CW4./=<\"#9IJV+>7P.'D3653Y
M#C";-*N@=+CAD7N0C5'NW.5%V5W;RCU+*R\-U+`3A2LN5YYROY)[@7:H)ON7
M<.@0Z[R;[%P"C<4Z[T7!E+KAKX.ID9@M8]C/`2$O(<9P(("08@'%^A]F]2\1
M_Y'0OQ1/3*S_<5;_$O&?9/4O+^'(*-R_IYKS1>[V&H5[-_3SRF8/HVX*A-PA
M]%+]RV42V>Q3F<XQVZ5,.LW@HPU`R6"H#4#)Y:P-P,IEL0W`RN:UL@#EJ2%W
MY-%`FT2>ZM;/T3_H>,(K0_(B./-R>/[JVSN'6<6&E1<H>H&9N5VBR`67(QD;
M(+ML$=D`H&Q9V0"@;*$I'U"&]&P`2*X8;0!6MCQM`%"V8&V`%HHEK$1-K4#"
M2H12(&$E0BF5L!)AE4K8QJV9!@`5,^_&[9L&`!4S[\8M'OF`"IBW1""ES%LB
MK&+F+1%0,?.62`O%S%N>&5S$O"5"*6#>$J&4,F^)L$J9MT18Q<Q;(J!BYBT1
M4#'SE@BHF'E+!%3,O!OU6S4`I)1Y2X15S+PE`BIFWA)IH9AYRTM:7,2\)4(I
M8-X2H90R;XFP2IFW1%C%S%LBH&+F+1%0,?.6"*B8>4L$5,R\Y0$J8-X2@90R
M;XFPBIFW1$#%S%LB+10S;WFYO(J8MT0H!<Q;(I12YBT15BGSE@BKF'E+!%3,
MO"4"*F;>$@$5,V^)@(J9MSQ`!<Q;(I!2YBT15C'SE@BHF'E+I(5BYBVO7$81
M\Y8(I8!Y2X12RKPEPBIEWA)A%3-OB8"*F;=$0,7,6R*@8N8M$5`Q\Y8'J(!Y
M2P12RKPEPBIFWA(!%3-O>8#4O&@&'D,M*2U5+'PB+UPTB&N0#K%7E`82AG@G
MJ21"#&)>,K%@C`V`[.6`_&3;7Q09F8ICL$:U8[:-F6G8-`YGUSL8VU6/RL[?
M?',B*4%CA%0_Y$8\Q1F-ZY878-#O9O4O[PRLW\OJ7YZ;MM_/ZE^>)Z$_R.I?
MGK+;#T4:Y<?!Q3)0%.6!&&:`4&4#&64`D4A&XXSN)5+1)*-[>40TR%KD@8)*
MC#P8:@:,89BC0AZ<;@:<D7PX150K/\XJFWP;@)-)QPW`R21H^7`**+L!8,4D
MW@#`8EIO8-DJ$+U$IEI(]$TS[P;@%!*]/#@5B%XBL&I$+Q%@-:*7N&P5B%ZB
MJ"\D>HEP"HF^:=5%/IP*1"\16#6BEPBP&M%+7+8*1"_1BBDD>HEP"HE>(IQ"
MHM^+XMX`L&I$+Q%@-:*7N&P5B%ZB:5U(]!+A%!*]1#B%1"\/3@6BEPBL&M%+
M!%B-Z"4N6P6BE^=_+R9ZB7`*B5XBG$*BEP>G`M%+!%:-Z"4"K$;T$I<M)'IZ
MGM6TSS$&I`FS-=9]$XI[K/LF5)=8]XWY'&,P&O4YQN`TZG-,4VV3/L<X^3;I
M<XS3<9,^QSA!-^ES3%%VDS['3!)OTN>82>M-^ASSB;X)GV,6T3?-O)OT.681
M?1,^QURB;\+G6$CT3?@<"XF^"9]C/M$WX7/,(OHF?(Y91-^TZM*DSS&7Z)OP
M.182?1,^QT*B;\+GF$_T3?@<LXB^"9]C%M$WX7/,(OJ]*.Y-^AP+B;X)GV,A
MT3?A<\PG^B9\CEE$WX3/,8OHF_`Y9A%]$S['7*)OPN=82/1-^!P+B;X)GV,^
MT3?A<\PB^B9\CEE$WX3/,8OHF_`YYA)]$S['0J)OPN=82/3E`/&YYD';>^_%
M)"X^_\__H"^>UV;P\9_^02S=6/Q/NQU^]Z=V6_F'L5"6'E'6KJVHG?^)OG6Q
M+]KTPW\KM.-8I4]7^>\/BH<('U^Y-BN2R/#_O]!1FW[;MF!L'WF>9=;DZ`>$
MT_;8>\=^FFF6WG:-?Y./G<2KN6VF7O%.;7=E/WU\(6[\Z89/ZL?))/%8<V!6
M/AYQN!M-Q]#CMF9Z'SN&I0R.^QM/"?\*&CE:>ZTY2\/"1JF'[1FMZ?OQN-/I
MJ-%'\(96:_SX9.CV4]MV-BL-/E[8EL=&H7:..]B</EEH:\-\@<DQUL15KLF3
M<F>O->NHY1+'6+`^9X9NM$W-6OK:DGS\Y>R'_\<7-5P9]CNYL+0%PDC]8*TW
M"OW\QR,^1#I\^F\XH`AG1>V**"O?"SA_WU(8TB&98O,`2KPO'#YM=&,!*<W)
M>D8<@-!2NAVUWU*\%<TC[\*P->=%@84C#M$5P_)L1;,47#N<8,U4M*5#"*VB
M_61X*_JA"[2F/,)$V$X+\'7HPXUCSXGK*CIY)*:]H5\`5>%SW9_3S6DOHL_G
MVL;U@5:!1`"P`:U=^)N^U]:V#Q]#Z_\*1H@#&0PZB2EN)5]W.]W$:_S^:67,
M5\J3YBH.F=M+"Z9&!Q".[2]7RCF9.3X.OCNFLS(X3B_G)K:]=>,Q^@4_@EGW
MR+/7-BP=B5^A5*<;[L;48/EF)K"C:*UFSH>P9[&W9-=SK*#WX]&)[[BV<VL;
M5E`$EC6AS$#13&-I_7@TIXMWI,QL1R<.K5<])Z;)]U_XVV7)RNGO''H1:,^C
MM&<![3F4]GX`"M"]%3;N?/<#1X<CY"B/'!W/WL0QU0-@#+VV218P399MD1\X
MQFT']0#A&?0B/.&<@#_DF/0'Q[U!0.F)N?Q?VGKSPY_582=CNC]X^MXP[(Y2
MZ.43#F=Z#(/X$XY`N*G%G1]2G&%A?=,R+I)D.V&ORXP=4#1QR5'Q]4?D&\01
MV-F5!GMV6(F3*:Z_V9@O(A/3+!L^<T(>ILWGL(1XIPX^8DP#NV6OX1/3A(6P
M_(4V]WPGY%TNXWVV!UQR#F+:`"+0`D:7Y$UJOXAUJ:.^?-:5OW`?/">^=S]0
M;I+'Z!IF>_5Z2WTV1_7MH_+G#OVG'DD--\_!`^P,]RVJ3?S9(Q;`MCSAZ1,)
M.`%[:!(/R*W->6OL.1!X>R4T9FJ*^U'1?,_^0:%#IIOF(PQ'<SS^*)J%9_[$
M<^`S+(`>\I:5X1$*-88VU86@=Q7^!&J.D*(=`>JS+P;TA1VZGF-_(6W.HO#]
MT1;RAW[^XQ%*@[3($:113/HDY486(P[$S'%W\%TV&64S\&`\Q^/N=S_`[G4\
M8ZZ9P1P#P_[A*"6F*NE0JXS]58A"K_==#14MLU%U%7"6U<<N.Z-WW*/_`&/I
M]]7)*]HG`16CD#GD=E$$8:;\R<`:7![,!,R`:6N1MJ#-ORR!:X-]%2S)@OX3
MBK.(F3->7JZ<"\(,D%G0"[>><G)WPS1R35F:_MQV"6[E]0;^"\8D;`8@#U]_
MH4T,T+AM!QX9%D@ST+VY6#M6IJX@SX+F0'B/!FCY*12IB-R`7,;G@`3`9W(Q
MTN6U#5@"S\8:;&?S);F=DJI:)CG#7-N^UUXZAMY>VSJL(]4AZ!PF1>UHF)2E
M^3;:#MM.]QVJ+<!H86W6@65#K"68CZ'I,]-<6#:8/VV^,L`LHB^@Z1PX$][>
M!$C$]8!,8$)E8894)T5_R&5V)>I#H;1_DRL)QF\T*U=NK&AK_17T5[KBG4I<
M1MGXSGP%]*O0^0ZM_$@-1OH'.A.8A\NY3XY6?/]DN*YR#@QZKKP[.OGE_.A]
M<O='&K.:W,;O$OQ#4*_[R<;OHPT`()2$JMWI5^]75<="OSOLIZTU\,)]4[CC
M2C3Y-Y?#F\OAT"Z'?]9T.30R<<)<[<>1\3,P05"I%D#HRB?#;O^5.+ZKF63]
MS9OR29H;==-$U^X<=^@>V]-:/"1%H8'Z[WIM@,VBHT<(%5O'?M%,SX#>X`%*
MPL2:*0M0\%'3HUYPHO-U7?C47X1-7$4#I5`!44C5L[B824JD[ZCJZ&\03E)R
M=81V7.F,5&S\M42R0AE%C$?`?L95<GN]T:P7Y=V%ZVC$-)23VPO4H+\0_3TB
M1A5906%/B,+A(`&<V@C0)B7X4FK%2M-ADWG*"T&L8#E1;B(J#BC$EH_S`L/5
M#=;*L.:^PU[3^7X!)+6981K>2QFC>*/GB)Y/(_/$-9XCN;2&QBME`]:"K8/"
MI\-2Y*Q@0#`A(<6)P;*3.M0RQLJRMT;1XNTZX1E"BZ[!OB8[-31Y_LZRWMXT
MN#<-[M`:W)>OX-#H9X%!W2P6QIP$(O-D91`P3>=X"(VQ(?SQE6'!+^",\/L,
M+%E[#?(3W8K$,5]2+2XLW<>_6\J#H^F$2K5+#1:9&J-,[(+)>W-R?_3^-9[6
M5".C8+W^"6,U%CS97<&FD2M&.WODZI\M='L$#CXWI!4F%[]WJ5A#(1L1U<E]
M*Z8F"DI>+ZF\M1/OCI/:%:B`H#6"UDDY-FB53(&$'GDP11AE`8*9PM?PS3_)
M'";!II@1O=68#JG;IJDYH?H8AH4$02/4VVM9/G4MHU,)]E2D_(9.T3ABEQ>?
M;NZ2&J9$=>^-MI.T/>4*/[2.UMM5GF"IPE5O*:X_QX`>#(Z+Q_1P&G&(J:%Y
MQ.G.I:XQ5.%!!P&;1S\&CJC,J0-QH2PTPT1#"`DCI%1O!42!7VTTQP..NC`L
MS9JC=0`VP<Q^)$E-U&#=VS.8(BUFF.$[0'45;;TWTFF0=*29?91ON9H1(Z&J
MEJ#R()JK(2VA:UHSS9CADNNCI>V3?N06+%=C7.A-HW_3Z+\*C;ZN3_80&OTY
M/X]RC6=D&]F'2+#U"4FZ*N(>$+?8!0)Z"]&<^8JQI9@$),\;3'/M,BT-FUDH
MCRQ"A2.H@?2+#/\@D[.M(,ZUT.&FCI*+$`X0^TZV3#1L(=X;8*?`_,Q2I]E7
M9FD4,<_@UU\^^&Y[J6F;CR?4AXM+YDXM_00F`1@?L<#.<T\-=V[:J*@\`+J?
M$*^?_O,_%.4OP;?W*UC<3ZBJ_FP#I<#WU["=UQO3?B'DGH=!/&"@B49CFW_3
M3)^><EX1;V7K9\^X!$1_`-M!50S]QZ,';:F.QD=X)(HS=$<6P-?'1S_=#OZN
MJE?JY#3"6R9L-BHP6C<?+VUKB<]N^<EN-#W3(*`$7T?83C*Q_<N'.KTE9_5F
M0\^"K>4E@4_<<^H>1RMZ[:]OM1>Z5*<^N;`>GNR_P^9S0V3&'0&9+F#G6P;[
M=7%Y?P1;=&ZL-1/D9;MW]--XTNETHCFM#5D:XFH1XI_O3T7$NUV9B%^"!D\(
M?@M=3!T@&A:?X@K]XEK=+'"/.$!4$?9=$7LD@M[P*D)P.PA)+*?SN>,3_2[0
MX$'AP7`F1OES]B/"J2?@U.L4SVAL-JL`2J)V83V"_4H'=&&=DAFVO=*<+X1R
MQ[-_^:"0WA/XU,#^D,^PX![T`N&$P.1X6>PF&DY?&(YZ]%/`4J'-]V?Z4G/N
MIU.UV^L/1I2L.]]G!`8I6<(SK1!E\VL>RI(95E='(=FJ]ZWD0R.J13)X<6:;
M.@-T??-P5G!DI[25:JB(6LS5].YO9P_33Y=GROW9R>>[BX>+L_M$UQ_+!/BK
M/`/K#PY_!C9]U`P3]VA[83MMU,(4-]RG5'5S"(9LHEWJH8>"VBX^:3&'EF^%
M9NL2MC,S3F$/H]Z'$4".SCT5T"M>6/,(GAEO0%`S98Y=,,!'#EF!N@CJ&-JT
M]AK_IQ#*-P"(9YBA?7RL?(Z`<E#4L$5D@U`JYOB8$0:@#>^MMD<P^!0U6-H2
MU(<E:^9Z@%?@M;$W/!#+I7A;BK'>P*CI:_8-'2-V`8B:ODZ#P:BFBL!MT]"I
MWR6O4Y]Z3&.=HK>G:!&^93_-:]@!#S'O64`^;K0D"GF$)]:<$>0C4R*MI;*Q
M\7:K@=[;<"VIU\>@5_1"<=CB9!*<-.L^C_-#*H+90A((K]-$^PL=>29>%$32
M!;Q<KT6_2'K7N:N'OD&W!^MK!1R9-HS0.%;N<O=IW'-.C<7D_M^*RF'K,$<E
MG2"VH<$6#6S"-YH^D/]Q'>ID\66F9._B>CX![9CTI([SWE@K>'AZ?'T\19M]
M370:)W]OFSY;\4M/5]X=T09'[X]9R^\Q=!XH'W%PT5QC%.7AT1\]W$!Z>B"F
M,GV$Z;[W4.$[>P8N:W$NN])`'FC*OWR;.='!I&-NS=A&H52+(?PQ5&'SK$&=
M1@][$+<3[R.+U#DV_#-*TDCB7TL\S6N@NE@\35P+Q-B:;"=-A4";]-5%%[F;
M@?<[P(+&,X[DV5UKV!VT)N-)4O7DZ\WH5Z3)JO<3QX+76VEBP-RM]K-C^YO0
MS>\2TZ1>_J)QO)&JI`,:-O?V$\JQ1-A[?)$GQ\FH]^]"_HA<S_=`,K*3[[=5
MVDDU0]4G2S/)7D`J-:;^$J2\TE,9!T%ID$R1,!'"--^61,:24,8<Z*C<7P\V
M(![.&0L#!;[/K)WYW%_[[%R\T/X#53:E1+YC'?-+Z(EE[>0P77$BWNY\?A5W
M/E,G.'W!G:0GPG>KG5E1^F1J1?P`B-M6A02EI!#J#G,1HF=J.Z'TG@6:Z`0#
MJV`>:8`1OH:]-%?0)/7P+ZJIE-U+;)#_Y$=55+AOE7<DU90W.7;,$W47=71/
M-<O`X3P0??HQ]SD]>W+C'O2+Z_.CGU30/4'UY&<_>2"2GO-;?A7BW+'7]V"&
MWRQ"E]RY[>"3Z&LV\@C%80&*&1[^<2=Q9E(?<LG\W3Q9Q'%7QN:6.!AGH8$5
M%^(Z$G`=Q'"]A46*(XNG$<>=R;A@(C-@)>>5TX(XA!.472%2XDGCH'@"07%(
MS&`!C%JD)AXAJN6DUJE%9%4F8R*>'?8:F0QDB>8+/Y.CX:,G-EZ.19$>GHE&
M!X,3\6!PT,D_T>P`5IU^)YR;:K!BV$UI/&9UY,1SOX%:<FHY8%NP!K`=L!-/
M``<E_*';V1*[@`2`;8#"8K'CPOE+X,JY`U6/'L2;5%I%)_T3\5`O,7\B5Z!T
MWSL>1B17$5[.(?4%U2@O;3<V92+3'_8&_5[)471;'8[ZV:?1$8@D#G<L+/16
M<[R76(A"X0GH1.3VAS@!E>>(;<Y.J7P\F8P=4MK*W=GE].'L5+F=WN$1(SQY
MN)M>WT]/'BYNKN^_8BMQG[&O-Y;R5Q_(C%K?G7%Q!H5$'-J3<&%N'C*<*)F+
MR\X=_W9]]W=T.1\K[[BAUQ_]@`^#7^,?WJ-2KP0W.>?\A,=^LF*Q^F<W+3"!
M`)WH073*\G#3"L-BL>L6AN#B85"8X"6XY,H<1N^H'S#$)F*72L0O8^@Q1W9F
M*^HEG]EX88`J_]1?#R@2@YK+&`G^HO@;X7:`$)2KZ-J+J]`LI,J3@[=T+?0E
MAB[T;,C!$.F)*IWE=\9[EKAFAI<M#!V3YCC(-*.0O.N+^P0F@TZK+]RA0"N(
MVT/H;B7:?!5>%N&3#A.NO$O&["4MOO>TV3LCAA#P__7,=_"N!';K$,VUV72%
MX8<&BUBA/F.@*(NP+)N4C``IM(8QH#ZZNI(Q+7^T\ZJ#\(L1M8=[)2E78#UT
M1JI\\V73<<@ELM(6M@*Z^]X-*(_^12_C;)C*0^/>P8[$\Z.DU3\H]0MTQ!2L
M25_#7#/GW/^%80L6T"H_\PKNO8L;"K2>),R(%'!??3Z^/U;8?:,6/PN.KAEA
M@`->_`C&!4-_8;X%&FA+&+?S77[O)&"4<\VA7059F.::NP*>9/ENT)/;4LAB
MP8858_EJ[VVW-+I;KNU'GJ>X5S5/<;!IBO>,(,"FX5=AFZ1TS=]7<2$*DX4B
M$YVW#N%QX#Q*@&Y2/,1S]&`[&PZ[,X7OP;J/27L:=8.(4$<=KMC:@K46QXZD
M&I"LX<S]-1[$S-F)@8[)PJ-(AG!:6BC+\*B&BE>'/!HNPI=[';\\\H_=39$>
M^U<Q\='7J.IG;?2J48!IMV,-JVP7CT;*$U82F*OV.SNX-*Y]Y!4TI#C5["S@
M$P%J*7]8/^YL\<@Z98]W.6(5P.SH*Q"=9`EOAF1?`1U2=,$``ZY`F:0M8K';
MGUZB)GQ%ID_`RYCCZ\)R/<=G,=[(5QX`W@TMDN#^1ER<H6#.L*5FF@DR`1U"
M=,<-JZ[%01`7'1SL5M#4TD^C.T%G3">/QB@Z]\K<9_W>..%H*02S%4:I2/ZR
MO=GM-XR1Z,6KXI)2U=ZP8;1$UQVBU2_A9**?K`96/Q.+.)H)+:?ZFB64T%#Q
M3.$E>O!*2`IF*DE2)8"VQ*KF2<VDU]D#4J(@JD)9@[U,ERB'JA#70.UNCUF!
M4[C;*3J>R?(']P:C83U_<!%X-76GJP1\%R9+(GB11U=9B[:JCNM.`8J::]NR
MDPTC/$3.7+(*P^3I5$[W-7$0>7&9=.AV&D`BB_.6;5MAU\I!).NPI(PRQ).2
MK1`1^86:/AJI=7DPI_^Z6(C\M(0Z2@AT2R2R6&>INM`()B+;K$(>O2TPN29>
M!M_JBFRSXE%>;Y1`(=%Y);A;\DMU4!4NG963>,A<U#(_@F.JHW,,]2OH^F;Q
MH#U'*-=DK>U)>I4DX-/T*&LR;U&(?B6CK"8=GEWCHV68/QZ!I0>&\X>FL=I&
M5/0/369W8?`J"[.+^L*0J>G-R04'=[.(`*;'7BJ<ME\,21C6%%S]ZCMC)P3W
M/@_59.?!EVL;P=H=OJ8UBV[P_JP9%@*]L4Z)8SQ2"\V=.@:F26#7:VYI^&QJ
M%GJB?"^UROH9RH54W/8W]E2VC#*CO=J._1J&+NHJ5=2ZT3<S^BQG8"4Y^@K&
MCSVF1R3J*Z5:677A(P.];0("JY&;+`Q%]:*:KZP:+\S',:-Q&C51KRAET>-Q
MT@HJ@+(%.J)X+W.DJ<-)D^ADB?$J!FJG.9SZ649SJ?$Z['2W0^E,<RQ@)BYP
MD^!`RICC88!A^EYT+MGMEYP3!=_',>OB'8)>/\*J!-B6F)6<%^5BUATVC5F5
M<Z-<]-1!T^A5.3_*1Z^[)7J_TZA@HD\?B:,M27"023^\B2[MYF)==+J4OJG1
M0==:?]Q5)['=L1T*<H=1=!R5.8SQH(<>JM<UBM+SJYP5&7>':G_XNL92>N*5
M.9:)VAV-)A.Y0Z%Y."Y<UR=Z7-EC"-"7/!K@[)DX<\.-#R-U5#8H'$+:^5P?
M>"7D,?DC*<9]D#(HA\5R;UP%\7S`TO!."<=1/8_%#J!3CN/QWD"+XJU$MWPM
MBY5*8YBZ<KC5C/']D1GX\[,3/Y\8I$18A2TZK+%'\W$0+K[R*.('>SK_EV\X
M!'.EXGV'V.W?".N:)WS]X2"IDU:!M@M^I2[4[&6E\5HI2.>^I;L7UAV+&K]9
MG/&LMG?(W-W/&QM>>0;/4A2B4-.\4:.HPIT0B`\D?J,XM@]`TORN.32M<\:6
MJ!E>,8[A70/>KF@.:X9AJ(';94M,LVYIXY[#8.8;[GY-W@<'K6:WDX8ZH.K&
MR:E)!EP.*H7:@K@8E:V9YX1$&V\HRH%^2OH)CG!U)&*2Z%E(#)R?OYG=?@KQ
MR+)G1F57J`=)6[X,6M4YR7):E>'2%8QX6?.2Y9X:E:V1$#\E:UZR#(8T+L6;
MI/K(LU3Z4=P\P<+.*>I4=QAY==RR?$^CLI3;_5UPRUV549;/J6R>U$Z_!K7F
MP\X*UBB;APQ>E@'[%820CS+.2@:=.+V_UC!RG1@?P^M'YZ:VC,:4UOM_6@#N
MY"\?4A]%??$$YN>&.]=,S/]^!K8OWK4+N\U(+]YN=\;MGLHZSNLA@G%JS^EH
MF3*<`I#V'/V$V7_:G6Z[.V8P,GN(`)Q9'DSKN6$2YP1>+&TGDL>CC.0`]["F
MT%:YHPF<\9X63QS+H&5T)\*Z(TL:-FMYUUHL\&^4]NO_=',WO<*;\[],[ZZF
M)V>?'RY.II?WRL7UR7$<7+)'$=X)P;3WYH6ED^>_D=CH1%8*`&$+JNIHV.M,
MXOT+/:0``(NR+:J`,6LEYA.)H*68(P8M#@NM));^IS/N]B;]7@*A`HAIVHG(
MZQR>1#LY5=>!4T^2;H2O\[IGY"4`2*N./_W:S>H^]G4:P,/+)B*35%4$%:>H
M_6NR5_R$=<2R%<>2/UWPLGAX1^<.F<Z]ISF1$$M5."A*'M*G*84Z$UB<BG"J
M(G5F149"1I6",I14%"65H.257I'-G5D9T`N+K70T-I&#]8JW!+I:)X-1S,^Z
M+Y1+!7!,X'!1Q-"/QBJRT_*Q3D;C<:'@S`.:L:RS\CF:U9ZC:9`O%VC+,2S7
MF%-_518'3"7KZJ7\>H)*U$L>E!YR%!GS>8M)GZ/1B=)$'%W.L=/P>"(.D78L
M:5]>VWR,Z3F(!L=4IF@H&:)*5?>V+VN@?&#FE4YN5N6<:-0]%/-Z#1LIFCQ1
M.2B]Y/$5<8-4#K>*A]`-<X.M"3WCV'_0*7;Q([$/)L/):Q35^[*54ZGH4O.6
M;2OW#F\L[Z+H9"6\&R1.\;+)I=?K[*+M[(1RAD=QH):R\^%PT/]6]+-4"@E*
MK"7'U:/N^#5SY7VI3*D<%U1E&E6D^`.K3(+HRO#BIL@@1WSUCP<BNW\%XJN7
MRGJ1<EEFAR>-1^K!=+4=F%DOE0&CVGC[_1XNWS?!S7JIG!MT#DHLSG[GZ]$Q
M>UDY/%(C_,HV:DI?&O4[PW+"'0Z&XJJ]AHVZ)S6SETI/DIJV;U'-[*7RG]!A
MEZJ9O?&X<Q@MLY=.CH(8ESL-)OU=,'X-W"R:@@Q-J3,JNV<H9&%YW7PYZZ1'
M'.'7Q9=3V6*HJ"FG6S"/_L#F?R\KRTURVKY)OIQ*JH/#[I:&G:N]G<XZ=L(X
M2Y7JEE[#&$Z^%>._EY7_9Z"6>62'7P]7SLHKE!K@3EPY2NB)"2NC">`)0+%D
MB9O:KFZ8_#/"M/&2#$)BUF1^5(]^8L$G#OVDI=`G.6E2E3TF><6R8-8R*^7K
M+B.XQ@(.0Z6MW#_<G/Q-^32]/SM53FZN;L^N[Z=8HB&C#'P2DYFS*QZI5+I*
MZL>AUBLSQ>XN&%1(K-OX@'EJY,RJ=KLD1@Z!T5P7L'5]Q[6=6QNK:#OA3/)*
MR;&QI>J,Y`Z6UM'#JGAJI_,=[).9[>C$06FDS(EI;C!!N[4,?_,B>_B;XD<1
M]&B18[J_/'MS)&V6/3WHBN/8'548T%X)S-/+L$W11\B+Z&+OGZ9D3HV6GWQ<
MR9^?^/!X+OSRO14T?*U3D9_RGL<SAH4,-%[&V5XD:T)/6H.14$`!@ZM`,6`U
M[%&FHW+AQJO)W-U_CI=KB9+7TWHT"ATQ9J)WR)Q@!027*:IA&1&*VO=87!TC
M`#F4,/]^\/9D99"%<O9,YCZMHW"S6("ZPDHOZ`;T[=E.JK+,V8U0YB96L8:6
MC7&8(D,KQ1C$905?<$`*!ICQ#/A/-A9YIZ55(YNB%99F210[;HW&R7+'?+@M
MK)L>KDZO0W$YA1EAOWD%7@:?K8U8N1VFE&'&"[#KO`0&75-:A"-9$J:7K-W;
M4GS7X$4W>8EW5.WP$:MUSQ!E==]3%;WQ$#\Y+([%M>;JVK^4$VUC(-*LREXF
MBFQLT>(GEMO'!.WF2X`@'6=0NL:@%^A8&1\'%H)$1749/9-C);=,=0U*9T"Q
MW@=?>URB6('J&HSF@^=$LND#%8[EZE">JB!9_TR4_GA3@MZ4H#<EZ*M7@F9O
M2I`\):C3&H^Z&:)!EEZSL'U'65,,,UI_LC5'Q\>G7*G)4$J@M[]J%I5T3'$8
M2%0<1J]-;WBM8G='YT-3+I::_*N^#-P34WB3N5^[S*TI85^[9)D?5U5QA:F)
M.WZ;5GU?^R2">(ZLM%Y@I=41SX-):SC),MT:\CN(E6XK^`W0:Q#'N=M+HAOW
M(]#BO08]24/4;(O$7Z=&WVOU.ID.!I2=*?N78M[M<O<%K2IKOB3!"P"&K>&@
MG]D_NCM:=+*(A7P09?9\%;@NI&H@W>0(=U-!\*3KFW)=9)#`JW)=[*90O;DD
MWM2C/X9Z]&V[)/1Z+HE]ZDBO>MYV5I#&X]9(?4W^"^5=0A?JMM11EOB"GNF)
M2G"8\[Y$J?*>[&0O5<]H^OU63U0)8H<TXJ',(/.H9BA1W^EW9+I<9.@[K]7E
MLOU)ATPY_XVJ*&].G#<MY9MWXI!MG3C?^)G);CI'?]@:#`5'?R#4-4LA/"MJ
MH"W<^S/7T`T`MX/CI%7/<])KC<<"AE(=)VIKTL_N?W^.DZZ@]_VQ%(DWK>)-
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M!H3F`\=[6\SUJ'F!AFGPZCF*JYD`1ELZA-6%$BZ-W=/7T^!U_&;;D^&ME*O+
MWUAK_!?@'BN7ER?Q^W#0(/[1QG<0,#UJ?5H9H&_'\5UK+RQ*B&KY+C'-V#FL
MX0FGKROMD1[>PKB"]`'0;D&PMEBD//L;A)7T#"9/&!68<!,VO[(`HY(:E#3P
M#?[?PAE#N#;EW3BYCNTOV;!!R\=7P03"[+04UY_]D\SIZ.;$\32\,`=,SJ7C
M`1:A&U0&'"M3&"T?FFN;>A@C17_$)REYGDQ@>'./G4\3<Z$XO#`"]@JS`C/`
M+"PPG&QGK=RW>\J[NWB;:UBA7J_75B>]P6#TO@6D,3=]G1V";QR;5N[R76HO
MZ)RTU$YP<0"&[/J;C4FAP/O92_*KZ&6B`TZ;,;<`M:V"5:=CW\#2TUFE:VQ0
M;ISR6A\G?<K?1>%C6*MNPZM#!4]Q9?!O39CKV"*"D6=35%N*90>-@*X(K`6Q
M6',:TL:LX^1FR#>C&$])&SBYHB26X839;4%U*PHRA'C#J9LFQXC$3U9VL$E1
MX:8A*`>TB%18::PRU(J8GH2+"'K.'![`!HD0SLKKE4!8+'K0HT4/>E6PS8+,
MD`8F^^7CPK8]"VSN2_BA/--'WLL&N#$@0V"E]2/^U+&11Z\\;_/QPX>GIZ?C
MYYEC'MO.\D.WT^E]P-<?L.$1[3SH'A8ST2O\UCS;"3HUM1DQ?SRBK@3,2<.>
MKAP<\Y]A:K`P]`>I'?9VZ+";[@_37$GM3Y4\8%HK,]ECL.2);F&CVZ!Z`I4]
MKTWH%?W5Q&I_OA<`!1]WZ]!%\-'13_>$*!3VX/@O'Q+89*(X=9*#UYQY`!>%
MDSB/GIV!('Q3@B-O\6&AS4'?"'!5N%<_18)2YB]:JWH3>!?$:;E4T#-3!)@Z
M;'D7F#(\^R]5XM1&:,;G-GJZZ^2JX7X4<$9^!,__\@%[,S[B?^'G_P=02P,$
M%`````@`"$"#1C2G%9*:#P``1=P``!4`'`!O<FUP+3(P,34P,C(X7V-A;"YX
M;6Q55`D``\^`'E7/@!Y5=7@+``$$)0X```0Y`0``Y5U9<QNY$7Y/5?X#HWT-
M3<GV)FO7.BE:DEVL:)<J2=YLY24%#4$)V>&``8:2N+\^P'!X87`T,$,#=%YT
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MVI-)&9KAR:N,S@;RZP%ELWD_R^ZYT+8B+I=S`21.9O,<KS][9'CZX:1J^OKT
M[/O3UZ]_D#*_VR$>M)//:9:WT&!%WEZ':3L=IBUUF!*$)\$JU-2M-"@IX2+"
ME.%:['!HKPDI"2&\I3(;)JWTF2-<A"M24^]JD*$\6^155)"Q:X\S?BE%^RT6
MI!I`-ZXDK&7D--OCF\LP1-F^RKNA>HKX?15PQ/SR@-!<!)ZSMP.<EWS]B>S<
MV_[I61UWOJL__O>0<UQNHDB.[G%>S5*:+TM2RNZH7P[BJGZ^8`P7I;4'2AMM
M1S9M]ONS,]Q#MM\UQ+(U1_%G8ZSW)X&ZQ8`O9K.*6Y^4>+:FGS(Z,YJ=PKIS
MOM6T][ZW3]$K:<_`@[()9B)/.>D]8_+P6%9_1AO3<\0?A\5$_KK\[X(\H5PH
MR8>E2'?84F10OZ!\@0UC[46K8`!(FPHV5`30=E:P0:<6M8L@H(BTD'5%T#W)
MQ:2"'2'#W%#!C*YAO&"8970A1N$:+=%]CL7PB$_8`D_`_0[@H`92'P[Q7<G2
M+]J%6?1>U23;"\X^TI)UL)]ID4%]K-G6[&:[;:/W<_F)LB]BO<A*1(H[]')-
M.9%C#>^]!P>#34`<DO(T3==H%Y9Q.MN6<M??O`2FY6^W)<U^>Z2YT(G+:;A<
M&N!F;JB@2M<P7B9(9S-:5"I9DSY#,S6_:S2+[Q66<:'@#NIQWV2]E[\U6*:%
M[!VO%1,@&.=0,O/\8B"+#Q5PUS2Q-#P_T8K21<]TDY*+!;ZC-SB7)?5KQ-Q9
ML)M`@8^-("G@6')<<*=#4EH;\S587B4"EVN&YXA,KG$A=V_.*3>6QBPM%8!H
M6\9'AKG(Y.X:M-2DY52/^>ND1OSR92Z4E.NM<?F(&:2TZ$&I1X2=,A6$6,*&
MOP4\"TT@`6GA22S7%[-%%>PJ946N-6?X47K`$QX5&9WA*\KYS[@<3\4ZPUR+
M">'2K,?X<8F/.5AJT\X\(2FSMT0`*H\PD0Q??OODDIHU]YLTO'M4/&%>SJIR
M=QV-MLI:M](\*!4O!E'&1Y8YG_#O.C2_`'%."T$7>"Y+2QR285C;JLL0?=M4
M<&%;?`!ZZ9DW&%BFA80Z*UX#]UIDQPR7A&&)YPL\)06>?,2%^*.\SE'!?>KK
MG?)6L]=N>,=')K@J?0AK!M:K.U(E+4\83B95L1WEUR+;'Q7G:$Y*E.^4*4UI
M,IA0S8P!A/$!"DR&?8T0E/\"A*0%JFM&YYB52^D&I?`7V:>Y]!*1HQM7]&Z2
MQE+>1A(?0K8J#[BS\'*/C64-C[=IP.,GQ'[#I=QCO\4B+`+.1P`H%'!8*5+!
MAB4S@_?8,S^S,@;@Y%A6SLX]J/;+9IV(M#SM!LL]=3RY1*P@Q0/?*:7(A"4C
M)H>#$RI^!R&,#R@8A+R-$#*[0X2D!BJ1^)),*-CFQ&@@EP;</+G$QYXS]+>S
MC.=TX"VLQN+W:6#Q8H$_">M6"S+/K68877/'V45W!`CS[;UO"<C-OD;17])`
M4:UIA@7J16(DMQ+L\'$3*+BQ$1P!8,#]]42*C6\-D;]J(/+C0#75E?C_P`\*
M50_,13R1I^YY.;8Q`13-<WIFBKB^&;:3VV+[]ECV;"&CK/IQ%SNV%KD-_X;N
MUR9R#DGHM572@"QM&P5"2IMX#C3'3`Q?\>#LE:6EZAZZEO&]03\LU*>'>KCO
M,=X#N(YA6G@6&3X61I2Y_05^PCFMRH+UN1[SXLQ-TUR*V6CBH\,V^#2L[WJT
M:`0I2RZ;@"9Z^M%S8TT(_U(PC'+R.YY\1J20?1P7%YB)1*X4;?B0$2XL<+%@
MXN>U^)Q.`F?K]H*`<WL;00F@VV=J!Z0$G9G=X",`=2&91!LU`7'Z"'(Z6R[2
M*GE3&*=UUG-]X(CNQUI;;#&WU@4(7>OXV'!G.*">^F8Y)J8)8L(04VYPEB/.
MR92L;A4:3OZS6!U?DZ6JX?A\](FR6Y3C\72[+]9B?=F)/(]%:4MY\9'=]?S5
M]2`<=AKK0-NF+\;/&W=CAGW%X6KN"M$)K3/\8[3/X@(>I-45Q9M$D/$9%T+#
M7-ZO,)F1@O"25<F:'2!`*@4G3JKX<`$N2_WZ'[0P=8I(#$BV8#I\0B27>PIU
MS-Q&S&U8;3&]A[#WF,W]V">`X0-,WBU,?/BYVD\YR^G,6%M9TVA;67*/#_''
M:T:?B-#]X_(+QY-1\8D4J,A$;!IF(N94IC07WST9-"OS8`8QS]!F&$^XS/U&
MG"_D]:CCJ?M<-IBN>9K611<_S@0,/0TWC3$!`^J@G,]UR4YKVT!_'&A50A-Q
MD&'$\05>_39M00>P`-T-:&(1<\]0AXE-OA4:TRP,8#%-RR"^'P<A@W9@+D-!
MU$,=I4(*5B,M[_XJF]P)S1`V9+2JI</EN4OKZ6!#UZ75`[\M@IF%`2R8:1G$
M2]#0LGKZ^8X.,Q$T&#8^@F/*U+P9J"F;!X-D/=.&"MJ!L;S<5J/,7A+GH41B
MV_B7TRG.Q'KT\B5[1,4#OD$E'A?ZB<^`UQ`6"F+]6,3';-L\I87)NLU4_!1)
M:UOO`L\9SDAE"O%WCLO54]C#&64E^;WZW`!9']+FI0X`TO@0;9?P!!BHRSP(
M)CXM.#8F@=M'H>P=9K.=*U&@4[Z-UC7;ZVF3163H1`\PT4'G>+W\SG9;]6\_
MV:L75?6A\5QV3SZ4^D_$F$@W^.4+9AGAV_)O#;9@^MJ:`?3)@LY1&6QKJBXJ
MA`$Z)!80=:7-^J""]=)@."&D5JT0'BLD@XUS\&JU(AQPY<@QINS!Q8NO4EK4
MJI'6Y2^?*!-:%*OG^++EG0A>'&72+.L3NA_Q5+0Q;[P'<%`"A!>'^)AME\.'
MFZO+5-Y+B\0.DC1ROBM:/)1A&;V%U)70:TF316=H/N\VT$'3>:WXQ/!X^X@8
M_BAFA(D\?H*%(UEJ'/;&ZFM&#(V311DP!H*,T&6X,PE,]`:E`V5%[C,W7R4K
MTJJ1UJ4Y>PL\T=V?4"D/C"VE%6B>XVJF'$^K8@-PYFG/T;*L\N88'^,MYZG.
MS-GI]-5&J[0\8'OJJ2IP[%0VY!E*S)Y(AOF8G>>(S(PW>8?P4._T]N.1+*Z!
M,V,;DW4Y87KJD=8U4ZH;"NW7GCB>ZFY4!,9L,!]'I`;P21;'@?'9UW2'C,H`
M7;K"LVF[0%WF?%H4$SXJ;C"?KS9^9_.<+C&^D<+YESD57ZWOKM;N'W3!<&]#
MH1W#8X5OY\;L`L==*-6\P2WN0V6;I_]756IW_@R@4!\FLU$D"U!@G@`W1Y=9
M@55J8A"KG@>Z>T3%'9[-*4-L.9K-$6%26]D'S'>TOY8'&*3'9/2AD-=3C(KU
M#:_"4IO'AZ:4<01('+ZJ;-V#:H>7?>P.%&.(NG3%KZ2_Y5K'B)5_L0;93>HJ
M6\`//`=R,>P'@+DDZS&>6P-A9CO$+@%8DR:*NSW^LSWTL3JOJ3WC8VRTFW=K
M&B6+&T>D!76ZBY!H$E2/^@]IQ*[M-5>ZJZ_,KUH!TS5.Q#KICA59H:;I]BRL
M4W:-OW>)),3J3LVHJ%\:>X&GF#&L?WFLJ;3;BEGCO8UAS(X=OYT8L=.J;Z!"
MZZ=G3I.%^C#+Z$)FPF@I,UTPJ@UT3@`WZ+X]K-I-<UA8-F2O$9C(0YD:1]J\
MCG#_383C^YP\5&;R"+5P7NY("^'U[8'7WX0'CK,0?=8@3^0D>;,7RGN%=][.
M!<:VFX43TC86WQZ2P08[+(!M:JQQV_K(LV'Y;4Q;ZG2%K^Z&VGW9M7`TR`N(
M#L5^=\G?*?MCQ?>!#=U9F:%3%==^\?90=2EGXB3^98M-6M_2*]KQMKM$*.]O
MS!\Z,?$!G2%4O[4GZ`Y<1+AS;TJ0(/G_OHNW3=Q9%V''TW595A=!S*UV8X&N
M57RO=AJ=0CMIN?U2PW_C>SJ^:5U,E,"=_Q%/M.S=^0T\TZ*E<9QJ46@2]`QE
M("V'6&S]![K)2ICMS(HB)"V?V=]5V-U1`.T.Z0BLVT+[!$<%'G#/@Y%CDY#6
M,_WFISG;/<#;[N'=Y![<A4S:[8SB/YE[RTL+>:.BQ`SS^G[$NE^[737/?CZD
MC9H?A#1!P)G#68`U@@,;3%9:]Q0(]4BM=JVPO(V9<%DUMZ^//"C5BRTAE`FB
MS!+6_(T1'M)`LM)"F?U:A'8W8;2[!2/MB=0<U\)L$AS:P.+2>MJR/KKH6A^[
MU\3IO/O.`R/FO@7C8(]E6D\G;I<1ZJDQYQK/1&!<XS4)$@2&9;H"=SU\EK*)
MZ&SCLMN*FC*K.BIJAM:&BEJC]7$!!M;I<+08^:^798F\-:BDA-,)*>/M8JR/
M#(K9=K4/:COB;&[:"&VZIA%CN:+.9KM,!I-SQ-A29!S/B$U,)V`".+A,8N,0
MWYNM@TV[,(S>NW5R]^<!#WFI58T5U>6I!)IA^9)2W<OKH5`$LG'AT<GFB$'I
M9Z*.D.D4FE:-L*'_+RA?K,8WS^FSO&8$BD@SI0N$.LHCQIW3$!U!32?'=OU>
MK%2'E(00'B_;62TUA=GJA/`C+O"4F$O?UM;-$Z[ZUO'*9'@B7SUK4.R<%F+:
M7(B9LYY"S6?;PQFIQ;,`1O'=WX4#VJ&E]`'!P&^OI!8@.:W\:/OR+OF8L$[C
M56%PTT7,+U]*AD0O2"&?K!<#R.799D$IQC:O*DZK]9_5P0\J41LD#B3QF$;N
M0OS!2Y)U-S(JQ_:6WW),)08=%JKT$/:W!;2#=$=Y`"*\&VE%QWK+I(/)/)B1
M?B?L&Y[,VUHJ?#(/D)S6:C+`\^I.=S<C*`S;3P@;AJG`..7Y0&_]8YL.-KVP
MN%>$U?0<":)HRVCC&SK-FP<0DN9]K!:2F-?6ZM7ZS,RO?88100U0$\6/0J!1
MI8%FT(<*FTCE.EFKJ+2RNV&6+6:+ZJ$KR.L;?=^*W#5[!:C=L3\^2!_(M.W`
MWYU2ME<R&N>]^@OYXQYQ+#[Y'U!+`P04````"``(0(-&38](N&([``#..@0`
M%0`<`&]R;7`M,C`Q-3`R,CA?9&5F+GAM;%54"0`#SX`>5<^`'E5U>`L``00E
M#@``!#D!``#M?5MWXS:VYONL-?^AIL[K.'5)TIWTZLQ9\BWQZ7+)+3O)Z7GI
M14N0S"F*<$#*MO+K!Z1N)'';``$04/FEEDL$]@T?-C9N&W__SY=E]N8)D2+%
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MLLRBE#4U&ZU^@!*:)ZNL=`/3'>VFQ#MQN[)6A#%)EFCVS10OW]5B8K)\/)E.
M"SQ-"Z06L2[^\?V'[]]__/A#+4N'0"\YBN1Q9BS#IG(_.Q2).?]-Y7[\LQ[L
ML][<R:('^[IR+_[+PIQ]7=>4^WE:3#-<K`@ZN;T;G_WCE_&G\XO)[<4_?[VZ
M^]<Y*I,T*TPD@]%U(G4UQ,]6&<+SWQ-"DKP<3<OT*2W7KM11,[2EY^GH]N+\
M;'Q]<_'Y=G1W-?YL424Q[7Y^C;K'^5,/WW(@T%N.`O>48T.@MQSI'.,$W:-'
MTD^<%AT+&)M<?!K=79S?C"9W5Q>W)W>3$87"686%6SM`@S#H95WR6!;X_IGT
M&$N;)'K)4N(T-Q=C6]N&Y_AE/+F[NYA<GU_<C&^O[BRUI9AL+ZL]SSX8VZRN
MVXO[8X)ZM-FV=C__@'KX!-3A3D/D-$^K26TU]6Z112\E%?;`K))`(UJNF>S8
M9'C:HIU5,VE,VC(W)PWSI+BO0_Q5<;)(DD<:ZG_X[AW*RF+W2Z7==R?O/VRG
MSO^Q_?G?MV52(CH#*"_^6-$1]@PO'W%._UN,7M(]HK/D'F7U^@N\3IF6E0&`
M==X-I7]'G//6*D!';VG9CKZ"LFT]#W`:D9W&VSF?^=+%G."E;EMA/27/]W*_
M^=L;$*<W)7X#XU`W.-7Q[1M,9HC\]+9R7_6<]6^5IT2SG][.D^PP/1P`,U3T
M)<YO2SS]<MU:B.G@15BN@Q5..9LXX2T9M4$B;Q$,UX@+#"[U)B#$5",`PQ[V
M=\G]85@1><Q6(9&+W!:RB`')8IS`7;0%Q6;.7^XG:A9-',!(1X")T6Q6:YUD
M-TDZN\K/DL>T3#*ILP#5Z2!&42=0)Z*CJ9E#@7%@@/0Q."!5.A+T4/78)W25
MT]@1J48<>7EVY!&5#Q0\4`V-1R(%=18TWWSW?7"XF513QQS-+A*2I_FBD()&
M7KB#&%'A0.$"TLT,*PK2'*#\&!Q.]B,NG<ZB*_JG<LK'%!0%,8V"%K'1V)\3
M!"ZL@+S@A1>'R:.5/5UNQ-*FQX8H[YFF+\D*'7[$>8E>RHNL)O;3VP(MJC]B
MGA?_^X,`(5YGQNWM4A=38T9/OY/C\(+?>A[W@#,J7['11NA31`49G\(6]#O>
M0+V+0B$C#R.DR8XPK)<9'`P/"4'%>%76)[;H,"G"@JA<%PILN2"1H%#'!`A"
MD@P.O@T0!Q6,KXIBA6;G*T*EOT$DQ;/?DFR%-C]?8G*6%`\R7Z%3G^="8/6#
MQ).A^J8.1XL5@[_OHL'?IE/U`*"$``R!7`(105!M`'L8E/%B0/A]-"!L=ZU;
M1)[2*1)/Q`QHF#C#`XV(T`@R@RNGR+!C,/F7:##9Z6IFH%00,7*04<(29@AG
MCE(-S+]&`\RZR]7ZG294SFJB3.?Z]3V#GPDN3-PF@)J&`Y52BPBSFJ:Q[%0A
MC!D4_Q`>BC^C<K.-\$F,36Z9#N(Z94+$D4P-`W3PR3%M_F-X;3XN'Q#A["15
MBE"MQO.[Y$4`!9VJ'83`JH8('`.E#?"DQ86S@!\>SF3^\S-ZKK^8C(=,78W1
MKU$W1*B9J&UY9&/9<!;UHP';)M(T1)N@LLZ\($Z\R16W/0^`(,[JU@'_-/5V
M!7N4S[:W>HH[?-I>4JP[2`=#)E6WAM2K&A)^>BBM@1XC+BQVK&XW&&-G4\(,
M/.VZ>NC9U8T0/ERU[>.GPX8%D-7]`A&`)$/R=4*^H+(ZP7&+IO1CF0J`9$BC
M!2AM&N$!JY\9M`%FRHX%FM4]`3V@;3I!3Z2IB0"@)B,2"];`AK`$-@`_%FU6
M5_L-W-JG](]5.JL7SLZ39;)`EX@?7!G2@+HU/HU8H`8U@TVW)F7'`LWJZKV)
M6^N)-#41L%N+&VM@0UAU:YIH"W"5?33[?ZNBK%2GT:?@\L<V/-T80;!.84R'
MN9>C32<DB-HRA\%"ACE+%JA6MP8,QM_ZV_BQTJ`Y/[IX0:2Z\MT%H35ZT'%9
M32\D4-HVC\WQ&LR:<V1WZ+';(DKU"(+']./!J9&!K([U/9`:X*8$9+3@GR1H
MVF&":/Q3I"7:GI/9V&N"IGBQL7N/:,$B=X,8PPKWD#K7L*9W%,_8%)3MM@%>
M"@$;Y;YKE'H3_Q/.%R4BRZM\2DFD3^@F2SST8B?"F'9JR\)$W<==-HS++N]&
M;M8#Q',=:!NCV#K="2:G<^+@6,YWZAK']JD$O1.>JZ*:*CQNNM(!VM7.86@@
M9F:$HJE4;SHZIY+Y="+"*]@<MD\B2UDJ$?I]@`AEIX*&$`40TG*MT8,4;A#K
M[K0?3/^RA^G?WW7,3&7YXC(%9IUK?;"I"`VQ9FFVJ@*MPZ;NQ<LT6U%%+BDR
MJM%I56[BL_DNUPNU?&UV!B/=R85E\MWI@C7RP[FH;:[O\;RG,M+T>TZ8=%V;
M928^LN98QR?V9'2N^[2E3<OINM$"D,0P\`1!/<UQNN83D*0=]L#1KG^5<PRL
MY3[3H5F:Y0E:#63#9C7O.9%]``D;&\Z%:Y.)W%J[@HKJ-`FK;!N3W;OBYC:$
M5V"V(<45_$Y$P&V!#=35`-F!8WN+4<G)%".>,AV[&=B5_=[%>,6?3%I54.TE
M["H609;G&X(IULIUM4!?TFY0I6=[A"33A%?LC*60B@',Y(1BPN9HL.K"V9>J
MNH]YE48+<V=,6B;@]GZU!/Q9#I#S$60X%6IZNKZCO"43$8V:T`[<K!F>12K9
MI',#C9I0BS1K>I\AZ+0P[F,&O;Y[X-[LO#I<(?UVZ'%UDN0+6?=COG=3E!^^
M#ZN#/.LZ6X*GAXNY!Z@+L%;&$.&Y@-[3:N5/Y]"(`9Z;V!:1?3=3OL@@*<UY
MCX%;VN_44\>C8%U=]5S>@6/WG089IQAP=$VML%PMI>CAENE@IE/&+U)XG1C#
MY!=[BDWQ9GOSZ1BWLN\5!F!0#8DDA"&F8@U`+@(HG."PCJ&?.5KN%KYO,-2"
MM^RI@\!6O&%O)H2_YAW>FE1/FXV6>)676CW"D+;=G;8=[1!6Z.WLGKLPMK=-
M<[O"Q]#OG"Z="(>:`1=/9*.-N]43V,#A<_TDP.LU6FL/0FQY6'V080BZ_`!#
MA/D"A(_$>$(`GJ-'@J9I[28G2<G-J:%=N;GAK5$YD!4([J#9RQ`]MD\,^<;@
M1,;S>3I%L#4N:=ENFF)^V4#0)5_?@NAI8W5+SB<&]%PG+^JU+5Z9[MI6NTQ8
M:UL2^;76MKATC%LY_+4MT?Z-M14LEH&V-;W?@I@6R7"W(*H[IW>(+&]69/J0
M%(C.SI9I"3G*HE&ST[5!-0=S8&+I9&=8@+7`EO!X8D6G(;&IQMP>#N#<[-Q0
MCO&?L!=K>KH^H_'D`I/U>%X9:%=B)MDU[TD-C%D%M0"M*9!7NFK3DQK8F@IJ
M_N?E?6$$\ATZ-M3T*5(I87X&)MT0)^1_269)D?(G:^("S06!3@&_`7=?DV.`
MEIIPD3+>+P'P&89]_ATZCH(ZK,X0HMD"3'3?5XHA.J9$9IRO"NZVFW[%9D<&
M5@RE@XN7]4PLT"?.-&#*(NJ;[X-;D@DB_A'N-@06`4G.10X?`,&V/$(,@3Y&
MU"ND1R&@U<`HC\(?&VKO=M:O\L4V,2<8W<]P7M`)4R+8)I&6:8[9;)E0X*`7
M?RMT=1*""WE&X(1N")ZCHJA3\EPBX2MZHF+LH9!.L5!0)'4J"NUL.!$A"P8C
MW[IW&J/94UI@(O88W`)-=]$I$$HKZ_D*F99.'`6?X1`(.*-%TFF235"!*.N'
M,5DD>?KG)OOO)LWG:$$0$NZ_]Z32&GH,J,0)N-[V<C-\F4O%0M?J[%,`WNND
M*!'IBG;WC,5(!59IPE)9)4X,ZEG"">"@(G#0]9?!T$7K\`\VZE4"(*Q9Z:@P
M)K2&3Y1QA.#@[*]#KLL>A*6?]59FN55A:[.=JJ$@SV1U5F8%A^NS?+8,NKX;
MRH?INB]=SW6,3FMH?Z5R58.!Z1*O)!-(:!TUJ)IUC@E80EMX!!='!A9@`X^%
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M#LI8HBKLDH94(^MF-FQGM^OTDXCM#@$>F#0>^NM_?D-%N7^BZ8/M.%/"PE:`
MR6416;^Q;M5!0TJ9>$R/^C&\_K2_R5O=W"W7UZA\P+.K_`EM7DME?T6HRL(E
MN=-F@Z0PC[@)R<&,*Q)+>H@;5JEC(%4E_U?2K*``&YI%<6E=7Z*FJP!*$D,6
MQ@G*DK+R9Z1<-R($&FLWO\BR/FL3Z"8TTB`0A)FD?5=<4*+V<'W4H/6PAK+\
M?!M@GJWD$6)>,?0S!P.!\-+.,$.!Y&Z.WY$`=@_G=2RPZ>3$Z>J\N3E9SGS+
M7@Z8W"XN/R?8^KO(2T22TQ1_*F?B,PWB4LW-/UXIOU-78&_%4+6X#2]GLM_T
MDQ`?I*7/\TJ8)9I5!YYO<94FEJ)5VNS`*DT,**MX3B8F[F[82$FE*^B@`$H]
M\*3Z!FD++*X2],U=8$64&/(AZZX4_Y9DJWH=;*/[Q<LCFE(@GZ=/Z0SE,T[R
M4P^<>NXZ@#A%MJ+JRL9#[$[H2,GVN?"ND5K2_S=,QY`THW[(?:_C\W+3[[J\
MOJ:>)[5S0'U/("?;^VQ>SPRB]TW2XLLE0>BJ"M;IN.^N[\DXV>UY?$Y?0[\#
MV#B`7B>5DNUS-J\Y!-'G=EZGLKAZB]X>"S?CVY;%U]"]9%8-H%_QQ6,[5,AG
M7F"*U^6+T>,CP4]H=HG)55&LDAQPFM,2_9Y=24+_*/L1U)Y#="*U;&P/"OF2
M`DSK?U(5J='7X_GAH:Q*\4/^^)Y=2,V@9Q^2,3C*3@2VZ!"]""`<VXW"NWBP
MZ_M4C1)/OU"U?T](?>Z:.H:=VF-REB6I\&T"(QJ=SJ!)(PJ\][&+#4B;\6=1
M"SQ#'^R^A/&)IKZ[$`:,V2QZX>TY5$?,NQLJ(M\@+<L\RLXM&T5?A^AIHT_+
M^;#HL7G_19B5DR/2^#E'I'A('P]78">HI,9GXJU>--I9/75I!(TL&W;I?8_9
MF#^;9BB\FUCGZ+Z\RHN2K.K\$,E4_BRSJGC'FXF+!PT[36UM^#0E*S9/1^A@
M:J[TWI;U4"]*M6!.0`HX.8$((:AA$?N@!#%G$WF$"=,S3'TYJ4+LS5]4FX.F
MF]6AS4Q6M%9O1H0#5QTBT4#6V#*V8&L@`)N5Q$/@*,C3E#YIYYYDZP!R;37J
MA((M*[FV1+;PF6N+E>&`L%51-4Q]Q3_)6ILTKJ%UF[[H(HNIH@96H\HQX4ID
M"8^P8D50H>JC553=HBG.9W;2B?>EU<2A.:TX`6K)=DZ0VULV%:2_M0KINX>4
M6$)T3U)-0!N3BA//=BSG!,Y]15.A^;L]FOV_!)X-]Q#X^!&1I,HO\0E1HQ>7
MJW)%T#75;[E:;E-1%.<K-+JG87LR%:U(&5+I3,2TJ0PV>05*>K8B!`F7\<R(
MF-EL3\2O7S+%!;9D):XGTA2J.:DU%,;I`Z1>$7V5WSWC?U'?*]IF,Z9CANLF
MG6.%MM!6`Z&;(T\$3Z[!E:O>JK`#<8:2,<@;E(X8YB)[#0=T5B*G[X:Y@/IL
M5!2H+)C58BFJ196D`&8K#??**Z*BH$HJ*EPSTV>GZ:L9R7A^AG-9=-N/6/=%
M6$-B0W9[(1JP92,!.GI7EM:;L?UDB"&3R@W!5)=R?9,E>3G*9]7]\<?ZS!?E
M+$VMHE&3?5]477,X;S>?TVG_Z2K-9K2!N:M"D*)=S\8MZK<3ZK08UM*2V\\`
M[%J#J(Q-#%WID)J!ZV%:ISB%:2C5587I)F55P_,OI^L*!I)T?1HUH?ZE67.(
M([Y:S8S[F$*12$S,OO/:,9CM,$E?8$FU=/2`6%TXP.FYP0-WD-$Y7-EILA>C
MNPCW^JWX]HSS3)D;V]^C`_X-/:33#!720(9?J.-6NX6B"%ZDFMD(6P0,8H"&
MT]A?F&?1(/KWD5_6W2`!R\'H<YCX-CPLUIZ7ZC&ICIYFU?WWO!!%R]*RS/((
MMVSHPR%$Q=Z+&S(6,6"F,VQ?Y5.\W!QBWIQLIK9)LO.4H&E97?<`KK^#R<@7
MWP%D0@=A3\/8#<K@W-E+%3ZBXB3+;-G=8#6@IZVU.+*W`5C[EF2%#C_BO$0O
MY456M]Q/;PNT6#8.#_@_'T,6PQV0V1TUHI[W'#VA#->C=F-Q>;>,?(=O$)E3
M@2\Q&9</B"BW7&R29I)CVR`=P-)<#T5@"WBV&`B7^?HS\.'UK&*1ZQLM&UJ0
M#;F_%GP_:TUZP%D@'6<\A$>L5):]V]+]WO5-A^_#ZB!=8N&4X.GA8G$%^,`*
M8V8,D9[?;W:T6DDC.#0B.,G6HZ<J]SBLTK8W9(OW2>*PNW+]RBIM>W8?=@7,
M+ABQ6VO;'J[YJVQV)8_`V6TW/:0C&;=,IQ-TRGA^*8,ST&"8_.+1;%.\"0X^
M':>-++CK=)KB_T)D520TJ!-?8Q*7:MY0XI7R_=")S4Z'H=K;]BCM[2*5#*:P
M\7UPP=J\Q<[X8'H`HJ\:E@8)T$&*X`8)K<F.^+TU]],=V4-KP-D.\`$UX_E.
M>!<;@H^[)2_X!1QY2Q_]"SGPACXA&%?H'5Z_NTY>U*$WKTPW]&Z7"2OTELBO
M%7ISZ3AM9%&.R(<4S6^G*05D6I2;,\SB$%Q=NI7W45+Z&$)RL#4\A.8`68:`
MUP2ODZQ<"W/LR0LUP<0I%`V&N#M"(-6=[NHH)##%RU%,Z01[-CZG98P(073@
M[=!U^&$\_[E.73Y!4Y0^\;,(FU.1N@``E6/T$;K&&\")P$6,X/[P:#HE*S3;
M*)FB8IO.8O,2Q52:TT2G:B<.AE6-&]\]S.3EO(.67.RYO>"0W.R#DM-`HF(=
MA++%C@.-"O6]($\H`WMZ,3B43:@!\A6ZI(VU44.XFB8HQZR+,>6.`V@J`WA!
MFE@(-O>P'&K>#\(NB^'.P5XF*:E>/42;(\:T-3ZER7WU<F]:7:9*BA5!LW$^
MJ=Z@(E7ZA7K,(+O_GB9%JCP0ZX1'IW-9YC&8T[&AA^R$K'7Z#MK!X_E8-]#$
M[NW-]:E6M6DZ5_M:Q']>=F^3T_7^SU]21*I!;?VI&M(D)P[U*HOZF*+R\*;9
M0J.^N<V**MVC-*(A,A2,AO^S?IHPX/D5`_/(?8=4%*Y3T!(A@H,5>QVN\L=5
M6=3*?Y!N"`)JB*#)J^%W6F#6CCPL*K67(P_"GPM`"=^P#W39'U=YS:(SQCB+
M*YB-`4WQ8O(;OH8]X1&<(`8^R5$;3^,>[,S,8"-?B(=?R!=45CWU\.BT\`R,
MN"AS%(97=*!!SM5$#V`/OW,VJ4"Z6/2Y)G:>%I4,5.^3V[OQV3]^&7\ZOYC<
M7OSSUZN[?YU7#X%FQ8#WQKE/+JN6P*#5F"5C5;4@[G)#7J&&7MO6IB6YH:U!
MR\]E;"`(!!>M34TC6'^7"R.Z+ZTO1/Q+/?KOK,.ZO_J%>!,"09A)<?Y<5%"B
M]H#GPK4;#VOHJM,[.3S;>V!"7A%,G_9)A6ZG*$](BB4=2EJV.R+PRPXX<F[$
M^#4O'M$TG:?==[N8T5%1GAD!A>6]]QUY.V%])?DG%WE<V@.8BOH0]T5'LZ>T
MP$1\3IU;H'F4L%/`]W$"H;?!``64?J]S-)Q/:XAV^STA]0F#&X*>4KPJLO7F
MN>.K_(:D3U3^FRR9;A8%Q&UK3*39_@9$_&)$W?&P)7L(CC0+V.]19<XV[)7E
M?B&[('[1"EV59\S!8HE"'*`X,80^MD("X8JP]Z!`MNW9/RJ`K>RZB`L\7%;8
MCG1WSU@9&C!E.-%!HTRH`8)(#<,8@247P=K[5?Z$BOKEW%N<S3[C\E^HW+^:
M>YID23Y%MP\)$:[(ZQ/H^`@=`L,A";IR9FR.WLME!ISCN:36*YB`3-O=Q`UR
MSD-X^<.NS`X;@#?0P96:XP"@4G`#@ZZBNB,%G'X$-[MJ9T+G*U/A!@M3H!L>
M-@J$[]J%ZO3?Z6`I.VU_@6_XF>""3DGQ%*%945UIJ":EU;!1/6^X7.+\ML33
M+SP'H5>SZ26@-<.%A[D!C'%CPM+I!3O]P48ZS="I!QQR0IZ.&*AK<>`!3%L&
MADKU;K(96-B:4+@T:T8%&*'*-B'#8<*"YAL/B^*?4%(]&+J9^\@V-:0%FZ`0
M%`P.`Q"%=)M<3C."R[.ZP8MV/?8YLW@#%U/E>X>[/8(6FY`3N)3ZMN]5/DN?
MTMDJR<0N15JPZ5($!8-S*1"%=%V*G*;N)6D;[7N9YI15<8FXZ;38K\V6;'X-
MMV/+%>DWZ^"0':(1)<')YU5EQ?'\5ZID=]':J"XP9.S4#1P>AD;H!QYMI@RT
M_AI<R+%YA$X0>LH+=8*);J&0Q@>0(AIC@X*>TW87N)3S/#E-\1+-TFF2W>)L
M52_P?RIGX@@`6*7I0)150FIU`R5UXP,H=081/P3G"<ZRI"C&\^W9GC&9I(N'
MO5\[N+ZS),O0['2].P.T+2C:7[5$M>-K>E,-=WAS8[C>DQY;XCCM"/K1UOZ7
M>OOB!I%J`->,NJ0T@-&7@$:X,+5A%&?1F)PY`\$?@_/%3/[7UV<%`WYG`P1K
M\U<%PWN\_/6E+?LO;=EL98-Q<#^4UT>L#`="*1'H2"@@$O%0"#&+N[%0SIT%
MHH=M+XBX^SL&_:`H(*,+1H;,$<!1;AKW@!3Q9R%YG.<ZC=\9,+L#HGY2`&IG
M;V/0%B&]AZ$.'>.1:$_G"'J_PC@>QZ.N`"PN/1P>Y*YOW"&RY(%/6;CU$I*X
M<.`P@JK9#RMJ+BP@O)SH(D_I](#;,^IB4\H]J;388'?\6#9&B;9WTJS<=DG@
MRH$#R-0,?9V/+E<68!X.:FS?1QD_YX@4#^GCZ?KN(24;_7B8@I1OPDA>/G#D
M:"C;#RP@1BP^/)P1V(V35WE!-:TWEI)L=[:->S(`5J.)$56-P%&BI7`_G`!9
ML4@);\O_)EG7@1@-P:K3:KLC;&>X$.[B0:ITSQ9*JX0++`.5^Y\HA/!BH>5A
MZVPW1[]XH7XR+?@OO`D+\;)N-`J%"P*06OT<BI@ZV]"!;E#%\(RZ+*,"='_'
M^3OJ`>[PO#[H;/U!Y_!:>3_:H-GYJDJ,2Z/A%,^V<Z3JZ+.@Z>$5F;1RZHKA
M#@O&ZO>_8@OG&`/PFE<HM@/A;AP4AJ"`*I+K+6R5\&&FH;+52RU"7BRT`LP*
M)>LI]<?-XH\PI.U/2,?G"0B%#\[>YG'K$^42L$`.+[51LT?JX!9<3^(MHT6E
MKO)6_:8NYCQL:TG[R*?TCU4ZJY?%SY-ELD""2V7&1%J[&OI$PH6;%;/TW.4P
MYLX"T<-V6N-Z[$;$T:I\P"3]$\U.T1P3-*)3]EE].Q^?(5*F\Y021]6"ZQ23
M1[S9O>%NQEJEW-JYM40Y<!P[,6#//6&[(K&(#^_N/W<;?+PJBS+)JZP&@M$>
M6@UR@:95+5S0&JKNY@H,CQ\+-YO;A0[AM@M:ZFL3AP-ZNTL\'W0P"*4%`:::
M5J1HU322&PB#A6!QK=C<#.8!K-WI2;S3;D1M])26ZZ%?QAH])V1V1[E(+OMP
MRW2Z3:?,L$D53ZN4K70(?T04C)M>2*JE\WJ/\W1]*+/=]ZR%/VB0SVZR)/],
MFU>>SMLA*UZB1^NLO-]GX@.IFR+2K4FY+JPE&)-9TI5`,=RT4AI`I#\S%NGV
M'C!AW;X"(!R?N3_C?+/P<T$GWN6Z.B5$5ILS'8<`<8*S[!*3JKSM5C'E;ZOQ
M]/E[?E+%'MQU_*6CYN+?$.FMHI;GM:[:4;MCD%4V9PP'<0UMUEZ]PHYU)`[!
M&-_>_`:W+>VZ#%TC^/,L'>5C<"K;*:GTK!6W3*>;=LH$UI_Z1.H89@@SC!L(
MUH0S7Z!A[O?K]*Q:.[8G54>)[AZ2;4]K]JS?4;4<1"L^(9(L4&O5:'1/*213
M_DW-8*1J;4<&(-5`+=_$N"VE>C>\2Z&,V]V-4'X<<S`H[^Z:#]\`XD$C$*,=
M-OF#,58,@=0A1X+YH-_*UL`\(&F9/O/<I#7ZPR;&L&4>#-L$423,Z"E-,]CC
M2Q%%WXA[8T;\1&M$6S.RNTB#[,W`+C8%LCL3X#4&!TL9/U>32?&9=.<,W2_]
M[1D&MD`1V8(?O]V.>IFOJ[);%^%]JKU5[RK?G.0-9[IM()B?*;>68*_3[@`:
MX77J;6:PKS0:4M[1\\#2?40TV`VK8XN)M&YY'4M4!+AI]FW4<='^'G)XD9&1
M:'YB(TW17J.C()KA-3XR-9FQTPMVD.4>/0P$!OX.)(:F\#`X2[+,Z\%61SM=
M/@ZN6A>=?1J<;7&*,G3X$=/YW4MYD=5<?GI;H$7U1Q#1EC*.K%3G'D3USM=*
MG*3%-Y*!H<_L:ZA6''X*YE]S]OGO8YB'58H&-P.#"N5U[J46ZG76%1(JON[Y
M%MA8VFYMR&O@IZ/;B_.S\?7-Q>?;T=W5^//0-[[M!>RO-SI?SP0.=";P=3H:
MT'24S<'I;#9J*7DX/V.)[+U;=8UN:G%9C=`TEQZG!-6!:3_<\49(`V(SG762
MXC#IV4%\`#UNZ+WWW2%*21_B%>FF`&T5&5P9:;<`)6X9/.4*U^@8J`47V4V*
MK42DT"0GP6'W-0?2;J`/XJC]$1RT?\V!9)X#*3CW</&"IJLR?:(A]#R=(B*]
M)R\OW(&TJ'`0R03%5^!!.NI$1>RE=@4+IZ@1K&O7&5_1C$)Y@HJR4N/C^_<_
M;+(@Y]43?E3:"N1<>/2@T%PQUJ7@%TCBY`G]U9>&(@?\]&$4@2NJ]"'IE&I4
M:U.]6EY,;G^5OX,%J<-,WZ1U`MNFM)390\=0@V3Z@`EH"N,CN*,KF6'ZNZ++
M%2("WV(PZ15>BAW^.JO>O!=V#[7OS#>\)UXBGRF^7LKV8M60IXOA]2GK2^SB
MUTN'6&27+&W87&,'/GGJ=)4]/&R=IP1-*6UIP,\OU,%.MU#@2PY2G?HM-0A(
M1X"&QB,U4D`(RW6?OF#+A;*``%4%N$R@)A=!\SN^(+R__6+[N(\A>UN'@K39
M![;:X3=1>+_&"CE/N*EFII[A"-97X*=@_"VW0&1RZLQ%Q^!7]T4Z2Q.ROE@^
M9GB-4"'>&5`6;AT;%Q<.-(K3TM$LF@.R8"_/>4"",P_U&RK*?<KQZNW!HDRR
MK"[*1=F0@OBY^"`5).:!/)@&#.JFK74=G?J'UVS]&C,]F0J:LSP^*=.F/H(X
M+JI<MCY&:"9N&.=()UICBLOCM4;QN"(VD9Y68S:6"7L!/CBO[';8.B1K\[X8
MPV?O;3&FRS[F&&[@QHIZ,4:@F5//`!XM[IZQSFC!%)>/%HWB<8T6(CVMCA8L
M$_9Z<)BCQ;VZG]QK]Y/18D'0@EKR*B])2@/,Z6])MD*<5^)Y(\C`(O%&E<%$
M.IJ1)HQ&]37Z#*VM4^\C&)'.'E(TOT:S=)IDHWQVAZ8/.<[P8BV[L6!0LSE.
M06N&/&09:=]C]-+DQT#I+V$.9+RL.^("/"?O-1N-!Y>K3.[BT`$J<J78Q)#,
M'75O\%"\]W13O2DR[JL'Q>#=FBUK]75W_>5@(/S7,-V@23?>;4;47XO14Y)F
MU3+I)2;UZ0/;JSU`=M8RSJO8'8W#=]\8(:_>0#6)I2>;S"%:ZU1M@]B><0-8
MV9I)2UD=3>]UVP@ASWPA6@SWE'@/C7:Z;#?]-\O&XE,QSC@QQUX<<(JY'_IK
M`B\'5]PIP?;"\*Z0&EN334W:7FBS'0=#^=D*A-7\8N[#OILCY%`8K`K;GWT<
M2K;DH]HGZBZ2Z4/C-)W+01;$V,68JV`<<_<=K(%B&9%A.K$=.KRSH^;G,UX>
M4U(7/D]*Z\,QG[JU,T8=ZC'W5;>F#GE@%0C.]KKPS@9>)BFI!_]14:R6NYSW
MCZC*Y'.>/J4SE,\FXFZE6[W3;^#5CZ%C&!K+`_*U)6.A'=Y!)IE2O^&,&BQ+
MR[4AN/D$-.#=)7#L`)<:;&"("V1C01[>(0>>6I.T^'))4'4@"!$:&&I"7%8=
M`'!^]6.%-\!8`X%;*AD+[?"VNV0]]@Z1I8'7;E;3\-6;:L<*88EQ!O;++8E8
MR/[@:5&*T;4QQ=Y.O+F;J3THJ&\DBRG$C-/^)AOF#K!2.!:]/P;G<,^RI"C&
M\^V5U#&95.^=[3=>T71%J%U1<4851;/3];9<L2TH.DI@B6HW'U1?JC'W$C>F
M]>#L;0G,)DVQN>UOIS=M_8#DW0Y.B0[*6R6.[JJW6']_%[UY,AS0M2JJ0;@.
M2I*LM7@^-*RD*3NY9?C0&BPA)\_P+#;@3X0TZ'':5YA.4]#"[\/;"*GA2Q%.
M>X$H`T`/"K`-#3X%OT,IOT75^P\`[67`8E-WF/")''BBR\0]*&@#;[`KQQ:`
MIW7KN`?P9!>/^<#[."3PM,<T8=II+Z.:+"NZSK`&RR-M=6`;M)G-S_#C[657
M]C+LX2S39AIA>_O?@+6U&RHZK(]A.CM`(X5\JL!$*U7__]:L_PM61W?IR:49
MJ82%FFN<G$(AWV)4Z=3C8J*8M#)V_*N+MI7FCQ$6XK5M)+EB5#I9:%N#\,Q-
MV])2@)[+*<9MWV:Q*%I8J)>--N805WIG)ZU\B5>2Z^OB4KPV;I:*H8F%6EEH
M80YM50-_9[6!MW%!4:SHI(_W0+2B5+.!>:6.9L$99@?WB\XJ.92C@-G",P@^
MW,FWLIP80MX7EE7&Y>-`O<`LH"MH3S\+S8(6W0DAC<>%A9IMR2GDQ]VK38J!
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M8S@_T!'`OSO8"_#J%7HTV'$XAZYNQ_S0I895-I.B`7U$6X`!?,1.@%<?T:/!
MCL1'='2+Y7E#6U;1R+3DC:]+CW"\N9U\-T]L_5\OFU1X>=*<&\/CY`'`WK<3
M>)TX]&^L8W`)RDE#>&GFW-O$WY0!P-Z[9WB=+O1NK*/P#*JI@LUL?@%Z!HVD
MVM[X^E@\.+XTWKZ;)[;>KY<X7)$&<9!SVP4V.K<MRB%:XNF7S4W^T;2D1BG7
M#+Y:&4,!Y5OY0:7E+>9"/9PB8CE>+!\SO$:H&.55X@*T^R_O2+,E:BT;]*#F
M\K@RO$&Q;;NPMRQD<ASRF_;G/^3!87@?%.DBND=K2$+14^4D!C&`^+Z2,1%#
M(PQSA]2TH;$E*X$ZKDRB0U\VEL3I44[1K;F=+.)[CX(BK9MRW2(>[SR:VQN#
M%.R%C,Y=21&G"`[Q&D>KV\?21K-9;<0D.T^+2JE5]3+X?5&29&K]67L=GI:?
M]%3PC+;]&NFO?D=58F@T&STADBS0Q0LBT[1`-R2=>GB8%<+=W3.M<NZ1S+2U
MNH>;]UPU6M'N5!RBNZ.'7T$Z?P5#0<,D$YQEEYA4']U[#@XS=XZBQ>P8FLI-
MJD\5'W<-%%D23QB<W3AK#UD\I>HY\L?"-)XA76RTM3YD,%%6W73L*9K)C-G?
MU<>@EG3X^6F"6=01)J_QOJH#2'L3P+J.S9M>`IPVQ1$O[8A+-7'&*Q75`H]2
M39MK/!)FID#P;5XW.[$Z`;G^/HHG\8;HRWU5^IE4[WE=Y3>(I'@VNL=/Z#HA
M7U#)6['QR%']WJ(]CL<6Y?MO)L_QOD\%G=[$]-*I94M+_CN\B33NG(&>-'$Y
M"O`2[N!V#6!)-Q0;F+J;HPH#=?;FAHL&85(>PTU^80ZJ\?Z`84KJ2B#PFZX3
M.Q)#=QG9NAA'.JP$TJZ!;Q&Z4CZ"[`"CK":.9GPC5<>6\T+D+?0J=_HXM'+`
M8ZR1_N:#I2:["-#7UP5P.J:C#5`))\M;H%Q.<0U/_C9!U<T2Z3:H3+%CZ-BJ
M(9>:=([2LAK2APQG#<6P'<YJBQ&7O_`?SO9KU\C#65/ECSF1C=@TC@(*"2?+
M`0674UP.PE]`H6Z62`,*F6)?0<?>>;2]\G>X3+*KO"1I7J33^KJNLZD#G+7U
MN02$=<`S[`%L/]QBMI:P$?39W8&<6T2>:!S!-\]GG#^AH@H]*DL4M<K-[V>X
M*#_C\E^HG*`I7N3IGT@T)#OGU^F=#OD%W"5]6=F\'[J7\!ARNZD7O3O>:)CM
M)`,A[&\F:0D15V@]Q%:2>9M&/O,V4ST&;U.YYNH]4C0[7]%P9;%1KS9&T?#;
M>PL(I]7&A+J]WH!07#U78U+<UZA#S7G-Y8Z@SS@+4S96HO;<_E25$[W2-(P0
MO@)I@1!?8W0-:8\`0VZYV,><2;7MVJH+>4YO^`KYN%F2:O(YVF'7<9-$NA(M
M5NLKZ,[2X\GUQ_.D1/L,DHXZNZ$4EEV!MA2OCL)%<T;J1DR5ULVQ/$BRU72.
M<8+NT2,QR;GJTM5M)E^C5?F`216@_4H5)(TP\29+#O.Q>AUC4C4H$_2"/)HM
M9B#'U9_9<*.2XBUKD&JG:U8Y7J9:OTR[3>>8J<N\MYZPC@=J(HUQI*^NK7'$
MCXZO^7M?\_>^YN\UME*0>5YB2=UG[,(XW=X#)WO1EIA3C"W$ZL+U2AXXN8R'
MO?LW'XA63M9M-HOM0$JDG7HV;D>K0?*F,T*-<R3)H:XNWLJG+BL>PBJ5G8;#
MVM9Q/P?H9FP'B/::M_\U;W](*4,]SUSMC%W`H(_O`)PJ:FD84RIXW-.'X8-3
M)C=HA.$I+]-J_/&I/&OK,4:HKQE@7S/`6@="@#Y^<P!C/&]LUVZW5WWX?35W
MER.!C'O$<SCYAM`@S3?4SI!G98<813@Q\3/66>=@BLO7.1K%(^XCX'4.D74"
M6.=@11LD?7F`LUW;[VCXF\;:?6XCT-CEWE(/83UQYQ#8!%5=B'X^PWE]EVN5
M9'>(+#_*8IMPI./%/B%(%['?5\=&(1@XF-@I(&,,D0*>XZAI>:U=)$X%17S5
MK!!Q3X-'6$(+A1!C<80+`XF7>$5T@,B6E^.P6?YK@*'0/@&@D"-;+"D@O8T@
MK2JG:)'FU7!RFE!R4R2Z_!JBB(-&?2H1(_8$`85^6D#X*N(_H$6<>CW9.T#N
M##%:+`A:)"62IJ(+0!+F_9\!)#DV]Q-.LWKV,B$H'D$"/2<;&(WKUP-L]8FY
M^]CJXW$_-J<R;/,=TU:?1-D(T@M9=:^L*4)::^\OG<M95Q_ICMHYA6#@8)Q7
M0,:()0V+-Y.UJGA93#(4:5`WUA7IU7<Y;^BOPF$)+*";QR6XQ2!6\:$6@[0E
M<;88I"')L;F7<)HU^L4@?<499_*CW)GX3`IU2$I],KGX-+J[.+\93>ZN+FY/
M[B:CS[>CL[NK\>?;<U0F:58,EBUJ@K+J:<J;A)3K.T*;A4:6&_6E>9^@U3J1
MC;I:`+F8!$(6I^O6%U"*)0-:PLQ)6K1\)$0"@X";VLC<-%Q'IQ*&GWO(1(@A
M4PHY[?0=K2592/0)P!P!ET`09I+>JA07E*@]6,(-@\;#&KKJ]$X.SV8_E?"*
MX%;O>4K0E-+FGO>2%^K`IEO(;PPM:04,5$2)B<-A*@6]6%(#F`PL@EZFY6`5
M-R`TQ!)U1*`X0V3OV.T`G5'15EF9YHL1G3]LGGBYH(,P8=XOT:W6NKT+J39<
M5U5%9(:J&P=?VOR&N)?WCYRLQ>=SV:]-/#2_AN2AY:)KN&81H0AN,%V\H.FJ
M3)^H"YRG4R0?D^6%NX^@"`J'A``MQ0S&:@5=IT?OG<Z(1DN\HIYI/&_\IC<E
MDE&`S8GX%,(=5_H;I/?\WH3U$/=#KG%>/F3K;9;\>I64-S#RAB+-JLUQ"EPU
M7(SU,$&_^$67YQ!'GT=YODHR$U#IU6QB"EHS<$@9&:`?HC191G#\]1(3E"[R
MLQ4A*)^N+UZF#]7NSH3:H[9$5N\1B<YC:-;NC*'@VN$"L9\A>H^=NFR='JD4
MWJO<[,7=D!23WTE:TO]^QB4-/3>ORO!\&[1.^WZEJDZX,#)1NI\G`S.+X*#:
M=B)3-'>U!0Y+5K3CG?A%P\60AHJ]_8Z4QQ"'ALX2,LIG9TGQ<(KS%3=>$A1I
MNA"F2+BM#5"IGX,0T=8]Q6&G=:7M*FW1>-K232LJV^_#^^`<>H^]7&&"6W^[
MN;+\M+:W<V%98SULZ'K8,+I#RT=,$K*^RJ<$)07:SL-HP%+/]'G.`5JGZ3/4
M=0)W)9I*]_,P8&:#8.;L(47S:S1+ITE&A[,[-'W(<887:]G6@D'-UI@#K!G2
MIH.YRKI;4II,V&#R_?OP!JS;U7V1SE+:"ZK=TN42YU1UV@FD.U>P2MT3AHI*
M(8'*2%&#'2T@?1Z4PCN(=(9)Y4]+]%^8-LAO5(T5X:=#TZC1`9&T1H@(@JMH
M`!\(<0YV5,.7]S>-R6-9X/MG\CC<<\:O!]1?#ZB_'E!_/:#^>D#]]8#ZZP'U
MU].+_::*D-.+KR?*U28^NA/E3L>MBY=J2PL5E[1IF\K^GI8/S2IZ@YDN5=@(
M!Z<:[I*E&\.Y.I:H+4X$681?SUN'=-Y:O<#I?66AQ&ENLJ@@VLA)7E`QSJ]R
MRH7-T]#:OI&6;&W:"$H.MP)04DQ4,S/IU)Y;J#MG[Q1R.1F'6!T#Y6>?$^03
M;LVE^01#F207:/K-`C^]FZ%T@P3Z1Q<`]*=_?T*+)+O(J2%X\UY)B:WIN"4\
MR;YAR9VABCXWI&Y_]C8;E9D4*P5O(95#JD*HD$0$D>Y^@R05/(.J+BC:ADI]
M/X8J;`?>AI-(#:;!FQ2Y6TLLI<"GHGQ'BB'>AS^);!'<]0@1(6^=PH%78\[4
M^/)KO(-#FHY-?AZHMVL+\*[H?(ZJ!_S0)JB@$49U^'V":`0P3;.T/IDZ*B\1
M%3_)*@ROJ"#K5F'11,<>Y>ZLR`9ECT]/P^-!^S8S"2)M2A%!%QC3(2&I;B!]
MPD5QEA"RGF/RG)"9:+]%7:%[%%Y2(4@<@C4T@1>`N.[]U(%2W=W^,I[<W5U,
MKL\O;L:W5W<]$MP)DWEB4E:9CZ_R)U24]?4XZ8P?5*&=&E-:P6)>TL8J>E&2
M=%JB^G@\;WX/K]!215[!^;P?9GMLH![;S:2\#ADK03Q"61WHL151W=J3[9!W
MOW>W!P[?A]5!.KODE.#IX6(^"=O*9JR,(<+SUX1WM%I["AP:$2P?M/O>]E;0
MQ1^K]"G)JG[+_U5ZX*,O069[S)Q@9&:5]S`+)*V8=K@^W!]:V(D]!3M'IM*V
MMRHM2!F!'[JF!ERNEM(>P"W3@72GC.?-2,X8@&'RBP>:3?$F)OAT(FCDJSJQ
M7%&>HH30.=8Y>L1%JG![H#H=$"CJ^-ZAMM"#L9E!+#HF%H8P0<)<2M>8@?0>
M,E2K\&I9^@\(\9W?"BI^DMP\#B^"DM]1#B6$@MYN#C>("F^U^#IY40=1O#+=
M(*I=)JP@2B*_5A#%I3-$JEO.<EEUXO`TR;\4NS&6LY=E5%>QNBJHZW$?0'.=
MTDQ]XR5+77:F<`HR^!&L4_:)91B2$3A90=A[E=<PT)O%="K!IC'[2B%V2R.%
M#?JC)I\ADLIN$_CI3'JUZS7].:Q>G)-?4\,XF0#K"Q/RGG&-WN?9!WL;P[\G
MA"2JS6!AH2:D.87L]<\=<>$F+[<`3SQ?F[ABFV&`R*R79>CMT<VG,^1FK*(1
M.3M2PN^\)C3>+U+(Q3V5*"G!D\W[B6NQY;HX4Q^Y9F@Q&`O@ONY.E''.W^66
M%^*U6:.0QS!-8-)NJXDT$#=<Y_:NF%#`R[U\G]:U#6B&TR+%6&7PYY=TG0^S
M%N?1_?!6*W7]CWPML;\'\K`(M$?4,U9[(*80-R@Y%`K/`XDTT/9`+*$A6^_G
MZE\TVSR[+&M!;D%>*W8*#M"2ZF!3IHQ)T,FG-T2[?D;/6Z'$G5)4IO5"'5,F
MG"ZID!_<(X5TAEA[.<N2HAC/MP*-R21=/-3K2;P65!9N90`5%PZJ<T*5TNF@
M:II#M/4_TAG!^>:A>DG2'6&I5O(=3JEPNJI2!W!GE5"*(*D%%X>[%RUOT71%
MJ`U0<99D&9J=KO>SE4U!T1J]):K=?)Q]J8;B5=R8">A^;#./%>07+W2BFQ;H
MAJ13M/^XUT_TEE,O6A!`JVE%`6--D]@`+YAE!`^.[2?9^6PC_7A5%F62S])\
M(4`FI$H'@/(JH>%,0T%-.($H.WT5S%(&BVJ>=YI069I/#HTJY1;UQL'I^E!D
M^P+!J+J3>9FDY+<D6Z%14:R6=2Q35#F\JIV]\_0IG2%J&?$E<&]\N_DUW/,-
MK1/X-K5F3_(G7@0OKM6:WJN-<:]CC&J2*`I.W#/D=4!'#(/L>3Z,:]+EW,KE
M]*VZ@(>^WW#U-&B6EFO?@Q^?LX_AK\LYR&[HU=PA#($"`9T^,QA@QYRDQ9=+
M@I#D,+=WOBX[)9_O47=)@*F'[)!2\=R^&JDZM[6;O&Z3+U>9G!9Y^B?BOAT-
MK\4]XR6I%0HZS=0TV64%$-=^UL_[N=7'!!EE+[8S2MP0_(A(N;[)J$&I/:O3
MPH]51V2:MN/FX14[?AI2,8"'D81BPMY"@E47/G^DJN[CQ2.-%N:^>:1E`NXI
M=[4$_(>.@)SC3\PD5/1T?4=Y2W+<:-2$]M]FS?`L4LDF?==(HR;4(LV:WE/-
MZ+0P[F,&O:Y[X-[LNSI<([C[_ZEZ:?@!9[.KY2/!3[6_D%_M!]3HH$Y:P^\5
M*9W6PR8ZZT'LP+4),0BW,(]^&P]PD&XM]/>*MYKD(H#Z-H=U!'W;Z0@CS-(Q
MX!@C2\;A;I"!)=?P.<R$=X][\V3/7@GI`",MVTVHS"\;Q:`"T=/&<"+G$P%X
MA/K^3'"A/6UH58+ZKFVE0'`EG=9J*6YA,@OD%P'.1M/I:KFJGR`[1X\$33<9
M[NG?&:I;.9^-EIB4Z9_U[T+%!8BT3;Z#77OD8T"Y(V-:Z`_6)7-ZS-_2\5F\
M?%R5B,`&>$7I[A%84>E`8"H?Y&&ZVACF59PB@%&SOPBPPRO2`4R[2"`HD3HS
MB5(6'!*7NNX!9^^;352$P;::JL?*T!\K:M"+)\`&DZHXY\DW?O%!W[5KB"3=
M.)(4E2OJ<4-(V2)82R'^`I.`1_?5.R%MUB&S1P$"W]7IZJ=:5U*65R!(N((T
MG,[*9R"%9>6Z#A/EJ!M(W'/@D8V0BZ3O`-:_0X&$8D-345K=!7@;EQZVZ51R
M2WRJUH:<@(_,K\*VW@;9"9&-`'*+@7<Z."P4QI+O9'QK\^S9=4*^H/*J*%9)
M/D6W28:*T8*@>@@;S^>H2N17GZ#C'4'3KMP\B:91>5`GRXU.>JFO':\8<CL@
M9U545J_//R99ZVRC'R31R>\R+:IN>$/[)?TA66@#2D8#BBL^C0CA!3"&?91)
MF:K`]M$,;($%PL)M57`H[&,SU48H`-LVM1P,"/S4!]4RQ_;WZI_JDA3]Y?\#
M4$L#!!0````(``A`@T92O1J*@^<``(7>#P`5`!P`;W)M<"TR,#$U,#(R.%]L
M86(N>&UL550)``//@!Y5SX`>575X"P`!!"4.```$.0$``.W];7/C2)(NB'Z_
M9O<_Q*W=M:DR4U9W*GO.F9X]AVM,B:K2Z4Q1(RJKIC=MK0TB0Q*V*$`-@,K4
M_/H;$0!(O,2+!^`!!$F9S72ER`AW!_'XXQX>;__C__K^M"8O-$G#./J?/[S_
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M#\`C)XW>?5G\0,*5,V63VT=*PD(@^7%5B/R)K#8)"]Z$22+/-`GC%6LE_EH&
M2?+*OWH)UAM*XGORG&LGM%!_0F)N`%GF.D@@3"`L]),D-X(\YU:POY_CA'\0
MI&6S[#%@71+*+*`DB\D=^U>8/L<I:\64?0NS1V8)2R'(*PT2\F.<"+,B]M,$
M:Q(S8]F[8N8M7Y=K>D+">\+RC0>:_/3S__C3#EMM/$Z3NJ<'R;)\W^R?!JP4
M+?ZTC%DX?\[>K:M4>)_$3PY]-G;M)P7<!?.2?R?8:OA+=O4`7O'./]Y;Q:):
M-'7).,*NX3B'J9M<;AGG?,LXS*L+F:046A!)"93ICD@*R:00739Y<_&ND-Q;
M)^>/X)>;GX+<7#>F<NKMI\-Z^^D/D^O."<*;/W?%WO[Z\VG+GU''8-/E,MY$
M67H=O`9W:\K^3#9T:V>_`5@_V?K15U?9+KBQWW,Z'7=U-LV:$CMJPAAQ!85J
M1I-"]PG_A&O?4JQQM+4.@[MP'8K/CVS(U=-+3>2-0@(&WNZFPTC:^\\QCL=8
M/8P:B%\THZM2("DDDD+D;KBU;R,K+SW9=DSEE2^[&DUUM`8VE"J\.6O/F[AS
MZ4ZCJ,ZZ)M-.$?_-:>V1MH].BSID8KIYYIW>QM/E/S=A0B\VT2J]C&YH^DR7
MV?Q^]O2\CE\IO0D?'K/TRW/,OLI8NR?%.`E%8'5PU%-@?WY#>2+$85!?>PQ$
MUD^\&/`L@_21Q)OL?AU_(YP>\G$.^YD?>:+"1AGW7"9/4Y)<*O^,%G))(@23
M#9/,OB]%5X=,^=B&_Y4/GGP8>N``/\:'GHSC>@EN$-M^.RCJ&**_)2Z=DX\6
M2@'\'18BR$7IC#<[9RSED)N*,^Y$O?F;#DE>>QQ.TM_/!/1,O[\Y3AV/Y?07
M]A'OS<ETT/';R=I)^N!.]@%_9K*_04[=[,.;FZ&#QV\W^X`Y%CZ+HQ4?>J_8
M/])X':ZX1UR$41`MPV"]8.,RH305LYV)&*5=LV;+UUOZ/?O(-/TA&Q#C2:V.
MBC&D]B<HO&=#'!^C&&7@*00=D_,P7:[C=)-49_G$F%:T)/=Q0I:E'OZOK2)R
M7VKBFRP*5?G*S%R7#^-A1-S'CD`GX[;^TAL$=RB>BCI01C+'N9?R(?-6"JF*
M(5LY9">(5"217!3YRH41(>W_>7-+&,+VQ#%QAM((=J"/IY%L<N^?IYW]\\T7
M89#:%U]$G1;['"1_T(S/RBWH<I.(E5.+>+V2)?BFMM6T7=VV/X^8[$!,L36J
M#"ZO[#FYVCS=T82GPNECD/#M`/?D:=N:I-OFA`'$BQD?XXN/K=Z/S-%4?1KN
M,P:L4/-!K9*.D.*YV^X[LON2\&\/!S_ZM*DG@G!2'*5T],1%JZDKD$XE[)0>
M%H:TX;XOAIR'YOFWB&'C,7R^I@R'+'P]-,'8I:LI<$N[NG$6C96.P[I<<P=/
MD@D2JT6>MW]S]XK+9OR/9?STQ$;2:<8SQC@A])^;,'O-%[PMP^=\G%TLG`^C
M%YIFE):5-%XF8UV"5)Y%^)I`Z/!H]F4SFHV.+1$!\/-Q?<%Y+J+2B>,'ZDQE
MVYCL6A\+<.WS&C3HNLMZ9,H&28)4BI$0S%*D'5:?CP^KUOD3'E91LZM?@U60
MAMEGRM-=60XE;5#-E!H-^KN15"-BUM.4;_"(>O-)\2?YFG_@0XE?_HIB\X\J
MPVZM80.A;E\U:E!O2[9YS3Q`'\*+UH=4\*N6A,<>E/,ICAYN:?)T7:P//V-)
M?YAQQYT^)%34??G7,C*R[%JE*7#7_JBVM!*1VN":#=X`%33A_RN6,XA=P>\R
M_N=VX?]RVTL,S1[B>)7R85U*DY=PZ<>8S!92<9]7+?-"H(B&?_H'9U3ZMM&)
M`V5.^;PI$3]VV9CL6I-M<]'D6*"K#R%.P8LS*H,J0Q^5V2A&PC#?2[I%:79,
M*-6.Q]RB%'4\QN?#-^LLB#1#,E6;QGK11AN4A2M2O;AK.9LJS&M*ZCTFNT]\
MRMV5+ZVUDD/W;FNP;K9MK[%P#@'L18)MX9:OOUC`=S@`,"Z2LX$`[D#NER1.
MT^LD7E*Z2B_8DUZFZ88?>3Z_/Q,3.8M,L4;>KF>5UZ`]^T/=SD9$#@0K-K@&
M4(Z8DWO@;?-]W&%4W\8=%KV:\W,^#-XL<13W>,$R[X-):/BD;PA&I7`+E2CH
MY70O6I*R:0[<RPIH\^9$M#\.S.ICAD/4XHS8@+K0!VP6>G'`*X9K;"S!MV(6
M%/Q<@S'GW_C^GO*#,(X$NMJ!G$OHH@[C+L)HQ1!W0:7KDMK?5E.<ZK?]G:FM
M"S%5J0DW^$2E[:3X-[GGRW?2-%Z&8@D_/XNR7&_'TXYB28]/Y6+)JXL-O[<,
MR+M6#;"Z>OFH4;XA%OSB>;0N7SW[<[]>ISZH`EXH3G"LR$,/@`W9\/=Z6G/I
M/7NOVH@#>:_=(D?QC.+Y4KK\^2%^^=.*ANPYW_^%_X-'E;^\^_/[XF:O_XU]
M](\IX^05Y^6+=?#0P(CR^^*Q)-_W0J-27S^"D8E5`['=>K+]D_"_Q\6B^IW$
MQI^Q@<96NQT>G;]9N^!A8!JY=(M7S*/(OK]D93"Q><VXU;S=HK-RPF,[S:&>
MB@!WJB:X@$[]XR38,L1T&*+3$%3-(B:5Y<+;:>K=K)]'%6\X..)NKTX6L(V=
M&W'<#S"BIN<P;7V!R&GX#8KZ40$Z&''&$&8UZ$,+F,K>F&0#D;P$)(&CJ"[\
MLF'ROX?D]\U_/<8;<OT8)$_!DFZR<!FLR8^_)/'F^2=R%O]\0CYEJY^/`\/:
M$1`^AE$K;9I5&D]\6]CG.,H>UZ\7X7>Z4I3C.HH`KBZ5BW"ZKDEG]3"K3146
M=%_F)!4HIBZ?\@_)/?]45!3OBRML^(I4HEJ1ZD,QL2OPP$ND`/"M^;JE*/B"
M*4^<8*@UJDK=N`X`6+,JNI&B'Q$=/2F]C@+^SJM9\>'O?'6K5.F0JUR5!B![
M@3@3JFR2EN<H\H5/_'3%8O;HI!THCM8)NBZ6=>`$J+G@3?P:K+-7_:$0RD;5
M?$[2J+^O*C4CYF0R'09W:W>1'-.0!FLJ]NX$47Z]ZQV-EH_\I`7"S^T-[T,J
MKC0,V/]M1US%=4;\3(8D5^)#UJ4&0`Q[73*O:35N^,4P@$+-;^32;<'$<Y3B
M0[_.-.@,`WT.80T$G#R@+18]TLM56./A=(<'K\X-Z(X';3BUQP/*50)ML;#K
M`0H\O-#D+NZ`","1_[).6T2P2%&/.Q'-2$)?:+3QXL*[[B#1'K!O#Q+4@_"G
MJY<PC1/U-)^T035?:C3HCU^I1L0\J2G?`-IZ\TGQIT_58?DKBLT_J@R/M88-
M++I]U:@93%NRS6L6ZPP.X$7K\Q7PJ\;)4^HBT7.4MGBK-WYZ(&]<FY'`W[C;
MP?GGX'OXM'G:?3"__R4)HBR]H4L:OE#IX<O=I6B']P`I#G(RL.TN"P00(VQ3
M.K/,R>^/-"JJ`GSY0)#P'1"!.,:1)8&!K/QP0K+',.67@;+?6I3Z^"S/4ZZK
MT4'(XFUS?;OM%*P)/U(R>PPRLHS#:!FN:#XUG+6*'COSGH/0BR.H>\#?D*#:
M^I$^?S5*,R6XGCJDVP(+3#VZ,\I+-*3H5_UH?D_RKJ3L>]P^85D*<N\5CHI)
M9KWNJTTP&_"=0UJO.H&%G2/W#KO"V`#>@9K0?@SC_T63#4]-GM2E$W6K:D(J
M:]7?C]6Z$1-*J1*#&TKZ3-AG9/NA3\,OS1N,@3^W#/_MU@U\#X4)U)Q&(=X:
M#SPG.41$Z#.&#IC`B?@2N>@17:'#'AJG`AKO#@X:VG#9!1JX)Y,]AO1^L0SY
M`#K-YO?WX9)JSB@SMJZ=5J9IC7!HE=$6S!/,=,I,AUFI^T[$=V3[)<F_]0GZ
M@%<>6[X7Z9%7RE[-PZ]&`A7NF6AZ-9T!)<Y).R9(&<Y1ZP\JW-V80L_L.UUN
M,C9RR?4DTV@E/O],5WR["OOSEBX?HW@=/[P630R,W%MBB[5[2$1RPM[/A,W^
M?0R".'1W^9.;7>T\C.Z9R/Q*I6>:9$$8\>6R#.XY+VRU%+S`E_ZM1)'\[';.
M:QV[:KH/E7$D>$OH!,MGVH336;*,E/;8$?$C9C]3G#KA+O+*/2S_KA`C/MD)
MVC;T+4;[Y7B`6.^'ZR%=*-[/!O2!/H(];CWP5.^!98Q[<S(8;GQWLH'V&W^,
MHTV:[W*1Y=]6'6%[BVL=7>XEDU@XR#[BNM[.V\:J8O(]PRS7Y9-W0;X]LK(N
M1&Q>$3--Z3-E7,"2XSO>FZ9DPP_\VFXL5EYUXT,R;(<UZ&8R-4YKK@\2`-XV
M-@;&!]HFW-2(@6_SEF#1N-@8?`Q0[;KEMR=876_OK:H:<%-O4RT*9B4;>`7I
M\@V$^4>;9T;$P9+%^Q=>I%CF]0K&XVN:9G'DQ=X0]TCNN&^W+Y)QIY%8$YZO
MW="4LE_V<9X\!%'X7R)%6.1;M0'GSG674BM@=I"",%SK;#MFH;*+$:91F;W,
M2=F'E)U(M1<INOEYJ%@/$,9(B)`.O:RE-8=;>^(6N&7#;NK174*4!]^<HA\>
M/'$+I/*>O5[\DEXW&_"]X_3-.WJ#PA?O0,TK/P<I`W)3T^VW6)U$`KM4,T9C
ME_[N#K0*(>29-1G\UR1@DC>0N"1KXY-;0I$0=WE3,G<S=&WXUOBH0ST!'JRP
M'_R*`XKC:$64.#QT#.I3(E04XJY_4BAC?32+3L&=`)1>[>3,O=J6N:/UFJYN
MGE41H:%VWFH/'$N""I!K*=$$<:U=9YAS#8S"P6B^H;(O'#G5WSZ&R5XS?7]`
M=F+[[I`<@O$O&*1M";_=Q\SWU3ZN'*UMES.VKZGJY%T5"6JNYXW\]RP)'B".
MI801P*MV?4%.-2SZAF+YAL:>,!27![*_LL<])OG>4.Q"\9W!B$SP^=&_U_F<
M[A>^FN9L>TSS5GLJY7F[KC6ZAW9%\#L[*Q%G\^":34X(%#0I3Y0O9N@YL.[X
M63PK6EDG53F%>WLH<,J;BGOEHU7X$JXVP=J+BUUM(1;W>?52WX6):+JP=_!&
MG96ST8D#;1YF2G`7;8EH3':M=Q''AW4G@R#7$'=<8A=G%@VJ#'WJS$8Q$H1/
MV_R\>8.P?@+,+811I[JF4<2B9I<\RJYG[8!?8$^$$T*M;,0\$ABJV'2D*$S.
M)&]W.!F4);CB'F]=>JPI2$+SO%//8(U[_#%<)0JDQ8').:BO]R+L#(!8P^'+
M[C"+=%PS3!?^.<YPO3C0/6WQ\1MT]:=(.X0N:K;TMRAY5<\@M+^M9CW5;_L[
M4UL78O92$V[PB4K;R=^N;O[N4]U4\D)BPZ\H@^>N50."KEXI:N1NB`6_3AZ!
M]_B%ZH,EX)5V+%@7SRB>+Z7+GQ_BES^M:,B>\_U?^#\XJ_SEW9_?O_OP7O`*
M^^@?9YLDX<7R,%T&Z[_3()E%J_,@:V(%TK1X6'W37EB%6-$/M@8-:@1K.TZ*
M;TC^%>'?$?8EX=^.BVW0BXUM7D`#\[HN.P<8"32H4XA&1=W0(W92'`%^E*S9
M'T$.SC3K?G99]S/*ACL":;0SQ[#.%@.<(58_H&BZ'P<4]3HCI?])7YU.//$(
MMO@G=.&=Q&5QXM:>G:KE%K2`4[+<P!;QU*NQ3K?".\4*=%K5YS`)@R?RMW"5
MQ-&QP=1\SI0CF+;+4.Y@ZN!V5@O-.$#]P&C6PV/3',-3>[&K2WBB7@&[6#[2
MU69-Y_<W=,TR_]5UD&2O'P,&BR5-;_DU[K?T>_:1R?Q#EJ%WZ5_-T^WZ]W?+
M+O8BYNR6Z@W^:25MPO[>K-DX>,5&>^LXW23Y77=Y3_+,NY*[HN_/9/8]>'I>
MT[3=)DN"*`V6_$'Y:<++]69%3\C=)A.7^45Q1M;A4YB)T]1.ZJWO:/:-THC\
M&/S$K_H+Q!A]&3\]!]&K2,["+"7IYBX-5V&0O/Z?Y,>[GW9_A[DU@3ATC9]>
M+/JS1LN?1&=:'.56R'E.^"U_SRSMB[]%+,"++WY<L;;,G=8A>R(OIL\[>5#<
M&]0RUK*1T^`NG_T8=1!CK1C1A\7.UJ(]]X2B!Q%=2-F'?!6]".]&1#\?0O+`
M,-</<@8".LZ`QTHC^K#'6CLFWD_K>-\B7-S;6D5_Z,5)<$-C7#M"&@KCN*?$
M!>)\WR!]%`?126O"\B:UXF^S"<)P3JX5LYS;TF`:G34Z3-@'(L=9LH^*@Q3+
MJY57FT1<\I!?=1S&7EQJK'J3,>27EXZZZDV;PROGJ,"MEDIDVR%"U#\9)GBI
MGG^8'P&[KR_>4+:T>?5(A<B&4/R*HT2!)0).9:RPMPC05P2M$-`M:LD6C(31
M"TTSOF;D0_%O'M<^5):-Y)_^XU+\AT>"2\;)#%_9#8NM-^QMTD7&`FP#:9:]
MBI\$W*L7_BUMZ\>&<&5JYX#*F.Q:D+()X6V(:$1$JW']QQ87<<>7UO`Q8.^=
MVWF%1-1U*S8Z>T.R/-@]OW?@+HC^("OZ'*=AQEY)`="$]3@I+S<X;'0JLP!7
M^$1>"J,?V6C'-*AYJ\MQC,4(IC)VV9<QBREE`8U35$F*BW>,/"JQ&H_41B)>
MC4"`K]$TZC"\2*R1AL,QAM7HHC:N\&H\`7V?AC&$Z7WZ-6Z812OK44.E#WC,
M(/HXSM,J=KD>+^2J^J1F7()IK,#:^)Z+5;%@D8FU(03/PO@J;(L<;"#D#3P^
M*#7VA*#%V"#XO@]C@^YX[#$NL$<D[IC@ECX]QTF0O%Y&RX0&*2WV25[31!PS
M(1LJ0/M41Q#F/OTS%:A=B.,-@$I#6F.4,"DN4>*77Y=M^<H7T9C]0RQAH5&:
M7T3`6NU.:.!#%_+$I8CKK0)^O>`RO`^7'HUIP&"*.[UK6:)EZMO(OWR`+NHP
M"J2L)VS%X;A;N):-MD<TL&9$M#M<!.H';\@8Q!GJ&;6@CP!!&OM"\;0*125S
M&KCR@(&J'95B`Q5UQ<;L^_*1IT7S^]^#A%?NI*5-=:MJAB)KU=^EU+H1LQ"I
M$H/72/I,RL]X%O&M^-3/2JCFE<;`WU\&]G;K!KR'`@EJO%>(MP8(C^E;B,SO
M2?GY?N-!'Z<[(`(G%DODHD=?A0Y[8)S*N6//@:&-BUV`@7L@(PL,*[J:1JL;
MFF9\H23[8?YMD<7+/UCLY=L17N@U>X_J#>[=)-0.:+24@'`V6">;,0]LM#7`
M=%28G;Q)T5ZLJBI[$-Z%B#YDVXGP7MM]<3X$[8YXBQ$`(#U,S$I2\U`QSY&/
M>Z:CO6I4U(LS'KOA_CAA;S@`<CC@(QT(::<3_V!(>_VX^#]]PW]'"(R-__Y3
M]O=!>B=^]$WZ[B$(GO,#XN@Z2\M/FB?%%1__8\KR\-4MTS+]'C8+(]HVQ8^F
M:-/+G[5Z^X4JE6BU*\I[3,2?A/]-OO)/1G8B_:N*0;]LPPVD;7=`A[WX/AO_
MM[NL9T_/Z_B5TGFDN6(3T+RVK5_7'&%+I-D:S$W[6FVF_8Z:SI/=EZ3\EK"O
M?0H=D!<?V[X<Z7Y%=;?F]L31P(6[D]R@ISNPQ#[Q(X.68<,W!KB0MG-K%.#O
MWC8HZX&QTR/$F'[#-0K&4`N4;46M>\7U05YUJ;VYN0M':5GC-,A7M5G[R:ZS
MU$O8UWY[B>G^>3A4##ZBNG5^/'`Y#O)U/=V!I0KRAPPMVR#?`5RN@OQ.P0!!
MOJZL!\840?Z@,689Y+M@##?(/P8)_1BD='5664QU&:59L%[SR/<;3?E%*Z*=
M='5.-PFU5,!2`H*'=;(9,V&P-<#DAG;R)E<;`;KXGJ3B$Y(]!AGAR];YNCH:
M+!_9?[>=?9A\[`BS&.&]2UW92E+3NST'/&X28Z\:%>PBU>'_(J(+J?8AE4ZD
MZ$7R;L<)>4..-!SHD3(I.YWXR96]?ESLGQ;83\7RZ`JE'RF\]>G9@/!&3>(^
MQ6EZS:_%XR?;"@73NS1+@F7S6"!@ZVIRIFO=WT'-MB!$(*T2@[]I^D[X=V(G
M3/YM'CC(U[*!#X,;P+N.+5^(S'/4O1I>,A::4+?H0G1UAE6^+3?-";LXJUKD
MZ(>%)GVB@8"G`6_U.R_&?-=B>X7Z2C]MN\I]?HIVO>]ET^KOQ[,Z\?J+V.2]
M)N7')/_<H_O7]&\Q!O_@DGO7I.WKEZX-B@WT"_O46CJ`A#/EX<)$>T%?5Z#@
MGCT@%LW-G\7M#--H56Z3T$P10CK4*H/Z#@@#1(A%F'4_@S[3Z$_;?9*O)"V^
M%R?W;O>V^%1P!Z$@MG]/TC&=KF-S"#<JVG"+;D9-?9`F2FHUK`7'@C5#@0P+
M;<A$73F2GV7'X3*CXC1C<1B_E*@A'50W,4DZX-YCH;0(DZ@-^BPNJFAWW]U+
M,;\GNP;Y.>OY!2Q>.`\(!>HK*$S(J;N.KJ/FBHGAT>;L1B"YICY(:]_Y<S18
M@]_ATPMMN$1=!@&^.R5\>,S2\^UU:]J+]&SZ56D;UJ^_/]G8ATCB0+4&#P-)
MF6RS'YYVY^W(KB'S-*\NU+("3-SY7<I<#]*_X8$^P125_<$*$2#*8\$;2*5O
M<D"8XLQK@S2ASV:#M6*@]92A=7IS,[VZ71P!%+7STJZ@B#H'?1$G-'R(RA-/
M/]*`'SMUGI\HJZD)VO2KIBZP?OU=S<8^Q-0%J-;@:2`IDZ+5]ASJ=W=Y.U(V
M]*FB8X67N/.KE/DAI'_##WU"*6KF`E:(@%">N30Q2CX>+T;UB8LCE.(D+B!-
MZ(D+6"L&6%GB<G6Y*,]2/RI<:K,85[A$W@X1)]DM39YV9[BGG\*(7F;T2;'[
M`="AOME!VP%CS2O`(I1UW7H]QH6LNNX3\37AWY-*`_*5-R&BC0\.!7O[S16K
M<,34:Y:ZCJW5J#8HPW68W\/L\6,0_9%6;S\`^HZVK\&-%'V=>)363M1]0F#5
M]OXFES39IEC\]@]QF'8JG%'<$Q)6G%%<I,XO#DE)D(K[#1XI^UM<],WZ4)J1
M%1/AQ^XA2Z@9?1:"5)/[2F68/7ETH"/O#[)0B@3R?$^0),(0WIR(]O5KF8X'
MPZ8M0$Y1C+7M!ZC-P88?"\U88#YM</818=6PG\<M5G&O0BCV>>?EVB_/<71#
MLS"A7+UN-X]-O]IU":!^".>@6]B'$$V`ZDQ'I$.D3&:?KS_-_SZ;D9O+7WZ]
M79`OU_,K<C.[O;R9?9Y=W?JU$\@*)W'G5R@]:AW0OWGX>A=T]O`^/CW";^F:
M1V<Q\_HD"^_6]"K.Z`U=\S-";^./-*+WX3(,UGF+E.7M%S3(-HET;(,BL.JO
M/07V=V24)T(<&O6UQT`!_<1/RNXDYM<4;060B$D@22Z"8_YN*Z1HQJ60^UR,
M#R,G'"#'^%"2,4TOP0T*VF^'0QVB];?$I;.)?4"EN\TC4A%!N`Q2""&W,=F)
M(3LYI!#TYFTZ''GM;SCCQGXFH`\F^YOCU.U.D:+<F]OIP.2WVZ$.@<LMB]-H
M-8O8<[]>1O?L"Y$'ZH;`-OUJ*36H'P*M6-B'F2##U)HX`B)EMP^7;P3+VY%*
MP\I0V(N<U@8P<>=W*75=0/^FAWH$4]RT$JH0`:*US>)&D!X^1@UYG1N4#G@F
M1V[#>?P4A%$#\JJO*R=PU+_N?;B"3%O_\S8:4O4G*-0:3PKP?\W_'AGNRO<1
MFWY#R<D(U6;U`Q&T[[3/PN<P6K&DZ()2]1FIJC:U!<VM-@C+[11Z,1<JMU68
M5M$U>[1/(PW3=,-&#GSMP7W>^E_8:,&+>ICR5<:@7UZZ,J[1MKD*;@!@X*X-
ME@FW!(58\YM_1MB'_AS*V?']&];LVB$`:2UN4RK^NEN9!EL@[(ZP5+#"'H-"
MOV#6$A2H8_'/0<K>\((F+^&23A\2*J;>U-MX(.VKT4[?OC^X(?8@1D&#.@/F
MM;TG^;>D^)ILO_=I93GH]<?6;TCF%KI^#1<9$V2H$=6HJ`?`>*0]0HCI`S(2
MR'`"M58#>M`V:NN#M5.>U25I1HX1<=IHCX4XU"S@.HF7E*[2"_:C*,ZKFGVG
MR3),Z4J6%73I7\T2[/KW][0N]B)F$9;J#8YH)6UR^TC)DI\)%$;WZ_@;"=(T
M7H9B`D^L\^=K^X,G,=F7T"4-7W@FSB23QW@M1FDTE\7W9+*V84)2<4)<7#DA
M[ENAUH=Q?"=HQKW1(G-]&SD-*O#905`S(&O%B,[!,Z2R/>$=B.:@S6VOX\.X
M/J4:".4X*9>51O04S%H[)MA/*V`7!%\0NSA`KF1P0><%M1\AT+69W%!`Q[\'
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M>4.OF"F*MNQ=#FR?\Z_%ZJR"T0]I@*OP%#=4K75+)\Q<U^B(BO>%`[P<E4I,
M',7_W8P[R_%FH>2-.'!Q?&#4X==0L6&;MV-#B9WC,$AM]"<IC+^Y/S(2#\W]
M\4=M*=_F?BGV%US$Y=*Z](;R)?;RI6T6W5KC*5,W)&Z#68<]TC%JA9".0<A$
MW%XGUJG1^WNZS"I[Q\1Q$]6](FG1FR1%=V_&)4#X2,C""GAMO]=WESFQ%Y#%
M3\P!^OK#=9LRI_D11"1O25C3<@%T2LK&AXY-0%**C4[$=-&@R$WN!U"*`-+=
M/CLS@QX\2,VI$SI(<9,:OG@LUW6^2;:I4V['I_"?FW`E8OEY\!0\T`LJ/Y^_
MJY!:PF,O!.FB]2Z68R9#'6R`7,IN)5*YM9[A,S_*GV^F9?^_WO4F*]'=EPWW
MW5$HN=:]!YKK%&`K3';YN_=>@9MO==*.[1$B%Q.K]XLD+.]6%!Z+8P9(I2?)
MN_)#"([9&0QIV]#N@)326:O%3_`ZF8#N%3SY^W5Z,UN0R\7BR^R<_)C2_!C'
ME/SW^Y].BNAQU!Z@SPD']X!VOCB(!WRP\8`7FMS%#GS@@PL?^*`_B$B>(1VU
M1WSPRR,^##:"^APD?]`LN%O3!5VR;[-0?NY79R'@$91<B&-BT%D^U`A*84,?
M5I"*;!P^M,K31;X;.E_Q(KCA:=N3I-NNW@^>M`"TX`8`D.',(!-FPPS>.,1P
M@R>E=FQG@`V>=CW)KNLQ^T*/L9,+;QA@["15.^S826D"NE.TQDX7\QOR>7KS
MM]GM]..G&5G,SK[<7-Y>L@;;417YM[N]&50Y=8WN@RHGKC%<$;[+<3HH`L&I
MY1#GB:`\T5`I9_\C>?J)5PY/Y4DI_[-Z=H/?Y_'@8-N"COJ<V--+L`U)>>^#
MPV6Y&*?^]%4`R'[WY&@@[]RM1Y(\I,,-D#P/?]Y0?W.<^AU+L&?_.;LYNUS,
MR/R"_#Z]N9E>W2[(].J<S*]O+^=7BWW)I4?QK.XY]J">-43N_5NPWM">ZU^,
M,@`9MD:&,W8QVNT^C]:9T(U"U!(GXJL#7/EBQA^(/*`PAK"%4A:,(+SRAB$R
M6KUR9$\PY*VYF^S;BA?73M`I'77E!DZ33K76H?),O078WF!8ZG+$D.^2)SJ#
M_&#98,^Y?*,,:#8X\,2ET>Z!LD'4>7RUQ(.<QC=C#\X(2)/X2ED6?."+)PR6
M"2)/X.MDFC/!/9N^=^T#W1-!!U[@/A$<=>9>;P&V,W2=MS]B7^B<(;KPA<$R
M1,2I>BMYT,QQQ$E"J^<9**-T-DT/DUZI.XI06V2<04H"PG[GS5H<5G`0D_-V
M:(9SCX.I>9!<"T;RW><&RUT=3LM#Y9MSVOV>E!_+S;JGO@,ZFON4V)OY>+@U
M+OT-,!O_YDHH<_"#NQ)N1KVY2\-5&"2OLZ?G=?Q*::J^/MK8N)8+JQLC,(')
M$LPL5J/+Y,+*KI/M!R*OW+8C7Y^\N5G5_+ICNY<B]2I5IZ;+C`(GW`1-JZ4K
ME$1JM<//#E<>W=&+AB1#LM,72TAIBE(\?@ZB5=494J<U2-'#AI0^Z/>&%&JX
MWF4#RT=^.J>TJJ5L5`W/DD;]D:_4C!B.93H,0&]WJ1Q-*;M"F18-:Y=IMF8C
M?:CYJ-]U#'LS,M"W&C?`/@QV4&.O7+HM;GBLK=0DBD_W&0;Z@&H-!)P`VA:+
M'CCE*JSQP(?9$J[8:T1HXZ$](AS%/\VL#FBJQDDM>(A)E0XS)=I-BMOX1K?%
M"L\CG;X`9#4/82K4#(,21Y'.HK8O+=A[67WO#`-HI`,"`3O2=2I3PT[NZE1]
MEI:4=:RQU]@`QCPH-G!+M)2]YH`]^77P>AFE&_'O<_H<IV$F7P,+Z5`KU>H[
M(%1$(!9AEFP-^DR%$6UW<;5:\!1O(K%&8%5\3L*(P2*(^!TI>0^RC)^>@^A5
ML8XU+;60Y^#5AP@+PTUL_V:EA15=QV9Q951\XM:`C9KZ8%/4@K>P8BW(M@DI
MVQPBT`QE82RH(96'M2KP2\1&=;T0=UI%'".R"OVM#AEQ^JHQ&N(&RR1FWY_I
M,J.KJ0ALMFF%O#<TQVCV=NMC<EL'RCY:RGLX7T-6(R]I^V%>WV8_'N_&4;C+
M0.*[=?@0Y`NO:"&VO&$D6FX2?EE&&-4SF/4Z_E:F-7?!6LA)'RG-R"K(_-B:
M;8]8.`5H(0]F@[H4"VH8TV<&RX@D:M'\!9`KD;('R;L<%Z2[)U5(H':?;C7T
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MPL3D&5?$OR"K,%VN8Y:_4Y%PE>N=22(DD`T301CK/(61>`(?TB@[%,7=WZ_,
M44$"&E[J%WI1\R:X1@SD\HRI;$CREH0W);NVY"MO341S'];J.P>K/E=R!E><
M+`FF"CU%@JM%02U?*?OY^M/\[[,9N;G\Y=?;!?ER/;\B-[/;RYO9Y]G5[5$`
M59L`N0.JDT6XM_RH%UF*(VT@6WQ;-,!;1U?3Z&#1;2D?N'@N;[Y;2/E5?.`#
M)<M?D7R9G.PUUG!;:ZA8'.?F53M9.;N3;/.::RMF]_A%P];)&E^U)#8B4,[T
M>RA=\BC[7D8X^?=X(*SJ<T`WA7@@#$7K"@;YWSY!L/9RY`B4O#\I_'@[!?I<
MO&(G-+,5;/%ZZR2SIR\8QC"&5^R&7\[CIR",=`Q3;R'CF+(%'@3K.AWPS%8!
M$(I%^PH4\T]\`F/C1<GA*'V;4CCF+16`=/7*G?!.1;35ZZYSSUZ_<!@#`5ZY
M&Q::1U1]"(^RD8R+*HWPL-G2[("1JCJ`*-UUV<&4?>;3H17J=R='J^H=2^&Z
M;:Q`K%LL.*&JNG1;'-0(ZU"0`*,N,!9PMS'NQ#K;L%]780V)TQ\FC'??[TZ6
M/`A,@+8OPC'AIEKX+38'M58C:=5PUPBQG-34[*)Z6-$!+2UMN^RHC'WF(VS;
M[TY195*\8WF=J6RLJC4YQ8*;\F)-NBT.:D'M4)``K#E"L8`;U'9BG06UN@IK
M2)SRU0P)I5Y'-7M0@*(:'!2H4>V*?BLTJ(.:JDTUIK7;]`>N2B]B1).H,*"V
MU6/"/BD!ZQ->E6\M!OW(,JPVVS:@.@0&4".95+CE^^=Q[+`0H`]BEAC`+2S]
M+5PE<90?*JWF*W6K*F/)6O7'JUHW(FM)E1AP*^DSR3\K;BKP";F:-Q@#?VX9
M=MNM&^@="A.H+*80;XT'SF2'B`@]GW7`!$Y:+I&+GI<K=-A#@V7F9[/Y]DZ3
M`P&&-C'O`@PG!:=/840O,_JD73#2:B0K.%4:X0TK6YH=%)RJ.H"CREV7RF0?
M_Y"(3WV`KOK=R4>4JG<L'4]N&RO&DVZQX*3@5)=NBX/ZM.^!(`%6<`)CP<TT
M\"_\?^DJOQ-91V+2AC(B:S3$`[#4`@>$UM0#!'.]F^P82]6-TS[L]=&_9CG2
M=9"08KW608'W8>#CA`/;&KI`I\:%Q3<D_^H0<`)C16NDX);CZZ*=E>3;:CH!
M1GYH[D/>YB`P`ZK2VV,&=4APM@[2='Y?:)HG8K/,+4V>9%'5V+@:636-^T/>
M:`EBA-7I,B!?W55LLN4[9\O+=`L/8.#(-]?Z$%[-[SNV>RLR1U!V:CC#.'A"
M#;EZ+5VQQ$.O^)+,[[>3!O,DWP%+>(M#@I(^$O<&$TY$5HM'C\IZ59TQ=;I-
MYP1+'12"M'&Y/X*<E.RFT2K?Q\H/[XA2>D.7\4,4_I?^GA=S+^E6,$TOQ-U#
M1MM<;!O3*87N-E++F%R$41`MPV`M3KAA7Q*.8!'@$[KDD`GOPZ4PMIKV^A#L
M+3"CV,`$!9LT#U;W5FUU&AFE;G:^Z=7U1FAMF,[OD2^.R2@:DEW+PT8D<*,=
M'B9Q1_H:/<Z&_0:=_:%Y*J'/`T<AJ$*`B4+4W.0B"!-Q,?MG&O`CHG@<_CW,
M'K]$\5U*DQ>^V?TR>MYD*;>`O==U*"(?^VN3\&KRQR`-T^TI9&?B6KS+:"M6
MEMD,I;.:%[G7V9\9AOI=$'.R`4PVD))S"R;Y1_PPVGOV(7GAG[)L,,C(8Y"2
M+/B#BN-J^54$K9N06*>$KO-<D3MZH2:D*7G*[5T1)J@B.&`!G;DO?8@300_\
M5@,FY1-]87CZ4%::*AT>0YHP'GSTXI*EP5P['L5S9!3O6G<C0+P1V0;W7)Q!
MC!V9Q/B0@?]!<D15M!"NAE3UD%P1J6LB6U5$Z-J=64P*?KR,R$[%&Q6YQ_X1
MD!'.B,NYE>CCM4$L'IN33LO4*JWG5F_<X1ZHQ\`=7HR3T[JYY<7QVTD'Z<HW
MY\HP1L8`9>-1-_B7\&`L#+'5$5>;5>=I8S[2I/?W_&J]8@A*B\:^S8&X=QX<
MTK9U5A2N-BI%(NG])@<OQI<P*\<BAOXCRK0UI"RU5-;`^+#P]&`(Q<W0T1M*
M&7>P:#;/FU$BS-31F(6?I2_)+=Z8P`46#Y,)7"S?VHXTK^-UN"S^5WL7DE5'
MR2(N4T>TM0@P"_&7<AGUPA8D&,1,\@_$Y4?-'5%!2IZ#1(QI`K(,GL,L6),D
M"--BAB](*"F7?.7-@]UU9SZ,=NPP)EW<8(5/V>H&O0#Y`@=/L.UB`1A`(P:N
M*\O`*I,Q!=:_%O_UZZ8DYV`%+0G#AROJPC"#*E=KPP!J45![6EF\V";A*@6S
M^)X"6/@H<`U99.8`U[C;U/BO&&5)7L4/TS_.$KH*,_XO0#)EW[NVD<VB-\+6
M$6M;,;>ZV2@W[2V!RYJ<[ZZ9Y-G4<LEOAN?%G>==^K44W4G"^ON0/'7`5-SS
M14NWJX"E-/>O>(IJW`UW=FK1$"VVY%5;$]Z(Y.WS?_N990V(:L-&/O>X1MKJ
M!]>'O_?/3C<>O$^;\.;IUXZ??:BW#8ED_8;"`9",FFO=!M]I.H\NHV7\1#_I
MC@K3MZSF4*J6_?U/;P-B;J149'`K1;^)^)S,(Y)_X]L!4H9W&UN\!)E7R'LT
M/&!HU*#F'AH5G1##<XK#QXP^*^B!&MR#R&81B\_!QS#^E*W4QP:K6U6Y4=8*
MX>YLI6Y$3I0J,5V*W>XSN:'/[(FHJ.M$;+#WE&<5SS3)@C`2^V)BDG<DK"=A
M77T8`VK>;PQ\&=++KENMFS=;#X085#Y4B+=&"^?!.A1\.CRV!R3TU-<!%#@#
M'(E<](&,0H<]-DZWV#@03&B'%ETP@5R63;//-'N,5Y?1"TTS'C+2^;>(O?+'
M\/F:)GP`$SS0&\IY7'Y625<9]1*MK0R,@7\WNU'+M=8F&&L`EA+%.6;/V\]Y
M(2`NFXNJ0/STQ")YFO'Q;9P0^L\-GVKD<S;A,GS.XSR_2O21[Y+E*BDM"\!T
M)0J_FVC%@<T:+)EUY$F85Z\3^Y`,=,9QL^S0RQT:I0<[6:T"A/]>A5PN[J`<
MV:/RTC'#>=Z)5'J1;3>RZT?*CL?K`J9*\J!.@%55MM3JH+;<P0)L7V#IW`[S
ME2B3O&'>4',>%O.H2>5YQ#/6)[H*E\%Z$:\W8MVFMM`"[%)-&8U=^CLQT"J$
MP&769/!,DX`):T!V+<BVB6_C;R@2XBYO2N9JAJX-SQH?=78)$R120!3V@Q_/
MB<Y_OOIY^O/!0TV?RZ""#;<B/EV]A&F<:.^R5K6I\G*[37^74.E%'(I+5!@P
MW^HQ*3[Q[>YBY5N+03^R#,?-M@W@#H$!U(&C5+CE^^<D=U@(T'.9)09PQE4M
MJ>CC)JD&6RB<'AP4M,,56RB@#C<6?$.8.%;OFF'G,4CI]"&A8D.9-IC9]*L&
M.%B__E"WL0\Q$`+5&CP")&6R:T7*9F3;SC?/L<)+W/E5ROP+TK_A<SZA%#54
M@Q4B()2']#>,RE[D@"C%'>9\HL$JC![RNEB<J,.#MF$U'B@:]G<MK06(C*_2
M8W`@>;=)\3$I/_?)/?3O-(;_^C+X2SLT\#XL5E!Y5ZVA"TXXLQXT4O14V1DK
MN&0XSQYI<AFMPI=PM0G6:C+4-JR2H:)A?X!K+4`D0Y4>`\CEW2:+S5U*_[GA
MF<+LA?^O:$=V#7W"O/XEQ_#7(4.\M$,#\<."!Y4=U1JZ`(>SXT$C1<^.G;&"
MRXZ:Y#2_^'1^_R4*Y:=XVO8%%A@:?9T.WZ1V#E-H:*KN/I2K2Q*+W:+MI;4;
M_B''U1TE:;RNW9&=[H9]S^6P+RBE>G'6I37$P.,]'4*A([Z:#/BH;S2`#U6C
M:"M%`K>Y5E'<UCR_)Z+#\4"X<]D"`\0X\QY@;>CS(5::L;!\:L!R>M*D\2-"
MLW8JQC6:AYJZV7YRG81+>DT3KMXRT]+*`&9<"AE./5IK]S`9F,J$[@XNEYAO
M/RC]^YE_Q=>)"I\6FP=X+J:E`K\=7P]!,`%`D`RE`:DL.!UXXQ!#96QJY<C.
M8,S@*I^)?GP7@<CECM<'.J=V+KS`>:HGUSIDRJ>V`-L9`"F@(FX<L3=T30V=
M>$.W5+'X[<7OGM+ESP_QRY]6-&2___N_\'_P-/(O[_[\_MV']R*19!_Q;;)A
M]OH[7:__%L7?H@4-TCBBJTM^Q&1S/@/<OO@)`>U[^3S8GGY1#J)&[<+FWI/\
M:\*_?_<';T#*%B1O,JY;PE][;/UF&LYF[+=SK-'!A;J;`*:M!\J*HR..#6?*
M)`<3:8/-G:1E06'Q&##P=AS::X5`Q_8*(6YS.*WE`XWN53;T2.+D(ALS+JGX
MTG*$[_EDBP&*\(P.`FEP0B<59I'1^>,:@XWSU=JQW0(PTM]-UN0]]V6L[]09
MNH_VG;B#^_&^7.V@`WZU">A>837KTP@E1^T6G8?];MQBZ('_;_%ZP]*AY/4B
M7#.T*P?\BG:M@7ZK'=(83*$?:V#?%@\9:C5[E0.L[><D_\*7897J)4J&4_KW
MW1Y$-=K+!D\#0</1L%RFI0-&*L/PPT,)8+!MCY,1!]?%92^]Q]<-.9V'V%LY
M`V=.#?O'&FCOS,!,GTJI\N$V'V$7E]\1&HD'R#]\C->KO$BTG4HI1^3:]8][
M-R)O@K='PB7W@^X95WF-6X^D:V27&F^`7C7`@3MU':87W=^<!'&\CN<F(XS:
M2\WC#MRK5KCPEJ[#]V]O[M+$AT_N,O1H_FR3),R@&_H<)_QLX`7+OS;J0;V^
M>6MLKVJ.-([36X,UTE=J@0SF%)W+$5WQ-=E^3_(&OHSL#.];,L`#(:0]RI-W
MDPWV1L&4HQ*!1EEW<%4*!L<"+T`9H2_`L(L*R4NXW`6$LSA*0S8Z%(/?/"C,
MGZL#X7HEP;)SO7P`[HR1MUE:BEHH@.LV)FA049.K9LX5O`0A$[7.!_O;T?WN
MF/Y8]"0/X0N-^(7+RZIPT2D@:6Z`;S4!6Q@VD[9N,&[D:4`AK>3,1S=`'MS;
M:,5R@7P8G\-UMQNRUKP<O><=C@G)IB&Z8RQC#<:AZAR,P&U4HT&:'ZR__>&W
M%%X0/*/Z_+3EHP*R8?#L&LA##Y/%Q-)9D-&'.'E5CHZEK5J#XD8KI'&+5#?6
M$+@I'#(XJ?<I1R3B4U)^[,LX1/[B),,/W1MNCSEJK65#C0&@X&CDVM9AC8G*
M./604`$8B]KA`G?D6=Q'LKV?Y./K[6.8K*Z#)&L2&[A]=7RI;]\_^X#8@SB*
M-*@SI!C:WI/BV\I@D5\&MR)W#!.\F;CW[=6'O`($@MCZ/<ER!UV_1KHP)M10
M1VI&13U@QEFV!-KN=JB/KT0T(:+-X2%,/]!"PAC.<$JK`7T$9=36!VJG.Z@U
M"2TL#M8\0*AIAT)84!MZP'.]N5N'RXMU'#07LVG;M`8[M39(^:U$+]9`IRX:
MDM)6>Y3I;/X9$1_ZDLS*7I8DE56_TW8:6VDK2V(=OWI'`YNF!DL,5`8UAX$"
MP'`&CH/!5N;>LHZTVVTD[9[`U;>UGF[O>FC;.,P*V[KB'G<^5.1,;N@S^S4H
M7^`71O>L:SY)\$P3?E^F."(TUJ^09<,E]B\?!DJ6P()?"J%$9:/P"I%@<2W$
M&)`>[`*3ADH4.`,N,>&-?3I?>@#,=K_*I"=JG2\_K>H:<L%I4R\.>$V+2H\3
MO%T7BO8&[]"#OAOZ$*897X=Z%3PU_<'4K#7T:S9#&@+(M6,-`%O2(?E_HU,Y
M`-A]3/CGOHP!%*]/,@S0ONCV.*#>7#84&`02C@:&$B7VV*@,#P\,'8!QHBT^
M<$>+Y9+[RRAEJL3MSL&ZO.]'>JT$K$=U=&CJT3\5@=F$.!HT*C1D'H;^C3V4
M8;75MFCLQ0T00#3$'5Z7+*_0]VSD$V/C#G7(!E#5"W.<@W?+=&MMMK>C^7#"
MO0/`Z<=AB)##&7<9=*"/MP#Z^B'OM(H\!=<=*/*T@RA,Y`V^@X[%T(0;L*+?
M_T;5BP,5[5K#IE8[K(U-<OUHN^1:XD$[F!J]MAN7\L^)^(*P;WQ)CU5O4;95
M2?O"V^EQH[UT:](PV'"UVTVBI0-(JOO;#@\FD*ULUD#!'4D5>Y73ZX2^A/$F
M7;^*0VU7E]%U$KX$&;U>!\M\G[-Z"JZSD.IXJX.0_EE)9\L11V5=;#"D+O8B
M83-WQ8$#*7G>"B:AD,PZ\<L$N&SRO!7NPUBO.SAC'*C(DB1K88V\:3^<!74H
MV4T[MJ/P@%5V(KM>^0GJP@N*CF37TZ<YEM&\03]<'=P?<`:U]FK1Q[G=3$!W
MB].*6P"#PU%[@W8(/;PWH%Y.>!8_/<71(HN7?^0;_::;[#%.PO^BJX^4I19T
MRE2OQ`1I?,;RB_`^9,(IKP(LX^0Y3FH)4S71Q)5<S3ZQ)/?G%-QG1,Q3T0PS
MD`^2'C$;\11\#Y\V3Y59B:607CE%ZRG,,D91^676!5^)73LT/_+Q]5]2LF2M
M&1F3(.+?K8-O*6O,36&?D*`TA\NH=:M8EY>G*_;YD!HCNU/L$,<RFL31T.#.
M0R,"U!P<T:1!2(!GZ[DD(D25IU7LA)%<&IE6G5CGMV]N:X>Z/7-<G'$!DBWH
M@P5$NX;QW].M_Z;"?X.=XVH",.OR'$2F"/SFR78@W#=/'NS"]7(2<SOLZG<Q
MFT(,<.>*6LPP1_<JK!_XU/BV%0CG]C:%-M8[[8KCS4O:#N)(>!4L[4_OU0.\
MQB\=Q'4XN=</5QG\-'B9?GPWL3H+?E=:WZ]+VYPY1_^#X-'=8[ACX)N*1SD%
M7F:$`R^Q.@.^%6J.WDUZ'P"/[R:H^>?L.TV687%/_`W#'IU'FDW1@.;5?%+;
MO+^O`ZQ!S`_UV@RNJ^L\*;\DXELBOB;L>Y\F>"%O/K9].S*GTG1K.,]XZ$)-
MJ4QZNB-+K(([-FSI,QL4=.%D*CH%Z!F)25D/D+$,XW__R\]__C?^^_VWG__\
MY\-%EC89P$'6X"O3FS6Q^29+LR!:A=&#>IDZH%-[S;JV$]8B98!E:*O9];I`
MJY9U(K8+F"L332?;<]%W#;U9SPQ!A6QQ,QQ-I</!.DL7/8^-0E?KYDTJ^\*Q
MNJ+^B`$)67J/"$G<1?GMP'/!X&PSVFNWUP_WJNU=9$QM>YP.^&KJK%.F2F]Y
M6LX;^)T]2=Z_*7U20L:0/>WZ&=.GX5#F>.#74-0#8<JAWX%CS';TUPEEKL9_
M%0T##``;VOJ`C0\!__KS^]-#!I;EX*\;L!S7=F^_Q3;1OM5<'^PKS5UX1\L:
MIZ&^JLW:-7:=Y23,OO?;5=IOWN0I*JP8W&3;S>@E0Z'+<8BOZ^F.+&6`/V1L
MV4;W#NAR%=MW"@8([75E/4#&`_M_^_DOHK;[WW_^MW\[7&19AO<NR'(=W/7G
M68,Z&`(\[E&_((O<!GF;LZKUW15D[-M9J#`4&-T&=M2TMJ/9<09$F^N@;W>,
MM$G`L6+-.OQW0YNS%,#E.=!F=;U`QQ.!]Z<__^5?#QM@MEE`1X#A;B'@,P?Y
MG:?391:^A-GK[.EY';]2FDZCU54<T>V?WT/I*:8=1=2V#MB*0%CJV<UJS"T#
MUA:85GA:"ISDVP^+FW+++F3;A[!.I-J+?.7]?'#>KIB+,3`@7<UI)ZJYDM-[
M_./N`^B@&Q?[8OW_&_J[(6!T_"/?\@17?AX_!:'T$)#.0CJ&P5+(H$10MWR<
M4+BU`8\0"I$=""'ON6>4T,!?9U*0XK@K*>3"NM/"B/XP5FBL:,?VA6[A\<T;
M#$=,#.X/R"O`2N&:.K&\2:TRW&R"4"V1:\6L_K8TF`HBC0Z3G>/X5`-1O*X8
M\O-*JQSUILVZAO-7CUN*E<BV>^VBW'HP+]Y00;5Y]<@W[U2(3\U-ZE95>I*U
M0KAH0JD;D:2D2DSW2;3[3.I1W1_0:EY@#/RUI7=#M%HW[X,8"!*XE]S(Q5O#
M05QF<WB`,%Q48P\)Y)H$7\M_%Z1TQ8^-HE$J7+]Y\-"7:$632E)XS5YM*MD@
MMML2D+=+IP\/"7T(,GH994D8I>'RMV"]:8+5`TMJU9&1+$$84H[Z&V+6:<9Z
M$-,`=QR[)MLO2%A^0U[X5_P\#'[(4IP+('%E%T^0EM_>!<R")27I(Z4967$Y
M_'2F@"1B3IZUHN5<_3,WSXNK"T8FA-B'%Z\;XX]B4;-0\$:55I;CEO#&>P0O
M:5(4$[>:256UY.A;H9W4BH_"`"(_BZ+"JX459$?*6SN(,.2-/'T@3T.)]'CI
M$^D(LW%LQS\%;;SG\)-%3W^85!J?D$"5>[[1G!<TIS_\[8AI#G?](N8S%)\$
M=VLZ<J'$VA)GA1(+2SP+7M:_H:^%$IL'&3)VP>T2AU)G<1:LR2I>KX.$K,+[
M>YI07OVXH]DW2B-R'X1)'L&V!9(--V3]RK/[XFX<?AUD\L+&";Q0PB_&$044
M?@5.HU3"1?`;FUG3YS@IJC#W\H(,Z[W<),R:;/U:RN%/E>NO%'+X16'16P&G
M%U$Y#,Y=6=-=:`9;Y#(T'P&%^UO`L7L$+^G;90&G8L3Q%7#VDSP'+.#L%WUZ
M6,"!V^YW`<?N.?QDT=/MUEO>^(@*.'M*<\,5</:,YG`+.,M'NMHPG?<6JYMO
MN972(DQO:;5"2@]I"(&@][-@%C3Z&&/BX^ZR)V5?/M;.;^,K1_C%K;G,8W9K
MU_A(/ZHN9EMM$G&P*AO+/],DC%=>#-#[@SA&1I*4`CM+;=+8GKH9[J"SGQG.
M7$P,_DHGF]_7!W:@;4%"C`_+13WR*\,8:GS/<K[%]E,8T<N,/D&/E&BU-VR<
MK;1WLB>P98_;[;!5=?:[_7:]%=OZOO(61#3QPE,A[]^X54\%F;JO:?J9M]\-
MAC+7FTSKBGH@3+UU]+`Q9KWSLPO*'&PR^-@</DX3,7G%:>KCZZ[)=?#*/YI^
M"Y)5,3[\)>$WRUU&UR)SGM[%+_1SD/Q!,S&H5,Z1.]?8F@MWJ!&IWN?\-\&>
MVW9I,*1\YT[_Y&I[HV4QY_S`.["A)-^/O1THDB#CU[S7YW=)P*6)5D]"9/ZQ
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M@7\[-RO1AWL(^/+:H6R:L+\W^4[Z=+F.TTVUGM+<=G[")Q,?DGCSS`*;X!WV
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MC17BS,%6F2*,&#]\>PR7C[RN\*XLEPAQ[,NM//TA?\L@(G>T<F@@"Q`O-&'A
MRHL"Q9"^BS09T)TV<(K^%OJQROL'R%A^+`>Q-=@#MD)9XG$B\N*BA)#K)!6E
M)]4TFK45BM_H:CB?."+"&GG)A8VE_BRNL+7:!]YB8_G?@R1?4E8].3E/GZ:;
MATV:D0_OWVAF.!P?$\WX,=9N&3IGXX;D]C$H'B2M7(Z@6[^!.A#'-@IEE(YG
MU(C1!?N7]6%\C_A,KL(2FHF3WPVK$_@ZBLK]`*WJ`(FS[>Z38@/+7H_[T:D"
M*?PYHC"<R(AE'%;8?*/6RD/X48A`?1K?:15GETJ[;$&$/80;M)T;K%[[:-B^
M\L;+_O*RH]+(H3+SR$45M,>PJKCDNX!GT<I5U07UL;PGZ6J]IGTI^4'4:PZ>
M-=U4>@Z6-=LUHKUDS0_VK+G(@B3SGC<_[`-O?M#RYH(1&14UT#?F])DY/[PQ
MI^7/M0_5]6*E*&2'Y+`5]@Z&#5-EMS+,Y^#9X1?>BVJ[W7.-%CUMS(14W2&5
M=OEQS(==?^]")$/%WNXD-U#TM3!PL`A\C`2\)S5YVR?:!_(=LC9?[ML!'S#U
MQMS^,_=8E?H]YV[?*_8VC^+/.DGTQ]H+"C_]87(IKK1\X\L]X,N1:O3[SI?=
MUG,6>!983NGRYX?XY4\K&C),O_\+_P>O1OWEW9_?O_OP7M2CV$?_."^&^!=A
MN@S6?Z=!<L$^:=Y&"&A9O&!MRUXQ`&!#OX1:KT!-CKI^D_(+DG]#^%=$?#<N
M?T'>:&SQTS?\6]-CYW"C8,5N^&4(X"8]G4##1RF'#AME(MT7.)Y<#6B,!B7?
M@PXT'+9<W\FT80KVEJ;Y/.;H]"OO1='>]LE&&W;8&8I6N"^['57IOANI##6D
MZ4-Y`PUIK$P<;%!SK(2\)T5\^V?:#S(>LI"_->RME']H3#Y6.?\`N-SWDK[=
MP^Q14=_^P?:$TD]W-Z0==FW_D`ATI/K^(1#H6#7^W#18E5_25EGGK[5%KMY*
M[,"N]==5V!1NJSU;A=LB8?2R="M[NYKBK1H,ZN)MI8^N?#L0=AS7_IN:.H)(
M5O\_3!A9S`+8`VG/9@+X:3[>S0%`C1JT^F\V:@\&)M!?=I\J_H!G&GLL8C01
M5.7?R7H[%,>:*@8>R%A2V+`#&)-Q0P]=CH):]ZMV#WH:WVEUA'J]8.>W.OW>
M\O+(M?E]8^8]J<<;'V/_*O&@1_*>H(_@`..#9\QQB_%[QYCC'9J,>CS%]"X5
MM\;V+A`YM:ISA<B150/'2J>_[5@U(E</A1DLW=CHXPF?Y&MIWO^S=P4GM]33
M(TX/P8G=P[03Z_K$Z3>R5C[%>%4G=X_C/5%WK3NYI^@WAO:9H1&+3\?!T2.4
MG]P\Q[CU)W?/Y#]5G^[F7M\=1KG^R#@3K_QT))R)7X!*I]&J+./>QA]I?E+*
M19R<!>GC;\%ZHUY&!._:*N5`NB(%![B5V$41D&8(RP($3<1_*M<U,U"1;V5Y
MGN'XCI)0="/W<4*6K*,W0WX+'$D8S!J%;9(QBY`Q@5<8QA\K`G7BX'<[ZDH)
M:TNV\TJW,?E(2=Z>L`Z$]R"BR[&@%S"P<(5?Q!0=H,Q-'@U4C`1CEI$N?IW>
MS!9D>G5.?I_>W$RO;A?D=DX^SLCE8O%E=DXNYC?D;+KXE?R84DJB.*/DW^Y^
M.AHXFW,^9W`>.'O*6W1+G^I][?*GLN\0KENW<]`,:JNZM^\6DB;%;;R'ET0U
MT&3KN%(P6OIM$=UM'7=X+`^<2564(N'8+I?*6QX/BONF4[UP/%1"56@;(:.J
M:,:"<_><ZJ3@\2-"=\_LJA^Z4?.KJSCBHB^C%YIF8?3`]%^$41`M^;^76?@2
M9B%-S;;)\B]LV=7\#$]V?Z;`?D[$_`[1-`/1H&F:W#Y2\F)=9^-GM@6,DR+Q
MQX_LT^<@R<H/?B(9ZYL&2_YS_4Q^N*Y\]P-A#L)HF<O-'H.,/,>)F(=FZODI
M<)6>G/-8ZW2SYH_(50IM"5W2\)G?O%;8\IRO*$K].T@.W2=CIZX@XU<L'0W^
M/41&0<VR48T:B$UXELYDY4GX5IK(V+?RR$X@`6?T;ZYLC\$]=&:<H02:->A#
M#53+AO+IT^W(VYP6O/FI/;CVT4]QB\YTN4F$YFOFV(]!2J</"16+#RZ8JW\6
M5^E**\XV'6OE9EA'A*J&C868A6:@7E,Y`R1FLFM&RG9DVY#PEN1KWM:/)?E6
ML(F[OU!IN0(BH%FK\`JNN+5DL$8,J(HJ,ARLQX!50^G8%5J13Z5:/M+59DWG
M]],HV@3K<_J<T&4H2/(FR&AZRW=!WM+OV4<F]@]I+.DFHA95;$4@.&PWJS$C
MC;4%)D>V%#AA?V_604)68;I<Q^DF$96L0'0FJTIODO#N7D2@CF"+,5Z^U,_M
M1#4]WGO@X\:L#KIQ02_B6-&%S.])WHE4>Q'1C7P5'0GO2417+X+:&/`W!+HA
M'0!IQM12*?[$:0<#D/W@M.('L<8/CA;T^JG304&/6C.X3N)GFF2OUPQ-V302
MFQ*>>;KR"XUH$JQUIT'8]JWF>/"^_1W<UD[$K,Y"M<&CP9(F94LBFHI)@6UC
M4K3V:^>H-9#B7N]7YL)0&0W?]1'&J#F:E5(D"/.L[`W$QK<[`HQQ$BZP-O1,
MRTHS%II/*VCF,S^T;'A$H-6F3ZY!.TS"U$S;K#(F56=0RM3N[-!'598.D31)
M='=UTI8HL7ZK*';Q^A8?!M6*7GQJEB^*6L?1P[MU^,*/]$Y3FOE0![/'%="/
M#;B$N7%3"-2/1\7U,%F45"L6IHUY5&M\?TQ0[IA(88'9<2K54C=<+B55C89I
MEDW58)L<&VR[I5)HL$5-ICX'*8/:@B8O_!R+[>PF"Z[JQ2K0/M74R=RGORM"
M[4),E``J#7YGE#"Y".^S1Y*W(T7#RCR_3^M1P,B(.[TXF;^9^C;<S`<<HB8V
M(&4],<C3&"7^>#.?UIDXPJ`^64%&(4YJ8M2"GI&`-/8%XRF8$@\8C=H<!!N-
MN!L'Q2[^^?U9'!7;H;8JTUG$#*$K6=)AT:VVW0_2#6&A/MPZS$UZ(*VFU?4`
M(:(T$VV/7UANFY)@VY;0O#$)([Z@_E64:MAG8?;J0VIB@Y^XZ[N5+H`W=V^N
M;?<&L[C;P(#Z^N-5;-Z"H?70D6G81.4"FTA;GP"*\'<U`94B0/3T#:*MUS@<
M1(>[JOT3?0C6,Q$&I]]#V07MBA:5:]E;+7I?J*W0V8_EY8+U=V8WVT_$!R3_
MA'SEGXV<QNM>40SX324783=:UJ^_-KWL'JGW['M&HQ5=72=AG/R>A!G[\RK.
M6-:?W[(MR[NA?:I)M[E/__@`M0LQW0:H-`0&HP21:-.B%;^?.$[(M[P=/T*"
M#W/S(R%.^`D1_W(=_3WZ')W?1K^R_RS^A<^0/@79B9@II=^#I^<U/6&MWO_]
M7S^__W#^+R3AM>14!!>>G;,_XX1?;G#/Y_99'(HC2EYID#`)O*KS%$?98WHB
MUDQDCR%KRLQ8!:]>[#P``S/NA!M9+#+U;00B']P`-8,'*>OI`CQW+]L0T8@4
MK4C>C.3M#A>!^I0=&8,XR;I1"WJF#M+8%XJG%2AJN/B`H:A-S;&A.%Q2?EX$
M_%LF5I*1R[ZNI./UKWOGXC)M_1/QAE1]%EYK/"G_(OS/\9-OZ=N(3;^@).VN
M-JOGW`[?J%T`-E"?5#C\U?+8NM<O5QD:X:\7>;NVS9TC5G?>_I:?:U(6,WC+
M8+T6367#M%$-Z7P5+)XA/M^4#O@%L4_F'N$Y1KL076=68^**_I,O+@XK+?@P
M^MMCN'PD`5>6DF_A>DWXH4(^C''']>JA;D.',TPM_1S%H,'N/#]$MAOOQE34
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M,&!`#=9RZ;9`$).\,BCL,Q+T0=8:"[B3P*7XVV^QF<%:C60,5FF$!]J69@<,
M5M4!!.ZNRPZV[#,O&:S]\N2X5;UD*6JWC16H=0L&)PQ6EVX+A!J#5:&PSTB`
M,1@8"XX8C+4"9&&29E(6JS9#A&Y;NPLFJVF!0KC2J0)A_JF??"9YD0H<*U^Y
M',>[YBHD.P>'&V9KR+<'1IW=:M#8=V0`.<X&&VYX3G\9E[J5C.5P[RU2ZW;`
M<387:$GZ[&#LW<58FE<H1S'LRJMV:P6"78/"";?975,E[:6`Q'XC`D9K%IC`
M);7/0?('S?BMA@'["1;!FJ;;FMW\_IXF8?3P&[\66SY#9]FY/E<'[HQ1MK:T
M%'7^#J[;6,F&BJK?9\[W:Q9WFHN[QL7Z@]VUI4&:7UO.[XLB3T*'^(HK(2G7
MLCM9P`>"ML==LQK>#;>-JCA02*L^[B/ND2<.;;1B83Z?3!3@+5L3T7PWD7-"
MRAY$=#DF+)NF&AVC&6OZ$:K.P42DC6HT4)]N0:UBY!/&VP6H7XX.U(:)2]>@
M1EXCI59[%C\],0"P1..:,@]A2<>#=4JFDP'-S.0RW#JVSNZ!\C2%"3V\7"I1
M9&W/^=\\&WM(XI3E9DF\I'3%D[17<8TAR]>6V^X<NR4C\&Z'E,QI$0NG#`#P
MP;PADV5!'[[XSV#YGE(YLN^`LK]=QQ.RZWJ\3M`])W3@!NXS1*G601-%I078
MW@!)&Y<5;WA^\X8>R:0+;T!-+1>4_>:K,]8P7`;K&YI2]BX>Y\E#$(7_)?*B
MYH(]]0Q'7UFU#?^=92%LQ>KY')C;[KN;8MH/U57R).])RJZD[$NJG3V_4J(W
M5&-4Q$CW%W64V=PBM(>.A+NCNX\1CIQ([*ONZ49O7M2&BX=^A#LK=_L8)DC1
MNJ>H:K#N+*H_Q?1\"L10W=T2`\ET%3P1'?<[3O<%:8P)%AF[=!39()?]<R#4
M$-W'!C?.PP-T3_=Y\QY(=![5?W!C<[&GOAC(2X[E-[2JG74N:85PH*Y2-^9Y
MYC(EIC-SVWTFY:E!994J/[7?AZ"D>84Q\/>6'GS;:MT\ZG8@4.">[BT7;PT(
M<8*W%!+[C0C#N=SVF.A(:M4#C^^#]$[\")OTW4,0/.>G'M-UEI:?-(\_+C[^
MQW2YC#<1/SGD.EZ'RY"FT[LT2X)EU@`@O$/QLT`Z]'(&N$7]O`*D1^T>@.Z3
MQ>4O5Y<7EV?3JULR/3N;?[FZO;SZA5S//UV>7<X6S&^*IB/[C@4(8OO7U/`G
M<\>=:W4`&UKB<!X_!6%D3AWJ[=3)0]D..U+4]3M+(+9JK")&T:L=,?(O/$PC
M&J]3%S:D;UX3-O+VVL#A%B0.$XJ*@@X`D285!43V'R$VJ048([ACIE*V]I@.
M9:,JZ4D:]0>S4C,BW<ET&*#<[C+9PM>W8SK4+R^&_=0R[+8:-X`[#!A0:4TN
MW18(G-"D4-AG).AYS!H+.,N)VF+1UPO)55A#XC2'!%V1F-]V]9+_2.\_G!`^
MB#L,A&@7Z-@C!'6)32E>>Y"+LI$LQJ&>W:'4["#&61SDTNZR(S;?#G)1OSPY
M;D$'N;0:*U#K%@Q.8IS502ZR3G(H[#,28#$.C`7<&+<3ZRS&U5580Z(6XR[H
M7;()DE=RFL>X?ST,A(!B'!PA_>_%ZUTF3J_S?2O3:,4^2=CK^Q0&=^$ZS$*:
MGFV2A$46?=W81H*\D`R3@%E9MK$9M=0,5`RN/8/D3<K&Y+K<I!2M2-&>5#J<
MD**+5S5I*X"IBM0=4*JH6D,D*<O8?D(=]2K#KOI1,<\3E"WJGRNH#PK4T^_\
MK'XZ\J4V8R%=F>H,C?7>25(7G7895)P%:URTZ].K;A+?T`YYX6.CW:.$3]PV
M8I7@R7KH$[IZ#Q=^+K/)2<+64&3MOK7^K83L)+^-S>_\2_K^37ZI`8W!"ZL]
MC5XW+-*&R)=:^GI!KI(/;0/$MS![)/=L:,I&JN(`JL=XO:+)86+/-N/IC+ZQ
MUW[QR',3OP;K2MQA,>F*_>0FL@=W;;,^H"N64X*M1(L#$(T@[S0+FI2C\FTS
M;]P1C@Z97]IB2^*>1A%2/_4)F:[B!DPQ#D1Y),D;O))UD>&^'@M((5'$$4S'
MCBN;I\TZR.CJG#XG=!F*V4;V[S45UQVR0<]3G&3%5H_K)'ZF2?9ZS?#&GX(O
M8GI^TL8>5/'M^(0D'HLI4)\6+<YA604B&AQEDXHD4A5U0K;"\FIW1=P)*06R
M?W&1)Z+)5JHW;(;K%#+&<^%V$DY$42/ES4-T;%=I`IYQPWDX3S<^T30E[W@Q
M<^OJJXK,O-)9$?;FOUWQMK<>[$MVE%<"XB?V*(\T2L,7>ADMXR?Z*4[3*YK-
M[V^#[^8DR$:*.M>!2<%F/AO;T3,7H'(K^@+)K.4AH@>I=2%Y'_(C[_73"6$=
M^2&@K*MW9&4%/ATG=4"QAG@@TK3\XJ\[N([W8!O0_:(H.V\](Q:>L:QY1BAZ
M';<;V$3@01QAW'BZ6H4\V@?KZR!<749GP7.8!6M^$F,<+;)X^8<JA(([-J,F
MH",.,X`M1(J-$'T`MS>+F>S:$-Z(^34IFN5G^_*36GA+3SP=#I6V<]O"K.7-
M1@$2!_8'HF[B%4PM!E9%5-JA]9DU>\?0NLP;'@,^S?'&"4)]C"K2_4!6?6"Q
M!&6#B)5=3B,(8`\13(+&$SW9,V`'!J@W:G<?@?J"/5`!O2%=[__=I!FOTZ2W
ML<+(WX,D":(LWT*B=,>.<EHN:BT'R6T[VH_ERO;J(>YM*W52Z<)!K,L<BYXD
M[^H+$72%H80<^B&Z31B6\F0DLB?.X2@-[6*%`R\1YZ+\Y]FOTZM?9F1^07Z?
MWMQ,KVX7Y,>44A+%&27_^M.;/P`RV>$]8N0\UVSM@B_W_!BD=,7K0#1*\Q,Z
M>8X^?^;_3&_H/S=A&F:T.+;SFB9AO+JAR_@A"JL[S3N$:$3M'0([BO;!&`_Q
MMQHNB<`Q&H=4,6RQ25B$OG=W7"&I:CS)JU^D4'I"MFJW!QCGBDE%\_[P.Z9/
M=XH*^*32)9(@6-$M_AP=JXV6_6'9[@V]B9M0;N=G?R,?IXO9.3F;?[Z>72VF
MMY?S*W(S^S2]91_>SLG\FG^R(+_P/#3_:/;Y^M/\[[/9@DROSLGYY<WL['9^
MLWBCK7$\X4B)RY]TFQL5+<,UO:+9;E+U-CX+TL?K)'X)5W3U\?4+>]C+:/Y,
MDX"?:SM=9N&+V"9J.JC9H2I=(HVF"C^^(/\*#E)D/`LM`P:6XF;RNY4K%C'5
MUC7QK[EX4LHG=Z_D1ZZ"I<@_D:T6LE/CWT'8+IU,'R+<N+0V&B"I-%#_X1.(
M^VP4T]!QF"2?=M]Q2<+C>I(7W)(MJ42,5-;\9G7V*?_WDO/))J<0$F\9)-B*
M__<WWL#&\,$QAS\9HBX+OFMFP<;,][=@O6F2W=!JNY9@.ZL=MDK1\]<9N.C:
MW5K$<D17(W#*K`=85^WKH=TK$SC<T+D@T5%]CTK$8;/2N$73/D:/3T^Z,ND;
MGPR%VZ-AE#U-6<7FDD]Q],#(XXEE[$Q$^$+Y?DWW2PJ<&(.6WO8S9N3P@O%+
MCIT*]WP&EQ&HEVDX:7.^:97;\(X;0;96B",R#G.]@AO"0(R.B`2&%S'[&(49
M1X^64#W+XGL_BJ_,VF-AQ!G[^\NG6[Y@]XT3_>%$A^.(0V#%<<<<:R&<KN0K
M0F;Y$>:J,8)5YV9.#^R,$S*L+$7*F:$Z`4P,$S79ME.FG*1HZPD_V@&HS6==
M`-AB'Y`0"5OX!V`W.0I<-1:210[`%Z/E`%Y6`4R/#\#F`.H4PN,&*!9)5^%Z
MP^/I@BXWB9ABGGU?KC<KNKI@;X-;O,DO8IS?SX(D"J.'E$79_)E>Y0*FW\-4
M%=7<:VR&0I<:<>C'_6^"%'2=&@K@-X?Z)]7OR.Y+\I5_[<M*O@&\ITVC@[EL
MBWG=:9;0]8`\L3<,_RF,Z&5&GQS1>4L\+G=7Q/M`U*VG]8*5JU8YI^"=,B7?
MEK((ISY2D<9/ERSE\4)]/@PC7[E,(H0>!DNWG0*;DE5NA\R_6S7H9*MV[+&9
M]2IXHN?Q4Q`JIWZ!W4!,6.WFD.':UKEDKIJVKHQ4$:)BFA/"&Y&O>3.ON4,"
M#R`G*($%\_5==Z@/:R`YMF^"Z67ZQ*_"<I/RU&7CYCNE;!^2G?IS>I'I;$UR
MGN84FK!RG!.2"_29HKHZ`'9N(_4OY,0FUX&>U?CGOFY*WFB6#>3'8I=7U9/3
MK:0WC[2'TA[ZY+A%^C2EF;(`4_NRF4X47^(02DT34D`O90(\.6\ZR?_KB=_5
M?_RVX\A>3@OWHI$$N/@OSY+.@=?$[T1#WR(GU%LNG01[]S;-/*9]GQXP27D5
MH^%D#EU;*<^TVB(B5V$')@NU54#AW.Q9<-3VZG/_#H30OEL%\/50D'M!HX_*
M*09$CIN,5JFI(X0X09Y]N;F97=V2Z6(QNUWX<B0``G*`#-H-.Q[P*XA808SJ
MQ"%<<F@'\FRRIJ=D"<6Z%3V:L.WT_3MDPDX46#M3Q;NTT/;]`TD.B@`/:.VL
M?MNX+EV$I(DN@KS#M-`^EK?20)_@W'Q1^LAM$Z\-<=K%:W<XK*UJL'S_NT%N
M<=V]AX-=.QC8)6X&((S*:!^#-$SG]]/EDE?WPNCA.EZ'R]?\?V_I]^SC6GTE
MGUWG!@=".Z-XB9VE.*P)UFEV)Z"HB6C'9\YV+4](WHI\+?[+FQ/1WI.TTA)%
M+<_LA,*FP\*$M#W90Q0[26<M5&/!N;A?MFA"GI,P6H;/:U^FFH:!K3'2N`7N
MJ+&)GP,XC5;\/_PN^)=@S;=,PD*35=]&9`+V17%I*SMQXA)4I=F/89(FXM3@
M(%KEQP=76OH?F^Q@U/+Q+BAL.CA(1MN_O0.QD[`$UXR$9E&/YC"FNR;'`U5C
M-'()UM%C4<,\9O#B,4ZR6[$7_X666_H!D:FC)$F<LI:$YO`=GP$OAMD;`.,`
M6[F"#TXDP8V'/-&U/'1IVYE\]3+2=86EE$SZ85Q&+)82Y32S-P[C+%YVL<.)
MYXCM][_.;V[)[>SF,SF?7<\7E[Z<J3.V/X!"[1@>,7H8EB0*XJR;RVB9T""E
MYS3_K]W(4"L"-D!4B'"98FNM=CI<5&GNG&?+!6H'C_D1A64?\F/9RY.K<SLA
M#9J80_`*S,ZEHL!)NB^H=S+W96T`+OQYA+R\.KN931<S!N]9_J^?R.45.9LN
M?A47\XE_S/[CR^5OTT\S;XZD&Q[[7<>F#M#O88B<9F=!DKR&T8/N6A&KOJ"@
MV.KKD!<4=KH,@VV570F@*4D7^(*,E(V):.VSSZO0`W1V/?A@/MZ0`77N$;%K
M%\R>!0O-HE77@";3C@1D43!5Q2HRO24S]OG\@ES/;B[GY\<#Y([A"@?*D@#E
M$LRG]F!>9$&28<'Y%!'.IP8X?YS]<GEU=7GURU&"^G1,4)\."NH/@TUGR31C
MP?E#)=%8!OLSKX6,VP]CXO;#7LQK&39S=!?4>58+>5-`]R<8>D[+:G-)![&R
MJKQWNU%Z`*Y'?1ZXJ\5>8)_:O-(1!N21=9"F\_O?&;$%439/;L*'QVR^R=*,
M11;&="K6`'9K<H2Q&PXC`*U#\G^S-H"WFX1,1`N^1KAH0^*$B%8GI-+.$Q^'
MPJ/MT7;`:OFOH;O$6_V`I)M98XC2_MCDI8+J;_PM;^A+'NH,B^92`#H:QZU0
MRXR;?:?),DSI=1(NZ?;+M/@V?6\30*"R(%'%+,N=7T.?PV'\`9C0T?&-DG61
MJNQ,1.]*FW3;R&?:``,4QB66>`?1BTDFD'-\=I_A8B7($D=^Q*/JUEV>A;L\
MTX2D_$RO-Q=I8\%#)\$KUW?2;E6^?Z')7>S.48"E_(ZRFX["XDHL24C)CV%$
M5O%Z'23ISIE\677D@S<9YP'&]*;V/,'(N>_5YNF.)O/[W:F,9\%Z35<?7YO&
MVV3!]E(A^;"-5'><9?]L#G-D*V,ZDI>%#EW>G(OAWU7.8,XED;O7_4JB.^`;
MQFZ='0?$<G#I0+[;-X\<+NVVM,FY:_)4?.>!(FE(2;#)'N,D_*_<`XL4X\WM
M8`C:$\<;M]P6/SV%Q411M#J+Q6Y_&BV9O>=ANES'Z2:AIMG=+C*:Z82=#!RJ
MZF(W4JI@J1K`/E82)V?SSY\O;S^+A4G>3=YVPE.;1WK`LL49-K(D#-$+W5ZP
M@;WOVWNZ>[\>S(O[^BSST-V7^4KOZM?>.VHGM^SNA%8NYQYF;K)8@[Y>>!,K
ML2LQX<<HSB@Y]:5LA0PT<XZ(!#7_<SOCB12=A'3)[M"WU7>R?,#\SO+T"3N1
M^OA!=EU\/&ZB&^:Z98#@0R:LA'7,`<?U@:'#ELH$;&=H!+=C!GF?R.<`YJ/'
MQSA:9,R.ZR"9)XLLR.A*++LO[[72!$5@3TDD-/9$<WV@C7@QSZP0YMLF.9.\
M$1&M3@AKQV<E\I;YKM?=M9#^N#L4,E(?M\.;S*T-$N2^[`U8G04GB%X4U(HP
ME.,VS7'[S'#[(M#JVZH;QV@%A2$7>/4EX'RF?'K`'%[J[=3!I&R'[8UU_>B!
M8BO>RL&*7K4@0+[FGWHTA)&_0IV[2-^VQC7R]EI'<`L,UZ1<T=(!(17"/32,
MV!`H&"6^D*/V%!I%,S4UHI[/H=".3HP6)\8T.S5R8_'A";E,TPU=>0=\TP9M
M_=O6@%ZUZ7H87+CF1:N36-K=&FGH_T[^_/.?WY]6TM$?/_SYY,]_%O]?78.2
MKTKY/\G[/Y_\V^F?3][_]8,H+;(_W__Y].1?__5?RW4KH4";^+*Z1C80*\\N
MZ%VR"9)7<OIO)X2QP;^*=M/-PR;-R(?WXK._G!`FYYDN^874ZU>/YB&Z`=>&
MKX'0]86M15Z=YOQB)FU9:S5WUUMCNZK,%G0F;RBQ\M=:WP:OY]]Y2^S2]ZQS
M$PTP-+Y2[:5UF>&0Y)K[6[HZ0ZH="6KT?5B8LF'@3JCRBX^GVZ@-Y>1V#Q,O
M5WNX\:BV38[XN::H@T-5^DMYFNP:>.I6DM=O=BTE9HS.M>L)<+`A@38,?3?T
M]4*<DL:#`\></:5W1)U?U`XX.0?0Q43N#HXG`5CEB-ZM3\K1"5`DXOX=D`-!
M@=G?+`[&T70%^-NPB'-WBJY):3_X<;;_./TTO3J;E41_J'"SY_?.@,/;1:]3
MXO"L6Y/:GJ`[/1[0&;>GXX$.[5!:G1(G9]&:%/:$VP=%1AL??HPU'S>+A[]1
M#Y>-GYX3^DBC-'RAE]$R?J)7-)O?WP;?U5FMJ4<[J57WP/(\DTUH*:U&$<C=
ME/TGM2])_BWY\5.<IC^=$-:,S]JPAB=DFF5)>+?)@KNUF*&X9HCR9D,R`!XR
M3P1B2N*&JIY2+QP/B,!,]Z\Y%"/ZP%=-W0+O0#*H[05,GNK>SF^GG\C9_//U
MS>S7V=7B\K<9^31?+,C%_(;<_CKSZQA]9`A"$F`4$(Y=X&C:95H>IV]OC@+8
MJZ+T]CB+`';+YQ2]Y>SOW5(IPRN'N!5T>9V\'\BAA@&6JQJU1EL/A'$:GRZ7
MFZ?-6JS/C[-']FLN:Z@+#QUU7:C<&G>CT_B&88T?2?_,-P`925S36D+ATM9H
M?J:Q!8^^Y4I@KB7K.RF_(-MO/'0AW6N6.I`9%S+GD?22N\[@0')&URI=G1%5
M3"6*K_)MP_P2RV?&U\'ZX#$&HN@^*!N9GJ,T7H>K(`OCZ)K]:_EJWOMO[M(B
M:ET7)"<S6X5%V5I-$"_3")C4OCTA^??D:_%?#W?E`]`@\34PAMKNINXJ\[E1
MD>>(XPT*^T&0L_UUPE+O\'E-Q=+L9;7UH<(.P/-8P!N;\?-J+;-K?G^=Q,\T
MR5[57*]IW&9Y:6,L+]-8@L;L<AT@AY)UG50_YZY4?N.-%^E>K\Q_S'"0^(VD
MD]1CAH:/*WI6J>J*HSP!KR")_7C/0;@B8426P7.8!>M#`A2$BGM`:F3Z39[C
M),CH_XK#*/N-C0(VB:FP;>S1(F)-#R1W,MJ$1<DZ11!_4O>?_*_?R/0AH=3+
MT:OYI4N\"8J4MD,I>\J\"@ZO(1TK90/J[#%>5:ZY5+J4IFW+F:1MD=Q(8P>6
M`\E50%Q'UG/"/R;YYZ3RA2]NHWNQ$H<QXZ#M*I(^,B<9&#:.<AF5IH[XX9G,
M[D^>O\PB9DMP./`!)"_=`31JZG).[S*64;TPZ+!\*O]71IEY:99LN'G5?6^J
MVQ>["6EPLJT0%*_K9CD.BUOK-KNGI<@);T]V'4[(M@O9]=EN;/-I_W%'R+7<
MO1=TFRQ@)ZQ-#WO@`DXB4@<3L'U!7#J<K,*(GU91+$%.Z)*&+\>->&/D&Q;S
MH\?*G5T7P9).G^)-I+HLQ=1<$O_DS='<7&<-7DQ3:(%YK+1S'J>J$8E_2?)O
M_?%.[<N6^B$`'C)_DW63>]8(@'(6(93*NB.K,BT6K$F0_Y#Q/7EF[S9,TYC%
M`G$[@G^1``=K(';OA[;1&5L;7'(;.X]K&MUM1S3;[L,D<@UK!QK%[+0BY&RE
M,.C(Q;<0884F^]1-CD?KE*T0TR%9&P?1XPQ*JLKQH)W?T[Y\9-+$Q=/E9=/'
MAN'^`X_>*!X]=.TLNN0%59IF-T%&\[.NKRGSGB@+'E3'I]H+T`Y(]`(<9)00
MBUT,6@QZ;9--K;CVP*9L3GC[D_*>@UT7?VC`$EN&G-0"G_H<52?(E+5ZA?$!
MQE%&]9A@%WN#HFC#!EIA"7(^X4Q^#%(2\&L1>$-/CG\=%N"6PS!7$!\YWMW3
M)*&KV^#[-$UIEEY&UTF\I&EZ0U/*7MWC-%J=TQ>ZCL4Z>V74ZR:F%?MLQ2"Q
M0S?KL>*@M78(05@*G90]^#D$).]SPB>5BVZD["<VK51Z^L(<'0$HX8]>4&YS
MB)TX&9/LA5,X"IP=C,#W#AY$:_A?55X8_?Y,H]27\YK&<P1`.!W:%?P*K5<4
M'#XK34TA4C1UX_$5*QR%NEQ#!X?E'>4AJSA-AY_@+S:,D.EZ'7\+F.-XZJ#5
M=VUVPC8RC&[&?Q&S*[G%D65T@)V-HU34#5"<Y?EOM2IAE3%8!>+;0X&./4>#
MP>,7U\[9P#;@-Z/R,[;.@B1YO8^3;T&R4JUC[B#!Q,PZ"6X<S6RS(Q[7*N[@
MC1IY<M;?=B"\!ZEU\=1Y`0`S^S08I49'5TL"^+]/4!]F(&+0CXKY,C#%6Y"O
M.<B7E3;'B7'[<.8(Y7X%OVWNNTU]H4%/W=,4[&0]W7B^VD9'P4VJL(.#2^3(
M@]G^C%TT>#'[M1%L1F]N2P!X\9A(=78F/E0W"FS%"?G!6OS>048HOX3PGN36
M'@=0[0,/$E31CM&'Z')WFCY4.PY<3VMPO:,/813Q+.K80&LZ>-\9:+&.X8?H
M@IW&7S^+&0>PL&/Y89(FG_B<V[M**A`<5RI@/*7?&5C'/+.?V1=&=%4];..:
MX8EO8+VAR_@ATMPW:-6WG<Y#^F(Y,=Q.M)0>I!+DO0!)DZ(9J9TTPQOR%=-\
MF=FVK3?>;($=F3];0T_BSV894H_V"[FNRD]`S4@0YBG^@K[01/#H<_"ZG>;F
M:T*2_.9PGD"U$'X\@(8,`IQ!>N2*TW.<AEF:Q]"S39+HEH9IVK;"D+0MDO-J
M[,`*,W(5$)^4]9R4'V\K0\4WOOB8[LU*?,H,A+8'2?K(/&9@W#@B>96FC@`2
M)/X8)^P7H\D3615M#@<]``;NCI^Q&3:ARU`,3=B_UU2,4:+5](F]SO"_Q.=J
MP@5W;?,OH"N66X&M1&-GB$:0KYD%3:JM3LBVG5@^6&WIC3?"02-S3EO(23S5
M*$+JN#X!UE58@"G&0>X_WM>Q*P`;'"%@(<'%$62]"3V`$`,()0X\T%UHL':D
MNKOXYQTP+[#`NA[3#EZV<UKM0)]-FMS7]V[%<OHWCS@W61%J-0GY0I.[V/KM
M0V<::UWJ0=*W32#6,##/#8)AT)[M&S)X)>$+,^.%_A*$$5^G-8]VG^EV8`#[
MM<*<L1^22P#MPPJ(9G40CS%)F>S^/"&\47$I,F$@JW[%VOKB65"<2-S-#F)M
M#S3TE[FE)^CL=$,RA,4A>A&`*FZ-$(?#B/F/^R!,R$NPWE3/BB'K,+@+UV$6
M^A,&W($5D#?@PW7D<5%I2=,R8TQ1=5`&DW8'9#]5680=/B1Z;-RQU;T6,,16
MCUJD\,WOE"]>XW`&L*C]K-E1YV"#`\S1&$ZKK@_2((SO'<UCP,V"V/L`SA,J
MYX'&BLI5';3C`J>>IK+(Q4B@!Y6WNK=S?Z^I7/GB#;E3)RIO=C3E2H,"S#&5
M2]7U0=I>4CD&W"QS]*Z`&Y?*PX0NF6SMO6_R1DW*;C3"\2*I9B1J;LH&.$F]
MRZ3\V[,KVQ3OJPU]W7MM@;W66`)P]^_?#7.V5=@"04QF%)^D!X$%,_59H6%D
MBDN7ZSC=)'1^SR^^IU$J"NTW=,W+9'Q=:"JNZ_@8I'1U';R*^ZU,=\\C26V1
M:$^I2%Z'\FQ8--W7&(@[]],QV0G(%W7O1)!"AMBXD!:W4KV[XW)(*8A\Y:*(
MD.4-;>#`6\(SF'[3IJ5>TF4\=@`.Z2AN]K?)N6>*);RW\[._D8_3Q>R<G,T_
M7\^N%M/;R_G5FZ/!,+,GKK8?.<9=U?;I79HEP5(YJ8XBM&N&H1`Z+)]IGVS@
M_$)E"R*)R54H&8Q\+=OL6]:@1VQW+H-X0F<BDPKOP6,P#QN0Q#;T-BZLO`X2
M/A%OV)MF[-`D'TT''&(Q6H1$&CH]`$)0=Y^P[SBFRF%#\;5O>]?,;[[MQ%"T
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MF.H6GH9QY$'#$8:_`L//7CAM9V?MYZ+6KCD,%,>()3@Q1-P[,%U<GI'IU3DY
MO_STY79V3J31Y+!QV3=X6"/3JV!Q':_#Y:MI?2NPER%8M'HY\5"%;6Z"15N9
MO6,V94B#1=Z(?"W^Z]T242A"C-ZIAY;)-QN]S;XY"B8'B1HRG;W!*48<?*?X
M,X/F,GYZBB.2\G:'C4+K&-$7A^/&B/M[NLSF][/O2['3[R;(Z#PZ"U)^(S3_
MS^R?F_`E6/.52JJ`T4%$,WI8B<!QVPY6(\45.\T`/[81.,E;\]T*97O"._!-
MQ+RM&*2(?U1Z>>+Q78#6=O_N<&TQ@84H"2WX#7HW@<O6`%ST\Y`VN[B8G=V2
M^069_>?9K].K7V;D9GH[(_F_%X2-A,ZFBU^/%?+F\#<8Z#T(C.$+O8Q8[D-O
M@^_<5'Z/1+0,U_F)?=/L@JYH$JP769!MF"&OM<;:>(DB61I&>TI&)!J49\0,
MNGT-@K)1/SV3K1"2?R$N.15!NB[HA%_+5\@B6V'-3B=\;+GT9G$/)OP53(?I
M6W+ZZZ5!Q8H'XK@.$X?^=@WBP>+@E#AYCA/QMID?\G^\N9\=>O;,`<?-5IZ>
MU_$KI0N:O(1+NMLM6=V'=!5'+S3E4YGB[O7;.`O6U>_Y!J6K./L[-=^9Z%Q?
M,[-QIP^'-EW_'DA9D$,S`<SJ3/ND%$T*V;73%JK=3\A6`<DUG-1/;1#73#(%
MY)7Z=]VD>[=K4_I`GMZB>5=Z)>1_K.3B)E-S:NV(+,.SNB]1L@/2LLH;Q8:F
M-YYP!](#9HK#3!ZO:1+&JXLX*3[B[=X/G5%JC1@JS508X7=XT/YRGB>D*MM'
MC!]RD]RGKJ+^QS23^S@A%=T''JKT?C]<_(+PSV`A36K,@''N<'APOW)G]2/X
M1H@\RR[X*GZA"?GV&"X?I:DV^1:NU^2.DEU*_D9I/CC$&ZD5/\=X&?T_-V'V
M>IFFFX"AM5QW-GWBYW&H\F]`EV:VK.V"P^D`JY`R4;TF`$WJ!$S.Z0M=Q\_\
MQ"\^4_M`R2S*POSLA;PG*;N>[-8"D[R[)[0&04B;A."X:A&&IJO$O<=%HUT^
M`-[J;E39#YCBF%3^9TI"UH#F@X1ED#Z>D.>$CT;XXE^?5OVB@]`<M]!@Z$%,
M^$RSQWAUF0<Y>A4\T?/X*0A5%U;#.DGC@KH3HB^:+,.,#1I=4"=4BICDG_'P
MP(;Y['/R-?_&ERT?,!PH'`^('[GCJ3JK7`^,NZ%=CZ>1<<3>,,#C%&VECM9J
MB^A?"CLPW:JM`NI-S9Z3(I':?NZE$ZE>K<)W]$B0NTRCC\I33,`9T$&^T^6&
M+[^9W]^SI$-_*9&^<=-%%(UQ?$1K"9*3J'0`O$3>=;+]G!1?>'9SC>$%MQT%
M`HB6IT@[25QE>`"Y*2VJ575%$A\\7`6KX(7\+5PE<22V#GT.DS!X*C\Y1&"9
M!PR]H(5V.IM"O)LCV33*.L/K](?)V6Q^F!@R';36$T-C'JEV$83);_R:R"D;
M!#\]\VIH.OO^3)<97?T6KX.,W_7^JMD@8R^@$?1M!*"XFKW%.,F!E5ZS'UJ(
MF_"V1#0FE=8GI&Q/=AW$+A0_O+<#M%H>W1F>31^'"VK[O<<0=Y*^6*K'Q+K8
M-%JB^F7[U3$"VICZ#`/I4>NH6S,_TX#?]<)K=OF)#K#S=:S[JX*;N3^NXT/M
M10YM`+46WFZ45@ULE<;^G\ICCRLU$5A"4\D")CD:$O`-W6ZC&D@[(LQY3+O8
MW>?^M&M^?&"&!S6'</8CI'U\W?[SUY`F[(4]OG[B*Q>FWT/5\3]VG57!S-`9
MU]=!EB*',9-."^?6BZH$L!.R_9Y\Y5_Z%JI@D%&[M@WDE%ZM%:)Q:3O(CEM_
MN0G3/RX22B\C%IEHFEE67W3=`;47>7=GPU*=M>[J+@JMW4:B4F'*F@MO37AS
M4K;WO.2BQ1-H?`I`)&1L*A,#&YEZ@.G!"BU*Y7C@%K?_L,_?W7,8AR6,_3DW
M8S@8=RJRX`+9CVR4&4FS=!JM/H7!'2_^A#0M\NC5/+JARTV2A-$#:W`5\WVY
M^9_\!.;TEM_7`PAP*/(U$;"G?'0Z07E>_!C:URP['NJGK99?Y]+$Q'=%7EDX
M6O%#-;<B1:NJ4'$K0$J^"KF^I>9HSJ'E04S_T]%D+SUZ'L5U<3^F:6]I\M1A
M<K;:S6)*-N_F?):J:IW[Z=="6[^)*"'$/-7*F_E''UIT6$U"27!E,_'$N]M-
M-PV(R,%G2[=*^T.S-C.:'0$(>\U_=H/AWJ?BG\*(7F;TR5@_QM3A("6OZ/`F
M+6\]MS^I>=6T8=+SG4;\%)W+)D+X`>7I;:]QDJNKG--%OK[5Y29G5W/`N.M/
M?@^SQR]1?)?21-Q4?!D];[*T?GSI3>-)\F<7.Q6ID9M=Z`*L:T'0Y6R5`-KO
MX&Z]#(:)W18=]-=<X_"*9/*-B295V207WCH;_:9.XB=;^G\]V>ZU]^1F$[=^
M!EH:@>W6D$44O77"%EP<-(L,MBX)Q]*1Z(2/5*>KE3B:Y<WG'8#O`+W>FY%W
MLRQP'KZ$*QJM.FZAD76WJ-;6NSNOD<FL=5^];6CM5RJK"3-7<\OFGJ_AT,+)
MJK*F`:1-?:TJQJ[.-B*D!R__MI3C8;M6#EZ5*'X-Z=J3@_F&@W&O0C$.D/T(
M7Y8!.55$9"$+N4@!TH54I##H&G5X`?H=QBU2F$QT-ZK0:^Y;I$AU58I<KF?,
MZ<3'T`8K-BZ--531ZL0;JNPM@]AE.,_B+-59M')7I#!;.Q*=B&OC@B1YY6SP
M(N`39"1[I(3G4?&]^&?^`[VQ`CX\#Y`7T,Z2<6.=U5$T.?`769!D8W$#[#0;
M5[H5W'!''\(HXA^_,81CF!XB0WAQ4M!YF"[7,7^H='J79DFP5!U3#NFB&K-)
MN^#2H\8JY!&47),%.\D$3"ZFES?DM^FG+S/RM?S4MQ4ONC>O9@0S7I1N+>FJ
M\4X(RL8MQ*3;#[?[5K5'TG:2`2B<:&0X2UJ,=KLK=.A4=\LJU!)5A8GTA%3F
M'RJ[P[TZ*+<;X$#9`!2WD!BOE`6+W7#XCQN1P0<:Z?H`8K*SHUUT=KF+RAT/
M*))*J$X:5AJ0K_Z>0J0%`RA,6Y\V).L+"]2#0L_ME)]28T\,BA.#MMGAX8(-
M7@]"@)L?<W3YH%$<7?)>>_(ZH(>*YV4]<%U-;1,RQTL567B7I'\M7<N_/R&B
M!7GOV?G'$`RH/<X('*6WM7MJ?&T,M+FE=86^7K#CE'X<((.3>D^8^4'H^HTM
MH@K8*AK6:X;@G-^!*E4(056%RP8.?@7DH(5KH07M8"JNA4GS9KYB045[&49C
M%49Q`H?'1[JZ\#(U?[KS:27M(JK4\/5Q,(C;1`3;T'&H1-Q[N7RDJPWS^_A>
M3B9!5BV6?DDYIRS"ARB\#Y=!E,G6=[WQ!C:&#XXYQDT1Z8HFP?HR6L9/]#;X
M/LNO4O]((WH?9F=QE(71ACW1_)DU$Y/'J@2PLZ!F>M=!$`[U=GX"I-2LBWX`
M6]J+G11]2-Z)L%ZDZ$9^+#K^=$)V?<FNLR>$UQV-;3KKB^P655D+E!#1_GB)
MF_2CFQDNW(6G#E]^7OS\AOP(L/]S%.R/&V+CA+(D\8RE!C1:OMXF090&2V[7
M+T$8?:3W['OV%*JX:M>[&4RAO7&XP<Y6I+`)5@IP?J"L2=&0E"U)I2GA;4_(
MG6C-8Z<GQ&`)I#8;=$)BBP!@4B1>[R.4W<0V"]UHF,[W:BX?F3`J3MDFJ_#^
MGO(^WAR*,A""S4',,89]"%<((\+.@N1!;(1<M_,3H(8V]!&AO=AMP-O?$6%W
M-*IX!'%$:"U0R2W[X"4NHZ:#$6$7P9/Y)DO#%24>C0Q']0!H4!W8!WP(M9)T
M@)]&*?Y<YV8";Q+M*P\\>C3*<YR$`Y_']0C3;$:?_-PD73L*S0^XK7;W_\+2
MWO"UR/CM/`(^`C#(M1D3>.YD`X]](=8X]#:QW'D3B:;!FBP+`6^>HX:%Q[[C
M:=C_%*=I]X*PM#<XI#=Z.^86J:VNPW53:1^ZJ,O2%X1YVWTJ",N!9$$1.B3"
MZ:`FQ<;Y1X3RP$&QK1L-TWM=$,9%<(^0AH-A3\,5+UKW"UE*"5;SF,/ZN]+F
M(>8S,4-86YYY7I/\R'O\M$_13(TQRPDBG*C6DF0[330RVH$1[J\YWB/ZP$('
MY/`V2PM0@5^+=94P)VHHV[N'F0NLZ'.<AMXLZQT8\STG1O%0[U,\+''#C]BM
MC#C?PV*AJ;<^#JI[NV`%DZU.XI]&J34%*&6UX]Z6#7C;DVH=U4O7-\+(Y/9`
M'!H<7B7%Z.Q^`'F(P9M6-QJBVX.W'UGN=G6YX(<!BCE)LHK7ZR#YZ;C@;!O!
MT`$]:N0JX^@\NHQ>6$8C#AUBEJXW*SXIFCW2Y)99?4N?GN,D2%XOGYZ#,!&M
M%-$,06(CPO62B$(6",^$$PG[&6+FDC[R)Y7!($^,*Q+XS26%#"*$D(Q)(5LQ
MI"+'#_;!0'&+D?!<H\E1/22W>6NO_<W16+2O14Y=CX?V7Z:75V1^11;33S,R
MOR"75[_-%K>?9U>W;PZEQXGG+N5)>K`(UG1^7['>&/Z5/93A7=(#F4Z4-F&'
M9YDB&PYH]V^&5]Z";TNOM/'-T]4(T'BR"39J/VWUU/GA"%CK%)IN84-*D]I>
MV!/QA:./P2XM8!=NOSY,U%G$AWZX\XK?%_RX`G&$P155':\.ZF/@^$8?)YXG
MM<L-SS=5V7M;78**ZW>M3@AKYZ?GR?%@]#T=C$R^5^MK]K[!T>>DBFC6V!.&
M,MI_"I(_:"9.LTFW;<F/49Q1\L&3RJ$+0%J'@SZ0'#<DT(AOI9]&J^GJ*8Q"
M?CU!%K[08N.$*BC`>C7#@JD7CFO";$,*#49E`*\TR)@4#<1<=+U)N07/$T\$
MHJ+MBU9P:OFBOK?$&WW`H9L@`=#9&Y`B4,RN9C?33V1Z=4ZFYY\OKRX7MS?3
MV\O?9F3VG]>SJ\5L<=B8-$<(9%2B7=QFTF-U!5L69\&Z/RYAUZB9I1P]51IO
M)D.'Y9BWA?V2!)&XVXR&XI`]5;:B:-9,3UK-</Q-H1TI`6E+!SA2L],D_X3L
M/O+$351OKNT7^G?<<H-&<PGNAT&#FS1`IL0>%B+0Y\!(#@88YL!M#8U1!W#Y
M5O=%%F3B"BG#98F&U@U&5+9&<06#+3C\J%9B]@=5W\G9_.J<Y[CGA/UK,?]T
M>3Z]97\L;ME_^!SL@D_)GLT_7]_,?F7M>%;\:;Y8>'>!H@D-+6>"P:?I48I>
M;<>"XFUH[^*EFPOVR\G.C\B7)&\/G*#I[#LS.DY68<1G=MF3I%?L3;">[*TP
M^QXNB]7D6@]UJE'JY8XT(C*%T]\$DVU<&0IE+#?Z)\7)3\4\!6<2^7%/Y<Z@
MW4E15"P)J^@A0M$)J:LBI2Z?V-&M)RH8=@CWE[.T$\TJIC]2SK'+^5]H<A=#
MLG[7%H]*/^)F*B:X))<P)Y>,RR`!'Z`\QTE&^68M<>4]$Y'&ZW#%%U60M,PH
M^)P6Z_><T$<:I;PJ5,CY<<U)[8UWW,+]P)D'K43KTD98>;>^*NF*9N/2#ZP^
M[-:"&OWDO!-'!7^\$8=;K!XZ<;2+Z/X1QX<NRQEATT.NS1Z7.CXPZN#5GX^S
MB_G-C-Q._W.VX&OW+Z_.YI\]N3?YX*CCP[%0QX?1JV/,WMU-UJ#ZL[:'M#JE
MZ(%(FEJ;,*M#*D50DI+WGS1HQ=-:L_[-*Q@"`A>Y?TM[JOP3AC&O:\_%'F2\
MTG)#8/_*\5;@6/E.XXE&J_ON['"2G93B>U9M"S$^44@O_&+D('*?0$@PRC-(
M,/('7_S,T0;=G@:Y=#D_S_[WRW=<E`0=>(\'"SNLS#YG_TBS<(D7_YL2^R<`
M.XEC,5/SF49+`2J&."&DK?R>24`I9V^9K(5B#"I3N`8"DY624:C,'W_S)Q6H
M6>34]?RZ&M8WUW&1!CAQ'@\2@=9E1J8*F[RUJKK6;(U;69/;@EQ5:RFQJ*@U
M^DYV`;!]RYU/OJQ^S^I:FA88RCI:O9>FAC8DDIRLGM?IZ@PI'@B*RNSM]#^W
MF^08JF97LXO+VY^*7=7OWQ\8OH`<WQUAR*LNVO)=;(C3Z>J.L=,?)K?^+DQ`
MP!)L04`/+(VYFVUKTPWEOVFX#D56<B:.$;V,SND]31*Z8@VF:4JS]+=@O1$M
MINMU_"V(6O#&%ZS*'GH(QG7=WD^(G)/TL<>"![JKF<SN[^E2;)"MY#S\T%I2
M%WI"<K%\@64I6+3-19.M;+(5?D*F3_'&ER.C$+U`S5=8'J8DMLX*-!RX_][K
M-@_L9]80;LRSRYU[\O7/=\%:O/7X7OSYLO7.8`L(-M8EJ]*3,U^N<?';3>'9
MK%>.ZDO](G@*(V'9-8V"-3__2'_.D$U7=65#TQ5[X&"T$KWFH=-H-9)0"ZI7
M0[;M3LBVI5^':UBA1C?V@&).,PQ1BM".27Q`K.O:BEXQ#G1Y7-R!-*%KL1V(
M_?(LW/$M0EG(&)0QJB_W&;I'KDTY!AF[?@2AW1*_UAW(JN"CZ6)>K(I]6S?$
M*F?+5>TNMM<*J`:5W??DJW>7TH-@`%FY"KU:7M<5M'9U2,BYC1(JA?VPQZ."
MQ[LP,*$&I_O>8/.#WNM#I*LX6M'59IF%=VO#D:8=),"JH7()+@LG.IN=UC<5
MBCM70*3R+"J6M?[E&&4OJI):V$'K&@#L`LL7,DG@.H4?#C!DB5"I']43>!AC
M/)P7]#C`BQ9QY-MH9B!L=RW.H:/;QU"HF/&<9A=TQ0_XY*=N;9A)K[O^C%+M
M@F4_';!PVE6'2[[I]]Q.0W)GTSI354>-X+!.@HP4HLA65K//7@3YGNX"I4H4
MKP12:3==8+(]'.<?,AWI8>'`+,!3FIU/\R+M7=[OS8_[`^T`/-F/Q.HZ7H?+
M5W#Y6-%<E>ZTFN.2E\(:Y"2DK<6"29J=*Z7B$Y)_2;X6__6W7*QZ[6IWUP-%
MZ;>-;AH7'!9:;D.<3%EWC(GEV3G*,KZ"]M"P!(\"G='D!S?7HPS[X*PZRVLW
MG%7UA@U4V[U=9J$J6YT.+B5*.R>,+5D6=5[^Q:[SZUX,_I3@@J:#!G0"T[RF
M%'`"-RZ\AQP^276CX5SL$&4@2C)^]R(?\CS':<A;'A=\NXY3T`#L8_PJSJ&H
MC8'.0\:+"666!VN[>`:5!HMO9FDN"0'Z+$[C'\"(SCQAE&T1'\NC49KMJO+V
M(FB"$0QE(4N7`'*222J8H_SVL2&#,,@69\Y6#`\3&J3Y#@NQRY+]MILU#R#Y
MB2JKLH.(X@D3D9+@^9D-DLIKI*(X$D="D71SEX:K,$A>W]Q-CBA/'6[L)$$@
M\)SF_[V,ILLEY^ST.GC5W'\([M<._*9^6/0#LP\MF!O5@9C$(&7'&#^6C7[B
MY%&V(T5#;R@`"!*9LUOA2^+4^OY2]_4#FJYB($`K`D9Y7-O"\;GXL?G=N<%R
MF6SHBM!\=L:?>J@SC$)"#SI*/0LG\^R1)OR<\4W"X]VG,+AC@3'3%DZM11B#
MC$Z$(Z<V6^TJ]&@U=_%PC4!50!)=R*X/J73RU?$!.`-P`!BM9C)0BX+P@E>8
M'RBF&0S`!;_8"9C$+V'*EY#QK>\;OXNN`^.]0_ASA7C?@F)^/&#T<!8\AUFP
M-M]P82G`'!"5`EQ1@\%B9\%0K;<3&ZC$*0-AV8$4/7R\1<,671!:@"$40`D*
M02!"\`7E0X4_G7I,N.\.ATDYR.,MR(/\Y"8^WEOOZ/??CQ'I7<*?`ZQ[%OJN
M$_H<A*OR@)EBJ>8T6HG@G1\V`PZ#-L*,(1$FS!%QV#R)JU`)M*$+CX!$JT)H
MT7E[:BXGEWQ\F7?TE5RLT`D@F@YH-U,.1"B$?KSW'G='Q7<UQI4CY>/2W&?*
M8JMPFE@X35F1"=Z<1PD1+]W'MTC.KSN/(V;C=<Q2#9J%B;@0?7ZW#A_$S*=%
M((?+,L=QB"Q71`1_#F=1'&1")^X!2%;&\+ROH*%Z;U+I[BT96<`3PD76:`<0
MD5DFB(?\=IZ!QM%02QQY$0_@9?'R5126Z=/S.GZEE"3APR.+*)MGYDN[OF]^
MTP:(AYXS<@#/;W<N<XI\/9*Q\@SIU`K)^DY(]`&Q#"O(&G1!>$`K8G)Q>36]
M.KN<?BKO6IY>G>]N]/"O9`R"A<2E+>#4]EQ=9YF+6L%P>$_,#2I2_:LXVE91
MKZC)'R%=%5ZI[XKJFQ`K<3W4H!'NIUI!D[)5N?K]QZ+A3^)\L&U;]A?U)C9;
M`$?IMQ:P4WFO3H3:AST!K:/T$Z@8![V5;<EBB7E88IEEE"LJUBQX,PYSC5E`
MMN@*M1[F@N;3)T"]0-D@_H$!(-M<YH.V)U/H9>QBS&ZZHW!;'\\SAB$#F!#"
MCZO0]H:FA`-CT6D0T>GL#4H>.K0#E<-&(SA:8.'1BQCQD08)"UGG16KPF3[=
MT<00(;1]%/%!T0?5([5VX<8&E2JX$\HE;./"N[O\>U(V(%_S)I[%!#T6E#X(
M@9#*_Z1]U=XW&O*<1@*UQIX0%&<$Q^MUD*3;`<,18`_,_ACH\Y'Y+Z./0?2'
M>DX7T@G&_=M.+EVP89E3]M_IZNQ[I0@-_X<1$6TJ(X:+,`JB)=^M?!FES.*-
M5].L(,1`O52.-*"3%IW!7CHD0H>,$E65?:$J-H)Z=?Z'"[QU#0L=$3=R8'AA
MAO%)S46\7EW%V=]I=LW0_1BD=/4QOQUT\1@DFKV=M@):`0,N`,DU;2W&"B06
M>B&>"A8WV;4EO#&?TLC(*\W(ML,)*;J<D+R3+PYNC2Z)LW=$:-OMH8)D%.`M
MRAT%(ROUF'#G0>IJ(S+T^)ZDVQ=R1TG*NAXCL`$1;0AH>Q+ITK(VM]M7:MBD
M`NZIC&V:GLCN;K01.YKI%-KXM5I.)7Y51T*5HPC\VC4"AXO&IZ%84[NR4H+.
MAST`JN.`I->+@EBQVG-^]0NYG=U\)N>SZ_GB\G8AYE4NKWZ;+6X_SZYNCP.M
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MSI.S=1`^*8MF760T,SH[&3A$VL5NI-S+4C6`Z:PD3LKFO&XN.H@<J>PB=JV6
MG0C[=][-$W+K!+<V8_5`;8N$;&1)F,5W\-NE!OG)F2^0[,#:"&1'$">AQ4]/
M<412X04AZTU7`O]IT?9X46\.O@/B'J_(9Z75KMP'3(JM+<"&_>D/DV*.3P)X
MDM!H11/JR_SI&,@W%@V'1'Z[D#@$\C_8(/^%)G<Q/O8_.,#^AQ\FOP7K#:TL
M&7AC?>F+]P'['T8<''VB;,Q&/]$@Y>,W;N.#.!0DW9[6R;^CZ2U-GN;W_.Y`
MS6$<_80UADM=A:'02+\GP1E`=;;!S"8=14_R?J3H2*H]3RH'2>>=3PCOSBFH
M%.`'X?1$:8MY4%#?)*!N0MM,M(=>Y*1(V\,45^[$!V8[GUF+,^G8TSR]>8D,
M"U[ZR:AU36$02RUNF)G!NCC$01F9-6U;@5?:%HD1-'9@A4VY"H@;RWI.VG&-
M-R@/>_;%6W7O5^*,9CBT/4W21^9(`Z/'4;A0:>H(([&&3E`\/33<`#BZ.W+&
M9]C'>+VZ?'I.XI<\(&C/%P#TD+&MJ@>>U^AM0F1>I2*@XRCZ3[9?DNJWGFWK
MAKQ^N5.!,"-U+'E/A7L!@3:@B^WN8#G+5Q:J/$O9L.E0DH8X?J2T`,E]9/(!
M7M/N-JE\=D**3SWQ$/5K;#N&Z96W_*'50>(&P\'#,C.!K:-6J.F"$YZ3B%72
MVQL7UK[=@=D/+N;,I!-@QLU)=N:P7$F4ESFIL[0V7YYCID]M-S69*KIA^X[6
M.G2B56FS<B>YD"H)BY4G^>?>^94>#CHO@P!)XW'2[EK_&Q."KLE<K;0_%G=$
MOVY@,JVT_1="CP*A-E$!":.^1(S=_AUSF&BW5<>&:EML;VS;@1X%:BJLW*W2
MLYYT[[[PSITD+U;G0TH<:-RFLI=9YRO#P,8U<S<T=<1/A:/CZ$%,!'F=CG=&
MD0W]6N/(%Z(M1@J&RTO,'8RU#>1+2\P6N:IU6%U6HNDNK7UX=S\)X,T#QK?`
M>TG4'2&CW<$0YF8B1Z^N#]3$PNHO-S>SJUORZ7+Z\?*3V![ER572N`CK4$GI
M@C%?Z+NRSQW,X.H^D+S9G9>I[7*81W=E<XD$55[M,Z=KL`!+DNR9O=T7F#(-
MB3S7%*_0V!."]?-OO*9Z-.!UR]([0L\7VI?6;N`1`-3=LL#NSCM!U@Y3<.\:
M+?3"%`5XG^,&#$'6%4_[:*(58U__'`G%KL.-63D>G*M7[NY_]1X/T[VK^?U1
M[47X>KV(DR_LO>3G,03?K\4.Y3B"U_PM)"B"&$@"*@-8V(P;RF"*X>X/D=>X
M<GO;G+#V9-O!W[D'&X`I^<`>I2I"`$A2<X*74'<:[Z#Z43'/H]YU$K^$_.9R
M@?K-%O490_UST>4X@0Z.?:ZA/FX$C*,'OBVG/*6;'W81BD.,/H41O<RH\E0?
MBY[-B`?IB>/^<!N1(AQ((<#+`7(FO-$[,==9-B.[=N0K;TE$4U_&:A:(:7NV
M-=Q:_FR6(/'C#ECUP7O/@HP^Q,GK_)[;N#V#_SQ^8CQD[=$@:6`O-TAS[/F@
M9W'-!B8C^C"$7K:>-4Y(V9MO/>?]=_?"D*^Y"._9!(96"X:Q@3^<=;12;9C(
MSI]\8*?\XC!K&JIW`_--V<TQL=2M<\T@6VU]J*(08N($G^YY`Z/#PK^EN(([
M<M[=QF,'1:2;@2U$:7]HEN?OA<6!W7P0RT"2;M9B3[E?AS&Y@Z9YK(H.3D]'
MI;?\+%WKP%'K!8X;12_'3EJSS774*)7U\<Q<AFGT*5IYGRK6@6'AES)$P9U2
M]+;Q23D4?7#(CZ^*]'/Z/;0O'8&D@1W8(,VQ8X.>Q;7#FXSH0P1ZV0:"N'O5
M#C6Y"._9`X96"U:Q@3^<;;12;5C(SI^&8Z?=*?N[\_45U*-KVN`5>5,4TM!9
M@<,("@UF=Y=VG%0NQ]E][(=[:M]HR_<`[[_I6+(N;:\9&"U.!G5*1=U@(RY!
MV0$G/3C@&(=EW:$SZO!+9I!A)2>D"X!?D=>Z0:QRQ[=6*S.U`N1W"7FW&!,$
M`I!G`1==ZKK"_$P)N'&]37^<$Z`'P-=P3_`!V.3.TVR.?-+UE^<YGIT"!7G[
M(">30P;B8\KS?D;%V6`YT9G5BBV]A'W+D/H@K5.^U`5KWF5/IOMQ07T`G(Y]
MER3(+G>\;G=GK%Z"G-N+0C7Q[MY6&")`W@>]057;%^9_@^)O,+ZWO574)&.R
M6#[2U68MKIC9L])*7PQVB@%=43AR'/@>/FV>M$<>2]NT>+[6!LFO)'JQ>+PN
M&N(NU1Z3XD_/3B>6ORD)]M4OM(WT2EL9LAV_=T?\V=1@"8`\)Q8?[.^;![`<
M_-V/RV)A9&8Q69LFB]7;X*!9IA>)Q1JB`2"N]9@4?_K&8M(WU<:RYH6VD%QM
M*T&RZ_?NAL5:&BP!(%@L_V!_W[R9Q2S>_:@L=A5DFX3.[XOK:.)(-3^L;MC@
M,UE#%'"K+<!A-JE\,[HEW2;Y9WP0L_N4#:A]&TIKWFD+_\;WWW2!=H>V'PR(
M%2=LJ%#3!32<%W^A$?MS?0C@,#)D-WB,RY4TNXR6\1/]%*=*FI2U:3)DO0T.
MX&5ZD7BQ(1J`[EJ/"?N3Y'^3'_DG/Y%IEB7AW28K5WM>!_[,(LG?8!ORFA?=
MPGJUK03FKO'@AOM:&BR!P1GO:G9+/LT7B_U]]6:BLWCY$GK#>/VG-J\??"%Y
M6X<M`$YS;EBS?^\Q`$PWWEL!`.O&^KI4V(WT?\T!$-&'(*.K6]B1Y6U%MBCX
ML*,!<C&_(;>_SLCU[.9R?K['H#!=!6\%BC&O<F>6G`7IHS@N9457'U^_I'1U
M&5V$41`M^:VVRRQ\@2R$ZRZHG3Y9"\+RJ8Y/@):(V>L'>:.M6$';O!,I>_%M
M"S_RCB2,?B+;OF37V;M%>3T`*7/^?N"6\(.E0"F)[(NCN,I0NYCAPF/$=MWI
MXE=R\6G^.PMS-_//Y.+R:GIU=GGU"YF>W5[^YM/9O^.Z!B2E'L$YQJX]R,R]
MC%YHFB&$88`@6!C6"G+)+H`G<!J&]?H[DXI.K"D,;_ON81B&`!+*-7!P`YE&
M(Q#,-#XZRI!AV&2&"X^1A>'+J]]FB]M]"L,#N4;7,.S8.?8D#/<.O[W#[N`L
M,E:812:+3F%UWP@#@RC0Z*$/+0R.<B<7/UJJQX3[[HK(B,%^R6&_R9'._J\$
M>G#40$>,A'V@[F/D*Z;F^P]``8)@D5`KR"57`)[`:634Z^],&3JQIDBY[;N'
M`U`((*&<`@<WD%DT`L$,XZ.C##D`-9GAPF-D`]#Y]>QFNE<#T(%<HVO8=>P<
M/H9A2=FZ]S1L[^G7P6>3QIIN19XTZC2]ZC5AZ-#58\((;9JHS_30X"@?<@"J
M4H\)=[$.L!QZKF@2OC"8<UB1^RW.]V3\Z0CGB!.B?9#N8^"3Q.G>X\[>X\W!
MT^>QQI?(67*G\:37A*!#5X\,&2TO[I,/#X[R(0.?2CTFW#65UW@+]#V)?(Z`
MCC@$[`/UD2/?M^ERR:\>8#8Q8Z.8WU8HKGVXCM?A\C7_7]-)2EW%M**@K1@D
MENAF/59$M-8.(0I+H2PZ?B.[+J3>YX3D[<G7XK_^;3?MBD`)@?3"<IM$[,3)
MJ&0OO,)1>;6#$?CND0\COZU?29BF&Q9&^5WF"5VR#NRS8!4_9^Q#I?L<NXL`
M(NW03C)NU&4OBR4'NVG8:+4=$HO;+4W3G+;]FW$6WA^'2FSM18JL%FH!G`&6
M-BF:5A;S<+[855;S:T^]FZNT1E6;&#H"L\4'4#D2(O`5VV[BHY5V1)#G!X8Q
M*T,^Q(RC?(@9U@`O*['Z,ODX(-;-T6\`M(\=[\*(8879./O^3*/B>ILT#>.H
M^$`=Z:`]VS'.W!.+`:`VHL4U@$*0LQOE3"J-2/$AV34K/_+&J\%HD?FS)=0D
M?FR2(/5@?W#J*D:!]*(`EL>ECT'T!UENO_%E^.48G)`PXP2>HX:6^?U]N*0?
M-^%ZQ4*>]L!,7=-&\)`W1?%"G14XX4&AP>Q>THZ3_%-2?NS9V9K:E]IR(P`$
MFEXCZ])V$Q!@AO:*V3\WX3,O@0#<0M%6ZA>MMHB.H;`#TS/:*J"NT>Q9^L;V
M<R^=0_5J%=ZA1X+</1I]5/XQ('"<9#)J31T1Q+.5`D,7FR0*Q<F>?.A\R(@R
M)BI],.5!,I*D+$7BF9$X5E++NO*F4M)M-D5T';D5F)3;T@#UET;'2?GIOY#J
MYS[YAN*5*EQ#"P"Y7]2[J-QB,+@X)%J)HFZXX30[76:;8$V>@]<G;XX#[8\8
M()=VP<RX3%JND_E$@Y2F%QL>&8N3S:_S5YB>;ZAAGJRCE";_VDK!\;5NMB.Q
MMK5R@&-:RISL%F3F/4Y(WH>4MSR4O0CKQKX,TR5S\+_3("&?^>'.8?;JW1Q;
M5T2VR:`7M%LL82=-0B#[X"-N0E4'&]"=102X*.(!;LT[E&'.E^FVL6!O#H\#
M`W\?@NIE=,NT4DZDJOT./21U"ZYU24.2A^P9!@VR#0/0N*,F%QYL3WBTY<O(
M16\1;CV98.D#RJY$HT%X1ZJI2NQ,-WZXRYCQMF6'$[_A<9>1[7]_<X#Z^_;,
M!?8DZGZ+<6)N0T[GB+N5,S"!-.P?.MKNU&-R1BFU2Z3]%N]GG&T"L0?)R#'=
MG6`*>7WH963W&#FZ5JUPX"=%9/UO;Y!'C*IXH/<CHAIO3-.T5$5%]-NR-#8@
M1S;+F]1D_2K1J7:KFF=N"+DSQ_SNE8ZDNSUG4*``.;[3Y4HJ=9V`(Q8R;,\:
M\^?6M;Z(@9.O)6;\(%`]W9]M$GYU8K_Q2$-(M\'(5LB0J5;#\D&'(3O=:+E5
M*=)V7NV*;_6^_4;7+ZQ%'&6/^S4,:>*O:T(FQW''7*P0UCD1&],?QAQW5$W`
M=HQBQ/&OQXQNK+$&$KX]"I*K:9K2+/T41E3LJP,%154G;1!L=W+@Y"K+7`0Y
MB2Y;WVV):`:Q%<E;D*^\3;[!VLLE'TI(&#S7`"6]GS8[F_S2",$QO)`ES6=!
MDKS>Q\FW(%F9/5#50>E][0[(GJ>R"-OK)'IL/*[5O>IM?(!3^]8W+U.^=HV'
M&:"B]JYF1YUG#0XOQYF:5%T?G)6'M>X.J..W=Y/EH:/-(NOJ@S>/LJDT+X0L
MLB`39_1<1F$6!NOS,*'+["Q.,^`D*%B,ONP`$.-BH`6VWDGI`:+=>HQE%BHI
M/Q25YFTO_HGH1_*.1/3TS?,M`6@:F=E"V3`R,XHSCLU\=8HAZ@\P(_"]@T?`
M<_H<IV%&&&WGBWF/'?BV18D!H#]N*,T>:7+[&$2W].DY3H+D]?+I.0@3;BH/
M^MQ^?AQ0<?A=PC?SW-!E_!"%_\7/H)T%2<0>-66IUO0E"-DOL:8,;&FPI@NZ
MY/LFU`>=#ZJ[&;2'T8U#:D/^3DCIP4`F`UAS$$LF0@W)F!ZR541VFDBNZH14
ME/%S<(4ZLM/'5VB5&OEL"4M?MEK?,;7ON%ZR4^P)G0_JR.T8,`*/M,+&$#9(
M8LT;C=5M=9/0#6:Y)WS&4\?+S]?3RYO/LZM;,K\@T]^FEY^F'S_-WI&+^<V[
MQ?33C"QF9U]NQ"UP;S0T/+Z/D(@DF;+/5'1J0T4O-+F+_2&C4X_(Z)21T2Z3
MBN])4+85XUJ1$J5O*=&(`#]&+CH=>]3.S]=(Z".-TO"%[A8#,JOG][?!=]V@
M&]A5-F8V=L4C:*"5B"-6LT8@)YH$%>/%6K/Z(FDQ^N-DQYI[1&E0Y,@9R0YW
M4CHQB%"P@3^H=3=`@2C&@:]8H'W[Z^R&G,T_7]_,?IU=+2Y_F_FT5-LY5F&)
MN!.TXJ;!)F6P++;;K@&H?B38LD3R=GX[_414X"4_7EZQ3V>^;%%QCV)0"N<&
MQ;XF4"P57`=I&MZ'3#U+#:>K_W>3)XL7[.U,YV>7%W&R8,G@_'Z7#O;(NE#T
M6:1J/?4Y9QZ4W\-]4MC7S'Z<UD\[)/UL:B`[%?FEUUR)&(!S-3Q3W2G:K^05
MQP&M^!?3YVTHNY=>.YX_:)H9/(OO;^V(?,/'"S>SLT_3Q>+RXO)L>GLYOR+3
M\__U97$KYA=NY^3B\FIZ=7;)<K,\`^-S#K],+Z\6A#?=3C[X/?=P(/S2:VBS
M+PPSR""JGX4.YP^<V3LFR[#AW?2)W]K);U,MY-`5QQ0M*KIO7.$.I(?,%;X.
M5;?3$X7Q.]-WS]=C9-I%O,5`U$Z\<[+N\K3NAYF65O7C7RMED$&D=O%:942Y
M7P/&3GYAQ<D]/,^&@&W4V/'M'OMVMW-R^@_QK&T<SM?Y`&[QY>-B]A]?^'CM
M?'9V,YLN9J)<+O[U$QNVD=M?9^1B>GE#?IM^^C*KK1KCB\9(8^!&KF]FOUW.
MORP^_9W\SCZZG5V1\_GO;+BW(/GBL]GY&Q=TQ>[>LL'XVR$6X4,D$D5F5'XE
M\FT21"F_=SJ.?@O6&Y8DGL7L$5=BHT<<_<(>-GJO2[!ZBI0E59U%XI%MSZ="
M3)ZZ6P(DT:X*BB2ITIT4_4E%P`D1(G@"5!-"A!2/2+`OCN7$A^,=4JKK*%I!
M;_OK<^X*UGT,<NM\(FMY#-AO2\(TW="5F*UZ"I(_:"96CWJY:-0K%X/E$UXX
MV?AYPPU=TO"%(XM7C@P''AH[R&*^H@,>NV@M0HS7*CU`0I!W+V)MY<MB"UW1
MP",GU[]YN0M#T")U3VE'A?.-@S!WT4FMK@_4>&3YA9%2EO*IAN+[?%4$ZT.6
MCR&])^DR9$W#]"!Q!PL,O9$W/JGG@U@=B]=;R&B[;('G176=B,2\%0QTCZ)]
M0;WY7Q[AO?%NY`"7OD`IGHOJMAS`KMZR.W*LR+=ZW?\HQ[7[^:9AW`5XU^.S
MT^P[OV*7GH?I<AVGFX2RC'E[XIGI0EMK`3)N`PK`<PHKBQ&9$:H7Z$DP<06O
M%HU/2+61?_?1V@-*[J9=0"GU89`@A8O["6QWP0"N'A/A/)1<A%$0+?D1;33O
MXE,Y9C`\PZ*2<T2/'],D<TA?HH0&:[X[]Y<@C/B,TCPZIPD;+F2L33I-PI0]
MPODF8?][S3Z/5QU7O?17!%S_TD>1T]GR_K^`VS4QO>SK/F/>0RUDG<Q./.'R
MB\])')&*$E)H(;D:DNO9GZ4S",X%GCA'<V3H!'IWA?"I]`,DC3$6V_2T=@P2
MX6G2EZN;V?33Y?\].R_VJO+]$3_5]D?(EMF\<0(F2@^*%<;/]?(GZ%Z^L.FO
MKLP.-\:SL1>]JHM5N@!)JU6$]Z%P804E77FQ?]D"(D=;F/0+T*X+V'@E"Z"\
M2L4B]'/&PSF,;6KHSH`\?ORJ6E645W3A2M-<%IVDS?%\5V,-8NR1:P$ZI*QS
M$5EJ$:7XSB,_U+UJN=N9P2'U,4DWA4L-#R=WS*]2UAU7@M>WN]!G_WD]NUIX
M-7I"012,MWMA"G=GM4R!U<;HS.(L*I6R'J@Z]7Q^`P=5H%W`_5`U^AY<9E08
M,8ZB:08+]8K6BDC?:HWJ0PI;<.-\6PG<<9I]=U&^_,;/(*]ZR4K?T:-"Y3B-
M7FJ_&11&3N.[3%=G//FX9`D!/>!PWA4_?@VQS(LQU:U-`RS\Y7MJ6QP-KVP7
M;TKZR@97WJWJU+QD<\H"7^W9[@5(5X:`D27M=DR`[5>'2GO[7"Q#`)+]@,H2
M2NZ&4X7\+@?\=H=3Q^'4MO>D>5+<@<')>B1E"Z<QQU'7P:NX=.$B3JZ3>$GI
M*N7'+Q4%7WXG`Z_N+K/P17=O8$<IC03`6@J*$W:T'2=AL%=N]E1;F9.R@]B,
M^V/91VR>^HF4DX9%/[+KZ(>;=X5>R_W[8;A)"I;2VF2Q%\[0::V0.5)UL0+=
M+SP;GXZ%<V,V-3321QW_EK;>QM/E/S=A0C_%T0,;GC]5[B\RQ$A(5T5@U'=%
M)0"(E;@AT*`1[M]:0;M@QW!8M".\X3O>LGH9K%]N#T*-TM<M,*=R;YT(M4][
M@EC'<<JH&@>\/")=L]_C,4C%P41KUH0(V*[R2^6/!K/@H(2/6K_"#PN8;#"9
MO5XS>&73:#5CGSX_J0\YL1=@"D4:`6[<VVBQH["DT]O!O]7BI"&J;'Y"1(<3
M$D0KLNWCJ=^;P67V?BA`C0R@%`3@`7]`/E0DTQN`B?=F5'LN&@J$TV-&N'V4
M<X)Q+R+>_'Z1Q<L_+M-T$[#7=!:GQH&6KHLBJLF[H+JXSBK<R*70!/==J8!=
M=.+W2_'O2=F`B!9^>:H6!$K?!$!'Y8NRKFKO&PEP=M.5X(M,C"K[84^<'BD0
M%Y:(6XJ?-XR6Z\V*5Z>7\=-3F(9Q=+`P!`>%_D#T@OBW\6GQ&"?9;;=2FZZO
M:8`C[^LF[=/9Z6A8HU#9(<.32I(.9D3+?2FX:;%CSNX`T#.F=3(9@(QN;.0.
M-591ZD8"<7.$DO(V>U%X<X!=^T$)(GK'C4A\BW<<L:&1F)JZ9B$RH1FSE)MV
M3N_#B*X^THC](^-CJ/13&-R%Z_S:*O;NM(</H\IN1C0<V3B\@?F<2!$1R20`
MV:!HFA1B1'TD7YU1ET0*4:20)2J&Z0FIB!.[OY<^G<&,ZP!M:G/@7RWBP]`A
M(<9#<U\G6Q3P+!O(CWE2,7MZ7L>OE)(D?'AD07'SS-QZ)^K-,^TAM8>^.6Y2
MP\RZ"I[H>?P4A)$J.Y$V:J89C48XA"/5C!3XF[(!GE_O,N%_$_X!^9I_Y,GQ
M*8H7UG8^W8MM^5"ML<09]``8'M/3[Z&R0B1IHL!SW@05S56MN%@N),.1+#I4
M<<P_\`S%M9>DQ+#D5:H0S)NJ\2M]X0.B-Z'/0;@J0HMVHDO=LHEE64L<2*MM
M0$*V5`$`X))^D^)#4@ZA?)JPTKS,-N:-;[X%_78/B0<,"1,WPP"%GDYXX2GZ
M]//\R]7M@EQ\N3J?G?,[56]FB^O9V2V_3'7V^?K3_.^S&;FY_.57UNC+]9Q_
M?WMY,_L\N[H]#&"9<^N.T!HW[\WM*?94EPG\-$UIENKO";/H*6=A?4],=X/8
MB,K2!H5@+]3*V;)XN7-^5PC+&WIVO9@-8%0.:8$VA7OJ)"C=U0^HNHP41KTH
MF!4S2`5JRQ.'!&QC`=NROA"(/L>!6FA80<<MVNYMB"X7YV)!]>(@]_2'R2VW
MBSR_X5?^:H?&[ZC;Q2L;]'X/$G[AXNP[399AJMX;#NC22I1T79"<UVP55FJD
MU03Q4HV`26V[-BF^)]L&OC@C``,2+P0CI^U\ZJXRKQL5;ZY68YI4]H->GM-4
MP4>+K_@:F6]YZX/%'R!]P4+@R./DG6&+8$T_!QF_H/V5A::S>+VFX@KP^;U8
MK`/<!]U?HB9<6$M$]^Z.SX0?;.P-L2,$6_D-MN#=3T@I0&23.Q%B<X'/JT01
M0*SEFWZ>H2,C2\EZKMH[=W-42^AGCU._:\?IE`GP>QVK9]YE%>S']"]O4H5R
M'\D\X4\PO^>;";-70$:@[Z@)_*J.Z(2CMQ`_C"OUV;&&0DR#&K9;^>)$!&A.
M$WE+_YC!`!4M`8!@IO-RN0"],X\,4>>A3Z,6`ZN20/88)/EHZHZ*/8%T)<ZP
MVX^!*#Y^K>(4'H(1*^I&558%]4ZE$HUB%!2?-E&\W<PJ4C*.Z*/`JKE^[@2K
MOE3/M^;=G\5/3W$DMM_:)$BR?I#\J-[/G=_*['.8'374=735FA1E;G1/\F;Y
M^0<>>ZL4(S!GU<`+Y*G5_D!''0.9=DF1&"2'+UTC2DLQ`DK;65$UGBQSG*;B
M+;PC47XO^;:%7[<?N81PM]2H)XC=)D8U378+#7KD]BVM&!AF.=$5@^9S#<?9
M(X?P/>6W))^0X)Y9359TM5F*<Z@#<A]&*YK\"VM-/;G!P"F`.^5+?0'<SI9<
M`?C#<(E]2R\&A#]`:?@(H/IA#*A^\"2Q%];,GWF1-BWG<%>0N5!=/]V,I[P?
M_D2+SCX'LY<*=99S)5(IS9E(`;FBU7;IS,H_1]5#1#_C`4"7=E9#UM\P=S$F
M,`=84Z/6BX!1_>J:/)^/\SZ'CU.[^3<DI'HSEY:7KZ8O0<B>8$TO8E'06M`E
MGQ4,:0J>6[,39%AD`Q'D9+(?_@1NEM2`]-O/Z`/$2A;0<#+8]GMW'R?OQ.3^
MKNN)M]-WEF@TSN=;(UM+(B"!YKE[C[UDD)4P0#-<N(MFW<NVY9M76$X:#N<7
M7H7?:;0J5^',[S\'R1\TXZ;O;`9&7[`<0_`%R''"*F#[W81>B'I[*C%+E05>
MOEYUNWB5D<JN8R7Z^LDO<!0:Z<46T"9N,<HS4XNWOC%(P(59X<!)U.'V:><9
MOD?>(3W#.NX.X1M>15WIPM=T?H^TQT0NJ<O>DJ:DX1:YRY]AP+TD+0.0UK(W
MY-KN'=G/#2,*1'9;RJZ%MXEK`!([+ESWQ5?&VP@BL<.)TZ@C<KAM)%QGCP+T
MT&Z#L_/#@>.,':CO:<H/<@K6%U0W^I4V:X?81C,L3I!J1PN.3>D@)ZYWFE0_
M(?PC;]Q._N9D/J5[QQ)WJ367^L(0:'!%_VTE]K#@Q'W&''ZS%BN=4IJ\A,O]
MAP:$2RW!@;G`KB[8V3Z#MIH.`#EM,,?!0`2PR,T6(B,O^)??J7@=K\/EZRW]
MGGU<:]?]6W5O!U9@=RP?LK(6+1!#M8(<#29L<EV_C[=^'2_[4+0G7XO_\HY$
M]/3E:&5;9,E<MPLV)0X-$B-U=!_1[2JQ@"O'@WDQ@O3W.M[!4`S)71SC>.P1
MG]S(7Y(XU8S_`)V@0:OHY-:9:Y8Y#E"EKA[^FHLP!2/1RG./K4,"[J<R*(%]
M4W2V\,CA(#AL%-FI[(O%?.B:^AX?>J&M>RSHA#<_>?^*JL]'-W>!<K[HXM;=
M*E8YYOM<4P\/XP),7,_:>.Y[51C`/:\-'K#7\9V%<)\;!G+#\GNIL!_VQ&C@
M9GX]N[G].YE>G9/9?WRYO.8773#8S;RY[0(;=MWIWAIXF.5,M1(W9Y(;%/:$
MWJEJ('K"][0?+/0`Y5`LZ'E9)IW>I5D2+*U3C68_:+ZQZ^?6#9OV.<X\*NIZ
M^.%6BBX*D*]E,]\KG2V,P%U3`2^P=Y;]+5Q4B4P/O+3S-$;G"8S!BKM#3UH@
M35=`)RK(UUNQ[&=_YB?ZU'1[STETJ>(.#]5AQQ9H<P^U68?%\I&N-OEJM5KB
MMVU^##CM/O3HA50_*TZW3+/^EFIX3W"<J?1T[+TM&UU'FJK"/FZ[DV.J3?&F
MOEV4;8$9"P=6`0[NOUL)-@ZL1JL'_OOQE=NGNY,;WA/JO]6>;OVW;:-C_ZTI
M[.&_%3DP__7I@G`+Q,"]5PDWL/?N)%AXKP:K'GCO>9@NUW&Z26CGT9Y&!-2?
MI2+<.K;&:L<>+M?<P]5E`@WCPUT7-E3<FT&B#FEP'C#C%4P($E$6S.`'ZH<=
M5JH,P(7_?D]I.8-Y]W$G.M#]'(M^"B-ZF=$GZU2VU1$:^2H=W7I^RT+'4:ZJ
MKX=S[\28*IZ\)1%-?0]C;;#`O5H%-+`G;P58^*\:I,/Y[`T#D&Z4V?J^X8&5
M[U$<K:4/QY^J8LUNLVL]$?_T:A37?B,MF*M>6A/-VW9MT*K?Z\#8_$R?[FBB
M0V>]A0R?90L\A-9U(F)T*QB(TJ)]B5.OJH6RMR/'JO052M&:MU3@5?&>!T0L
M70<975T'C.YODR!*@WPO.KP<T$%"$_$V$G`\PMYF)(^Q4@SP*`MYDZ(Q$:U)
MM;G?98`N"&M[;6>8MKP:+DGB]3YCW4D%P%8_*NCY^/]F]FEZ.SLGU].;V\O9
M@KPCMS?3J\7T[/9R?K4X3H@;"P!#@7S4X;_"3NTD-*@/+,"A3CR#['(:Q"PF
MF_42U('*MW01A`6HGX(FE+5]P9XX^B2RPB[=L-[<`^9UF$-_LTU./0Y>'M#T
MUWF;3T4$P/N'>AJDT*#N"?:RL8L1<JM,I6UH-YBW89>UH=8Y]3N[DK91B,X#
MO2MF@^$!=49H(=O4'>R67A2Q%8SQ%&^B+)W?5SZSC(<:"<#X*)7@-%YJ;'8;
M/^6*N\=3F3RU=Y^0H@-?!%WYW&M'UP(,'(#-*(4&9(DD>(#V`NI#5EV4^E$Q
MSZLN^><<V=FQ([MKL04=VSX66]*/K]5O[$>`&@'`>0:9`*>E5[7%;F<9I'J[
MUULEXC1S#"?D[I74O]Z#\:4.7>`"K!&AT.IK6Q"\^`I`^>AD,"NNJ^?G9%=M
M_SW,'JM=[!C"5BJ,-N!277*)[;,Y)1@+8SJS#EB'+N\NA>2GYM=F0K\Q.76:
M\IJ?K+$-):V.3@-D,JAT,+WMES<ZNKP8PRKGCLD'!UO_8Z\W*7SMF7WIS;44
MOGI;UZ'$:/[FS9`#/*D+GLEU-GWK>LZVXT2M?';6WQE9FVE8Z[E7R(2KK[.L
MJ>'4)6@WX/`:^<PEJ'5NA])6)RX9A1C6*'EWYA(8(>`A,O#$)5-W^'#8@_.6
M;FA*V8_^.(U6Y_2%KN/\(*@DX2N#^3_/XDC8>!M?T^0^3IXNXF2>/=(D->ZU
M1Y7=<G04V4AL@/B<6)2!8Q*$5S`T34HQ8B-511"I2#HAI2SN8H4TPOZ'Y/(\
M/#P`UP4D3(;O86VZ0]`AXT07#CPV<19#$BM";/0!$=VVCT,":]CEDIAVJKH2
M3BE!321%"Y]YH8D$H+_+`03SXZ(OU#\'Q)VC*6F3QIX`S!?[+V;3F[-?Q6;_
M\]EOLT]SL=V?S/[S>G:UF"T\VO?O`HB``A$>%$<N[F@LRZ_6Z1(*ZCUM`D+9
MT[U[UFT<(#AL%?;TT$*.,5#X?[^:#8;L/%@*0"LO+GXS.U\>&KW#AYB*7A08
MBW!3!?)JU_`X0-HOV/2`J8>!!S1Z,AYQBBH;KVR#?DPJZG..7K:Q/&H51Q-J
MV<:S21Q,)\`LW(#/?471@5JX\>+LV![V?S)N6\(3C4><G]"W/^$]Y>BT^<ER
M&Q6"(A32]')7%B+Z,1E3Y5N(A/E)MP/,@><.2I=9$BXSNCH+4OX0_#_\,+:7
M8,V,UU`AJ%N;Y@S=L"@,9!T:/9FT@:A'+V2R:T'X=X)=Q#\JK;QA"A@X9"Q@
M`RN)AVN[2[W7!T"ZJE28E?9'9E&C*+&YHL]Q&OI3G7"$1$A=`AF+8U<D"N,6
M6;S\XTL49NG-XHO^($)('V6$D/9!]D:-7=BQ0:[*QOUD$JJ>)[XGH@'YD35)
M?R)?\V;^9)``/&A<T0PCM1=*^NI<<"3T.0X$*HT]8=@(`:D`XD8`\?`1:!$)
M^F/0DQA0!*C+Z(5]Q`<YYO6^\*ZF,8.TJYLT36.EH[&#7&.'+$TF2#J&J#3T
M<!&P!6S,.9P9=,8L3B("D,F-"]EA1A<JQ3C8Y2'F(@@3PI+A#25/-.!G/'HU
M#^H8J?8C#C2L^A5U&L.B:786),EK&#W\QJ'1L6"ED&)9OVI)&:1ZH+!]F.I6
M6WG_DD)3)JCV=4+.-DGB+R$``6==B=`CU[8LT9!F7Z7PP@5&J:?);$#WA<90
M:\D:'S?>>Q?BL!'O=;!4/(%VDU=/@98A5"=P$"HQ/]$P@55K1W]>T8@'A5O?
M]F'U1:DU#X&1;TM(:L'VW&3A3;Z3%'"JH;M(%*)R5"KN_E1CDE6G:8X."B8:
MEO)MV6%_F"(QE>7\B;UH++;RX`*KC$&(KF9!$K$L+YTNEYNGC=CS?T[OPV6H
MKGI#.[:XQ]P1B6&@%F+Q"$`?A"V,8B9E&U(V(C]6FI&BW4^^$`,8*1+WMT19
MV\E-`F2N[`U"'0WV06HQH"J.,JX@<QVGWBSD<HE*P,C=!2Y''I_7S3,DM;K&
MAI"!G(CJ+'$3&JR21VG728F2H.)=JTW"FI#LD58WTY$T"_A5H9ZM5M"^?Z/+
M`3,\62>S8PV`KT&(W7(5C*)SB\`/$DK6C&T'II&9^85&&\H/F_PE"70KWQ7M
M6GS<:H?D*@K]6"S<%@_QBV:O2?%1?OQQ_J$OKJ!Z@1(OT+_K-OP;[67('P@6
MCLA3IJ4#/CAE%C]10I<T?*&K_4<'@![M\2$A12R$G((0\M<<(1%]X,&M"T9.
M.V+D](?))\I"Z3ORD/]:@DMXYC8_6XARW\<P)O^+)ILT6-,G<K&)#@%%IRY0
M=#IB:%T\!@F]"U*Z.HN?^!$+`3\>4WR:3C?98YR$_T577Z(53<22U_DS__Z:
MX26=?:?),DSI=1(NZ0W?4E=\$MRM:=XN_9V&#X\,FM,7F@3;!GF7]XHH[H-)
MC81A7)-0*,:'7Q4G#1KY2<QL.:J!$Z'GG5!/JOI/2&X!V9E`-MR&8G-*+IT(
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M*\<N+QT)LQ]`>5[_;'M#\>:B?;(EX&6%@/F`YX2(`<\;#^\3#WM6W=\_)CZ<
M,=I\DZ59$*W80P(F.S[2AS#B/\C'@(D;:#43DHDN1VN]3?0OL"/]ZAZ.V_H_
MV<"1O:_!3D=P%>..>744%DFY31EPJ=1IUM#35,>IPQOA-Q_)_^$<Q@/N%_/S
M@5U%Q#&NQCH*7AYV/'?0S.SAR`XPJ<@/I\E>+Z,T2S;BH%QQG]/M8Q`5O\'T
MX2$1^Z4NV4`VC-)P*>8@*S\6]GHO1).P5H2AF#3N0@[$7W7D564X3^)P#0B&
M@1@KTW([2,60_$H^DC%3=D.NK35D:TZ^GJTV1/,YP@],*G@K5_"I#FUE"X)I
MB&M?W@B8/X)?:^VP'LAO)N8CH=LX"];D?G=G0WQ/`BX_)8R0Q?D[G#[9IV)W
M]QM5^DF5[I8!'AQ9[N=@IGB\WVC*!FU7&WX0S_P^'PUB#U(`JK`&'UI5X\8T
MP*\P\F!!;Z'#T*-3C)'<;]/W7,,)R77P()1KV?,H!'$PO.@"=V>TF*%1B1@+
M]I,\_$IT38:.PR*B1)]_35[$]R2,R#--PMB3HX/VW_?=98RC>[^'&9ZKNOVH
MFT7Z6S?J\J.]6E+<_[?>QT5''FT6Z6&K!TN-CFJS"`(OC3RS[<5FD>Y6CCV;
M?23,?@"KB[S:+-++6L.:HF/<+'+`/.S9XJ+]8^)QQVA+&@5)&'^)TF>Z#.]#
MNLHO(%.-FDSMF^,8=7N<^&.R!RG7UZ@!4+.R]Z3\ZH14OO3L$CCS.V]S$Q`F
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MZ%AR[UW532T-QZPA?)97L&I>6YV`V'KF?9R0V=/S.GZEWJS"\=HIS74B+]UR
MY.I,V_SJS'_5?+ZX,U\QL#LXLG/ZTE\)()7IH\095_9_<G<I3B_;NE%G#Y7*
MU*>QQK&1^VPE5P_:WJM$",%Y0/R+YJ00)NZN#,;*!T8&@R51/4T<FA6:R97\
M7/TWW\9`WD%XMR?YU^S^GO+\D%Y&R_B)W@;?;X*,WE`.HW`=BF>PS+:ZBU3F
M5EU$(I-G]Z?"SILZ66+#AQT4U+AOVY_D`@B30+@(4I>Q!\E/#RQKZ+"WAZBI
MSUZTCNCVTN\<IR@=#7+K@,WTH^%H[).=*_I7UO'%RRQ2C+']S)/T(;?W([V/
MDYWMY^P_:18NI]'J@GT>/MAF$+VD*I.(CE*1^:S7LV&G$EV-L2&S;CIJ;%9P
MUYV046&R$U+*$9?0%Y+V(*WH!W`-YV%XCIKT.DG7\=X>NZ3C+*.[3<Y]LYEK
M5#,+_D>^CB;,CQ8IOEQD+)Z)TQS>7!&&JCUQ1D_RD'-Z3Y.$KIC%TS2E6<KL
M_10&=RQYXFMY+/./3M*4>8>E-&1RZ_0LV'F&K1$V'&8GN\9<95=1H,@[BT2B
MTGT/DHEN:-4P5Q_XJ_G*2JJ.I_;(GQPG"?:V.'.L9E*P=2V?ZP[C>HY%K!_'
M=SR)[5^BA"[CAXAO6F)V?Z01O0^S]"9>KUE*PF=>+,-[5X'*"&\O$)F4NCX1
M=ISO8(<-(UF+KU%2M;>(^&5_P@600L(>!/S.^-4P5T^?4%.7K6`=>^V=GSF.
M_YW,<>EPS2Q`[7+EHL0WW]*AQFOO\B0]N*'K(.,K,9+L]38)HC18=EDC:B=&
MF0I`Q2`3DYWUV&$?K-V&>X!"&].>H@\1G4BUUQZ$=4L$:@BG$Y;5)`,3IZ,6
MK[W"<9"V,`+?/=KK`JH.,OO.-PSX-RX?VA,L`NY0ON!)<)7O+KF*(UIL$3H/
M6=+`S!"+'\4R2'Z.".HVTY[:+/>>=M8VR"ZWGK_%,+M4NQO9?QM<5]W`_:P5
M\:247VST$!K$07X'L,^UK\]9[[/#<7(U;Z-JM=^/=Y"L,LJ&VCZVCD8O\*VW
M3,&[/=M^NR]<T7NCKN]LX4G.>!:DC_S_^44N+\&:+_J91JO%8YQD_%RXRXB?
M]R[6`EFFAWT%*S/![H*1Z;GO$V+G=SWLL>':SFHFO-<)X?]+*IW%(HY*KSU(
MPWIC6\.B2'ZCILNN"G3,N/<^Z3@[ZF76$,[9RGEX#W$>.3FGSW$:^K<6U$<G
MM,A:?')#3W*1^3--6$H5/7RB/,G*U[P(2XW9AKFK,I_0=45F)[.5V#F!5J,-
ML6@$U8ACVX[D#<N5FIX>P0C`C88FP*A3TX!:A,[1+3`[RCYU<2OD9YH]QJL=
MZ;0_I?0J>*+3[Z'RSD0$D>I]ZAU$8N^7[?Q4Z/O4NUABM4W67L%DU^Z$\$_)
M5_ZY=R32`YNZ';%]$:\F'7O1VOVP_?W(IZ4H'U]KWX#2CPZRK!>E2&4--`>O
M>8ZAEJ?(3<"8A)=)!BY4.>$WI]:_]C31Z8+0#E/U9L#;S]9+9':9LH?XSQ@\
M=)W$+)O+7GFI.&/#-4Z<SYQ!8=0#ZZYD&U-W9(*!68O-*4:M-C1B$#8IOS\1
MT\N9*&]NV_A*#T`4:1C!"H=J$M"+T?F])9)'*7!DCS2YBJ.X'+X5NWA?^7Q2
M''%;P?,K'62I2R`VLK!K(O;/@5XDL3+!JFIB(;E>1N$=2;5GL3=/9!S;WGLP
M5](%I[J22V?8:VHP<)G:HLQ^>)'CJ0Y;2QRY4^N(SS`*HF48K`L_>G.3#G,6
MPSN*+S,338N+Q=@XD1L@#!ZZM<)<LP[@29P';[T-O>A&)]H4OHN^^Q^_(6BU
M828X^BV(22/4BIE\]::A@[C)%%=NI0[COFZ'&=-?^H3R`3S&DV"NN(0%<N/N
MQ]?VG;NP,IU+I;87MO54.LP-42B_S$`7O?6U%>%"J7XF0"^($UK(3@W9<#WU
M%?)"E4AS2FU$J"-"GZ\%4*?^:7^1%28OJ(.`"^4=KK_"Y2-_0LHT2;B98L'=
MQU?Y/11]HH>U?,M`82%_D)A@_;S#T+^-6?V9'JX-1.JD*H^3MO*.K/UB;GO?
ML";IKNYGR\=@/?;4V]W#1V%9'A,>XS4+#VF^O.@JSNCO`7^(+)TG-^'#8Y9:
M[&#O)D_-HK;RL%FSV_.@LZ2U&5:L:"F]O96SZ/PO).].>/\34DH@<4)R&7M0
MG.N*8!W7]7(*#;?9R=5RV7[YF>N=UQVL<>APS8I=T=#;,^3&=R&;K<ZC.=&!
MUNYZGG:#IWBP&M[`IU7@_4*^U_)03\9!,&/PFI[7B9)K]QVPQ(=TG$Y_`X8L
M]>T=;8URW@Z2V3[PE\@C-T]/0?*:WUMT'R=/><F*'[U37-U+?N'I"B,ML<HZ
MER:XB+?9LZ-Y]IN->A_8LY]\Y$E>?$-3RJ#X.(U6Y_2%KF.Q\KU2WCN+HRP)
MEMEM?$T3[DH7<2+F[H$;[+$4:+:]]56`OA<.YXGQ-\CUMLMNUUQ/=8VM=+DT
MP=<5>=5IB!-2BN0.70C-25^(]74B`LU%M/ON4-U0S=%]%>EWZ"&[^H",R^QE
M9B[I69QFZ7L5;<I;-;FOV0J'P.2ZD5BH)1Q`)8T^D^T'1'SBB1LK7EG;%[7O
MMN50]=82KQ@"!&[&(A(=UFCX1PT/S\$KH7ZMZ^P("W,V;`F,<?-,T^2Q:NYX
M]OTY3$3C\R!3)IFXTILLBR4=QS%QGQ6)U=&,`O@_DJX)9$&+=CW+"=F))%RF
M)XR#[`UMIG+B;BU^P]$BX<5#]&<W`1K1ML$<FR<$%;]<O?EE9RCMJ6?N::8C
MIM`OHS1+-F(YG1BOWCX&45&I%H7J]#)B(]HP7J&G0MW4H^5*MNI')M]NO];8
MV9:UU2Y9V](8E'PM7Z]745ILM,V8VG)&Z"2?$DI)&)%<][['CXZNC1A@>I$+
M7ORQ,P,S0!TTO7F6?'8PWA^>X^FKZ)>2AWQF^HU]QD+ST?*/WQFT<J.)]%E^
MIWP=*EU->37T@=9FXKLFT?@6V.;1F!8,$VOP?[.!LFE4PQ$"#:(]H)Q:OZGO
M1)TVGY!2.2FT-Q9_[DED<^#M]L'-&>581S<\2SH$N&/FO7'2;&3[O2)`GFR7
MZT"+;/N$T)*CGM\X:GRH'SE+23)Q_WGJU(:GF("[V#>F.O6.J4Y_F)0KU=^1
M("-/0?('S=XXR@>8'SM'G?I<+5`]YE5<U#[:M9%-EF9!M`JCAZO-TQU-NI8)
M$%5CS;-9J1ZW"-WA5QIY?LW.8H<U9QM#,.;5^#7FQ4;/]A3;":DH96V%VCT)
M69@>C%?0[LX?:*5L"Q,0R]B'R5YVX_IG$8\769!D#B?1;,WW@\SX>'YW#,_N
M6Q*D8@\[HP,J(/G^C7^&QO;1,=!P0W<,8ZW&[*ZG\&T-]X1]3K7L,]T\;-*,
M?'CCGL$Q?7S<TQZ2>\P]'\:I%V*9[@G[?/AA\AN_)#<_RJ+"/V]\,S2.CX]O
M/OA<`C25.B_BY)Z&V88QXIBKACJ:@;UTR-H,/^:G.OYZGBPBLK=^@.DI6Z-P
MEQ-5M!_?FJ*N7(`_(=:/E=#GQ"S-<3`Q=AS\Z.=BHRX/X1]1\C)ET65OEO<?
M+&&Y7VJT=Y3E]_)_U;->!&'R6[#>T&F:;I[R!^=WR2W94_X6KYF8-1O%W`09
M_1Q\#Y\V3]C3^IT-P)K<[V#`N$6BSK_8R!/]7>QV6"6R-P=CTI]K)4(MJ>@5
MAZ((S62GFG#=)Z30OB<1#]_-\:I2?:D&K3)E;0AB?>KPZ<ZOC;7=S/>)]XJS
M87)Z2L7Y]&(!+7G94=6/_\=/)^3IC:G&Q_Q1<]7!Y^!A-'(.7C=@A!R\-&!O
M@E+]%]N?''QKMQ^QJ#!GI!P\UWX\D:WAYJ-$-BG5C!'7<D/&B6M[2G=[FX-7
MS/>)]^`Y^!M3C8_YH^8J#W-PJWS9*K=U2LQ#Y(P]>$Z=B_G,/K9,T<FGH?[G
M%#X#QN!>\5)<1B!"6HZDY8$BJ6-\@&+)0][MM5RRG%Q%/[370J7[#<05E;XN
M/6_]*MYN&*Y:.LKZ\IT!`VP0WBKSF221_7&()>HJ%AA@8?I6]2`+TO>)>_PJ
M*$`-'I>$\J+!&TD,!,R#IPF?]^;NC(3MR?UK3A01?0@RNAJ9*D;;C5LUX8TJ
MAH/FX5/%7IYN93SP.]\J.MIM,G+U@]TFTU3O^74+\E_+]]MD6E:/><M"PY@!
M;Y,I-F4?S6TR"M<>\#X'+;F@12I+,X:\S6&OZ<VO\7$7X_WAN<IM,B_BBS?R
M&0O,1TL_^SF;(ULL<!.F?UPDE%Y&C'78,PZ\EPR@WN4J5JUZ_Q9U`7XM#U>P
MZJT>>!V7SAB7JU>Y7L(5DU+SP6\@@_BVVP5A<'9QNAA,8X;CI6"'PV]^9=!=
MC/>'Z'@&S;]^=\_Y*"SY*.$76!_X5C&O.6G8):I>LM)^)M;B?_@((8P>\@'"
M>^SD6:,"*T&6JA@W2&B>>N1$5VZ90XZ7*<1(6,5_2"'X,,JY.E_!(W>S1Z+1
MMT05(D7OA]_[E0"J#!R6`'@B5WKN\YOGHJ!K[WUW/U,HZ0U=OR1QFF)G4F9-
M6`F53M.X_&K^#49.K[0&.B19C5Z,9$MSK[10LN?T#7`M/!8'^S$:E:LU(C+Z
M/I*&7[F9P<Y1V$-R*_.;K^-"[\"\??SEW!K;1KH-N:.EXWC\`=QN[+OO.UNQ
M/;;O[^7Z[$]A1"\S^H0^8FL)QAJ@502/2[6M)QQY^%6UQR%[[M3T'UR1KUP:
M$>+^GSWGUS;@\>A4Y4QHW+E5@$B5:D<=F!>-ER49KS%"OT##U=4_EI?R5*_+
M\>[:&LC]#."K7G0W&KAYN^[&U]97BFPO^_B/3<Q3V^4Z3OGT0Y'=IN+U^Y;C
M@E\_;#1I!`#NV"T7Z7#(M5-@!0(VP&$Y:_65\RMAQ9^"^^\H2>.U3W4..`Y`
M(PLS#O8RCU=O("W&L]CY/5BA^P-_M@I]W4G?^$6\/>QG9^<H6^=+]0,<]//+
M091SX3XXQ*9\N=^C#5&,B@?9CK\O7./7[`[,W#%)AV?'EVFZ>>,$MV@\:%;P
M<14/-_R6F;=\I/.(?J;5Z\EAN:!.`BRYDTMPR:`ZFYVF7PK%G:E-*D^3(.79
M3]&#L"[D:][)[_*J%F-0H@(`%<@[,DE@(O$#[4,F`$K]J+`7M]6&29J1D#%O
ML%Z+?/^XX=TUL*(#W//0=_LM[AGZ6A*L0U]%PD!DT+)YJ-!758S!`3MYX-#'
MNNP=-[0QUH$;5$"U9X:MI"[,,"+:1PI]=?VHL!?'S@;+1Y)N[E+ZSPT/?/L<
M!'&!CA`$<:#N8Q#L,ZR=;S*&L6@51@\W\7I]$2>\_7`S"7K][B<65/I]K?WI
M?R]OIQV49H]2$%18,\"D1$4S^<IUDT*YW[SNT,.'*%&"2&:`>J7<CD'*EX?!
M<_LRY:&QWB/"XRGG[T$BUCF_T<]X6#YB`O([G4X-6P1FWY_#1'3:[A/XG88/
MCQE=35]H$CS0\FAWX_K4$<RP3:[1S1@F]CCZ]09*M?&M1PA`V$:!$N\4NH>[
MHKVZD;NT@!0F;&\"\VY5]!A<8!\'W;*2=3!$-J=#3'SC1[=KXH=^"/^(LKC/
M/$SV9@G3P=)5_^S]X`C+[UR^]T&8^3WMV)7QCNH'/WR]5+\GAQ/7?ZU].7Q]
M:[4/9Q(7QHQS^'JN?$^"'+9OCW#0L91=T`I2EF:,<<SQ7O*;7^7P+L;[0W3F
MP]??.&E<C!\M*_F=6)M'$?D88>02>0<C\`OD5D;X4O[I\,MY4QRWLWV0BH^-
M2=B%\4+W,9;%N_B_BRI3=QYR4&&R,,9)?>G0^=#78KCM(_A&C'DAO+@U_8VB
M?`#X&TGY4P+_)8Y7Z33BJW'HT_,Z?J5T09,79F#*U[.GP9(_&A^!B%_C,\T>
MX]7L^S-=LN>ZI<F3^9HD/!7*+!M#!7+,P'MJ[`P9Q3(;FD=06,MNA3P21"M2
MD4A*D:0B\X1LI9)<K%CS(003+MFW@(#H*QJZ1_=(-97W5Z4CZH/T>\>9()*!
MPQ)`L9PA=]SLS7$1P+7WKNM)!H50T"T?ZSQ\"5<T6O&"[A"K!W1Z72X;D.OU
M;SY-]_MXN%!`8>[`$V=2*UPN#=C&A5*C6!G@6X!P[:YN9]T`3.%TLDVFW_$L
MVSZ3E/^S_4JK/6"K6K*Y*DGE-:3K%9_??V.6X>![1-RRG^FL>OTO=@)KUH1\
MZ:=4DQ?W>6E^`S\N_90;Z/X2+YE>U$L_I1O&]CP@`!P+_2HPLQ>C4;Y:(_Y%
M8'M%&<`D\:\Y:43T@06IE<,TT6#I*.RQ?]NH//=RYY=]CN7G>YV^7<3)/0VS
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MRV,+@N+8`EH>6_"\1\<6["&#.$\Y?>*0_4Q%\S1Z?B^^3:<O0;CFV?5%G(A+
MC+&S4*`ZM+N<3.I&OM($]FN,?5.3T4J7]Y08E*/<PY2/5N/[O%%*MFK(?9P0
MH6C/@P34[Q"O.+'R=+3`8%"+>7W)7G.+7]DDQ-CQ2(;GD#N.2'..8/]/DQ=&
M)IPB'MXHPB5$#Y8D]C-G5)UV<QMGP?HRRI(P2L.EV/+B=A8:I-K-Q+1!M1?E
M!)M?R8_2)M#BP6:I](:XF.2N'[BX59AO>][S"-/%>5W-B]E0AZ.),JT)SN;.
M#H6X_$I@;0WW@\%X8KNCF!>!.Y;AQO79^$-9..D_[PPU1>\A\^QG)JS;VOU;
MO&9BUF'V.O1I/G+-0YSGT]3L[V$9\M_(XS-]6@:/=$Y&PXY!SO79Z3STDWT4
MKCO,"1Q:WD`+17`+!CJ#8U])RZ\,V-)N+]BK=L[/R_:K-WX9%KY'QC"25-=?
MCCFUX9@7FMS%OK#,J3<L<UIAF32+EW_DZXXJC'/@IXKYQ#JGQ\HZIX<RP);=
M?C;$\%JG=^@[=GV,(+K?Q\.!M<)<#VZ9'.,>W0.,/EI_'?Z.RB'CCDS_"'=2
M[@M+^3^25EKM`5UI;L-]8Y7AH'M$O.+G"%IJZ1Z,GY5V^\`MI]J;MM_X93@`
M'Q._[.58N9AM%PM+53<0BB_/V2-N?PI'*S0[6H&\6-/:"B^6/W7\[?Q8PFEO
MO/NU4+8VH2[LS)5KK]'.5YUS&RK#]CV/;3UY`'W]53]"PEZ(96D-_IJLHV!&
MO\;U/9[!.XJ4;JL7NZ#>K3B-W7,:>WFCL;%IS/F*TGTCLO%+!QWM]JR0T.,I
M_".S4PF9[1BLNB1>4!R_%&R3A-$#R1[I`9U.M[<DYZQ&L:\DM\_UB_DF2[,@
M6C'_:CQHN8_@FJ^><52WL-2.7*\`:_<BA%G^5G[4)^!&NX]34%M0ZQ$5I9)2
M1*F87!_.T5BV/HT>S[J1"G84`UJ!'[T.DM7L:@O/(G#/H@'NW["QWQN*JQX"
M'>^Z'.0AT/M"1\YK![X3DC>U`JB]5C6"G)(669!D_I#2,/4!N#4J4KJC#V$4
M\3_>J&E4I!\K-?DWPL\?8!JM+AE,HRQ\H=?,C=/K>!TN7ZU&ZR!)H)&W09)#
M<@<]@\L1L<F`KBRKEZL<J98#4,*P3;9=B>A+\L[D:_'?6_H](Q\9@/_P^G1W
M&$R!%&F#>1C9:25"B<M3!QIP8M=LAQ-/X@.BA=@KF/O2LM+QS2GJ&/#,+?;S
M*)MV_N'T'D&E'G<5=:\N"5,^OW=5\@'O$6QK=5?Y/J1[!-7.Y'*`-L@]@BU]
M3H=<?E/$/I2<![U+4*;W&,O(@SO]D*7AP=S>QW)O8=E>%'8KMH[A^L=<K!V>
M``8LP`Y'`/X55<6GZ723/<9)^%]T]25:T434!?*'$,/.6F7XAC_]IS"BEQE]
M2JU&;UC*0$.X_LH<<C76+^%R,(=@8U>:[JU:4R;.99.=<++ATDE>#"N*R$+!
M26.Q$A%*R%>NA@@]7I>/T;P-R/;(W@TC_+Y*H:R/SB9C$W^G,#;(W2M&?>XJ
M>%Y>5F#\/;RKZ(UPGXI:N[L*WT%>GF+V/I?)_Z#7I"CU.AT*[!?'>+G#56_M
MB&3#RX,7NGU=;QSA#J`'S!(>SOB"$N*/K^V4>/H]=%`U,&G"*QFH-8U=+S#]
M!J,7"S0&.JT4*/5.Y`-\_MW^#^V-+H$YK@?Z'^*@7J41=40/=O:]H./VLYS'
M3T$8#5'$K6MR6<$M-8U-QZ;?8'0ZUA@X<.&VT.NT:IOKV']:-[J6VW*MU(^=
MUFISC8X+M0K2&)O6.XT=;N+U^B).^)?N2[029>[JLS5EOA5.)+^$=Y79NHV#
M5DJJJEW59,E7KH44:KSF>C1G<UEJ43NWPRI+1:G3$LN^D(GO)=BFJ6.Q"B^^
M%DMY=H77-PIP`<2#)`$/BZR51TI5SR3^YY;9-XU6/+F]"IZZ#.MQ5-FF?IU4
M#</5/7Z%@=*^;A8BT',7Q9/9/S?\(D+19"]&XT@>84_._?W/FI@[J.Q`RQC>
M/C8E=ZPOY(G)_+X2>HI@-$3QU:S=94%6I]V_(JWYM_*P<*LU>N!BKL86AP7>
M<L,ES_VK%8&Y_^,`=T[MMA0,9A6GY6&U%8Y+QH=":P/6%]S8[@V_52L0NR_?
MJ&<<-!\I^7A2QO@ECE<I2^>OXH@^/:_C5TH7-'EA]J>W;$"0!DMN+5_=)GZ&
MSY3]`"O]?>[*#-F!+F4^C*H+.4PX^!VP<UU<$VV8'U-S+8\5@L6Q8Q71I)1-
M*L)/R%8\R>7S7#;70'8JO+POVX6/:6*$.Y=6QP-$G3KV/Q(&<9Q68ELZ$I7P
ME'%+`2_;K]Z\'Q^&!^C_GN1ZB/EL\4UPMZ8CU$?5VH>HC\JT^UM(4/]6'M='
MI4:/5#^0V#)0?;2B^0CJHQJG'J9(862504H4;2L&*E'L.ZWM3WU48;LW_%:I
MC]+=EV_4,PZ:CY1\/,F9.XT";L+TCXN$TLN(T0Q-,W?549TFW-JH7),/=0W=
M;^!%751AH/-2AE0O8DV4RR=<`2DU'$Y)5.M8V"41@!<CET-D&M&+(?M%&3X6
M0I5VCL(=/"_DG[^[YSX?ECZ?O/D\.@0/S.OW.9DK2[KGX4NXHM'*_52W3).;
MB>ZZ)A^86?<;>)',*0P<;%ZJIM?%!'>IX'!R.:U?N9K>TCBQHZFMJD9G$UO[
MP1@^YG)*.T>A#I[+;3W]-:1K[\Z\VT]7'VH>>W!GWZL4[C\V0<1^_]?Y_8(N
M-TF8A32]3-,--9^T@:6@9\*F4S`*ZYJ?>)ST3&L7/K5JU'5.QDJ9?,YW)Y7D
M8O>3E@'^T9N-P3[8EX+5BOHS[Q[YN1=)E<&\(1U>7,V:+_<(<S3<QPE)"Q%O
M?ML'87OMN7N5*IT%SV$6K/F<[5F<9DCYD4)JSZ2H)744AE0\VSCI3]L8?`IL
MZNB<Z%0$$2YI/SE2A>W>Q*AWFKY<V)#>GP"]]$8ODA293<[=DJ<C50=;OCD8
M&"M[XF)[E5@4*\*>GY/XA:XNXH0G1T'4<G]G\GLF&QKYHQ"=\7G'24!T9N%S
MGEI;YZ2D7+%?R!2#N%+J?O*GV3-Z,RG4^?HRJE)/?V[=&__V(J716S>@HU>J
M+L%NDPUWVK"$QOZ78<;T8/2L:`P?'C]3JIY>JLMX9.UDF4N]'1Y#R?0C9A(-
M\4"BJ/4JW+UV@KA';BU]@7+WU+QKJ9-5VRN<90A8V`6@9YJ$\6H6K8!!J*6I
M`T9X4/@X_32].IN=D%1\N_\(@1&Q)48DQ(B%DE-[E"RR(,FZX.2T(TY.#Q$G
MIRYP<CIF``T?HO`^7`91-ETNXTV4,8NNXW6X#%GXI]^SCTSY'ZJH:M6Y&6J!
MG7%<R,I2I*`,U0GP+IBH2:4=V34D94ORE;<EHK$O!TW;0:CMHET@V/):D!")
M*_L'83<C6+AJ+"R+L>?E+U>7%Y=GTZM;,CT[FW^YNKV\^H5<SS]=GEW.%L<$
M8'."XA3"XX[QLB`3AZ4OEC0*6"ZCNR]7U[89@.1M<9Q59P=2>%&H`'B@M.>D
M_,NOVUZU+[3M38#WWW(=61^)IX#@,H);W/*M_"9_J#52.4+1"-<#:IJ1H5_*
MML!\WF6R_9OE1/P3W^!>?U]JG,O>JQ+@HK$&V?+W/P*D/X41O63_--)\JZ$*
MVI6&N/!N68`,\:I\"YCONE6ASC\EXF/?\-Y^D6K,JUZZ$O?;#AKLJP$R`O[G
M]^(\E\=XO6(9>GY/T/0NS9)@J5PV:--7Y27ZOKB.`[$3V9<,*BW<2RMI<C:_
M.I]=+6;GA/UKP88KY]-;]L?BEOWG\^SJ=D'F%^3LU^G5+[,%N;QB7\S/_O;K
M_-/Y[&;Q+V3V'U\N;__.LK!"GF^N"@*8VGLM\*ET:)T,C8];P7L4MS\+TL>+
M=?PMA7N[LHO:R25=L'U;:16Z2\LT67ER6P#0@:>+7\G%I_GO"Y]]50T/G8N:
M0*7QS%97K4.:H3B"'^;,P,]<BR-^21NDX*#KH_)$>1]<5]39A>R+"E46SBB5
M4-Z3N/O8SPJ%%@%J9P,`1^EMLKX:=P/A;92X=Q%&0;0,@_5UG(9\N0D\_AF[
MJN.@IBMV/#1:B1X7=1JMXJ-:D"I.%O.^9/'K;';K=70T@T<7):'0TT1+I0AM
MU(0#=TAO9JEUOBOO?)/P681\W8&8[LX_OXB3<F69TJ^["&EYN)T0)%_O8CF6
MUUOJAOB_E<A)?NAZL>$S[T'R+N6R[Y/R6[YF=.'7FM%NJ)-00P_TMDG"1IB,
M+KSW`C>3U?8F8+N#F+S^=7K#JSN+Q1<6$2_F-V0QN_GM\FRV\&PYU"C8-\]G
M#XI^O*5Z=FJMUO&]T.0N=N`!P`5^MD(G;)SQ%$<D%9'!WV,;QL&_<2'AL/@?
M=0FBW%1^4!:M'&N_/=)>>;!45SFP]%$GQR5WF.UWFD1JU7>F#8U4;2HI^IW4
MKOA)MY?[^'*`4V<<0DD%#&D@JZCE@8G%/^\8,KDT6.'`3<0MB?\YNSF[7,SX
M9,3\^O9R?N7+FL@1/:!K9NG4!T9>/ZFV=IL)\'F8#G%5VM\BGC;Z.V<*J;WN
MXV=3;3]"J$N;G-,7NHZ?Q0J?118\4#+CIV6%O.12C:7;Z%FIPW`)_G.&'&56
M7*$#J@U#U.38,<.H6!\\&K:U(X)>7F#A$_(GY&IV>WR([A7UL##M?Y3K-ON@
ME]$EV@U3==7;/6#4PYAY4$B$C!;W;=[!@+=N+-%OUD$NJR-7C(G^\>(@SHR#
M4J9FPN%XP8X3%I'@[F-X+#:C9X\TL8N)DHXVL_!%1_=S+C4+!YAM+_7UG%#)
MQ8!FU453KUU<AA6[^1,9SJQF3(0`RUF283%J%YAPY@)WBC'@*C^D_5N0)`%?
MLTGWHDJ/A-5^\]N=T>I+B'EO#B;-'TC>!-OYK)S,*A18>]'[.KU[YQ7O0?BW
MP/E[+:)=O&S7R?Y[>^Y\+V?)^/Z>BNC.CY+V;W0*Q((-ZQG0X&)%SGOWZVW>
MVZ^FX5TF%T&8D!<^;.`W$RWW;>4,%!\6JUY,^/!PQ4KNU@A+5@"";`9;(TS+
M`YY@@,$8^K(5G=C:J=A\CPV-TOS>URG/@!_R+?AWKZ3:[CIX%1]/69K,QG2%
MT)/MDA86)*)BQ.>=T]LBUBZ-1ES>HA%HF63[Y4G#+Y]VL,1%+UBVQF6/UD\[
M=XA^XTQG+C',>FJYZA'65*L-<>(6I]++\$2R&!=+(O>IV.+>27HMMG;G).T4
M=C`G^0!RDK_F3A+1AR"CD$.FNQGBQ$D^L-CQY@2R5^Z7$WSP=1QW1;^)KSIM
M56UUMAFO53J[YX>6I0.,RZHZ>SK_3A1HLHPUSUOL0_;8!I$=#ZA`:.7Y6R&6
MWCX.B(<?$M558Z'9L,!QCX9`:"#N-]3I#6-?IM;:&PZXG>(BGVK1Z9<D3KLL
M<P1(L]DNIY/F?EN0^5D&V#JG-:+GSB"-[(DX5)!\G.:GLWR^GETMIKQ^XC5G
M@#%HMU$(#&H@IYBD6FX9LO"2T3FGR.6Q2`<LSFK"8RS:`3_-$),?;HC'+!R4
MB*LF2TZ($.(U2<$Q:SENQZ8IHUC;$;RW?C7"5(C!&'<.)L8&BN"^1P.#0?VG
MYSS)$![DXP"C<5R(_29AC8!.A[:YWSJIL7C(P]KZ;A26B;/8*5R&Z<O=!)/W
M6X5U6.MX7$_WS<(205T/Z1D%\R,>S=9_P[!<X($4U-`!CG066U^(#WP&FU`Y
MYOEK6P-082Y=&[`\4NI&.F6M-[(]7*LJ"D\=ISCE?2W*P@/-#<GM=%_R19G>
M;$B"['/?D\E-!7RL*KH]IS;K,NRJM:.`=_!MZTC3FBU9^WUL"Q9J>^U+[XO;
M\0L-=O>:F3K(`H_;&\Q,%B&&F#YWE2F[3ZK?_0LI[E>99ED2WFVR\I+(:Y;(
M\$L#O;N]P0@(N5-VNW%,U5'A?.,`SUUX4*OK@\!M";MQZ=V_'R+$8&3?&V2>
MT3J8SL$T[LR+7--V1V>QHFE?'<?&8:S=!.(>SE!CQ[G/(A&;1=!5]&U572#$
M>;:XC.D0`-*!22$0P:T\UD5;51ASD"RR(,DZP<2BFMCL>%`P`97][&&"NE^G
M+AJV'Z?,W^(L6'<"B,5NFV;'R2W7FF\SVX8D*KX]",R`ML?88V;T[2TU<Z[B
MC%J/MV6=C,E:O9,CMY%9YBJ):^CJXD4U$<42'O]O_0;!`>!A&AB9?:W:&>)W
M6OB-[8'G8;I<Q^DFH;?T>_:1Z?_#RADU_4%^*>WOT$4U]KKT5KG:KHXKDR8?
MH/'69-><?.4=B.CAM5/K8`7T;S,R8:XND0/U>@_`/5`U3J<=$>6[Y::-6'5\
M6.XP_L1'LV=U/FZE^'3QO`ZSLSAZ85^%<73#5[9JSX'L(`84WG1B'!*!V7J7
MP4ZKO2L;:(2J0U^YE%3T.R&[GD1T]9DU```$D@<8RC`&48N#$HEW3C%@D#08
M@>\=/&3>4/X1+<[E27DSDKPY0`P\)'10%Q@WI&[N4OK/#8VRV0O[G]0X)C2U
M;P9)=7L<QS?9@Q3V-&H`'JSL/=E]1?+O?!RP&=]YVRV!,&EYGZJ?Q,W&0I:;
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M(D6"P4WR/D8?<0^<(4;$%4T=$21&PCL,T0/%D.U0V`I%/@V!;YF^\_@I""-@
M&M]J;\CE*^V=)/0M>]QD]54U]JG]KG>;@/F7Y&O^M9\>)'GGQE1?!1-3OK_M
M9T[ZU<@:U9NFWT-@XM]L;?:DO+4K/ZK:XLR+"B6=?$CT57D0_])?_ZF]9XCW
M2(`!\!W>"^0Y4B0-ZS?A*@R2D*;&7%_>4.(MS89HCB*W`,]'6O)A[M'H-JE^
MYF%2IGB/4F_0OG.9(]0[R'W`@(\1X/\ZOS\3-T7F6P!AKJ#MI'(+12=<%]%:
MANPN*ET6KB,7L7.C5WZ39]YBNY7>3Z_20T+M81`H*;U-VEGC>3`(#NF%3T_"
M*GZXACC%<[I>Q]\"]K.;5W#`N[8\$M(5R2_A5F)Y)T@CQ$<!@B9%*^ZFVW9D
MV["8.B$>K@6Q0(_$>:VQUW9ALPB9(WN%7$<%,Z!B'`CS<IH,N3?Q>GT?)_Q*
MV6.!+*#DY@JTHQ;D;I-@%48/"[K<).(@WWRYXUF<JI:E`'HT8HZV!XK#`FS"
MB3!Z16:OU/6?%%^2W;<GQ;IXO@H^]>2(#LC[;[D@'#1-O]/T;+O;J$AS$A%,
M^GI!CO._^"%9!I-NOS],F!D)'@MHH]+YERBAR_@A"O^+KFZ#[Q]I1._#3%41
M-K1NT+BR-8IC&6S!H6^U$K,?J?I.JE\0]@TIO_+#D4PON>5$,%0TW4?1J^TZ
MH\#(V5E+.GV=,25.70K6(A</,L(,X0S]=QHDAP4I(R?W!17:P4PJ^>Y.9])I
M[`ZLTQJP/M*',(IXRGF8\#(=X]0;7F.>RZZP*3^P]S):)C1(Z3G-_VN7`.AE
MP-("E0R7[JBWVVD*H53=V5<5$M7IQDEQG#LI^Y`?RUX_>>W8!KA!W1V$6B`%
MR&6!B<$?\#L9E-I;@.P%/$':H7Q5HIR$$=DP%":96,+#?.,Y3D->=4O%-2;9
M(R5LP":FTEY]#W=.O:)KYN7$+\8=,:=T?C]+L_`IR)3WF,@;-0-AHQ&.LTLU
M(X6RIFR`E]:[3-C?/'?<?L)B4+P.EZ_D:_%?[V:_%*^R[4ZZ5][REEICB3NX
MAX8;HF^KL,4(I^H")73[`W%V9ES\G-#G(,EGG]CW]V'$1B:A."24->.W#/I2
M0^D$&C/)6L%F5)K\C;^\Z$&SO%32HD&0M18H+B#1B4.-=<%FS%?;3XH_O%H4
M*GL[+?BJ7V$3N966;=CJWO/@B-5N+Y"VD:,6=1N!5"\J<BVV"]1[[-#KU:8`
M^9M2(1BT^+_65HGBT1?YMU<.G--[R@8Q/+&>IBG-SA[9"Z:7T?0IWD2J:?NN
M8IK>8"T&QV$Z6H_D4_;:`6YG*U2V5.>$E)U$*4AT.Y$5@$Y(+L43;^X*QK;#
M]X-UBQ,LQ4EH8S\<Q,EPH9,1^)["AQS3U2HO_!P[X(V#D.$A/_)`YC%<K@W[
M?N2-6HEAO1%29BC3C)4:-F1#<L-:ETGYMV<[$13O2Y(>:MYK.S^L-I8EB-KW
M/QRD?P^2)#!LWY&V:0"ZT08%SU*].'!NBC:CN=YC4OSI&9;E;ZH%9=T+;2*Y
MUK8-9.?OW4FRT=9@"0">)AP.!(QQW@8$:.MFZE*M5LN\T.0NM@<";'U,LT\)
M!-\"6R<DF):]6"%AS"4NY4N91JN;\.$Q2^LW&AC.S[3L+0^&YMZ8?@*U%36`
M`I2"'<HH:_+[].9F>G6[\.X(3ENXJ)S0$F\*YS1)4;JM-6!'=.?Y)DNS(.(K
MZ:$^+.EB<MQ:%S?>*K'*D8O6-77PRZJ`7=1C'Y#\>U)IX*ECRC!@]D8U<HPN
M6.D*\+MA\>8RMU8K[`>\2N:=DA^CF$]^_S=/UBCBHPV:F2/@;=3*VN^4FT-7
M4Y:Y!P_T:L/SQ_G]XC%(:,7&CT$:+IGQY^%ZPUJKB+^7L&9(Z"@,QWE[/0E2
M&.EJ`\#/NXF>E/U(T9'D/?DZ(-&W%HA.B.@OPE0AP1.VZ`?3-H]@P+[%+YV$
M2IAG_]S(373L;HHK?Q(1=7;YRZ^WLW,R_6UV,_UE1JZ^?/XXNR'S"[+X=7HS
M6_!_G<T_?YY?D?P^QB\+UOKRBG]X_>7V\NH7\G&ZN#PCTZMS<G[YZ0L7]FF^
M6)!K)J;:\\WY9!#STOUV*4'UI7UB_V(?EA^Q_[D+4LH^^?\#4$L#!!0````(
M``A`@T:#RW0.;6$``*`A!P`5`!P`;W)M<"TR,#$U,#(R.%]P<F4N>&UL550)
M``//@!Y5SX`>575X"P`!!"4.```$.0$``.V]67?C.+8F^MYKW?^0-_NU(S,B
MLH;,LRIO+]F6HW3*8?G(BLQ3]R4734$R.BA"15(.JWY]`Z0H<<`,D"!HO>1@
M88_X]B;&C;_][]=M]-T+2%*(XE^___##^^^_`W&(5C#>_/K]/GT7I"&$WW^7
M9D&\"B(4@U^_/X#T^__]__T__^-O_^^[=]<)"#*P^N[I\-W__^X?WWV*T%,0
M_:_O'M`WD!1_GBUFC]]=!\D3BM^](U01C+_^!_G'4Y""[[#X.,W_]]?OG[-L
M]Q\__OCMV[<?7I^2Z`>4;'[\^/[]3S^6K;\_-B>_KK(30;7QGW\L?JPVA1S6
M,":FA6?6$:?Q?]]A1<XMFTI_^REO^N&77W[Y,?_UU#1=T1IBGA]^_._/=X_A
M,]@&Y\90W/A=1>\4_D>:__$.A4&6]Z/0D]\Q6Y#_>U<V>T?^].[#QW<_??@!
M&_$][K_OOBMZ,$$16(#U=^3?7Q:SFDR4!%NP^B%$VQ_)SS_>P#2,4+I/P+O'
MY?SZ'W^?W]U,%X_3__HR6_Z3&+3:1P"M?P^2)(BS29C!%Y@=;D`6P"C%%N8"
ML\,.@R^%VUT$RK\])V#]Z_<HV>ZPIA_^_/[CQY^)GO_34."/ENR\FCQ.;Z[G
MGQ^F]X^3Y6Q^;]$D-F]=[7.9:;!;Z:A7(;;AO;_/%\OE=/'Y9OHP?YPM'RTY
MCLG6R&<@V2?Z3CM2&VM@I("A_%4`H+;\@MA(?H9@K-\#1VHC#;ZM/FC+SVG-
MHC9,48H"@\@],3#6`ZX1"L`3V!G$1(N/:4[;F>2TG9V<-OMT/[N=74_NEY/K
MZ_F7^^7L_M/#_&YV/9L^+H.G"!BG-QD)IIXT<:2A]!"C(EQK*U"2&^KPI-5-
M%>(NOH^V/XS=:&D'Y2RN9OVJWZFFDE.#O%T0F\F/#,1'QM*3C8'XG-CPBY49
M?*4R4^E/^KC+:8V_UNL7PU%#P<`\KT=F>3VRH0-,@9D6.0,C/;:I?G?DM!;R
M]NUDMOAM<O=E:F?6U69GY*'UB[:#"*GI/"-%*Y@9S35*#A9Z:CGY[^GC_'YV
M?SW_//TMB/;Y^L\DBM`WLCBT0%&T1LFW(%G9Z4H->>;^AAF$T"`LZDS,]4F0
M,0".+$QU,5'"7+K^A[,@-N^)??9DV!$%![-\!`/]KT9!;"Q?WPM':F,-],%P
MI#;\:AI\-(UEZ]N>TQI)WP4@UI=_I#;6P$@!"_+U\7^DMK7B7]MHZ&H#P^8^
MQ6)Z-UE.;QXFB^5L^OANN9C</TZNR7Z"I35W&0%&_9_LLA0]?4L,]BVJ+$QU
MT0_&@MA4OHEX2W,H_37""@?C53H3+7+J3G*"G24P)ENS]8!G_8%,3FLFW4"X
MN6R#11#C\=,W_9TC4\GZZ>*;0K:HGC#XI1`?@PTY.'(7/`&)E1\:KRA):JS(
M685?R%F%#W_)M:Q+,%=U"9(4=*]O58P%I5$61#TH71%CKO0]R+I7^2RDJO`N
M`2D>$N?+&G?X#S4-P&N&!XOG5$&D='CN)5>K5"Q"84V7B)SU00G5';DKUD'Z
ME/MCG[[;!,$.N_G#GWX$49:6?R%!_:=W[S\<#_?\S^.?_YB0]9LEEC)YA:<O
M541\E9\(8[?)8$8<PFCSHRM['I^#!%P%.$]?H^T.Q&FQ:$5\O@%;W-OIU>'<
MYB$XD+_ERI\MB%</41#?X^Z]0=L`Q@RW="FJX=UN1-4[J1H-DZ3>84%RVKK`
M_]D*A?JALF.+'W=8GSA[%S[#\Z;3.D%;$;!0KRY^J)C]W7]\1U7MNPQ]UZU*
M*%F!Y-?O/[S7"AWZ5UNL:E737+OIO_8X)\WB-$OVN2WS[!DDR^<@GN\(;3K?
M9_GI4!AO?@=P\XQSZ^0%),$&3%]!0D;S#PD,P>0)<PC.NVW'R!F85D<$#$8K
M1SU?Q:@MHXP[ODNEM/N]&Z6<I>'!`/^<^(?2)[Q/Q$#<1CY*0W'7\?/U)_SY
MPOA=@R0YSL4X^"S`"1*(5M.X/G.[I,"NE/KCPR4)7I*@'E0N:5`R#7[03(./
M69!D'B7"3V0A`ZQF\4.N_G"2H89B_:1#)<4N*;&WE*@/F#>;%)5<=DR,'Y43
M8]9:(!]V2BSM3H>7%+54ZR<M*JIV28R])483T+S9U*CHM&-R_.FM)$=R>F%P
M:5%6J5X3HEBI2RKL.Q4J`N6M)T&QNX[I[\]]IS]+^\W'C?WY6G]C,#_/Q=ID
MMLV_N;-LC[_S[63[OD)RAR`8>\C6]*GN/S?T,-LX[NG,!<NX.QB#60:VK(,G
M]ABKGJ>08#QNN%MW?9\Q8D/YRJC<?4_;ZPRM<5(?IS!8^#`V76^LTY')KN9Z
MCA/]/3IZK.W1LP?)A=+;XD*I[>^!KGQ;GPUU^2/+.:Y[L-/LXL`X[9W&@:T9
ML2VOS!_O]]LGD%A=%M*0:V7E1TFNOSE`.UJ-EW'T.]9VBE#U@?F:C)+MGB^[
M=-HKU(3C0G2OXX^WG78<=N\0,D^_YKL]*'5)01*B6\?_+DEH7$E(=+[S[:0A
M]6/K8QT#E:M6/2[`M$1VGVXJ(B]IIJ?N''ERJ9BMOL1+K9(PIK1R/"O:7U)I
M".P^I9P$7A)*+UTY\G1R,MK5P6D[J>3WHM;%9\"9RU#;-`*VT6;X,692E@#)
M^48W`C14JX*]H9+V1/X%)$_(/4(?,Q1^?481MB(MHO`>9:SR!6I$S8^.@,@]
MJ.6L0ET>0.%#FZM@+2/;4ZQUONIO/[8ZZ`[_H;>R0LRGH"X5A"X5A"X5A)1'
MI&.K(*3Z(8YLGP4X#F;3=$^JQ%.2@J!5=9^=UJHK3:F1*FS'UM9YC(C\C.3-
MH]UB:',^[6#3.>Y3XJA\PA-$!*80);C9K]^_-QA'6H=OJ?4\!M1Y"[]1%0Z4
M1D/"0GO:(66:&`KG20.+82=(Z.9D4ZG]\AL2PZ'5B`:'2B./X,`R31L.%882
M</!T`>0\>)^OJQ_[!8C(4N\U2K,T_]0_53[UJ6#Z:8=I8WQHRO1R`>MR`<L6
M,MTM,9@9T/$21']#(SN1*34%EIJ\\J>=)I_WR39?C<'SJ05(,]+'V'\_YRM-
M,_R1BC/X`HAT]K=?CT-U8*#*P7F8LQ>NS3W"",SV@K26*-U0&L1@`J>/+8IS
MX[@[*LQVC:BBM!LPM&2MDP80AV$YZ/02)F/==.MDNTQUH^LG+R%16LE9H:<U
M87R%:<MP#O'`6OG56;.M\JR"P?UBJQT@',>Q#T&2'988WBD>M6(/<$=H4C0-
MJ`AH[(W?KI\A6$]?0;@GG_KY>@U#D.#A0/[WSV`%PR#"_[L$X7.,(K0Y')NP
MQW-V.%;'=Z8<G4>:'`)0%PYDQ"E7H]/HT%031\,`'M3U(:T/W9%"M'\H*D#N
M+\/`W./^*84K&"2'Z787H0/@;XM(-*_=HN4U]PQ2\J8;X8@KIKS.,%CP<#=1
M))KSP3.$C15;X)'<;C$%3T5,>1]XL.!)5:"3J@`G'0ULZ&9;!DW:G!,/!#(W
M,`$A;LS]1#$;52%":>09-$1F&D&"PEQB"_=/SH]VE'IS/T/,1C2`^/O)$9EI
M!2!J>_Q_'@Y`<"N)'$)I1@5)M9FO,&&::@<H5?8RIX.&@Y5;M.=,O=FM:$BI
MMO(4*$Q#K>"DRET&)LHC$]<+M*6AW-T;>J/6@9YZ(W_P)&6F+IQ8S+W>WVFN
M<7+1PV_<0!&KL7]HDC+;%%4L(5Z?.V!8S]E,E*"0VS`:R%:CC#U(;\=,#7'-
M?4F!)*O;E&.K<#WL@N[*'Z)1]YG<E:$^>HVI27^SEK%TJL31DS[CL*[&)75R
M>DS^^]YG!W*UTMW+=STAM%>&^_*VQE#"Q[KK/7U;XV./JWAVHO$WD&8PWG"F
M/I06C?BHM1@WT-G.Z!.Q-2V\V(>@&T_J0P511`P]FI2WHUZOU^,@+G'/YN`>
MR?:R*K\*O:0773UHPU9/=R.VPS<CGL2.>&HZXOCV3E'$=;X^_N_1UFD0/E<\
MP(R-O@2W0JI[P:.-Q)[[K*<`[MZJ<BX[LL`_FEL\L<S^"G8FJ8O0;DJZQ+)F
MK_@3O$TSRF@=R+4#;8\)'\\[&E[ZH9*R%(:T/2G2S[/?7$5&FPH<]^G`'IZT
M9Z77MYBOHR!-Y^OC+=QYLB"O:Y9V/H)PCV?M$*37V%RPNCH<VZ7'AJS5&4M<
MFQ?I3;F.++2[\78O3S@:JUP&W2]>1MUM`)/?@F@/)FFZWQ8Y9OJZ`V$&5K^A
M"+LVP@EI$62L:DGJ#!JQI,)@I&&C[<->(D1%NW(H^]?1!,,"IE]O$P!F,581
M?WP50X%'+A$(=/(W%`82_G,6!'3=RA#X>30A4`;[$B1;C:]`E4PA]Q=D;PCJ
M''\YS_.%3B6TQS?4N8$O<`7BE>9`AT:N`/4Z^1N$/,=_SJ%?UTW[GLD@0D![
M!5.X+C'9;)+\-3/\,4Q@G,(P]V?E+27>J23'*M'.,SE3::3A/Z!^[B6EN+57
M]V"+WUFJLD8*5J<U'-J1F3Y$V<HJ7%&7;*';+\/.`EP[RD&(G[?+]#='7G<P
MR1O?L(?IEKG;.NK<Y#[FN+7N_?Y"U8;JVG=_/(].T;@E?^(TG<7%N0?KX:LG
MWEI\JXJ_)`";_3?P#*%JF]>WQ[7=)/4D<S$6LIT]-$1W_\0X1?0E:]CJMV%G
M#"6[)&ZX**_8#^6UYDX/4H&5L]$(77QOHY&F^$M>L=E_P\XMRK9Y72DI]\%#
M`D/N@D&M`2T*CPW&'"<T'_2'Y*/T(]8\WE[3^MS7%O@F+P&,R)W66Y3D,P/K
MHUTY<=9&N")Q8XZJ[OMGV%\;H2VNGO]U'/+';VUE.%_?SK,=\[+R;`6]6-XE
MZHUZ:-AA+S:FC'L_AY7D]4D\8L'CY/P=P2\QS-+%XQ=N'4XIFE:91"[-\&.(
M6;7C7`4O7HE?^E/QG6YD:*A:KT;%5='K-=WCM3/NLW'4-O12./1GX1S`EU:O
MIEW.1J6.9X4CI21-R4FF=J#R@,AUK21&@.7!@X,L?&:^)67`06Z\0N<P%/BQ
MTYZ^0_CP;&<O)4F=P'<0B4[L!M9;(@8<E#$\I%=(+&!8\4D2`PRKO4_RT0*&
M__9CJV/P2/MK\1OUIUJG@=<L?_"\]$RKVU""!R.K'T*T+33(BSJDP6[UO;6"
M$'<H31]`<GPVF_AX\H2'.D%(+;8D;ETMK<!K[2X)G(K23>(,KF"45W@_7P:>
MOH;1'G?*+0X$@K1]T7GS]31(8HQ,8E%N2ZU.7C-/="*DF4HL"W&6;62AA7IR
M<",U"=2K)2G+:IWG%?9*P#PD:`>2[$`F.QF>])`MHQV9#GT",4B"B!?_JK35
M;"!/.X#<P%16+NKER)GQ+")W&ZG*(*#&K9*+:!$IJP8]/D7B*R-=9W"<A"':
MQWDY*13!$.</1FS*$S0@QR-P/OB4L`:ICDL8HTZVJ%/9'YZ(#JZ%#]O?FM\!
M?>_+"RR']WY>T3^O,UX'Z3,V=!:_X#_E*YB"X%<A92Y$\T@]`:B!/[3PJ2:O
MA*>?2\7YXO<SBK`-:7'4Z!YE(/_KXRZ"V37"-B<I=M^"./$#:Z"DR:8Y8%)F
MXQF$#?UD!&=UV5[?2S6<KUT=Z`PX;POT(+$YVNM2XL!ZKKWC*.5^RD:EC`^K
M9.YS3`_`0MJ.9"6E[I2N/<\F5-9HR640N>A.\%:0;?9VLTR%O:\=,-F2[VLW
MWJ_SMNOZDK?O&:R-4&&Z,O-_-SGMCG9HRY+ZC@ZLL*J2DU%E60$E7I5U6-D/
ML4L1U*I\\PD&BGCZL2EE#RC!LW[^24;6`+Z8[-5<+)D[#%2@;"1;*4IW%;?S
M+`"2DU;<<PV"ULT*V:S6SL-(I3>1JOF,,)*06:M)S9+E]]F:XHET.;1QVS:P
MQFCK*])D3+>#,X8DBZ=?AI3GKP[-M[]E\WR;4C;/5RF'BT>*?<CD\Z>*SK/\
MVO/,,G*'L`?+5%0TRY8GE,6;V<Q8]33(#<`H#F'>SY3*N7K$4N=!VL3#C2[J
M5-/(-ZKQ59LEJDKV>\RQ()<[.#F_]7MSV_/\NUL;^#>+VBUH=@QF9-3V.I(Q
MAH'[$[?:5FN5RQ"^$I^#5[C=;[G]2&W3Z,E&FV'T94-C)&<2KS\+@FJ/-CA5
M1JGN^A3&XCZEM6GV:;W-X/N48Y)BG]8Y#2%.6V<TR+_(]_$EB$#[I4)5,M&Q
MFA:9>S"H')+A':[A>X0%'`GIW",V+:GVU[5=W+OMYG"[O4T0A;,'K/NZ5DVT
MN$'"-XVUU'T!B?P^L6^(J-AQ?H-S0-TO>9!>9M&'N18F[#.^$E(K/U7AS+'"
M6#RM'1P6'-T&]$^^^YDUT[?HSHJ(UNRD[WN@-S`-(Y3N$_#N\>_SQ7(Y77R^
MF3[,'V?+QQN0!3!*[=T0/3NK/ORBW822)ZAMSO,);+Y^CI*,/'=6&6>RUG'E
M">JOB7,)W%[<DNL8I&$[[7X65UKE-6VNE'-YRO&M,@ZV^Q6SJEQO<_+H@!<$
MZ'_EH<&8H>(B`H^A;WBSY3LS@!IHT<5];4J&_!UFSU=!_#7E/%RL12OXE#%H
M'<-,ZCO%^:K)>(2**)Y@W@>.(=#K(F*E*5<@2$C]%K!#*23/7N2&,I*E'%$C
M(8J(/$&CE@^T8"@KZ?PY]A!_)!TW4W*\HOE&<(U6GU'SE*0&(^>3<`/KD<;T
MCS$_5]?BG&[YT@=P5OFRXV]KQ_^RX=]-5SK<\+_L]_?>I5WO]WLWNY>L\ZS/
MTLH,?SCX,I^U&Z\!**%76U_S50(KL<%8)[A%"8";F#'*9]^E4Z&KK@_(T7D*
MSW:^U/65512>DZZ".EX_\:0"9R4:N56%T<%8QT<=05A2%7O+8D[*]8)DGUBL
MUSO=[B)T`&`!-\]9^F6'X@7(8)*_<<"KW*E"5\WR<G065[O!"R#EG,%#0)ZQ
MV^?_74*"NL0M0U!;U^83N%T^5.HFI.$"V@JBC-#S`@M?V,`*"W"4G;[N`$E>
MU&H=FM2R.&M2CPQT7.=TBL"FY",<_S0,.-Z`-8Q)`7OR7-+3GGB`'#PJE;Z#
MP1.,8':@@5&5M@I%>5H/@:CI&&,8RLOUNC`>P\QKE&8+$*)-#/]]'A(U!N)*
MM(T!N22M7X`U<8P)8!7E>CUC/'T>B%4ILP0IO56SPFBSE9]PXQMK`U@M"?8V
MDYW-VBZ3-AOV+7$'7&%F7U4-;!'*6E@A]"M<M5UB/):1%&JQ7("3J%X%`-J+
MZAL4[G-OQJMIC'L"3T;6^(<"7IRH5J&KC>*EZ`R_NRD(?]B@EQ]7`!:?7/P?
MS2\M_M,?$ZS)BFAS&P6;AI7,WX_64'YW&ZA*/8+$!M+B448&B4<*[P$<S)*%
MQ?4^(9Z^A6D81/\$03*-5S?MPZDR32M@83?U#S>29IM"B"WFB*:_>("FTN`'
MD$"T8D.)VZZ"(T8[_T`D8[`I@A@R!C`WE(5/8>+O((K^$:-O\2,(4H1GO[,T
MW;?V#J7;5^`D:.\?K%0<8`HO@:PA5*92P]EO*-IC?R2'6QAA'9CX8K1KX:K5
MSE<\\0VV@Z.6C!(_+F]3J.'G^,5>@!U*R.,LC]@G>S:,^,U;:&(U]Q544N;;
MP19+U!%BOWB#L#PVKO%7?(.2YAZ3H%4+3XU6OL*(9ZP=]#0DE'G)A\E<8<##
M_BF"X6V$@N9J!K=-"S&U-K[BA6VH';34^)=8\6>LO0`;2,R*,_*,`!,N]&8M
MQ#2;^0H:KKEV<-,4X>C<@\'H!YN;!-$L7H'7?P#VUXG1KCW>:;;S%3Q\@RV-
M<)HR!G!B01$^Q;.\^>N$I&A7.M]G:1;$*SQ>8V-)@J@-+"Z1MRB3=X4ER'$%
MEE\^'_)7:?MYJ?46_X4V<1.TI"Q4MEKZAR\YHVTM5K:D')'D\C5H/2`5RZYR
M4**T98*IUM9W.+$-MPNHFIPCI/[J$:1(944.BJH_4X!3_.PO5BCFV8)'P=KS
M*RH9@K'.%17]X1KU23;6SZTAF//'U1[W3RE<P2"!@'\3C=VP>="0TM!9P#$[
M`BE8UHBP)L_:X4$*KRYNR"Z#5SS.C&<QAC_SE5R)EM5#.:R6SK`Y7:]!2$H=
M%RIA_4AU*7*Z-PYA5#S^,LEN`79O$.5+V5B10ZTQ`\P6.3?0;X6SV^^3`#&H
M2S?2/F9T?:I19T4/KVN6S7?8-+*C<X?2]#I(D@/^WG\+DA6K7IF8H`%L'H$O
M>)4V6@^&//8>'7R[`YL@*CYPE.J@G!:5T4VKA=,1`$M?)!RI43[]#6;UM:#F
M>W].RPT<T]NYQ+:@7IP$12,I<"G<6SY]#;8PSCOO`<1!5#R6L`-QRAH8J)"R
M?,$E=5Y]0::3D9%#&#46.(+K)11D!`X@G1K,N;!O0.L1@.9\B]JH.==J-/(-
M75PCS7#49#VD]V[H5B.5&1OK.8@:Z].E&!;+(;T"PW2*>,0A[0PJJR8RG"Q<
M?5M]L'>=YW<\]@SB+&6^:T%M4%T+:#2PMW!1,J:,+)F_TQ0;0E5XNA>1V!+:
M]*+&[!2X=29=K"25$KB+2,Q&M*YA+AT-LW\D,ZQ$)TDD5AL]15UQYK2@]1%]
MW=E5!S4G96)C>)U3SLJH7+H,H7E,+X;,;T3KGDJC8?10>_5<RBA>-YT7SUFL
MAE6`Z13[WY"XEUN-J!_7<R,O>IEEE$8O5U@YFLHQ>OD>?#OJR.YD5IMJ'[?;
M#+J+!28I]'";D]'#5XQN^@=<)2B>[XA"[(YBMZIV%:W5H#M+:)9"=]%X#:O2
M6*GX)_)/L"J.V/%R+[4A+?\V&@ZCS]O#T68:YMG'Z_F[UH,^#([#^NY>1T&:
MSM='7>=)7MB#O)U!PX"P<14'G,9#QX*LG6IXX'`=UE?Z--2/5T6=E^/",+.,
MFR(5=<6!0S5TN"A;KI='>.R'<`O:X$TF6F1,7T$2PA0\)#`$IQ_3XZ_,>FU&
MO!H;`)J\!HQ7FUZ21K&AT`%<4;(,[?L]&0K.U^='YJ^#*`*KJT/3?!60JW.5
M@;L*5U^!K^TY.R&@(GX`554,MF;)$/@I2$EAT2WYAAVQD9!W@LA6TM7AW.0A
M..2'K,D1G]L`)K\%T1Y,TG2_S:=3:5D_EXR@F,4[.Q?8W#+N4*`'T=6;OY4#
MKTO-!G#/PS`FK\2.N5)QS`U\@2N`QZOL0\*]R:5%:+=R?0G4'KVO%Z_=*CB`
M^G8#"]O?4(39D%KT?0<N77(?H=N4_%:#E]L#PPC?IHH#N+([D`!>P/3K;0(`
M[6'Z+L.7)[?+X*7+?6NA*^%]MX%+5W``Y=#TP[:U&,NN'Z)"T@@6/HD'.%>P
M61FB?-X#J$AC$5WW*`/2-TP4J4688U$[/\RL:F?KI(W\<7A)4>T3./QC\4;/
M]Y:)]C,(B`XD`_\.L^<O,7I*0?)"),_B'8Z)^A7-!5E=).]FXM0-T].K4]?/
M)+//XA-;VMY>7S*K.X/=R_06R#UWAZ78Z%[K81VMT;4WK1L\?0US2\][8S8C
M5%J8C="4$/;F8E*U`QP'HX2Z7H_`+">IO$H]:Q>W4UF-T5U'LGP,US[=;QZM
M'6OK]7ZRI21V<@IM_-N++$O!*I#U%H-5Q?WN@U6@K>Z.U:Y\F><2L(:R_F`=
M_+B$;#\AV^H`7X)6^6QW$;2/69!D[BL_IF&*4A3H%']DS([SBL[%S9@)J2Z&
M'58^+DHZ[1[%X/2_C-OLFBRJ,UEE%O:6!Q1$L^\D:S/1=,(P;C;K=CRRY#7:
MEH6B3J>)N(8N7:PJGV2R[_LQFE21U&KB#4X8EP'Y-AOBH'%9L"6KBWZNRN?<
MP66VJMW"I;3RO<.%EMOM<YJX+JI;/(;/8+6/P'RMH"NSP(TYM]KGQX";8[B9
M^T'CDR19\D9?.9UO4W<E="A*M(X>"(9$K?:"T<_=4&KL=`LPEEOZ0].=I9H^
M=E8G)E'._'A5NW4(BE_;4HVXL7H@2SRXKVL;0LC0)9+?USO:R2!9@5XO>I?!
M]@B2%Q@"NJDX"E]`BCV1G\U+ER@+HNKOURC-[E'V3Y`Q+W7W)J]9X[T[>7Z%
M3U^.-XFX#G7T>ANY,[^4#PPEQS^1=JS;CVZ4Z"N<&4I<8ERZBP89^`S%W^9E
MK:(CTLEJE?LAB,X[&*G@,'`O,FW=\9"3Z5=H]]D!)I'<L9Y^UY(W]$U9W"2=
MQ45>RU/@+,X2&*<PY&U?]RG:<AC+B7Y;T:S1'2Z#6DY=KROSF+JH<NMH@:+H
MMGB,J*-HY@NS'+\L86\K8J5<[C)&60IZ_=3:>0PQ7U?=L@`16=@C,X:T5:A%
M-!:VP[019:9,G1_MLN059'M3D'&BRTS=\RZ$@9J=;&\99H&\NNSI,_T[((?=
M\(3[!23!!M2*ZTV>T`OX'"1?09;_/W7SS+DVM:TYA]HX#\]^YH]H`*Z6B?Y.
MO7%.#@Z]4$Z4?_#SPRUT72KP'1Z_K`',2+_(.%!WH-V1&JI#<.MJO)U\-9"N
M=I6HW)D_[NF^R%W3UQU,B@/_+O.3IAJV\Y.R&I?\U'-7>Y^?E,WW^EB/!7<U
MEFS=9"<-)>SG)B4E+IFIUVX>05Y2,M[K<TP6UZB[2$=VI7>WC7))0)WMS8PI
M\]BRVOLZ`6\B[3!K"5P2C^^)1[9*P6A3C_(:-JO:P?"VV/K?1NM_JVR$VV&"
MXQS=[(.YV>NBF]K1)M?;V\A27[;J[(@G4Y+U$YT426\@)?374[VG@DY-4UZ)
M_:5(`#'8D+,\OJ<`RLY:1RF`(\ER"J!*NJ0`BSWE;0J@FJ:\63RN%'"<%I%S
M@\7SGMU>\VC+Z>9.1U7.)?BM]9*WH4\Q[&V^ABES`##_\09G-]9;&XZUL)PR
ME+6X))2>>MC;=*-L]MM\(K#='YV.09ARNMO7N(Q!K/>2MTF!8MAE`]15Z/>Q
MJ7D)_@[Z:83A[V83TE("()<3\T=:5C=[4EN^&/+DGD@K-Q=/I]&8*XS:C)H!
MK,'H+46HJ9_=!:"&YLJ'&CFK>\X>-(!KA`+P!';)Y5V#R[L&EW<-+N\:7-XU
MN+QK<'G78(CO&ERJRYA4E^ESXG*NKT(=N1;#RLD^>T8)J??Y!8_=D@K0'J(@
M3J\.M6.E"S+6I;U&T:_0YH2H8Z'.)T_V"@0YZ:?.Z@CU90WK.^EB'MU/QW7R
M&DH_-A@_FN+RNVC@D+8[[ABOL_0C3&K9V5S8&XK(7OO-6>QV;>7Y2*R/44YS
M'67YJ@=)]N*;+>D2W!WTF,^1S3:QLY*03Y924&7]O[PTN-DD^3(\MP[Y`#1I
MW6]SH(G[5-#M5Q<-J:>5ML!,75"_#^?`=$?EU/I(.I5CP8Z3CK(FG24=!4TN
M2:?'GAY!TE$PW?\#L=TYC5?9@/7&VA!4HDV)G*GT!G+7,!SM-HD-PP?^WS7J
MS74+0#9H\;#T&L7Y3L8^B)8@V7X<1&(3:N<TQW&TNZ0[QXAX(YF/XP[_G\;L
M;O+-^WY<@0V,B4NO`LRNIR&>)16[3(?&*EYRXA"P,8[$:.P3_XN"]^9*IT-$
M<^V<YL3+$'%0/G^+F5`\1!S3(\R:7BRN",[7;6_V<5I)++W+XTL\Z6\M2?7>
MHVZ34!_F>OWN;"=>:L_J^TPR;.E])!F:]$N2Z;A'QY5D:.:.\#4532]1+\_V
M(*G+Y.'\&FX?QR&[RA(R5WH[M*^S=-#I]>#V-"L&G*O"XN:U:\.\YCYC7`@^
MI.RP/CY=S8O)/.4<C6:E<7J+]HD*4-OM^4BMMG^C4&6Z;!!8K6HWK*.DE+/X
MWY`*5EO-^5"M-'^C2&4Y;!!`K2CG:!U2'J>XO=+GGT(@P&J5X*VBE>FT8>"U
MJIZ][4,W9:Z"W4ZCMI6=Z>XD#-$^SDA%,13!$`)1)0TQ06/RR2.PER>N$79\
MG*,O3K&<%:D3<`OC(`YA$#WB#BO>C<7HQ2&7=U^NSF&).^T*2_I*2R;VN%8S
MC@VNSM.2!`Y05UYDI""V2J=,8D,59V]G,:#_>T`*#69W,'B"$<P.A<(2Z%8B
MK`)8DM`GC.KX0A^&DM+*^>U`QF(X9D)`MJV)P0N8?KW&^L",_)=<+E6D;N1,
M:6J?<*?M%:,<*"VR1&#?LU8[@QL\'(7I?-WPB2`UZA$W!CVRQ)Y`U<@G6DA5
ME>CU$<+K('V>Q"ORK^F_]O`EB/(QB!1,E6@;*)6D]0RD.AXQPJBDP"-$?_$3
MHJ?QLG#FI$+2!"27Q#<<RMMO!C^N'*]OGDR#A!R63!]`DJ\DR0%/DJJ!/2&5
M9_!3\X(1`H6BRF'D>R]1>'JKZC,(2$U*LD*@,I)4IF\@4X'>,XSJ>L8(K0I"
M2]SZ.:R\10F`F_AZC]6.L5U)$*?8%^20%AZNY/\;Y2Z4'&H:\VOB6I^?;SBW
MY#DSW.LKX?6)OED<HBU8!J]R*!<U;X"8W=PSC$K:;01!M@ROJT3<!UE>JGJ^
M`\6J&NL,.;MA`U6TAI[A26BK$9)HW+V^W'`/OE4L3U",_S,\;D8IC#5UV33Q
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M>!]$-P!W9PB+`T4$2[F?N:?!-%G4*G^KLO`D\"WX1_]PF+)<BUM[KD[?7_)!
MSX-8N(GA&H9D#MG23[0<H$;<'*I*$GN2*8Q\8C8@E91H;TG627((PQ2%:W?Y
M8?5_]FF6+PPNT0*$*`YA!.Y!5NRCW*$4_YT<.WM(T`O$UET=\)@.3P>.J^+Q
MYOBZH41FZ5!4,R=U(LKR*RM8A2LP2],]6-VBY!$D+S`$Z8)@*#FCJ/4DBAQ9
MZ_T2$9G[?-0E/)"V!UDYK`-MZZ^"B+0L%YG>O^_[R!/_DE`Z?0V?R05**H29
MC2B7?ZJ-W@8\1=YQ`4:*3F?H^;E=5)UQX/^.P'&1:[)%20;_G?^=\1%3(6V^
MY2Y%.GJ@&WBR9_BK:7H,BO>]W]FT%1,)?`G("N^G`,;$9_/X_#?L3&9`2-*U
MHD%(]X9"0<V'SN)`J.;YRR!_GO67(@KB_*&RE>LX8!]A+(V^`FO<9AF\*I]A
M97*0/K5*X?!FHD3?KX[B14EAY=N%PPJ;<T9X#,C2[BQ^`4??,L)$@J(1%ER*
M-Q,&\GYS!'NN@N5=L1_D3^W4@;X<PF`)>RH!00IN0/'OBF^N@QW,@DBP%J;.
MH'TF7)K!FPD-;:\ZBA05?;V^VDN6L<A#//-U7I@+SYW*587*TM8\N8X"N&5]
M+[1X-*-&C<?;"1P#W[J*'365=:\7[5`*R>S&=03-LV>0+)^#>`FV.Y0$R6&V
MW04P(0XFO@1IY3/[0-8E4$R\OHE)3;Q97-Z?Q1TP>0E@1+;8\=@SQ5_H1Q#N
MD]S/C,CK578C8GN2_68BW45?.LH0/9EZ7O)07OA[`<D3<O]UIA_]5#K4JW1N
M]PV%FY2W',4'2[=A59%NCY'SPHEP=3QSG^9A7JRQ9!,<U1FY:KP`$9DL/@0)
ML?[X*VT_L@/VU9U,J^R=1XW&_`IU[F=&],CK>MKIM*JC\K$D6^MYTG%T/%65
M/@0'\FG#_YOLP<E6LR`RX\V/(%W>XPH?*Q[N,G9T%?3Z(JK0#=+K@0PZX3)@
MB\Y3V.MZQ@JD%83[?A:&XACRE;O'H\TB(LL*PNSU`1T6XN5L#HO105K:7QVC
MFZ>'N_.&70'].+J[.9IR_#3A+U/NAF*`)PUY%69"\,LQ&UT8:/BPXX"0TTAG
M"6A8V_<4R[&AQ3&W!X0]!3)8E+&;/T5P4R^V(XX->5[BT)#A-;[(4/9@UX$A
MHU!YID5ALW](7XQ[D-&6UXYO>2C<?-%GU*J9I,[(WA("%AL"L$IO,=0K#RRE
ME;VW\ADEZME_'?KJ4H`:O?,<8-#KR-QCC/A75^HTQ5=3IES_^N'GOXX]^HVC
MWCC:O4>[L<^LPEU'&X-MP`SASZYKN%>C^W2V(BE.\)$:7!FKRH\\8;MLFI!P
M)+!6]E$G<);1PO=9/M7&]37:;E&<?[144$RCDP%QG6[,&.9XJ#\(UY70K0<P
ME)->#`<59U4LS#HD&,F-0[B,+,XZ@L/Q#,0DQ$DJ`;?[>)7.X@5(=R#,<.K:
M[B)T`&`!-\]9^F5'3O&4TU'J-,0&P]J\Q(SA4/.##%!0!SY52QP<+<\S%S/M
ME,^.#FMM3]YQQHG$.(%X'PW&/K.*?AUM3$:`@YC('(/]%B75T4*^8"^/>4TN
MS=&A*I>1H-_,>YV$@+)*_F_JM#Y[=RC>X%G:5GPY4X64@7D^Z<B`KN"G3M'-
MUT/Y9._`\<RL%2^+:B$#$;8Y#,:*<%F?]8-SCC;.3N!VA/;'9Y1D2[WTS:,5
M89Q..U9X2WBJ'V33%5$^'3LP4%?W$(,(?"9O+,'L0-XV1E$$\NH8\W5NN^1(
MQ9PC9TE7F>-8PL*:5[L)%A/URE&0IX6ZFK9CFTOSY^O/0?(59.1DLO!6KS8?
M0;A(\!EID*AZL)?0D%#J%!!^GF"72@:I3$DB`TXZWY`FIY&&A;H7W7TSFFJ=
M%H$\?>*&X3+UXMWZC.3V`A0*;P\G,!0O@_=0`%TM<B0OBG>CM]?W_&K&LT.F
MW:8=#=4V(P$ZS_).$-H0J'L$9"#U..1]89RLC9/TF#"KY[.N`"VMC7+ET"'M
MUI++AMC0\Q@N7IV.@LTRL!6.2U3IFTB7I[=WI(F\)4=N$<_C:X0%)QG$,[)[
ME('CE7CR\D,,UC"$052T('=M;D'^(#GM2),5AM4C388,W><$95B@#ES)2@VR
MRIT.,!DJI5O\KIN*/MC\:Y;YY[Q6O(%2N5M2>PZ%,*`%@FW>U9BPQ]OC\.C(
MP=8BQ9Y^Y?S$SW/P.`MD"7S:%POAY2XIXR/*;]SX8K(:^PEJ)1?80*E(X&DQ
MUL];<S?@*3M_@8Y?*S)TQ1[8DR6$R99\R#XPD*A*WGI41);<;[1JNLDF?N55
ML/=`HZNZNY6G*(^^JKSE\%L0[?,[*'&*IVI)[MQ/\`7$+(S;8$FKDJO-TN]8
ML.A.F_%AII;7BZ./V(-%,8@U&4K=1NB;:!HO0]*L+<LE<3?PPKJ0+27\+W(6
M[26(R+KY`T@@6C7+:+"&8QHLFH,T)1;.$X!4]R,K'F+$.$^#VK!-2;)V*=TA
M+,W139UDUWC.=,"I+\]?2A!FT$IAMT4[$M#R?=()6ELBRT=YE*_,YK"?QLZ/
M%78.U3]8(Z\W#=:65WJ%J_I;'CE<L3))YAJPT_6ZN'AZ?%1W@1TTC^GV,W"K
MPZ(!7C46WF'8P$.&0%:3W$69-`^ZQ[@JFF$GZ<C7WFL=84?)%Y+HIJ.X\NU/
MH/WM*./C8X8=)7,,S.+JH`\=I7EJP;1_Y,4>N^6OYMWRMQ];O7*'_U#\1OVI
MUF/@-0/QZES>L-5G*`FV8/5#B+:%!OFN<Q@^I=^[&MP598'+=T+X"U_<MHWA
M&J.MLT%L31\9^V3L&D`T\_L$R1G'>M2)QKMVV+;.4_O9S\L*TO`GY=)`L[AT
M)`2@VB3<SUV]&Y!7>TME,ABW;6O_F=K6'Z#)&*L++`9OK[>Z;O;@5$5&YKDL
M9;HFP,1T'H%-T0G:P!/+L3?<=0!"VJU./OPD*!K`XU+X`SEYPW7!QI5@?_FH
M[Z,P"Q`"/";`YI%W<?DH$Q/0CK$P"/S!F+39NA#C"2@OK'J)L(?:<YOU5W;X
M4%.@;-W4EJ#T!WSJCM!%H92D<F?9T].L"X#MAB$>,)A,936Y-("JS,4?T)HY
M2!?`RE(=/8QM<[%.:C52:AER,.N/7%.X)@PF1,1KC"J09Z\J=G$@;<!.XZ^J
M:_JPQ=3KA;!*L9/R"WY^_E/P`J8T9>M-/PE*#T"F[@%ER$F)\'H![3B*/#XG
M>(U23G$F9DOZD+[>T@-`B2U4!A"590D83P?ES)*O>![,Q(Z8I%W!BT/B!9JD
M;=:`%8^WUZM<E3>OY7;PQ00-9/$(W(VEZ^_:XS[%?TGVN.=:VK(&W.H<FJ-R
M%0[.(U"BWY$-[S""DRV^-F95$>OU2+9A:3Y64@(LC8(/T#J%WX#D6&\3@'4Q
MOC\V>+,'I"">TK:O@*"]W\LD\`QPTK8;X8TGQ>N)DO1W6/IS.X*O:K<?3\XW
MTL]B:Q6#*LL(TL-;-@T;632:8=FO8K>*O<,*)D[?T>.):;0XI-JR&%%5E3&*
MP#K<HN1+'.*I<0#C9?#ZD+\IBV)YN"EP8(!0BH._T%1WD"W`2DDNYU"^KJT5
M"X7E8C,V,4M.+Z'>@#6,P:HH-9B1M9]4):-:Y=U<K;/#V[^PZ,*II@%C22>O
MER,J-F$_Y$^3/Z,(&Y22M=+L(#_JDB)G#T@$Y`X+%&ZW\+2U1:KAP7@#XI!=
MU5J"HE6JD$,QI%B7ZV.DXPMQ,'.%UTL6<H2.9=&?Z@W-*-6,3L^QJ>@5BP`5
M2]:NA#RD\R^6.D?K>(QAM_1P>L;?#A&NKW33)S2QGD]CE,=;RB,L^3&59WB4
M]H1%,/)D>GWHME*8X5AH(8C*90/YBIA"4G9E3`ZI<Y0J6=@ZW*E=(8,IJWW6
M<V2?*5V':TY&+76%O'2O]_<F8;C?[O-]RV*3'&VQ%<]D*>4%G!^WN@?8;\O@
ME7VF08=+^YR#&I<!0%OE&V?F)2:N93YURJ*[*`[7)ZQ7JSRR<8P'<#6+KX,=
MS,@C-=LMBG.7L9`L3=@$KP2A;WA5]8491"6D>;W:4[&$6X&&T8RRR%AOYAFZ
M!'8:8:G-V^M5_04@>W]@-0V2&,:;M)+-;_+GMUBC>7G"UJU/,:%G>%/VA1$"
M9:1Y/L>47*V67I\>Y(JTZ2J&34QUN[+<=\%$\KA@A-)]`MX]_GV^6"ZGB\\W
MTX?YXVSYZ*R&(KF+W;R/C6=_SRC)EB#95B_&\==1]!E1BLJI,G):>4].V27&
MRU7$'H<;<-)V8(63\[QC@!]DTXN,A*6N7K/6G[):Y0C.PIG](:6Z95Y+YY+P
M_$QXC^$S6.TC4%1`EL0TZ7%1_K/'N#G*LL!X)-G1NH\[298VM+0W^W535MM=
M>F2?/3HG=5%FU.$A?Z2,QF.(Q^O.>@K'?EI,=#PVJ)RF!1.YPWEBM[%2EXI2
MDH?VJ,KXGJ'28'5)4IXDJ3L4;\@'\V&?A,]!"LYZY]]-UJE+.:KFH4L1E?]Y
M1\TQMA.-4+KN]GSD^JVV?(7O,\B>R1.?9&@'P#U./3=H&\"8`5(YHN9[;`(B
M#1?D21$;]N?W'S_^G)M%_O+'-,;Y.KB"Z"Y;?0;;)Y`T[!"T.BK.;.4\F"3]
MCV0M940+7PP)#R9[B\LH@TK=^$,.\L>$E--WBU(ZA5<H[<4(6]QDDX#\"!/Y
MF18XBJ35:)(F=1YB*AV)C!S#.FHJ5N`4@=*"'9UL4,?@EM15^8R_S\_1X1:^
M@M4M:(Z83%A(8I+.8FS8E'!4MQBE*^!HWYJ!U04Z!%%V>`!)2!RQH:*1V:B*
M-THC+Q$E,M8"9B@BRJI*O9\85,YA5RC>IP6VU3(7A5`N7]4(O<24CE,ZS4TU
ML<[N#3&P1RJ>5D?G^;QV_BW&PI[A[APUY2DA&@QU>501J<[#2W`:NLH"3M4U
MT#ZX,X1I&-5<YLHBIVUK!9':UC=0JIAN!CZ!)*_?%[L!3]DUPN8D11%I\E\9
M>=@YS9(],?#Q&7=<.DO3/5A]8*!/CTGK?44U)K[BU<A9=H"LJL)IU/G1STQ*
M[#T;=QN$@#HPE6U.`2Z]N<\0E7"`/3#2A7G]WEG=K!E9),:?C$60@?R2Y(HY
ME=9GP,4EG\$XD*K@I"ZPRQ=?/I?F)9K)IR"(0S!?Y^?C)_'J]R!)`CS^N47)
M(TA>8`C2>7(=!9"Y.:#%H_F^C!H/7V%MXBH[R%;4H)QH^9FK18NSRKM=W/&"
MF,Q7V"HZQ`Y2Q4*]OI;XD*`U2-/\SNXM8!;08S5KOWS3:.8KU@0&V\%66XC7
M=2CR:=T5-GM%2A.`.#WV,\[KFWR;-+TZG-L\!(<\BKX%R6J^RZOA?LJ_`+,8
MCVL@6OT.X.89CW(F>/J(ASC35SS:@2EX2/"W@77BOG\-FD?S^]3`U^!RUTUV
MXK97_<O/BY\%$X2N8GDJ_\=O>+H#XTWA)M;R8!<B5*-:2<1HPU;?T3W%I9*"
M9>!Y>K=?UQ?4%/4I02EK;-BA)%MAR)/TYJ)1VNV.@Y*G9QF;O@^4/R&T(H?E
M[U$,MKL('0`H5S^6V.XT"(D/2/V;W&O%]N#T=0?(V_.D$\0?17LBF-%H0X3_
M86C=T;;CSX:"9>#YN1UMR1>_H0C_E;SK0M;BNXU`NJQN0K$IZXW')-?U@PK.
MIJ9EE/JY7F[HE`5,O]XF`%3WR[J)49XDNQ%*E_1&XU/"[8.(3KJ>Y1+OFXS-
M,F'=P!>X`O&J^^\G35(W7\^ZI#<:FQ)N'T1LTO4LOYM^GJ)0=<E_[?',&H\9
MYNM'$.Z3O$YZ<2C/4DB*!1A&(D_`6PE`:2>[B3N>>N4EM+?Q*3P6PX;_)BMA
M*?/Q#CM<#0.KQ?6M1!/?G6Y"J*53^9GR\[BTJOG%:?');I>@%["Z14EY>,Q2
M!`GY&\82A_];B2I9%[N)+XYVY95^/[]0;+]=X^'N!B7XJTR\5_Z^XM:E,>0F
M?4Q1P,W>#<^_!ZL@A1F[B`VU0?5N9J/!@,-9KHN0A.'*,<H5?;I]V1"I>ZA2
MO^(3\QIPG.ZC#`]BV3AAM:E?XVVV&0U:!.9W!)BVU/ZKA#$P,UF]P!0E;,!0
M&U31TF@P&JCP#.\()PV1ND5Z["<6W`2&0;3`5N..>)XGFR"&_\[-/PY23O6%
M.*E'FTLM.6EP&0TFC5W858+3T,O5>)6!\<]!BADWE5U^0VQ`2Y)4T2LD&0U4
MU9S3$2Z%2CBJ6*"&04P#E%'8)I+`895H[$AD.JA?+%;5<'3-6PF-MVC/&2W*
MTHBQ6*49.129[ND5B54M7!W*44*B*@I5$?A&T.<>>0W4#:30(R-*X(ORM[A-
M(Y'^*C0C!R#3/?VFOXH6^Y1T3GZF/X@(&B%*8';X]?OW[LY$*:'T$;ZJ@K1%
M(L9HA63D$&4YIU>$5I20`&CO)Q48`'T$(8I7=E:03'E5(:W/:S18M^3.CH)`
M7SN)Z/BS38@OGV%B">&&K*H`UV8U&GS;<69'\-963@+=?QET)]:?Z9$JFG/'
M>#-#N6]RV7(U<RHRRS&?=X_Z<.I9'Q@PG;Q"]3=-I+A)GZH0<!L7M%5<UR7<
M!7KT?\C!3@0L0)27'PR2[%`Y1Y5>':J_<$"OSJ"!<Q4&/D);VT'F:%81K7T-
MWS6"SP_RMI_A(EYA/<[%P;0-ELQWGG58^HA[BTXTCP0S9:R>1AI4[\E]7:4^
MU"HG1Y4[E*NGW`=<H-\8/N#<,[_LAIP/,OVDK@,(:WQ%&=]@%4#*2V5]=IOP
M4G[GT?IAM9N8/$&Y!2LRL7Y$T3ZWB/L"J"1)=75%2#(H1#$62-3LEL!08XU#
MR+^#UT$=>-K*2*`2S4JOZC)ZQ42G:JR+=+$3]VX>48\N;Z@K\AC`)&B^`TE`
MM+P#^?@H34&6\AY25R%E3FIXI,[SCQX0J%,9:1<QTHZ2*O0)#$^%\LSP>X=0
MK.N7WNXS;-)G&,/M?GNL"9C>[$7!J\FE`5!E+D/WVBS.#T3^$P0):_'"@).>
M]^J<G$>[+G*031<RPE]1MVH"T-+)T3/6?8?$-V0G(!I\M,/AQ.=M!0/=?2Y#
MX:21UX\Q2-I[O4\(',RBH,%$+P1.3-X0_NF.<P;^DSI>/VE#'>O>-0\[<)'.
M(N(BNTWD[H@"P*H`HA56KOHN10,(9-%[OB8S"LZHVHQ9\X"")K.!)04F0)!E
MOTGE@J8VM;T-32TZ6$7L-0"P37BRO""^BTBQOSAEK65PV[;@2VWK)3K%5EL`
M'U5(9<7!XQ5J=9^;K4\8]X:R^'(`[&<.:)@[BT.T+1Y.)9;.8IC!(+J!"0@S
M4E9-<B8HS88_"I9@XS_`57UE&^$2\LN+'7Y"_"%!V.+L\!`%<8;S+-E8VN5G
M6;!D[L:^`F7[C4<QI;N@7Z]A"*[V&-08!M3=:9FFS>"E-G4>H"J=B)0,9T2B
MA,!:.%(%54:6SF#R&WB&8012+D#HC1K0:#;R%11<8^W`H2FB,KP87@:].A`C
M..<]%2AE,VB5<K@XHMB'3#XLJN`ZRV^\I2N6RT2<TP,N$OO#S#&68*5*>)"%
M+9L]KFK+'(-?U>/9DG.E!+<^FFY.]R2;R_$>_X[WE#<AL;HWX`5$*(=793&P
M7/9;H@>0K'%7WZ)DGCWC*8[<(2!;`IA'A<P%.,]+%@\4679W=\>.S!4M\]X/
M>I?++1V7)^KRKK,U?V\>CC__[M8&[G2'TH)FQV`F.FVO(QEC6">N2VZU0_E5
M+N=-46>=^#EX)8NUW&ZDMFET9*/-,+JRH3&2,XG7G05!M4,;G,XG/-QU:;'^
MSN]26IMFE];;#+Y+.28I=FF=TP"BU."K)UQUL,J[=8?+"F\?_2Y<+[?*VY[?
MV6ON3BY'V<0FZM;YS(M7%FRHW^NSHKM16F-<ZKN"Z#]!LD^#"-"_/X)6U:M[
MM%8^`Y*^6"[G$/O0JJ^G,[5P=&R/]<#!,P3K1SQ=Q!/'-"OV@C@/&0A;UQXL
MX+0>*>RD'=0+_'C:#&!4;6!L:RG=WDB`M4IOE[6]"%Z@0Q!E!RPK)(#:-!<"
M^8VJ\4IIY'.8MCL227K#?G#>50_"L'08UI>AI>!Q6G[^PWS]"9N>I0L0`OC2
M>I#8D`L7F1)<W@AT5?WI!-L22GI]CV<2ALD>K`J[(4B/=S2*1RU#[NT=%=+&
METB.='1Q8."YCL&OIIG75SBKX<O9?60U:R"YW6RTJ!5XI">$MK5P]`2%K9G$
M"XCWX!;W8&$9<UK`:-<:X[?:C1:0(I_TA$B*&N>*Y1Y?0.G@0$!S!U7GU).I
M,JT-V&8]Q;$[OH,MGGX[S8X!K"7O2X>+5Y1\Z>^[UAG2GYP><$S#S-GYQO.A
M*G(/=TON2N:F'6L!YA>6'I\Q5I_(8=+RPI[@P*,=IHTQC"E3BP_AG`"=R[LB
M\JH:Y7]-)_OL&27PWV#U!4,B><Q0^'6>/_9`SMSBI#-]!4D(4_"0P!#DWQP\
MFP+;780.`.1X7V(\76'-OM)6HMQI47M\QX$6SC.S)7RCH?0D(W&;F7E^_L>!
M>?:'VD[.4#,<=O9-.@DS^`*S`S=?V&?,/#.MSWA$4=V9OSL+5)L:>[WR37/`
MT6&3;T&RJCK@MR#:%P!-T_VV^)MV')H+D8A)$R%O)#ZM]8.36#71WNOZ6Z+$
M51DK%*484#'$R#U%1AA6/Z2&TA2_KMK2WDA(V^\9Y]]A;3.\WA;I;"9A/'"V
M)EAU8&U!\!O,`M;[RWE"L&&1O0U\-\NH3^%E&76(RZ@]N[@Z$$Y%F=T25UTG
ML[B.,"?;]73G"==877O3*4>;4BE:OP3N*F]<4JKS\72U<N_5@;[*(%>KPQ)_
MQ=&Q`O\1)MRNO.]\K*N@^!`N9E_J>+1;.`^W2QT/:C=>ZG@T.%[J>`RQ2_NN
MX^'T])^MK[>-8[:&NO!/V;I,CD+#6';="6[NVF/<'/Q:8#QNE%MW?9_A84/Y
M`7RASB-^OAE/33-N`YB076M0V;$F;WF$>"Y!GHWYP(NW3@72XK`C@>[CTUX(
M-0.SCSYB!:RQ5:U([<@:O\]DZ+J9YYC?4(391#`[+(*LO(AM^]NKK8"M;[2&
M`F/.%2[ZL+_<T9-U?A_]Z,%1Q5S082ZI*^`@EY0*7'*)W3X<32XIK?.ZUH-5
M1RU@^O4V`6`68]M`FO4\*I$0WV4>X8J_9!&;_>=?#N':=LP@?[UD$*J;^AN+
M2(CO/8-<QB%=]-](,DAC#/*72P8I!VLW\`6N0+PB;NIS&D.3V\?LI2[WDBRL
M])A_68)NU#$]_'Q)#_2YG+MU#G<+')<D8:W7_$T33;-T[ZN_@.0)C2Q5T`9<
MKB8AKF8?ER1AJ<?\2Q%THW2+R=`2A)L75,,4A9&SFQS3((EAO$D?0%)V!0Q)
MW388[7$^%ES94*1N9`MI:F?Y6Z"AGE?TO#&`S*?:VTC7)8SD)"F_FH&$<KT^
MQ/$[@)MG8CG.9L$&W._)2=GC2;?Y/DNS(%YAZ^50:\:L`69=9CYCW(H#[4%?
M5QVO2T3-8OQU!8_8?_GX0O#Y$K1N8)K9VIFU9%25@&<\L((OH%#O'F3S]3)X
M95@L0=%^W)Q-X3Q<13V(=$QGQ"!#5C7FN#+*3XW\M^:7(K)BL"&W])8H"Z*A
ME!I7<+S>(%&_$Z3EE1WB9ZK[%,#X#J7I/)[%+W@^E!]AG[Z&T9ZD];R:\O(Y
MB)=@N\,3C^0PV^[PK"IOQ4@.%C@VW]HPX>@3QNVY3A_W1CJ4*_+OW^NF)^?Q
M`&(\T(EPH$]66QA#XJ`,IV&RM!BGS$=CY*B:N!91>85=)1<8X%,D9P0C3Q)_
MY%D14N`>QGL2=SN0Y,Y*K\`:)<=1`1X0`!R;V`/8:!B3:"2+9^3))E(:'T58
MOTVYTL4=O78JD3H"[DBB3R'3G^OUPZU3'<^?"_ECIK*CV=Z#%MM^S$%7.$6M
M(3_@F*VIP4)I[1_012:;@I3"_PPP/^]$X&G?.0`9>**V::"HT<8G[/#,TT=,
M@ZOR0;,!9J%C1B;Y58`83LL&;J@M?4*/V%1]#%%Y*U^;&"*2.),\8B5(*U/#
M!Y00URU`B#8QJ4LZB\NE$QQDDY<`1N3B.QXCI$$$'D&X3R!Y892%S3YE-]'>
MCVROXL=!=QA$9#_:GD<5?DXR<S=1%IF)BP0K_RJDM.@2DGH7'&K.,,2V4%BY
M&/W>^^\/PU0<KE&0IG`-PP(5J_^S+P*:S$\G\^O9+4H>@[Q4RRED#4!M19Y"
M)!C*&TOXV'1[-S%GJ*'79]=Y?CE].(_FGXT_>\@@'G78*X2?&ONQ1)N!4[L)
M+C6%E"^:-KYY0PZI+W$"@H@,3\\;<S<@@2_YID<Z26"*1ZPWV#OQY@'_':TT
M@\M<D&28F0@:0\!9<[3]T#-1[1B$OW@?A/<H1N7*#G_75]2<%A#4YM[!6FRT
M(3BI`KQ^\K5E5N$*66C56XN05;;V&EA4DRWBJN2O7#5K6"=6%M@AN$.>R=DT
M\`(BM",>X&<N*9IF=7<^C4]04S%?'W`"*9Z_'I/?.(+8$&>W:OZUA]F!C&)0
MC&V[05L\9F'=I>&U;=Z@H;=U%M^3U0J2?@NBAP"N9O%UL(-9$'$KPDO1-.P6
MT#B/;WX?(CWC61<E:+*JL2V0H7L&+7+\+<$6;X]/@'/QQ6S7/O;?;.</CD1&
MZF*'PM?K^V.4B:0(//SVXKLC7H))RF@#4+'XE\GHAS_Y.7-:@`P;"U;E[BS_
ME2)NX]:0EM[8'UA)F:N+*1;S$Z#D%WN&A*?3H)W[L!VU4;-01:.1>Y/N1&^5
M,!NR3+L;TELB]$Y!"O:Q*E;4.->J3U`X^CJ\.]G2"/V4\WB=%`T+/'0:GW`D
M8;4^I.C,=0>#^NC*)_08,W]^__'CSSEBR%_^R(>HLS3=@U5US3^_#IG>0:S\
M*C?Z)M@&&W`+FKG4C,G1N[I,A@.R=BI"EGPC0MY=M9R.KL0RV2F<*;+SM==!
MY><@^8I'+4^<DZ9F3*1126?B/2HE?&,9E72)99+\Q0=4YC_.BP)4DWCU>T!J
M5Y%;M2`A2ZC-6BKV&$JC5<S0>^0J^LPRBL72RSS[IV$C.B^H9OCQ%_*0P"V'
MA\=0E?6,-71R!):`?.\!(`V_^T(>LH`<W5=?UC-V`<G_YO_L`2`M?O*5^,D"
M==0??!V/V06P_.?^IZ&`.1^F5'1=HBM06'>+DNL@?<X-H^)6C;0&45E2+]"H
MY0<-X,G**1/F7[S!6-%"#V1U6C64E;3C@!G5$UW@K!14`NVO?0/-UA&;\E(!
M-I%QM./H@\)\YK$;33ZMHSC*?`8.7%L>4@*Q@=#RZ_QQO("FEU6O#EP6`$\+
M4YCA07CR`D-0C&^.%Z9)"X,PL"A=(WBL2!]1R-GOC<X"U8JJ97C_>>3AW7JS
M/C\$?X?B#;9C.XM#S`*^@(<HZ"':.U%&-_@M*S.V7-!E7W6;&BQK7F:*WJ=0
MEP)BYG#7J!W&1R&];-B'WE?(+W5@!H(P>R5@^,!3J_[2^U$-B^^<I957)5A'
MTECM:.^(U=MY`BN1A5H8HC`M`:.^"+W+/Y73V/GU1VW0_/%A_+!IV6@9..K+
M(P5NL+PD<XX<WGF-TS+G<6C(/AZKPZ1U7E:-B2]P-/&-'E(5)99U7SW]7DIN
M0+(VG8WYR,&8Q\=O)$M[R":8>4+W*=GRVA5S8X)IB!*8'7[]_OVY2M+XL%[;
MDM+`.)5>`=L-^A%@FN<1ZUAN""O'I+V?@^P1J'J#"CX/'<".94@AY9GN@-L:
M4'BZKR!]@EES1"'!2&5D/,HQA;R/[(^0#485?I8NX'KC'GS+?]*:^K6(58!=
M(1X#F%F^L`_@BJ2RJM>H@%F,_:D[X)\2]@Z/(3>5:1Z/F]]85O26_2D?3_3I
M20+_KJ3SOD>VD"[-3FGX,5ZLJ_JK@Z$(3[;$@*3W>Z%]KDFKKW-P&&BM18]A
MI4/LDP[7H.MK'>.:+^:?*\W1,YU6800RFK$SUQ/61Q?MD?-/'H^<GU&$;4B+
M^BH\`%(;TM#6:.@3M'@VZN.HP;7,9+H[PD,X2:"/'/99@C%AQ])I`@YZ_#Y.
M<+1ZOFZ;V*Q&S2JR)4/+*K;%IQT.ZJ1LI-7BHI7B$T&0)XQ:D^LHQ&H1+I?>
MYA8PJWA9ID2VR-DT654G,V18\;63(NC;=.6L_OEM`)-\Z'9U./WGWR%(,$:>
M#W>DX#RGJI\:<2/CR!([2\4GK3Z#(-TG.3;3MJK<DO%:/%B.DN/A/&DHH@+9
M\18CJ\@I4TTOBDJ<TXY[H$[2%&3DJO4=#)Y@E!<\.5JQFI,W:O<)F;#A!O<H
M3LK_O0I2F/*JV%KGSP*X.?_A@-^:KVCQH9)O18%AJB@U=@0*CB1H6C.?#@*G
M/;NR'SP5&6\D@#KH$"=Q9L>.\U/D[QU&I$3U-9FFC?@8:"VU;I"(E%S4(6*I
M:S;<>FP_>WK]\>2M6;S;9VG^D?O`?5Q"@H*5XVD4PX&RTJB=EI6%#A$A5D8#
M:AZE2:YE10^120LWP0JB#(E$?F6M%YI4_:+)>411\^RH5-MJ52]V6^>!)=4;
M2,UF1@3Q1)TJ>;%%.'IY2@$J\V\QEO4,=P\@(<4;@@VU"*$BJ0A(5%+_<27V
MB&V842666\SV4#?@SNAZ,4:SQSI0Z_3=_>AR-L*KE8"MB((TA6L8%E`YE96Y
MQ7T[F5_/R'6.(`+S]=EK!K4PK,A3**!A*,^[F.K+]X8QUJ&:NH^BOX#D";D?
MZCXD*`1@E1);"R,G+P&,B$N/9I^-YA[*T&?4""\=1M[%C;&W#`-"1[[NJVN#
MF-)5SMY]8""8UH1]\+&U`N\!ZC@6&N*ISODT#OG)Y3ADF02D6$H3R-<H94WB
M)2@:@.!2>(</>?L-X<(55-X<,\\S?9])N8%I&"$R8']W.YDM?IO<?9G>D$=<
MH]3],96S<J*U+!D2UCHKE<0P!:0@_&&#7GZ$\0M(,V+Z3\?_)D;_5#&Z^.L?
ML_Q?9`@WBS$J\'\O@@PL@G@#\J.*#;L5J8ZF2U,Y3P-2_8ET_2!:6:8():E`
M6IC$92.70Q*;X)S&S459)1II8.8T(X)EVP>=@3(7)0%)"TMK3DY4KE\N7ZJA
M&+_$77B%97Y5L+Y%(V%^A<:;I*#C`\VD("G*WDZ.D\#/$$S1"F;N#E072W++
MX/7L7T'X2U`TX,^E<!;\-T>\8+V*38!9G"_0D,7)%)`=^$F\NB%;[&A'ODH,
M=^BR:?A(G8WSK"$#!&3-48P\PE&BFD;4A0]@E&L1V_=`&K^5IB*,YDV]QV';
M8,M8RP5H+["@+(@&AZ?Y#B38/?&&;.9<!TER6*/D6Y"L6$<@-3B(T,?CX#TH
MI=UC&:L\N8Z.S70$83*J+!`11>A;$(>L^R0*E"+(TBB]AZK0'98A2I.GO`#P
M2P'-&&R"#*R&LH"]G/SW]'%^/[N_GG^>MNU<H"@ZAJ/K%>[+O.&22,:<2/RM
MZ-$I/IDU/]XJ0F7+@W2`4:\+A[3M:II^_4R6_F?Q9(OVS-47738-]*JS\0W*
MAHXR0[6Z<.VG=H:TL`LS"*'#8AEO=XQV"S!\@NBDW/255-,$5R`&:YA=HQC/
M</=XDGN<[:*8>25:FU%S"TB#D6\YQMA99EE&1[R]8T\N4(X2`#>Q!91K,VJB
M7(.1=R@W=98ARC7$ZQZ7'P3*SY<&R+EIFH%78(V=<O((2*>OV&W8:!@'R2&_
MUWV/\*]QAJW"^FW*`R;<KV"G$JE?T8XD^A9@_;G?+!([U=-P0?,>.)_A:;CG
MF-OLA66#H7G4G1B^@:"B.Z_WF#FIH;PCSUGC]R,>;O!_I!D,[05$DZ-Y1)PY
MOH&08+BO]Y@XZZ&\)SO$H&@-8T7+$_36K*6)9FL_@2HRVP8(*3+*UX+-SZVX
M6XA+T.6(I2>?O,O4[3)U&\?43?F8U$"*$UP^R9Y\DO_JY5'2DU4+@*,GA!',
MW5-N`.J?7K#'F`5:`\;>XMN6,RV%@H$Z]LMON8\:_`G"(^)]F,&G"!S3A%IX
M\#C(Q0&=PT@`+^&>3I!-E^OU;B7#4L97;I(=MW/).RM[K-+A3!]DBB`WDR$7
M!KHR1A(H5ES<22CI:N;U!3"&+_`?BLG.!N`_,NN5*U++!4B;>B30%[BE$U"W
M96JOTPT8KLVS#B0P;^`:6X<="DD5"!7XRG*3@[.8VTC@K>BV3N`NUL'>$1=7
MR]27]>DA6"XJ_R%#(K9]2,4_=+.$V`&64@%5D/8=B.$$?':)^/XKDH;/>%I-
M2J].\=<#3Z]?0.VCTAQEX=FW*"/88-FL>&K$TK>,8M&!9AG'3!&OUQ?/IA<6
M-[:_RO,FDWAU'(HIAH815V9T:'+U-T!LN-%6C&CJXO6RRMGZUI9#_0D)Q?#0
MXL8,"T5N_H:#B=MLA8&B#E[74#E;_86\A8(V,?QW;OEQ334E!2INBP(5BA&@
MRY`9!.H,_8T#0^?9"@5U-;S>T'K<;[=!<IBOV[O-0MPKD#81+D7J'9;5'6*(
M6BF!9;;VL"S^^?3K/GNZ''[MWW)&-F18+6C=L)C9VK>XES/;+-29,G1G[(,I
M]6,%8LR2/F,'F>72/2*8*0_Y!U2MAV';0ZXA]D\"@A3<@.+?:O#C\Y"#)(O'
M2(`JY:).P,N2;&\1Q\U["S``#D=$Q46!2;S*7T@L>D@X*)(A:HV+^$0.]UUI
MBHFW7J6HI)PPK*F25-\B74\P,P-/;'TG5B#.]\U8D@]<3I'>?$+(M3F>SSQ_
MJ.Y1C,IRU`)WJ#.@O2\LR<##C*'M'^/DH2+9Z[VABA_T(:Q"3T.P'+VO`-;P
MCAW\R@EVM+>3?\(P*/_\_N/'GW-(DK_\,7T-\^M1\_7O09($<6M=0-#JZ$!F
M*^<@TLAI2-9J!FSD11((,45YO0EX@^>$+P$Y'$/N3\_C\_\S$IN8H%5+FDW@
M*>J4?6$%@#)2O?[F'L^87.^QVG%X6.+X2K'M9&:`#2W.IBR#5P8P%:GIM2[%
MU)Y#5L]+5O$KK8+79_"P%^!Q6'+TT#7:;F&:8COY=WL5*!L@EJ+T',#JWK$*
M7BGQ7A^$R/W2-I,WSV&WILUJ:*T]!Z6<%ZP"D2G2XBD'I^/13P&,E<:C+`+F
M>+1-,`P8*DV,J<-1@2MX0)013A^-MH6.=#1*#-4?C5*II4>C#6J_`:OG))OH
ME=;`ZT\ZL:68*SX&Y&CG(PCW27Z@F?V2K!1-`[8"&K_!JN(0FQ`5R/5Z]:E<
MN"U\<AS"5!W"QJ<**6/CC$_J-UHUW&,3M'+BO9[@5_PBW@,2[_+X#CBVL39Q
M59/B>94(<D[!Y:WQ-W].X7S7I9Q,G[!WO`YYN$;;'8IQQ\O??=+@Q;SVI,3+
M>?Y0WP>VX37C/6%-);P>>'%L+@NK6<&^!#-Y\'.9C0O]\G[K$OY<+3P_-;QU
M]]KZYR#Y"C)R>?(\EQ-\>&5(&H'$)W$XY7O!L-SBWDQ)J=\G@M"SJM-_[6%V
MJ"@<KZY!DN$I\#()5F10F-_*5JGPU*VXUEBG*W'.\YL4!%'OGF?D/YZV]8EJ
M5UK:&Q\XRH_NYB9O.D'2U!)E.2D:"?-]SC<J/C!,&@)1GD?^+L`,G<7^0T*&
MG]GA(0IBDHQ)"MZ1_"Q(`-)TC3"0H'.6"IBZB?*!/*&L-X:4&>2[&AFXA)$C
MA,*KB4)&Z`BRQ259##E9R$^6=%C(>FB8DQJ[J41[MF(GJ8RRM"[)+^YN<UX2
M#&W-F/U9(V-BX2JQ'#ES75A$[F=2T72/C80B+_H\5AG>9VZ))=^@;0!9+\XK
M4$J/BBN4SCQ"%N?W.%N?M/H,MD\@87A!T+IA.;/U<(.,TIM(U7S5J#K+K,85
M4Y;7YU[N2-&89Q2M9MM=@EY`OG;*A9P$10-V7`I?H2?O!COPX\H;0":?K]<P
M!')9B]NV>:B*WM97V,B8;@<P#$E>G^)GNN#J0)PP>86L`GL*E++#A2KE<.%(
ML4]J'8TUBE(%YUF^W%):1>X`LAI33SP?!OE+XZIX:Q'*PJU"Z,P=DS#<;_=1
MD('5#<`H#XOG-O!_1R`'>[R:;%&2P7_G?V?:PG":;?8-U]IC/]QP;\,+=>Y?
MU91PTK&:$>SIYO47KFH[(TIH35JW(JM-/$4KQTXKB*OSU[T2]@*2)^0>-TS3
M/R4H5?Y(U8AD/U!'(D_1IN0+*_@32;1_)-E!9R@OA,IT"7/,SN@7626D>J<J
MG#5"'8NC68/5/OQ<D7W^HKO9NCIOQ;U[7,ZO__'W^=W-=/$X_:\OL^4_;T`6
MP,C=^>,%J6#&F?FV?F_D\\KOSKY>N0[<)2-*"YH=@UD>:GL=R1C#"*P3MVKD
MU+A4-H8=GG5\A=O]EMN/U#:MLXRU-L/HRX;&2,XD7G\6!/63B#5.9=ISVJ<P
M%O<IK4VS3^MM!M^G'),4^[3.:0AQN@#Y-/LAP)_=:KTVP9*6+%DS+PO)[-55
MS4?.>$01`K!*;W&'S])T3]Z-FJ])82\4/V;M\U(:E-7ZJ[*4[B$OVW_(Q">L
MZ!`(/]5DE17J:->5`;Q;B`>427H+FN=E&+]6`53]U3^0,&TS!4*5L;W:`#8Z
M.T<@@258W>P3&&^*IU@>G[%WTSN()S"K8NTRV`8;P,"$-I,J=#28^(<P4T^9
M`E%#?CER4\Y.QJN)#,B6]:VGKR`)87J>^U8AR6Q4A1RED7^0$EEJ"AD*_W+@
M]_-0('$=!6EZJGP^3Q9P\YPM0;*E04/8N`H13F/_H")KN2ED.')*Z`QDK'.^
M)?>P3\+G(`6330+R`TGW>S++(:\-MY\ZU**M?>RD:?U#F:9?C#]MTF*/&/S+
MX"%X^LM#`D.`/]7$`$4H<GE(0I+!8U30E/%3AQ!EB#]"5?E#VS]4RQ@KAI*:
M6.4RD04K@\FXT"KCJ2[ARI!O\4Y7[X`]#E>,,=O@HPW;$Y^1(Y?NKU[!>U*A
MQ&_?!ZZ8^$U>\.?@I/DUBE.XRFM@H;C0?KZC'*_2(ZXC59K81WCJ><8<D])R
M7;V5P``BCI$0*SS_%F/VSW!W=5@^PZ0PF88]F?95N/';^X<P!?M-0<475>)H
M(,O-9>:=Q2DV?T\L"J*BTA5*J+-L.8HJED04_J%)R0>F>!()*Q$UD.ES92.M
MR*"3??:,$O+`?/%(P@1GVE5^7`N1"FEP#3%S0.P+4;)#">UX<@><:XN*ECC[
MA^1.?&J\7&E)J7*G9"#?;)D1<+FX;SA?9[!1G?JTV/@'<'-O]3'Q:6E0)G67
M]].HNP;S?99F04PJ6C*.\LB2->L'",F\`I^F-PS`)B^QS(M]CT$[A&6Y&9JO
MUI[CZ?AK^D$%J[*\9``LYC4>5"OZK2NHB]4H\:\\8A[(?2RJV:<UM-/GYCJ(
M(CQB.C0]H!(+ZEQEHD*%ZWCB0]N7746*BD+'F/FKEY^,<^GN1Q2M[E'V3Y"5
M@['551"1(Z#%3(,1&^H,F-7>Q0R\1+RVARR`6T6VUV^Q/`2'?-J`0[8\-TAL
MNT8I,ZO+D#0OX7))O$2G@A<LX)$OK42@<BH=R.BC>G[^^)THAUR<N^!"DO9-
M<`Z)GR"4]X(-$'*E5:Y_>0]"F7LXRG0<.([A#HZN/RP#DW__QL\GE*OVY?84
M6\C,X_'*=!QH,NB\AZ:,/RQ#DR&R3)S*!U(&DCCS<7"^-,*`8;M!L[QRI8&7
MP&)::`%!5=ZZM:*&@A3>U:3\`4`6@J0)F\B2(/03<:H>L8%$"9GE5.27,4)4
MY=NKST@%PF/Z.AM[K&N("[[?R@M``X$\PS_IU:'Z"Z]DCS(#N9H+5`:#<!.W
MU#^[(<=L>B'_X40NKS.1@NUJ,4J16BLI1)%F5(57_9@-M=*,&I'D$9KAU*)A
M]['$$1FE&C4M23)'8!P_=,#`T&3U`E.4L/%";5#%1J.!#SC@V:3>YPUNCO9=
M&/U[$P=7$&W!"H9!](BB_%1M>I>MV#TN25+%@)#$!U2HV:V.$R'_85VY/,)Z
M^0T)DT.K#24_5-KX``:!9=I9HL+0485M]<$$%P(J=))#"L^@HN$!JP.+-J3^
M9!,8=R!_U;V\A\%&`K=AM>L9#7WH:QD;U3N7P?5<K\M>;^;K8;-X!5_@:A]$
M[-[D-JSV)J.A#[TI8Z-Z;S*XGFM_]).T,2&]&+`&I6SBKE+Z```M+]A-WE4Q
M9?K^P<]#6S<P`2'K$\%OU'QYH]%HX%B2LDT)-BR.Y\.I#I^\!7&00/0E3G<@
MA&L(5MQU1V'[UJ.VS/;V*_GA3GF!:)]&AV)U?18_)/`%=\A#%(2<9QS-F-`J
M`2HP<1X-XBYME@C4=1'SB02&`JW:@0J"O3XP>WXT0F[-6NY5:@U>S">JE7@-
M`.(F/FB^4J#SR(J"W-9[!K5W53Z.RIUJY=,[\[)0C4JYR=%[7[REVG,_4!4:
MP$.8C]@#^4>G_(!QMJ^Y;5N',:AMQP,\&6=TA3&&[/,^GGLW<[V#U,?B+%?2
MY-1<Q>8_B.A#X5?R^#<>L)$'LK+#/<K`Y"G-$HP$WH$I(1'M<!2'R)D+"F7*
MP^@/(,F/$$VV:,]\3E:&I&$^GV0`X2+5I4C+!\S0X<FLQA!?5KE'^/Z]U7-=
M7O2"C7F)<?=H*G'LM_<_G!*@P^?W%M.[R7)Z\S!9+&?3QW?+Q>3^<7*]G,WO
M'YV_PR<YOO?O5:7/*,Z>H\/QRN07\BP+J<*XCS(8;\Z%<F@+38JDU>4E:5+G
M^4"YX)&>5TR+'$E+'=@YKSC>!Y$.^-0H:R<_)"G]@YZ63TR1)RO4T9U"5I7$
M()G$J^L@?;Y"\9Z*,$:36MW"9A/_,,.WTKB28)/[L`Z3"?J?V_->]WE7O=WL
M9^6+3=WT\Q)L257*Y#"+PP201R6*=(6G,?F'D];]LC155(AI_`.+HA],,206
M-[`G%<HB3K2OWC3&,NGOL2F0T6HY<\G\`YFZ-VQ5=>9*'-:A^>EQ;OV00)3\
MGL`,_^\]RHKG<2"BPDR6IHHQ,8U_`%/T@RFZQ.(<O;EE9SGD%B4`;N+K/58[
M#@_3U_"9[.\NL'-RMT2YXUA%/Q6I&XLCTM1>@=3,-Q;N\DH+=O1<KQW@SM=K
M'(-)>HVV.X#]06QBH)37M`%)>E,O\2=AM06PT:5X7>*287ZQ09+.UY6_J2T6
M\SC(K1O3.7@)3WT?64"MDO!*`?GQH/E2Y>!2Y>!2Y2`?X?\C3@[L,]CM7ZL3
MK.JO@^I<QG%IIC7J=TZJK%@'08U6=)\A6'\N+C-/XM42A,\QBM#F<!QRL+M,
MC;*V%BQ)Z4-7:WE!'0:R8L[G2GPME'I]?!`)_">"<?8;=M,^H5^`4Z!HUOCG
M40P<=>I6:]U8XK(_H<SI<S^7>VI]W5-SV<O35Q#N,_@">!\DN<;-XXV,QI[T
MOI2M6BA@<=8]"C.0+\OC_BF%*Q@DA[)Z\T/>%5Q$R1$USPT+B#Q!F)+M6D@3
M2:@=DQW$K+4ZL1(<.9<EDYS(#^#8^>5V8C_K!(Y.3XO4L7=^>@B[36_V+N-;
MN$CJYU7&ON\2Y&M"R2Y+T=.W9+>ZW!;0ORW0J2.FKV37#^3//%0Q]3O,GJLD
M:GY2Y2KG1GFNSI.0Q0TU35]VM\DFKY#GL[K+SMMEY^VR\W;9>>MCY^VR#CJ@
M_G:^#NKQ)MME1>NRHG59T;JL:%U6M+QQ_F5%2V5%*QO:6I9/GU96E6HJD([/
MU:<Y;):XPZZB]FO&VO2UBM5*],X3@LJGT-0_!I\_#=$CK[#*1;(I&^5QGM>X
MMN2M7D9W#)1;>-?%U4?P\@UT/;UDJ78NXB7*,QH<)-U#Y>!E=M'WD87$HB3<
MWI?324X)PQ219VEWSC++J73I?-VN]2<L`:I`RZK,RZ>U-]B^A:0R5'H+0/$Z
M,&U`S6I3'32WVS@/<;5^0'+&BDK=\F2=AL%M&=X'[%,ZB&#%GL53"1A$#RB%
M.=:D8U5(R@Y5#JG#^RWDF&L.1OS-F">YNJO?@FA_*A++\(D"9>N^BP3ED/*"
MN,^1B5_$R8*I0/V.C(1@KR?+%0N+C%B\OB(&**TU&Y3UUF,`(L=^^^"K"W-4
ML+0CP$WVV3-*X+_E0=>F$`&O2C$>\#']T!4`JP(=/8K;$0CG^RS-@I@\[BF+
M0@J)"(8UDO'@D.V)KH!8DVBOC*[#2N^/R_GU/_X^O[N9+AZG__5EMOQGOEKI
MKK[[Y0V.RHHR7<7RZ;IYLH";YRR5WU'0Y,?<6E#F-X#DH_^HA)GW+#XLH:R(
MQ4*M3E8;TF=P24A#>Q=)?JM!F5[*,</<9M!(,)K>,4\H\H(]7ZU,'::/_5,*
M_K7'!DU?\#]$.Y6BYI1Z`/3F3HLA5%42)@=1>X')@PI^4>\A=;M98<X0U2R"
MP!#A?4"[NU/ZUB.:>U*=TY1OZ%#.F1N$L,IS<NK1VSH5KA:XD>O3<75K[@0W
ML$7-^6"Z8]VX=@\H]@NV<A;+`:K]1BV3N^XRUL``M<3R>(\E\UL+<M.IM:]H
M8MAK!TQGYKH[1/I88KVE&"1?05:^D?H81"`]/2HR7V/-8+S)MU-IIU^4B6OO
M*<H3#PU,[92###TBAZ^[UJ,="O+V*?'\CD@((H([B!(\D_WU^_>#>Y^(9Q79
M:H!IBJUX`$E(?+91QB:/ARQ$Z3S&@50)_W0!6+I8"=Q^[!NWG7V8N74AA.W%
M'V=ZE0AW-@L+/S+;\FT=S`5Z<9^QQR(JU^B9<CC#D79I!5M!-`Q'LVJ,R,:1
MO*N;=44X$JQ,2YTL)7USMI!4;MA-XE6Q8U=??A>L*RE2-Q*+-+6]X4]+I'@#
M29FN.LR1HW,>X:K]B/3=PHA\20U.@QTYR;[O.7]S=\MMK(G!TI.'`4SRR=\=
M#)Y@!#,(TL\@(-JMYO$"A/N$S`^O@A2F7V*$/UG)"UG!F,6[?89_1G&(J7*H
MB/:FNA35?$RQ$U$^9K<>G6^>$+M5MH]=NN,OY!]/00KP7_XO4$L#!!0````(
M``A`@T8>S\W>^!0``''T```1`!P`;W)M<"TR,#$U,#(R."YX<V155`D``\^`
M'E7/@!Y5=7@+``$$)0X```0Y`0``[5U?<]LXDG^_JOL./+]<MFH5V\DDDZ22
MV9)E.=%&EG22G,S<RQ1$0A(J%*$!2-O:3W\-D)1`$@0I^4^@6[[8(M``T?T#
M&HU&`_SXC_N5[]QBQ@D-/IV<OSP[<7#@4H\$BT\G$6\A[A)RXO`0!1[R:8`_
MG6PP/_G';__Y'Q__J]7J,(Q"[#FSC?._K:_.9Y_.D/]W9T3O,(N3>^/>Q.D@
M-J-!JR5*W7/O`W>7>(4<>'?`/]S[)/CQZ609ANL/IZ=W=W<O[UZ_I&QQ>O[^
M_?M3F7N2DG)/1_CJ[.S\]/?K_D16NR,FU<0M$@C>7)R6*C3F?L;\M.#K4Y$]
M0WQ++G*]<%M`)7YS&F>FI`S/2RM^>PJY*6%`@R!:Z6F]D)V&FS4^!:(64&%&
MW&VYZD*Y`G@AT"MMU?M31GTH%9.I+!.#B/(2O?<-Q+_W%7@I6ZTSM)2A%?9>
MNG0%U.=OSEZ]>I?2DN`6\YS@.79?+NCM:9PGBKQNG9VW7I^GA3Q,]"4@0Y#_
MDB6'_K]`:->D.>(SV?0D(U,$A2$CLRC$5\#&)9ZCR(?F1<%?$?+)G`CY81^O
M<!!F")3L$+$%#@?`,E\C%U=*`D:3X\CQA(*`ABB$,2S3TM3UF@1SFB1!HNB\
M'](>/,9S1PZN#Z)K?#KA9+7V!6@R;2E[JP"DE;[OSS7#+T$P*8GH&P9D9=>!
M(APXEDWK[UZ<5H&86ZBE,/BA$KK&+"28*\/O]-'8<I&_+UM0Q(U\J[GR\'Q?
MKJ`("8C-3/EHMB]34`3[3\N/J&<*'#CBQ\VX5S9P97LD0Q[",*D2+^%//FXK
M3:O=P?$;3%E.R[FD;B3TA_H3IF6G&X0DA)D6QCI;R4[Y\31?0[[RB&-O&/PF
M?^<':5(Z(3&5S(V#^@6S74U?+DE-I?M@H;ONC"M"EX]FH;\"24]`+CB1>F<X
MN.P.)MU+\6LR[/<NVU-XN&CWVX-.UYE\Z7:GDT;V);)?YX2_KI#^ZT.D[[P8
MM<?=P?1+=]KKM/M_:]#0HL&IZV?@D`EF/'ZIA\=D"O^N`8*),[R"K.O1N/L%
MZ'K?NDY_.&G&1RDB1$PN64Q$DAF5-P>A\J4]^-R=.+T!9`P[7[\,^Y?=\>2_
MG>[_W/2F?S00&2!::S"J4F5OGP`DT'2(075+'!(09*/I2D&;YQ&;5\#UZT%P
MM2=?G*O^\'NCX71(<*0.'/%DPN`\-G@)=WW*(X8%(+W/@]X53.J#J=/N=(8W
M@VEO\-D9`1R=7K<1NK;[JSV_0N"O\@*'J?NZ-Y7]NQ&N1KCS6T6Z\&`6[^N\
M>*_:O;'SK=V_Z3;2U4AWI:[55N:5VKFT33/2O6Z/OW:G[8L^+`RZ'7CCM-$1
M)8IYJ5J=XLDLZC<%Q2R,$Z<Q(6N(>J8J9/%D%O5;O:@OVK$I<CT"HZ0][0T'
MC;0UTF;K4)&V>#)+^]>\M,?=OK3S1NVQT!Z0,AVW0>(=(?)&F6A[>$:75*F2
M=X7^?7,Q`?T!)H?3_09_&QGK[`Z"5"G+1Z.<S\\*MD=OT!YT>NT^+"Y!CW2=
M]N#2Z?XN]$DS2VJ%'E+582^>S"(O+%^F[=]!A0P'B<0;(6>%O)-5:_)E.)Y.
MN^/KR^YH..E-)['@C11F,`K6H:S`$34X:14-()I>OT8X4+J]?#2+NF`=CL;#
M47<\_2-6,6`;CL2*\N_.H-MH=YW([Q1YWU4(NV`??F^/P4)I.K-6LIA%3!&N
M?#3+MV`1=J]'_>$?75#DX][G+].)<S,"C3[N3GMCZ0ALY*[W_.5<?V;?WZN]
M?7_.BQ'UB;MI?."&674GPIT$4P%.T<S'O#C/UBAC0O+U`4C&U39([F$?E:%7
M0F=&K.`&UMA*#4HU4%*V[&*76!E,981FG/1NN,(>80.4T4&4\Q"9742O]W41
M->(WV@6N*GWQ9!;^>VV/+SI#&ZE7>8_"G/NH0O)[^H\:^5<XDL*L)ZE*^E6N
MI$;>52Z,,.?#J)+X/DZ,1OI&;X8J^KLJN9?Z,QHAF[?*P\Q>N5G,[\[."OI<
MNUO>"+W"J^%EO1J>4>R_G.T?T^2\N,0A(GX#@3ZZB2,5`OEHAD#C6E*BG)P7
M$\QNB8N=]H)A&?S'_]9@8,;`ST#@5R-@BC-S7O0QXKB1>I74V2(C=O%8)?="
M`%I&[F.0&V+NTOG,4-/M:TRY7F;*K1+_+T7%4S+G-F(_P+66"*V&;RVE-,/U
M1C-5ZZ+<&K@.@DL<O?<B']/Y=\2$OFF[(;DEX:8^CI555`%<]'-K_:?I>QPZ
M=Y(W.>FK&B59&W[II5.==$:D2ZG-H+XM&[4Z'V&#G-$UR^G\-F-=;Y.J,-`/
M+!T$ZMBZ0H0YWY`?@?'->;1:B_H:,Z0&3IP6<)))53@5[,%:.$U"ZOYPAA*>
M1A'N`1.94XKP#*]9'BTUIPJT8B1;*6C1:H781F"F7`S@P*\$/>X,HU#>ZT."
M17R/P#UF+N'"Z2-N[DD>L3-B8DT\1L$"-TC7F?*27<%D4["E;@F6S7LUBIC[
MQJ_%R:]J<[)!TKPYS.GLCF6\?$IB%1J%:;`*#57+7B!?W*#$G3L2+ITQ]N4E
M6R,D;R)IQF#5&82,AL556+W3F(VY<PB-Q"OWE+W<GG*%U,_/BE*OV%5N(#!O
M*P=>=E\YJ()`LR%1V%H>B#4O6'G-S%\-`*<>"7,@)&E50!1FBP(0ZO1PB>>8
MB?L5>P$T`CM3=-],"[4`@G<2P@L8I<E5,!763$:85'3$@Q]Y@!D)G'")T\SM
M-1,-?G7P8U0SPN+$*NP*2R<C=F/LTL`E/HF733DT&ZQJ8!6%LP)4,JT*J4+X
MC1&IFX`!5HN`_`L&%Z#C7.``ZFL&5+VUJI3M<!!+5CC@9.O;OD_OQ!)D3'U_
M3MD=8E[9TG7_&JHZ0"$.J-`!MJ]QMN]QE!<UT!]TD*#4*5]&:`92MXNF.TS0
M0&6*H//.U1`Z>#(+7;,)LHNB:R1=<3Y0G;#B9[.T-5ZWJC."#0J5\;I>+EZW
M"@6-!\<8L=L`4#DWB-NIY.5497-"@<#L9-,<!=Q=@/5O@<C'T_R=[$E*]NYV
M>7,[6:TI"YU`>Q5\V0<)XH\J]*DK*S,4$4^MM%Q+)+7.7[5>G[^\%ROCTQK-
MT'_FH&8#T@+BS6_JO[/DDPDU7RJIQ1O?MLY>M5[]>N![]9]?J-,&M>0@+BB:
M\UZ(_OSM@YMS6%,>JQV:;T74:8C/6*;4HS1$_0#%?D,B+7?0D"C]M$7]-OB'
MCT7#ER]*WE]6+/G=VE5Q8%/RG]2HTXZTC/C1VA6NWP+C%SI,+=`6/,5^R-,4
M4WN2#WO(!GTZZ04N$V',ESC^WPM&#*\1\;KW:QQPS(?A$K-.Q,3UO6W.<<C;
M@9?L\B6;?$GNSA#Z\U%KC3^X(+_D\F%%`YA]V:87XI68KT!0T8R')(R$F#XS
M&JU34@(D)TY`?%\$"7PZ"5D$Y`BH&7+#3R=SY,M/XTCB6;R)^>D$VNN)0V]Q
M\AI4#O6FL@%>Q"06>PFS[;HT"D(^0AO1"GB$5FRE<)`D#ZWR6<7HX=G!4@3&
MI)-Y2MON7Q%A^"H*/-X+QC!^L!L.Y]W5VJ<;C,=DL0SYS9I"5@ATJZSH'EC/
M\72[#@T\`;X'/SCUB2?@OR(!5$V0O_/:RS$8UQ;?03+%]^&%3]T?BM0>H[)8
M=/&GH3Z$:?IC"V]/*5TC]@-`A'HGV(T8$8-C0M4C(7^6DZB=@2\1V/(6<C.\
M"S#C2[(>8>:*M<8"5S"G+9&@!]"MX]2G9#6V8T(#IU^0AS@)K_%JAI4[D?[,
MI6?ZG$=7B`2/T.[X^2"$^C183#%;C2+F+D%S=^AJ14)!L#VQ);(5CFJ74'MC
MVI*?W!^%MHA\`64!J&*6=5C!>SAH-.IB[/$K1E<]SB.AF8=S`0(-9"BIPE/=
M`D<SZ8*&]T`57&%59:B)1\/)3KNEXV@[>@I=LP:M=7W5H"56PC"\ID&X]#=7
MY![F[0R<>Y>TQ`2JGB/&=(/\<*.=]S1YELUP;>]61`84>F<NW;J>6)#L-;HG
MJVBU2QC.XR.:8^QB<JO&W15AJ5'8,MPN"/TG9A%'D%H`3Y=I'8*=)<'SB4L@
MA7!8$<V)BXOSMX'(3HZZ]Z#712!@W%@&BV*9?@T:QD4^/$ZQNPRH3Q>;A$3/
M]0,JLDXRY=K_@@81CZ>`6K-%AMZ2.:).U_!)(%!+CX\/V0(%Y%^R6'*90KFE
M<$AAZ[K`->(A9OGF3N]H@=U*RF/A;0D_ZG*GTAX)?U<T*JJN:E+[N(M-S\1E
M=R.6'<FRD02+W0TG*I-U2SR'@MK3W@.Q(W\/7NL6L$075TO@:\`VA6ZK)EK7
M00^S'X[13DCC58=S92-ADY[RDM=LZ?S&^Q6STD/<0=+`0WPI+1P5S'S.T7A#
M]-P<'Q]3++911>N2#;%$&\)R4<X$"GO5I$?#=?<>3.]`+(63^SQ4&'691\-9
M&WY[V)/;E5QL*GFOSL[>2:\IP":6FK=X!.\I.D7V+&B??H5W$H\`,.G^XS`H
MFJA&JB/@2;>H,%+9QY/8YKM`<B=T)3;7XVT68=OXOJ#[!OT/##!)IX[+?0M:
MM[?8%WL;PL:4&QFB1>VDWHQ[H)PHPU'(@->?#*70#LE-$J`X4G59[*!F.ONZ
MJ&)S"3F[H`W%Y"ZMK1+;3$-W`%Q>^&&Y$4[8:(9[3\=@BH#0]C)(8Q>4J[-!
MZY%;:7M>48;)`K0$K-P!HPN,!`Z7>$TYT?34>N3V==@E97(/NR<#]^2RM4\"
MV86R*M1(9YU^*3;W.PF7%RCXP5.(QF"JF#DL*6+9IH<I:$HS3=0CMPU0H3>$
M>WL8="C@PT(";QC0$"=KVRF-#VZ*D*B8@D.%5QB%H&H4[A]8S]%8\Y?4C22B
M@=<%"SS<*-<X:3I%/7+;.L4N&J)@\A6SK#/J]$[AFKYC:R<4-02GQ'I+KP93
M-Y_W*W8TPU!VOEE^Y=$6#"TDW<5F1Y)X1=KB#'+"_B`2,`_GR6.R3NDB=ZFL
M7O(KG:=_GW5CZ;'X3A@>R;<7EI!/\`)5D@2LC`5F-HB2BWE01-!A#PS;1/GP
ML7#TL,RXK45]/,-5.JTD(Y<1V^(4,]DG?T4B^!JJN$0KM,#96*X#RMHWC$P\
MZ,*5Z_*O+WM<_.\QFSVPGF.1B[QQ][!A82AJR9[I`\5RV&@Q%/W_(9:'#Z*:
MU1R1N`I.>(T?M)S&NA7`#HQX-\S3^`.5O*,Q#DQ]]2B4.+[%3(@!S%.PYB/Y
M.W509D+PC71'@Y>)#W$X4_C<"S&6^Q2R1,54>P@OQ;43\OQ@R,A,MDALR*;\
M]`F:$9^$&]4A5+O(T4C!Y/C4[5W4I+=R\R+51_E]IUSZ$>PSW1.NVT^2R8<U
MWR/P'N'5?8;F7\KY6,-`FF'M[*T+@=#D6=M^7;B#)L^Z]@_P7=+,0O.+6=:U
M_BOQ&`UBP[P83JK)M(Z#M(_H-D$U>;9MB:1-E`>UL%?8%RG)M\Y8[?B(\VT<
MW9#)23AW.MM`H_)CR7GL0BA$<D'(>'O_K"EN0D-\-(:X^#I3[-C`2$1^I%OK
M-P&=<<QN13MZP3J2!PN5>Y/'POLAAM0%XH1O3<Z.7#GV@FVUZK;?D[_*$G/W
M"<7.L\(P1KP^X3N.IGLG3=YVFOCRE?+[7&K26[FN@/6@"'B)Z<:$_^C('BI^
M&2^PJ5W(2J[EK>W#(+[#76<8E!'89AUT11P3NB"T'WH%\TR7:9UYUJ$<K-]P
M23TE$$US:<Y87`D:9.;4_8L^:Z!7G:">0,"SBH\P3:@OW\YU6%926@=L<K6"
M;ME6S+*N]89K2[1Q][7(K>.RCY'XW%\\?#378Y3D6\>'O.NP%WCDEG@1\@M\
ME.1;QX>A&Z7Q)C=!WKE?MXAU2T)#T[<I\F.3H,H%#_6X+BF:4?URE6PQ]RER
M\6I^/_9+RAX5^@4>$A/[4!%LBV?<"-@E*^3_=#%DXT#%L7/BX;A<S$#L8,OP
M7KO,\\)>O6>36&5;*^UB,UT2%I]D5J-'C63/:L95\V2:_+678]0M8-W\E`XL
M$3N:O!H&4&(=J+-2%:':+>V(DDS]%".&;PF-N+^)(U7$O<KD%H7BQ*L;JY?2
M;8@]REH'K7*G8JQ!VA&LK)CP3%[@.658G@J6791VQ#&+.:Q$0BP@=BD3I\%S
M2NJQ*K1-@]69>+8=XJ"9NU#:NKD[C8J1)I;\$KAN=]%(9=T`*+96>_./F>P(
MN-(M7XU4Q\"3=IJMH+..+R4&LNV&L%8-=\&![<`;T`!O'[-1%'N7M#?08@]6
M"K$8!Y2UKA.4AXS:'RBJ"K@8[*#)M(X#_:F@O/TB[P=3.IL(I..:V2X*A3$A
M/&AI9/,")GOQ;9N>B,*#H>3F]SM_5@/LV)RK87T]IGR2%-'TGP/0'@TX&H"V
M%V'LH8W+;]/8OY+#IK;G"('4\**]F<%(9ML.I/XJGN(YRHN2<Y3Q!=2P4I:O
M;<_H;7)<1HZ2RCM_'N]%UBVR'I?A[UB$'6&O+<+AMYHGUD7/)O7]&F&?RWZG
MEK1BJ34+7&R*\X"BQFK<_OA\+[<R>./@+CE(8U6[?T7R1@QHC;PD@ROS<.R$
M>8P1L-?KK/-R'<IU@5FY]SI=HD087#%*3>K@,1!XO+8\KRKZF?`D<<1U-/:S
M0+17>^R;,9Y,+BGGM>;69T%JSQ;]^V$EFFP+2M5M.6J5]ZCJ7W.]E@V-L7(E
MJ![>SUPB(R[#U/I2ZI1X5N?'P\[^5[*DO\RV5A'KEJA@XHKVQ1O[XDL)0?H=
M4_@=^R[$]STK&<RZB1^IRB/J-.6;PMH]R)KT]GG7MTO8^',;EWC-L)L<V$%A
MK4\?U"QIY<IUQ"B4"#=B*2YO9H0Y82WR/^,`-+VOF6CJ%[%M.BAM>1Z[.MP6
MRU@6`U;R02!R6_?32"JI=0,WC4S1?1-'GC+)G,NH16U?!%CW/I3?/0`SB[+O
MH%_A<4##.(@8*LI$%E219@)-[3BO^G1KBN0.1#7H+[E9LOK2_B=_OWT=3:\`
M)N2^IJI0**W3%)<$]'1(F2X>3)-G;?MU45*:/'O;KXV(TN9:RX/6]M5E6L=!
MO(V5?K!\@GQ8JZ2C=SB?8V&=Y1?#>Y2Q9&53QRHJYTE^[)2+:++=2<V:XM`7
MM<PBG(CS\=Z#OHAZ>!76C0AY?.-!PCBX!NMDD=@S2=?.A7+J,NV-ULRVMA"0
MJ<^V#I"T@3JC19-G;?MU1HLF[V>V_^.I:#YWEWB%X/'_`%!+`0(>`Q0````(
M``A`@T87RE4^-5T``,>6`P`1`!@```````$```"D@0````!O<FUP+3(P,34P
M,C(X+GAM;%54!0`#SX`>575X"P`!!"4.```$.0$``%!+`0(>`Q0````(``A`
M@T8TIQ62F@\``$7<```5`!@```````$```"D@8!=``!O<FUP+3(P,34P,C(X
M7V-A;"YX;6Q55`4``\^`'E5U>`L``00E#@``!#D!``!02P$"'@,4````"``(
M0(-&38](N&([``#..@0`%0`8```````!````I(%I;0``;W)M<"TR,#$U,#(R
M.%]D968N>&UL550%``//@!Y5=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`
M"$"#1E*]&HJ#YP``A=X/`!4`&````````0```*2!&JD``&]R;7`M,C`Q-3`R
M,CA?;&%B+GAM;%54!0`#SX`>575X"P`!!"4.```$.0$``%!+`0(>`Q0````(
M``A`@T:#RW0.;6$``*`A!P`5`!@```````$```"D@>R0`0!O<FUP+3(P,34P
M,C(X7W!R92YX;6Q55`4``\^`'E5U>`L``00E#@``!#D!``!02P$"'@,4````
M"``(0(-&'L_-WO@4``!Q]```$0`8```````!````I(&H\@$`;W)M<"TR,#$U
M,#(R."YX<V155`4``\^`'E5U>`L``00E#@``!#D!``!02P4&``````8`!@`:
)`@``ZP<"````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div>
<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE <font>3</font> - FAIR VALUE:</font></div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into <font>three</font> broad levels, which are described as follows:</font></div>
<div>&#160;</div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 43pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 63pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Level <font>1</font>:</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level <font>1</font> inputs.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div>&#160;</div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 43pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 63pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Level <font>2</font>:</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Observable prices that are based on inputs other than quoted prices included within Level <font>1</font> that are observable for the asset or liability, either directly or indirectly.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div>&#160;</div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 43pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 63pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Level <font>3</font>:</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Unobservable inputs are used when little or <font>no</font> market data is available. The fair value hierarchy gives the lowest priority to Level <font>3</font> inputs.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">As of February 28, 2015, the assets or liabilities measured at fair value were comprised of available for sale securities (Level <font>1</font>). See also note <font>4</font>.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">As of February 28, 2015, the carrying amount of cash and cash equivalents, short term deposits, other current assets, accounts payables and accrued expenses approximates their fair values due to the short-term maturities of these instruments<font style="display: inline;">.</font></font></div>

<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"><font style="display: inline;">The f<font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;">air value of long-term deposits also approximates their carrying value, since they bear interest at rates close to the prevailing market rates. The long-term bank deposits bear an annual interest rate of <font>0.93</font>%-<font>1.00</font>% and will mature during the third quarter of fiscal year 2016. The amounts funded in respect of employee rights are stated at cash surrender value which approximates its fair value.</font></font></font></div>
<div style="text-indent: 0pt; display: block;">&#160;</div>
<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><br/></div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13433-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13504-108611<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>23
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V
M83%C,CDY-38B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A<R!A(%=E8B!!<F-H:79E(&9I;&4N("!)
M9B!Y;W4@87)E('-E96EN9R!T:&ES(&UE<W-A9V4L('EO=7(@8G)O=W-E<B!O
M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C
M,#`V83%C,CDY-38-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C=E
M9#<P9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V+U=O<FMB;V]K+FAT
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].1$5.4T5$7T-/
M3E-/3$E$051%1%]"04Q!3D-%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].1$5.4T5$7T-/3E-/3$E$051%1%]"04Q!3D-%,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970P,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-/3D1%3E-%
M1%]#3TY33TQ)1$%4141?4U1!5$5-13PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P-"YH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5-
M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,#4N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#3TY$
M14Y3141?0T].4T],241!5$5$7U-4051%344R/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^4TE'3DE&24-!3E1?04-#3U5.5$E.1U]0
M3TQ)0TE%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#`W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M0T]-34E4345.5%,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,#@N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y&04E27U9!3%5%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`Y+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^34%22T5404),15]314-54DE42453/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$P
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1/0TM?2$],1$524U]%455)5%D\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,3$N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y35$]#2U]"
M05-%1%]#3TU014Y3051)3TX\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713
M;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3(N:'1M;"(O/@T*("`@
M/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@
M("`@/'@Z3F%M93Y214Q!5$5$7U!!4E1)15-?5%)!3E-!0U1)3TY3/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#$S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U5"4T51545.5%]%
M5D5.5#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970Q-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-)
M1TY)1DE#04Y47T%#0T]53E1)3D=?4$],24-)13$\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,34N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#3TU-251-14Y44U]397)V:6-E7T%G
M<F5E;65N=',\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T,38N:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y#3TU-251-14Y44U],96%S97-?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX
M.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-RYH
M=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@("`\>#I.86UE/D-/34U)5$U%3E137U)E<V5A<F-H7T=R
M86YT<U]$93PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970Q."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/D9!25)?5D%,545?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q.2YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/DU!4DM%5$%"3$5?4T5#55))5$E%4U]$971A:6QS/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#(P+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1/0TM?2$],
M1$524U]%455)5%E?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,2YH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/E-43T-+7T)!4T5$7T-/35!%3E-!5$E/3E]$971A:3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970R,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E)%3$%4141?
M4$%25$E%4U]44D%.4T%#5$E/3E-?1#PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R,RYH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/E-50E-%455%3E1?159%3E1?1&5T86EL<SPO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970R-"YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M(#PO>#I%>&-E;%=O<FMS:&5E=',^#0H@(#QX.E-T>6QE<VAE970@2%)E9CTS
M1")7;W)K<VAE971S+W)E<&]R="YC<W,B+SX-"B`@/'@Z06-T:79E4VAE970^
M,#PO>#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T<G5C='5R93Y&86QS
M93PO>#I0<F]T96-T4W1R=6-T=7)E/@T*("`\>#I0<F]T96-T5VEN9&]W<SY&
M86QS93PO>#I0<F]T96-T5VEN9&]W<SX-"B`\+W@Z17AC96Q7;W)K8F]O:SX-
M"CPO>&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP
M/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC<F]S;V9T($5X
M8V5L(%A0(&]R(&YE=V5R+CPO<#X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM
M+2TM+2T]7TYE>'1087)T7S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A
M,6,R.3DU-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R-V5D-S!F
M85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R:W-H965T<R]3:&5E
M=#`Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP
M<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U
M<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M
M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H
M87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S
M<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO
M/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,]
M,T1R97!O<G0@:60],T1)1#!%,4%!13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SY$;V-U;65N="!A;F0@16YT:71Y($EN9F]R;6%T:6]N/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@
M36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q-3QB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$;V-U;65N="!A
M;F0@16YT:71Y($EN9F]R;6%T:6]N(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@5'EP93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^,3`M43QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UE;F1M96YT
M($9L86<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/F9A;'-E/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$
M;V-U;65N="!097)I;V0@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/D9E8B`R."P-"@D),C`Q-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y(%)E9VES=')A;G0@
M3F%M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^3U)!345$(%!(
M05)-04-%551)0T%,4R!)3D,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@0V5N=')A;"!);F1E>"!+97D\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C`P,#$Q-S8S,#D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-U
M<G)E;G0@1FES8V%L(%EE87(@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/BTM,#@M,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!097)I;V0@
M1F]C=7,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/E$R/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U
M;65N="!&:7-C86P@665A<B!&;V-U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^,C`Q-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^16YT:71Y($9I;&5R($-A=&5G;W)Y/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#Y3;6%L;&5R(%)E<&]R=&EN9R!#;VUP
M86YY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y%;G1I='D@0V]M;6]N(%-T;V-K+"!3:&%R97,@3W5T<W1A;F1I;F<\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#@R,RPY-#,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S(W960W,&9A
M7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-@T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C
M,CDY-38O5V]R:W-H965T<R]3:&5E=#`R+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%3T=!1SX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#3TY$14Y3140@0T].4T],241!5$5$
M($)!3$%.0T4@4TA%1513("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE
M<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^075G+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#55)214Y4($%34T54
M4SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q+#$P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,2PW-C(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H;W)T('1E<FT@9&5P;W-I
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#,U,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$X+#0X
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^36%R:V5T86)L92!S96-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XV.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#`T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!C87-H/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N<V5S
M(&%N9"!O=&AE<B!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3(Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E)E;&%T960@<&%R=&EE<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F%N=',@
M<F5C96EV86)L92!F<F]M('1H92!C:&EE9B!S8VEE;G1I<W0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&-U<G)E;G0@87-S
M971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ."PR.34\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,2PW
M-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DQ/3D<@5$5232!$15!/4TE44R!!3D0@24Y615-4345.5#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PV-C4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!34]53E13($953D1%
M1"!)3B!215-014-4($]&($5-4$Q/645%(%))1TA44R!54$].(%)%5$E214U%
M3E0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y04D]015)4
M62!!3D0@15%525!-14Y4+"!.150\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;"!A<W-E=',\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(R+#DX,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(Q+#@P,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#55)214Y4($Q)
M04))3$E42453.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE(&%N9"!A8V-R=65D(&5X<&5N<V5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-S`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,C8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E;&%T
M960@<&%R=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E1O=&%L(&-U<G)E;G0@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C8P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/CDW,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY,3TY'(%1%4DT@3$E!
M0DE,251)15,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5M<&QO>65E(')I9VAT<R!U<&]N(')E=&ER96UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]V:7-I;VX@9F]R('5N
M8V5R=&%I;B!T87@@<&]S:71I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;"!L;VYG('1E<FT@;&EA8FEL:71I97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-/34U)5$U%3E13
M("AN;W1E(#(I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4U1/0TM(3TQ$15)3)R!%
M455)5%DZ/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;6UO;B!S=&]C:RP@)"`P+C`Q,B!P87(@=F%L=64@*#,P+#`P,"PP
M,#`@875T:&]R:7IE9"!S:&%R97,[(#$P+#@R,"PQ.3,@86YD(#$P+#$P,BPU
M-34@<VAA<F5S(&ES<W5E9"!A;F0@;W5T<W1A;F1I;F<@87,@;V8@1F5B<G5A
M<GD@,C@L(#(P,34@86YD($%U9W5S="`S,2P@,C`Q-"P@<F5S<&5C=&EV96QY
M*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(Y/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3(Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!9&1I
M=&EO;F%L('!A:60M:6X@8V%P:71A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^-3,L-#8S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-#@L,#0P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-U;75L871E9"!O=&AE<B!C;VUP
M<F5H96YS:79E(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#4R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!8V-U;75L871E9"!L;W-S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@S,2PS-3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,C<L.#(P*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L('-T;V-K:&]L
M9&5R<R<@97%U:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M,BPS,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,"PW.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;"!L:6%B:6QI=&EE<R!A;F0@<W1O8VMH;VQD
M97)S)R!E<75I='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,C(L.3@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R,2PX,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU
M-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R-V5D-S!F85]A860T
M7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R:W-H965T<R]3:&5E=#`S+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%-D9!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#3TY$
M14Y3140@0T].4T],241!5$5$($)!3$%.0T4@4TA%1513("A005)%3E1(151)
M0T%,*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^075G+B`S,2P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#3TY$14Y3140@0T].4T],241!
M5$5$($)!3$%.0T4@4TA%1513(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!P87(@
M=F%L=64@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#`N,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P+C`Q,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!S:&%R97,@875T:&]R
M:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S`L,#`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&ES<W5E9#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L.#(P+#$Y,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#$P,BPU
M-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PX,C`L,3DS/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L,3`R+#4U-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C=E9#<P
M9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A
M,6,R.3DU-B]7;W)K<VAE971S+U-H965T,#0N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5)-D%%
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3D1%3E-%1"!#3TY33TQ)1$%4
M140@4U1!5$5-14Y44R!/1B!#3TU04D5(14Y3259%($Q/4U,@*%531"`D*3QB
M<CY);B!4:&]U<V%N9',L(&5X8V5P="!3:&%R92!D871A+"!U;FQE<W,@;W1H
M97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD
M960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-3QB<CX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#3TY$14Y3140@0T].
M4T],241!5$5$(%-4051%345.5%,@3T8@0T]-4%)%2$5.4TE612!,3U-3(%M!
M8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4D5314%20T@@04Y$($1%5D5,3U!-14Y4($584$5.4T53+"!.150\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PQ,S8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8W-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,BPT,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$L-#(T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y'14Y%4D%,($%.1"!!1$U)3DE35%)!5$E612!%6%!%
M3E-%4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3,X/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3$R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PQ
M,S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XY,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/4$52051)3D<@3$]34SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PV-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#$X-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L-3<V/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPS-30\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9)3D%.0TE!3"!)3D-/
M344\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,X*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<T*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#8U*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$R
M,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D9)3D%.0TE!3"!%6%!%3E-%4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y.150@3$]34R!&3U(@5$A%(%!%4DE/1#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PV,S<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$Q-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-3,S/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPR
M,SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E-50E-%455%3E0@1$5#4D5!4T4@*$E.0U)%05-%*2!)3B!42$4@1D%)
M4B!604Q512!/1B!!5D%)3$%"3$4@1D]2(%-!3$4@4T5#55))5$E%4R!04D56
M24]54TQ9(%=2251414X@1$]73B!!4R!)35!!25)%1#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-#DI/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#4T*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4D5#3$%3
M4TE&24-!5$E/3B!!1$I54U1-14Y4(%1/($9)3D%.0TE!3"!)3D-/344@3T8@
M1T%)3E,@3TX@059!24Q!0DQ%+49/4BU304Q%(%-%0U52251)15,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(V/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E5.4D5!3$E:140@3$]34R`H1T%)3BD@3TX@059!24Q!0DQ%
M($9/4B!304Q%(%-%0U52251)15,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-#DP*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6T^*#4S-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y43U1!3"!/5$A%4B!#3TU04D5(14Y3
M259%($Q/4U,@*$E.0T]-12D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-3$S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C,U,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#4T-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y43U1!3"!#3TU04D5(14Y3259%($Q/4U,@
M1D]2(%1(12!015))3T0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,2PV,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#8P,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,RPX.#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L-CDU/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQ/4U,@4$52
M($-/34U/3B!32$%213H\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0D%324,@04Y$($1)3%54140@3$]34R!015(@0T]-34].
M(%-(05)%/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N,34\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#`N,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`N,C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E=%24=(5$5$($%615)!1T4@3E5-0D52($]&
M(%-(05)%4R!/1B!#3TU-3TX@4U1/0TL@55-%1"!)3B!#3TU0551)3D<@0D%3
M24,@04Y$($1)3%54140@3$]34R!015(@0T]-34].(%-43T-+/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PX,C8L,30V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PQ,C<L-SDY/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L
M-#@R+#$Y,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C@L-3,Q+#$U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM
M+3U?3F5X=%!A<G1?,C=E9#<P9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y
M.34V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(W960W,&9A7V%A
M9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-B]7;W)K<VAE971S+U-H965T,#4N
M:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT
M86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E
M=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS
M1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C
M<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E
M<&]R="!I9#TS1$E$,$55-4%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/D-/
M3D1%3E-%1"!#3TY33TQ)1$%4140@4U1!5$5-14Y44R!/1B!#2$%.1T53($E.
M(%-43T-+2$],1$524R<@15%52519("A54T0@)"D\8G(^26X@5&AO=7-A;F1S
M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^5&]T86P\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^
M0V]M;6]N(%-T;V-K(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/D%D9&ET:6]N86P@<&%I9"UI;B!C87!I=&%L(%M-96UB97)=
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%C8W5M=6QA=&5D
M(&]T:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE(%M-96UB97)=/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D%C8W5M=6QA=&5D(&QO<W,@6TUE
M;6)E<ET\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)!
M3$%.0T4@870@075G+B`S,2P@,C`Q-#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`R,"PW.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$R,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-#@L,#0P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`T-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#(W+#@R,"D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)!3$%.0T4L('-H87)E
M<R!A="!!=6<N(#,Q+"`R,#$T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,"PQ,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-(
M05)%4R!)4U-5140@1D]2($-!4T@L($Y%5#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PX,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-"PX,C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-(05)%4R!)4U-5
M140@1D]2($-!4T@L($Y%5"P@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XV.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-(05)%4R!)4U-5140@1D]2(%-%4E9)0T53/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\<W5P/ELQ73PO<W5P/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-(05)%4R!)4U-5140@1D]2(%-%4E9)0T53+"!S:&%R97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5815)#25-%($]&($]05$E/3E,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/'-U<#Y;,5T\
M+W-U<#X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XF;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5815)#25-%($]&($]05$E/3E,L('-H87)E
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4U1/0TL@0D%3140@0T]-4$5.4T%424].
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-C0\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^
M/'-U<#Y;,5T\+W-U<#X\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4V-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4U1/0TL@0D%3140@0T]-
M4$5.4T%424].+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.150@3$]3
M4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,RPU,S,I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,RPU,S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/5$A%4B!#3TU04D5(14Y3259%($Q/
M4U,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,U,BD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@S-3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y"04Q!3D-%(&%T($9E8BX@,C@L(#(P,34\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C(L,S,Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,CD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4S+#0V,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3`P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@S
M,2PS-3,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y"04Q!3D-%+"!S:&%R97,@870@1F5B+B`R."P@,C`Q-3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L.#(P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L<W!A;CTS1#<^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1I;FYE<D9O;W1N
M;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P/ELQ73PO=&0^#0H@("`@
M("`@(#QT9"!C;VQS<&%N/3-$-B!V86QI9VX],T1T;W`^4F5P<F5S96YT<R!A
M;B!A;6]U;G0@;V8@;&5S<R!T:&%N("0Q+CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
M97AT4&%R=%\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38-
M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C=E9#<P9F%?86%D-%\T
M,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V+U=O<FMS:&5E=',O4VAE970P-BYH=&UL
M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE
M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB
M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P149(04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T].1$5.
M4T5$($-/3E-/3$E$051%1"!35$%414U%3E13($]&($-!4T@@1DQ/5U,@*%53
M1"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF
M:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#0^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^
M1F5B+B`R."P@,C`Q-3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:"!C;VQS<&%N/3-$,CY&96(N(#(X+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-!4T@@1DQ/5U,@1E)/32!/
M4$52051)3D<@04-4259)5$E%4SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,RPU,S,I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XD("@R+#(S.2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^061J=7-T;65N=',@<F5Q=6ER960@
M=&\@<F5C;VYC:6QE(&YE="!L;W-S('1O(&YE="!C87-H('5S960@:6X@;W!E
M<F%T:6YG(&%C=&EV:71I97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO;B!A
M;F0@86UO<G1I>F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^17AC:&%N9V4@9&EF9F5R96YC97,@86YD
M(&EN=&5R97-T(&]N(&1E<&]S:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@S-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S,RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&)A<V5D(&-O
M;7!E;G-A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-38T
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VL@:7-S=65D(&9O<B!S
M97)V:6-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1V%I;B!O;B!S86QE(&]F(&EN=F5S=&UE;G0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0T*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#:&%N9V5S(&EN(&]P97)A=&EN9R!A
M<W-E=',@86YD(&QI86)I;&ET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X
M<&5N<V5S+"!O=&AE<B!C=7)R96YT(&%S<V5T<R!A;F0@<F5L871E9"!P87)T
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-#$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-C<I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y!8V-O=6YT<R!P87EA8FQE+"!A8V-R=65D(&5X<&5N
M<V5S(&%N9"!R96QA=&5D('!A<G1I97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#,V."D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q
M-#@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y,:6%B:6QI='D@
M9F]R(&5M<&QO>65E(')I9VAT<R!U<&]N(')E=&ER96UE;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y4;W1A;"!N970@8V%S:"!U<V5D(&EN(&]P97)A=&EN9R!A8W1I
M=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#`P,RD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#(S,"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0T%32"!&3$]74R!&4D]-
M($E.5D535$E.1R!!0U1)5DE42453.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O
M9B!P<F]P97)T>2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DI
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!S
M:&]R="!T97)M(&1E<&]S:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q+#4W,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q."PV
M,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O
M9B!L;VYG('1E<FT@9&5P;W-I=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#0L-C4R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M8V5E9',@9G)O;2!S86QE(&]F('-H;W)T('1E<FT@9&5P;W-I=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,L-S4P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-2PR,S8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!R;V-E961S(&9R;VT@<V%L92!O9B!M87)K971A8FQE('-E8W5R
M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&=6YD<R!I;B!R97-P96-T(&]F(&5M
M<&QO>65E(')I9VAT<R!U<&]N(')E=&ER96UE;G0\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@;F5T(&-A<V@@=7-E9"!I;B!I;G9E<W1I;F<@86-T:79I=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,BPT-S<I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,L,CDT*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#05-(($9,3U=3($923TT@1DE.
M04Y#24Y'($%#5$E6251)15,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@
M:7-S=6%N8V4@;V8@8V]M;6]N('-T;V-K("T@;F5T(&]F(&ES<W5A;F-E(&5X
M<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#@S,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\<W5P
M/ELQ73PO<W5P/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30L
M.#@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N
M/CQS=7`^6S%=/"]S=7`^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E!R;V-E961S(&9R;VT@97AE<F-I<V4@;V8@=V%R<F%N=',@86YD(&]P
M=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0Y,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!S:&%R97,@=&\@8F4@:7-S
M=65D(&9O<B!E>&5R8VES92!O9B!W87)R86YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3$X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3F5T(&-A<V@@9&5R:79E9"!F<F]M(&9I;F%N8VEN9R!A8W1I=FET:65S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#@T,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#0Y-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^149&14-4($]&($580TA!3D=%(%)!5$4@0TA!3D=%
M4R!/3B!#05-(/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,2D\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DE.0U)%05-%("A$14-214%312D@24X@0T%3
M2"!!3D0@0T%32"!%455)5D%,14Y44SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH-C8P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDX
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0T%32"!!3D0@0T%3
M2"!%455)5D%,14Y44R!!5"!"14=)3DY)3D<@3T8@4$5224]$/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#<V,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(L,C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#05-(($%.1"!#05-(($5154E604Q%3E13($%4($5.1"!/1B!015))
M3T0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PQ,#(\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,L,C4S/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L<W!A;CTS1#4^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1I;FYE<D9O;W1N
M;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P/ELQ73PO=&0^#0H@("`@
M("`@(#QT9"!C;VQS<&%N/3-$-"!V86QI9VX],T1T;W`^4V5E(&YO=&4@-2X\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C=E9#<P9F%?86%D-%\T,C@S
M7V(Q.3%?8S`P-F$Q8S(Y.34V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-B]7;W)K
M<VAE971S+U-H965T,#<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS
M1#(^/'-T<F]N9SY324=.249)0T%.5"!!0T-/54Y424Y'(%!/3$E#2453/&)R
M/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\
M8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4R!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-)1TY)
M1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQD:78@:60],T1%9&=A<E-!03$R,S0U-S@Y,#`P,"!S
M='EL93TS1"=F;VYT+69A;6EL>2`Z("=4:6UE<R!.97<@4F]M86XG.R<^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P
M<'0[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM
M<FEG:'0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@
M9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3D]412`\9F]N=#XQ/"]F;VYT/B`M
M(%-)1TY)1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,Z/"]F;VYT/CPO9&EV
M/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R<^)B,Q-C`[/"]D:78^#0H\9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQB<B\^
M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R<^#0H\9&EV/@T*/&1I=B!C;&%S<STS1$-U<G-O<E!O:6YT
M97(^#0H\=&%B;&4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,"!C96QL<&%D
M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!W:61T:#H@
M,3`P)3LG/@T*#0H\='(@=F%L:6=N/3-$=&]P/@T*/'1D('-T>6QE/3-$)V)O
M<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT
M;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`T-2XS-7!T
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M;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O
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M>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^)B,Q-C`[/"]D:78^
M#0H\9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!T97AT
M+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P
M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@8VQA<W,],T1#=7)S;W)0
M;VEN=&5R/@T*/'1A8FQE(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E
M;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M
M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@=VED=&@Z(#$P,"4[)SX-"@T*
M/'1R('9A;&EG;CTS1'1O<#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@
M)W1I;65S(&YE=R!R;VUA;B<[(&)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M
M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ
M(&YO;F4[('=I9'1H.B`W,G!T.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS
M1')I9VAT('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUL969T
M.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[
M(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`R-W!T.R<^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z
M(#!P=#LG/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M=V5I9VAT.B!B;VQD.R<^/&9O;G0^,2D\+V9O;G0^/"]F;VYT/CPO9&EV
M/@T*/"]T9#X-"CQT9"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@;&5F=#L@8F]R9&5R+6QE9G0Z(&YO;F4[(&)O<F1E<BUR:6=H=#H@;F]N
M93L@8F]R9&5R+71O<#H@;F]N93L@8F]R9&5R+6)O='1O;3H@;F]N93LG/@T*
M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN
M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[
M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#LG/DEN8V]R<&]R871I;VX@86YD(&]P
M97)A=&EO;G,\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"@T*/"]T86)L
M93X-"CPO9&EV/@T*/"]D:78^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X
M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P
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M>F4Z(#$P<'0[)SY/<F%M960@4&AA<FUA8V5U=&EC86QS($EN8RX@*'1H92`F
M(S$T-SM#;VUP86YY)B,Q-#@[*2!W87,@:6YC;W)P;W)A=&5D(&]N($%P<FEL
M(#$R+"`R,#`R+"!U;F1E<B!T:&4@;&%W<R!O9B!T:&4@4W1A=&4@;V8@3F5V
M861A+B!/;B!&96)R=6%R>2`Q-RP@,C`P-BP@=&AE($-O;7!A;GD@96YT97)E
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M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA
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M<'0[)SY/;B!-87)C:"`Q,2P@,C`Q,2P@=&AE($-O;7!A;GD@=V%S(')E:6YC
M;W)P;W)A=&5D(&9R;VT@=&AE(%-T871E(&]F($YE=F%D82!T;R!T:&4@4W1A
M=&4@;V8@1&5L87=A<F4N/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z
M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&IU<W1I9GD^)B,Q
M-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@.3EP=#L@;6%R9VEN+7)I9VAT
M.B`P<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@
M:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M
M<VEZ93H@,3!P=#LG/D]N($UA>2`Q-"P@,C`P-RP@=&AE($-O;7!A;GD@:6YC
M;W)P;W)A=&5D(&$@=VAO;&QY+6]W;F5D('-U8G-I9&EA<GD@:6X@27-R865L
M+"!/<F%M960@3'1D+B`H=&AE("8C,30W.U-U8G-I9&EA<GDF(S$T.#LI+"!W
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M8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<@
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M(&%D;W!T:6]N(&]F($%C8V]U;G1I;F<@4W1A;F1A<F1S(%5P9&%T92`H)B,Q
M-#<[05-5)B,Q-#@[*2`\9F]N=#XR,#$T/"]F;VYT/BT\9F]N=#XQ,#PO9F]N
M=#XL($1E=F5L;W!M96YT(%-T86=E($5N=&ET:65S("A4;W!I8R`\9F]N=#XY
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M9VAT.B`P<'0[)SX-"CQD:78@8VQA<W,],T1#=7)S;W)0;VEN=&5R/@T*/'1A
M8FQE(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$
M,"!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM
M97,@;F5W(')O;6%N)SL@=VED=&@Z(#$P,"4[)SX-"@T*/'1R('9A;&EG;CTS
M1'1O<#X-"CQT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<[(&)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[
M(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H
M.B`W,G!T.R<^)B,Q-C`[/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUL969T.B!N;VYE.R!B;W)D
M97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T
M;VTZ(&YO;F4[('=I9'1H.B`R-W!T.R<^#0H\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E
M:6=H=#H@8F]L9#LG/D1E=F5L;W!M96YT(&%N9"!L:7%U:61I='D@<FES:W,\
M+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"@T*/"]T86)L93X-"CPO9&EV
M/@T*/"]D:78^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SX\8G(O/CPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+6QE9G0Z(#DY<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$
M;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M
M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^5&AE
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M<F=I;BUR:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W
M(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^4W5C8V5S<V9U;"!C;VUP;&5T
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M(&ET<R!P<F]D=6-T<R!I;G1E<FYA=&EO;F%L;'DN(%1H97)E(&-A;B!B92`\
M9F]N=#YN;SPO9F]N=#X@87-S=7)A;F-E('1H870@=&AE($-O;7!A;GD@=VEL
M;"!R96-E:79E(')E9W5L871O<GD@87!P<F]V86P@;V8@86YY(&]F(&ET<R!P
M<F]D=6-T(&-A;F1I9&%T97,L(&%N9"!A('-U8G-T86YT:6%L(&%M;W5N="!O
M9B!T:6UE(&UA>2!P87-S(&)E9F]R92!T:&4@0V]M<&%N>2!A8VAI979E<R!A
M(&QE=F5L(&]F(')E=F5N=65S(&%D97%U871E('1O('-U<'!O<G0@:71S(&]P
M97)A=&EO;G,L(&EF(&%T(&%L;"X@5&AE($-O;7!A;GD@86QS;R!E>'!E8W1S
M('1O(&EN8W5R('-U8G-T86YT:6%L(&5X<&5N9&ET=7)E<R!I;B!C;VYN96-T
M:6]N('=I=&@@=&AE(')E9W5L871O<GD@87!P<F]V86P@<')O8V5S<R!F;W(@
M96%C:"!O9B!I=',@<')O9'5C="!C86YD:61A=&5S(&1U<FEN9R!T:&5I<B!R
M97-P96-T:79E(&1E=F5L;W!M96YT86P@<&5R:6]D<RX@3V)T86EN:6YG(&UA
M<FME=&EN9R!A<'!R;W9A;"!W:6QL(&)E(&1I<F5C=&QY(&1E<&5N9&5N="!O
M;B!T:&4@0V]M<&%N>2=S(&%B:6QI='D@=&\@:6UP;&5M96YT('1H92!N96-E
M<W-A<GD@<F5G=6QA=&]R>2!S=&5P<R!R97%U:7)E9"!T;R!O8G1A:6X@;6%R
M:V5T:6YG(&%P<')O=F%L(&EN('1H92!5;FET960@4W1A=&5S(&%N9"!I;B!O
M=&AE<B!C;W5N=')I97,N(%1H92!#;VUP86YY(&-A;FYO="!P<F5D:6-T('1H
M92!O=71C;VUE(&]F('1H97-E(&%C=&EV:71I97,N/"]F;VYT/CPO9&EV/@T*
M/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C
M:SLG/CQB<B\^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@.3EP=#L@;6%R9VEN
M+7)I9VAT.B`M,"XP-7!T.R<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)V1I<W!L87DZ(&EN;&EN93L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M
M86XG.R!F;VYT+7-I>F4Z(#$P<'0[)SY"87-E9"!O;B!I=',@8W5R<F5N="!C
M87-H(')E<V]U<F-E<R!A;F0@8V]M;6ET;65N=',L(&%N9"!C87-H(')E8V5I
M=F5D(&EN('!R:79A=&4@86YD('!U8FQI8R!O9F9E<FEN9W,@:6X@=&AE('-I
M>"8C,38P.VUO;G1H('!E<FEO9"!E;F1E9"!&96)R=6%R>2`R."P@,C`Q-2!A
M;F0@:6X@=&AE('EE87(@96YD960@075G=7-T(#,Q+"`R,#$T+"!T:&4@0V]M
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M<F4@:7-S=65D+"!A;'1H;W5G:"`\9F]N=#YN;SPO9F]N=#X@87-S=7)A;F-E
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M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P
M<'0[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM
M<FEG:'0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@
M9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P
M<'0[)SX\+V9O;G0^/&)R+SX\+V1I=CX-"CPO9&EV/@T*#0H\9&EV('-T>6QE
M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$:G5S=&EF
M>3XF(S$V,#L\+V1I=CX-"CQD:78^#0H\9&EV(&-L87-S/3-$0W5R<V]R4&]I
M;G1E<CX\8G(O/CPO9&EV/@T*/"]D:78^#0H\9&EV/@T*/&1I=CX-"CQD:78@
M8VQA<W,],T1#=7)S;W)0;VEN=&5R/@T*/'1A8FQE(&%L:6=N/3-$8V5N=&5R
M(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@
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M;G0Z(#!P=#L@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[
M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E
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M/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X
M="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`W
M,G!T.R!M87)G:6XM<FEG:'0Z("TP+C`U<'0[)R!A;&EG;CTS1&QE9G0^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I
M;65S($YE=R!2;VUA;B<[(&9O;G0M<VEZ93H@,3!P=#LG/DEN($%U9W5S="`R
M,#$T+"!T:&4@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A<F1S($)O87)D
M("AT:&4@)B,Q-#<[1D%30B8C,30X.RD@:7-S=65D($%C8V]U;G1I;F<@4W1A
M;F1A<F1S(%5P9&%T92`H)B,Q-#<[05-5)B,Q-#@[*2`\9F]N=#XR,#$T/"]F
M;VYT/BT\9F]N=#XQ-3PO9F]N=#XL(%!R97-E;G1A=&EO;B!O9B!&:6YA;F-I
M86P@4W1A=&5M96YT<RU';VEN9R!#;VYC97)N("A3=6)T;W!I8R`\9F]N=#XR
M,#4\+V9O;G0^+3QF;VYT/C0P/"]F;VYT/BDZ($1I<V-L;W-U<F4@;V8@56YC
M97)T86EN=&EE<R!A8F]U="!A;B!%;G1I='DG<R!!8FEL:71Y('1O($-O;G1I
M;G5E(&%S(&$@1V]I;F<@0V]N8V5R;B`H)B,Q-#<[05-5(#QF;VYT/C(P,30\
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M;6)E<B`Q-2P@,C`Q-B!A;F0@:6YT97)I;2!P97)I;V1S('1H97)E:6XN($5A
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M>65A<B`\9F]N=#XR,#$T/"]F;VYT/BX@5&AE(&%D;W!T:6]N(&]F($%352`\
M9F]N=#XR,#$T/"]F;VYT/BT\9F]N=#XQ-3PO9F]N=#X@9&ED(&YO="!H879E
M(&%N>2!M871E<FEA;"!E9F9E8W0@;VX@=&AE(&-O;G-O;&ED871E9"!F:6YA
M;F-I86P@<W1A=&5M96YT('!R97-E;G1A=&EO;BX\+V9O;G0^/"]D:78^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K
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M:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I9'1H.B`Q
M,#`E.R<^#0H-"CQT<B!V86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4],T0G8F]R
M9&5R+6QE9G0Z(&YO;F4[(&)O<F1E<BUR:6=H=#H@;F]N93L@8F]R9&5R+71O
M<#H@;F]N93L@8F]R9&5R+6)O='1O;3H@;F]N93L@=VED=&@Z(#0U+C,U<'0[
M)SX-"CQD:78^)B,Q-C`[/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)V)O
M<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT
M;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`R-W!T.R<^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA<F=I;BUL969T
M.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[
M(&9O;G0M<VEZ93H@,3!P=#L@9F]N="UW96EG:'0Z(&)O;&0[)SYC+CPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>3X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H
M=#H@8F]L9#LG/D-O;F1E;G-E9"!#;VYS;VQI9&%T960@1FEN86YC:6%L(%-T
M871E;65N=',@4')E<&%R871I;VX\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T
M<CX-"@T*/"]T86)L93X-"CPO9&EV/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I
M=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUL969T.B`W,G!T.R!M87)G:6XM<FEG:'0Z("TP+C`U
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M(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE<R`H(E4N4RX@1T%!4"(I
M(&%N9"!O;B!T:&4@<V%M92!B87-I<R!A<R!T:&4@875D:71E9"!C;VYS;VQI
M9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D960@:6X@=&AE($-O
M;7!A;GDG<R!!;FYU86P@4F5P;W)T(&]N($9O<FT@,3`M2R!F;W(@=&AE(&9I
M<V-A;"!Y96%R(&5N9&5D($%U9W5S="8C,38P.S,Q+"`\9F]N=#XR,#$T/"]F
M;VYT/B`H=&AE("8C,30W.SQF;VYT/C(P,30\+V9O;G0^($9O<FT@,3`M2R8C
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M:6]N(&%N9"!D:7-C;&]S=7)E<R!R97%U:7)E9"!B>2!5+E,N($=!05`@9F]R
M(&%N;G5A;"!F:6YA;F-I86P@<W1A=&5M96YT<RP@=&AE>2!S:&]U;&0@8F4@
M<F5A9"!I;B!C;VYJ=6YC=&EO;B!W:71H('1H92!A=61I=&5D(&-O;G-O;&ED
M871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A;F0@;F]T97,@:6YC;'5D960@
M:6X@=&AE(#QF;VYT/C(P,30\+V9O;G0^($9O<FT@,3`M2RX@5&AE(')E<W5L
M=',@9F]R(&EN=&5R:6T@<&5R:6]D<R!A<F4@;F]T(&YE8V5S<V%R:6QY(&EN
M9&EC871I=F4@;V8@82!F=6QL(&9I<V-A;"!Y96%R)W,@<F5S=6QT<RX\+V9O
M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CPO9&EV/@T*/&1I=B!S='EL
M93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQB<B\^
M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA<F=I
M;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^#0H\9&EV/@T*/&1I
M=B!S='EL93TS1"=W:61T:#H@,3`P)3LG(&%L:6=N/3-$;&5F=#X\8G(O/CPO
M9&EV/@T*/"]D:78^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D
M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R-V5D-S!F85]A860T
M7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO,C=E9#<P9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V
M+U=O<FMS:&5E=',O4VAE970P."YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N
M8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O
M:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-
M"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0]
M,T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T
M97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E
M(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@
M("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/D-/34U)5$U%3E13/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0T]-34E4345.5%,@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y#3TU-251-14Y44SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/&1I=B!I9#TS1$5D9V%R4T%!,3(S-#4W.#DP,#`P('-T>6QE/3-$)V9O
M;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQD:78@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN
M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-"CQD:78@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T
M.R<^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL
M>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M<VEZ93H@,3!P=#L@9F]N="UW
M96EG:'0Z(&)O;&0[)SY.3U1%(#QF;VYT/C(\+V9O;G0^("T@0T]-34E4345.
M5%,Z/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M
M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T
M.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\
M+V1I=CX-"CQD:78^#0H\9&EV(&-L87-S/3-$0W5R<V]R4&]I;G1E<CX-"CQT
M86)L92!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$
M,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I9'1H.B`Q,#`E.R<^
M#0H-"CQT<B!V86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4],T0G8F]R9&5R+6QE
M9G0Z(&YO;F4[(&)O<F1E<BUR:6=H=#H@;F]N93L@8F]R9&5R+71O<#H@;F]N
M93L@8F]R9&5R+6)O='1O;3H@;F]N93L@=VED=&@Z(#0U+C,U<'0[)SX-"CQD
M:78^)B,Q-C`[/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)V)O<F1E<BUL
M969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO
M;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`R-W!T.R<^#0H\9&EV
M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA<F=I;BUL969T.B`P<'0[
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M:6-E<B`H=&AE("8C,30W.T-43R8C,30X.RD@86YD($1R+B!$86YI96P@4V-H
M=7)R(%-U8G-I9&EA<GD@*'1H92`F(S$T-SM(861A<VET($%G<F5E;65N="8C
M,30X.RD@=&\@<F5T86EN(&-O;G-U;'1I;F<@86YD(&-L:6YI8V%L('1R:6%L
M('-E<G9I8V5S+B!!8V-O<F1I;F<@=&\@=&AE($AA9&%S:70@06=R965M96YT
M+"!(861A<VET('=I;&P@8F4@96YT:71L960@=&\@82!C;VYS:61E<F%T:6]N
M(&]F("0\9F]N=#XR,#`\+V9O;G0^('1O(&)E('!A:60@8GD@=&AE(%-U8G-I
M9&EA<GDF(S$V,#MI;B!A8V-O<F1A;F-E('=I=&@@=&AE(&%C='5A;"!P<F]G
M<F5S<R!O9B!T:&4@<W1U9&EE<RP@)#QF;VYT/CDU/"]F;VYT/B!O9B!W:&EC
M:"!W97)E(')E8V]G;FEZ960@=&AR;W5G:"!&96)R=6%R>2`R."P@,C`Q-2X@
M4V5E(&%L<V\@;F]T92`\9F]N=#XQ/"]F;VYT/F$\9F]N=#XH,2D\+V9O;G0^
M+CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*#0H\+W1A8FQE/@T*/"]D
M:78^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[)SX\8G(O/CPO9&EV/@T*/&1I=CX-"CQD:78@8VQA
M<W,],T1#=7)S;W)0;VEN=&5R/@T*/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O
M<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
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M(#!P=#L@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^8BX\+V9O;G0^
M/"]D:78^#0H\+W1D/@T*/'1D/@T*/&1I=B!A;&EG;CTS1&QE9G0^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[(&9O;G0M<VEZ93H@,3!P=#LG/D]N($9E8G)U87)Y(#$U
M+"`R,#$Q+"!T:&4@4W5B<VED:6%R>2!E;G1E<F5D(&EN=&\@82!C;VYS=6QT
M:6YG(&%G<F5E;65N="!W:71H(&$@=&AI<F0@<&%R='D@*'1H92`F(S$T-SM#
M;VYS=6QT86YT)B,Q-#@[*2!F;W(@82!P97)I;V0@;V8@/&9O;G0^9FEV93PO
M9F]N=#X@>65A<G,L('!U<G-U86YT('1O('=H:6-H('1H92!#;VYS=6QT86YT
M('=I;&P@<')O=FED92!C;VYS=6QT871I;VX@;VX@<V-I96YT:69I8R!A;F0@
M8VQI;FEC86P@;6%T=&5R<RX@5&AE($-O;G-U;'1A;G0@:7,@96YT:71L960@
M=&\@82!F:7AE9"!M;VYT:&QY(&9E92!O9B`D/&9O;G0^.#PO9F]N=#XL(')O
M>6%L=&EE<R!O9B`\9F]N=#XX/"]F;VYT/B4@;V8@=&AE(&YE="!R;WEA;'1I
M97,@86-T=6%L;'D@<F5C96EV960@8GD@=&AE(%-U8G-I9&EA<GD@:6X@<F5S
M<&5C="!O9B!T:&4@<&%T96YT('1H870@=V%S('-O;&0@=&\@16YT97)A($)I
M;R!,=&0N("@F(S$T-SM%;G1E<F$F(S$T.#LI(&]N($UA<F-H(#,Q+"`R,#$Q
M(&%N9"!A;B!O<'1I;VX@=&\@<'5R8VAA<V4@=7`@=&\@/&9O;G0^,C`L.#,T
M/"]F;VYT/B!S:&%R97,@;V8@=&AE($-O;7!A;GD@870@86X@97AE<F-I<V4@
M<')I8V4@;V8@)#QF;VYT/C8N,#`\+V9O;G0^('!E<B!S:&%R92X@5&AE(&]P
M=&EO;B!V97-T<R!I;B`\9F]N=#YF:79E/"]F;VYT/B!A;FYU86P@:6YS=&%L
M;&UE;G1S(&-O;6UE;F-I;F<@1F5B<G5A<GD@,38L(#(P,3(@86YD(&5X<&ER
M97,@;VX@1F5B<G5A<GD@,38L(#(P,C$N(%1H92!F86ER('9A;'5E(&]F('1H
M92!O<'1I;VX@87,@;V8@1F5B<G5A<GD@,C@L(#(P,34@=V%S("0\9F]N=#XQ
M,#4\+V9O;G0^+"!U<VEN9R!T:&4@9F]L;&]W:6YG(&%S<W5M<'1I;VYS.B!D
M:79I9&5N9"!Y:65L9"!O9B`\9F]N=#XP/"]F;VYT/B4[(&%N9"!E>'!E8W1E
M9"!T97)M(&]F(#QF;VYT/C4N.3<\+V9O;G0^)B,Q-C`[>65A<G,[(&5X<&5C
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M96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!W
M:61T:#H@,3`P)3LG/@T*#0H\='(@=F%L:6=N/3-$=&]P/@T*/'1D('-T>6QE
M/3-$)V)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O
M<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`T
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M=&0^#0H\=&0^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R<^3VX@
M07!R:6P@,C@L(#(P,3,L('1H92!3=6)S:61I87)Y(&5N=&5R960@:6YT;R!A
M(&YE=R!L96%S92!A9W)E96UE;G0@9F]R(&ET<R!O9F9I8V4@9F%C:6QI=&EE
M<R!I;B!)<W)A96PL('=H:6-H(')E<&QA8V5D('1H92!L96%S92!A9W)E96UE
M;G0@9G)O;2`\9F]N=#XR,#$R/"]F;VYT/BX@5&AE(&YE=R!L96%S92!A9W)E
M96UE;G0@:7,@9F]R(&$@<&5R:6]D(&]F(#QF;VYT/C,V/"]F;VYT/B!M;VYT
M:',@8V]M;65N8VEN9R!.;W9E;6)E<B`T+"`R,#$S+B!4:&4@86YN=6%L(&QE
M87-E('!A>6UE;G0@:7,@3DE3(#QF;VYT/C@Y+#`P,#PO9F]N=#X@9G)O;2`\
M9F]N=#XR,#$T/"]F;VYT/B!T:')O=6=H(#QF;VYT/C(P,38\+V9O;G0^+"!A
M;F0@=VEL;"!B92!L:6YK960@=&\@=&AE(&EN8W)E87-E(&EN('1H92!)<W)A
M96QI(&-O;G-U;65R('!R:6-E(&EN9&5X("@F(S$T-SM#4$DF(S$T.#LI("AA
M<R!O9B`\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R<^
M1F5B<G5A<GD@,C@L(#(P,34\+V9O;G0^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R<^+"!T:&4@9G5T=7)E(&%N;G5A;"!L96%S92!P87EM96YT
M<R!U;F1E<B!T:&4@;F5W(&%G<F5E;65N="!W:6QL(&)E("0\9F]N=#XR,CPO
M9F]N=#XL(&)A<V5D(&]N('1H92!E>&-H86YG92!R871E(&%S(&]F(#PO9F]N
M=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[)SY&96)R=6%R>2`R
M.#PO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[)SXL(#(P
M,34I+CPO9F]N=#X\8G(O/CPO=&0^#0H\+W1R/@T*#0H\+W1A8FQE/@T*/"]D
M:78^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`W,G!T.R!M87)G:6XM<FEG
M:'0Z(#(N-#5P=#LG(&%L:6=N/3-$;&5F=#XF(S$V,#L\+V1I=CX-"CQD:78@
M<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUL969T.B`W,G!T.R!M87)G:6XM<FEG:'0Z(#(N-#5P=#LG(&%L:6=N
M/3-$;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M
M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^
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M/@T*/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`@8V5L;'!A9&1I
M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SL@=VED=&@Z(#$P
M,"4[)SX-"@T*/'1R('9A;&EG;CTS1'1O<#X-"CQT9"!S='EL93TS1"=B;W)D
M97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D97(M=&]P
M.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R!W:61T:#H@-#4N,S5P=#LG
M/@T*/&1I=CXF(S$V,#L\+V1I=CX-"CPO=&0^#0H\=&0@<W1Y;&4],T0G8F]R
M9&5R+6QE9G0Z(&YO;F4[(&)O<F1E<BUR:6=H=#H@;F]N93L@8F]R9&5R+71O
M<#H@;F]N93L@8F]R9&5R+6)O='1O;3H@;F]N93L@=VED=&@Z(#(W<'0[)SX-
M"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN+6QE9G0Z
M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@
M9F]N="US:7IE.B`Q,'!T.R<^9"X\+V9O;G0^/"]D:78^#0H\+W1D/@T*/'1D
M/@T*/&1I=B!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@
M:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M
M<VEZ93H@,3!P=#LG/D]N($UA>2`Q,RP@,C`Q-"P@=&AE($-O;7!A;GD@96YT
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M(&%N9"`\9F]N=#XQ-2PP,#`\+V9O;G0^('-H87)E<R!O9B!T:&4@0V]M<&%N
M>2=S(&-O;6UO;B!S=&]C:R!T:&%T('=I;&P@8F4@:7-S=65D(&EN(#QF;VYT
M/F9O=7(\+V9O;G0^(&5Q=6%L(&EN<W1A;&QM96YT<RP@;VX@;W(@86)O=70\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M=V5I9VAT.B!B
M;VQD.R<^)B,Q-C`[/"]F;VYT/F5A8V@@;V8@075G=7-T(#$L(#(P,30L($YO
M=F5M8F5R(#$L(#(P,30L($9E8G)U87)Y(#$L(#(P,34@86YD($UA>2`Q+"`R
M,#$U+B!!<R!O9B!&96)R=6%R>2`R."P@,C`Q-2P@=&AE($-O;7!A;GD@:7-S
M=65D('1O('-U8V@@861V:7-O<B`\9F]N=#XW+#4P,#PO9F]N=#X@<VAA<F5S
M+B!4:&4@86=G<F5G871E(&9A:7(@=F%L=64@;V8@=&AE('-H87)E<R!A="!T
M:&4@9&%T97,@;V8@=&AE(&=R86YT('=A<R`D/&9O;G0^-C0\+V9O;G0^+CPO
M9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R/@T*#0H\+W1A8FQE/@T*/"]D:78^
M#0H\+V1I=CX-"@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SLG/CQB<B\^/"]D:78^#0H\9&EV/@T*/&1I=B!C;&%S
M<STS1$-U<G-O<E!O:6YT97(^#0H\=&%B;&4@86QI9VX],T1C96YT97(@8F]R
M9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!W:61T:#H@,3`P)3LG/@T*#0H\='(@=F%L:6=N/3-$=&]P/@T*
M/'1D('-T>6QE/3-$)V)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z
M(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[
M('=I9'1H.B`T-2XS-7!T.R<^#0H\9&EV/B8C,38P.SPO9&EV/@T*/"]T9#X-
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M<CH@(S`P,#`P,#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F
M;VYT+7-I>F4Z(#$S+C,S,S,S,S`Q-30T,3EP>#L@9F]N="US='EL93H@;F]R
M;6%L.R!F;VYT+79A<FEA;G0Z(&YO<FUA;#L@9F]N="UW96EG:'0Z(&YO<FUA
M;#L@;&5T=&5R+7-P86-I;F<Z(&YO<FUA;#L@;&EN92UH96EG:'0Z(&YO<FUA
M;#L@;W)P:&%N<SH@875T;SL@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T
M97AT+6EN9&5N=#H@,'!X.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M
M<W!A8V4Z(&YO<FUA;#L@=VED;W=S.B`Q.R!W;W)D+7-P86-I;F<Z(#!P>#L@
M+7=E8FMI="UT97AT+7-T<F]K92UW:61T:#H@,'!X.R!D:7-P;&%Y.B!I;FQI
M;F4@(6EM<&]R=&%N=#L@9FQO870Z(&YO;F4[(&)A8VMG<F]U;F0M8V]L;W(Z
M("-F9F9F9F8[)SY/;B!&96)R=6%R>2`V+"`R,#$T+"!T:&4@4W5B<VED:6%R
M>2!E;G1E<F5D(&EN=&\@82!S96-O;F0@86=R965M96YT('=I=&@@82!C;&EN
M:6-A;"!R97-E87)C:"!O<F=A;FEZ871I;VX@*"8C,30W.T-23R8C,30X.RDL
M(&9O<B!I=',@4&AA<V4@24EA(&-L:6YI8V%L('1R:6%L(&9O<B!A;B!O<F%L
M(&EN<W5L:6X@8V%P<W5L92!F;W(@='EP92`Q(&1I86)E=&5S('!A=&EE;G1S
M+"!W:&EC:"!W87,@8V]M<&QE=&5D(&EN($]C=&]B97(@,C`Q-"X@07,@8V]N
M<VED97)A=&EO;B!F;W(@:71S('-E<G9I8V5S+"!T:&4@4W5B<VED:6%R>2!P
M86ED('1H92!#4D\@82!T;W1A;"!A;6]U;G0@;V8@87!P<F]X:6UA=&5L>2`D
M/&9O;G0^,C@P/"]F;VYT/B!D=7)I;F<@=&AE('1E<FT@;V8@=&AE(&5N9V%G
M96UE;G0@86YD(&)A<V5D(&]N(&%C:&EE=F5M96YT(&]F(&-E<G1A:6X@;6EL
M97-T;VYE<RP@86QL(&]F('=H:6-H('=E<F4@<F5C;V=N:7IE9"!T:')O=6=H
M($9E8G)U87)Y(#(X+"`R,#$U+CPO9F]N=#X\+V9O;G0^/&)R+SX\+V1I=CX-
M"CPO=&0^#0H\+W1R/@T*#0H\+W1A8FQE/@T*/"]D:78^#0H\+V1I=CX-"CQD
M:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M)SXF(S$V,#L\8G(O/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N
M=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/@T*/&1I=B!S='EL93TS1"=C;VQO
M<CH@(S`P,#`P,#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F
M;VYT+7-I>F4Z(#$S+C,S,S,S,S`Q-30T,3EP>#L@9F]N="US='EL93H@;F]R
M;6%L.R!F;VYT+79A<FEA;G0Z(&YO<FUA;#L@9F]N="UW96EG:'0Z(&YO<FUA
M;#L@;&5T=&5R+7-P86-I;F<Z(&YO<FUA;#L@;&EN92UH96EG:'0Z(&YO<FUA
M;#L@;W)P:&%N<SH@875T;SL@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T
M97AT+6EN9&5N=#H@,'!T.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M
M<W!A8V4Z(&YO<FUA;#L@=VED;W=S.B`Q.R!W;W)D+7-P86-I;F<Z(#!P>#L@
M+7=E8FMI="UT97AT+7-T<F]K92UW:61T:#H@,'!X.R!D:7-P;&%Y.B!B;&]C
M:SL@;6%R9VEN+6QE9G0Z(#4T<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P=#L@
M<&%D9&EN9RUL969T.B`S,'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F
M.R<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN
M93L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z
M(#$P<'0[)SY/;B!*=6QY(#(R+"`R,#$T+"!T:&4@4W5B<VED:6%R>2!E;G1E
M<F5D(&EN=&\@82!T:&ER9"!A9W)E96UE;G0@=VET:"!T:&4@<V%M92!#4D\L
M(&9O<B!I=',@4&AA<V4@24EB(&-L:6YI8V%L('1R:6%L(&9O<B!A;B!O<F%L
M(&EN<W5L:6X@8V%P<W5L92!F;W(@='EP92`R(&1I86)E=&5S('!A=&EE;G1S
M+"!W:&EC:"!I<R!E>'!E8W1E9"!T;R!B96=I;B!I;B!T:&4@<V5C;VYD('%U
M87)T97(@;V8@8V%L96YD87(@>65A<B`R,#$U+B!!<R!C;VYS:61E<F%T:6]N
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M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CQD
M:78^#0H\9&EV(&-L87-S/3-$0W5R<V]R4&]I;G1E<CX-"CQT86)L92!A;&EG
M;CTS1&-E;G1E<B!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$,"!C96QL<W!A
M8VEN9STS1#`@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I9'1H.B`Q,#`E.R<^#0H-"CQT<B!V
M86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4],T0G8F]R9&5R+6QE9G0Z(&YO;F4[
M(&)O<F1E<BUR:6=H=#H@;F]N93L@8F]R9&5R+71O<#H@;F]N93L@8F]R9&5R
M+6)O='1O;3H@;F]N93L@=VED=&@Z(#0U+C,U<'0[)SX-"CQD:78^)B,Q-C`[
M/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)V)O<F1E<BUL969T.B!N;VYE
M.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E
M<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`R-W!T.R<^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M:6YD96YT.B`P<'0[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR
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M;B!-87)C:"`S+"`R,#$T+"!T:&4@4W5B<VED:6%R>2!E;G1E<F5D(&EN=&\@
M86X@861D:71I;VYA;"!A9W)E96UE;G0@=VET:"!A('9E;F1O<BP@9F]R('1H
M92!P<F]C97-S(&1E=F5L;W!M96YT(&%N9"!P<F]D=6-T:6]N(&]F(#QF;VYT
M/F]N93PO9F]N=#X@;V8@:71S(&]R86P@8V%P<W5L92!I;F=R961I96YT<R!I
M;B!T:&4@86UO=6YT(&]F("0\9F]N=#XS,3$\+V9O;G0^+"`D/&9O;G0^-#`\
M+V9O;G0^(&]F('=H:6-H('=E<F4@<F5C;V=N:7IE9"!T:')O=6=H($9E8G)U
M87)Y(#(X+"`R,#$U+"!A;F0@8F]N=7,@<&%Y;65N=',@;V8@=7`@=&\@)#QF
M;VYT/C8P,#PO9F]N=#X@=&AA="!W:6QL(&)E('!A:60@=7!O;B!A8VAI979I
M;F<@8V5R=&%I;B!M:6QE<W1O;F5S+"!A<R!D97-C<FEB960@:6X@=&AE(&%G
M<F5E;65N="!A;F0@=VAI8V@@=V5R92!N;W0@<F5C;V=N:7IE9"!T:')O=6=H
M($9E8G)U87)Y(#(X+"`R,#$U+CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\+W1R
M/@T*#0H\+W1A8FQE/@T*/"]D:78^#0H\+V1I=CX-"CQD:78@<W1Y;&4],T0G
M=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SX\8G(O/CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+6QE9G0Z(#<R<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P
M=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI
M;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE
M.B`Q,'!T.R<^3VX@36%Y(#$U+"`R,#$T+"!T:&4@4W5B<VED:6%R>2!E;G1E
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M:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N
M)SL@9F]N="US:7IE.B`Q,'!T.R<^/"]F;VYT/CQB<B\^/"]D:78^#0H\9&EV
M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM;&5F=#H@-S)P=#L@;6%R9VEN+7)I9VAT.B`M,"XP-7!T.R<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P<'0[
M)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^(#PA+2T@
M6VEF(&=T92!M<V\@.5T^/'AM;#X@/&\Z3V9F:6-E1&]C=6UE;G13971T:6YG
M<SX@/&\Z4F5L>4]N5DU,/CPO;SI296QY3VY634P^(#QO.D%L;&]W4$Y'/CPO
M;SI!;&QO=U!.1SX@/"]O.D]F9FEC941O8W5M96YT4V5T=&EN9W,^#0H\+WAM
M;#X\(5ME;F1I9ETM+3X@/"$M+2!;:68@9W1E(&US;R`Y73X\>&UL/B`\=SI7
M;W)D1&]C=6UE;G0^(#QW.E9I97<^3F]R;6%L/"]W.E9I97<^(#QW.EIO;VT^
M,#PO=SI:;V]M/B`\=SI4<F%C:TUO=F5S/CPO=SI4<F%C:TUO=F5S/B`\=SI4
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M=SI!;'=A>7-3:&]W4&QA8V5H;VQD97)497AT/B`\=SI$;TYO=%!R;VUO=&51
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M;G1'<F]W075T;V9I=#X\+W<Z1&]N=$=R;W=!=71O9FET/B`\=SI3<&QI=%!G
M0G)E86M!;F1087)A36%R:SX\+W<Z4W!L:7109T)R96%K06YD4&%R84UA<FL^
M(#QW.D5N86)L94]P96Y4>7!E2V5R;FEN9SX\+W<Z16YA8FQE3W!E;E1Y<&5+
M97)N:6YG/B`\=SI$;VYT1FQI<$UI<G)O<DEN9&5N=',^/"]W.D1O;G1&;&EP
M36ER<F]R26YD96YT<SX@/'<Z3W9E<G)I9&5486)L95-T>6QE2'!S/CPO=SI/
M=F5R<FED951A8FQE4W1Y;&5(<',^(#PO=SI#;VUP871I8FEL:71Y/B`\;3IM
M871H4'(^(#QM.FUA=&A&;VYT(&TZ=F%L/3-$)T-A;6)R:6$@36%T:"<^/"]M
M.FUA=&A&;VYT/B`\;3IB<FM":6X@;3IV86P],T1B969O<F4^/"]M.F)R:T)I
M;CX@/&TZ8G)K0FEN4W5B(&TZ=F%L/3-$)B,T-3LM/CPO;3IB<FM":6Y3=6(^
M(#QM.G-M86QL1G)A8R!M.G9A;#TS1&]F9CX\+VTZ<VUA;&Q&<F%C/B`\;3ID
M:7-P1&5F/CPO;3ID:7-P1&5F/B`\;3IL36%R9VEN(&TZ=F%L/3-$,#X\+VTZ
M;$UA<F=I;CX@/&TZ<DUA<F=I;B!M.G9A;#TS1#`^/"]M.G)-87)G:6X^(#QM
M.F1E9DIC(&TZ=F%L/3-$8V5N=&5R1W)O=7`^/"]M.F1E9DIC/B`\;3IW<F%P
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M9&EN9R`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
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M:&5A9&EN9R`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M,T0G:&5A9&EN9R`X)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
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M/3-$=')U92!5;FAI9&57:&5N57-E9#TS1'1R=64@3F%M93TS1"=I;F1E>"`R
M)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$
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M>"`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
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M;F1E>"`X)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
M:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960]
M,T1T<G5E($YA;64],T0G:6YD97@@.2<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z
M3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y/3-$,SD@4V5M
M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G
M=&]C(#$G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K
M960],T1F86QS92!0<FEO<FET>3TS1#,Y(%-E;6E(:61D96X],T1T<G5E(%5N
M:&ED95=H96Y5<V5D/3-$=')U92!.86UE/3-$)W1O8R`R)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
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M96Y5<V5D/3-$=')U92!.86UE/3-$)W1O8R`U)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0S
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M/3-$=')U92!.86UE/3-$)W1O8R`X)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
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M97AT)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
M/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T
M<G5E($YA;64],T0G86YN;W1A=&EO;B!T97AT)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS
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M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
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M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI
M9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G96YV
M96QO<&4@<F5T=7)N)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE
M;E5S960],T1T<G5E($YA;64],T0G9F]O=&YO=&4@<F5F97)E;F-E)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
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M86UE/3-$)W!A9V4@;G5M8F5R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M
M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T1,
M:7-T/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960]
M,T1F86QS92!396UI2&ED9&5N/3-$=')U92!5;FAI9&57:&5N57-E9#TS1'1R
M=64@3F%M93TS1"=,:7-T($)U;&QE="<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z
M3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%-E;6E(:61D96X],T1T<G5E
M(%5N:&ED95=H96Y5<V5D/3-$=')U92!.86UE/3-$)TQI<W0@3G5M8F5R)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA
M;64],T0G3&ES="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE
M;E5S960],T1T<G5E($YA;64],T0G3&ES="`S)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS
M1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G3&ES="`T)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA
M;64],T0G3&ES="`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE
M;E5S960],T1T<G5E($YA;64],T0G3&ES="!"=6QL970@,B<^/"]W.DQS9$5X
M8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%-E;6E(
M:61D96X],T1T<G5E(%5N:&ED95=H96Y5<V5D/3-$=')U92!.86UE/3-$)TQI
M<W0@0G5L;&5T(#,G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO
M;B!,;V-K960],T1F86QS92!396UI2&ED9&5N/3-$=')U92!5;FAI9&57:&5N
M57-E9#TS1'1R=64@3F%M93TS1"=,:7-T($)U;&QE="`T)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI
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M($YU;6)E<B`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M;64],T14:71L93X\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
M3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S
M960],T1T<G5E($YA;64],T1#;&]S:6YG/CPO=SI,<V1%>&-E<'1I;VX^(#QW
M.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!396UI2&ED9&5N/3-$=')U
M92!5;FAI9&57:&5N57-E9#TS1'1R=64@3F%M93TS1%-I9VYA='5R93X\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
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M17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M
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M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4')I;W)I='D],T0Q,2!11F]R;6%T/3-$=')U92!.86UE/3-$4W5B=&ET
M;&4^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS
M1&9A;'-E(%-E;6E(:61D96X],T1T<G5E(%5N:&ED95=H96Y5<V5D/3-$=')U
M92!.86UE/3-$4V%L=71A=&EO;CX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
M>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH
M:61E5VAE;E5S960],T1T<G5E($YA;64],T1$871E/CPO=SI,<V1%>&-E<'1I
M;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!396UI2&ED9&5N
M/3-$=')U92!5;FAI9&57:&5N57-E9#TS1'1R=64@3F%M93TS1"=";V1Y(%1E
M>'0@1FER<W0@26YD96YT)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
M<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E
M5VAE;E5S960],T1T<G5E($YA;64],T0G0F]D>2!497AT($9I<G-T($EN9&5N
M="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
M/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T
M<G5E($YA;64],T0G3F]T92!(96%D:6YG)SX\+W<Z3'-D17AC97!T:6]N/B`\
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M=64@3F%M93TS1$AY<&5R;&EN:SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
M>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH
M:61E5VAE;E5S960],T1T<G5E($YA;64],T1&;VQL;W=E9$AY<&5R;&EN:SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4')I;W)I='D],T0R,B!11F]R;6%T/3-$=')U92!.86UE/3-$4W1R;VYG
M/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F
M86QS92!0<FEO<FET>3TS1#(P(%%&;W)M870],T1T<G5E($YA;64],T1%;7!H
M87-I<SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
M/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T
M<G5E($YA;64],T0G1&]C=6UE;G0@36%P)SX\+W<Z3'-D17AC97!T:6]N/B`\
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M;W)M)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
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M($ME>6)O87)D)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E
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M;F4@3&ES="`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M<V5D/3-$=')U92!.86UE/3-$)U1A8FQE(%-I;7!L92`S)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI
M9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B
M;&4@0VQA<W-I8R`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE
M;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@0VQA<W-I8R`R)SX\+W<Z3'-D
M17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M
M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G
M5&%B;&4@0VQA<W-I8R`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
M<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E
M5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@0VQA<W-I8R`T)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
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M3F%M93TS1"=486)L92!#;VQO<F9U;"`S)SX\+W<Z3'-D17AC97!T:6]N/B`\
M=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R
M=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@0V]L=6UN
M<R`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
M/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T
M<G5E($YA;64],T0G5&%B;&4@0V]L=6UN<R`R)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS
M1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@0V]L
M=6UN<R`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
M:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960]
M,T1T<G5E($YA;64],T0G5&%B;&4@0V]L=6UN<R`T)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E
M;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@
M0V]L=6UN<R`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
M3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S
M960],T1T<G5E($YA;64],T0G5&%B;&4@1W)I9"`Q)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E
M;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@
M1W)I9"`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
M:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960]
M,T1T<G5E($YA;64],T0G5&%B;&4@1W)I9"`S)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS
M1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@1W)I
M9"`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
M/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T
M<G5E($YA;64],T0G5&%B;&4@1W)I9"`U)SX\+W<Z3'-D17AC97!T:6]N/B`\
M=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R
M=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@1W)I9"`V
M)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$
M9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E
M($YA;64],T0G5&%B;&4@1W)I9"`W)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
M<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@
M56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@1W)I9"`X)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA
M;64],T0G5&%B;&4@3&ES="`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
M>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH
M:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@3&ES="`R)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
M4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64]
M,T0G5&%B;&4@3&ES="`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
M<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E
M5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@3&ES="`T)SX\+W<Z3'-D
M17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M
M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G
M5&%B;&4@3&ES="`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE
M;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@3&ES="`V)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI
M9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B
M;&4@3&ES="`W)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
M3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S
M960],T1T<G5E($YA;64],T0G5&%B;&4@3&ES="`X)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E
M;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@
M,T0@969F96-T<R`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE
M;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@,T0@969F96-T<R`R)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
M4V5M:4AI9&1E;CTS1'1R=64@56YH:61E5VAE;E5S960],T1T<G5E($YA;64]
M,T0G5&%B;&4@,T0@969F96-T<R`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
M<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@
M56YH:61E5VAE;E5S960],T1T<G5E($YA;64],T0G5&%B;&4@0V]N=&5M<&]R
M87)Y)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
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M/3-$=')U92!.86UE/3-$)U1A8FQE(%-U8G1L92`Q)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E
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M8B`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
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M)U1A8FQE(%1H96UE)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4V5M:4AI9&1E;CTS1'1R=64@3F%M93TS1"=0
M;&%C96AO;&1E<B!497AT)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
M<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0Q(%%&;W)M870],T1T
M<G5E($YA;64],T0G3F\@4W!A8VEN9R<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z
M3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y/3-$-C`@3F%M
M93TS1"=,:6=H="!3:&%D:6YG)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M9R`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
M/3-$9F%L<V4@4')I;W)I='D],T0V-"!.86UE/3-$)TUE9&EU;2!3:&%D:6YG
M(#(G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960]
M,T1F86QS92!0<FEO<FET>3TS1#8U($YA;64],T0G365D:75M($QI<W0@,2<^
M/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A
M;'-E(%!R:6]R:71Y/3-$-C8@3F%M93TS1"=-961I=6T@3&ES="`R)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
M4')I;W)I='D],T0V-R!.86UE/3-$)TUE9&EU;2!'<FED(#$G/CPO=SI,<V1%
M>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO
M<FET>3TS1#8X($YA;64],T0G365D:75M($=R:60@,B<^/"]W.DQS9$5X8V5P
M=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y
M/3-$-CD@3F%M93TS1"=-961I=6T@1W)I9"`S)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0W
M,"!.86UE/3-$)T1A<FL@3&ES="<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D
M17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y/3-$-S$@3F%M93TS
M1"=#;VQO<F9U;"!3:&%D:6YG)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
M>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0W,B!.86UE/3-$
M)T-O;&]R9G5L($QI<W0G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P
M=&EO;B!,;V-K960],T1F86QS92!0<FEO<FET>3TS1#<S($YA;64],T0G0V]L
M;W)F=6P@1W)I9"<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N
M($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y/3-$-C`@3F%M93TS1"=,:6=H="!3
M:&%D:6YG($%C8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
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M1"=-961I=6T@4VAA9&EN9R`Q($%C8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0V
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M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0S-"!11F]R;6%T/3-$=')U92!.86UE/3-$)TQI<W0@4&%R86=R87!H
M)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$
M9F%L<V4@4')I;W)I='D],T0R.2!11F]R;6%T/3-$=')U92!.86UE/3-$475O
M=&4^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS
M1&9A;'-E(%!R:6]R:71Y/3-$,S`@449O<FUA=#TS1'1R=64@3F%M93TS1"=)
M;G1E;G-E(%%U;W1E)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
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M93TS1"=-961I=6T@1W)I9"`R($%C8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0V
M.2!.86UE/3-$)TUE9&EU;2!'<FED(#,@06-C96YT(#$G/CPO=SI,<V1%>&-E
M<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO<FET
M>3TS1#<P($YA;64],T0G1&%R:R!,:7-T($%C8V5N="`Q)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
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M8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
M:V5D/3-$9F%L<V4@4')I;W)I='D],T0V,"!.86UE/3-$)TQI9VAT(%-H861I
M;F<@06-C96YT(#(G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO
M;B!,;V-K960],T1F86QS92!0<FEO<FET>3TS1#8Q($YA;64],T0G3&EG:'0@
M3&ES="!!8V-E;G0@,B<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T
M:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y/3-$-C(@3F%M93TS1"=,:6=H
M="!'<FED($%C8V5N="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
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M/3-$-C4@3F%M93TS1"=-961I=6T@3&ES="`Q($%C8V5N="`R)SX\+W<Z3'-D
M17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I
M;W)I='D],T0V-B!.86UE/3-$)TUE9&EU;2!,:7-T(#(@06-C96YT(#(G/CPO
M=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS
M92!0<FEO<FET>3TS1#8W($YA;64],T0G365D:75M($=R:60@,2!!8V-E;G0@
M,B<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS
M1&9A;'-E(%!R:6]R:71Y/3-$-C@@3F%M93TS1"=-961I=6T@1W)I9"`R($%C
M8V5N="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
M:V5D/3-$9F%L<V4@4')I;W)I='D],T0V.2!.86UE/3-$)TUE9&EU;2!'<FED
M(#,@06-C96YT(#(G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO
M;B!,;V-K960],T1F86QS92!0<FEO<FET>3TS1#<P($YA;64],T0G1&%R:R!,
M:7-T($%C8V5N="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
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M3F%M93TS1"=#;VQO<F9U;"!'<FED($%C8V5N="`R)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
M,T0V,"!.86UE/3-$)TQI9VAT(%-H861I;F<@06-C96YT(#,G/CPO=SI,<V1%
M>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO
M<FET>3TS1#8Q($YA;64],T0G3&EG:'0@3&ES="!!8V-E;G0@,R<^/"]W.DQS
M9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R
M:6]R:71Y/3-$-C(@3F%M93TS1"=,:6=H="!'<FED($%C8V5N="`S)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
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M3&ES="`Q($%C8V5N="`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
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M3F%M93TS1"=-961I=6T@1W)I9"`R($%C8V5N="`S)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
M,T0V.2!.86UE/3-$)TUE9&EU;2!'<FED(#,@06-C96YT(#,G/CPO=SI,<V1%
M>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO
M<FET>3TS1#<P($YA;64],T0G1&%R:R!,:7-T($%C8V5N="`S)SX\+W<Z3'-D
M17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I
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M($%C8V5N="`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M:6=H="!'<FED($%C8V5N="`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M:71Y/3-$-C4@3F%M93TS1"=-961I=6T@3&ES="`Q($%C8V5N="`T)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
M4')I;W)I='D],T0V-B!.86UE/3-$)TUE9&EU;2!,:7-T(#(@06-C96YT(#0G
M/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F
M86QS92!0<FEO<FET>3TS1#8W($YA;64],T0G365D:75M($=R:60@,2!!8V-E
M;G0@-"<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME
M9#TS1&9A;'-E(%!R:6]R:71Y/3-$-C@@3F%M93TS1"=-961I=6T@1W)I9"`R
M($%C8V5N="`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
M3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0V.2!.86UE/3-$)TUE9&EU;2!'
M<FED(#,@06-C96YT(#0G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P
M=&EO;B!,;V-K960],T1F86QS92!0<FEO<FET>3TS1#<P($YA;64],T0G1&%R
M:R!,:7-T($%C8V5N="`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E
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M-S,@3F%M93TS1"=#;VQO<F9U;"!'<FED($%C8V5N="`T)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0V,"!.86UE/3-$)TQI9VAT(%-H861I;F<@06-C96YT(#4G/CPO=SI,
M<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0
M<FEO<FET>3TS1#8Q($YA;64],T0G3&EG:'0@3&ES="!!8V-E;G0@-2<^/"]W
M.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E
M(%!R:6]R:71Y/3-$-C(@3F%M93TS1"=,:6=H="!'<FED($%C8V5N="`U)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4')I;W)I='D],T0V,R!.86UE/3-$)TUE9&EU;2!3:&%D:6YG(#$@06-C
M96YT(#4G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K
M960],T1F86QS92!0<FEO<FET>3TS1#8T($YA;64],T0G365D:75M(%-H861I
M;F<@,B!!8V-E;G0@-2<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T
M:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y/3-$-C4@3F%M93TS1"=-961I
M=6T@3&ES="`Q($%C8V5N="`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M-C@@3F%M93TS1"=-961I=6T@1W)I9"`R($%C8V5N="`U)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0V.2!.86UE/3-$)TUE9&EU;2!'<FED(#,@06-C96YT(#4G/CPO=SI,
M<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0
M<FEO<FET>3TS1#<P($YA;64],T0G1&%R:R!,:7-T($%C8V5N="`U)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
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M<FED($%C8V5N="`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
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M1"=,:6=H="!'<FED($%C8V5N="`V)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
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M:6]R:71Y/3-$-C4@3F%M93TS1"=-961I=6T@3&ES="`Q($%C8V5N="`V)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
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M9"`R($%C8V5N="`V)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0V.2!.86UE/3-$)TUE9&EU
M;2!'<FED(#,@06-C96YT(#8G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X
M8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO<FET>3TS1#<P($YA;64],T0G
M1&%R:R!,:7-T($%C8V5N="`V)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M/3-$-S,@3F%M93TS1"=#;VQO<F9U;"!'<FED($%C8V5N="`V)SX\+W<Z3'-D
M17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I
M;W)I='D],T0Q.2!11F]R;6%T/3-$=')U92!.86UE/3-$)U-U8G1L92!%;7!H
M87-I<R<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME
M9#TS1&9A;'-E(%!R:6]R:71Y/3-$,C$@449O<FUA=#TS1'1R=64@3F%M93TS
M1"=);G1E;G-E($5M<&AA<VES)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M;'-E(%!R:6]R:71Y/3-$-#(@3F%M93TS1"=0;&%I;B!486)L92`R)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
M4')I;W)I='D],T0T,R!.86UE/3-$)U!L86EN(%1A8FQE(#,G/CPO=SI,<V1%
M>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO
M<FET>3TS1#0T($YA;64],T0G4&QA:6X@5&%B;&4@-"<^/"]W.DQS9$5X8V5P
M=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y
M/3-$-#4@3F%M93TS1"=0;&%I;B!486)L92`U)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0T
M,"!.86UE/3-$)T=R:60@5&%B;&4@3&EG:'0G/CPO=SI,<V1%>&-E<'1I;VX^
M(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO<FET>3TS1#0V
M($YA;64],T0G1W)I9"!486)L92`Q($QI9VAT)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0T
M-R!.86UE/3-$)T=R:60@5&%B;&4@,B<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z
M3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R:71Y/3-$-#@@3F%M
M93TS1"='<FED(%1A8FQE(#,G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X
M8V5P=&EO;B!,;V-K960],T1F86QS92!0<FEO<FET>3TS1#0Y($YA;64],T0G
M1W)I9"!486)L92`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U,"!.86UE/3-$)T=R:60@
M5&%B;&4@-2!$87)K)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
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M,T0G1W)I9"!486)L92`Q($QI9VAT($%C8V5N="`Q)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
M,T0T-R!.86UE/3-$)T=R:60@5&%B;&4@,B!!8V-E;G0@,2<^/"]W.DQS9$5X
M8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R
M:71Y/3-$-#@@3F%M93TS1"='<FED(%1A8FQE(#,@06-C96YT(#$G/CPO=SI,
M<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0
M<FEO<FET>3TS1#0Y($YA;64],T0G1W)I9"!486)L92`T($%C8V5N="`Q)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4')I;W)I='D],T0U,"!.86UE/3-$)T=R:60@5&%B;&4@-2!$87)K($%C
M8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
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M>3TS1#0V($YA;64],T0G1W)I9"!486)L92`Q($QI9VAT($%C8V5N="`R)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4')I;W)I='D],T0T-R!.86UE/3-$)T=R:60@5&%B;&4@,B!!8V-E;G0@
M,B<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS
M1&9A;'-E(%!R:6]R:71Y/3-$-#@@3F%M93TS1"='<FED(%1A8FQE(#,@06-C
M96YT(#(G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K
M960],T1F86QS92!0<FEO<FET>3TS1#0Y($YA;64],T0G1W)I9"!486)L92`T
M($%C8V5N="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
M3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U,"!.86UE/3-$)T=R:60@5&%B
M;&4@-2!$87)K($%C8V5N="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M86QS92!0<FEO<FET>3TS1#0V($YA;64],T0G1W)I9"!486)L92`Q($QI9VAT
M($%C8V5N="`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M1W)I9"!486)L92`T($%C8V5N="`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
M<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U,"!.86UE
M/3-$)T=R:60@5&%B;&4@-2!$87)K($%C8V5N="`S)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
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M86)L92`Q($QI9VAT($%C8V5N="`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
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M1#0Y($YA;64],T0G1W)I9"!486)L92`T($%C8V5N="`T)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0U,"!.86UE/3-$)T=R:60@5&%B;&4@-2!$87)K($%C8V5N="`T)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
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M;64],T0G1W)I9"!486)L92`Q($QI9VAT($%C8V5N="`U)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0T-R!.86UE/3-$)T=R:60@5&%B;&4@,B!!8V-E;G0@-2<^/"]W.DQS
M9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R
M:6]R:71Y/3-$-#@@3F%M93TS1"='<FED(%1A8FQE(#,@06-C96YT(#4G/CPO
M=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS
M92!0<FEO<FET>3TS1#0Y($YA;64],T0G1W)I9"!486)L92`T($%C8V5N="`U
M)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$
M9F%L<V4@4')I;W)I='D],T0U,"!.86UE/3-$)T=R:60@5&%B;&4@-2!$87)K
M($%C8V5N="`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M<FET>3TS1#0V($YA;64],T0G1W)I9"!486)L92`Q($QI9VAT($%C8V5N="`V
M)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$
M9F%L<V4@4')I;W)I='D],T0T-R!.86UE/3-$)T=R:60@5&%B;&4@,B!!8V-E
M;G0@-B<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME
M9#TS1&9A;'-E(%!R:6]R:71Y/3-$-#@@3F%M93TS1"='<FED(%1A8FQE(#,@
M06-C96YT(#8G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,
M;V-K960],T1F86QS92!0<FEO<FET>3TS1#0Y($YA;64],T0G1W)I9"!486)L
M92`T($%C8V5N="`V)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I
M;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U,"!.86UE/3-$)T=R:60@
M5&%B;&4@-2!$87)K($%C8V5N="`V)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
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M,T1F86QS92!0<FEO<FET>3TS1#0V($YA;64],T0G3&ES="!486)L92`Q($QI
M9VAT)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D
M/3-$9F%L<V4@4')I;W)I='D],T0T-R!.86UE/3-$)TQI<W0@5&%B;&4@,B<^
M/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A
M;'-E(%!R:6]R:71Y/3-$-#@@3F%M93TS1"=,:7-T(%1A8FQE(#,G/CPO=SI,
M<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0
M<FEO<FET>3TS1#0Y($YA;64],T0G3&ES="!486)L92`T)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0U,"!.86UE/3-$)TQI<W0@5&%B;&4@-2!$87)K)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0U,2!.86UE/3-$)TQI<W0@5&%B;&4@-B!#;VQO<F9U;"<^/"]W.DQS
M9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R
M:6]R:71Y/3-$-3(@3F%M93TS1"=,:7-T(%1A8FQE(#<@0V]L;W)F=6PG/CPO
M=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS
M92!0<FEO<FET>3TS1#0V($YA;64],T0G3&ES="!486)L92`Q($QI9VAT($%C
M8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
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M="!486)L92`T($%C8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
M>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U,"!.86UE/3-$
M)TQI<W0@5&%B;&4@-2!$87)K($%C8V5N="`Q)SX\+W<Z3'-D17AC97!T:6]N
M/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U
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M92`Q($QI9VAT($%C8V5N="`R)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M($YA;64],T0G3&ES="!486)L92`T($%C8V5N="`R)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
M,T0U,"!.86UE/3-$)TQI<W0@5&%B;&4@-2!$87)K($%C8V5N="`R)SX\+W<Z
M3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@
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M,T0G3&ES="!486)L92`Q($QI9VAT($%C8V5N="`S)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
M,T0T-R!.86UE/3-$)TQI<W0@5&%B;&4@,B!!8V-E;G0@,R<^/"]W.DQS9$5X
M8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS1&9A;'-E(%!R:6]R
M:71Y/3-$-#@@3F%M93TS1"=,:7-T(%1A8FQE(#,@06-C96YT(#,G/CPO=SI,
M<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K960],T1F86QS92!0
M<FEO<FET>3TS1#0Y($YA;64],T0G3&ES="!486)L92`T($%C8V5N="`S)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4')I;W)I='D],T0U,"!.86UE/3-$)TQI<W0@5&%B;&4@-2!$87)K($%C
M8V5N="`S)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C
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M>3TS1#0V($YA;64],T0G3&ES="!486)L92`Q($QI9VAT($%C8V5N="`T)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
M<V4@4')I;W)I='D],T0T-R!.86UE/3-$)TQI<W0@5&%B;&4@,B!!8V-E;G0@
M-"<^/"]W.DQS9$5X8V5P=&EO;CX@/'<Z3'-D17AC97!T:6]N($QO8VME9#TS
M1&9A;'-E(%!R:6]R:71Y/3-$-#@@3F%M93TS1"=,:7-T(%1A8FQE(#,@06-C
M96YT(#0G/CPO=SI,<V1%>&-E<'1I;VX^(#QW.DQS9$5X8V5P=&EO;B!,;V-K
M960],T1F86QS92!0<FEO<FET>3TS1#0Y($YA;64],T0G3&ES="!486)L92`T
M($%C8V5N="`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
M3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U,"!.86UE/3-$)TQI<W0@5&%B
M;&4@-2!$87)K($%C8V5N="`T)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%
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M86QS92!0<FEO<FET>3TS1#0V($YA;64],T0G3&ES="!486)L92`Q($QI9VAT
M($%C8V5N="`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@
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M3&ES="!486)L92`T($%C8V5N="`U)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
M<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D],T0U,"!.86UE
M/3-$)TQI<W0@5&%B;&4@-2!$87)K($%C8V5N="`U)SX\+W<Z3'-D17AC97!T
M:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I='D]
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M86)L92`Q($QI9VAT($%C8V5N="`V)SX\+W<Z3'-D17AC97!T:6]N/B`\=SI,
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M1#0Y($YA;64],T0G3&ES="!486)L92`T($%C8V5N="`V)SX\+W<Z3'-D17AC
M97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L<V4@4')I;W)I
M='D],T0U,"!.86UE/3-$)TQI<W0@5&%B;&4@-2!$87)K($%C8V5N="`V)SX\
M+W<Z3'-D17AC97!T:6]N/B`\=SI,<V1%>&-E<'1I;VX@3&]C:V5D/3-$9F%L
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M9W1E(&US;R`Q,%T^#0H\<W1Y;&4^("\J(%-T>6QE($1E9FEN:71I;VYS("HO
M('1A8FQE+DUS;TYO<FUA;%1A8FQE('MM<V\M<W1Y;&4M;F%M93HB5&%B;&4@
M3F]R;6%L(CL@;7-O+71S='EL92UR;W=B86YD+7-I>F4Z,#L@;7-O+71S='EL
M92UC;VQB86YD+7-I>F4Z,#L@;7-O+7-T>6QE+6YO<VAO=SIY97,[(&US;RUS
M='EL92UP<FEO<FET>3HY.3L@;7-O+7-T>6QE+7!A<F5N=#HB(CL@;7-O+7!A
M9&1I;F<M86QT.C!I;B`U+C1P="`P:6X@-2XT<'0[(&US;RUP87)A+6UA<F=I
M;CHP:6X[(&US;RUP87)A+6UA<F=I;BUB;W1T;VTZ+C`P,#%P=#L@;7-O+7!A
M9VEN871I;VXZ=VED;W<M;W)P:&%N.R!F;VYT+7-I>F4Z,3`N,'!T.R!F;VYT
M+69A;6EL>3HB5&EM97,@3F5W(%)O;6%N(BQS97)I9CL@;7-O+6)I9&DM;&%N
M9W5A9V4Z2$4[?0T*/"]S='EL93X-"CPA6V5N9&EF72TM/CPO9F]N=#X\+V9O
M;G0^#0H\<"!S='EL93TS1"=M87)G:6XZ(#!I;B`P:6X@,"XP,#`Q<'0[(&9O
M;G0M<VEZ93H@,3)P=#L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG
M+"!S97)I9CLG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#LG/D]N
M($1E8V5M8F5R(#$R+"`R,#$T+"!T:&4@4W5B<VED:6%R>2!E;G1E<F5D(&EN
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M,T1C96YT97(@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I
M;F<],T0P('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG.R!W:61T:#H@,3`P)3LG/@T*#0H\='(@=F%L
M:6=N/3-$=&]P/@T*/'1D('-T>6QE/3-$)V)O<F1E<BUL969T.B!N;VYE.R!B
M;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB
M;W1T;VTZ(&YO;F4[('=I9'1H.B`T-2XS-7!T.R<^#0H\9&EV/B8C,38P.SPO
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M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^3VX@
M36%Y(#(V+"`R,#$T+"!T:&4@4W5B<VED:6%R>2!E;G1E<F5D(&EN=&\@82!S
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M<B\^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R<^#0H\9&EV('-T>6QE/3-$)V-O;&]R.B`C,#`P,#`P
M.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M<VEZ93H@
M,39P>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A<FEA;G0Z(&YO<FUA
M;#L@9F]N="UW96EG:'0Z(&YO<FUA;#L@;&5T=&5R+7-P86-I;F<Z(&YO<FUA
M;#L@;&EN92UH96EG:'0Z(&YO<FUA;#L@;W)P:&%N<SH@875T;SL@=&5X="UA
M;&EG;CH@<W1A<G0[('1E>'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M
M.B!N;VYE.R!W:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(#$[('=O<F0M
M<W!A8VEN9SH@,'!X.R`M=V5B:VET+71E>'0M<W1R;VME+7=I9'1H.B`P<'@[
M)SX-"CQD:78@8VQA<W,],T1#=7)S;W)0;VEN=&5R/@T*/'1A8FQE('=I9'1H
M/3-$,3`P)2!C96QL<&%D9&EN9STS1#`@8F]R9&5R/3-$,"!C96QL<W!A8VEN
M9STS1#`^#0H-"CQT<CX-"CQT9"!S='EL93TS1"=W:61T:#H@,2XR-24[)SX\
M8G(O/CPO=&0^#0H\=&0@<W1Y;&4],T0G=VED=&@Z(#`N.#(E.R!V97)T:6-A
M;"UA;&EG;CH@=&]P.R<@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P=#LG/F@N/"]F;VYT/CPO=&0^#0H\=&0@<W1Y;&4],T0G
M=VED=&@Z(#,S)3LG/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P=#LG
M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N
M)RP@<V5R:68[)SX\8CX\9F]N="!S='EL93TS1"=C;VQO<CH@(S`P,#`P,#L@
M9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$S
M+C,S,S,S,S`Q-30T,3EP>#L@9F]N="US='EL93H@;F]R;6%L.R!F;VYT+79A
M<FEA;G0Z(&YO<FUA;#L@9F]N="UW96EG:'0Z(&YO<FUA;#L@;&5T=&5R+7-P
M86-I;F<Z(&YO<FUA;#L@;&EN92UH96EG:'0Z(&YO<FUA;#L@;W)P:&%N<SH@
M875T;SL@=&5X="UA;&EG;CH@+7=E8FMI="UL969T.R!T97AT+6EN9&5N=#H@
M,'!X.R!T97AT+71R86YS9F]R;3H@;F]N93L@=VAI=&4M<W!A8V4Z(&YO<FUA
M;#L@=VED;W=S.B`Q.R!W;W)D+7-P86-I;F<Z(#!P>#L@+7=E8FMI="UT97AT
M+7-T<F]K92UW:61T:#H@,'!X.R!D:7-P;&%Y.B!I;FQI;F4@(6EM<&]R=&%N
M=#L@9FQO870Z(&YO;F4[(&)A8VMG<F]U;F0M8V]L;W(Z("-F9F9F9F8[)SY/
M;B!&96)R=6%R>2`R+"`R,#$U+"!T:&4@4W5B<VED:6%R>2!E;G1E<F5D(&EN
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M9B!W:&EC:"!W87,@<F5C;V=N:7IE9"!T:')O=6=H($9E8G)U87)Y(#(X+"`R
M,#$U+CPO9F]N=#X\+V9O;G0^/"]T9#X-"CPO='(^#0H-"CPO=&%B;&4^#0H\
M8G(O/CPO9&EV/@T*/&1I=B!C;&%S<STS1$-U<G-O<E!O:6YT97(^#0H\=&%B
M;&4@=VED=&@],T0Q,#`E(&-E;&QP861D:6YG/3-$,"!B;W)D97(],T0P(&-E
M;&QS<&%C:6YG/3-$,#X-"@T*/'1R/@T*/'1D('-T>6QE/3-$)W=I9'1H.B`Q
M+C(U)3LG/CQB<B\^/"]T9#X-"CQT9"!S='EL93TS1"=W:61T:#H@,"XX,B4[
M('9E<G1I8V%L+6%L:6=N.B!T;W`[)R!V86QI9VX],T1T;W`^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R<^:2X\+V9O;G0^/"]T9#X-"CQT9"!S
M='EL93TS1"=W:61T:#H@,S,E.R<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T.R<^3VXF(S$V,#M*86YU87)Y(#(P+"`R,#$U+"!T:&4@4W5B<VED
M:6%R>2!E;G1E<F5D(&EN=&\@82!P=7)C:&%S92!O<F1E<B!F;W(@=&AE(&UA
M;G5F86-T=7)I;F<@;V8@:6YS=6QI;B!C87!S=6QE<R!F;W(@82!T;W1A;"!C
M;VYS:61E<F%T:6]N(&]F(%-W:7-S($9R86YC("@B0TA&(BDF(S$V,#L\9F]N
M=#XR,3$\+V9O;G0^("AA<'!R;WAI;6%T96QY("0\9F]N=#XR-#$\+V9O;G0^
M*2!O9B!W:&EC:"!#2$8@/&9O;G0^,3`T/"]F;VYT/B`H87!P<F]X:6UA=&5L
M>2`D/&9O;G0^,3$X/"]F;VYT/BD@=V%S(')E8V]G;FEZ960@=&AR;W5G:"!&
M96)R=6%R>2`R."P@,C`Q-2X\+V9O;G0^/"]T9#X-"CPO='(^#0H-"CPO=&%B
M;&4^#0H\+V1I=CX-"CQD:78@8VQA<W,],T1#=7)S;W)0;VEN=&5R/CQB<B\^
M/"]D:78^#0H\+V1I=CX-"CPO9&EV/@T*/&1I=CX-"CQD:78@8VQA<W,],T1#
M=7)S;W)0;VEN=&5R/@T*/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS
M1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
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M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@
M3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^:BX\+V9O;G0^/"]D:78^
M#0H\+W1D/@T*/'1D('-T>6QE/3-$)V)O<F1E<BUL969T.B!N;VYE.R!B;W)D
M97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T
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M)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F
M=#H@-S)P=#L@;6%R9VEN+7)I9VAT.B`M,"XP-7!T.R<@86QI9VX],T1L969T
M/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@9F]N="UF86UI;'DZ
M("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P<'0[)SY4:&4@4W5B
M<VED:6%R>2!I<R!C;VUM:71T960@=&\@<&%Y(')O>6%L=&EE<R!T;R!T:&4@
M0FEO+4IE<G5S86QE;2!F=6YD(&]N('!R;V-E961S(&9R;VT@9G5T=7)E('-A
M;&5S(&%T(&$@<F%T92!O9B`\9F]N=#XT/"]F;VYT/B4@86YD('5P('1O(#QF
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M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R!M87)G:6XM;&5F=#H@-S)P=#L@;6%R9VEN+7)I9VAT.B`M,"XP
M-7!T.R<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN
M;&EN93L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I
M>F4Z(#$P<'0[)SY$=7)I;F<@=&AE('-I>"8C,38P.VUO;G1H('!E<FEO9"!E
M;F1E9"!&96)R=6%R>2`R."P@,C`Q-2P@=&AE($-O;7!A;GD@<F5C96EV960@
M/&9O;G0^;F\\+V9O;G0^(&=R86YT<R!F<F]M('1H92!":6\M2F5R=7-A;&5M
M(&9U;F0N/"]F;VYT/CPO9&EV/@T*#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD
M96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M
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M<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!W:61T
M:#H@,3`P)3LG/@T*#0H\='(@=F%L:6=N/3-$=&]P/@T*/'1D('-T>6QE/3-$
M)V)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E
M<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`T-2XS
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M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@
M9F]N="US:7IE.B`Q,'!T.R<^1W)A;G1S(&9R;VT@=&AE($]F9FEC92!O9B!T
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M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&IU
M<W1I9GD^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@-S)P=#L@;6%R
M9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<[(&9O;G0M<VEZ93H@,3!P=#LG/E5N9&5R('1H92!T97)M<R!O9B!T:&4@
M0V]M<&%N>2=S(&9U;F1I;F<@9G)O;2!T:&4@3T-3+"!R;WEA;'1I97,@;V8@
M/&9O;G0^,SPO9F]N=#XE+3QF;VYT/C,N-3PO9F]N=#XE(&%R92!P87EA8FQE
M(&]N('-A;&5S(&]F('!R;V1U8W1S(&1E=F5L;W!E9"!F<F]M(&$@<')O:F5C
M="!S;R!F=6YD960L('5P('1O(#QF;VYT/C$P,#PO9F]N=#XE(&]F('1H92!A
M;6]U;G0@;V8@=&AE(&=R86YT(')E8V5I=F5D(&)Y('1H92!#;VUP86YY("AD
M;VQL87(@;&EN:V5D*2!W:71H('1H92!A9&1I=&EO;B!O9B!A;FYU86P@:6YT
M97)E<W0@870@82!R871E(&)A<V5D(&]N(#QF;VYT/DQ)0D]2/"]F;VYT/BX\
M+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[
M(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG
M:'0Z(#!P=#LG(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX-"CQD:78@
M<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA
M<F=I;BUL969T.B`W,G!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$
M;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M
M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^070@
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M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z
M(#!P=#LG(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX-"CQD:78@<W1Y
M;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUL969T.B`W,G!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$;&5F
M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^07,@;V8@
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M9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!W:61T:#H@,3`P)3LG/@T*#0H\='(@=F%L:6=N/3-$=&]P/@T*
M/'1D('-T>6QE/3-$)V)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z
M(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[
M('=I9'1H.B`T-2XS-7!T.R<^#0H\9&EV/B8C,38P.SPO9&EV/@T*/"]T9#X-
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M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@
M3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^1F]R('1H92!S:7@@86YD
M)B,Q-C`[/&9O;G0^=&AR964\+V9O;G0^(&UO;G1H('!E<FEO9',@96YD960@
M1F5B<G5A<GD@,C@L(#(P,34L('1H92!R97-E87)C:"!A;F0@9&5V96QO<&UE
M;G0@97AP96YS97,@87)E('!R97-E;G1E9"!N970@;V8@3T-3(&%N9"!":6\M
M2F5R=7-A;&5M(&9U;F0@9W)A;G1S+"!I;B!T:&4@=&]T86P@86UO=6YT(&]F
M("0\9F]N=#XQ-SPO9F]N=#XF(S$V,#MA;F0@)#QF;VYT/C$\+V9O;G0^+"!R
M97-P96-T:79E;'DN/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO='(^#0H-"CPO
M=&%B;&4^#0H\+V1I=CX-"CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6EN
M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@
M;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&IU<W1I9GD^/&)R+SX\+V1I
M=CX-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?,C=E9#<P9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(W960W,&9A7V%A9#1?-#(X
M,U]B,3DQ7V,P,#9A,6,R.3DU-B]7;W)K<VAE971S+U-H965T,#DN:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY&04E2(%9!3%5%
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P
M,34\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^1D%)4B!604Q512!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9!25(@5D%,544\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQD:78@:60],T1%9&=A<E-!03$R,S0U-S@Y
M,#`P,"!S='EL93TS1"=F;VYT+69A;6EL>2`Z("=4:6UE<R!.97<@4F]M86XG
M.R<^#0H\9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!T
M97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG
M:'0Z(#!P=#LG/@T*/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z
M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@
M9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#LG/DY/5$4@/&9O
M;G0^,SPO9F]N=#X@+2!&04E2(%9!3%5%.CPO9F]N=#X\+V1I=CX-"CPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SLG/CQB<B\^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@-#5P=#L@;6%R
M9VEN+7)I9VAT.B`M,"XP-7!T.R<@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ(&EN;&EN93L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@
M4F]M86XG.R!F;VYT+7-I>F4Z(#$P<'0[)SY&86ER('9A;'5E(&ES(&)A<V5D
M(&]N('1H92!P<FEC92!T:&%T('=O=6QD(&)E(')E8V5I=F5D('1O('-E;&P@
M86X@87-S970@;W(@<&%I9"!T;R!T<F%N<V9E<B!A(&QI86)I;&ET>2!I;B!A
M;B!O<F1E<FQY('1R86YS86-T:6]N(&)E='=E96X@;6%R:V5T('!A<G1I8VEP
M86YT<R!A="!T:&4@;65A<W5R96UE;G0@9&%T92X@26X@;W)D97(@=&\@:6YC
M<F5A<V4@8V]N<VES=&5N8WD@86YD(&-O;7!A<F%B:6QI='D@:6X@9F%I<B!V
M86QU92!M96%S=7)E;65N=',L('1H92!G=6ED86YC92!E<W1A8FQI<VAE<R!A
M(&9A:7(@=F%L=64@:&EE<F%R8VAY('1H870@<')I;W)I=&EZ97,@;V)S97)V
M86)L92!A;F0@=6YO8G-E<G9A8FQE(&EN<'5T<R!U<V5D('1O(&UE87-U<F4@
M9F%I<B!V86QU92!I;G1O(#QF;VYT/G1H<F5E/"]F;VYT/B!B<F]A9"!L979E
M;',L('=H:6-H(&%R92!D97-C<FEB960@87,@9F]L;&]W<SH\+V9O;G0^/"]D
M:78^#0H\9&EV/B8C,38P.SPO9&EV/@T*/&1I=CX-"CQD:78@8VQA<W,],T1#
M=7)S;W)0;VEN=&5R/@T*/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS
M1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N
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M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W
M(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[3&5V96P@/&9O;G0^
M,3PO9F]N=#XZ/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9#X-"CQD:78@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@9F]N
M="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P<'0[
M)SY1=6]T960@<')I8V5S("AU;F%D:G5S=&5D*2!I;B!A8W1I=F4@;6%R:V5T
M<R!T:&%T(&%R92!A8V-E<W-I8FQE(&%T('1H92!M96%S=7)E;65N="!D871E
M(&9O<B!A<W-E=',@;W(@;&EA8FEL:71I97,N(%1H92!F86ER('9A;'5E(&AI
M97)A<F-H>2!G:79E<R!T:&4@:&EG:&5S="!P<FEO<FET>2!T;R!,979E;"`\
M9F]N=#XQ/"]F;VYT/B!I;G!U=',N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CPO
M='(^#0H-"CPO=&%B;&4^#0H\+V1I=CX-"CPO9&EV/@T*/&1I=CXF(S$V,#L\
M+V1I=CX-"CQD:78^#0H\9&EV(&-L87-S/3-$0W5R<V]R4&]I;G1E<CX-"CQT
M86)L92!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$
M,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I9'1H.B`Q,#`E.R<^
M#0H-"CQT<B!V86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4],T0G8F]R9&5R+6QE
M9G0Z(&YO;F4[(&)O<F1E<BUR:6=H=#H@;F]N93L@8F]R9&5R+71O<#H@;F]N
M93L@8F]R9&5R+6)O='1O;3H@;F]N93L@=VED=&@Z(#0S<'0[)SX-"CQD:78^
M)B,Q-C`[/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)V)O<F1E<BUL969T
M.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[
M(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`V,W!T.R<^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA<F=I;BUL969T.B`P<'0[(&UA
M<F=I;BUR:6=H=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@:6YL
M:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M<VEZ
M93H@,3!P=#LG/B8C,38P.TQE=F5L(#QF;VYT/C(\+V9O;G0^.CPO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0^#0H\9&EV(&%L:6=N/3-$;&5F=#X\9F]N="!S
M='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@
M3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^3V)S97)V86)L92!P<FEC
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M;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I
M9'1H.B`Q,#`E.R<^#0H-"CQT<B!V86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6QE9G0Z(&YO;F4[(&)O<F1E<BUR:6=H=#H@;F]N93L@8F]R
M9&5R+71O<#H@;F]N93L@8F]R9&5R+6)O='1O;3H@;F]N93L@=VED=&@Z(#0S
M<'0[)SX-"CQD:78^)B,Q-C`[/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$
M)V)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E
M<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`V,W!T
M.R<^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA<F=I;BUL
M969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<[(&9O;G0M<VEZ93H@,3!P=#LG/B8C,38P.TQE=F5L(#QF;VYT/C,\+V9O
M;G0^.CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0^#0H\9&EV(&%L:6=N/3-$
M;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M
M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^56YO
M8G-E<G9A8FQE(&EN<'5T<R!A<F4@=7-E9"!W:&5N(&QI='1L92!O<B`\9F]N
M=#YN;SPO9F]N=#X@;6%R:V5T(&1A=&$@:7,@879A:6QA8FQE+B!4:&4@9F%I
M<B!V86QU92!H:65R87)C:'D@9VEV97,@=&AE(&QO=V5S="!P<FEO<FET>2!T
M;R!,979E;"`\9F]N=#XS/"]F;VYT/B!I;G!U=',N/"]F;VYT/CPO9&EV/@T*
M/"]T9#X-"CPO='(^#0H-"CPO=&%B;&4^#0H\+V1I=CX-"CPO9&EV/@T*/&1I
M=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS
M1&IU<W1I9GD^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD
M96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@-#5P=#L@
M;6%R9VEN+7)I9VAT.B`M,"XP-7!T.R<@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@9F]N="UF86UI;'DZ("=4:6UE<R!.
M97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P<'0[)SY!<R!O9B!&96)R=6%R>2`R
M."P@,C`Q-2P@=&AE(&%S<V5T<R!O<B!L:6%B:6QI=&EE<R!M96%S=7)E9"!A
M="!F86ER('9A;'5E('=E<F4@8V]M<')I<V5D(&]F(&%V86EL86)L92!F;W(@
M<V%L92!S96-U<FET:65S("A,979E;"`\9F]N=#XQ/"]F;VYT/BDN(%-E92!A
M;'-O(&YO=&4@/&9O;G0^-#PO9F]N=#XN/"]F;VYT/CPO9&EV/@T*/&1I=B!S
M='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&IU
M<W1I9GD^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@-#5P=#L@;6%R
M9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<[(&9O;G0M<VEZ93H@,3!P=#LG/D%S(&]F($9E8G)U87)Y(#(X+"`R,#$U
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M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[
M)R!A;&EG;CTS1&IU<W1I9GD^)B,Q-C`[/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F
M=#H@-#5P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&QE9G0^/&9O
M;G0@<W1Y;&4],T0G9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I
M;65S($YE=R!2;VUA;B<[(&9O;G0M<VEZ93H@,3!P=#LG/CQF;VYT('-T>6QE
M/3-$)V1I<W!L87DZ(&EN;&EN93LG/E1H92!F/&9O;G0@<W1Y;&4],T0G8V]L
M;W(Z(",P,#`P,#`[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@
M9F]N="US:7IE.B`Q,RXS,S,S,S,P,34T-#$Y<'@[(&9O;G0M<W1Y;&4Z(&YO
M<FUA;#L@9F]N="UV87)I86YT.B!N;W)M86P[(&9O;G0M=V5I9VAT.B!N;W)M
M86P[(&QE='1E<BUS<&%C:6YG.B!N;W)M86P[(&QI;F4M:&5I9VAT.B!N;W)M
M86P[(&]R<&AA;G,Z(&%U=&\[('1E>'0M86QI9VXZ("UW96)K:70M;&5F=#L@
M=&5X="UI;F1E;G0Z(#!P>#L@=&5X="UT<F%N<V9O<FTZ(&YO;F4[('=H:71E
M+7-P86-E.B!N;W)M86P[('=I9&]W<SH@,3L@=V]R9"US<&%C:6YG.B`P<'@[
M("UW96)K:70M=&5X="US=')O:V4M=VED=&@Z(#!P>#L@9&ES<&QA>3H@:6YL
M:6YE("%I;7!O<G1A;G0[(&9L;V%T.B!N;VYE.R!B86-K9W)O=6YD+6-O;&]R
M.B`C9F9F9F9F.R<^86ER('9A;'5E(&]F(&QO;F<M=&5R;2!D97!O<VET<R!A
M;'-O(&%P<')O>&EM871E<R!T:&5I<B!C87)R>6EN9R!V86QU92P@<VEN8V4@
M=&AE>2!B96%R(&EN=&5R97-T(&%T(')A=&5S(&-L;W-E('1O('1H92!P<F5V
M86EL:6YG(&UA<FME="!R871E<RX@5&AE(&QO;F<M=&5R;2!B86YK(&1E<&]S
M:71S(&)E87(@86X@86YN=6%L(&EN=&5R97-T(')A=&4@;V8@/&9O;G0^,"XY
M,SPO9F]N=#XE+3QF;VYT/C$N,#`\+V9O;G0^)2!A;F0@=VEL;"!M871U<F4@
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M9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\8G(O/CPO9&EV/@T*/"]D
M:78^#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE
M>'1087)T7S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-@T*
M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R-V5D-S!F85]A860T7S0R
M.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R:W-H965T<R]3:&5E=#$P+FAT;6P-
M"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-
M"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-
M"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#
M;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F
M+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W
M+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^
M/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@
M:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^34%22T5404),
M12!314-54DE42453/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^34%22T5404),12!314-54DE42453(%M!8G-T<F%C
M=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M34%22T5404),12!314-54DE42453/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\9&EV(&ED/3-$161G87)304$Q,C,T-3<X.3`P,#`@<W1Y;&4]
M,T0G9F]N="UF86UI;'D@.B`G5&EM97,@3F5W(%)O;6%N)SLG/@T*/&1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z
M(#!P=#L@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX-
M"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I
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M)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F
M=#H@-#5P=#L@;6%R9VEN+7)I9VAT.B`M,"XP-7!T.R<@86QI9VX],T1L969T
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M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA
M<F=I;BUR:6=H=#H@,'!T.R<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV
M/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B
M;&]C:SL@;6%R9VEN+6QE9G0Z(#0U<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P
M=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI
M;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE
M.B`Q,'!T.R<^5&AE($-O;7!A;GD@8V]N<VED97)S(&%V86EL86)L92!E=FED
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M;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@
M,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#0U<'0[(&UA<F=I
M;BUR:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS
M1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O
M;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^07,@;V8@1F5B<G5A<GD@,C@L(#(P
M,34L(&UA<FME=&%B;&4@<V5C=7)I=&EE<R!C;VYS:7-T960@=VAO;&QY(&]F
M(&5Q=6ET>2!S96-U<FET:65S(&]F($0N3BY!($)I;VUE9&EC86P@4V]L=71I
M;VYS($QT9"`H(D0N3BY!(BDN($0N3BY!)W,@;W)D:6YA<GD@<VAA<F5S(&%R
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M<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$;&5F=#X\9F]N
M="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM
M97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^1'5R:6YG('1H92`\
M9F]N=#YS:7@\+V9O;G0^)B,Q-C`[;6]N=&@@<&5R:6]D(&5N9&5D($9E8G)U
M87)Y(#(X+"`R,#$T+"!T:&4@4W5B<VED:6%R>2!S;VQD(&EN(&%G9W)E9V%T
M92`\9F]N=#XQ+#8R-2PY.#D\+V9O;G0^(&]F('1H92!$+DXN02!O<F1I;F%R
M>2!S:&%R97,@9F]R('1O=&%L(&-O;G-I9&5R871I;VX@;V8@)#QF;VYT/C@P
M/"]F;VYT/BX@1'5R:6YG('1H92`\9F]N=#YS:7@\+V9O;G0^)B,Q-C`[;6]N
M=&@@<&5R:6]D(&5N9&5D($9E8G)U87)Y(#(X+"`R,#$U+"!T:&4@1W)O=7`@
M9&ED(&YO="!S96QL(&%N>2!O9B!T:&4@1"Y.+D$@;W)D:6YA<GD@<VAA<F5S
M+CPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[)SX\8G(O/CPO9&EV/@T*/&1I=B!S='EL93TS
M1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE
M9G0Z(#0U<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$;&5F
M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^07,@;V8@
M1F5B<G5A<GD@,C@L(#(P,34L('1H92!'<F]U<"!O=VYS(&%P<')O>&EM871E
M;'D@/&9O;G0^.2XX/"]F;VYT/B4@;V8@1"Y.+D$G<R!O=71S=&%N9&EN9R!O
M<F1I;F%R>2!S:&%R97,N/"]F;VYT/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQB<B\^/"]D:78^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM;&5F=#H@-#5P=#L@;6%R9VEN+7)I9VAT.B`M,"XP-7!T
M.R<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN
M93L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z
M(#$P<'0[)SY4:&4@8V]S="!O9B!T:&4@<V5C=7)I=&EE<R!A<R!O9B!&96)R
M=6%R>2`R."P@,C`Q-2!A;F0@075G=7-T(#,Q+"`R,#$T(&ES("0\9F]N=#XU
M.34\+V9O;G0^+CPO9F]N=#X\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI
M;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SX\8G(O/CPO9&EV/@T*/&1I
M=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+6QE9G0Z(#0U<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P=#LG(&%L
M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T
M.R<^5&AE(&-O<W0@;V8@=&AE('-E8W5R:71I97,@<V]L9"!A;F0@=&AE(&%M
M;W5N="!R96-L87-S:69I960@;W5T(&]F(&%C8W5M=6QA=&5D(&]T:&5R(&-O
M;7!R96AE;G-I=F4@:6YC;VUE(&EN=&\@9FEN86YC:6%L(&EN8V]M92`H86UO
M=6YT:6YG('1O("0\9F]N=#XP/"]F;VYT/B8C,38P.SQF;VYT('-T>6QE/3-$
M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<[(&9O;G0M<VEZ93H@,3,N,S,S,S,S,#$U-#0Q.7!X.R!F;VYT+7-T>6QE
M.B!N;W)M86P[(&9O;G0M=F%R:6%N=#H@;F]R;6%L.R!F;VYT+7=E:6=H=#H@
M;F]R;6%L.R!L971T97(M<W!A8VEN9SH@;F]R;6%L.R!L:6YE+6AE:6=H=#H@
M;F]R;6%L.R!O<G!H86YS.B!A=71O.R!T97AT+6%L:6=N.B`M=V5B:VET+6QE
M9G0[('1E>'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W
M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(#$[('=O<F0M<W!A8VEN9SH@
M,'!X.R`M=V5B:VET+71E>'0M<W1R;VME+7=I9'1H.B`P<'@[(&1I<W!L87DZ
M(&EN;&EN92`A:6UP;W)T86YT.R!F;&]A=#H@;F]N93L@8F%C:V=R;W5N9"UC
M;VQO<CH@(V9F9F9F9CLG/F%N9"`D/&9O;G0^-#0\+V9O;G0^(&1U<FEN9R!T
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M)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F
M=#H@-#5P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&QE9G0^/&)R
M+SX\+V1I=CX-"CPO9&EV/@T*#0H\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ
M7V,P,#9A,6,R.3DU-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R
M-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R:W-H965T
M<R]3:&5E=#$Q+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^4U1/0TL@2$],1$524R<@15%52519/&)R/CPO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4U1/0TL@2$],1$524R<@
M15%52519(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4U1/0TL@2$],1$524R<@15%52519/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&ED/3-$161G87)304$Q,C,T
M-3<X.3`P,#`@<W1Y;&4],T0G9F]N="UF86UI;'D@.B`G5&EM97,@3F5W(%)O
M;6%N)SLG/@T*/&1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR
M:6=H=#H@,'!T.R<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ(&EN;&EN93L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3D]412`\9F]N
M=#XU/"]F;VYT/B`M(%-43T-+($A/3$1%4E,G($5154E463H\+V9O;G0^/"]D
M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E
M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`T-7!T.R!M
M87)G:6XM<FEG:'0Z("TP+C`U<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y
M;&4],T0G9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE
M=R!2;VUA;B<[(&9O;G0M<VEZ93H@,3!P=#LG/D]N(#QF;VYT('-T>6QE/3-$
M)V-O;&]R.B`C,#`P,#`P.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
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M<W!A8V4Z(&YO<FUA;#L@=VED;W=S.B`Q.R!W;W)D+7-P86-I;F<Z(#!P>#L@
M+7=E8FMI="UT97AT+7-T<F]K92UW:61T:#H@,'!X.R!D:7-P;&%Y.B!I;FQI
M;F4@(6EM<&]R=&%N=#L@9FQO870Z(&YO;F4[(&)A8VMG<F]U;F0M8V]L;W(Z
M("-F9F9F9F8[)SY.;W9E;6)E<B`S+"`R,#$T+"!T:&4@0V]M<&%N>2!E;G1E
M<F5D(&EN=&\@82!3=&]C:R!0=7)C:&%S92!!9W)E96UE;G0@=VET:"!'=6%N
M9WAI(%=U>FAO=2!0:&%R;6%C975T:6-A;"`H1W)O=7`I($-O+BP@3'1D+B`H
M=&AE("8C,30W.TEN=F5S=&]R)B,Q-#@[*2P@<'5R<W5A;G0@=&\@=VAI8V@@
M=&AE($-O;7!A;GD@:7-S=65D('1O('1H92!);G9E<W1O<B!A;B!A9V=R96=A
M=&4@;V8\+V9O;G0^)B,Q-C`[/&9O;G0^-CDV+#,W.#PO9F]N=#X@<VAA<F5S
M(&]F(&-O;6UO;B!S=&]C:RP@870@82!P<FEC92!O9B`D/&9O;G0^-RXQ.#PO
M9F]N=#X@<&5R('-H87)E+"!W:&EC:"!W87,@97%U86P@=&\@=&AE(&-L;W-I
M;F<@<')I8V4@;V8@=&AE($-O;7!A;GDG<R!C;VUM;VX@<W1O8VL@;VX@=&AE
M($YA<V1A<2!#87!I=&%L($UA<FME="!O;B!/8W1O8F5R(#,Q+"`R,#$T+"!F
M;W(@86=G<F5G871E(&=R;W-S('!R;V-E961S(&]F(&%P<')O>&EM871E;'D@
M)#QF;VYT/C4L,#`P/"]F;VYT/BXF(S$V,#LF(S$V,#M4:&4@;F5T('!R;V-E
M961S('1O('1H92!#;VUP86YY(&9R;VT@=&AE(&]F9F5R:6YG('=E<F4@87!P
M<F]X:6UA=&5L>2`D/&9O;G0^-"PX,S,\+V9O;G0^+"!A9G1E<B!D961U8W1I
M;F<@82!F:6YD97(G<R!F964@;V8@)#QF;VYT/C$U,#PO9F]N=#X@86YD(&]T
M:&5R(&]F9F5R:6YG(&5X<&5N<V5S(&]F('1H92!#;VUP86YY+B!4:&4@;V9F
M97)I;F<@8VQO<V5D(&]N($YO=F5M8F5R(#(X+"`R,#$T+CPO9F]N=#X\+V1I
M=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUL969T.B`T-7!T.R!M87)G:6XM<FEG:'0Z("TP+C`U
M<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@:6YL
M:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M<VEZ
M93H@,3!P=#LG/CPO9F]N=#X\8G(O/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z
M(#0U<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$;&5F=#X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^/&9O;G0@<W1Y
M;&4],T0G8V]L;W(Z(",P,#`P,#`[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W
M(%)O;6%N)SL@9F]N="US:7IE.B`Q,RXS,S,S,S,P,34T-#$Y<'@[(&9O;G0M
M<W1Y;&4Z(&YO<FUA;#L@9F]N="UV87)I86YT.B!N;W)M86P[(&9O;G0M=V5I
M9VAT.B!N;W)M86P[(&QE='1E<BUS<&%C:6YG.B!N;W)M86P[(&QI;F4M:&5I
M9VAT.B!N;W)M86P[(&]R<&AA;G,Z(&%U=&\[('1E>'0M86QI9VXZ(&IU<W1I
M9GD[('1E>'0M:6YD96YT.B`P<'@[('1E>'0M=')A;G-F;W)M.B!N;VYE.R!W
M:&ET92US<&%C93H@;F]R;6%L.R!W:61O=W,Z(#$[('=O<F0M<W!A8VEN9SH@
M,'!X.R`M=V5B:VET+71E>'0M<W1R;VME+7=I9'1H.B`P<'@[(&1I<W!L87DZ
M(&EN;&EN92`A:6UP;W)T86YT.R!F;&]A=#H@;F]N93L@8F%C:V=R;W5N9"UC
M;VQO<CH@(V9F9F9F9CLG/E-E92!A;'-O(&YO=&4@."!W:71H(')E<W!E8W0@
M=&\@86X@870@;6%R:V5T(&ES<W5A;F-E('-A;&5S(&%G<F5E;65N="X\+V9O
M;G0^/"]F;VYT/CPO9&EV/@T*/"]D:78^#0H\+V1I=CX\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S(W960W,&9A7V%A9#1?-#(X
M,U]B,3DQ7V,P,#9A,6,R.3DU-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R
M:W-H965T<R]3:&5E=#$R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^4U1/0TL@0D%3140@0T]-4$5.4T%424]./&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4U1/0TL@
M0D%3140@0T]-4$5.4T%424].(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4U1/0TL@0D%3140@0T]-4$5.
M4T%424]./"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV(&ED
M/3-$161G87)304$Q,C,T-3<X.3`P,#`@<W1Y;&4],T0G9F]N="UF86UI;'D@
M.B`G5&EM97,@3F5W(%)O;6%N)SLG/CQD:78@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T
M.R<^(#QD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<@
M86QI9VX],T1L969T/CQS=')O;F<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T
M.R<^3D]412`V("T@4U1/0TL@0D%3140@0T]-4$5.4T%424]..CPO9F]N=#X\
M+W-T<F]N9SX\8G(@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<O/CPO9&EV/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA
M;B<L('1I;65S.R!F;VYT+7-I>F4Z(#$P<'0[)SX@/&1I=B!S='EL93TS1"=T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[(&9O
M;G0M<VEZ93H@,3!P=#LG/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL
M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<L('1I;65S.R!F
M;VYT+7-I>F4Z(#$P<'0[)SX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L
M969T.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN
M+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX@/&1I=B!C;&%S<STS
M1$-U<G-O<E!O:6YT97(^/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!W:61T:#H@,3`P
M)3LG(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$
M,#X@(#QT<B!V86QI9VX],T1T;W`@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^(#QT
M9"!S='EL93TS1"=W:61T:#H@,C=P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[
M/"]F;VYT/CPO=&0^(#QT9"!S='EL93TS1"=W:61T:#H@,C=P=#L@=&5X="UA
M;&EG;CH@;&5F=#LG(&%L:6=N/3-$<FEG:'0^(#QD:78@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^/&9O
M;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG+"!T
M:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^82X\+V9O;G0^/"]D:78^(#PO=&0^
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R<^(#QD:78@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H
M=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N
M97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^3VX@3F]V96UB
M97(@,3,L(#(P,30L('1H92!#;VUP86YY(&=R86YT960@82!T;W1A;"!O9B`\
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M(&EN<W1A;&QM96YT<RP@96%C:"!O9B`\9F]N=#XY+#<X.#PO9F]N=#X@<VAA
M<F5S+"!O;B!.;W9E;6)E<B`S,"!A;F0@1&5C96UB97(@,S$L(#(P,30N(%1H
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M9"!O=71S=&%N9&EN9RX\+V9O;G0^/"]D:78^(#PO=&0^(#PO='(^("`\+W1A
M8FQE/CPO9&EV/B`\+V1I=CX@/"]D:78^(#QD:78@<W1Y;&4],T0G=&5X="UI
M;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[
M(&UA<F=I;BUR:6=H=#H@,'!T.R<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[
M(&9O;G0M<VEZ93H@,3!P=#LG/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S
M='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<L('1I;65S
M.R!F;VYT+7-I>F4Z(#$P<'0[)SX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R
M9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX@/&1I=B!C;&%S
M<STS1$-U<G-O<E!O:6YT97(^/'1A8FQE('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R!W:61T:#H@
M,3`P)3LG(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG
M/3-$,#X@(#QT<B!V86QI9VX],T1T;W`@<W1Y;&4],T0G9F]N="UF86UI;'DZ
M("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^
M(#QT9"!S='EL93TS1"=W:61T:#H@,C=P=#L@9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T
M:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q
M-C`[/"]F;VYT/CPO=&0^(#QT9"!S='EL93TS1"=W:61T:#H@,C=P=#L@=&5X
M="UA;&EG;CH@;&5F=#LG(&%L:6=N/3-$<FEG:'0^(#QD:78@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^8BX\+V9O;G0^/"]D:78^(#PO
M=&0^(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R<^(#QD:78@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR
M:6=H=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^3VX@3F]V
M96UB97(@,3,L(#(P,30L('1H92!#;VUP86YY(&=R86YT960@82!T;W1A;"!O
M9B`\9F]N=#XQ,"PX-S(\+V9O;G0^(%)357,@<F5P<F5S96YT:6YG(&$@<FEG
M:'0@=&\@<F5C96EV92!S:&%R97,@;V8@=&AE($-O;7!A;GDG<R!C;VUM;VX@
M<W1O8VL@=&\@9F]U<B!M96UB97)S(&]F('1H92!#;VUP86YY)W,@0F]A<F0@
M;V8@1&ER96-T;W)S+B!4:&4@4E-5<R!V97-T960@;VX@2F%N=6%R>2`Q+"`R
M,#$U+B!4:&4@=&]T86P@9F%I<B!V86QU92!O9B!T:&5S92!24U5S(&]N('1H
M92!D871E(&]F(&=R86YT('=A<R`D/&9O;G0^-S4\+V9O;G0^+"!U<VEN9R!T
M:&4@<75O=&5D(&-L;W-I;F<@;6%R:V5T('-H87)E('!R:6-E(&]F("0\9F]N
M=#XV+CDP/"]F;VYT/B!O;B!T:&4@3F%S9&%Q($-A<&ET86P@36%R:V5T(&]N
M('1H92!D871E(&]F(&=R86YT+CPO9F]N=#X\+V1I=CX@/"]T9#X@/"]T<CX@
M(#PO=&%B;&4^/"]D:78^(#PO9&EV/B`\+V1I=CX@/&1I=B!S='EL93TS1"=T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/B`\9&EV('-T>6QE
M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^/&)R('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[
M(&9O;G0M<VEZ93H@,3!P=#LG+SX\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T.R!T97AT+6EN9&5N=#H@,'!T.R!M87)G:6XM;&5F=#H@
M,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG/B`\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L
M;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG/B`\
M9&EV(&-L87-S/3-$0W5R<V]R4&]I;G1E<CX\=&%B;&4@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[
M('=I9'1H.B`Q,#`E.R<@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L
M;'-P86-I;F<],T0P/B`@/'1R('9A;&EG;CTS1'1O<"!S='EL93TS1"=F;VYT
M+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<L('1I;65S.R!F;VYT+7-I>F4Z
M(#$P<'0[)SX@/'1D('-T>6QE/3-$)W=I9'1H.B`R-W!T.R!F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<[)SX\9F]N="!S='EL93TS1"=F;VYT+69A
M;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<L('1I;65S.R!F;VYT+7-I>F4Z(#$P
M<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X@/'1D('-T>6QE/3-$)W=I9'1H.B`R
M-W!T.R<@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N
M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@
M;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S
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M+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I
M;65S(&YE=R!R;VUA;B<L('1I;65S.R!F;VYT+7-I>F4Z(#$P<'0[)SY/;B!&
M96)R=6%R>2`R,RP@,C`Q-2P@=&AE($-O;7!A;GD@9W)A;G1E9"!A('1O=&%L
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M;&UE;G0@;V8@/&9O;G0^,3,L,S`X/"]F;VYT/B!S:&%R97,@;VX@1F5B<G5A
M<GD@,C@L(#(P,34@86YD(#(R(&5Q=6%L(&UO;G1H;'D@:6YS=&%L;&UE;G1S
M(&]F(#QF;VYT/C8L-C4T/"]F;VYT/B!S:&%R97,@96%C:"P@8V]M;65N8VEN
M9R!-87)C:"`S,2P@,C`Q-2X@5&AE('1O=&%L(&9A:7(@=F%L=64@;V8@=&AE
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M=6%R>2`R."P@,C`Q-2P@82!T;W1A;"!O9B`\9F]N=#XQ,RPS,#@\+V9O;G0^
M(%)357,@=V5R92!V97-T960@86YD(&]U='-T86YD:6YG+CPO9F]N=#X\+V1I
M=CX@/"]T9#X@/"]T<CX@(#PO=&%B;&4^/"]D:78^(#PO9&EV/B`\+V1I=CX@
M/"]D:78^(#QD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S
M(&YE=R!R;VUA;B<L('1I;65S.R!F;VYT+7-I>F4Z(#$P<'0[)SXF(S$V,#L\
M+V9O;G0^/"]D:78^(#QD:78@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE
M<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^(#QD:78@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E;G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H
M=#H@,'!T.R<^(#QD:78@8VQA<W,],T1#=7)S;W)0;VEN=&5R/CQT86)L92!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@
M;F5W(')O;6%N)SL@=VED=&@Z(#$P,"4[)R!B;W)D97(],T0P(&-E;&QP861D
M:6YG/3-$,"!C96QL<W!A8VEN9STS1#`^("`\='(@=F%L:6=N/3-$=&]P('-T
M>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[
M(&9O;G0M<VEZ93H@,3!P=#LG/B`\=&0@<W1Y;&4],T0G=VED=&@Z(#(W<'0[
M(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)SLG/CQF;VYT('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[(&9O
M;G0M<VEZ93H@,3!P=#LG/B8C,38P.SPO9F]N=#X\+W1D/B`\=&0@<W1Y;&4]
M,T0G=VED=&@Z(#(W<'0[('1E>'0M86QI9VXZ(&QE9G0[)R!A;&EG;CTS1')I
M9VAT/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD
M96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M
M87)G:6XM<FEG:'0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY
M.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[(&9O;G0M<VEZ93H@,3!P=#LG
M/F0N/"]F;VYT/CPO9&EV/B`\+W1D/B`\=&0@86QI9VX],T1L969T('-T>6QE
M/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[(&9O
M;G0M<VEZ93H@,3!P=#LG/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE
M9G0[('1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG/CQF;VYT('-T>6QE/3-$
M)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[(&9O;G0M
M<VEZ93H@,3!P=#LG/D]N($9E8G)U87)Y(#(S+"`R,#$U+"!T:&4@0V]M<&%N
M>2!G<F%N=&5D(&$@=&]T86P@;V8@/&9O;G0^.#@L-S$R/"]F;VYT/B!24U5S
M(')E<')E<V5N=&EN9R!A(')I9VAT('1O(')E8V5I=F4@<VAA<F5S(&]F('1H
M92!#;VUP86YY)W,@8V]M;6]N('-T;V-K('1O(&9O=7(@;65M8F5R<R!O9B!T
M:&4@0V]M<&%N>2=S($)O87)D(&]F($1I<F5C=&]R<R`H/&9O;G0^,C(L,3<X
M/"]F;VYT/B!24U5S('1O(&5A8V@@9&ER96-T;W(I+B!4:&4@4E-5<R!V97-T
M(&EN(#QF;VYT/G1W;SPO9F]N=#X@97%U86P@:6YS=&%L;&UE;G1S+"!E86-H
M(&]F(#QF;VYT/C0T+#,U-CPO9F]N=#X@<VAA<F5S+"!O;B!$96-E;6)E<B`S
M,2P@,C`Q-2!A;F0@1&5C96UB97(@,S$L(#(P,38N(%1H92!T;W1A;"!F86ER
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M9&EV/B`\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6EN9&5N=#H@,'!T.R!D
M:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT
M.B`P<'0[)R!A;&EG;CTS1&IU<W1I9GD^(#QD:78@<W1Y;&4],T0G9F]N="UF
M86UI;'DZ("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q
M,'!T.R<^/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT
M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)RP@=&EM97,[(&9O;G0M<VEZ93H@,3!P=#LG/B`\9&EV('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GD[('1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z
M(#!P=#LG/B`\9&EV(&-L87-S/3-$0W5R<V]R4&]I;G1E<CX\=&%B;&4@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE
M=R!R;VUA;B<[('=I9'1H.B`Q,#`E.R<@8F]R9&5R/3-$,"!C96QL<&%D9&EN
M9STS1#`@8V5L;'-P86-I;F<],T0P/B`@/'1R('9A;&EG;CTS1'1O<"!S='EL
M93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<L('1I;65S.R!F
M;VYT+7-I>F4Z(#$P<'0[)SX@/'1D('-T>6QE/3-$)W=I9'1H.B`R-W!T.R!F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[)SX\9F]N="!S='EL93TS
M1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<L('1I;65S.R!F;VYT
M+7-I>F4Z(#$P<'0[)SXF(S$V,#L\+V9O;G0^/"]T9#X@/'1D('-T>6QE/3-$
M)W=I9'1H.B`R-W!T.R<@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y
M.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[
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M;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL
M>3H@)W1I;65S(&YE=R!R;VUA;B<L('1I;65S.R!F;VYT+7-I>F4Z(#$P<'0[
M)SY/;B!&96)R=6%R>2`R,RP@,C`Q-2P@=&AE($-O;7!A;GD@9W)A;G1E9"!A
M('1O=&%L(&]F(#QF;VYT/C0V+#4V,#PO9F]N=#X@4E-5<R!T;R!A;B!E;7!L
M;WEE92!O9B!T:&4@4W5B<VED:6%R>2X@5&AE(%)357,@=F5S="!I;B`\9F]N
M=#XR,SPO9F]N=#X@:6YS=&%L;&UE;G1S+"!C;VYS:7-T:6YG(&]F(&]N92!I
M;G-T86QL;65N="!O9B`\9F]N=#XS+#@X,#PO9F]N=#X@<VAA<F5S(&]N($9E
M8G)U87)Y(#(X+"`R,#$U(&%N9"`R,B!E<75A;"!M;VYT:&QY(&EN<W1A;&QM
M96YT<R!O9B`\9F]N=#XQ+#DT,#PO9F]N=#X@<VAA<F5S(&5A8V@L(&-O;6UE
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M+V1I=CX@/"]T9#X@/"]T<CX@(#PO=&%B;&4^/"]D:78^(#PO9&EV/B`\+V1I
M=CX@/"]D:78^(#QD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES
M<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@
M,'!T.R<@86QI9VX],T1J=7-T:69Y/B`\9&EV('-T>6QE/3-$)V9O;G0M9F%M
M:6QY.B`G=&EM97,@;F5W(')O;6%N)RP@=&EM97,[(&9O;G0M<VEZ93H@,3!P
M=#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B`G=&EM97,@;F5W(')O
M;6%N)RP@=&EM97,[(&9O;G0M<VEZ93H@,3!P=#LG/B8C,38P.SPO9F]N=#X\
M+V1I=CX@/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R
M;VUA;B<L('1I;65S.R!F;VYT+7-I>F4Z(#$P<'0[)SX@/&1I=B!S='EL93TS
M1"=T97AT+6%L:6=N.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,'!T.R!D:7-P
M;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P
M<'0[)SX@/&1I=B!C;&%S<STS1$-U<G-O<E!O:6YT97(^/'1A8FQE('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P=#L@9F]N="UF86UI;'DZ("=T:6UE<R!N97<@
M<F]M86XG.R!W:61T:#H@,3`P)3LG(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<]
M,T0P(&-E;&QS<&%C:6YG/3-$,#X@(#QT<B!V86QI9VX],T1T;W`@<W1Y;&4]
M,T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N
M="US:7IE.B`Q,'!T.R<^(#QT9"!S='EL93TS1"=W:61T:#H@,C=P=#L@9F]N
M="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG.R<^/&9O;G0@<W1Y;&4],T0G
M9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US
M:7IE.B`Q,'!T.R<^)B,Q-C`[/"]F;VYT/CPO=&0^(#QT9"!S='EL93TS1"=W
M:61T:#H@,C=P=#LG(&%L:6=N/3-$<FEG:'0^(#QD:78@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^
M/&9O;G0@<W1Y;&4],T0G9F]N="UF86UI;'DZ("=T:6UE<R!N97<@<F]M86XG
M+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T.R<^9BXF(S$V,#L\+V9O;G0^/"]D
M:78^(#PO=&0^(#QT9"!A;&EG;CTS1&QE9G0@<W1Y;&4],T0G9F]N="UF86UI
M;'DZ("=T:6UE<R!N97<@<F]M86XG+"!T:6UE<SL@9F]N="US:7IE.B`Q,'!T
M.R<^(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>3L@=&5X="UI
M;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[
M(&UA<F=I;BUR:6=H=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@
M:6YL:6YE.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I
M>F4Z(#$P<'0[)SY/;B!&96)R=6%R>2`R,RP@,C`Q-2P@=&AE($-O;7!A;GD@
M9W)A;G1E9"!A('1O=&%L(&]F(#QF;VYT/C$V+#8U-CPO9F]N=#X@4E-5<R!T
M;R!E;7!L;WEE97,@;V8@=&AE(%-U8G-I9&EA<GDN(%1H92!24U5S('9E<W0@
M:6X@/&9O;G0^,C,\+V9O;G0^(&EN<W1A;&QM96YT<RP@8V]N<VES=&EN9R!O
M9B!O;F4@:6YS=&%L;&UE;G0@;V8@/&9O;G0^,2PS.#@\+V9O;G0^('-H87)E
M<R!O;B!&96)R=6%R>2`R."P@,C`Q-2!A;F0@,C(@97%U86P@;6]N=&AL>2!I
M;G-T86QL;65N=',@;V8@/&9O;G0^-CDT/"]F;VYT/B!S:&%R97,@96%C:"P@
M8V]M;65N8VEN9R!-87)C:"`S,2P@,C`Q-2X@5&AE('1O=&%L(&9A:7(@=F%L
M=64@;V8@=&AE<V4@4E-5<R!O;B!T:&4@9&%T92!O9B!G<F%N="!W87,@)#QF
M;VYT/C<V/"]F;VYT/BP@=7-I;F<@=&AE('%U;W1E9"!C;&]S:6YG(&UA<FME
M="!S:&%R92!P<FEC92!O9B`D/&9O;G0^-"XU-CPO9F]N=#X@;VX@=&AE($YA
M<V1A<2!#87!I=&%L($UA<FME="!O;B!T:&4@9&%T92!O9B!G<F%N="X\+V9O
M;G0^/"]D:78^(#PO=&0^(#PO='(^("`\+W1A8FQE/CPO9&EV/B`\+V1I=CX@
M/"]D:78^(#PO9&EV/B`\+V1I=CX\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ
M7V,P,#9A,6,R.3DU-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R
M-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R:W-H965T
M<R]3:&5E=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^4D5,051%1"!005)42453("T@5%)!3E-!0U1)3TY3/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4D5,051%
M1"!005)42453("T@5%)!3E-!0U1)3TY3(%M!8G-T<F%C=%T\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4D5,051%1"!005)4
M2453("T@5%)!3E-!0U1)3TY3/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\9&EV(&ED/3-$161G87)304$Q,C,T-3<X.3`P,#`@<W1Y;&4],T0G
M9F]N="UF86UI;'D@.B`G5&EM97,@3F5W(%)O;6%N)SLG/@T*/&1I=CX-"CQD
M:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<@86QI9VX]
M,T1L969T/CQF;VYT('-T>6QE/3-$)V1I<W!L87DZ(&EN;&EN93L@9F]N="UF
M86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F;VYT+7-I>F4Z(#$P<'0[(&9O
M;G0M=V5I9VAT.B!B;VQD.R<^3D]412`\9F]N=#XW/"]F;VYT/B`M(%)%3$%4
M140@4$%25$E%4R`M(%1204Y304-424].4SPO9F]N=#X\+V1I=CX-"CQD:78@
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M(&5N=&5R960@:6YT;R`\9F]N=#YT=V\\+V9O;G0^(&-O;G-U;'1I;F<@86=R
M965M96YT<R!W:71H($M.4ED@3'1D+B`H)B,Q-#<[2TY2628C,30X.RDL(&%N
M($ES<F%E;&D@8V]M<&%N>2!O=VYE9"!B>2!T:&4@0T5/+"!W:&5R96)Y('1H
M92!#14\@86YD('1H92!#5$\L('1H<F]U9V@@2TY262P@<')O=FED92!S97)V
M:6-E<R!T;R!T:&4@1W)O=7`@*'1H92`F(S$T-SM#;VYS=6QT:6YG($%G<F5E
M;65N=',F(S$T.#LI+B!4:&4@0V]N<W5L=&EN9R!!9W)E96UE;G1S(&%R92!B
M;W1H('1E<FUI;F%B;&4@8GD@96ET:&5R('!A<G1Y('5P;VX@/&9O;G0^-C`\
M+V9O;G0^(&1A>7,@<')I;W(@=W)I='1E;B!N;W1I8V4N(%1H92!#;VYS=6QT
M:6YG($%G<F5E;65N=',@<')O=FED92!T:&%T($M.4ED@*&DI('=I;&P@8F4@
M<&%I9"!A(&=R;W-S(&%M;W5N="!O9B!.25,@/&9O;G0^-3`L-#`P/"]F;VYT
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M9VAT.B`P<'0[)R!A;&EG;CTS1&IU<W1I9GD^)B,Q-C`[/"]D:78^#0H\9&EV
M('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M
M87)G:6XM;&5F=#H@-#5P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS
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M86YN=6%L('!A>6UE;G0@=V%S('-E="!A="`D/&9O;G0^,C4P/"]F;VYT/B!A
M;F0@)#QF;VYT/C(P,#PO9F]N=#XL(')E<W!E8W1I=F5L>2P@8V%L8W5L871E
M9"!A="!A;B!E>&-H86YG92!R871E(&]F($Y)4R`\9F]N=#XS+C8\+V9O;G0^
M("8C,38P.W!E<B!5+E,N(&1O;&QA<BP@86YD(&EN(&%D9&ET:6]N('1O('-U
M8V@@<&%Y;65N="!T:&5Y('=E<F4@9W)A;G1E9"!T:&4@=7-E(&]F(&$@8V]M
M<&%N>2!C87(@86YD(&-E<G1A:6X@8V%S:"!B;VYU<R!P87EM96YT<RP@969F
M96-T:79E($IU;'D@,2P@,C`Q,RX\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE
M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM
M;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$:G5S=&EF
M>3XF(S$V,#L\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P
M=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`T-7!T.R!M87)G:6XM
M<FEG:'0Z(#!P=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=D:7-P
M;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@
M9F]N="US:7IE.B`Q,'!T.R<^3VX@3F]V96UB97(@,3,L(#(P,30L('1H92!3
M=6)S:61I87)Y(&5N=&5R960@:6YT;R!A;B!A;65N9&UE;G0@=&\@=&AE($-O
M;G-U;'1I;F<@06=R965M96YT<R`H=&AE("8C,30W.T%M96YD;65N="!!9W)E
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M)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<CL@=&5X="UI;F1E;G0Z(#!P=#L@
M9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H
M=#H@,'!T.R<^/&)R+SX\+V1I=CX-"CPO9&EV/@T*/&1I=B!S='EL93TS1"=T
M97AT+6EN9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SL@;6%R9VEN+6QE9G0Z
M(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@
M<W1Y;&4],T0G9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S
M($YE=R!2;VUA;B<[(&9O;G0M<VEZ93H@,3!P=#LG/B8C,38P.SPO9F]N=#X\
M+V1I=CX-"CPO9&EV/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V
M83%C,CDY-38-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C=E9#<P
M9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V+U=O<FMS:&5E=',O4VAE
M970Q-"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/E-50E-%455%3E0@159%3E0\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1F5B+B`R."P@,C`Q-3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY354)315%514Y4($5614Y4(%M!8G-T<F%C
M=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4U5"4T51545.5"!%5D5.5#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/&1I=B!I9#TS1$5D9V%R4T%!,3(S-#4W.#DP,#`P('-T>6QE/3-$)V9O
M;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA;B<[)SX-"CQD:78@<W1Y;&4]
M,T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL
M969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<@86QI9VX],T1L969T/CQS
M=')O;F<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R<^3D]412`X
M("8C,34P.R!354)315%514Y4($5614Y4/"]F;VYT/CPO<W1R;VYG/CQB<B\^
M/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L
M87DZ(&)L;V-K.R<^/'-T<F]N9SXF(S$V,#L\+W-T<F]N9SX\+V1I=CX-"CQD
M:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[
M(&UA<F=I;BUL969T.B`U-'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N
M/3-$;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M
M9F%M:6QY.B!4:6UE<R!.97<@4F]M86X[(&9O;G0M<VEZ93H@,3!P=#LG/D]N
M($%P<FEL(#(L(#(P,34L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!A
M="!M87)K970@:7-S=6%N8V4@<V%L97,@86=R965M96YT("AT:&4@)B,Q-#<[
M4V%L97,@06=R965M96YT)B,Q-#@[*2!W:71H($U,5B`F86UP.R!#;RX@3$Q#
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M;65N="!O;B!&;W)M(%,M,R`H4F5G:7-T<F%T:6]N($YO+B`S,S,M,3DS-34W
M*2P@:6YC;'5D:6YG(&$@<')O<W!E8W1U<R!D871E9"!!<')I;"`Q,"P@,C`Q
M-"P@87,@<W5P<&QE;65N=&5D(&)Y(&$@<')O<W!E8W1U<R!S=7!P;&5M96YT
M(&1A=&5D($%P<FEL(#(L(#(P,34N)B,Q-C`[(%1H92!#;VUP86YY('=I;&P@
M<&%Y($U,5B!A(&-O;6UI<W-I;VX@;V8@/&9O;G0^,RXP/"]F;VYT/B4@;V8@
M=&AE(&=R;W-S('!R;V-E961S(&]F('1H92!S86QE(&]F(&%N>2!S:&%R97,@
M<V]L9"!T:')O=6=H($U,5BX@5&\@9&%T92P@;F\@<VAA<F5S(&AA=F4@8F5E
M;B!S;VQD('5N9&5R('1H92!386QE<R!!9W)E96UE;G0N/"]F;VYT/CPO9&EV
M/@T*/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT
M4&%R=%\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38-"D-O
M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C=E9#<P9F%?86%D-%\T,C@S
M7V(Q.3%?8S`P-F$Q8S(Y.34V+U=O<FMS:&5E=',O4VAE970Q-2YH=&UL#0I#
M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#
M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-
M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P14M(/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-)1TY)1DE#04Y4
M($%#0T]53E1)3D<@4$],24-)15,@*%!O;&EC>2D\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-3QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY324=.249)0T%.5"!!
M0T-/54Y424Y'(%!/3$E#2453(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V5N97)A;#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!I9#TS1$5D9V%R4T%!,3(S-#4W
M.#DP,#`P('-T>6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE=R!2;VUA
M;B<[)SX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[)SX\8G(O/CPO9&EV/@T*/&1I=B!S='EL93TS1"=T97AT+6EN
M9&5N=#H@,'!T.R!D:7-P;&%Y.B!B;&]C:SLG/@T*/&1I=CX-"CQD:78@8VQA
M<W,],T1#=7)S;W)0;VEN=&5R/@T*/'1A8FQE(&%L:6=N/3-$8V5N=&5R(&)O
M<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G=&EM97,@;F5W
M(')O;6%N)SL@=VED=&@Z(#$P,"4[)SX-"@T*/'1R('9A;&EG;CTS1'1O<#X-
M"CQT9"!S='EL93TS1"=B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT
M.B!N;VYE.R!B;W)D97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE
M.R!W:61T:#H@-#4N,S5P=#LG/@T*/&1I=CXF(S$V,#L\+V1I=CX-"CPO=&0^
M#0H\=&0@<W1Y;&4],T0G8F]R9&5R+6QE9G0Z(&YO;F4[(&)O<F1E<BUR:6=H
M=#H@;F]N93L@8F]R9&5R+71O<#H@;F]N93L@8F]R9&5R+6)O='1O;3H@;F]N
M93L@=VED=&@Z(#(W<'0[)SX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z
M(#!P=#L@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H
M=#H@8F]L9#LG/F$N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT9"!S='EL93TS
M1"=B;W)D97(M;&5F=#H@;F]N93L@8F]R9&5R+7)I9VAT.B!N;VYE.R!B;W)D
M97(M=&]P.B!N;VYE.R!B;W)D97(M8F]T=&]M.B!N;VYE.R<^#0H\9&EV(&%L
M:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[
M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q
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M(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^#0H\9&EV
M(&-L87-S/3-$0W5R<V]R4&]I;G1E<CX-"CQT86)L92!B;W)D97(],T0P(&-E
M;&QP861D:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I
M9'1H.B`Q,#`E.R<^#0H-"CQT<B!V86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4]
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M=#L@;6%R9VEN+7)I9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y
M.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N
M="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H=#H@8F]L9#LG/CQF;VYT/C$I/"]F
M;VYT/CPO9F]N=#X\+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O<F1E<BUL969T.B!N;VYE.R!B
M;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB
M;W1T;VTZ(&YO;F4[)SX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M=#L@=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL
M969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G
M9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA
M;B<[(&9O;G0M<VEZ93H@,3!P=#L@9F]N="UW96EG:'0Z(&)O;&0[)SY);F-O
M<G!O<F%T:6]N(&%N9"!O<&5R871I;VYS/"]F;VYT/CPO9&EV/@T*/"]T9#X-
M"CPO='(^#0H-"CPO=&%B;&4^#0H\+V1I=CX-"CPO9&EV/@T*/"]D:78^#0H\
M9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K
M.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N
M/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI
M;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`Y.7!T
M.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL
M93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W
M(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^3W)A;65D(%!H87)M86-E=71I
M8V%L<R!);F,N("AT:&4@)B,Q-#<[0V]M<&%N>28C,30X.RD@=V%S(&EN8V]R
M<&]R871E9"!O;B!!<')I;"`Q,BP@,C`P,BP@=6YD97(@=&AE(&QA=W,@;V8@
M=&AE(%-T871E(&]F($YE=F%D82X@3VX@1F5B<G5A<GD@,3<L(#(P,#8L('1H
M92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!A9W)E96UE;G0@=VET:"!(861A
M<VET($UE9&EC86P@4V5R=FEC97,@86YD($1E=F5L;W!M96YT($QT9"`H)B,Q
M-#<[2&%D87-I="8C,30X.RD@=&\@86-Q=6ER92!T:&4@<')O=FES:6]N86P@
M<&%T96YT(')E;&%T960@=&\@86X@;W)A;&QY(&EN9V5S=&EB;&4@:6YS=6QI
M;B!C87!S=6QE('1O(&)E('5S960@9F]R('1H92!T<F5A=&UE;G0@;V8@:6YD
M:79I9'5A;',@=VET:"!D:6%B971E<RX\+V9O;G0^/"]D:78^#0H\9&EV('-T
M>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G
M:6XM;&5F=#H@,'!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$:G5S
M=&EF>3XF(S$V,#L\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z
M(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`Y.7!T.R!M87)G
M:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=D
M:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N
M)SL@9F]N="US:7IE.B`Q,'!T.R<^3VX@36%R8V@@,3$L(#(P,3$L('1H92!#
M;VUP86YY('=A<R!R96EN8V]R<&]R871E9"!F<F]M('1H92!3=&%T92!O9B!.
M979A9&$@=&\@=&AE(%-T871E(&]F($1E;&%W87)E+CPO9F]N=#X\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<@86QI
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M:61I87)Y(&EN($ES<F%E;"P@3W)A;65D($QT9"X@*'1H92`F(S$T-SM3=6)S
M:61I87)Y)B,Q-#@[*2P@=VAI8V@@:7,@96YG86=E9"!I;B!R97-E87)C:"!A
M;F0@9&5V96QO<&UE;G0N(%5N;&5S<R!T:&4@8V]N=&5X="!I;F1I8V%T97,@
M;W1H97)W:7-E+"!T:&4@=&5R;2`F(S$T-SM'<F]U<"8C,30X.R!R969E<G,@
M=&\@3W)A;65D(%!H87)M86-E=71I8V%L<R!);F,N(&%N9"!T:&4@4W5B<VED
M:6%R>2X\+V9O;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT
M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R!M87)G:6XM;&5F=#H@,'!T.R!M87)G
M:6XM<FEG:'0Z(#!P=#LG(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX-
M"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO
M8VL[(&UA<F=I;BUL969T.B`Y.7!T.R!M87)G:6XM<FEG:'0Z(#!P=#LG(&%L
M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T
M.R<^1F]L;&]W:6YG('1H92!A9&]P=&EO;B!O9B!!8V-O=6YT:6YG(%-T86YD
M87)D<R!5<&1A=&4@*"8C,30W.T%3528C,30X.RD@/&9O;G0^,C`Q-#PO9F]N
M=#XM/&9O;G0^,3`\+V9O;G0^+"!$979E;&]P;65N="!3=&%G92!%;G1I=&EE
M<R`H5&]P:6,@/&9O;G0^.3$U/"]F;VYT/BDL('1H92!#;VUP86YY(')E;6]V
M960@=&AE(&EN8V5P=&EO;B!T;R!D871E(&EN9F]R;6%T:6]N(&%N9"!A;&P@
M<F5F97)E;F-E('1O(&1E=F5L;W!M96YT+CPO9F]N=#X\+V1I=CX-"CQD:78@
M<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[)SXF
M(S$V,#L\+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@
M=&5X="UI;F1E;G0Z(#!P=#L@;6%R9VEN+6QE9G0Z(#!P=#L@;6%R9VEN+7)I
M9VAT.B`P<'0[)SX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@
M=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T
M.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^#0H\9&EV(&-L87-S/3-$0W5R
M<V]R4&]I;G1E<CX-"CQT86)L92!B;W)D97(],T0P(&-E;&QP861D:6YG/3-$
M,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I9'1H.B`Q,#`E.R<^
M#0H-"CQT<B!V86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4],T0G9F]N="UF86UI
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M9VAT.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O
M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T
M.R!F;VYT+7=E:6=H=#H@8F]L9#LG/CQF;VYT/C(I/"]F;VYT/CPO9F]N=#X\
M+V1I=CX-"CPO=&0^#0H\=&0@86QI9VX],T1L969T('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&QE9G0[(&)O<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z
M(&YO;F4[(&)O<F1E<BUT;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[
M)SX-"CQD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F=#L@=&5X="UI;F1E
M;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL969T.B`P<'0[(&UA
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M/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^/&)R+SX\
M+V1I=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA
M>3H@8FQO8VL[(&UA<F=I;BUL969T.B`Y.7!T.R!M87)G:6XM<FEG:'0Z("TP
M+C`U<'0[)R!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@
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M.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CQD:78@<W1Y
M;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I
M;BUL969T.B`Y.7!T.R!M87)G:6XM<FEG:'0Z("TP+C`U<'0[)R!A;&EG;CTS
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M1')U9R!!9&UI;FES=')A=&EO;B`H)B,Q-#<[1D1!)B,Q-#@[*2!P<FEO<B!T
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M9G0Z(#DY<'0[(&UA<F=I;BUR:6=H=#H@+3`N,#5P=#LG(&%L:6=N/3-$;&5F
M=#X\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY
M.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R<^0F%S960@
M;VX@:71S(&-U<G)E;G0@8V%S:"!R97-O=7)C97,@86YD(&-O;6UI=&UE;G1S
M+"!A;F0@8V%S:"!R96-E:79E9"!I;B!P<FEV871E(&%N9"!P=6)L:6,@;V9F
M97)I;F=S(&EN('1H92!S:7@F(S$V,#MM;VYT:"!P97)I;V0@96YD960@1F5B
M<G5A<GD@,C@L(#(P,34@86YD(&EN('1H92!Y96%R(&5N9&5D($%U9W5S="`S
M,2P@,C`Q-"P@=&AE($-O;7!A;GD@8F5L:65V97,@:70@=VEL;"!B92!A8FQE
M('1O(&UA:6YT86EN(&ET<R!C=7)R96YT('!L86YN960@9&5V96QO<&UE;G0@
M86-T:79I=&EE<R!A;F0@=&AE(&-O<G)E<W!O;F1I;F<@;&5V96P@;V8@97AP
M96YD:71U<F5S(&9O<B!A="!L96%S="!T:&4@;F5X="`\9F]N=#XQ,CPO9F]N
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M965K(&%D9&ET:6]N86P@9FEN86YC:6YG(&1U<FEN9R!T:&4@;F5X="`\9F]N
M=#XQ,CPO9F]N=#X@;6]N=&AS+CPO9F]N=#X\+V1I=CX-"@T*/"]D:78^#0H\
M+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYE=VQY(&ES<W5E9"!A;F0@<F5C96YT;'D@861O<'1E9"!!8V-O
M=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\9&EV(&ED/3-$161G87)304$Q,C,T-3<X.3`P,#`@<W1Y;&4]
M,T0G9F]N="UF86UI;'D@.B`G5&EM97,@3F5W(%)O;6%N)SLG/@T*/&1I=CX-
M"CQD:78@8VQA<W,],T1#=7)S;W)0;VEN=&5R/@T*/'1A8FQE(&%L:6=N/3-$
M8V5N=&5R(&)O<F1E<CTS1#`@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG
M/3-$,"!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G
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M.B`P<'0[)SX\9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M
M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F
M;VYT+7=E:6=H=#H@8F]L9#LG/F(N/"]F;VYT/CPO9&EV/@T*/"]T9#X-"CQT
M9#X-"CQD:78@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)V1I<W!L
M87DZ(&EN;&EN93L@9F]N="UF86UI;'DZ("=4:6UE<R!.97<@4F]M86XG.R!F
M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M=V5I9VAT.B!B;VQD.R<^3F5W;'D@:7-S
M=65D(&%N9"!R96-E;G1L>2!A9&]P=&5D($%C8V]U;G1I;F<@4')O;F]U;F-E
M;65N=',\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T<CX-"@T*/"]T86)L93X-
M"CPO9&EV/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P
M<'0[(&1I<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CQD:78@<W1Y;&4]
M,T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@8FQO8VL[(&UA<F=I;BUL
M969T.B`W,G!T.R!M87)G:6XM<FEG:'0Z("TP+C`U<'0[)R!A;&EG;CTS1&QE
M9G0^/&9O;G0@<W1Y;&4],T0G9&ES<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL
M>3H@)U1I;65S($YE=R!2;VUA;B<[(&9O;G0M<VEZ93H@,3!P=#LG/DEN($%U
M9W5S="`R,#$T+"!T:&4@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A<F1S
M($)O87)D("AT:&4@)B,Q-#<[1D%30B8C,30X.RD@:7-S=65D($%C8V]U;G1I
M;F<@4W1A;F1A<F1S(%5P9&%T92`H)B,Q-#<[05-5)B,Q-#@[*2`\9F]N=#XR
M,#$T/"]F;VYT/BT\9F]N=#XQ-3PO9F]N=#XL(%!R97-E;G1A=&EO;B!O9B!&
M:6YA;F-I86P@4W1A=&5M96YT<RU';VEN9R!#;VYC97)N("A3=6)T;W!I8R`\
M9F]N=#XR,#4\+V9O;G0^+3QF;VYT/C0P/"]F;VYT/BDZ($1I<V-L;W-U<F4@
M;V8@56YC97)T86EN=&EE<R!A8F]U="!A;B!%;G1I='DG<R!!8FEL:71Y('1O
M($-O;G1I;G5E(&%S(&$@1V]I;F<@0V]N8V5R;B`H)B,Q-#<[05-5(#QF;VYT
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M<B!$96-E;6)E<B`Q-2P@,C`Q-B!A;F0@:6YT97)I;2!P97)I;V1S('1H97)E
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M:7-C86P@>65A<B`\9F]N=#XR,#$T/"]F;VYT/BX@5&AE(&%D;W!T:6]N(&]F
M($%352`\9F]N=#XR,#$T/"]F;VYT/BT\9F]N=#XQ-3PO9F]N=#X@9&ED(&YO
M="!H879E(&%N>2!M871E<FEA;"!E9F9E8W0@;VX@=&AE(&-O;G-O;&ED871E
M9"!F:6YA;F-I86P@<W1A=&5M96YT('!R97-E;G1A=&EO;BX\+V9O;G0^/"]D
M:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ
M(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CPO9&EV/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N9&5N<V5D($-O;G-O
M;&ED871E9"!&:6YA;F-I86P@4W1A=&5M96YT<R!0<F5P87)A=&EO;CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/&1I=B!I9#TS1$5D9V%R4T%!
M,3(S-#4W.#DP,#`P('-T>6QE/3-$)V9O;G0M9F%M:6QY(#H@)U1I;65S($YE
M=R!2;VUA;B<[)SX-"CQD:78^#0H\9&EV(&-L87-S/3-$0W5R<V]R4&]I;G1E
M<CX-"CQT86)L92!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P(&-E;&QP861D
M:6YG/3-$,"!C96QL<W!A8VEN9STS1#`@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T.R!F;VYT+69A;6EL>3H@)W1I;65S(&YE=R!R;VUA;B<[('=I9'1H.B`Q
M,#`E.R<^#0H-"CQT<B!V86QI9VX],T1T;W`^#0H\=&0@<W1Y;&4],T0G8F]R
M9&5R+6QE9G0Z(&YO;F4[(&)O<F1E<BUR:6=H=#H@;F]N93L@8F]R9&5R+71O
M<#H@;F]N93L@8F]R9&5R+6)O='1O;3H@;F]N93L@=VED=&@Z(#0U+C,U<'0[
M)SX-"CQD:78^)B,Q-C`[/"]D:78^#0H\+W1D/@T*/'1D('-T>6QE/3-$)V)O
M<F1E<BUL969T.B!N;VYE.R!B;W)D97(M<FEG:'0Z(&YO;F4[(&)O<F1E<BUT
M;W`Z(&YO;F4[(&)O<F1E<BUB;W1T;VTZ(&YO;F4[('=I9'1H.B`R-W!T.R<^
M#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&UA<F=I;BUL969T
M.B`P<'0[(&UA<F=I;BUR:6=H=#H@,'!T.R<^/&9O;G0@<W1Y;&4],T0G9&ES
M<&QA>3H@:6YL:6YE.R!F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;B<[
M(&9O;G0M<VEZ93H@,3!P=#L@9F]N="UW96EG:'0Z(&)O;&0[)SYC+CPO9F]N
M=#X\+V1I=CX-"CPO=&0^#0H\=&0^#0H\9&EV(&%L:6=N/3-$:G5S=&EF>3X\
M9F]N="!S='EL93TS1"=D:7-P;&%Y.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B`G
M5&EM97,@3F5W(%)O;6%N)SL@9F]N="US:7IE.B`Q,'!T.R!F;VYT+7=E:6=H
M=#H@8F]L9#LG/D-O;F1E;G-E9"!#;VYS;VQI9&%T960@1FEN86YC:6%L(%-T
M871E;65N=',@4')E<&%R871I;VX\+V9O;G0^/"]D:78^#0H\+W1D/@T*/"]T
M<CX-"@T*/"]T86)L93X-"CPO9&EV/@T*/"]D:78^#0H\9&EV('-T>6QE/3-$
M)W1E>'0M:6YD96YT.B`P<'0[(&1I<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I
M=CX-"CQD:78@<W1Y;&4],T0G=&5X="UI;F1E;G0Z(#!P=#L@9&ES<&QA>3H@
M8FQO8VL[(&UA<F=I;BUL969T.B`W,G!T.R!M87)G:6XM<FEG:'0Z("TP+C`U
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M(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE<R`H(E4N4RX@1T%!4"(I
M(&%N9"!O;B!T:&4@<V%M92!B87-I<R!A<R!T:&4@875D:71E9"!C;VYS;VQI
M9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D960@:6X@=&AE($-O
M;7!A;GDG<R!!;FYU86P@4F5P;W)T(&]N($9O<FT@,3`M2R!F;W(@=&AE(&9I
M<V-A;"!Y96%R(&5N9&5D($%U9W5S="8C,38P.S,Q+"`\9F]N=#XR,#$T/"]F
M;VYT/B`H=&AE("8C,30W.SQF;VYT/C(P,30\+V9O;G0^($9O<FT@,3`M2R8C
M,30X.RDN(%1H97-E(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L
M('-T871E;65N=',@<F5F;&5C="!A;&P@861J=7-T;65N=',@=&AA="!A<F4@
M;V8@82!N;W)M86P@<F5C=7)R:6YG(&YA='5R92!A;F0@=&AA="!A<F4@8V]N
M<VED97)E9"!N96-E<W-A<GD@9F]R(&$@9F%I<B!S=&%T96UE;G0@;V8@=&AE
M(')E<W5L=',@;V8@=&AE('!E<FEO9',@<')E<V5N=&5D+B!#97)T86EN(&EN
M9F]R;6%T:6]N(&%N9"!D:7-C;&]S=7)E<R!N;W)M86QL>2!I;F-L=61E9"!I
M;B!A;FYU86P@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!S=&%T96UE;G1S(&AA
M=F4@8F5E;B!O;6ET=&5D(&EN('1H:7,@:6YT97)I;2!P97)I;V0@<F5P;W)T
M('!U<G-U86YT('1O('1H92!R=6QE<R!A;F0@<F5G=6QA=&EO;G,@;V8@=&AE
M(%-E8W5R:71I97,@86YD($5X8VAA;F=E($-O;6UI<W-I;VXN($)E8V%U<V4@
M=&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@:6YT97)I;2!F:6YA;F-I86P@
M<W1A=&5M96YT<R!D;R!N;W0@:6YC;'5D92!A;&P@;V8@=&AE(&EN9F]R;6%T
M:6]N(&%N9"!D:7-C;&]S=7)E<R!R97%U:7)E9"!B>2!5+E,N($=!05`@9F]R
M(&%N;G5A;"!F:6YA;F-I86P@<W1A=&5M96YT<RP@=&AE>2!S:&]U;&0@8F4@
M<F5A9"!I;B!C;VYJ=6YC=&EO;B!W:71H('1H92!A=61I=&5D(&-O;G-O;&ED
M871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A;F0@;F]T97,@:6YC;'5D960@
M:6X@=&AE(#QF;VYT/C(P,30\+V9O;G0^($9O<FT@,3`M2RX@5&AE(')E<W5L
M=',@9F]R(&EN=&5R:6T@<&5R:6]D<R!A<F4@;F]T(&YE8V5S<V%R:6QY(&EN
M9&EC871I=F4@;V8@82!F=6QL(&9I<V-A;"!Y96%R)W,@<F5S=6QT<RX\+V9O
M;G0^/"]D:78^#0H\9&EV('-T>6QE/3-$)W1E>'0M:6YD96YT.B`P<'0[(&1I
M<W!L87DZ(&)L;V-K.R<^/&)R+SX\+V1I=CX-"CPO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^
M#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C=E9#<P9F%?86%D-%\T
M,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE
M.B\O+T,Z+S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-B]7
M;W)K<VAE971S+U-H965T,38N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O
M9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT
M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@
M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$
M)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X
M="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4
M:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@
M(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$562T-)/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S
M<&%N/3-$,CX\<W1R;VYG/D-/34U)5$U%3E13("A397)V:6-E($%G<F5E;65N
M=',I("A$971A:6QS*3QB<CY);B!4:&]U<V%N9',L(&5X8V5P="!3:&%R92!D
M871A+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C8@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS
M1#$^,34U($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,"!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^-R!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,2!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXR($UO;G1H
M<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$U/&)R/E531"`H)"D\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-#QB
M<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E
M8BX@,C@L(#(P,34\8G(^2&%D87-I="!;365M8F5R73QB<CY54T0@*"0I/&)R
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\
M8G(^0V]N<W5L=&%N="!;365M8F5R73QB<CY54T0@*"0I/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D%U9RX@,S$L(#(P,3$\8G(^0V]N<W5L
M=&%N="!;365M8F5R73QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/DUA>2`Q,RP@,C`Q-#QB<CY!9'9I<V]R(%M-96UB97)=
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P
M,34\8G(^061V:7-O<B!;365M8F5R73QB<CY54T0@*"0I/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^4V5C;VYD
M($-L:6YI8V%L(%)E<V5A<F-H($]R9V%N:7IA=&EO;B!397)V:6-E($%G<F5E
M;65N="!;365M8F5R73QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^5&AI<F0@0VQI;FEC86P@
M4F5S96%R8V@@3W)G86YI>F%T:6]N(%-E<G9I8V4@06=R965M96YT(%M-96UB
M97)=/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^1F5B+B`R."P@,C`Q-3QB<CY396-O;F0@36%S=&5R(%-E<G9I8V4@06=R
M965M96YT(%M-96UB97)=/&)R/E531"`H)"D\8G(^/"]T:#X-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-3QB<CY4:&ER9"!-87-T97(@
M4V5R=FEC92!!9W)E96UE;G0@6TUE;6)E<ET\8G(^55-$("@D*3QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$U/&)R/D9O
M=7)T:"!-87-T97(@4V5R=FEC92!!9W)E96UE;G0@6TUE;6)E<ET\8G(^55-$
M("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(X
M+"`R,#$U/&)R/D9I9G1H($UA<W1E<B!397)V:6-E($%G<F5E;65N="!;365M
M8F5R73QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D9E8BX@,C@L(#(P,34\8G(^0VQI;FEC86P@4F5S96%R8V@@3W)G86YI
M>F%T:6]N(%-E<G9I8V4@06=R965M96YT(%M-96UB97)=/&)R/E531"`H)"D\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q
M-3QB<CY3:7AT:"!-87-T97(@4V5R=FEC92!!9W)E96UE;G0@6TUE;6)E<ET\
M8G(^55-$("@D*3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&
M96(N(#(X+"`R,#$U/&)R/E-I>'1H($UA<W1E<B!397)V:6-E($%G<F5E;65N
M="!;365M8F5R73QB<CY#2$8\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^3&]N9RUT97)M(%!U<F-H87-E($-O;6UI=&UE
M;G0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UI=&UE;G1S(&9O<B!C;VYS=6QT:6YG('-E<G9I
M8V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RPR
M.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#,Q,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,C$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`R,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#4U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C<V/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-#$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#X@,C$Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM:71M
M96YT<R!F;W(@8F]N=7,@<&%Y;65N=',@=7!O;B!A8VAI979I;F<@8V5R=&%I
M;B!M:6QE<W1O;F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;G-U;'1I;F<@<V5R=FEC97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/CDU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,C@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S8Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-S0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#(\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XF;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,3@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%G<F5E;65N="!T97)M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XU('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y#;VUM:71M96YT<R!F;W(@8V]N<W5L=&EN9R!S97)V
M:6-E+"!M;VYT:&QY(&9I>&5D(&9E93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4F]Y86QT>2!P97)C96YT86=E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XX+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!G<F%N=&5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PX,S0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@9W)A
M;G1E9"P@97AE<F-I<V4@<')I8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^0V%P:71A;&EZ960@8V]S=#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X<&5C=&5D('1E<FT\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/C4@>65A<G,@,3$@;6]N=&AS
M(#$Y(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D5X<&5C=&5D('9O;&%T:6QI='D\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<Y+C<T)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4FES:RUF<F5E(&EN=&5R97-T(')A
M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$N.#8E/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R
M97,@875T:&]R:7IE9"!F;W(@:7-S=6%N8V4@9F]R('-E<G9I8V5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-2PP,#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!I<W-U
M960@9F]R('-E<G9I8V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XW+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4VAA<F5S(&ES<W5E9"!F;W(@<V5R=FEC97,@<F5N9&5R960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8T/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V-#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C=E9#<P
M9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A
M,6,R.3DU-B]7;W)K<VAE971S+U-H965T,3<N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5(1T%#
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/34U)5$U%3E13("A,96%S97,I
M("A$971A:6QS*2`H3V9F:6-E($)U:6QD:6YG(%M-96UB97)=*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,CXV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$U/&)R/E53
M1"`H)"D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R
M."P@,C`Q-3QB<CY)3%,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^3W!E<F%T:6YG($QE87-E9"!!<W-E=',@6TQI;F4@
M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D]P97)A=&EN9R!L96%S92!T97)M/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XS-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XS-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06YN=6%L
M(&QE87-E('!A>6UE;G1S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#XR,#$U/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(R+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B`X.2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/C(P,38\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@,C(L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^(#@Y+#`P,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C=E9#<P9F%?86%D-%\T,C@S7V(Q
M.3%?8S`P-F$Q8S(Y.34V#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-B]7;W)K<VAE
M971S+U-H965T,3@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R2T%'/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/D-/34U)5$U%3E13("A297-E87)C:"!'<F%N=',I("A$971A
M:6QS*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES
M92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XS($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C8@36]N=&AS($5N9&5D/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,34U($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y&96(N(#(X+"`R,#$U/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-3QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY297-E87)C
M:"!A;F0@1&5V96QO<&UE;G0@07)R86YG96UE;G0L($-O;G1R86-T('1O(%!E
M<F9O<FT@9F]R($]T:&5R<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A;G1S(')E8V5I=F5D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y":6\M2F5R
M=7-A;&5M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4F5S96%R8V@@86YD($1E=F5L;W!M96YT($%R<F%N9V5M
M96YT+"!#;VYT<F%C="!T;R!097)F;W)M(&9O<B!/=&AE<G,@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E)O>6%L='D@<&5R8V5N=&%G93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2;WEA;'1Y('!E<F-E;G1A9V4L(&UA
M>&EM=6T@<&5R8V5N=&%G92!O9B!G<F%N=',@<F5C96EV960\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,"XP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,#`N,#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+C`P)3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4F]Y86QT>2!L:6%B:6QI='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1W)A;G1S(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C8U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^0VAI968@4V-I96YT:7-T($]F9FEC92!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E)E<V5A<F-H(&%N9"!$979E;&]P;65N="!!<G)A;F=E;65N="P@0V]N
M=')A8W0@=&\@4&5R9F]R;2!F;W(@3W1H97)S(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y2;WEA;'1Y
M('!E<F-E;G1A9V4L(&UA>&EM=6T@<&5R8V5N=&%G92!O9B!G<F%N=',@<F5C
M96EV960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P,"XP,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,#`N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3`P+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^1W)A;G1S(')E8V5I=F5D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#(L,38P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&EE9B!38VEE;G1I<W0@3V9F
M:6-E(%M-96UB97)=('P@36EN:6UU;2!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E<V5A<F-H(&%N9"!$979E
M;&]P;65N="!!<G)A;F=E;65N="P@0V]N=')A8W0@=&\@4&5R9F]R;2!F;W(@
M3W1H97)S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y2;WEA;'1Y('!E<F-E;G1A9V4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C,N,#`E/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RXP,"4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C`P)3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAI968@
M4V-I96YT:7-T($]F9FEC92!;365M8F5R72!\($UA>&EM=6T@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY297-E
M87)C:"!A;F0@1&5V96QO<&UE;G0@07)R86YG96UE;G0L($-O;G1R86-T('1O
M(%!E<F9O<FT@9F]R($]T:&5R<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F]Y86QT>2!P97)C96YT
M86=E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C4P)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,N-3`E
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,RXU,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-@T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\R-V5D-S!F85]A860T7S0R.#-?8C$Y
M,5]C,#`V83%C,CDY-38O5V]R:W-H965T<R]3:&5E=#$Y+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%1D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1D%)4B!604Q512`H1&5T
M86EL<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^-B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R
M."P@,C`Q-3QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY&04E2(%9!3%5%(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&)A;FL@9&5P
M;W-I="!I;G1E<F5S="!R871E+"!M:6YI;75M/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XP+CDS)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT97)M(&)A;FL@9&5P;W-I="!I
M;G1E<F5S="!R871E+"!M87AI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?,C=E9#<P9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(W960W,&9A7V%A9#1?
M-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-B]7;W)K<VAE971S+U-H965T,C`N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5)1T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DU!4DM%
M5$%"3$4@4T5#55))5$E%4R`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U
M<V%N9',L(&5X8V5P="!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W:7-E('-P
M96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0R/C,@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^-B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3X\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M1F5B+B`R."P@,C`Q-3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y&96(N(#(X+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^1F5B+B`R."P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y!=6<N(#,Q+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/DU!4DM%5$%"3$4@4T5#55))5$E%4R!;
M06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYU;6)E<B!O9B!S:&%R97,@<V]L9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L-C(U+#DX.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O8V5E9',@9G)O;2!S86QE
M(&]F('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]W;F5R<VAI<"!P97)C96YT86=E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XY+C@P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/CDN.#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;W-T(&]F('-E8W5R:71I97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Y-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Y-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4Y-3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO
M=6YT(')E8VQA<W-I9FEE9"!T;R!E87)N:6YG<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S(W
M960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R.3DU-@T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C
M,#`V83%C,CDY-38O5V]R:W-H965T<R]3:&5E=#(Q+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M64U!13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY35$]#2R!(3TQ$15)3)R!%
M455)5%D@*$1E=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E
M<'0@4VAA<F4@9&%T82P@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M-#XV($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C`@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X]
M,T0R/D9E8BX@,C@L(#(P,34\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#(^1F5B+B`R."P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y.;W8N(#`S+"`R,#$T/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E;&%T960@4&%R
M='D@5')A;G-A8W1I;VX@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!P
M<F]C965D<R!F<F]M('1H92!O9F9E<FEN9RP@869T97(@9&5D=6-T:6YG(&$@
M9FEN9&5R)W,@9F5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#0L.#,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CQS=7`^6S%=/"]S=7`^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#$T+#@X-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1F;CX\<W5P/ELQ73PO<W5P/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=&]C:R!0=7)C:&%S92!!9W)E96UE;G0@=VET:"!'
M=6%N9WAI(%=U>FAO=2!0:&%R;6%C975T:6-A;"`H1W)O=7`I($-O+BP@3'1D
M+B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E)E;&%T960@4&%R='D@5')A;G-A8W1I
M;VX@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!S:&%R97,@
M=&\@8F4@<V]L9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-CDV+#,W.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4&5R('-H87)E('!R:6-E(&]F('-H87)E
M<R!T;R!B92!S;VQD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#<N,3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%G9W)E9V%T92!G<F]S<R!P<F]C965D
M<R!F<F]M('1H92!O9F9E<FEN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&9N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&9N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!P<F]C965D<R!F<F]M
M('1H92!O9F9E<FEN9RP@869T97(@9&5D=6-T:6YG(&$@9FEN9&5R)W,@9F5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$9FX^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT+#@S,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1FEN9&5R<R!F964\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1F;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1F;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,34P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L<W!A
M;CTS1#8^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1I
M;FYE<D9O;W1N;W1E/@T*("`@("`@("`\=&0@=F%L:6=N/3-$=&]P/ELQ73PO
M=&0^#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$-2!V86QI9VX],T1T;W`^4V5E
M(&YO=&4@-2X\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,C=E9#<P9F%?
M86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ7V,P,#9A,6,R
M.3DU-B]7;W)K<VAE971S+U-H965T,C(N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5'5$1)/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-43T-+($)!4T5$($-/35!%3E-!5$E/
M3B`H1&5T86EL<RD@*%)E<W1R:6-T960@<W1O8VL@=6YI=',@6TUE;6)E<ETL
M(%531"`D*3QB<CY);B!4:&]U<V%N9',L(&5X8V5P="!3:&%R92!D871A+"!U
M;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C`@36]N=&AS($5N9&5D
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/D9E8BX@,C,L(#(P,34\8G(^:71E;3QB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y.;W8N(#$S+"`R,#$T/&)R/FET96T\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1F5B+B`R."P@,C`Q-3QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAI968@17AE8W5T
M:79E($]F9FEC97(@86YD('1H92!#5$\@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP
M96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N="!!
M=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^07=A<F1S(&=R86YT960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$U.2PV.38\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PU-S8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU;6)E<B!O9B!E<75A
M;"!I;G-T86QL;65N=',@:6X@=VAI8V@@87=A<F1S('=I;&P@=F5S=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@<&5R(&EN
M<W1A;&QM96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#<X
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P@9F%I<B!V86QU92!O9B!A=V%R9',@;VX@=&AE(&1A=&4@;V8@
M9W)A;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-S(X/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E%U;W1E9"!C;&]S:6YG(&UA<FME="!S:&%R92!P<FEC93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T+C4V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V+CD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-H:65F($5X
M96-U=&EV92!/9F9I8V5R(&%N9"!T:&4@0U1/(%M-96UB97)=('P@27-S=65D
M(&]N($YO=F5M8F5R(#$S+"`R,#$T(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F4M8F%S960@0V]M<&5N
M<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A<V5D(%!A>6UE;G0@07=A
M<F0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E9E<W1E9"!A;F0@;W5T<W1A;F1I;F<\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$Y+#4W-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0VAI968@17AE8W5T:79E
M($]F9FEC97(@86YD('1H92!#5$\@6TUE;6)E<ET@?"!)<W-U960@;VX@1F5B
M<G5A<GD@,C,L(#(P,34@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@
M07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN
M92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5F5S=&5D(&%N9"!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3,L,S`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#:&EE9B!%>&5C=71I=F4@3V9F:6-E
M<B!A;F0@=&AE($-43R!;365M8F5R72!\($9I<G-T(&EN<W1A;&QM96YT(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H
M87)E+6)A<V5D(%!A>6UE;G0@07=A<F0@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H87)E<R!P97(@
M:6YS=&%L;&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S
M+#,P.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0VAI968@17AE8W5T:79E($]F9FEC97(@86YD('1H92!#5$\@6TUE
M;6)E<ET@?"!%86-H('-U8G-E<75E;G0@:6YS=&%L;&UE;G0@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R
M92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S
M960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S('!E<B!I;G-T86QL
M;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPV-30\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I
M<F5C=&]R<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E
M;65N="!B>2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!
M=V%R9',@9W)A;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M.#@L-S$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3`L.#<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@97%U86P@:6YS=&%L;&UE;G1S(&EN
M('=H:6-H(&%W87)D<R!W:6QL('9E<W0\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E-H87)E<R!P97(@:6YS=&%L;&UE;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0T+#,U-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@9F%I<B!V86QU
M92!O9B!A=V%R9',@;VX@=&AE(&1A=&4@;V8@9W)A;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0P-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C<U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y1=6]T960@8VQO<VEN9R!M87)K
M970@<VAA<F4@<')I8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-"XU-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-BXY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$:7)E8W1O<B!/;F4@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB87-E9"!#
M;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N
M="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^07=A<F1S(&=R86YT960\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(R+#$W.#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&ER96-T;W(@5'=O(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E
M+6)A<V5D(%!A>6UE;G0@07=A<F0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%W87)D<R!G<F%N=&5D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,BPQ-S@\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1I<F5C
M=&]R(%1H<F5E(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N
M9V5M96YT(&)Y(%-H87)E+6)A<V5D(%!A>6UE;G0@07=A<F0@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D%W87)D<R!G<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XR,BPQ-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D1I<F5C=&]R($9O=7(@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP
M96YS871I;VX@07)R86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N="!!
M=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^07=A<F1S(&=R86YT960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(R+#$W.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5B<VED:6%R>2!E;7!L;WEE97,@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@8GD@
M4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^07=A<F1S(&=R
M86YT960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V+#8U-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3G5M8F5R(&]F(&5Q=6%L(&EN<W1A;&QM96YT<R!I;B!W:&EC:"!A=V%R9',@
M=VEL;"!V97-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5&]T86P@9F%I<B!V86QU92!O9B!A=V%R9',@;VX@=&AE(&1A=&4@;V8@9W)A
M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<V/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y1=6]T960@
M8VQO<VEN9R!M87)K970@<VAA<F4@<')I8V4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-"XU-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4W5B<VED:6%R>2!E;7!L;WEE97,@6TUE
M;6)E<ET@?"!&:7)S="!I;G-T86QL;65N="!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D($-O
M;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM96YT
M($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@<&5R(&EN<W1A;&QM96YT/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,X.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W5B<VED:6%R>2!E
M;7!L;WEE97,@6TUE;6)E<ET@?"!%86-H('-U8G-E<75E;G0@:6YS=&%L;&UE
M;G0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@
M8GD@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAA<F5S
M('!E<B!I;G-T86QL;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-CDT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3=6)S:61I87)Y($5M<&QO>65E($]N92!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A
M<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!0
M87EM96YT($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!=V%R9',@9W)A;G1E9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#8L-38P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.=6UB97(@;V8@97%U
M86P@:6YS=&%L;&UE;G1S(&EN('=H:6-H(&%W87)D<R!W:6QL('9E<W0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!F86ER('9A
M;'5E(&]F(&%W87)D<R!O;B!T:&4@9&%T92!O9B!G<F%N=#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R,3(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E%U;W1E9"!C;&]S:6YG(&UA
M<FME="!S:&%R92!P<FEC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`T+C4V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y3=6)S:61I87)Y($5M<&QO>65E($]N92!;365M8F5R72!\
M($9I<G-T(&EN<W1A;&QM96YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F4M8F%S960@0V]M<&5N<V%T
M:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A<V5D(%!A>6UE;G0@07=A<F0@
M6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E-H87)E<R!P97(@:6YS=&%L;&UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,L.#@P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6)S:61I87)Y($5M<&QO>65E
M($]N92!;365M8F5R72!\($5A8V@@<W5B<V5Q=65N="!I;G-T86QL;65N="!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3
M:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3:&%R97,@<&5R
M(&EN<W1A;&QM96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#DT,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,C=E9#<P9F%?86%D-%\T,C@S7V(Q.3%?8S`P-F$Q8S(Y.34V#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S(W960W,&9A7V%A9#1?-#(X,U]B,3DQ
M7V,P,#9A,6,R.3DU-B]7;W)K<VAE971S+U-H965T,C,N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$4S0T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E)%3$%4140@4$%25$E%
M4R`M(%1204Y304-424].4R`H1&5T86EL<RD\8G(^/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^,"!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@^2G5L+B`P,2P@,C`P.#QB<CY+3E)9(%M-96UB97)=/&)R
M/E531"`H)"D\8G(^:71E;3QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6PN(#`Q+"`R,#`X/&)R/DM.4ED@6TUE;6)E<ET\8G(^24Q3/&)R
M/FET96T\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5L+B`Q
M-RP@,C`Q,SQB<CY#14\@6TUE;6)E<ET\8G(^55-$("@D*3QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6PN(#$W+"`R,#$S/&)R/D-43R!;
M365M8F5R73QB<CY54T0@*"0I/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E)E;&%T960@4&%R='D@5')A;G-A8W1I;VX@
M6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/DYU;6)E<B!O9B!C;VYS=6QT:6YG(&%G<F5E;65N=',@96YT
M97)E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUO;G1H
M;'D@<&%Y;65N="!U;F1E<B!#;VYS=6QT:6YG($%G<F5E;65N=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,30L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^(#4P+#0P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06YN
M=6%L('!A>6UE;G0@=6YD97(@0V]N<W5L=&EN9R!!9W)E96UE;G1S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(U,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(P,"PP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D5X8VAA;F=E(')A=&4@*&EN($Y)4R!P97(@52Y3+B!D;VQL87(I/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+C8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S(W960W,&9A7V%A9#1?-#(X
M,U]B,3DQ7V,P,#9A,6,R.3DU-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R
M:W-H965T<R]3:&5E=#(T+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D5!0SX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A
M;CTS1#$^/'-T<F]N9SY354)315%514Y4($5614Y4("A$971A:6QS*2`H4W5B
M<V5Q=65N="!E=F5N="!;365M8F5R72P@55-$("0I/&)R/DEN($UI;&QI;VYS
M+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D%P<BX@,#(L(#(P,34\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U8G-E<75E;G0@979E;G0@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY3=6)S97%U96YT($5V96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-87)K970@:7-S=6%N
M8V4@<V%L97,@86=R965M96YT+"!O9F9E<FEN9R!V86QU93PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%R:V5T(&ES<W5A;F-E('-A
M;&5S(&%G<F5E;65N="P@8V]M;6ES<VEO;BP@<&5R8V5N=&%G93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RXP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S(W960W,&9A7V%A9#1?-#(X,U]B
M,3DQ7V,P,#9A,6,R.3DU-@T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\R-V5D-S!F85]A860T7S0R.#-?8C$Y,5]C,#`V83%C,CDY-38O5V]R:W-H
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M/3-$(E-H965T,#$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`R
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P,RYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#<N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`X+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970P.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,3`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Q+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q,BYH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,3,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-2YH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,38N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3DN:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(P+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970R,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(S+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-"YH=&UL(B\^#0H\+WAM;#X-
M"BTM+2TM+3U?3F5X=%!A<G1?,C=E9#<P9F%?86%D-%\T,C@S7V(Q.3%?8S`P
--F$Q8S(Y.34V+2T-"@``
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE <font>2</font> - COMMITMENTS:</font></div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">a.</font></div>
</td>
<td>
<div align="justify"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On September 11, 2011, the Subsidiary entered into an agreement with Hadasit, the Company's Medical and Chief Technology Officer (the &#147;CTO&#148;) and Dr. Daniel Schurr Subsidiary (the &#147;Hadasit Agreement&#148;) to retain consulting and clinical trial services. According to the Hadasit Agreement, Hadasit will be entitled to a consideration of $<font>200</font> to be paid by the Subsidiary&#160;in accordance with the actual progress of the studies, $<font>95</font> of which were recognized through February 28, 2015. See also note <font>1</font>a<font>(1)</font>.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">b.</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On February 15, 2011, the Subsidiary entered into a consulting agreement with a third party (the &#147;Consultant&#148;) for a period of <font>five</font> years, pursuant to which the Consultant will provide consultation on scientific and clinical matters. The Consultant is entitled to a fixed monthly fee of $<font>8</font>, royalties of <font>8</font>% of the net royalties actually received by the Subsidiary in respect of the patent that was sold to Entera Bio Ltd. (&#147;Entera&#148;) on March 31, 2011 and an option to purchase up to <font>20,834</font> shares of the Company at an exercise price of $<font>6.00</font> per share. The option vests in <font>five</font> annual installments commencing February 16, 2012 and expires on February 16, 2021. The fair value of the option as of February 28, 2015 was $<font>105</font>, using the following assumptions: dividend yield of <font>0</font>%; and expected term of <font>5.97</font>&#160;years; expected volatility of <font>79.74</font>%; and risk-free interest rate of <font>1.86</font>%. The fair value of the unvested options is remeasured at each balance sheet reporting date and is recognized over the related service period using the straight-line method.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">c.</font></div>
</td>
<td><font style="font-size: 10pt;">On April 28, 2013, the Subsidiary entered into a new lease agreement for its office facilities in Israel, which replaced the lease agreement from <font>2012</font>. The new lease agreement is for a period of <font>36</font> months commencing November 4, 2013. The annual lease payment is NIS <font>89,000</font> from <font>2014</font> through <font>2016</font>, and will be linked to the increase in the Israeli consumer price index (&#147;CPI&#148;) (as of </font><font style="font-size: 10pt;">February 28, 2015</font><font style="font-size: 10pt;">, the future annual lease payments under the new agreement will be $<font>22</font>, based on the exchange rate as of </font><font style="font-size: 10pt;">February 28</font><font style="font-size: 10pt;">, 2015).</font><br/></td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 2.45pt;" align="left">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 2.45pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">As security for its obligation under this lease agreement the Company provided a bank guarantee in an amount equal to <font>three</font> monthly lease payments.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">d.</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On May 13, 2014, the Company entered into a consulting agreement with a third party advisor for a period of <font>twelve</font> months, pursuant to which the advisor will provide investor relations services and will be entitled to receive a monthly cash fee and <font>15,000</font> shares of the Company's common stock that will be issued in <font>four</font> equal installments, on or about<font style="display: inline; font-weight: bold;">&#160;</font>each of August 1, 2014, November 1, 2014, February 1, 2015 and May 1, 2015. As of February 28, 2015, the Company issued to such advisor <font>7,500</font> shares. The aggregate fair value of the shares at the dates of the grant was $<font>64</font>.</font></div>
</td>
</tr>

</table>
</div>
</div>

<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">e.</font></div>
</td>
<td>
<div align="left"><font style="font-size: 10pt;"><font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;">On February 6, 2014, the Subsidiary entered into a second agreement with a clinical research organization (&#147;CRO&#148;), for its Phase IIa clinical trial for an oral insulin capsule for type 1 diabetes patients, which was completed in October 2014. As consideration for its services, the Subsidiary paid the CRO a total amount of approximately $<font>280</font> during the term of the engagement and based on achievement of certain milestones, all of which were recognized through February 28, 2015.</font></font><br/></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;">&#160;<br/></div>
<div style="text-indent: 0pt; display: block;">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0pt; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: block; margin-left: 54pt; margin-right: -0.05pt; padding-left: 30px; background-color: #ffffff;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On July 22, 2014, the Subsidiary entered into a third agreement with the same CRO, for its Phase IIb clinical trial for an oral insulin capsule for type 2 diabetes patients, which is expected to begin in the second quarter of calendar year 2015. As consideration for its services, the Subsidiary will pay the CRO a total amount of approximately<font style="display: inline; font-weight: bold;">&#160;</font>$<font>3,290</font> during the term of the engagement and based on achievement of certain milestones, $<font>761</font> of which were recognized through February 28, 2015.</font></div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">f.</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On March 3, 2014, the Subsidiary entered into an additional agreement with a vendor, for the process development and production of <font>one</font> of its oral capsule ingredients in the amount of $<font>311</font>, $<font>40</font> of which were recognized through February 28, 2015, and bonus payments of up to $<font>600</font> that will be paid upon achieving certain milestones, as described in the agreement and which were not recognized through February 28, 2015.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On May 15, 2014, the Subsidiary entered into an additional agreement with the same vendor, for the process development and production of the same capsule ingredients in the amount of $<font>217</font>, all&#160;of which was recognized through February 28, 2015.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"></font><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"> <!-- [if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:RelyOnVML></o:RelyOnVML> <o:AllowPNG></o:AllowPNG> </o:OfficeDocumentSettings>
</xml><![endif]--> <!-- [if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:TrackMoves></w:TrackMoves> <w:TrackFormatting></w:TrackFormatting> <w:PunctuationKerning></w:PunctuationKerning> <w:ValidateAgainstSchemas></w:ValidateAgainstSchemas> <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid> <w:IgnoreMixedContent>false</w:IgnoreMixedContent> <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText> <w:DoNotPromoteQF></w:DoNotPromoteQF> <w:LidThemeOther>EN-US</w:LidThemeOther> <w:LidThemeAsian>X-NONE</w:LidThemeAsian> <w:LidThemeComplexScript>HE</w:LidThemeComplexScript> <w:Compatibility> <w:BreakWrappedTables></w:BreakWrappedTables> <w:SnapToGridInCell></w:SnapToGridInCell> <w:WrapTextWithPunct></w:WrapTextWithPunct> <w:UseAsianBreakRules></w:UseAsianBreakRules> <w:DontGrowAutofit></w:DontGrowAutofit> <w:SplitPgBreakAndParaMark></w:SplitPgBreakAndParaMark> <w:EnableOpenTypeKerning></w:EnableOpenTypeKerning> <w:DontFlipMirrorIndents></w:DontFlipMirrorIndents> <w:OverrideTableStyleHps></w:OverrideTableStyleHps> </w:Compatibility> <m:mathPr> <m:mathFont m:val="Cambria Math"></m:mathFont> <m:brkBin m:val="before"></m:brkBin> <m:brkBinSub m:val="&#45;-"></m:brkBinSub> <m:smallFrac m:val="off"></m:smallFrac> <m:dispDef></m:dispDef> <m:lMargin m:val="0"></m:lMargin> <m:rMargin m:val="0"></m:rMargin> <m:defJc m:val="centerGroup"></m:defJc> <m:wrapIndent m:val="1440"></m:wrapIndent> <m:intLim m:val="subSup"></m:intLim> <m:naryLim m:val="undOvr"></m:naryLim> </m:mathPr></w:WordDocument>
</xml><![endif]--><!-- [if gte mso 9]><xml> <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false" DefSemiHidden="false" DefQFormat="false" DefPriority="99" LatentStyleCount="371"> <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"></w:LsdException> <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 2"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 3"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 4"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 5"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 6"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 7"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 8"></w:LsdException> <w:LsdException Locked="false" Priority="9" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="heading 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index 9"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 1"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 2"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 3"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 4"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 5"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 6"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 7"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 8"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" Name="toc 9"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="header"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footer"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="index heading"></w:LsdException> <w:LsdException Locked="false" Priority="35" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="caption"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of figures"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="envelope return"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="footnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="line number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="page number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote reference"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="endnote text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="table of authorities"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="macro"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="toa heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Bullet 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Number 5"></w:LsdException> <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Closing"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Signature"></w:LsdException> <w:LsdException Locked="false" Priority="1" SemiHidden="true" UnhideWhenUsed="true" Name="Default Paragraph Font"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="List Continue 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Message Header"></w:LsdException> <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Salutation"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Date"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text First Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Note Heading"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Body Text Indent 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Block Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Hyperlink"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="FollowedHyperlink"></w:LsdException> <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"></w:LsdException> <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Document Map"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Plain Text"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="E-mail Signature"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Top of Form"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Bottom of Form"></w:LsdException> <w:LsdException Locked="false" Priority="0" SemiHidden="true" UnhideWhenUsed="true" Name="Normal (Web)"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Acronym"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Address"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Cite"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Code"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Definition"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Keyboard"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Preformatted"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Sample"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Typewriter"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="HTML Variable"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Normal Table"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="annotation subject"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="No List"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Outline List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Simple 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Classic 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Colorful 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Columns 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Grid 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 4"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 5"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 6"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 7"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table List 8"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table 3D effects 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Contemporary"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Elegant"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Professional"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Subtle 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 2"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Web 3"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Balloon Text"></w:LsdException> <w:LsdException Locked="false" Priority="39" Name="Table Grid"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true" Name="Table Theme"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"></w:LsdException> <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" SemiHidden="true" Name="Revision"></w:LsdException> <w:LsdException Locked="false" Priority="34" QFormat="true" Name="List Paragraph"></w:LsdException> <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"></w:LsdException> <w:LsdException Locked="false" Priority="30" QFormat="true" Name="Intense Quote"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="19" QFormat="true" Name="Subtle Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="21" QFormat="true" Name="Intense Emphasis"></w:LsdException> <w:LsdException Locked="false" Priority="31" QFormat="true" Name="Subtle Reference"></w:LsdException> <w:LsdException Locked="false" Priority="32" QFormat="true" Name="Intense Reference"></w:LsdException> <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"></w:LsdException> <w:LsdException Locked="false" Priority="37" SemiHidden="true" UnhideWhenUsed="true" Name="Bibliography"></w:LsdException> <w:LsdException Locked="false" Priority="39" SemiHidden="true" UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"></w:LsdException> <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"></w:LsdException> <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"></w:LsdException> <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 1"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 2"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 3"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 4"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 5"></w:LsdException> <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful Accent 6"></w:LsdException> <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful Accent 6"></w:LsdException> </w:LatentStyles>
</xml><![endif]--> <!-- [if gte mso 10]>
<style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif; mso-bidi-language:HE;}
</style>
<![endif]--></font></font>
<p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;"><font style="font-size: 10pt;">On December 12, 2014, the Subsidiary entered into an additional agreement with the same vendor, for the process development and production of the same capsule ingredients in the amount of $<font>550</font>, $<font>202</font> of which was recognized through February 28, 2015.</font></p>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">g.</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On May 26, 2014, the Subsidiary entered into a supply agreement with another vendor, according to which the vendor will manufacture capsules for total consideration of $<font>214</font>, $<font>174</font> of which was recognized through February 28, 2015.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block;">
<div style="color: #000000; font-family: 'Times New Roman'; font-size: 16px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
<div class="CursorPointer">
<table width="100%" cellpadding="0" border="0" cellspacing="0">

<tr>
<td style="width: 1.25%;"><br/></td>
<td style="width: 0.82%; vertical-align: top;" valign="top"><font style="font-size: 10pt;">h.</font></td>
<td style="width: 33%;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman', serif;"><b><font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;">On February 2, 2015, the Subsidiary entered into an agreement with a different CRO, for a glucose clamp clinical study for its oral insulin capsule. As consideration for its services, the Subsidiary will pay the CRO a total amount of approximately</font>&#160;</b><font style="layout-grid-mode: line;">$<font>276</font> </font></font><font style="font-family: 'Times New Roman', serif;">during the term of the engagement and based on achievement of certain milestones, </font><font style="font-family: 'Times New Roman', serif;">none of which was recognized through February 28, 2015.</font></font></td>
</tr>

</table>
<br/></div>
<div class="CursorPointer">
<table width="100%" cellpadding="0" border="0" cellspacing="0">

<tr>
<td style="width: 1.25%;"><br/></td>
<td style="width: 0.82%; vertical-align: top;" valign="top"><font style="font-size: 10pt;">i.</font></td>
<td style="width: 33%;"><font style="font-size: 10pt;">On&#160;January 20, 2015, the Subsidiary entered into a purchase order for the manufacturing of insulin capsules for a total consideration of Swiss Franc ("CHF")&#160;<font>211</font> (approximately $<font>241</font>) of which CHF <font>104</font> (approximately $<font>118</font>) was recognized through February 28, 2015.</font></td>
</tr>

</table>
</div>
<div class="CursorPointer"><br/></div>
</div>
</div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">j.</font></div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none;">
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Grants from Bio-Jerusalem</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The Subsidiary is committed to pay royalties to the Bio-Jerusalem fund on proceeds from future sales at a rate of <font>4</font>% and up to <font>100</font>% of the amount of the grant received by the Company (Israeli CPI linked) at the total amount of $<font>65</font>. As of February 28, 2015, the Subsidiary had not yet realized any revenues and did not incur any royalty liability.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">During the six&#160;month period ended February 28, 2015, the Company received <font>no</font> grants from the Bio-Jerusalem fund.</font></div>

<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 72pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"></font><br/></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">k.</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Grants from the Office of the Chief Scientist of the Ministry of Economy (formerly the Ministry of Industry, Trade and Labor) of Israel ("OCS").</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Under the terms of the Company's funding from the OCS, royalties of <font>3</font>%-<font>3.5</font>% are payable on sales of products developed from a project so funded, up to <font>100</font>% of the amount of the grant received by the Company (dollar linked) with the addition of annual interest at a rate based on <font>LIBOR</font>.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">At the time the grants were received, successful development of the related projects was not assured. In case of failure of a project that was partly financed as above, the Company is not obligated to pay any such royalties.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">As of February 28, 2015, the Subsidiary had not yet realized any revenues from said projects and did not incur any royalty liability. The total amount that was actually received through February 28, 2015 was $<font>2,160</font>.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">j.</font></div>
</td>
<td>
<div align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">For the six and&#160;<font>three</font> month periods ended February 28, 2015, the research and development expenses are presented net of OCS and Bio-Jerusalem fund grants, in the total amount of $<font>17</font>&#160;and $<font>1</font>, respectively.</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><br/></div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EOGAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">$ 1,102</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">$ 1,762</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short term deposits</a></td>
        <td class="nump"><a title="us-gaap_DepositsAssetsCurrent" onclick="toggleNextSibling(this);">16,351</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DepositsAssetsCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_DepositsAssetsCurrent" onclick="toggleNextSibling(this);">18,481</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DepositsAssetsCurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="nump"><a title="us-gaap_MarketableSecuritiesCurrent" onclick="toggleNextSibling(this);">695</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_MarketableSecuritiesCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_MarketableSecuritiesCurrent" onclick="toggleNextSibling(this);">1,047</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_MarketableSecuritiesCurrent</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
        <td class="nump"><a title="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">16</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">16</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump"><a title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" onclick="toggleNextSibling(this);">129</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" onclick="toggleNextSibling(this);">64</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromOtherRelatedPartiesCurrent', window );">Related parties</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump"><a title="us-gaap_DueFromOtherRelatedPartiesCurrent" onclick="toggleNextSibling(this);">330</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DueFromOtherRelatedPartiesCurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Grants receivable from the chief scientist</a></td>
        <td class="nump"><a title="us-gaap_OtherReceivablesNetCurrent" onclick="toggleNextSibling(this);">2</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherReceivablesNetCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_OtherReceivablesNetCurrent" onclick="toggleNextSibling(this);">78</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherReceivablesNetCurrent</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump"><a title="us-gaap_AssetsCurrent" onclick="toggleNextSibling(this);">18,295</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AssetsCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_AssetsCurrent" onclick="toggleNextSibling(this);">21,778</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AssetsCurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndOtherNoncurrentAssets', window );">LONG TERM DEPOSITS AND INVESTMENT</a></td>
        <td class="nump"><a title="us-gaap_InvestmentsAndOtherNoncurrentAssets" onclick="toggleNextSibling(this);">4,665</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_InvestmentsAndOtherNoncurrentAssets</span><span></span></td>
        <td class="nump"><a title="us-gaap_InvestmentsAndOtherNoncurrentAssets" onclick="toggleNextSibling(this);">3</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_InvestmentsAndOtherNoncurrentAssets</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidPensionCosts', window );">AMOUNTS FUNDED IN RESPECT OF EMPLOYEE RIGHTS UPON RETIREMENT</a></td>
        <td class="nump"><a title="us-gaap_PrepaidPensionCosts" onclick="toggleNextSibling(this);">7</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PrepaidPensionCosts</span><span></span></td>
        <td class="nump"><a title="us-gaap_PrepaidPensionCosts" onclick="toggleNextSibling(this);">7</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PrepaidPensionCosts</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, NET</a></td>
        <td class="nump"><a title="us-gaap_PropertyPlantAndEquipmentNet" onclick="toggleNextSibling(this);">13</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PropertyPlantAndEquipmentNet</span><span></span></td>
        <td class="nump"><a title="us-gaap_PropertyPlantAndEquipmentNet" onclick="toggleNextSibling(this);">14</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PropertyPlantAndEquipmentNet</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump"><a title="us-gaap_Assets" onclick="toggleNextSibling(this);">22,980</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_Assets</span><span></span></td>
        <td class="nump"><a title="us-gaap_Assets" onclick="toggleNextSibling(this);">21,802</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_Assets</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
        <td class="nump"><a title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" onclick="toggleNextSibling(this);">570</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" onclick="toggleNextSibling(this);">926</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Related parties</a></td>
        <td class="nump"><a title="us-gaap_DueToRelatedPartiesCurrent" onclick="toggleNextSibling(this);">35</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DueToRelatedPartiesCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_DueToRelatedPartiesCurrent" onclick="toggleNextSibling(this);">47</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DueToRelatedPartiesCurrent</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump"><a title="us-gaap_LiabilitiesCurrent" onclick="toggleNextSibling(this);">605</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesCurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_LiabilitiesCurrent" onclick="toggleNextSibling(this);">973</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesCurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG TERM LIABILITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Employee rights upon retirement</a></td>
        <td class="nump"><a title="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" onclick="toggleNextSibling(this);">9</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" onclick="toggleNextSibling(this);">9</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Provision for uncertain tax position</a></td>
        <td class="nump"><a title="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" onclick="toggleNextSibling(this);">27</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" onclick="toggleNextSibling(this);">27</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long term liabilities</a></td>
        <td class="nump"><a title="us-gaap_LiabilitiesNoncurrent" onclick="toggleNextSibling(this);">36</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesNoncurrent</span><span></span></td>
        <td class="nump"><a title="us-gaap_LiabilitiesNoncurrent" onclick="toggleNextSibling(this);">36</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesNoncurrent</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS (note 2)</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $ 0.012 par value (30,000,000 authorized shares; 10,820,193 and 10,102,555 shares issued and outstanding as of February 28, 2015 and August 31, 2014, respectively)</a></td>
        <td class="nump"><a title="us-gaap_CommonStockValue" onclick="toggleNextSibling(this);">129</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockValue</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockValue" onclick="toggleNextSibling(this);">121</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockValue</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
        <td class="nump"><a title="us-gaap_AdditionalPaidInCapitalCommonStock" onclick="toggleNextSibling(this);">53,463</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdditionalPaidInCapitalCommonStock</span><span></span></td>
        <td class="nump"><a title="us-gaap_AdditionalPaidInCapitalCommonStock" onclick="toggleNextSibling(this);">48,040</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AdditionalPaidInCapitalCommonStock</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
        <td class="nump"><a title="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" onclick="toggleNextSibling(this);">100</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" onclick="toggleNextSibling(this);">452</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated loss</a></td>
        <td class="num"><a title="us-gaap_RetainedEarningsAccumulatedDeficit" onclick="toggleNextSibling(this);">(31,353)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RetainedEarningsAccumulatedDeficit</span><span></span></td>
        <td class="num"><a title="us-gaap_RetainedEarningsAccumulatedDeficit" onclick="toggleNextSibling(this);">(27,820)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RetainedEarningsAccumulatedDeficit</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">22,339</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">20,793</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
        <td class="nump"><a title="us-gaap_LiabilitiesAndStockholdersEquity" onclick="toggleNextSibling(this);">$ 22,980</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesAndStockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_LiabilitiesAndStockholdersEquity" onclick="toggleNextSibling(this);">$ 21,802</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LiabilitiesAndStockholdersEquity</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_Assets</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromOtherRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amounts due within 1 year (or 1 business cycle) from other related parties which are not otherwise stated in the taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> -Subparagraph 1<br><br><br><br> -Article 4<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3(a)(2))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DueFromOtherRelatedPartiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 235<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.4-08.(k)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 850<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (d)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 08<br><br><br><br> -Paragraph k<br><br><br><br> -Subparagraph 1<br><br><br><br> -Article 4<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndOtherNoncurrentAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of investments and other noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_InvestmentsAndOtherNoncurrentAssets</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 22, 23, 24, 25, 26, 27<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 2<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount of other receivables, net, due within one year of the balance sheet date (or one operating cycle, if longer) from third parties or arising from transactions not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 715<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35743120&amp;loc=d3e2417-114920<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 715<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35743120&amp;loc=d3e2410-114920<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 715<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35743120&amp;loc=d3e1928-114920<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 715<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=21915240&amp;loc=d3e1703-114919<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidPensionCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cumulative employer's contributions in excess of net pension cost recognized, before the adoption of the recognition provisions of FAS 158. Under FAS 158, prepaid pension costs are no longer recognized in the statement of financial position. Note that there is a separate concept for noncurrent assets relating to defined benefit pension and other defined benefit postretirement plans for use under the recognition provisions of FAS 158.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 715<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=21915240&amp;loc=d3e1703-114919<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PrepaidPensionCosts</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EFHAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="4">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th" colspan="2">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th" colspan="2">
          <div>Feb. 28, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ (3,533)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">$ (2,239)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
        <td class="nump"><a title="us-gaap_DepreciationDepletionAndAmortization" onclick="toggleNextSibling(this);">3</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DepreciationDepletionAndAmortization</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_DepreciationDepletionAndAmortization" onclick="toggleNextSibling(this);">3</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_DepreciationDepletionAndAmortization</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Exchange differences and interest on deposits</a></td>
        <td class="num"><a title="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" onclick="toggleNextSibling(this);">(36)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" onclick="toggleNextSibling(this);">(33)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensation" onclick="toggleNextSibling(this);">564</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensation</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensation" onclick="toggleNextSibling(this);">333</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensation</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Common stock issued for services</a></td>
        <td class="nump"><a title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" onclick="toggleNextSibling(this);">26</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" onclick="toggleNextSibling(this);">64</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfInvestments', window );">Gain on sale of investment</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="us-gaap_GainLossOnSaleOfInvestments" onclick="toggleNextSibling(this);">(44)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GainLossOnSaleOfInvestments</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent', window );">Prepaid expenses, other current assets and related parties</a></td>
        <td class="nump"><a title="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" onclick="toggleNextSibling(this);">341</a><span style="display:none;white-space:normal;text-align:left;">ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent" onclick="toggleNextSibling(this);">(167)</a><span style="display:none;white-space:normal;text-align:left;">ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent', window );">Accounts payable, accrued expenses and related parties</a></td>
        <td class="num"><a title="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" onclick="toggleNextSibling(this);">(368)</a><span style="display:none;white-space:normal;text-align:left;">ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent" onclick="toggleNextSibling(this);">(148)</a><span style="display:none;white-space:normal;text-align:left;">ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">Liability for employee rights upon retirement</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" onclick="toggleNextSibling(this);">1</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Total net cash used in operating activities</a></td>
        <td class="num"><a title="us-gaap_NetCashProvidedByUsedInOperatingActivities" onclick="toggleNextSibling(this);">(3,003)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInOperatingActivities</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="us-gaap_NetCashProvidedByUsedInOperatingActivities" onclick="toggleNextSibling(this);">(2,230)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInOperatingActivities</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num"><a title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" onclick="toggleNextSibling(this);">(2)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" onclick="toggleNextSibling(this);">(9)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short term deposits</a></td>
        <td class="num"><a title="us-gaap_PaymentsToAcquireShortTermInvestments" onclick="toggleNextSibling(this);">(1,573)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PaymentsToAcquireShortTermInvestments</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="us-gaap_PaymentsToAcquireShortTermInvestments" onclick="toggleNextSibling(this);">(18,600)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PaymentsToAcquireShortTermInvestments</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLongtermInvestments', window );">Purchase of long term deposits</a></td>
        <td class="num"><a title="us-gaap_PaymentsToAcquireLongtermInvestments" onclick="toggleNextSibling(this);">(4,652)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_PaymentsToAcquireLongtermInvestments</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments', window );">Proceeds from sale of short term deposits</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" onclick="toggleNextSibling(this);">3,750</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments" onclick="toggleNextSibling(this);">5,236</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale of marketable securities</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" onclick="toggleNextSibling(this);">80</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement', window );">Funds in respect of employee rights upon retirement</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement" onclick="toggleNextSibling(this);">(1)</a><span style="display:none;white-space:normal;text-align:left;">ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Total net cash used in investing activities</a></td>
        <td class="num"><a title="us-gaap_NetCashProvidedByUsedInInvestingActivities" onclick="toggleNextSibling(this);">(2,477)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInInvestingActivities</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="num"><a title="us-gaap_NetCashProvidedByUsedInInvestingActivities" onclick="toggleNextSibling(this);">(13,294)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInInvestingActivities</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock - net of issuance expenses</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">4,833</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">14,887</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ProceedsFromStockOptionsAndWarrantsExercised', window );">Proceeds from exercise of warrants and options</a></td>
        <td class="nump"><a title="ormp_ProceedsFromStockOptionsAndWarrantsExercised" onclick="toggleNextSibling(this);">8</a><span style="display:none;white-space:normal;text-align:left;">ormp_ProceedsFromStockOptionsAndWarrantsExercised</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="ormp_ProceedsFromStockOptionsAndWarrantsExercised" onclick="toggleNextSibling(this);">1,490</a><span style="display:none;white-space:normal;text-align:left;">ormp_ProceedsFromStockOptionsAndWarrantsExercised</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from shares to be issued for exercise of warrants</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" onclick="toggleNextSibling(this);">118</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash derived from financing activities</a></td>
        <td class="nump"><a title="us-gaap_NetCashProvidedByUsedInFinancingActivities" onclick="toggleNextSibling(this);">4,841</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInFinancingActivities</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_NetCashProvidedByUsedInFinancingActivities" onclick="toggleNextSibling(this);">16,495</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetCashProvidedByUsedInFinancingActivities</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
        <td class="num"><a title="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" onclick="toggleNextSibling(this);">(21)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" onclick="toggleNextSibling(this);">10</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</a></td>
        <td class="num"><a title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" onclick="toggleNextSibling(this);">(660)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" onclick="toggleNextSibling(this);">981</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">1,762</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">2,272</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">CASH AND CASH EQUIVALENTS AT END OF PERIOD</a></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">$ 1,102</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_CashAndCashEquivalentsAtCarryingValue" onclick="toggleNextSibling(this);">$ 3,253</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CashAndCashEquivalentsAtCarryingValue</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
      </tr>
      <tr>
        <td colspan="5"></td>
      </tr>
      <tr>
        <td colspan="5">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">See note 5.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the period in the carrying value of accounts payable, accrued expenses and related parties reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_IncreaseDecreaseInAccountsPayableAccruedExpensesAndRelatedPartiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the period in the carrying value of prepaid expenses, other current assets and related parties reported as assets that are due to be disposed of within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_IncreaseDecreaseInPrepaidExpensesOtherCurrentAssetsAndRelatedPartiesCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow from the purchase of funds in respect of employee rights upon retirement during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_PaymentsToAcquireFundsInRespectOfEmployeeRightsUponRetirement</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_ProceedsFromStockOptionsAndWarrantsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock options and warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_ProceedsFromStockOptionsAndWarrantsExercised</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfInvestments</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount due to fund pension and non-pension benefits to employees, retired and disabled former employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLongtermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLongtermInvestments</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EGTDI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Details) (Restricted stock units [Member], USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">0 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 23, 2015

</div>
          <div>item</div>
        </th>
        <th class="th">
          <div>Nov. 13, 2014

</div>
          <div>item</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember', window );">Chief Executive Officer and the CTO [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">159,696</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">19,576</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments', window );">Number of equal installments in which awards will vest</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">23</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">2</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">9,788</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Total fair value of awards on the date of grant</a></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">$ 728</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">$ 135</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Quoted closing market share price</a></td>
        <td class="nump"><a title="us-gaap_SharePrice[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">$ 4.56</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_SharePrice[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">$ 6.90</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember', window );">Chief Executive Officer and the CTO [Member] | Issued on November 13, 2014 [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Vested and outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;ormp_EquityIssuanceAxis=ormp_IssuanceOneMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">19,576</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ ormp_EquityIssuanceAxis<br>= ormp_IssuanceOneMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember', window );">Chief Executive Officer and the CTO [Member] | Issued on February 23, 2015 [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Vested and outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;ormp_EquityIssuanceAxis=ormp_IssuanceTwoMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">13,308</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ ormp_EquityIssuanceAxis<br>= ormp_IssuanceTwoMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember', window );">Chief Executive Officer and the CTO [Member] | First installment [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember;us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember]" onclick="toggleNextSibling(this);">13,308</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember<br>/ us-gaap_VestingAxis<br>= us-gaap_ShareBasedCompensationAwardTrancheOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember', window );">Chief Executive Officer and the CTO [Member] | Each subsequent installment [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember;us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember]" onclick="toggleNextSibling(this);">6,654</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember<br>/ us-gaap_VestingAxis<br>= us-gaap_ShareBasedCompensationAwardTrancheTwoMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember', window );">Directors [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">88,712</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">10,872</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments', window );">Number of equal installments in which awards will vest</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">2</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">44,356</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Total fair value of awards on the date of grant</a></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">405</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">75</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Quoted closing market share price</a></td>
        <td class="nump"><a title="us-gaap_SharePrice[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">$ 4.56</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_SharePrice[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember]" onclick="toggleNextSibling(this);">$ 6.90</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= us-gaap_DirectorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorOneMember', window );">Director One [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_DirectorOneMember]" onclick="toggleNextSibling(this);">22,178</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_DirectorOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorTwoMember', window );">Director Two [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_DirectorTwoMember]" onclick="toggleNextSibling(this);">22,178</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_DirectorTwoMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorThreeMember', window );">Director Three [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_DirectorThreeMember]" onclick="toggleNextSibling(this);">22,178</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_DirectorThreeMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorFourMember', window );">Director Four [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_DirectorFourMember]" onclick="toggleNextSibling(this);">22,178</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_DirectorFourMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember', window );">Subsidiary employees [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember]" onclick="toggleNextSibling(this);">16,656</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeesMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments', window );">Number of equal installments in which awards will vest</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember]" onclick="toggleNextSibling(this);">23</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeesMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Total fair value of awards on the date of grant</a></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember]" onclick="toggleNextSibling(this);">76</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeesMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Quoted closing market share price</a></td>
        <td class="nump"><a title="us-gaap_SharePrice[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember]" onclick="toggleNextSibling(this);">$ 4.56</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeesMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember', window );">Subsidiary employees [Member] | First installment [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember;us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember]" onclick="toggleNextSibling(this);">1,388</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeesMember<br>/ us-gaap_VestingAxis<br>= us-gaap_ShareBasedCompensationAwardTrancheOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember', window );">Subsidiary employees [Member] | Each subsequent installment [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember;us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember]" onclick="toggleNextSibling(this);">694</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeesMember<br>/ us-gaap_VestingAxis<br>= us-gaap_ShareBasedCompensationAwardTrancheTwoMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember', window );">Subsidiary Employee One [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted</a></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember]" onclick="toggleNextSibling(this);">46,560</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeeOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments', window );">Number of equal installments in which awards will vest</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember]" onclick="toggleNextSibling(this);">23</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeeOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Total fair value of awards on the date of grant</a></td>
        <td class="nump"><a title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember]" onclick="toggleNextSibling(this);">$ 212</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeeOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Quoted closing market share price</a></td>
        <td class="nump"><a title="us-gaap_SharePrice[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember]" onclick="toggleNextSibling(this);">$ 4.56</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeeOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember', window );">Subsidiary Employee One [Member] | First installment [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember;us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember]" onclick="toggleNextSibling(this);">3,880</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeeOneMember<br>/ us-gaap_VestingAxis<br>= us-gaap_ShareBasedCompensationAwardTrancheOneMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember', window );">Subsidiary Employee One [Member] | Each subsequent installment [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_ShareBasedCompensationInstallmentVestingShares', window );">Shares per installment</a></td>
        <td class="nump"><a title="ormp_ShareBasedCompensationInstallmentVestingShares[us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember;us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember;us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember]" onclick="toggleNextSibling(this);">1,940</a><span style="display:none;white-space:normal;text-align:left;">ormp_ShareBasedCompensationInstallmentVestingShares<br>/ us-gaap_AwardTypeAxis<br>= us-gaap_RestrictedStockUnitsRSUMember<br>/ us-gaap_RelatedPartyTransactionAxis<br>= ormp_SubsidiaryEmployeeOneMember<br>/ us-gaap_VestingAxis<br>= us-gaap_ShareBasedCompensationAwardTrancheTwoMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equal installments in which awards will vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestingNumberOfInstallments</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_ShareBasedCompensationInstallmentVestingShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares that vest in each installment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_ShareBasedCompensationInstallmentVestingShares</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ormp_ChiefExecutiveOfficerAndChiefMedicalAndTechnologyOfficerMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorFourMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ormp_DirectorFourMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorOneMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ormp_DirectorOneMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorThreeMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ormp_DirectorThreeMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ormp_DirectorTwoMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ormp_DirectorTwoMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeeOneMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ormp_SubsidiaryEmployeesMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_DirectorMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E6EAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) (Subsequent event [Member], USD $)<br>In Millions, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Apr. 02, 2015</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top">
          <div class="a">Subsequent event [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_MarketIssuanceSalesAgreementOfferingValue', window );">Market issuance sales agreement, offering value</a></td>
        <td class="nump"><a title="ormp_MarketIssuanceSalesAgreementOfferingValue[us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember]" onclick="toggleNextSibling(this);">$ 25</a><span style="display:none;white-space:normal;text-align:left;">ormp_MarketIssuanceSalesAgreementOfferingValue<br>/ us-gaap_SubsequentEventTypeAxis<br>= us-gaap_SubsequentEventMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_MarketIssuanceSalesAgreementCommissionPercentage', window );">Market issuance sales agreement, commission, percentage</a></td>
        <td class="nump"><a title="ormp_MarketIssuanceSalesAgreementCommissionPercentage[us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember]" onclick="toggleNextSibling(this);">3.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_MarketIssuanceSalesAgreementCommissionPercentage<br>/ us-gaap_SubsequentEventTypeAxis<br>= us-gaap_SubsequentEventMember</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_MarketIssuanceSalesAgreementCommissionPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percent of gross proceeds payable as commission to sales agent as part of a market issuance sales agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_MarketIssuanceSalesAgreementCommissionPercentage</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_MarketIssuanceSalesAgreementOfferingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The value of the shares that will be issued as part of a market issuance sales agreement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_MarketIssuanceSalesAgreementOfferingValue</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE <font>1</font> - SIGNIFICANT ACCOUNTING POLICIES:</font></div>
</div>
<div style="text-indent: 0pt; display: block;">&#160;</div>
<div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block;">
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">a.</font></div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none;">
<div align="justify"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">General:</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;">&#160;</div>
<div>
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">
<div class="CursorPointer">
<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;">&#160;</td>
<td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font>1)</font></font></div>
</td>
<td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Incorporation and operations</font></div>
</td>
</tr>

</table>
</div>
</div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Oramed Pharmaceuticals Inc. (the &#147;Company&#148;) was incorporated on April 12, 2002, under the laws of the State of Nevada. On February 17, 2006, the Company entered into an agreement with Hadasit Medical Services and Development Ltd (&#147;Hadasit&#148;) to acquire the provisional patent related to an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On March 11, 2011, the Company was reincorporated from the State of Nevada to the State of Delaware.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On May 14, 2007, the Company incorporated a wholly-owned subsidiary in Israel, Oramed Ltd. (the &#147;Subsidiary&#148;), which is engaged in research and development. Unless the context indicates otherwise, the term &#147;Group&#148; refers to Oramed Pharmaceuticals Inc. and the Subsidiary.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Following the adoption of Accounting Standards Update (&#147;ASU&#148;) <font>2014</font>-<font>10</font>, Development Stage Entities (Topic <font>915</font>), the Company removed the inception to date information and all reference to development.</font></div>
<div style="text-indent: 0pt; display: block;">&#160;</div>
<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">
<div class="CursorPointer">
<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;">&#160;</td>
<td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font>2)</font></font></div>
</td>
<td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Development and liquidity risks</font></div>
</td>
</tr>

</table>
</div>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The Group is engaged in research and development in the biotechnology field for innovative pharmaceutical solutions, including an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules for delivery of other polypeptides, and has not generated any revenues from its operations. Continued operation of the Company is contingent upon obtaining sufficient funding until it becomes profitable.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>

<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Successful completion of the Company's development programs and its transition to normal operations is dependent upon obtaining necessary regulatory approvals from the U.S. Food and Drug Administration (&#147;FDA&#148;) prior to selling its products within the United States, and foreign regulatory approvals must be obtained to sell its products internationally. There can be <font>no</font> assurance that the Company will receive regulatory approval of any of its product candidates, and a substantial amount of time may pass before the Company achieves a level of revenues adequate to support its operations, if at all. The Company also expects to incur substantial expenditures in connection with the regulatory approval process for each of its product candidates during their respective developmental periods. Obtaining marketing approval will be directly dependent on the Company's ability to implement the necessary regulatory steps required to obtain marketing approval in the United States and in other countries. The Company cannot predict the outcome of these activities.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Based on its current cash resources and commitments, and cash received in private and public offerings in the six&#160;month period ended February 28, 2015 and in the year ended August 31, 2014, the Company believes it will be able to maintain its current planned development activities and the corresponding level of expenditures for at least the next <font>12</font> months and beyond the date that the financial statements are issued, although <font>no</font> assurance can be given that it will not need additional funds prior to such time. If there are unexpected increases in general and administrative expenses or research and development expenses, the Company may need to seek additional financing during the next <font>12</font> months.</font></div>

</div>
</div>
<div style="text-indent: 0pt; display: block;">

<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"></font><br/></div>
</div>

<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div>
<div class="CursorPointer"><br/></div>
</div>
<div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">b.</font></div>
</td>
<td>
<div align="justify"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Newly issued and recently adopted Accounting Pronouncements</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">In August 2014, the Financial Accounting Standards Board (the &#147;FASB&#148;) issued Accounting Standards Update (&#147;ASU&#148;) <font>2014</font>-<font>15</font>, Presentation of Financial Statements-Going Concern (Subtopic <font>205</font>-<font>40</font>): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (&#147;ASU <font>2014</font>-<font>15</font>&#148;). This new standard requires management to assess the entity's ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (<font>1</font>) provide a definition of the term substantial doubt, (<font>2</font>) require an evaluation every reporting period including interim periods, (<font>3</font>) provide principles for considering the mitigating effect of management's plans, (<font>4</font>) require certain disclosures when substantial doubt is alleviated as a result of consideration of management's plans, (<font>5</font>) require an express statement and other disclosures when substantial doubt is not alleviated, and (<font>6</font>) require an assessment for a period of <font>one</font> year after the date that the financial statements are issued (or available to be issued). ASU <font>2014</font>-<font>15</font> will be effective prospectively for annual reporting periods ending after the first annual period ending after December 15, 2016 and interim periods therein. Early application of the standard is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has elected to early adopt the provisions of ASU <font>2014</font>-<font>15</font> in fiscal year <font>2014</font>. The adoption of ASU <font>2014</font>-<font>15</font> did not have any material effect on the consolidated financial statement presentation.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div>
<div class="CursorPointer"><br/></div>
</div>
<div>
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">c.</font></div>
</td>
<td>
<div align="justify"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Condensed Consolidated Financial Statements Preparation</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The condensed consolidated financial statements included herein have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") and on the same basis as the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended August&#160;31, <font>2014</font> (the &#147;<font>2014</font> Form 10-K&#148;). These condensed consolidated financial statements reflect all adjustments that are of a normal recurring nature and that are considered necessary for a fair statement of the results of the periods presented. Certain information and disclosures normally included in annual consolidated financial statements have been omitted in this interim period report pursuant to the rules and regulations of the Securities and Exchange Commission. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by U.S. GAAP for annual financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in the <font>2014</font> Form 10-K. The results for interim periods are not necessarily indicative of a full fiscal year's results.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div>
<div style="width: 100%;" align="left"><br/></div>
</div>
</div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E6FAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
        <td class="nump"><a title="us-gaap_CommonStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.012</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockParOrStatedValuePerShare</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockParOrStatedValuePerShare" onclick="toggleNextSibling(this);">$ 0.012</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockParOrStatedValuePerShare</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesAuthorized" onclick="toggleNextSibling(this);">30,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesAuthorized</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesAuthorized" onclick="toggleNextSibling(this);">30,000,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesAuthorized</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesIssued" onclick="toggleNextSibling(this);">10,820,193</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesIssued</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesIssued" onclick="toggleNextSibling(this);">10,102,555</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesIssued</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesOutstanding" onclick="toggleNextSibling(this);">10,820,193</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesOutstanding</span><span></span></td>
        <td class="nump"><a title="us-gaap_CommonStockSharesOutstanding" onclick="toggleNextSibling(this);">10,102,555</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_CommonStockSharesOutstanding</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EHGAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS (Leases) (Details) (Office Building [Member])<br></strong></div>
        </th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>ILS</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract', window );">Operating lease term</a></td>
        <td class="text">36 months<span></span></td>
        <td class="text">36 months<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Annual lease payments:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2015</a></td>
        <td class="nump"><a title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent[us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeBuildingMember]" onclick="toggleNextSibling(this);">$ 22,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent<br>/ us-gaap_PropertyPlantAndEquipmentByTypeAxis<br>= us-gaap_OfficeBuildingMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent[us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeBuildingMember]" onclick="toggleNextSibling(this);"> 89,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent<br>/ us-gaap_PropertyPlantAndEquipmentByTypeAxis<br>= us-gaap_OfficeBuildingMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2016</a></td>
        <td class="nump"><a title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears[us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeBuildingMember]" onclick="toggleNextSibling(this);">$ 22,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears<br>/ us-gaap_PropertyPlantAndEquipmentByTypeAxis<br>= us-gaap_OfficeBuildingMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears[us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeBuildingMember]" onclick="toggleNextSibling(this);"> 89,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears<br>/ us-gaap_PropertyPlantAndEquipmentByTypeAxis<br>= us-gaap_OfficeBuildingMember</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Term of the lessee's leasing arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E1AAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Mar. 31, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Feb. 28,  2015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">ORAMED PHARMACEUTICALS INC.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001176309<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--08-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q2<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2015<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="dei_EntityCommonStockSharesOutstanding" onclick="toggleNextSibling(this);">10,823,943</a><span style="display:none;white-space:normal;text-align:left;">dei_EntityCommonStockSharesOutstanding</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_AmendmentFlag</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_DocumentType</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityFilerCategory</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">dei_EntityRegistrantName</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_DocumentAndEntityInformationAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E2KAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS (Research Grants) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">155 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Grants received</a></td>
        <td class="nump"><a title="us-gaap_RevenueFromGrants" onclick="toggleNextSibling(this);">$ 1</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RevenueFromGrants</span><span></span></td>
        <td class="nump"><a title="us-gaap_RevenueFromGrants" onclick="toggleNextSibling(this);">$ 17</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RevenueFromGrants</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember', window );">Bio-Jerusalem [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_RoyaltyPercentage', window );">Royalty percentage</a></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">4.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">4.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">4.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived', window );">Royalty percentage, maximum percentage of grants received</a></td>
        <td class="nump"><a title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">100.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">100.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">100.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent', window );">Royalty liability</a></td>
        <td class="nump"><a title="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">0</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedRoyaltiesCurrentAndNoncurrent<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">0</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedRoyaltiesCurrentAndNoncurrent<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_AccruedRoyaltiesCurrentAndNoncurrent[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">0</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_AccruedRoyaltiesCurrentAndNoncurrent<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants receivable</a></td>
        <td class="nump"><a title="us-gaap_GrantsReceivable[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">65</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GrantsReceivable<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_GrantsReceivable[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">65</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GrantsReceivable<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_GrantsReceivable[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember]" onclick="toggleNextSibling(this);">65</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GrantsReceivable<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_BioJerusalemMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember', window );">Chief Scientist Office [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived', window );">Royalty percentage, maximum percentage of grants received</a></td>
        <td class="nump"><a title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">100.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">100.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">100.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Grants received</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_RevenueFromGrants[us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">$ 2,160</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_RevenueFromGrants<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember', window );">Chief Scientist Office [Member] | Minimum [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_RoyaltyPercentage', window );">Royalty percentage</a></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_RangeAxis=us-gaap_MinimumMember;us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">3.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_RangeAxis<br>= us-gaap_MinimumMember<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_RangeAxis=us-gaap_MinimumMember;us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">3.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_RangeAxis<br>= us-gaap_MinimumMember<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_RangeAxis=us-gaap_MinimumMember;us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">3.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_RangeAxis<br>= us-gaap_MinimumMember<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember', window );">Chief Scientist Office [Member] | Maximum [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_RoyaltyPercentage', window );">Royalty percentage</a></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_RangeAxis=us-gaap_MaximumMember;us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">3.50%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_RangeAxis<br>= us-gaap_MaximumMember<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_RangeAxis=us-gaap_MaximumMember;us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">3.50%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_RangeAxis<br>= us-gaap_MaximumMember<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_RangeAxis=us-gaap_MaximumMember;us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember]" onclick="toggleNextSibling(this);">3.50%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_RangeAxis<br>= us-gaap_MaximumMember<br>/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis<br>= ormp_ChiefScientistOfficeMember</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_RoyaltyPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percentage of sales or another benchmark specified in an agreement payable as royalty.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_RoyaltyPercentage</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>When royalties are granted as a percentage of sales, this represents the maximum percentage of grants received from the entity that coincide with the percentage of royalties paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_RoyaltyPercentageMaximumPercentageOfGrantsReceived</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.15(5))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-03.15(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 15<br><br> -Subparagraph a<br><br> -Article 7<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 15<br><br> -Subparagraph 5<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrentAndNoncurrent</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RevenueFromGrants</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_BioJerusalemMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=ormp_ChiefScientistOfficeMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EI6AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">RESEARCH AND DEVELOPMENT EXPENSES, NET</a></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">$ 1,136</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">$ 674</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">$ 2,438</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_ResearchAndDevelopmentExpense" onclick="toggleNextSibling(this);">$ 1,424</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ResearchAndDevelopmentExpense</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
        <td class="nump"><a title="us-gaap_GeneralAndAdministrativeExpense" onclick="toggleNextSibling(this);">538</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GeneralAndAdministrativeExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_GeneralAndAdministrativeExpense" onclick="toggleNextSibling(this);">512</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GeneralAndAdministrativeExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_GeneralAndAdministrativeExpense" onclick="toggleNextSibling(this);">1,138</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GeneralAndAdministrativeExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_GeneralAndAdministrativeExpense" onclick="toggleNextSibling(this);">930</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_GeneralAndAdministrativeExpense</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">OPERATING LOSS</a></td>
        <td class="nump"><a title="us-gaap_OperatingIncomeLoss" onclick="toggleNextSibling(this);">1,674</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingIncomeLoss</span><span></span></td>
        <td class="nump"><a title="us-gaap_OperatingIncomeLoss" onclick="toggleNextSibling(this);">1,186</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingIncomeLoss</span><span></span></td>
        <td class="nump"><a title="us-gaap_OperatingIncomeLoss" onclick="toggleNextSibling(this);">3,576</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingIncomeLoss</span><span></span></td>
        <td class="nump"><a title="us-gaap_OperatingIncomeLoss" onclick="toggleNextSibling(this);">2,354</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OperatingIncomeLoss</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">FINANCIAL INCOME</a></td>
        <td class="num"><a title="us-gaap_OtherNonoperatingIncome" onclick="toggleNextSibling(this);">(38)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingIncome</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherNonoperatingIncome" onclick="toggleNextSibling(this);">(74)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingIncome</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherNonoperatingIncome" onclick="toggleNextSibling(this);">(65)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingIncome</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherNonoperatingIncome" onclick="toggleNextSibling(this);">(120)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingIncome</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">FINANCIAL EXPENSES</a></td>
        <td class="nump"><a title="us-gaap_OtherNonoperatingExpense" onclick="toggleNextSibling(this);">1</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_OtherNonoperatingExpense" onclick="toggleNextSibling(this);">3</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_OtherNonoperatingExpense" onclick="toggleNextSibling(this);">22</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingExpense</span><span></span></td>
        <td class="nump"><a title="us-gaap_OtherNonoperatingExpense" onclick="toggleNextSibling(this);">5</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherNonoperatingExpense</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS FOR THE PERIOD</a></td>
        <td class="nump"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">1,637</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="nump"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">1,115</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="nump"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">3,533</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="nump"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">2,239</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">SUBSEQUENT DECREASE (INCREASE) IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" onclick="toggleNextSibling(this);">(49)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</span><span></span></td>
        <td class="nump"><a title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" onclick="toggleNextSibling(this);">9</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" onclick="toggleNextSibling(this);">(54)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">RECLASSIFICATION ADJUSTMENT TO FINANCIAL INCOME OF GAINS ON AVAILABLE-FOR-SALE SECURITIES</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump"><a title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" onclick="toggleNextSibling(this);">26</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump"><a title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" onclick="toggleNextSibling(this);">44</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">UNREALIZED LOSS (GAIN) ON AVAILABLE FOR SALE SECURITIES</a></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" onclick="toggleNextSibling(this);">(7)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" onclick="toggleNextSibling(this);">(490)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</span><span></span></td>
        <td class="nump"><a title="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" onclick="toggleNextSibling(this);">343</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" onclick="toggleNextSibling(this);">(534)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</span><span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">TOTAL OTHER COMPREHENSIVE LOSS (INCOME)</a></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" onclick="toggleNextSibling(this);">(7)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" onclick="toggleNextSibling(this);">(513)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</span><span></span></td>
        <td class="nump"><a title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" onclick="toggleNextSibling(this);">352</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</span><span></span></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" onclick="toggleNextSibling(this);">(544)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</span><span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">TOTAL COMPREHENSIVE LOSS FOR THE PERIOD</a></td>
        <td class="nump"><a title="us-gaap_ComprehensiveIncomeNetOfTax" onclick="toggleNextSibling(this);">$ 1,630</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ComprehensiveIncomeNetOfTax</span><span></span></td>
        <td class="nump"><a title="us-gaap_ComprehensiveIncomeNetOfTax" onclick="toggleNextSibling(this);">$ 602</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ComprehensiveIncomeNetOfTax</span><span></span></td>
        <td class="nump"><a title="us-gaap_ComprehensiveIncomeNetOfTax" onclick="toggleNextSibling(this);">$ 3,885</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ComprehensiveIncomeNetOfTax</span><span></span></td>
        <td class="nump"><a title="us-gaap_ComprehensiveIncomeNetOfTax" onclick="toggleNextSibling(this);">$ 1,695</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ComprehensiveIncomeNetOfTax</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>LOSS PER COMMON SHARE:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">BASIC AND DILUTED LOSS PER COMMON SHARE</a></td>
        <td class="nump"><a title="us-gaap_EarningsPerShareBasicAndDiluted" onclick="toggleNextSibling(this);">$ 0.15</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EarningsPerShareBasicAndDiluted</span><span></span></td>
        <td class="nump"><a title="us-gaap_EarningsPerShareBasicAndDiluted" onclick="toggleNextSibling(this);">$ 0.12</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EarningsPerShareBasicAndDiluted</span><span></span></td>
        <td class="nump"><a title="us-gaap_EarningsPerShareBasicAndDiluted" onclick="toggleNextSibling(this);">$ 0.34</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EarningsPerShareBasicAndDiluted</span><span></span></td>
        <td class="nump"><a title="us-gaap_EarningsPerShareBasicAndDiluted" onclick="toggleNextSibling(this);">$ 0.26</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_EarningsPerShareBasicAndDiluted</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER COMMON STOCK</a></td>
        <td class="nump"><a title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="toggleNextSibling(this);">10,826,146</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</span><span></span></td>
        <td class="nump"><a title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="toggleNextSibling(this);">9,127,799</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</span><span></span></td>
        <td class="nump"><a title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="toggleNextSibling(this);">10,482,190</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</span><span></span></td>
        <td class="nump"><a title="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="toggleNextSibling(this);">8,531,150</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35737396<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e557-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e689-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4C<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5624171-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of other expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating expense recognized during the period. Such amounts may include: (a) unusual costs, (b) loss on foreign exchange transactions, (c) losses on securities (net of profits), and (d) miscellaneous other expense items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 9<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of other income amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK BASED COMPENSATION<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>STOCK BASED COMPENSATION [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK BASED COMPENSATION</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"><div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><strong><font style="font-family: 'times new roman', times; font-size: 10pt;">NOTE 6 - STOCK BASED COMPENSATION:</font></strong><br style="font-family: 'times new roman', times; font-size: 10pt;"/></div> </div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-indent: 0pt; display: block;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div class="CursorPointer"><table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0">  <tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"> <td style="width: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="width: 27pt; text-align: left;" align="right"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">a.</font></div> </td> <td style="text-align: justify;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">On November 13, 2014, the Company granted a total of <font>19,576</font> restricted stock units (&#147;RSUs&#148;) representing a right to receive shares of the Company's common stock to the Company's Chief Executive Officer and director (the &#147;CEO&#148;), and the CTO, both related parties. The RSUs vested in two equal installments, each of <font>9,788</font> shares, on November 30 and December 31, 2014. The total fair value of these RSUs on the date of grant was $<font>135</font>, using the quoted closing market share price of $<font>6.90</font> on the Nasdaq Capital Market on the date of grant. The shares of common stock underlying the RSUs will be issued upon request of the grantee. As of February 28, 2015, a total of <font>19,576</font> RSUs were vested and outstanding.</font></div> </td> </tr>  </table></div> </div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div class="CursorPointer"><table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0">  <tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"> <td style="width: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="width: 27pt; text-align: left;" align="right"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">b.</font></div> </td> <td style="text-align: justify;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">On November 13, 2014, the Company granted a total of <font>10,872</font> RSUs representing a right to receive shares of the Company's common stock to four members of the Company's Board of Directors. The RSUs vested on January 1, 2015. The total fair value of these RSUs on the date of grant was $<font>75</font>, using the quoted closing market share price of $<font>6.90</font> on the Nasdaq Capital Market on the date of grant.</font></div> </td> </tr>  </table></div> </div> </div> <div style="text-indent: 0pt; display: block;"> <div style="text-indent: 0pt; display: block;"><br style="font-family: 'times new roman', times; font-size: 10pt;"/></div> <div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div class="CursorPointer"><table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0">  <tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"> <td style="width: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="width: 27pt;" align="right"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">c.&#160;</font></div> </td> <td align="left" style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">On February 23, 2015, the Company granted a total of <font>159,696</font> RSUs representing a right to receive shares of the Company's common stock to the Company's CEO and the CTO, both related parties. The RSUs vest in <font>23</font> installments consisting of one installment of <font>13,308</font> shares on February 28, 2015 and 22 equal monthly installments of <font>6,654</font> shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $<font>728</font>, using the quoted closing market share price of $<font>4.56</font> on the Nasdaq Capital Market on the date of grant. The shares of common stock underlying the RSUs will be issued upon request of the grantee. As of February 28, 2015, a total of <font>13,308</font> RSUs were vested and outstanding.</font></div> </td> </tr>  </table></div> </div> </div> </div> <div style="text-indent: 0pt; display: block;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div class="CursorPointer"><table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0">  <tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"> <td style="width: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="width: 27pt; text-align: left;" align="right"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">d.</font></div> </td> <td align="left" style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">On February 23, 2015, the Company granted a total of <font>88,712</font> RSUs representing a right to receive shares of the Company's common stock to four members of the Company's Board of Directors (<font>22,178</font> RSUs to each director). The RSUs vest in <font>two</font> equal installments, each of <font>44,356</font> shares, on December 31, 2015 and December 31, 2016. The total fair value of these RSUs on the date of grant was $<font>405</font>, using the quoted closing market share price of $<font>4.56</font> on the Nasdaq Capital Market on the date of grant.</font></div> </td> </tr>  </table></div> </div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"> <div style="font-family: 'times new roman', times; font-size: 10pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div class="CursorPointer"><table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0">  <tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"> <td style="width: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="width: 27pt;" align="right"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">e.&#160;</font></div> </td> <td style="text-align: justify;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">On February 23, 2015, the Company granted a total of <font>46,560</font> RSUs to an employee of the Subsidiary. The RSUs vest in <font>23</font> installments, consisting of one installment of <font>3,880</font> shares on February 28, 2015 and 22 equal monthly installments of <font>1,940</font> shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $<font>212</font>, using the quoted closing market share price of $<font>4.56</font> on the Nasdaq Capital Market on the date of grant.</font></div> </td> </tr>  </table></div> </div> </div> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"> <div style="font-family: 'times new roman', times; font-size: 10pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></div> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"> <div class="CursorPointer"><table style="font-size: 10pt; font-family: 'times new roman'; width: 100%;" border="0" cellpadding="0" cellspacing="0">  <tr valign="top" style="font-family: 'times new roman', times; font-size: 10pt;"> <td style="width: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></td> <td style="width: 27pt;" align="right"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="font-family: 'times new roman', times; font-size: 10pt;">f.&#160;</font></div> </td> <td align="left" style="font-family: 'times new roman', times; font-size: 10pt;"> <div style="text-align: justify; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">On February 23, 2015, the Company granted a total of <font>16,656</font> RSUs to employees of the Subsidiary. The RSUs vest in <font>23</font> installments, consisting of one installment of <font>1,388</font> shares on February 28, 2015 and 22 equal monthly installments of <font>694</font> shares each, commencing March 31, 2015. The total fair value of these RSUs on the date of grant was $<font>76</font>, using the quoted closing market share price of $<font>4.56</font> on the Nasdaq Capital Market on the date of grant.</font></div> </td> </tr>  </table></div> </div> </div> </div> </div></div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK HOLDERS' EQUITY<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCK HOLDERS' EQUITY [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCK HOLDERS' EQUITY</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE <font>5</font> - STOCK HOLDERS' EQUITY:</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On <font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;">November 3, 2014, the Company entered into a Stock Purchase Agreement with Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (the &#147;Investor&#148;), pursuant to which the Company issued to the Investor an aggregate of</font>&#160;<font>696,378</font> shares of common stock, at a price of $<font>7.18</font> per share, which was equal to the closing price of the Company's common stock on the Nasdaq Capital Market on October 31, 2014, for aggregate gross proceeds of approximately $<font>5,000</font>.&#160;&#160;The net proceeds to the Company from the offering were approximately $<font>4,833</font>, after deducting a finder's fee of $<font>150</font> and other offering expenses of the Company. The offering closed on November 28, 2014.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"></font><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;"><font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;">See also note 8 with respect to an at market issuance sales agreement.</font></font></div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0E3CAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>RELATED PARTIES - TRANSACTIONS (Details)<br></strong></div>
        </th>
        <th class="th" colspan="2">0 Months Ended</th>
        <th class="th" colspan="2"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jul. 01, 2008

</div>
          <div>KNRY [Member]

</div>
          <div>USD ($)

</div>
          <div>item</div>
        </th>
        <th class="th">
          <div>Jul. 01, 2008

</div>
          <div>KNRY [Member]

</div>
          <div>ILS

</div>
          <div>item</div>
        </th>
        <th class="th">
          <div>Jul. 17, 2013

</div>
          <div>CEO [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Jul. 17, 2013

</div>
          <div>CTO [Member]

</div>
          <div>USD ($)</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_NumberOfConsultingAgreementsEntered', window );">Number of consulting agreements entered</a></td>
        <td class="nump"><a title="ormp_NumberOfConsultingAgreementsEntered[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_KnryMember]" onclick="toggleNextSibling(this);">2</a><span style="display:none;white-space:normal;text-align:left;">ormp_NumberOfConsultingAgreementsEntered<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_KnryMember</span><span></span></td>
        <td class="nump"><a title="ormp_NumberOfConsultingAgreementsEntered[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_KnryMember]" onclick="toggleNextSibling(this);">2</a><span style="display:none;white-space:normal;text-align:left;">ormp_NumberOfConsultingAgreementsEntered<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_KnryMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_MonthlyPaymentUnderConsultingAgreements', window );">Monthly payment under Consulting Agreements</a></td>
        <td class="nump"><a title="ormp_MonthlyPaymentUnderConsultingAgreements[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_KnryMember]" onclick="toggleNextSibling(this);">$ 14,000</a><span style="display:none;white-space:normal;text-align:left;">ormp_MonthlyPaymentUnderConsultingAgreements<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_KnryMember</span><span></span></td>
        <td class="nump"><a title="ormp_MonthlyPaymentUnderConsultingAgreements[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_KnryMember]" onclick="toggleNextSibling(this);"> 50,400</a><span style="display:none;white-space:normal;text-align:left;">ormp_MonthlyPaymentUnderConsultingAgreements<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_KnryMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_AnnualPaymentUnderConsultingAgreements', window );">Annual payment under Consulting Agreements</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="ormp_AnnualPaymentUnderConsultingAgreements[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ExecutiveOfficerMember]" onclick="toggleNextSibling(this);">$ 250,000</a><span style="display:none;white-space:normal;text-align:left;">ormp_AnnualPaymentUnderConsultingAgreements<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_ExecutiveOfficerMember</span><span></span></td>
        <td class="nump"><a title="ormp_AnnualPaymentUnderConsultingAgreements[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_ChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">$ 200,000</a><span style="display:none;white-space:normal;text-align:left;">ormp_AnnualPaymentUnderConsultingAgreements<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_ChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Exchange rate (in NIS per U.S. dollar)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ForeignCurrencyExchangeRateTranslation1[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ExecutiveOfficerMember]" onclick="toggleNextSibling(this);">3.6</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ForeignCurrencyExchangeRateTranslation1<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= us-gaap_ExecutiveOfficerMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ForeignCurrencyExchangeRateTranslation1[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_ChiefMedicalAndTechnologyOfficerMember]" onclick="toggleNextSibling(this);">3.6</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ForeignCurrencyExchangeRateTranslation1<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_ChiefMedicalAndTechnologyOfficerMember</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_AnnualPaymentUnderConsultingAgreements">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Annual payment to be made under the consulting agreements to the individuals.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_AnnualPaymentUnderConsultingAgreements</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_MonthlyPaymentUnderConsultingAgreements">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Monthly payment to be made under the consulting agreements to the individuals.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_MonthlyPaymentUnderConsultingAgreements</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_NumberOfConsultingAgreementsEntered">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of consulting agreements entered into by the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_NumberOfConsultingAgreementsEntered</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:integerItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section S99<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EFG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE (Details)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentInterestRateRangeStart', window );">Long-term bank deposit interest rate, minimum</a></td>
        <td class="nump"><a title="invest_InvestmentInterestRateRangeStart" onclick="toggleNextSibling(this);">0.93%</a><span style="display:none;white-space:normal;text-align:left;">invest_InvestmentInterestRateRangeStart</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_InvestmentInterestRateRangeEnd', window );">Long-term bank deposit interest rate, maximum</a></td>
        <td class="nump"><a title="invest_InvestmentInterestRateRangeEnd" onclick="toggleNextSibling(this);">1.00%</a><span style="display:none;white-space:normal;text-align:left;">invest_InvestmentInterestRateRangeEnd</span><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentInterestRateRangeEnd">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The highest interest rate in the aggregated short-term debt instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 12<br><br> -Section 12<br><br> -Footnote 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">invest_InvestmentInterestRateRangeEnd</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>invest_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_InvestmentInterestRateRangeStart">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The lowest interest rate in the aggregated short-term debt instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 12<br><br> -Section 12<br><br> -Footnote 2<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">invest_InvestmentInterestRateRangeStart</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>invest_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:pureItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EKH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policy)<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">General</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block;">
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">a.</font></div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none;">
<div align="justify"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">General:</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;">&#160;</div>
<div>
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">
<div class="CursorPointer">
<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;">&#160;</td>
<td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font>1)</font></font></div>
</td>
<td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Incorporation and operations</font></div>
</td>
</tr>

</table>
</div>
</div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Oramed Pharmaceuticals Inc. (the &#147;Company&#148;) was incorporated on April 12, 2002, under the laws of the State of Nevada. On February 17, 2006, the Company entered into an agreement with Hadasit Medical Services and Development Ltd (&#147;Hadasit&#148;) to acquire the provisional patent related to an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On March 11, 2011, the Company was reincorporated from the State of Nevada to the State of Delaware.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On May 14, 2007, the Company incorporated a wholly-owned subsidiary in Israel, Oramed Ltd. (the &#147;Subsidiary&#148;), which is engaged in research and development. Unless the context indicates otherwise, the term &#147;Group&#148; refers to Oramed Pharmaceuticals Inc. and the Subsidiary.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Following the adoption of Accounting Standards Update (&#147;ASU&#148;) <font>2014</font>-<font>10</font>, Development Stage Entities (Topic <font>915</font>), the Company removed the inception to date information and all reference to development.</font></div>
<div style="text-indent: 0pt; display: block;">&#160;</div>
<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;">
<div class="CursorPointer">
<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 72pt;">&#160;</td>
<td align="right" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><font>2)</font></font></div>
</td>
<td align="left" style="text-align: left; border-left: none; border-right: none; border-top: none; border-bottom: none;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Development and liquidity risks</font></div>
</td>
</tr>

</table>
</div>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The Group is engaged in research and development in the biotechnology field for innovative pharmaceutical solutions, including an orally ingestible insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules for delivery of other polypeptides, and has not generated any revenues from its operations. Continued operation of the Company is contingent upon obtaining sufficient funding until it becomes profitable.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>

<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Successful completion of the Company's development programs and its transition to normal operations is dependent upon obtaining necessary regulatory approvals from the U.S. Food and Drug Administration (&#147;FDA&#148;) prior to selling its products within the United States, and foreign regulatory approvals must be obtained to sell its products internationally. There can be <font>no</font> assurance that the Company will receive regulatory approval of any of its product candidates, and a substantial amount of time may pass before the Company achieves a level of revenues adequate to support its operations, if at all. The Company also expects to incur substantial expenditures in connection with the regulatory approval process for each of its product candidates during their respective developmental periods. Obtaining marketing approval will be directly dependent on the Company's ability to implement the necessary regulatory steps required to obtain marketing approval in the United States and in other countries. The Company cannot predict the outcome of these activities.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 99pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Based on its current cash resources and commitments, and cash received in private and public offerings in the six&#160;month period ended February 28, 2015 and in the year ended August 31, 2014, the Company believes it will be able to maintain its current planned development activities and the corresponding level of expenditures for at least the next <font>12</font> months and beyond the date that the financial statements are issued, although <font>no</font> assurance can be given that it will not need additional funds prior to such time. If there are unexpected increases in general and administrative expenses or research and development expenses, the Company may need to seek additional financing during the next <font>12</font> months.</font></div>

</div>
</div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Newly issued and recently adopted Accounting Pronouncements</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">b.</font></div>
</td>
<td>
<div align="justify"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Newly issued and recently adopted Accounting Pronouncements</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">In August 2014, the Financial Accounting Standards Board (the &#147;FASB&#148;) issued Accounting Standards Update (&#147;ASU&#148;) <font>2014</font>-<font>15</font>, Presentation of Financial Statements-Going Concern (Subtopic <font>205</font>-<font>40</font>): Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (&#147;ASU <font>2014</font>-<font>15</font>&#148;). This new standard requires management to assess the entity's ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (<font>1</font>) provide a definition of the term substantial doubt, (<font>2</font>) require an evaluation every reporting period including interim periods, (<font>3</font>) provide principles for considering the mitigating effect of management's plans, (<font>4</font>) require certain disclosures when substantial doubt is alleviated as a result of consideration of management's plans, (<font>5</font>) require an express statement and other disclosures when substantial doubt is not alleviated, and (<font>6</font>) require an assessment for a period of <font>one</font> year after the date that the financial statements are issued (or available to be issued). ASU <font>2014</font>-<font>15</font> will be effective prospectively for annual reporting periods ending after the first annual period ending after December 15, 2016 and interim periods therein. Early application of the standard is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has elected to early adopt the provisions of ASU <font>2014</font>-<font>15</font> in fiscal year <font>2014</font>. The adoption of ASU <font>2014</font>-<font>15</font> did not have any material effect on the consolidated financial statement presentation.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
</div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock', window );">Condensed Consolidated Financial Statements Preparation</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div>
<div class="CursorPointer">
<table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'times new roman'; width: 100%;">

<tr valign="top">
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 45.35pt;">
<div>&#160;</div>
</td>
<td style="border-left: none; border-right: none; border-top: none; border-bottom: none; width: 27pt;">
<div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">c.</font></div>
</td>
<td>
<div align="justify"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Condensed Consolidated Financial Statements Preparation</font></div>
</td>
</tr>

</table>
</div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 72pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The condensed consolidated financial statements included herein have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") and on the same basis as the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended August&#160;31, <font>2014</font> (the &#147;<font>2014</font> Form 10-K&#148;). These condensed consolidated financial statements reflect all adjustments that are of a normal recurring nature and that are considered necessary for a fair statement of the results of the periods presented. Certain information and disclosures normally included in annual consolidated financial statements have been omitted in this interim period report pursuant to the rules and regulations of the Securities and Exchange Commission. Because the condensed consolidated interim financial statements do not include all of the information and disclosures required by U.S. GAAP for annual financial statements, they should be read in conjunction with the audited consolidated financial statements and notes included in the <font>2014</font> Form 10-K. The results for interim periods are not necessarily indicative of a full fiscal year's results.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for condensed consolidated financial statements preparation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_CondensedConsolidatedFinancialStatementsPreparationPolicyTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>RELATED PARTIES - TRANSACTIONS<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>RELATED PARTIES - TRANSACTIONS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES - TRANSACTIONS</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE <font>7</font> - RELATED PARTIES - TRANSACTIONS</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On July 1, 2008, the Subsidiary entered into <font>two</font> consulting agreements with KNRY Ltd. (&#147;KNRY&#148;), an Israeli company owned by the CEO, whereby the CEO and the CTO, through KNRY, provide services to the Group (the &#147;Consulting Agreements&#148;). The Consulting Agreements are both terminable by either party upon <font>60</font> days prior written notice. The Consulting Agreements provide that KNRY (i) will be paid a gross amount of NIS <font>50,400</font> per month for each of the CEO and CTO ($<font>14</font>) and (ii) will be reimbursed for reasonable expenses incurred in connection with performance of the Consulting Agreements.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On July 17, 2013, the Subsidiary entered into amendments to the Consulting Agreements with KNRY, according to which, the CEO's and CTO's annual payment was set at $<font>250</font> and $<font>200</font>, respectively, calculated at an exchange rate of NIS <font>3.6</font> &#160;per U.S. dollar, and in addition to such payment they were granted the use of a company car and certain cash bonus payments, effective July 1, 2013.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">On November 13, 2014, the Subsidiary entered into an amendment to the Consulting Agreements (the &#147;Amendment Agreement&#148;), according to which, the CEO and the CTO made some representations with regards to their relationship with KNRY and agreed to indemnify the Subsidiary in certain circumstances as defined in the amendment, among other revisions.</font></div>

<div style="text-indent: 0pt; display: block;">
<div style="text-align: center; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><br/></div>
</div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</font></div>
</div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph b<br><br> -Article 3A<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(k))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph k<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 850<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>SUBSEQUENT EVENT [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENT</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="left"><strong><font style="font-size: 10pt;">NOTE 8 &#150; SUBSEQUENT EVENT</font></strong><br/></div>
<div style="text-indent: 0pt; display: block;"><strong>&#160;</strong></div>
<div style="text-indent: 0pt; display: block; margin-left: 54pt; margin-right: 0pt;" align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">On April 2, 2015, the Company entered into an at market issuance sales agreement (the &#147;Sales Agreement&#148;) with MLV &amp; Co. LLC (&#147;MLV&#148;) pursuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $<font>25</font> million from time to time, at its option, through MLV as its sales agent, subject to certain terms and conditions. Any shares sold will be sold pursuant to the Company's effective shelf registration statement on Form S-3 (Registration No. 333-193557), including a prospectus dated April 10, 2014, as supplemented by a prospectus supplement dated April 2, 2015.&#160; The Company will pay MLV a commission of <font>3.0</font>% of the gross proceeds of the sale of any shares sold through MLV. To date, no shares have been sold under the Sales Agreement.</font></div>
</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EVKCI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS (Service Agreements) (Details)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="1">155 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="1">6 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">7 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
        <th class="th" colspan="1">3 Months Ended</th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="2">2 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Hadasit [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Consultant [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2011

</div>
          <div>Consultant [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>May 13, 2014

</div>
          <div>Advisor [Member]</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Advisor [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Second Clinical Research Organization Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Third Clinical Research Organization Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Second Master Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Third Master Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Fourth Master Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Fifth Master Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Clinical Research Organization Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Sixth Master Service Agreement [Member]

</div>
          <div>USD ($)</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015

</div>
          <div>Sixth Master Service Agreement [Member]

</div>
          <div>CHF</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Commitments for consulting services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_HadasitMember]" onclick="toggleNextSibling(this);">$ 200</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_HadasitMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ThirdClinicalResearchOrganizationServiceAgreementMember]" onclick="toggleNextSibling(this);">$ 3,290</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ThirdClinicalResearchOrganizationServiceAgreementMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementTwoMember]" onclick="toggleNextSibling(this);">$ 311</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementTwoMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementThreeMember]" onclick="toggleNextSibling(this);">$ 217</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementThreeMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementFourMember]" onclick="toggleNextSibling(this);">$ 214</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementFourMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementFiveMember]" onclick="toggleNextSibling(this);">$ 550</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementFiveMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ClinicalResearchOrganizationServiceAgreementMember]" onclick="toggleNextSibling(this);">$ 276</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ClinicalResearchOrganizationServiceAgreementMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementSixMember]" onclick="toggleNextSibling(this);">$ 241</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementSixMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_LongTermPurchaseCommitmentAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementSixMember]" onclick="toggleNextSibling(this);"> 211</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_LongTermPurchaseCommitmentAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementSixMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_LongTermPurchaseCommitmentBonusAmount', window );">Commitments for bonus payments upon achieving certain milestones</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="ormp_LongTermPurchaseCommitmentBonusAmount[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementTwoMember]" onclick="toggleNextSibling(this);">600</a><span style="display:none;white-space:normal;text-align:left;">ormp_LongTermPurchaseCommitmentBonusAmount<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementTwoMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Consulting services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_HadasitMember]" onclick="toggleNextSibling(this);">95</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_HadasitMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_SecondClinicalResearchOrganizationServiceAgreementMember]" onclick="toggleNextSibling(this);">280</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_SecondClinicalResearchOrganizationServiceAgreementMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ThirdClinicalResearchOrganizationServiceAgreementMember]" onclick="toggleNextSibling(this);">761</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ThirdClinicalResearchOrganizationServiceAgreementMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementTwoMember]" onclick="toggleNextSibling(this);">40</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementTwoMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementThreeMember]" onclick="toggleNextSibling(this);">217</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementThreeMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementFourMember]" onclick="toggleNextSibling(this);">174</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementFourMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementFiveMember]" onclick="toggleNextSibling(this);">202</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementFiveMember</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementSixMember]" onclick="toggleNextSibling(this);">118</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementSixMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_ProfessionalFees[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_MasterServiceAgreementSixMember]" onclick="toggleNextSibling(this);">104</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProfessionalFees<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_MasterServiceAgreementSixMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_LongTermPurchaseCommitmentAgreementTerm', window );">Agreement term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee', window );">Commitments for consulting service, monthly fixed fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">8</a><span style="display:none;white-space:normal;text-align:left;">ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_RoyaltyPercentage', window );">Royalty percentage</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="ormp_RoyaltyPercentage[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">8.00%</a><span style="display:none;white-space:normal;text-align:left;">ormp_RoyaltyPercentage<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">20,834</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">$ 6.00</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost', window );">Capitalized cost</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">105</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate', window );">Dividend yield</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">0.00%</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1', window );">Expected term</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">5 years 11 months 19 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate', window );">Expected volatility</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">79.74%</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_ConsultantMember]" onclick="toggleNextSibling(this);">1.86%</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_ConsultantMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance', window );">Shares authorized for issuance for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_AdvisorMember]" onclick="toggleNextSibling(this);">15,000</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_AdvisorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued', window );">Shares issued for services</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_AdvisorMember]" onclick="toggleNextSibling(this);">7,500</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_AdvisorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Shares issued for services rendered</a></td>
        <td class="nump"><a title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" onclick="toggleNextSibling(this);">$ 26</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</span><span></span></td>
        <td class="nump"><a title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" onclick="toggleNextSibling(this);">$ 64</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims[us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=ormp_AdvisorMember]" onclick="toggleNextSibling(this);">$ 64</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims<br>/ us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis<br>= ormp_AdvisorMember</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_LongTermPurchaseCommitmentAgreementTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Term of a long-term purchase commitment for goods or services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_LongTermPurchaseCommitmentAgreementTerm</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The monthly fixed fee for the long term purchase commitment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_LongTermPurchaseCommitmentAmountMonthlyFixedFee</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_LongTermPurchaseCommitmentBonusAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum amount the entity agreed to spend on bonuses under the long-term purchase commitment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_LongTermPurchaseCommitmentBonusAmount</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_RoyaltyPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percentage of sales or another benchmark specified in an agreement payable as royalty.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_RoyaltyPercentage</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 946<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606610-122999<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 946<br><br> -SubTopic 225<br><br> -Section 45<br><br> -Paragraph 3<br><br> -Subparagraph (k)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6488370&amp;loc=d3e13550-115849<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount by which an asset or assets increased resulting from the transaction in which equity securities were issued to pay for goods or nonemployee services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section I<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares or units of entity securities issued in the transaction in which equity securities were issued to pay for goods or nonemployee services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period an equity-based award is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The estimated measure of the percentage amount by which a share price is expected to fluctuate during the expected term of a nonvested share or option award issued to other than an employee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The risk-free interest rate assumption that is used in valuing a nonvested share or option award issued to other than an employee.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (f)(2)(iv)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EYMAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCK HOLDERS' EQUITY (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="4">6 Months Ended</th>
        <th class="th" colspan="1">0 Months Ended</th>
      </tr>
      <tr>
        <th class="th" colspan="2">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th" colspan="2">
          <div>Feb. 28, 2014</div>
        </th>
        <th class="th">
          <div>Nov. 03, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from the offering, after deducting a finder's fee</a></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">$ 4,833</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock" onclick="toggleNextSibling(this);">$ 14,887</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember', window );">Stock Purchase Agreement with Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. [Member]</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares', window );">Number of shares to be sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_InvestmentSoldNotYetPurchasedBalanceShares[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember]" onclick="toggleNextSibling(this);">696,378</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_InvestmentSoldNotYetPurchasedBalanceShares<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_SecuritiesPurchaseAgreementMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Per share price of shares to be sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_SharePrice[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember]" onclick="toggleNextSibling(this);">$ 7.18</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharePrice<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_SecuritiesPurchaseAgreementMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_GrossProceedsFromIssuanceOfCommonStock', window );">Aggregate gross proceeds from the offering</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="ormp_GrossProceedsFromIssuanceOfCommonStock[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember]" onclick="toggleNextSibling(this);">5,000</a><span style="display:none;white-space:normal;text-align:left;">ormp_GrossProceedsFromIssuanceOfCommonStock<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_SecuritiesPurchaseAgreementMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from the offering, after deducting a finder's fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_ProceedsFromIssuanceOfCommonStock[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember]" onclick="toggleNextSibling(this);">4,833</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromIssuanceOfCommonStock<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_SecuritiesPurchaseAgreementMember</span><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_FindersFee', window );">Finders fee</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="ormp_FindersFee[us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember]" onclick="toggleNextSibling(this);">$ 150</a><span style="display:none;white-space:normal;text-align:left;">ormp_FindersFee<br>/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis<br>= ormp_SecuritiesPurchaseAgreementMember</span><span></span></td>
      </tr>
      <tr>
        <td colspan="6"></td>
      </tr>
      <tr>
        <td colspan="6">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">See note 5.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_FindersFee">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Finders fee associated with shares issued for services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_FindersFee</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_GrossProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The gross cash inflow from the issuance of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_GrossProceedsFromIssuanceOfCommonStock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentSoldNotYetPurchasedBalanceShares">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of securities sold short (the short position) as of the end of the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 946<br><br> -SubTopic 320<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.12-12A.Column B)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34726532&amp;loc=d3e611177-123010<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 12A<br><br> -Paragraph Column B<br><br> -Article 12<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_InvestmentSoldNotYetPurchasedBalanceShares</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Price of a single share of a number of saleable stocks of a company.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharePrice</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ormp_SecuritiesPurchaseAgreementMember</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td></td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td></td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EU5AG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)<br>In Thousands</strong></div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
        <th class="th" colspan="2">
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Additional paid-in capital [Member]</div>
        </th>
        <th class="th">
          <div>Accumulated other comprehensive income [Member]</div>
        </th>
        <th class="th">
          <div>Accumulated loss [Member]</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Aug. 31, 2014</a></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">$ 20,793</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">$ 121</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">$ 48,040</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_ComprehensiveIncomeMember]" onclick="toggleNextSibling(this);">$ 452</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_ComprehensiveIncomeMember</span><span></span></td>
        <td class="num"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember]" onclick="toggleNextSibling(this);">$ (27,820)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_RetainedEarningsMember</span><span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">BALANCE, shares at Aug. 31, 2014</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharesOutstanding[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">10,103</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharesOutstanding<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">SHARES ISSUED FOR CASH, NET</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueNewIssues" onclick="toggleNextSibling(this);">4,833</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueNewIssues</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueNewIssues[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">8</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueNewIssues<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueNewIssues[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">4,825</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueNewIssues<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">SHARES ISSUED FOR CASH, NET, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesNewIssues[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">696</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesNewIssues<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">SHARES ISSUED FOR SERVICES</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" onclick="toggleNextSibling(this);">26</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueIssuedForServices[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">26</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">SHARES ISSUED FOR SERVICES, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">4</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">EXERCISE OF OPTIONS</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" onclick="toggleNextSibling(this);">8</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">8</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">EXERCISE OF OPTIONS, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">1</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">STOCK BASED COMPENSATION</a></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" onclick="toggleNextSibling(this);">564</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">564</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">STOCK BASED COMPENSATION, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">16</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS</a></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss" onclick="toggleNextSibling(this);">(3,533)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num"><a title="us-gaap_NetIncomeLoss[us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember]" onclick="toggleNextSibling(this);">(3,533)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_NetIncomeLoss<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_RetainedEarningsMember</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">OTHER COMPREHENSIVE LOSS</a></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeLossNetOfTax" onclick="toggleNextSibling(this);">(352)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num"><a title="us-gaap_OtherComprehensiveIncomeLossNetOfTax[us-gaap_StatementEquityComponentsAxis=us-gaap_ComprehensiveIncomeMember]" onclick="toggleNextSibling(this);">(352)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossNetOfTax<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_ComprehensiveIncomeMember</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">BALANCE at Feb. 28, 2015</a></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity" onclick="toggleNextSibling(this);">$ 22,339</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">$ 129</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember]" onclick="toggleNextSibling(this);">$ 53,463</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_AdditionalPaidInCapitalMember</span><span></span></td>
        <td class="nump"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_ComprehensiveIncomeMember]" onclick="toggleNextSibling(this);">$ 100</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_ComprehensiveIncomeMember</span><span></span></td>
        <td class="num"><a title="us-gaap_StockholdersEquity[us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember]" onclick="toggleNextSibling(this);">$ (31,353)</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_StockholdersEquity<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_RetainedEarningsMember</span><span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">BALANCE, shares at Feb. 28, 2015</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_SharesOutstanding[us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember]" onclick="toggleNextSibling(this);">10,820</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_SharesOutstanding<br>/ us-gaap_StatementEquityComponentsAxis<br>= us-gaap_CommonStockMember</span><span></span></td>
        <td class="fn" style="border-bottom: 0px;"></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr>
        <td colspan="7"></td>
      </tr>
      <tr>
        <td colspan="7">
          <table class="outerFootnotes" width="100%">
            <tr class="outerFootnote">
              <td style="vertical-align: top;" valign="top">[1]</td>
              <td style="vertical-align: top;" valign="top">Represents an amount of less than $1.</td>
            </tr>
          </table>
        </td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued which are neither cancelled nor held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Gross value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued as a result of the exercise of stock options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES<br></strong></div>
        </th>
        <th class="th" colspan="1">6 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>MARKETABLE SECURITIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">MARKETABLE SECURITIES</a></td>
        <td class="text"><div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">
<div>
<div style="text-align: left; text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;">
<div style="text-align: left; text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE <font>4</font> - <font style="display: inline; font-size: 10pt;">MARKETABLE SECURITIES</font>:</font></div>
</div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">Available-for-sale securities are reported at fair value, with unrealized gains and losses recorded as a separate component of other comprehensive income in equity until realized. Unrealized losses that are considered to be other-than-temporary are charged to statement of operations as an impairment charge and are included in the consolidated statement of operations under impairment of available-for-sale securities.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The Company considers available evidence in evaluating potential impairments of its investments, including the duration and extent to which fair value is less than cost, and the Company's ability and intent to hold the investment. Realized gains and losses on sales of the securities are included in the consolidated statement of operations as financial income or expenses.</font></div>
<div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify">&#160;</div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">As of February 28, 2015, marketable securities consisted wholly of equity securities of D.N.A Biomedical Solutions Ltd ("D.N.A"). D.N.A's ordinary shares are traded on the Tel Aviv Stock Exchange and have a quoted price. The fair value of those securities is measured at the quoted prices of the securities on the measurement date.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">During the <font>six</font>&#160;month period ended February 28, 2014, the Subsidiary sold in aggregate <font>1,625,989</font> of the D.N.A ordinary shares for total consideration of $<font>80</font>. During the <font>six</font>&#160;month period ended February 28, 2015, the Group did not sell any of the D.N.A ordinary shares.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">As of February 28, 2015, the Group owns approximately <font>9.8</font>% of D.N.A's outstanding ordinary shares.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The cost of the securities as of February 28, 2015 and August 31, 2014 is $<font>595</font>.</font></div>
<div style="text-indent: 0pt; display: block;"><br/></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: -0.05pt;" align="left"><font style="display: inline; font-family: 'Times New Roman'; font-size: 10pt;">The cost of the securities sold and the amount reclassified out of accumulated other comprehensive income into financial income (amounting to $<font>0</font>&#160;<font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333330154419px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: -webkit-left; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; display: inline !important; float: none; background-color: #ffffff;">and $<font>44</font> during the six month periods ended February 28, 2015 and 2014, respectively, and to $<font>0</font> and $<font>26</font> during the three month periods ended February 28, 2015 and 2014, respectively) were determined by specific identification.</font></font></div>
<div style="text-indent: 0pt; display: block; margin-left: 45pt; margin-right: 0pt;" align="left"><br/></div>
</div>

</div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for  investments in certain debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -Glossary Debt Security<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6379141&amp;loc=d3e15032-111544<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -Glossary Equity Security<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6511694<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.1.9</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>73</ContextCount>
  <ElementCount>137</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-daei</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-ccbs</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-ccbsp</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-ccsocl</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-ccsocise</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-ccsocf</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>101 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-sap</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>102 - Disclosure - COMMITMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-c</Role>
      <ShortName>COMMITMENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>103 - Disclosure - FAIR VALUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-fv</Role>
      <ShortName>FAIR VALUE</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>104 - Disclosure - MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-ms</Role>
      <ShortName>MARKETABLE SECURITIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>105 - Disclosure - STOCK HOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-she</Role>
      <ShortName>STOCK HOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>106 - Disclosure - STOCK BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-sbc</Role>
      <ShortName>STOCK BASED COMPENSATION</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>107 - Disclosure - RELATED PARTIES - TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-rpt</Role>
      <ShortName>RELATED PARTIES - TRANSACTIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>108 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-se</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-sapp</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policy)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>40201 - Disclosure - COMMITMENTS (Service Agreements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-csad</Role>
      <ShortName>COMMITMENTS (Service Agreements) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>40202 - Disclosure - COMMITMENTS (Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-cld</Role>
      <ShortName>COMMITMENTS (Leases) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>40203 - Disclosure - COMMITMENTS (Research Grants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-crgd</Role>
      <ShortName>COMMITMENTS (Research Grants) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>40301 - Disclosure - FAIR VALUE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/Disclosure-FAIRVALUEDetails</Role>
      <ShortName>FAIR VALUE (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>40401 - Disclosure - MARKETABLE SECURITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-msd</Role>
      <ShortName>MARKETABLE SECURITIES (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>40501 - Disclosure - STOCK HOLDERS' EQUITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/Disclosure-STOCKHOLDERSEQUITYDetails</Role>
      <ShortName>STOCK HOLDERS' EQUITY (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>40601 - Disclosure - STOCK BASED COMPENSATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/Disclosure-STOCKBASEDCOMPENSATIONDetails</Role>
      <ShortName>STOCK BASED COMPENSATION (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>40701 - Disclosure - RELATED PARTIES - TRANSACTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/Disclosure-RELATEDPARTIES-TRANSACTIONSDetails</Role>
      <ShortName>RELATED PARTIES - TRANSACTIONS (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>40801 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.oramed.com/role/ormp-sed</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Element ormp_RoyaltyPercentage had a mix of decimals attribute values: 2 3.</Log>
    <Log type="Info">Columns in Cash Flows statement 'CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 180 days and at least 25 values. Shorter duration columns must have at least one fourth (6) as many values. Column '12/1/2013 - 2/28/2014' is shorter (89 days) and has only 2 values, so it is being removed.</Log>
    <Log type="Info">Columns in Cash Flows statement 'CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 180 days and at least 25 values. Shorter duration columns must have at least one fourth (6) as many values. Column '12/1/2014 - 2/28/2015' is shorter (89 days) and has only 2 values, so it is being removed.</Log>
    <Log type="Info">Process Flow-Through: 002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Feb. 28, 2014'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Aug. 31, 2013'</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</Log>
    <Log type="Info">Process Flow-Through: 007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</Log>
  </Logs>
  <InputFiles>
    <File>ormp-20150228.xml</File>
    <File>ormp-20150228.xsd</File>
    <File>ormp-20150228_cal.xml</File>
    <File>ormp-20150228_def.xml</File>
    <File>ormp-20150228_lab.xml</File>
    <File>ormp-20150228_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <title></title>
    <link rel="stylesheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else {
							e.nextSibling.style.display='none';
							}
							}</script></head>
  <body><span style="display: none;">v2.4.1.9</span><table class="report" border="0" cellspacing="2" id="ID0EIGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">6 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2015</div>
        </th>
        <th class="th">
          <div>Feb. 28, 2014</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>MARKETABLE SECURITIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_MarketableSecuritiesSold', window );">Number of shares sold</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="ormp_MarketableSecuritiesSold" onclick="toggleNextSibling(this);">0</a><span style="display:none;white-space:normal;text-align:left;">ormp_MarketableSecuritiesSold</span><span></span></td>
        <td class="nump"><a title="ormp_MarketableSecuritiesSold" onclick="toggleNextSibling(this);">1,625,989</a><span style="display:none;white-space:normal;text-align:left;">ormp_MarketableSecuritiesSold</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity', window );">Proceeds from sale of securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" onclick="toggleNextSibling(this);">$ 80</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ormp_MarketableSecuritiesOwnershipPercentage', window );">Ownership percentage</a></td>
        <td class="nump"><a title="ormp_MarketableSecuritiesOwnershipPercentage" onclick="toggleNextSibling(this);">9.80%</a><span style="display:none;white-space:normal;text-align:left;">ormp_MarketableSecuritiesOwnershipPercentage</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="ormp_MarketableSecuritiesOwnershipPercentage" onclick="toggleNextSibling(this);">9.80%</a><span style="display:none;white-space:normal;text-align:left;">ormp_MarketableSecuritiesOwnershipPercentage</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesEquityCost', window );">Cost of securities</a></td>
        <td class="nump"><a title="us-gaap_TradingSecuritiesEquityCost" onclick="toggleNextSibling(this);">595</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_TradingSecuritiesEquityCost</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_TradingSecuritiesEquityCost" onclick="toggleNextSibling(this);">595</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_TradingSecuritiesEquityCost</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump"><a title="us-gaap_TradingSecuritiesEquityCost" onclick="toggleNextSibling(this);">595</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_TradingSecuritiesEquityCost</span><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Amount reclassified to earnings</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump"><a title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" onclick="toggleNextSibling(this);">$ 26</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</span><span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump"><a title="us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" onclick="toggleNextSibling(this);">$ 44</a><span style="display:none;white-space:normal;text-align:left;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</span><span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_MarketableSecuritiesOwnershipPercentage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The percentage of ownership of common stock or equity participation in the investee accounted for as marketable securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_MarketableSecuritiesOwnershipPercentage</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ormp_MarketableSecuritiesSold">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of marketable securities sold.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">ormp_MarketableSecuritiesSold</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>ormp_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e689-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the sale of equity securities classified as available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesEquityCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cost of investments in equity securities and other forms of securities that provide ownership interests classified as trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td style="white-space:nowrap;">us-gaap_TradingSecuritiesEquityCost</td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
